1	The	DT	O	the	det	3	SENT_1	[p1l998t81r1035b103],
2	NEW	NNP	O	NEW	nn	3	SENT_1	[p1l1047t83r1127b103],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_1	[p1l1141t83r1316b103],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_1	[p1l1330t83r1496b110],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_1	[p1l1510t81r1726b109],

1	l	NN	O	l	_	0	SENT_2	[p1l662t187r664b312],
2	REVIEW	NNP	O	REVIEW	dep	1	SENT_2	[p1l1164t235r1346b261],
3	ARTICLE	NN	O	article	dep	1	SENT_2	[p1l1361t235r1560b261],
4	‘	CD	NUMBER	‘	num	3	SENT_2	[p1l2062t185r2065b312],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_3	[p1l1115t387r1374b410],
2	OF	IN	O	of	_	0	SENT_3	[p1l1392t387r1440b410],
3	DISEASE	NN	O	disease	prep_of	1	SENT_3	[p1l1459t387r1612b410],

1	Tyrosine	NN	O	tyrosine	nn	2	SENT_4	[p1l670t452r921b522],
2	Kinases	NNS	O	kinase	_	0	SENT_4	[p1l939t452r1166b508],
3	as	IN	O	as	_	0	SENT_4	[p1l1185t470r1244b506],
4	Targets	NNS	O	target	prep_as	2	SENT_4	[p1l1260t456r1476b522],
5	for	IN	O	for	_	0	SENT_4	[p1l1495t451r1580b507],
6	Cancer	NN	O	cancer	nn	7	SENT_4	[p1l1596t456r1802b507],
7	Therapy	NN	O	therapy	prep_for	2	SENT_4	[p1l1815t452r2059b522],

1	Daniela	NNP	PERSON	Daniela	nn	3	SENT_5	[p1l770t586r895b617],
2	S.	NNP	PERSON	S.	nn	3	SENT_5	[p1l910t589r937b617],
3	Krause	NNP	PERSON	Krause	_	0	SENT_5	[p1l954t589r1075b623],
4	,	,	O	,	_	0	SENT_5	[p1l954t589r1075b623],
5	M.D.	NNP	O	M.D.	conj_and	3	SENT_5	[p1l1093t589r1183b623],
6	,	,	O	,	_	0	SENT_5	[p1l1093t589r1183b623],
7	Ph.D.	NNP	O	Ph.D.	conj_and	3	SENT_5	[p1l1200t586r1299b623],
8	,	,	O	,	_	0	SENT_5	[p1l1200t586r1299b623],
9	and	CC	O	and	_	0	SENT_5	[p1l1314t586r1374b617],
10	Richard	NNP	PERSON	Richard	nn	13	SENT_5	[p1l1391t586r1515b617],
11	A.	NNP	PERSON	A.	nn	13	SENT_5	[p1l1529t588r1560b617],
12	Van	NNP	PERSON	Van	nn	13	SENT_5	[p1l1574t589r1634b618],
13	Etten	NNP	PERSON	Etten	conj_and	3	SENT_5	[p1l1651t589r1745b623],
14	,	,	O	,	_	0	SENT_5	[p1l1651t589r1745b623],
15	M.D.	NNP	O	M.D.	nn	17	SENT_5	[p1l1762t589r1852b623],
16	,	,	O	,	_	0	SENT_5	[p1l1762t589r1852b623],
17	Ph.D.	NNP	O	Ph.D.	appos	13	SENT_5	[p1l1869t586r1958b617],
18	.	.	O	.	_	0	SENT_5	[p1l1869t586r1958b617],

1	lnsﬂtute	NN	O	lnsﬂtute	_	0	SENT_6	[p1l91t742r196b801],
2	t	NN	O	t	nn	5	SENT_6	[p1l202t741r397b801],
3	(	NN	O	(	nn	5	SENT_6	[p1l202t741r397b801],
4	D	NN	O	d	nn	5	SENT_6	[p1l202t741r397b801],
5	|	NN	O	|	dep	1	SENT_6	[p1l202t741r397b801],
6	.	.	O	.	_	0	SENT_6	[p1l202t741r397b801],

1	s_l	NN	O	s_l	dep	2	SENT_7	[p1l202t741r397b801],
2	<	JJR	O	<	_	0	SENT_7	[p1l202t741r397b801],
3	.	.	O	.	_	0	SENT_7	[p1l202t741r397b801],

1	,	,	O	,	_	0	SENT_8	[p1l202t741r397b801],
2	oR_A	NN	O	or_a	_	0	SENT_8	[p1l202t741r397b801],
3	.	.	O	.	_	0	SENT_8	[p1l202t741r397b801],

1	?	.	O	?	_	0	SENT_9	[p1l202t741r397b801],

1	/	:	O	/	_	0	SENT_10	[p1l202t741r397b801],
2	.	.	O	.	_	0	SENT_10	[p1l202t741r397b801],
3	)	SYM	O	)	dep	1	SENT_10	[p1l202t741r397b801],

1	an	DT	O	a	_	0	SENT_11	[p1l412t740r457b801],
2	;	:	O	;	_	0	SENT_11	[p1l412t740r457b801],
3	rlrertoivistionf	NN	O	rlrertoivistionf	nn	4	SENT_11	[p1l469t740r629b801],
4	transfer	NN	O	transfer	dep	1	SENT_11	[p1l786t745r913b776],
5	of	IN	O	of	_	0	SENT_11	[p1l920t745r958b776],
6	phosphate	NN	O	phosphate	prep_of	4	SENT_11	[p1l958t745r1130b784],
7	from	IN	O	from	_	0	SENT_11	[p1l1137t745r1217b776],
8	ATP	NN	ORGANIZATION	atp	prep_from	6	SENT_11	[p1l1224t748r1291b775],
9	to	TO	O	to	_	0	SENT_11	[p1l1298t752r1328b776],
10	tyrosine	NN	O	tyrosine	nn	11	SENT_11	[p1l1337t746r1465b784],
11	residues	NNS	O	residue	prep_to	8	SENT_11	[p1l1473t745r1607b776],
12	in	IN	O	in	_	0	SENT_11	[p1l1615t746r1646b775],
13	polypeptides	NNS	O	polypeptide	prep_in	11	SENT_11	[p1l1653t745r1869b784],
14	.	.	O	.	_	0	SENT_11	[p1l1653t745r1869b784],

1	The	DT	O	the	det	5	SENT_12	[p1l1878t745r1940b776],
2	human	JJ	O	human	amod	5	SENT_12	[p1l1948t745r2063b776],
3	o	NN	O	o	nn	5	SENT_12	[p1l89t786r103b801],
4	ema	NN	O	ema	nn	5	SENT_12	[p1l147t786r201b801],
5	o	NN	O	o	nsubj	11	SENT_12	[p1l213t786r227b801],
6	og	NN	O	og	nn	10	SENT_12	[p1l237t786r297b809],
7	)	CD	NUMBER	)	num	10	SENT_12	[p1l237t786r297b809],
8	’	CD	NUMBER	’	num	10	SENT_12	[p1l237t786r297b809],
9	NCO	NNP	O	NCO	nn	10	SENT_12	[p1l323t786r367b801],
10	Og	NNP	O	Og	dep	5	SENT_12	[p1l377t786r424b809],
11	)	VBD	O	)	dep	29	SENT_12	[p1l377t786r424b809],
12	’	CD	NUMBER	’	dobj	11	SENT_12	[p1l377t786r424b809],
13	,	,	O	,	_	0	SENT_12	[p1l377t786r424b809],
14	epa	FW	O	epa	appos	12	SENT_12	[p1l458t786r502b808],
15	men	NNS	O	man	nn	16	SENT_12	[p1l526t786r580b801],
16	o	NN	O	o	dep	14	SENT_12	[p1l601t786r616b801],
17	. . .	CD	NUMBER	. . .	num	18	SENT_12	[p1l1925t796r1930b801],[p1l1017t796r1022b801],
18	Medicine	NNP	O	Medicine	tmod	11	SENT_12	[p1l91t815r207b839],
19	(	CD	NUMBER	(	num	18	SENT_12	[p1l234t817r266b846],
20	R.	NNP	O	R.	nn	21	SENT_12	[p1l234t817r266b846],
21	A_V	NNP	O	A_V	nsubj	22	SENT_12	[p1l268t817r315b839],
22	_	VBD	O	_	rcmod	18	SENT_12	[p1l268t817r315b839],
23	)	CD	NUMBER	)	number	24	SENT_12	[p1l318t817r334b846],
24	1	CD	NUMBER	1	num	26	SENT_12	[p1l318t817r334b846],
25	Tuns_N	NN	O	tuns_n	nn	26	SENT_12	[p1l359t815r458b839],
26	ew	NN	O	ew	dobj	22	SENT_12	[p1l463t823r497b839],
27	England	NNP	LOCATION	England	nn	28	SENT_12	[p1l523t815r623b846],
28	genome	NN	O	genome	dep	18	SENT_12	[p1l785t805r916b835],
29	contains	VBZ	O	contain	_	0	SENT_12	[p1l923t802r1062b851],
30	about	IN	O	about	_	0	SENT_12	[p1l1070t795r1164b851],
31	90	CD	NUMBER	90	num	32	SENT_12	[p1l1170t798r1209b826],
32	TIC	NN	O	tic	prep_about	29	SENT_12	[p1l1216t798r1266b851],
33	and	CC	O	and	_	0	SENT_12	[p1l1272t795r1332b826],
34	43:5	CD	NUMBER	43:5	num	35	SENT_12	[p1l1340t798r1378b851],
35	TK	NN	O	tk	conj_and	32	SENT_12	[p1l1386t795r1504b851],
36	—	CD	NUMBER	—	num	37	SENT_12	[p1l1386t795r1504b851],
37	lil	NN	O	lil	dep	38	SENT_12	[p1l1386t795r1504b851],
38	<	JJR	O	<	dobj	29	SENT_12	[p1l1386t795r1504b851],
39	e	SYM	O	e	dep	38	SENT_12	[p1l1386t795r1504b851],
40	genes	NNS	O	gene	nsubj	29	SENT_12	[p1l1512t805r1613b851],
41	,	,	O	,	_	0	SENT_12	[p1l1512t805r1613b851],
42	the	DT	O	the	det	43	SENT_12	[p1l1624t795r1673b826],
43	products	NNS	O	product	appos	40	SENT_12	[p1l1681t795r1823b851],
44	of	IN	O	of	_	0	SENT_12	[p1l1832t795r1871b826],
45	which	WDT	O	which	prep_of	43	SENT_12	[p1l1871t795r1970b826],
46	reguMedical	NNP	O	reguMedical	nn	49	SENT_12	[p1l1978t805r2063b835, p1l91t853r188b876],
47	Center	NNP	O	Center	nn	49	SENT_12	[p1l205t854r292b880],
48	,	,	O	,	_	0	SENT_12	[p1l205t854r292b880],
49	Boston	NNP	LOCATION	Boston	dep	43	SENT_12	[p1l310t855r405b876],
50	.	.	O	.	_	0	SENT_12	[p1l310t855r405b876],

1	Address	NN	O	address	nsubj	2	SENT_13	[p1l420t853r524b876],
2	reprint	VB	O	reprint	_	0	SENT_13	[p1l541t855r625b883],
3	late	JJ	O	late	amod	5	SENT_13	[p1l664t845r720b876],
4	cellular	JJ	O	cellular	amod	5	SENT_13	[p1l729t845r847b876],
5	proliferation	NN	O	proliferation	dobj	2	SENT_13	[p1l854t845r1066b884],
6	,	,	O	,	_	0	SENT_13	[p1l854t845r1066b884],
7	survival	NN	O	survival	appos	5	SENT_13	[p1l1078t845r1210b883],
8	,	,	O	,	_	0	SENT_13	[p1l1078t845r1210b883],
9	differentiation	NN	O	differentiation	appos	5	SENT_13	[p1l1221t845r1466b883],
10	,	,	O	,	_	0	SENT_13	[p1l1221t845r1466b883],
11	function	NN	O	function	appos	5	SENT_13	[p1l1477t845r1625b882],
12	,	,	O	,	_	0	SENT_13	[p1l1477t845r1625b882],
13	and	CC	O	and	_	0	SENT_13	[p1l1635t845r1696b876],
14	motility	NN	O	motility	appos	5	SENT_13	[p1l1705t845r1837b884],
15	.	.	O	.	_	0	SENT_13	[p1l1705t845r1837b884],

1	More	JJR	O	more	mwe	2	SENT_14	[p1l1847t848r1933b876],
2	than	IN	O	than	quantmod	4	SENT_14	[p1l1942t845r2015b876],
3	25	CD	NUMBER	25	number	4	SENT_14	[p1l2024t848r2062b876],
4	“	CD	NUMBER	“	num	5	SENT_14	[p1l90t895r197b921],
5	quests	NNS	O	quest	_	0	SENT_14	[p1l90t895r197b921],
6	t	NN	O	t	dep	5	SENT_14	[p1l213t895r238b914],
7	°	NN	O	°	dep	6	SENT_14	[p1l213t895r238b914],
8	'	''	O	'	_	0	SENT_14	[p1l256t892r289b933],
9	?	.	O	?	_	0	SENT_14	[p1l256t892r289b933],

1	’	SYM	O	’	dep	5	SENT_15	[p1l256t892r289b933],
2	-	:	O	-	_	0	SENT_15	[p1l256t892r289b933],
3	V3	NN	O	v3	nn	5	SENT_15	[p1l305t892r351b914],
4	”	CD	NUMBER	”	num	5	SENT_15	[p1l305t892r351b914],
5	Elle	NNP	PERSON	Elle	_	0	SENT_15	[p1l370t892r433b914],
6	”	CD	NUMBER	”	number	7	SENT_15	[p1l370t892r433b914],
7	3	CD	NUMBER	3	nsubjpass	22	SENT_15	[p1l451t895r473b914],
8	‘	NN	O	‘	nn	10	SENT_15	[p1l451t895r473b914],
9	T	NN	O	t	nn	10	SENT_15	[p1l488t890r625b933],
10	”	NN	O	”	dep	7	SENT_15	[p1l488t890r625b933],
11	&	CC	O	&	_	0	SENT_15	[p1l488t890r625b933],
12	5	CD	NUMBER	5	num	13	SENT_15	[p1l488t890r625b933],
13	_	NN	O	_	nsubjpass	22	SENT_15	[p1l488t890r625b933],
14	‘	CD	NUMBER	‘	num	15	SENT_15	[p1l488t890r625b933],
15	Ne	NN	O	ne	tmod	13	SENT_15	[p1l488t890r625b933],
16	‘”	CD	NUMBER	‘”	num	17	SENT_15	[p1l488t890r625b933],
17	years	NNS	DATE	year	npadvmod	18	SENT_15	[p1l663t906r746b934],
18	ago	RB	DATE	ago	advmod	15	SENT_15	[p1l756t905r823b935],
19	,	,	O	,	_	0	SENT_15	[p1l756t905r823b935],
20	TKs	NNS	O	tk	appos	7	SENT_15	[p1l833t898r897b927],
21	were	VBD	O	be	auxpass	22	SENT_15	[p1l905t906r982b926],
22	implicated	VBN	O	implicate	rcmod	5	SENT_15	[p1l991t895r1162b934],
23	as	IN	O	as	_	0	SENT_15	[p1l1171t906r1203b926],
24	oncogenes	NNS	O	oncogene	prep_as	22	SENT_15	[p1l1213t905r1386b935],
25	in	IN	O	in	_	0	SENT_15	[p1l1395t896r1427b926],
26	animal	NN	O	animal	nn	27	SENT_15	[p1l1435t896r1546b926],
27	tumors	NNS	O	tumor	prep_in	24	SENT_15	[p1l1556t902r1671b926],
28	induced	VBN	O	induce	partmod	27	SENT_15	[p1l1680t895r1809b926],
29	by	IN	O	by	_	0	SENT_15	[p1l1819t896r1856b934],
30	retroviruses	NNS	O	retrovirus	agent	28	SENT_15	[p1l1863t896r2061b926],
31	.	.	O	.	_	0	SENT_15	[p1l1863t896r2061b926],

1	England	NNP	ORGANIZATION	England	nn	3	SENT_16	[p1l91t928r192b959],
2	Medical	NNP	ORGANIZATION	Medical	nn	3	SENT_16	[p1l206t928r304b951],
3	Center	NNP	ORGANIZATION	Center	_	0	SENT_16	[p1l317t929r403b956],
4	,	,	O	,	_	0	SENT_16	[p1l317t929r403b956],
5	750	CD	NUMBER	750	num	7	SENT_16	[p1l417t929r461b951],
6	Washington	NNP	LOCATION	Washington	nn	7	SENT_16	[p1l471t928r623b959],
7	HO	NNP	O	HO	appos	3	SENT_16	[p1l664t948r713b976],
8	th	DT	O	th	det	9	SENT_16	[p1l830t946r862b976],
9	I	PRP	O	I	dep	7	SENT_16	[p1l998t946r1008b976],
10	I	PRP	O	I	dep	7	SENT_16	[p1l1081t946r1090b976],
11	.	.	O	.	_	0	SENT_16	[p1l1122t946r1127b951],

1	o	NN	O	o	nsubj	2	SENT_17	[p1l1174t955r1192b976],
2	d	NN	O	d	_	0	SENT_17	[p1l1227t946r1247b976],
3	.	.	O	.	_	0	SENT_17	[p1l1262t946r1267b951],

1	d	NN	O	d	nn	2	SENT_18	[p1l1304t946r1323b976],
2	d	NN	O	d	_	0	SENT_18	[p1l1393t946r1412b976],
3	10	CD	NUMBER	10	num	5	SENT_18	[p1l1466t946r1496b976],
4	t	NN	O	t	nn	5	SENT_18	[p1l1594t952r1606b976],
5	b	NN	O	b	dep	2	SENT_18	[p1l1617t946r1636b976],
6	of	IN	O	of	prep	5	SENT_18	[p1l1759t945r1798b976],
7	.	.	O	.	_	0	SENT_18	[p1l1914t946r1918b951],

1	of	IN	O	of	_	0	SENT_19	[p1l1962t945r2001b976],
2	.	.	O	.	_	0	SENT_19	[p1l2043t946r2063b967],

1	_	CD	NUMBER	_	num	2	SENT_20	[p1l2043t946r2063b967],
2	St.	NNP	O	St.	nsubj	26	SENT_20	[p1l89t967r128b993],
3	’	CD	NUMBER	’	num	2	SENT_20	[p1l89t967r128b993],
4	BOX	NNP	O	BOX	nsubj	21	SENT_20	[p1l146t967r191b989],
5	5609	CD	DATE	5609	num	4	SENT_20	[p1l206t967r273b993],
6	,	,	O	,	_	0	SENT_20	[p1l206t967r273b993],
7	Boston	NNP	LOCATION	Boston	nn	9	SENT_20	[p1l291t967r386b993],
8	,	,	O	,	_	0	SENT_20	[p1l291t967r386b993],
9	MA	NNP	LOCATION	MA	appos	4	SENT_20	[p1l405t967r448b989],
10	02111	CD	DATE	02111	number	11	SENT_20	[p1l462t967r545b993],
11	’	CD	NUMBER	’	dep	9	SENT_20	[p1l462t967r545b993],
12	or	CC	O	or	_	0	SENT_20	[p1l562t974r588b989],
13	at	IN	O	at	advmod	9	SENT_20	[p1l603t970r625b989],
14	wever	NN	O	wever	appos	4	SENT_20	[p1l713t956r815b983],
15	,	,	O	,	_	0	SENT_20	[p1l713t956r815b983],
16	ey	NN	O	ey	appos	14	SENT_20	[p1l864t956r898b984],
17	were	VBD	O	be	cop	21	SENT_20	[p1l908t956r986b1001],
18	arge	FW	O	arge	nn	21	SENT_20	[p1l1009t956r1080b1001],
19	y	FW	O	y	nn	21	SENT_20	[p1l1090t956r1108b984],
20	ign	FW	O	ign	nn	21	SENT_20	[p1l1119t956r1172b985],
21	re	FW	O	re	rcmod	2	SENT_20	[p1l1195t956r1225b976],
22	in	IN	O	in	_	0	SENT_20	[p1l1259t956r1291b976],
23	rug	NN	O	rug	nn	25	SENT_20	[p1l1325t956r1381b985],
24	eve	NN	O	eve	nn	25	SENT_20	[p1l1414t956r1464b976],
25	pmen	NNS	O	pman	prep_in	21	SENT_20	[p1l1497t956r1592b985],
26	ecause	VBP	O	ecause	_	0	SENT_20	[p1l1638t956r1746b976],
27	a	DT	O	a	det	30	SENT_20	[p1l1803t956r1820b976],
28	paucity	NN	O	paucity	nn	30	SENT_20	[p1l1832t952r1951b1001],
29	evi	NN	O	evus	nn	30	SENT_20	[p1l2007t956r2050b976],
30	rvanetten@tufts-nerneorg	NN	O	rvanetten@tufts-nerneorg	dobj	26	SENT_20	[p1l90t1002r438b1033],
31	.	.	O	.	_	0	SENT_20	[p1l90t1002r438b1033],

1	dence	NN	O	dence	_	0	SENT_21	[p1l665t995r759b1026],
2	for	IN	O	for	_	0	SENT_21	[p1l767t995r815b1026],
3	a	DT	O	a	det	5	SENT_21	[p1l822t1005r839b1026],
4	causative	JJ	O	causative	amod	5	SENT_21	[p1l847t1002r994b1026],
5	role	NN	O	role	prep_for	1	SENT_21	[p1l1002t995r1065b1026],
6	in	IN	O	in	_	0	SENT_21	[p1l1073t1005r1104b1025],
7	human	JJ	O	human	amod	8	SENT_21	[p1l1112t995r1229b1026],
8	cancer	NN	O	cancer	prep_in	5	SENT_21	[p1l1237t1005r1344b1026],
9	and	CC	O	and	_	0	SENT_21	[p1l1351t995r1411b1026],
10	concerns	NNS	O	concern	conj_and	8	SENT_21	[p1l1419t1005r1566b1026],
11	about	IN	O	about	_	0	SENT_21	[p1l1575t995r1670b1026],
12	drug	NN	O	drug	nn	13	SENT_21	[p1l1676t995r1754b1034],
13	speciﬁcity	NN	O	speciﬁcity	prep_about	1	SENT_21	[p1l1761t995r1925b1034],
14	and	CC	O	and	_	0	SENT_21	[p1l1932t995r1992b1026],
15	toxicity	NN	O	toxicity	conj_and	13	SENT_21	[p1l2000t1002r2063b1026, p1l664t1046r736b1084],
16	.	.	O	.	_	0	SENT_21	[p1l2000t1002r2063b1026, p1l664t1046r736b1084],

1	The	DT	O	the	det	2	SENT_22	[p1l746t1045r809b1076],
2	landscape	NN	O	landscape	nsubjpass	4	SENT_22	[p1l817t1045r984b1084],
3	was	VBD	O	be	auxpass	4	SENT_22	[p1l992t1055r1055b1076],
4	changed	VBN	O	change	_	0	SENT_22	[p1l1066t1045r1207b1084],
5	radically	RB	O	radically	advmod	4	SENT_22	[p1l1217t1045r1359b1084],
6	by	IN	O	by	_	0	SENT_22	[p1l1367t1045r1405b1084],
7	the	DT	O	the	det	8	SENT_22	[p1l1413t1045r1464b1076],
8	success	NN	O	success	agent	4	SENT_22	[p1l1474t1055r1598b1076],
9	of	IN	O	of	_	0	SENT_22	[p1l1609t1045r1648b1076],
10	imatinib	NN	O	imatinib	nn	11	SENT_22	[p1l1651t1045r1792b1076],
11	mesylate	NN	O	mesylate	prep_of	8	SENT_22	[p1l1802t1045r1957b1084],
12	,	,	O	,	_	0	SENT_22	[p1l1802t1045r1957b1084],
13	an	DT	O	a	det	14	SENT_22	[p1l1968t1055r2008b1076],
14	inhibitor	NN	O	inhibitor	appos	11	SENT_22	[p1l2017t1046r2062b1075, p1l664t1095r779b1126],
15	of	IN	O	of	_	0	SENT_22	[p1l789t1095r828b1126],
16	the	DT	O	the	det	17	SENT_22	[p1l832t1095r883b1126],
17	BCR	NN	O	bcr	prep_of	14	SENT_22	[p1l893t1097r1047b1128],
18	.	.	O	.	_	0	SENT_22	[p1l893t1097r1047b1128],

1	—	NN	O	—	_	0	SENT_23	[p1l893t1097r1047b1128],
2	.	.	O	.	_	0	SENT_23	[p1l893t1097r1047b1128],

1	ABL	NNP	ORGANIZATION	ABL	nn	2	SENT_24	[p1l893t1097r1047b1128],
2	TK	NN	O	tk	nsubj	8	SENT_24	[p1l1055t1098r1105b1126],
3	in	IN	O	in	_	0	SENT_24	[p1l1113t1096r1145b1125],
4	chronic	JJ	O	chronic	amod	7	SENT_24	[p1l1155t1095r1279b1126],
5	myeloid	JJ	O	myeloid	amod	7	SENT_24	[p1l1288t1095r1419b1134],
6	leukemia	NN	O	leukemia	nn	7	SENT_24	[p1l1428t1095r1578b1126],
7	(	NN	O	(	prep_in	2	SENT_24	[p1l1589t1097r1690b1130],
8	CML	NN	ORGANIZATION	cml	_	0	SENT_24	[p1l1589t1097r1690b1130],
9	)	CD	NUMBER	)	number	10	SENT_24	[p1l1589t1097r1690b1130],
10	—	CD	NUMBER	—	dobj	8	SENT_24	[p1l1700t1113r1742b1116],
11	a	DT	O	a	det	12	SENT_24	[p1l1750t1105r1767b1126],
12	result	NN	O	result	nsubj	13	SENT_24	[p1l1776t1095r1870b1126],
13	heralded	VBD	O	herald	rcmod	10	SENT_24	[p1l1878t1095r2020b1126],
14	as	IN	O	as	_	0	SENT_24	[p1l2030t1105r2062b1126],
15	a	DT	O	a	det	17	SENT_24	[p1l664t1155r681b1176],
16	proof	NN	O	proof	nn	17	SENT_24	[p1l689t1145r987b1184],
17	—	NN	O	—	prep_as	13	SENT_24	[p1l689t1145r987b1184],
18	of	IN	O	of	_	0	SENT_24	[p1l689t1145r987b1184],
19	—	CD	NUMBER	—	num	20	SENT_24	[p1l689t1145r987b1184],
20	principle	NN	O	principle	prep_of	17	SENT_24	[p1l689t1145r987b1184],
21	and	CC	O	and	_	0	SENT_24	[p1l995t1145r1056b1176],
22	a	DT	O	a	det	23	SENT_24	[p1l1064t1155r1081b1176],
23	triumph	NN	O	triumph	prep_as	13	SENT_24	[p1l1089t1145r1224b1184],
24	of	IN	O	of	_	0	SENT_24	[p1l1233t1145r1272b1176],
25	targeted	VBN	O	target	amod	27	SENT_24	[p1l1273t1145r1407b1184],
26	cancer	NN	O	cancer	nn	27	SENT_24	[p1l1416t1155r1523b1176],
27	therapy	NN	O	therapy	prep_of	23	SENT_24	[p1l1530t1145r1657b1184],
28	.	.	O	.	_	0	SENT_24	[p1l1530t1145r1657b1184],

1	TKs	NNS	O	tk	nsubjpass	4	SENT_25	[p1l1667t1147r1732b1176],
2	are	VBP	O	be	auxpass	4	SENT_25	[p1l1741t1155r1790b1176],
3	now	RB	DATE	now	advmod	4	SENT_25	[p1l1798t1155r1870b1176],
4	regarded	VBN	O	regard	_	0	SENT_25	[p1l1876t1145r2021b1184],
5	as	IN	O	as	_	0	SENT_25	[p1l2030t1155r2062b1176],
6	excellent	JJ	O	excellent	amod	7	SENT_25	[p1l665t1195r810b1226],
7	targets	NNS	O	target	prep_as	4	SENT_25	[p1l819t1202r929b1234],
8	for	IN	O	for	_	0	SENT_25	[p1l941t1195r989b1226],
9	cancer	NN	O	cancer	nn	10	SENT_25	[p1l999t1205r1106b1226],
10	chemotherapy	NN	O	chemotherapy	prep_for	7	SENT_25	[p1l1116t1195r1356b1234],
11	,	,	O	,	_	0	SENT_25	[p1l1116t1195r1356b1234],
12	but	CC	O	but	_	0	SENT_25	[p1l1369t1195r1424b1226],
13	reality	NN	O	reality	nsubj	14	SENT_25	[p1l1433t1195r1533b1234],
14	lies	VBZ	O	lie	conj_but	4	SENT_25	[p1l1542t1195r1596b1226],
15	somewhere	RB	O	somewhere	advmod	14	SENT_25	[p1l1609t1195r1796b1226],
16	between	IN	O	between	_	0	SENT_25	[p1l1808t1195r1943b1226],
17	the	DT	O	the	det	18	SENT_25	[p1l1954t1195r2005b1226],
18	extremes	NNS	O	extreme	prep_between	14	SENT_25	[p1l2016t1205r2063b1226, p1l664t1251r775b1275],
19	of	IN	O	of	_	0	SENT_25	[p1l787t1244r826b1275],
20	triumph	NN	O	triumph	prep_of	18	SENT_25	[p1l831t1244r966b1283],
21	and	CC	O	and	_	0	SENT_25	[p1l977t1244r1037b1275],
22	tribulation	NN	O	tribulation	prep_of	18	SENT_25	[p1l1049t1244r1232b1275],
23	.	.	O	.	_	0	SENT_25	[p1l1049t1244r1232b1275],

1	In	IN	O	in	_	0	SENT_26	[p1l1245t1247r1279b1274],
2	this	DT	O	this	det	3	SENT_26	[p1l1290t1244r1350b1275],
3	article	NN	O	article	prep_in	6	SENT_26	[p1l1362t1244r1462b1275],
4	we	PRP	O	we	nsubj	20	SENT_26	[p1l1472t1254r1518b1275],
5	will	MD	O	will	aux	6	SENT_26	[p1l1528t1244r1589b1275],
6	review	VB	O	review	_	0	SENT_26	[p1l1600t1245r1706b1275],
7	mechanisms	NNS	O	mechanism	dobj	6	SENT_26	[p1l1716t1244r1923b1275],
8	of	IN	O	of	_	0	SENT_26	[p1l1936t1244r1975b1275],
9	aberrant	JJ	O	aberrant	amod	11	SENT_26	[p1l1979t1244r2063b1275, p1l664t1300r732b1324],
10	TK	NN	O	tk	nn	11	SENT_26	[p1l744t1296r794b1324],
11	signaling	NN	O	signaling	prep_of	7	SENT_26	[p1l809t1293r962b1332],
12	and	CC	O	and	_	0	SENT_26	[p1l976t1293r1036b1324],
13	strategies	NNS	O	strategy	prep_of	7	SENT_26	[p1l1053t1294r1207b1332],
14	to	TO	O	to	aux	15	SENT_26	[p1l1224t1300r1255b1324],
15	inhibit	VB	O	inhibit	xcomp	6	SENT_26	[p1l1271t1293r1382b1324],
16	TKs	NN	O	tk	dobj	15	SENT_26	[p1l1394t1296r1459b1324],
17	in	IN	O	in	_	0	SENT_26	[p1l1475t1294r1507b1323],
18	cancer	NN	O	cancer	prep_in	15	SENT_26	[p1l1522t1303r1635b1330],
19	,	,	O	,	_	0	SENT_26	[p1l1522t1303r1635b1330],
20	summarize	VBP	O	summarize	conj_and	6	SENT_26	[p1l1654t1294r1837b1324],
21	the	DT	O	the	det	22	SENT_26	[p1l1853t1293r1903b1324],
22	status	NN	O	status	nsubj	26	SENT_26	[p1l1919t1300r2015b1324],
23	of	IN	O	of	_	0	SENT_26	[p1l2031t1293r2070b1324],
24	TK	NN	O	tk	nn	25	SENT_26	[p1l663t1342r856b1373],
25	—	NN	O	—	prep_of	22	SENT_26	[p1l663t1342r856b1373],
26	directed	VBD	O	direct	ccomp	20	SENT_26	[p1l663t1342r856b1373],
27	cancer	NN	O	cancer	nn	28	SENT_26	[p1l865t1352r972b1373],
28	therapies	NNS	O	therapy	dobj	26	SENT_26	[p1l981t1342r1140b1381],
29	,	,	O	,	_	0	SENT_26	[p1l981t1342r1140b1381],
30	and	CC	O	and	_	0	SENT_26	[p1l1151t1342r1212b1373],
31	discuss	VBP	O	discuss	conj_and	6	SENT_26	[p1l1222t1342r1340b1373],
32	challenges	NNS	O	challenge	dobj	31	SENT_26	[p1l1351t1342r1524b1381],
33	and	CC	O	and	_	0	SENT_26	[p1l1534t1342r1594b1373],
34	prospects	NNS	O	prospects	conj_and	32	SENT_26	[p1l1603t1349r1761b1381],
35	for	IN	O	for	_	0	SENT_26	[p1l1771t1342r1819b1373],
36	the	DT	O	the	det	37	SENT_26	[p1l1828t1342r1878b1373],
37	ﬁiture	NN	O	ﬁiture	prep_for	31	SENT_26	[p1l1888t1342r1995b1373],
38	.	.	O	.	_	0	SENT_26	[p1l1888t1342r1995b1373],

1	From	IN	O	from	_	0	SENT_27	[p1l91t704r154b726],
2	the	DT	O	the	det	6	SENT_27	[p1l171t702r210b726],
3	Molecular	JJ	ORGANIZATION	molecular	amod	6	SENT_27	[p1l229t702r356b726],
4	Oncology	NNP	ORGANIZATION	Oncology	nn	6	SENT_27	[p1l371t702r494b733],
5	Research	NNP	ORGANIZATION	Research	nn	6	SENT_27	[p1l511t702r624b726],
6	P	NN	O	p	prep_from	10	SENT_27	[p1l664t699r770b824],
7	ROTEIN	NNP	O	ROTEIN	nn	9	SENT_27	[p1l787t704r924b726],
8	TYROSINE	NNP	O	TYROSINE	nn	9	SENT_27	[p1l944t704r1121b726],
9	KINASES	NNP	O	KINASES	nsubj	10	SENT_27	[p1l1142t704r1291b726],
10	(	VBD	O	(	_	0	SENT_27	[p1l1314t698r1396b731],
11	TKs	NNS	O	tk	dobj	10	SENT_27	[p1l1314t698r1396b731],
12	)	CD	NUMBER	)	nsubj	14	SENT_27	[p1l1314t698r1396b731],
13	ARE	VBP	O	be	cop	14	SENT_27	[p1l1416t704r1485b726],
14	ENZYMES	NNS	O	enzyme	rcmod	11	SENT_27	[p1l1507t704r1669b726],
15	THAT	WDT	O	that	nsubj	16	SENT_27	[p1l1688t704r1783b725],
16	CATALYZE	VBP	O	catalyze	rcmod	14	SENT_27	[p1l1803t704r1971b726],
17	THE	DT	O	the	dobj	16	SENT_27	[p1l1990t704r2063b725],

1	N	NN	O	n	nn	2	SENT_28	[p1l91t1079r108b1101],
2	EI	NN	O	eus	dep	5	SENT_28	[p1l122t1077r190b1108],
3	'	''	O	'	_	0	SENT_28	[p1l122t1077r190b1108],
4	lglJ	NN	O	lglj	nsubj	5	SENT_28	[p1l122t1077r190b1108],
5	Med	VBD	O	med	_	0	SENT_28	[p1l203t1077r257b1101],
6	2005	CD	DATE	2005	dobj	5	SENT_28	[p1l267t1079r484b1105],
7	;	:	O	;	_	0	SENT_28	[p1l267t1079r484b1105],
8	353:172	CD	NUMBER	353:172	num	9	SENT_28	[p1l267t1079r484b1105],
9	-87	CD	NUMBER	-87	dep	6	SENT_28	[p1l267t1079r484b1105],
10	.	.	O	.	_	0	SENT_28	[p1l267t1079r484b1105],

1	Copyright	NN	O	copyright	_	0	SENT_29	[p1l89t1119r182b1144],
2	©	CD	NUMBER	©	num	6	SENT_29	[p1l190t1121r211b1142],
3	2005	CD	DATE	2005	num	6	SENT_29	[p1l220t1120r269b1138],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_29	[p1l277t1119r417b1138],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_29	[p1l425t1119r502b1138],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_29	[p1l509t1120r580b1144],
7	.	.	O	.	_	0	SENT_29	[p1l509t1120r580b1144],

1	TK	NN	O	tk	_	0	SENT_30	[p1l966t1479r1020b1502],
2	REGULATION	NN	O	regulation	dep	1	SENT_30	[p1l1039t1479r1343b1509],
3	,	,	O	,	_	0	SENT_30	[p1l1039t1479r1343b1509],
4	DYSREGULATION	NN	O	dysregulation	appos	2	SENT_30	[p1l1366t1479r1753b1509],
5	,	,	O	,	_	0	SENT_30	[p1l1366t1479r1753b1509],
6	AND	CC	O	and	_	0	SENT_30	[p1l1010t1526r1103b1549],
7	THERAPEUTIC	NNP	O	THERAPEUTIC	nn	8	SENT_30	[p1l1122t1526r1433b1549],
8	TARGETING	NNP	O	TARGETING	conj_and	2	SENT_30	[p1l1452t1526r1711b1549],

1	REGULATION	NN	O	regulation	nn	4	SENT_31	[p1l666t1614r873b1634],
2	or	CC	O	or	_	0	SENT_31	[p1l891t1614r931b1634],
3	NORMAL	NN	O	normal	nn	4	SENT_31	[p1l949t1614r1087b1634],
4	TK	NN	O	tk	nsubj	13	SENT_31	[p1l1100t1614r1137b1634],
5	ACTIVITY	NN	O	activity	nn	6	SENT_31	[p1l1152t1614r1296b1634],
6	TKs	NNS	O	tk	nsubjpass	8	SENT_31	[p1l663t1655r728b1684],
7	are	VBP	O	be	auxpass	8	SENT_31	[p1l739t1663r788b1683],
8	divided	VBN	O	divide	rcmod	4	SENT_31	[p1l799t1653r917b1683],
9	into	IN	O	into	_	0	SENT_31	[p1l928t1653r992b1683],
10	two	CD	NUMBER	two	num	12	SENT_31	[p1l1003t1659r1062b1684],
11	main	JJ	O	main	amod	12	SENT_31	[p1l1073t1653r1157b1683],
12	classes	NNS	O	class	prep_into	8	SENT_31	[p1l1167t1653r1279b1683],
13	(	VBP	O	(	_	0	SENT_31	[p1l1293t1653r1364b1692],
14	Fig	NN	O	fig	dobj	13	SENT_31	[p1l1293t1653r1364b1692],
15	.	.	O	.	_	0	SENT_31	[p1l1293t1653r1364b1692],

1	1	CD	NUMBER	1	_	0	SENT_32	[p1l1378t1655r1418b1688],
2	)	NN	O	)	dep	1	SENT_32	[p1l1378t1655r1418b1688],
3	.	.	O	.	_	0	SENT_32	[p1l1378t1655r1418b1688],

1	Receptor	NN	O	receptor	nn	2	SENT_33	[p1l1430t1655r1578b1692],
2	TKs	NNS	O	tk	nsubj	5	SENT_33	[p1l1586t1655r1651b1684],
3	are	VBP	O	be	cop	5	SENT_33	[p1l1662t1663r1711b1683],
4	transmembrane	JJ	O	transmembrane	amod	5	SENT_33	[p1l1722t1653r1984b1683],
5	proteins	NNS	O	protein	_	0	SENT_33	[p1l1994t1663r2063b1692, p1l664t1702r742b1732],
6	with	IN	O	with	_	0	SENT_33	[p1l754t1702r828b1732],
7	a	DT	O	a	det	10	SENT_33	[p1l840t1712r857b1732],
8	ligand-binding	JJ	O	ligand-binding	amod	10	SENT_33	[p1l869t1702r1122b1741],
9	extracellular	JJ	O	extracellular	amod	10	SENT_33	[p1l1133t1702r1340b1732],
10	domain	NN	O	domain	prep_with	5	SENT_33	[p1l1351t1702r1479b1732],
11	and	CC	O	and	_	0	SENT_33	[p1l1491t1702r1552b1732],
12	a	DT	O	a	det	16	SENT_33	[p1l1564t1712r1581b1732],
13	catalytic	JJ	O	catalytic	amod	16	SENT_33	[p1l1593t1702r1729b1741],
14	intracellular	JJ	O	intracellular	amod	16	SENT_33	[p1l1741t1702r1945b1732],
15	kinase	NN	O	kinase	nn	16	SENT_33	[p1l1956t1702r2063b1733],
16	domain	NN	O	domain	conj_and	10	SENT_33	[p1l665t1751r802b1788],
17	,	,	O	,	_	0	SENT_33	[p1l665t1751r802b1788],
18	whereas	IN	O	whereas	mark	21	SENT_33	[p1l812t1751r947b1782],
19	nonreceptor	NN	O	nonreceptor	nn	20	SENT_33	[p1l957t1758r1159b1790],
20	TKs	NNS	O	tk	nsubjpass	26	SENT_33	[p1l1166t1754r1231b1783],
21	lack	VBP	O	lack	advcl	5	SENT_33	[p1l1240t1751r1308b1782],
22	transmembrane	JJ	O	transmembrane	amod	23	SENT_33	[p1l1316t1751r1577b1782],
23	domains	NNS	O	domain	dobj	21	SENT_33	[p1l1587t1751r1728b1782],
24	and	CC	O	and	_	0	SENT_33	[p1l1738t1751r1799b1782],
25	are	VBP	O	be	auxpass	26	SENT_33	[p1l1808t1761r1857b1782],
26	found	VBN	O	find	conj_and	21	SENT_33	[p1l1866t1751r1963b1782],
27	in	IN	O	in	_	0	SENT_33	[p1l1972t1752r2004b1781],
28	the	DT	O	the	det	29	SENT_33	[p1l2013t1751r2063b1782],
29	cytosol	NN	O	cytosol	prep_in	26	SENT_33	[p1l665t1800r787b1839],
30	,	,	O	,	_	0	SENT_33	[p1l665t1800r787b1839],
31	the	DT	O	the	det	32	SENT_33	[p1l798t1800r848b1831],
32	nucleus	NN	O	nucleus	prep_in	26	SENT_33	[p1l857t1800r992b1837],
33	,	,	O	,	_	0	SENT_33	[p1l857t1800r992b1837],
34	and	CC	O	and	_	0	SENT_33	[p1l1002t1800r1062b1831],
35	the	DT	O	the	det	37	SENT_33	[p1l1071t1800r1121b1831],
36	inner	JJ	O	inner	amod	37	SENT_33	[p1l1129t1801r1216b1831],
37	surface	NN	O	surface	conj_and	29	SENT_33	[p1l1224t1800r1341b1831],
38	of	IN	O	of	_	0	SENT_33	[p1l1349t1800r1389b1831],
39	the	DT	O	the	det	41	SENT_33	[p1l1390t1800r1440b1831],
40	plasma	NN	O	plasma	nn	41	SENT_33	[p1l1448t1800r1567b1839],
41	membrane	NN	O	membrane	prep_of	37	SENT_33	[p1l1574t1800r1762b1831],
42	.	.	O	.	_	0	SENT_33	[p1l1574t1800r1762b1831],

1	The	DT	O	the	det	3	SENT_34	[p1l1771t1800r1833b1831],
2	enzymatic	JJ	O	enzymatic	amod	3	SENT_34	[p1l1842t1801r2008b1839],
3	activities	NNS	O	activity	nsubj	10	SENT_34	[p1l2016t1810r2063b1831, p1l664t1850r769b1880],
4	of	IN	O	of	_	0	SENT_34	[p1l782t1849r821b1880],
5	both	DT	O	both	det	6	SENT_34	[p1l825t1849r900b1880],
6	types	NNS	O	type	prep_of	3	SENT_34	[p1l911t1856r994b1889],
7	of	IN	O	of	_	0	SENT_34	[p1l1006t1849r1045b1880],
8	T	NN	O	t	nn	9	SENT_34	[p1l1047t1852r1071b1880],
9	K	NN	O	k	prep_of	6	SENT_34	[p1l1072t1852r1098b1881],
10	are	VBP	O	be	_	0	SENT_34	[p1l1107t1859r1156b1880],
11	under	IN	O	under	_	0	SENT_34	[p1l1168t1849r1264b1880],
12	tight	JJ	O	tight	amod	13	SENT_34	[p1l1275t1849r1353b1889],
13	control	NN	O	control	prep_under	10	SENT_34	[p1l1362t1849r1489b1887],
14	,	,	O	,	_	0	SENT_34	[p1l1362t1849r1489b1887],
15	so	RB	O	so	advmod	19	SENT_34	[p1l1503t1859r1538b1880],
16	that	IN	O	that	dep	19	SENT_34	[p1l1550t1849r1614b1880],
17	nonproliferating	JJ	O	nonproliferating	amod	18	SENT_34	[p1l1623t1849r1897b1889],
18	cells	NNS	O	cell	nsubj	19	SENT_34	[p1l1907t1849r1978b1880],
19	have	VBP	O	have	advcl	10	SENT_34	[p1l1990t1849r2063b1880],
20	very	RB	O	very	advmod	21	SENT_34	[p1l662t1909r730b1938],
21	low	JJ	O	low	amod	22	SENT_34	[p1l737t1899r798b1930],
22	levels	NNS	O	level	dobj	19	SENT_34	[p1l806t1899r894b1930],
23	of	IN	O	of	_	0	SENT_34	[p1l905t1899r944b1930],
24	tyrosyl	NN	O	tyrosyl	prep_of	22	SENT_34	[p1l947t1899r1054b1938],
25	phosphorylated	VBN	O	phosphorylate	partmod	24	SENT_34	[p1l1063t1899r1320b1938],
26	proteins	NNS	O	protein	dobj	25	SENT_34	[p1l1330t1900r1475b1938],
27	.	.	O	.	_	0	SENT_34	[p1l1330t1900r1475b1938],

1	The	DT	O	the	det	3	SENT_35	[p1l1485t1899r1548b1930],
2	kinase	NN	O	kinase	nn	3	SENT_35	[p1l1558t1899r1663b1930],
3	domains	NNS	O	domain	nsubj	8	SENT_35	[p1l1673t1899r1815b1930],
4	of	IN	O	of	_	0	SENT_35	[p1l1826t1899r1865b1930],
5	all	DT	O	all	det	7	SENT_35	[p1l1868t1899r1906b1930],
6	T	NN	O	t	nn	7	SENT_35	[p1l1914t1902r1938b1929],
7	Ks	NNS	O	k	prep_of	3	SENT_35	[p1l1939t1902r1979b1931],
8	have	VBP	O	have	_	0	SENT_35	[p1l1990t1899r2063b1930],
9	a	DT	O	a	det	11	SENT_35	[p1l664t1959r681b1979],
10	bilobar	JJ	O	bilobar	amod	11	SENT_35	[p1l689t1949r807b1979],
11	structure	NN	O	structure	dobj	8	SENT_35	[p1l814t1955r969b1986],
12	,	,	O	,	_	0	SENT_35	[p1l814t1955r969b1986],
13	with	IN	O	with	_	0	SENT_35	[p1l978t1949r1051b1979],
14	an	DT	O	a	det	15	SENT_35	[p1l1059t1959r1098b1979],
15	N	NN	O	n	prep_with	8	SENT_35	[p1l1105t1952r1134b1979],
16	—	JJ	O	—	amod	17	SENT_35	[p1l1136t1949r1288b1979],
17	terminal	JJ	O	terminal	amod	18	SENT_35	[p1l1136t1949r1288b1979],
18	lobe	NN	O	lobe	dep	15	SENT_35	[p1l1295t1949r1365b1979],
19	that	WDT	O	that	nsubj	20	SENT_35	[p1l1374t1949r1438b1979],
20	binds	VBZ	O	bind	ccomp	18	SENT_35	[p1l1445t1949r1535b1979],
21	ATP	NN	O	atp	dobj	20	SENT_35	[p1l1543t1951r1610b1979],
22	and	CC	O	and	_	0	SENT_35	[p1l1617t1949r1678b1979],
23	magnesium	NN	O	magnesium	conj_and	21	SENT_35	[p1l1686t1949r1889b1988],
24	,	,	O	,	_	0	SENT_35	[p1l1686t1949r1889b1988],
25	a	DT	O	a	det	27	SENT_35	[p1l1899t1959r1916b1979],
26	Cterminal	JJ	MISC	cterminal	amod	27	SENT_35	[p1l1924t1949r2063b1979, p1l664t1998r714b2029],
27	lobe	NN	O	lobe	conj_and	18	SENT_35	[p1l723t1998r792b2029],
28	containing	VBG	O	contain	partmod	27	SENT_35	[p1l802t1999r981b2038],
29	an	DT	O	a	det	31	SENT_35	[p1l988t2008r1027b2029],
30	activation	NN	O	activation	nn	31	SENT_35	[p1l1036t1999r1194b2029],
31	loop	NN	O	loop	dobj	28	SENT_35	[p1l1203t1998r1286b2038],
32	,	,	O	,	_	0	SENT_35	[p1l1203t1998r1286b2038],
33	and	CC	O	and	_	0	SENT_35	[p1l1297t1998r1357b2029],
34	a	DT	O	a	det	35	SENT_35	[p1l1366t2009r1384b2029],
35	cleft	NN	O	cleft	dep	15	SENT_35	[p1l1393t1998r1463b2029],
36	between	IN	O	between	_	0	SENT_35	[p1l1471t1998r1607b2029],
37	the	DT	O	the	det	38	SENT_35	[p1l1616t1998r1666b2029],
38	lobes	NNS	O	lobe	prep_between	35	SENT_35	[p1l1675t1998r1761b2029],
39	to	TO	O	to	_	0	SENT_35	[p1l1771t2005r1802b2029],
40	which	WDT	O	which	rel	43	SENT_35	[p1l1810t1998r1911b2029],
41	polypeptide	NN	O	polypeptide	nn	42	SENT_35	[p1l1920t1998r2063b2038, p1l664t2049r724b2080],
42	substrates	NNS	O	substrate	nsubj	43	SENT_35	[p1l735t2049r900b2080],
43	bind	VBP	O	bind	rcmod	35	SENT_35	[p1l910t2049r993b2080],
44	.	.	O	.	_	0	SENT_35	[p1l910t2049r993b2080],

1	In	IN	O	in	_	0	SENT_36	[p1l714t2101r748b2129],
2	the	DT	O	the	det	3	SENT_36	[p1l758t2098r809b2129],
3	absence	NN	O	absence	prep_in	11	SENT_36	[p1l819t2098r949b2129],
4	of	IN	O	of	_	0	SENT_36	[p1l961t2098r1000b2129],
5	ligand	NN	O	ligand	prep_of	3	SENT_36	[p1l1003t2098r1115b2138],
6	,	,	O	,	_	0	SENT_36	[p1l1003t2098r1115b2138],
7	receptor	NN	O	receptor	nn	9	SENT_36	[p1l1128t2105r1264b2138],
8	T	NN	O	t	nn	9	SENT_36	[p1l1272t2101r1296b2129],
9	Ks	NNS	O	k	nsubj	13	SENT_36	[p1l1297t2101r1337b2130],
10	are	VBP	O	be	cop	11	SENT_36	[p1l1349t2108r1397b2129],
11	unphosphorylated	JJ	O	unphosphorylated	_	0	SENT_36	[p1l1408t2098r1709b2138],
12	and	CC	O	and	_	0	SENT_36	[p1l1719t2098r1780b2129],
13	monomeric	JJ	O	monomeric	conj_and	11	SENT_36	[p1l1790t2099r1990b2136],
14	,	,	O	,	_	0	SENT_36	[p1l1790t2099r1990b2136],
15	and	CC	O	and	_	0	SENT_36	[p1l2003t2098r2063b2129],
16	the	DT	O	the	det	17	SENT_36	[p1l664t2148r715b2179],
17	conformation	NN	O	conformation	nsubj	23	SENT_36	[p1l725t2148r955b2179],
18	of	IN	O	of	_	0	SENT_36	[p1l964t2148r1004b2179],
19	their	PRP$	O	they	poss	21	SENT_36	[p1l1006t2148r1084b2179],
20	kinase	NN	O	kinase	nn	21	SENT_36	[p1l1092t2148r1200b2179],
21	domains	NNS	O	domain	prep_of	17	SENT_36	[p1l1209t2148r1353b2179],
22	is	VBZ	O	be	cop	23	SENT_36	[p1l1363t2149r1389b2179],
23	inactive	JJ	O	inactive	conj_and	11	SENT_36	[p1l1399t2149r1536b2179],
24	.	.	O	.	_	0	SENT_36	[p1l1399t2149r1536b2179],

1	In	IN	O	in	_	0	SENT_37	[p1l1546t2151r1581b2178],
2	some	DT	O	some	det	5	SENT_37	[p1l1591t2158r1679b2179],
3	receptor	NN	O	receptor	nn	5	SENT_37	[p1l1688t2155r1828b2187],
4	T	NN	O	t	nn	5	SENT_37	[p1l1834t2151r1858b2178],
5	Ks	NNS	O	k	prep_in	12	SENT_37	[p1l1859t2151r1911b2185],
6	,	,	O	,	_	0	SENT_37	[p1l1859t2151r1911b2185],
7	the	DT	O	the	det	10	SENT_37	[p1l1922t2148r1973b2179],
8	cytoplasmic	JJ	O	cytoplasmic	amod	10	SENT_37	[p1l1983t2155r2062b2187, p1l664t2197r795b2237],
9	juxtamembrane	NN	O	juxtamembrane	nn	10	SENT_37	[p1l800t2197r1063b2237],
10	region	NN	O	region	nsubj	12	SENT_37	[p1l1073t2198r1179b2237],
11	further	JJ	O	further	amod	10	SENT_37	[p1l1189t2197r1304b2228],
12	inhibits	VBZ	O	inhibit	_	0	SENT_37	[p1l1312t2197r1437b2228],
13	the	DT	O	the	det	14	SENT_37	[p1l1449t2197r1499b2228],
14	enzyme	NN	O	enzyme	dobj	12	SENT_37	[p1l1509t2207r1634b2237],
15	by	IN	O	by	_	0	SENT_37	[p1l1644t2197r1682b2237],
16	interacting	VBG	O	interact	prepc_by	12	SENT_37	[p1l1690t2198r1869b2237],
17	with	IN	O	with	_	0	SENT_37	[p1l1876t2197r1950b2228],
18	the	DT	O	the	det	20	SENT_37	[p1l1960t2197r2010b2228],
19	kinase	NN	O	kinase	nn	20	SENT_37	[p1l2020t2197r2063b2229, p1l664t2257r738b2277],
20	domain	NN	O	domain	prep_with	16	SENT_37	[p1l749t2245r902b2277],
21	?	.	O	?	_	0	SENT_37	[p1l749t2245r902b2277],

1	Receptor	NN	O	receptor	nn	2	SENT_38	[p1l913t2249r1061b2286],
2	TKs	NNS	O	tk	nsubjpass	4	SENT_38	[p1l1070t2249r1135b2278],
3	become	VBP	O	become	auxpass	4	SENT_38	[p1l1147t2247r1274b2277],
4	activated	VBN	O	activate	_	0	SENT_38	[p1l1286t2247r1429b2277],
5	when	WRB	O	when	advmod	7	SENT_38	[p1l1439t2247r1529b2278],
6	ligand	NN	O	ligand	nsubj	7	SENT_38	[p1l1541t2247r1644b2286],
7	binds	VBZ	O	bind	advcl	4	SENT_38	[p1l1655t2247r1745b2277],
8	to	TO	O	to	_	0	SENT_38	[p1l1758t2253r1788b2277],
9	the	DT	O	the	det	11	SENT_38	[p1l1801t2247r1851b2277],
10	extracellular	JJ	O	extracellular	amod	11	SENT_38	[p1l1863t2247r2064b2278],
11	domain	NN	O	domain	prep_to	7	SENT_38	[p1l665t2296r801b2334],
12	,	,	O	,	_	0	SENT_38	[p1l665t2296r801b2334],
13	resulting	VBG	O	result	xcomp	7	SENT_38	[p1l815t2296r965b2336],
14	in	IN	O	in	_	0	SENT_38	[p1l975t2297r1007b2327],
15	receptor	NN	O	receptor	nn	16	SENT_38	[p1l1018t2303r1157b2336],
16	oligomerization	NN	O	oligomerization	prep_in	13	SENT_38	[p1l1167t2296r1445b2336],
17	,	,	O	,	_	0	SENT_38	[p1l1167t2296r1445b2336],
18	disruption	NN	O	disruption	prep_in	13	SENT_38	[p1l1459t2296r1634b2336],
19	of	IN	O	of	_	0	SENT_38	[p1l1645t2296r1684b2327],
20	the	DT	O	the	det	24	SENT_38	[p1l1689t2296r1740b2327],
21	autoinhibitoryjux	NN	O	autoinhibitoryjux	nn	24	SENT_38	[p1l1751t2296r2062b2336],
22	—	NN	O	—	nn	24	SENT_38	[p1l1751t2296r2062b2336],
23	tamembrane	NN	O	tamembrane	nn	24	SENT_38	[p1l664t2346r877b2377],
24	interaction	NN	O	interaction	prep_of	18	SENT_38	[p1l887t2347r1074b2384],
25	,	,	O	,	_	0	SENT_38	[p1l887t2347r1074b2384],
26	and	CC	O	and	_	0	SENT_38	[p1l1086t2346r1147b2377],
27	autophosphorylation	NN	O	autophosphorylation	prep_in	13	SENT_38	[p1l1157t2346r1501b2386],
28	of	IN	O	of	_	0	SENT_38	[p1l1512t2346r1551b2377],
29	a	DT	O	a	det	31	SENT_38	[p1l1554t2357r1571b2377],
30	regulatory	JJ	O	regulatory	amod	31	SENT_38	[p1l1581t2346r1749b2386],
31	tyrosine	NN	O	tyrosine	prep_of	27	SENT_38	[p1l1757t2347r1887b2386],
32	within	IN	O	within	_	0	SENT_38	[p1l1896t2346r2002b2378],
33	the	DT	O	the	det	35	SENT_38	[p1l2013t2346r2063b2377],
34	activation	NN	O	activation	nn	35	SENT_38	[p1l664t2397r825b2427],
35	loop	NN	O	loop	prep_within	13	SENT_38	[p1l836t2396r910b2436],
36	of	IN	O	of	_	0	SENT_38	[p1l921t2396r960b2427],
37	the	DT	O	the	det	40	SENT_38	[p1l964t2396r1015b2427],
38	kinase	NN	O	kinase	nn	40	SENT_38	[p1l1025t2396r1132b2427],
39	(	NN	O	(	nn	40	SENT_38	[p1l1145t2397r1218b2436],
40	Fig	NN	O	fig	prep_of	35	SENT_38	[p1l1145t2397r1218b2436],
41	.	.	O	.	_	0	SENT_38	[p1l1145t2397r1218b2436],

1	1	CD	NUMBER	1	_	0	SENT_39	[p1l1232t2399r1272b2432],
2	)	NN	O	)	dep	1	SENT_39	[p1l1232t2399r1272b2432],
3	.	.	O	.	_	0	SENT_39	[p1l1232t2399r1272b2432],

1	These	DT	O	these	det	2	SENT_40	[p1l1284t2396r1383b2427],
2	changes	NNS	O	change	nsubj	3	SENT_40	[p1l1393t2396r1529b2436],
3	reorient	VBP	O	reorient	_	0	SENT_40	[p1l1540t2397r1674b2427],
4	critical	JJ	O	critical	amod	7	SENT_40	[p1l1683t2396r1796b2427],
5	amino	NN	O	amino	nn	7	SENT_40	[p1l1806t2397r1912b2427],
6	acid	NN	O	acid	nn	7	SENT_40	[p1l1923t2396r1991b2427],
7	residues	NNS	O	residue	dobj	3	SENT_40	[p1l2001t2406r2062b2427, p1l664t2446r763b2484],
8	,	,	O	,	_	0	SENT_40	[p1l2001t2406r2062b2427, p1l664t2446r763b2484],
9	thereby	RB	O	thereby	advmod	10	SENT_40	[p1l776t2446r903b2486],
10	increasing	VBG	O	increase	xcomp	3	SENT_40	[p1l911t2447r1090b2486],
11	the	DT	O	the	det	13	SENT_40	[p1l1099t2446r1150b2477],
12	catalytic	JJ	O	catalytic	amod	13	SENT_40	[p1l1161t2446r1300b2486],
13	activity	NN	O	activity	dobj	10	SENT_40	[p1l1309t2447r1430b2486],
14	of	IN	O	of	_	0	SENT_40	[p1l1438t2446r1478b2477],
15	the	DT	O	the	det	16	SENT_40	[p1l1481t2446r1533b2477],
16	enzyme	NN	O	enzyme	prep_of	13	SENT_40	[p1l1543t2456r1682b2486],
17	.	.	O	.	_	0	SENT_40	[p1l1543t2456r1682b2486],

1	After	IN	O	after	_	0	SENT_41	[p1l1693t2446r1779b2477],
2	activation	NN	O	activation	prep_after	5	SENT_41	[p1l1787t2447r1963b2484],
3	,	,	O	,	_	0	SENT_41	[p1l1787t2447r1963b2484],
4	autophosphorylation	NN	O	autophosphorylation	nsubj	5	SENT_41	[p1l1974t2453r2062b2477, p1l664t2496r946b2536],
5	generates	VBZ	O	generate	_	0	SENT_41	[p1l959t2503r1118b2536],
6	binding	VBG	O	bind	amod	7	SENT_41	[p1l1132t2496r1264b2536],
7	sites	NNS	O	site	dobj	5	SENT_41	[p1l1276t2497r1349b2527],
8	for	IN	O	for	_	0	SENT_41	[p1l1363t2496r1412b2527],
9	signaling	NN	O	signaling	nn	10	SENT_41	[p1l1424t2496r1580b2536],
10	proteins	NNS	O	protein	prep_for	7	SENT_41	[p1l1592t2497r1740b2536],
11	,	,	O	,	_	0	SENT_41	[p1l1592t2497r1740b2536],
12	recruiting	VBG	O	recruit	dep	5	SENT_41	[p1l1755t2497r1921b2536],
13	them	PRP	O	they	dobj	12	SENT_41	[p1l1933t2496r2018b2527],
14	to	TO	O	to	_	0	SENT_41	[p1l2031t2503r2062b2527],
15	the	DT	O	the	det	16	SENT_41	[p1l664t2546r715b2576],
16	membrane	NN	O	membrane	prep_to	12	SENT_41	[p1l726t2546r906b2576],
17	and	CC	O	and	_	0	SENT_41	[p1l917t2546r978b2576],
18	activating	VBG	O	activate	dep	5	SENT_41	[p1l988t2546r1147b2585],
19	multiple	JJ	O	multiple	amod	21	SENT_41	[p1l1155t2546r1292b2585],
20	signaling	NN	O	signaling	nn	21	SENT_41	[p1l1303t2546r1456b2585],
21	pathways	NNS	O	pathway	nn	22	SENT_41	[p1l1463t2544r1642b2585],
22	.3	NN	NUMBER	.3	dobj	18	SENT_41	[p1l1463t2544r1642b2585],
23	The	DT	O	the	det	26	SENT_41	[p1l713t2595r776b2626],
24	nonreceptor	JJ	O	nonreceptor	amod	26	SENT_41	[p1l785t2602r992b2634],
25	T	NN	O	t	nn	26	SENT_41	[p1l998t2598r1022b2625],
26	Ks	NNS	O	k	dep	22	SENT_41	[p1l1023t2598r1074b2632],
27	,	,	O	,	_	0	SENT_41	[p1l1023t2598r1074b2632],
28	typified	VBN	O	typify	partmod	22	SENT_41	[p1l1086t2595r1211b2634],
29	by	IN	O	by	_	0	SENT_41	[p1l1221t2595r1259b2634],
30	c	NN	O	c	agent	28	SENT_41	[p1l1266t2598r1375b2632],
31	.	.	O	.	_	0	SENT_41	[p1l1266t2598r1375b2632],

1	—	NN	O	—	_	0	SENT_42	[p1l1266t2598r1375b2632],
2	.	.	O	.	_	0	SENT_42	[p1l1266t2598r1375b2632],

1	ABL	NNP	ORGANIZATION	ABL	nsubjpass	4	SENT_43	[p1l1266t2598r1375b2632],
2	,	,	O	,	_	0	SENT_43	[p1l1266t2598r1375b2632],
3	are	VBP	O	be	auxpass	4	SENT_43	[p1l1386t2605r1436b2626],
4	maintained	VBN	O	maintain	conj_and	4	SENT_43	[p1l1445t2595r1636b2626],
5	in	IN	O	in	_	0	SENT_43	[p1l1645t2596r1677b2625],
6	an	DT	O	a	det	8	SENT_43	[p1l1686t2605r1725b2626],
7	inactive	JJ	O	inactive	amod	8	SENT_43	[p1l1734t2596r1861b2626],
8	state	NN	O	state	prep_in	4	SENT_43	[p1l1871t2602r1949b2626],
9	by	IN	O	by	_	0	SENT_43	[p1l1958t2595r1996b2634],
10	cellular	JJ	O	cellular	amod	12	SENT_43	[p1l2004t2595r2062b2626, p1l664t2645r741b2675],
11	inhibitor	NN	O	inhibitor	nn	12	SENT_43	[p1l749t2645r898b2675],
12	proteins	NNS	O	protein	agent	4	SENT_43	[p1l906t2645r1044b2684],
13	and	CC	O	and	_	0	SENT_43	[p1l1054t2645r1115b2675],
14	lipids	NNS	O	lipid	agent	4	SENT_43	[p1l1124t2645r1216b2684],
15	and	CC	O	and	_	0	SENT_43	[p1l1226t2645r1288b2675],
16	through	IN	O	through	_	0	SENT_43	[p1l1297t2645r1432b2684],
17	intramolecular	JJ	O	intramolecular	amod	19	SENT_43	[p1l1442t2645r1690b2676],
18	autoinhibition	NN	O	autoinhibition	nn	19	SENT_43	[p1l1698t2643r1967b2675],
19	.1	NN	NUMBER	.1	prep_through	4	SENT_43	[p1l1698t2643r1967b2675],
20	Nonreceptor	NN	O	nonreceptor	nn	21	SENT_43	[p1l1976t2648r2062b2675, p1l664t2701r805b2734],
21	TKs	NNS	O	tk	nsubjpass	23	SENT_43	[p1l817t2697r883b2726],
22	are	VBP	O	be	auxpass	23	SENT_43	[p1l898t2704r948b2725],
23	activated	VBN	O	activate	dep	4	SENT_43	[p1l962t2694r1110b2725],
24	by	IN	O	by	_	0	SENT_43	[p1l1125t2694r1163b2734],
25	diverse	JJ	O	diverse	amod	27	SENT_43	[p1l1176t2694r1293b2725],
26	intracellular	JJ	O	intracellular	amod	27	SENT_43	[p1l1307t2694r1514b2725],
27	signals	NNS	O	signal	agent	23	SENT_43	[p1l1527t2694r1645b2734],
28	through	IN	O	through	_	0	SENT_43	[p1l1660t2694r1796b2734],
29	dissociation	NN	O	dissociation	prep_through	23	SENT_43	[p1l1811t2694r2016b2725],
30	of	IN	O	of	prep	29	SENT_43	[p1l2030t2694r2070b2725],

1	172	CD	NUMBER	172	num	3	SENT_44	[p1l90t2809r146b2830],
2	N	NN	O	n	nn	3	SENT_44	[p1l1004t2811r1017b2826],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_44	[p1l1033t2810r1117b2832],
4	MED	VBD	O	med	_	0	SENT_44	[p1l1132t2811r1184b2826],
5	353:2	CD	NUMBER	353:2	num	7	SENT_44	[p1l1197t2810r1260b2832],
6	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	7	SENT_44	[p1l1295t2810r1507b2832],
7	JULY14	NN	O	july14	dobj	4	SENT_44	[p1l1540t2810r1647b2832],
8	,	,	O	,	_	0	SENT_44	[p1l1540t2810r1647b2832],
9	2005	CD	DATE	2005	appos	7	SENT_44	[p1l1660t2810r1723b2832],

1	The	DT	O	the	det	5	SENT_45	[p1l877t2907r928b2931],
2	New	NNP	O	New	nn	5	SENT_45	[p1l937t2908r999b2931],
3	England	NNP	O	England	nn	5	SENT_45	[p1l1008t2907r1119b2938],
4	J	NNP	O	J	nn	5	SENT_45	[p1l1127t2908r1140b2931],
5	oumal	NN	O	oumal	_	0	SENT_45	[p1l1141t2907r1225b2931],
6	of	IN	O	of	_	0	SENT_45	[p1l1235t2907r1263b2931],
7	Medicine	NN	O	medicine	prep_of	5	SENT_45	[p1l1270t2907r1395b2931],

1	Downloaded	VBN	O	download	_	0	SENT_46	[p1l319t2948r489b2971],
2	from	IN	O	from	_	0	SENT_46	[p1l497t2948r562b2971],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_46	[p1l571t2948r689b2978],
4	at	IN	O	at	_	0	SENT_46	[p1l699t2952r722b2971],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_46	[p1l731t2948r913b2971],
6	on	IN	O	on	_	0	SENT_46	[p1l923t2955r955b2971],
7	January	NNP	DATE	January	prep_on	1	SENT_46	[p1l964t2948r1067b2978],
8	5	CD	DATE	5	num	7	SENT_46	[p1l1077t2948r1099b2975],
9	,	,	DATE	,	_	0	SENT_46	[p1l1077t2948r1099b2975],
10	2014	CD	DATE	2014	num	7	SENT_46	[p1l1110t2948r1182b2971],
11	.	.	O	.	_	0	SENT_46	[p1l1110t2948r1182b2971],

1	For	IN	O	for	_	0	SENT_47	[p1l1193t2948r1239b2971],
2	personal	JJ	O	personal	amod	3	SENT_47	[p1l1247t2948r1360b2978],
3	use	NN	O	use	pobj	1	SENT_47	[p1l1369t2955r1412b2971],
4	only	RB	O	only	advmod	3	SENT_47	[p1l1422t2948r1487b2978],
5	.	.	O	.	_	0	SENT_47	[p1l1422t2948r1487b2978],

1	No	DT	O	no	det	3	SENT_48	[p1l1497t2948r1537b2971],
2	other	JJ	O	other	amod	3	SENT_48	[p1l1547t2948r1615b2971],
3	uses	NNS	O	use	_	0	SENT_48	[p1l1623t2955r1679b2971],
4	without	IN	O	without	_	0	SENT_48	[p1l1690t2948r1791b2971],
5	permission	NN	O	permission	prep_without	3	SENT_48	[p1l1799t2948r1952b2978],
6	.	.	O	.	_	0	SENT_48	[p1l1799t2948r1952b2978],

1	Copyright	NN	O	copyright	_	0	SENT_49	[p1l669t2989r803b3020],
2	©	CD	NUMBER	©	num	6	SENT_49	[p1l813t2989r836b3013],
3	2005	CD	DATE	2005	num	6	SENT_49	[p1l846t2989r910b3013],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_49	[p1l921t2989r1112b3013],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_49	[p1l1122t2989r1230b3013],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_49	[p1l1240t2989r1345b3020],
7	.	.	O	.	_	0	SENT_49	[p1l1240t2989r1345b3020],

1	All	DT	O	all	det	2	SENT_50	[p1l1356t2989r1397b3013],
2	rights	NNS	O	rights	nsubj	3	SENT_50	[p1l1407t2989r1481b3020],
3	reserved	VBN	O	reserve	_	0	SENT_50	[p1l1491t2989r1610b3013],
4	.	.	O	.	_	0	SENT_50	[p1l1491t2989r1610b3013],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_51	[p1l862t3095r1090b3114],
2	OF	IN	O	of	_	0	SENT_51	[p1l1105t3095r1146b3114],
3	DISEASE	NN	O	disease	prep_of	1	SENT_51	[p1l1160t3095r1297b3114],

1	inhibitors	NNS	O	inhibitor	nsubj	8	SENT_52	[p1l10t3308r460b3404],
2	,	,	O	,	_	0	SENT_52	[p1l10t3308r460b3404],
3	by	IN	O	by	_	0	SENT_52	[p1l503t3308r601b3409],
4	recruitment	NN	O	recruitment	prep_by	1	SENT_52	[p1l633t3309r1145b3388],
5	to	TO	O	to	_	0	SENT_52	[p1l1176t3325r1256b3387],
6	transmembrane	NN	O	transmembrane	nn	7	SENT_52	[p1l1295t3309r1983b3387],
7	receptors	NNS	O	receptor	prep_to	4	SENT_52	[p1l2019t3335r2133b3387, p1l11t3453r324b3537],
8	(	VBP	O	(	_	0	SENT_52	[p1l369t3437r734b3537],
9	causing	VBG	O	cause	dep	8	SENT_52	[p1l369t3437r734b3537],
10	oligomerization	NN	O	oligomerization	nn	13	SENT_52	[p1l770t3437r1463b3537],
11	and	CC	O	and	_	0	SENT_52	[p1l1501t3437r1659b3515],
12	autophosphorylation	NN	O	autophosphorylation	conj_and	10	SENT_52	[p1l1696t3436r2133b3537, p1l9t3565r571b3665],
13	)	NN	O	)	dobj	9	SENT_52	[p1l1696t3436r2133b3537, p1l9t3565r571b3665],
14	,	,	O	,	_	0	SENT_52	[p1l1696t3436r2133b3537, p1l9t3565r571b3665],
15	and	CC	O	and	_	0	SENT_52	[p1l606t3565r765b3643],
16	through	IN	O	through	conj_and	9	SENT_52	[p1l795t3564r1147b3665],
17	tran	JJ	O	tran	amod	18	SENT_52	[p1l1177t3564r2134b3665],
18	$	$	MONEY	$	pobj	16	SENT_52	[p1l1177t3564r2134b3665],
19	.	.	MONEY	.	_	0	SENT_52	[p1l1177t3564r2134b3665],

1	—	NN	O	—	_	0	SENT_53	[p1l1177t3564r2134b3665],
2	.	.	O	.	_	0	SENT_53	[p1l1177t3564r2134b3665],

1	phosphorylation	NN	O	phosphorylation	nsubj	5	SENT_54	[p1l1177t3564r2134b3665],
2	by	IN	O	by	_	0	SENT_54	[p1l11t3692r109b3793],
3	other	JJ	O	other	amod	4	SENT_54	[p1l145t3693r373b3771],
4	kinases	NNS	O	kinase	prep_by	1	SENT_54	[p1l409t3693r728b3772],
5	(	VBP	O	(	_	0	SENT_54	[p1l774t3693r962b3793],
6	Fig	NN	O	fig	dobj	5	SENT_54	[p1l774t3693r962b3793],
7	.	.	O	.	_	0	SENT_54	[p1l774t3693r962b3793],

1	1	CD	NUMBER	1	_	0	SENT_55	[p1l1010t3698r1115b3784],
2	)	NN	O	)	dep	1	SENT_55	[p1l1010t3698r1115b3784],
3	.	.	O	.	_	0	SENT_55	[p1l1010t3698r1115b3784],

1	TK	NN	O	tk	nn	2	SENT_56	[p1l1157t3698r1286b3774],
2	signaling	NN	O	signaling	nsubjpass	4	SENT_56	[p1l1324t3693r1727b3793],
3	is	VBZ	O	be	auxpass	4	SENT_56	[p1l1762t3693r1828b3771],
4	terminated	VBN	O	terminate	_	0	SENT_56	[p1l1870t3693r2133b3771, p2l11t21r247b99],

1	in	IN	O	in	_	0	SENT_57	[p2l274t21r356b98],
2	part	NN	O	part	pobj	1	SENT_57	[p2l382t37r558b121],
3	through	IN	O	through	_	0	SENT_57	[p2l581t20r930b121],
4	the	DT	O	the	det	5	SENT_57	[p2l957t21r1089b99],
5	action	NN	O	action	prep_through	2	SENT_57	[p2l1116t21r1380b99],
6	of	IN	O	of	_	0	SENT_57	[p2l1408t20r1509b99],
7	tyrosine	NN	O	tyrosine	nn	8	SENT_57	[p2l1519t21r1862b121],
8	phosphatases	NNS	O	phosphatase	prep_of	5	SENT_57	[p2l1887t20r2133b121, p2l9t149r386b249],
9	that	WDT	O	that	nsubj	10	SENT_57	[p2l415t149r584b227],
10	hydrolyze	VBP	O	hydrolyze	rcmod	5	SENT_57	[p2l606t148r1021b249],
11	tyrosyl	NN	O	tyrosyl	nn	12	SENT_57	[p2l1048t149r1326b249],
12	phosphates	NNS	O	phosphate	dobj	10	SENT_57	[p2l1349t148r1836b249],
13	and	CC	O	and	_	0	SENT_57	[p2l1862t148r2018b227],
14	by	IN	O	by	_	0	SENT_57	[p2l2043t149r2140b249],
15	the	DT	O	the	det	16	SENT_57	[p2l11t277r140b355],
16	induction	NN	O	induction	prep_by	2	SENT_57	[p2l165t277r573b356],
17	of	IN	O	of	_	0	SENT_57	[p2l598t276r699b355],
18	inhibitory	JJ	O	inhibitory	amod	19	SENT_57	[p2l704t277r1124b377],
19	molecules	NNS	O	molecule	prep_of	16	SENT_57	[p2l1145t277r1596b356],
20	.	.	O	.	_	0	SENT_57	[p2l1145t277r1596b356],

1	M	NN	O	m	nn	3	SENT_58	[p2l18t561r70b610],
2	ECHAN	NNP	O	ECHAN	nn	3	SENT_58	[p2l95t561r372b610],
3	ISMS	NNP	O	ISMS	nsubj	9	SENT_58	[p2l396t561r592b610],
4	or	CC	O	or	_	0	SENT_58	[p2l632t561r736b610],
5	TK	NN	O	tk	nn	6	SENT_58	[p2l772t561r867b610],
6	DYSREGULATION	NN	O	dysregulation	conj_or	3	SENT_58	[p2l912t561r1609b610],
7	IN	IN	O	in	_	0	SENT_58	[p2l1660t561r1740b610],
8	CANCER	NNP	O	CANCER	prep_in	6	SENT_58	[p2l1787t561r2113b610],
9	Given	VBN	O	give	partmod	21	SENT_58	[p2l11t662r260b741],
10	the	DT	O	the	det	12	SENT_58	[p2l285t661r415b740],
11	multiple	JJ	O	multiple	amod	12	SENT_58	[p2l440t662r801b762],
12	levels	NNS	O	level	dobj	9	SENT_58	[p2l824t662r1058b741],
13	of	IN	O	of	_	0	SENT_58	[p2l1084t661r1186b740],
14	regulation	NN	O	regulation	prep_of	12	SENT_58	[p2l1191t662r1634b762],
15	of	IN	O	of	_	0	SENT_58	[p2l1659t661r1761b740],
16	TKs	NNS	O	tk	prep_of	14	SENT_58	[p2l1763t667r1958b757],
17	,	,	O	,	_	0	SENT_58	[p2l1763t667r1958b757],
18	it	PRP	O	it	nsubj	21	SENT_58	[p2l1987t662r2048b740],
19	is	VBZ	O	be	cop	21	SENT_58	[p2l2066t662r2132b740],
20	not	RB	O	not	neg	21	SENT_58	[p2l11t806r156b868],
21	surprising	JJ	O	surprising	_	0	SENT_58	[p2l184t790r621b890],
22	that	IN	O	that	complm	25	SENT_58	[p2l647t790r814b868],
23	TKs	NNS	O	tk	nsubjpass	25	SENT_58	[p2l834t795r1001b871],
24	are	VBP	O	be	auxpass	25	SENT_58	[p2l1032t816r1158b868],
25	dysregulated	VBN	O	dysregulate	ccomp	21	SENT_58	[p2l1188t789r1724b890],
26	in	IN	O	in	_	0	SENT_58	[p2l1752t790r1833b867],
27	cancer	NN	O	cancer	nn	28	SENT_58	[p2l1863t815r2138b868],
28	cells	NNS	O	cell	prep_in	25	SENT_58	[p2l11t918r198b996],
29	in	IN	O	in	_	0	SENT_58	[p2l234t918r317b995],
30	several	JJ	O	several	amod	31	SENT_58	[p2l353t917r645b997],
31	Ways	NNPS	O	Ways	prep_in	28	SENT_58	[p2l674t944r881b1018],
32	(	CD	NUMBER	(	num	33	SENT_58	[p2l923t918r1111b1018],
33	Fig	NN	O	fig	dep	31	SENT_58	[p2l923t918r1111b1018],
34	.	.	O	.	_	0	SENT_58	[p2l923t918r1111b1018],

1	2	CD	NUMBER	2	num	2	SENT_59	[p2l1152t923r1260b1009],
2	)	CD	NUMBER	)	_	0	SENT_59	[p2l1152t923r1260b1009],
3	.	.	O	.	_	0	SENT_59	[p2l1152t923r1260b1009],

1	A	DT	O	a	det	3	SENT_60	[p2l1297t925r1363b995],
2	common	JJ	O	common	amod	3	SENT_60	[p2l1396t943r1782b996],
3	mechanism	NN	O	mechanism	nsubj	12	SENT_60	[p2l1816t918r2133b996, p2l11t1046r224b1124],
4	of	IN	O	of	_	0	SENT_60	[p2l248t1045r349b1124],
5	TK	NN	O	tk	nn	6	SENT_60	[p2l350t1051r479b1127],
6	activation	NN	O	activation	prep_of	3	SENT_60	[p2l497t1046r904b1125],
7	in	IN	O	in	_	0	SENT_60	[p2l926t1046r1007b1123],
8	hematologic	JJ	O	hematologic	amod	9	SENT_60	[p2l1029t1046r1558b1146],
9	cancers	NNS	O	cancer	prep_in	6	SENT_60	[p2l1580t1071r1893b1124],
10	is	VBZ	O	be	cop	12	SENT_60	[p2l1917t1046r1982b1124],
11	the	DT	O	the	det	12	SENT_60	[p2l2006t1046r2135b1124],
12	fusion	NN	O	fusion	_	0	SENT_60	[p2l11t1173r277b1253],
13	of	IN	O	of	_	0	SENT_60	[p2l304t1173r404b1252],
14	a	DT	O	a	det	18	SENT_60	[p2l410t1200r455b1252],
15	receptor	NN	O	receptor	nn	18	SENT_60	[p2l478t1190r830b1274],
16	or	CC	O	or	_	0	SENT_60	[p2l853t1199r943b1252],
17	nonreceptor	NN	O	nonreceptor	nn	18	SENT_60	[p2l965t1190r1486b1274],
18	TK	NN	O	tk	prep_of	12	SENT_60	[p2l1505t1179r1634b1255],
19	with	IN	O	with	_	0	SENT_60	[p2l1652t1174r1841b1253],
20	a	DT	O	a	det	22	SENT_60	[p2l1866t1200r1910b1252],
21	partner	NN	O	partner	nn	22	SENT_60	[p2l1933t1190r2134b1274, p2l11t1327r149b1380],
22	protein	NN	O	protein	prep_with	18	SENT_60	[p2l168t1302r499b1402],
23	,	,	O	,	_	0	SENT_60	[p2l168t1302r499b1402],
24	usually	RB	O	usually	advmod	18	SENT_60	[p2l527t1301r826b1402],
25	as	IN	O	as	amod	18	SENT_60	[p2l843t1328r928b1380],
26	a	DT	O	a	det	27	SENT_60	[p2l953t1328r997b1380],
27	consequence	NN	O	consequence	dep	18	SENT_60	[p2l1019t1327r1565b1402],
28	of	IN	O	of	_	0	SENT_60	[p2l1589t1301r1689b1380],
29	a	DT	O	a	det	32	SENT_60	[p2l1693t1328r1738b1380],
30	balanced	JJ	O	balanced	amod	32	SENT_60	[p2l1760t1301r2135b1380],
31	chromosomal	JJ	O	chromosomal	amod	32	SENT_60	[p2l11t1430r612b1508],
32	translocation	NN	O	translocation	prep_of	27	SENT_60	[p2l636t1429r1230b1508],
33	.	.	O	.	_	0	SENT_60	[p2l636t1429r1230b1508],

1	A	DT	O	a	det	3	SENT_61	[p2l1255t1437r1321b1507],
2	frequent	JJ	O	frequent	amod	3	SENT_61	[p2l1342t1429r1711b1530],
3	feature	NN	O	feature	nsubj	10	SENT_61	[p2l1730t1429r2027b1509],
4	of	IN	O	of	_	0	SENT_61	[p2l2051t1429r2153b1508],
5	the	DT	O	the	det	7	SENT_61	[p2l11t1557r142b1636],
6	partner	NN	O	partner	nn	7	SENT_61	[p2l164t1574r483b1658],
7	protein	NN	O	protein	prep_of	3	SENT_61	[p2l501t1558r815b1658],
8	is	VBZ	O	be	cop	10	SENT_61	[p2l837t1558r903b1636],
9	a	DT	O	a	det	10	SENT_61	[p2l928t1584r973b1636],
10	domain	NN	O	domain	_	0	SENT_61	[p2l995t1558r1324b1636],
11	that	WDT	O	that	nsubj	12	SENT_61	[p2l1348t1558r1517b1636],
12	causes	VBZ	O	cause	rcmod	10	SENT_61	[p2l1536t1584r1814b1637],
13	constitutive	JJ	O	constitutive	amod	14	SENT_61	[p2l1839t1558r2133b1636, p2l11t1686r247b1765],
14	oligomerization	NN	O	oligomerization	dobj	12	SENT_61	[p2l273t1686r973b1786],
15	of	IN	O	of	_	0	SENT_61	[p2l999t1685r1101b1764],
16	the	DT	O	the	det	18	SENT_61	[p2l1108t1686r1240b1764],
17	T	NN	O	t	nn	18	SENT_61	[p2l1262t1691r1324b1763],
18	K	NN	O	k	prep_of	14	SENT_61	[p2l1326t1693r1393b1767],
19	in	IN	O	in	_	0	SENT_61	[p2l1414t1686r1497b1763],
20	the	DT	O	the	det	21	SENT_61	[p2l1522t1686r1655b1764],
21	absence	NN	O	absence	prep_in	12	SENT_61	[p2l1679t1686r2024b1764],
22	of	IN	O	of	_	0	SENT_61	[p2l2051t1685r2153b1764],
23	ligand	NN	O	ligand	nn	24	SENT_61	[p2l10t1813r284b1914],
24	binding	NN	O	binding	prep_of	21	SENT_61	[p2l317t1814r659b1914],
25	or	CC	O	or	_	0	SENT_61	[p2l689t1839r779b1892],
26	physiologic	JJ	O	physiologic	amod	28	SENT_61	[p2l807t1814r1312b1914],
27	activating	NN	O	activating	nn	28	SENT_61	[p2l1343t1814r1768b1914],
28	signals	NNS	O	signal	prep_of	21	SENT_61	[p2l1799t1813r2129b1914],
29	,	,	O	,	_	0	SENT_61	[p2l1799t1813r2129b1914],
30	thereby	RB	O	thereby	advmod	31	SENT_61	[p2l11t1941r331b2042],
31	promoting	VBG	O	promote	partmod	12	SENT_61	[p2l349t1942r818b2042],
32	autophosphorylation	NN	O	autophosphorylation	dobj	31	SENT_61	[p2l837t1942r1745b2042],
33	and	CC	O	and	_	0	SENT_61	[p2l1768t1941r1926b2020],
34	activation	NN	O	activation	conj_and	32	SENT_61	[p2l1949t1942r2134b2020, p2l6t2070r298b2149],
35	.	.	O	.	_	0	SENT_61	[p2l1949t1942r2134b2020, p2l6t2070r298b2149],

1	A	DT	O	a	det	3	SENT_62	[p2l332t2077r398b2147],
2	primary	JJ	O	primary	amod	3	SENT_62	[p2l426t2070r775b2170],
3	example	NN	O	example	nsubj	8	SENT_62	[p2l806t2070r1170b2170],
4	of	IN	O	of	_	0	SENT_62	[p2l1206t2069r1308b2148],
5	this	DT	O	this	det	6	SENT_62	[p2l1324t2070r1483b2148],
6	mechanism	NN	O	mechanism	prep_of	3	SENT_62	[p2l1519t2070r2031b2148],
7	is	VBZ	O	be	cop	8	SENT_62	[p2l2064t2070r2131b2148],
8	BCR	NN	O	bcr	_	0	SENT_62	[p2l9t2203r433b2293],
9	.	.	O	.	_	0	SENT_62	[p2l9t2203r433b2293],

1	—	NN	O	—	_	0	SENT_63	[p2l9t2203r433b2293],
2	.	.	O	.	_	0	SENT_63	[p2l9t2203r433b2293],

1	ABL	NNP	ORGANIZATION	ABL	_	0	SENT_64	[p2l9t2203r433b2293],
2	,	,	O	,	_	0	SENT_64	[p2l9t2203r433b2293],
3	the	DT	O	the	det	6	SENT_64	[p2l474t2198r606b2276],
4	nonreceptor	JJ	O	nonreceptor	amod	6	SENT_64	[p2l641t2214r1173b2298],
5	fusion	NN	O	fusion	nn	6	SENT_64	[p2l1204t2197r1476b2277],
6	TK	NN	O	tk	appos	1	SENT_64	[p2l1508t2203r1638b2279],
7	in	IN	O	in	_	0	SENT_64	[p2l1669t2198r1751b2275],
8	CML	NN	ORGANIZATION	cml	prep_in	6	SENT_64	[p2l1785t2203r2013b2293],
9	,	,	O	,	_	0	SENT_64	[p2l1785t2203r2013b2293],
10	in	IN	O	in	_	0	SENT_64	[p2l2052t2198r2134b2275],
11	Which	WDT	O	which	rel	17	SENT_64	[p2l6t2326r265b2405],
12	a	DT	O	a	det	14	SENT_64	[p2l291t2352r335b2404],
13	tetramerization	NN	O	tetramerization	nn	14	SENT_64	[p2l361t2326r1001b2404],
14	domain	NN	O	domain	nsubj	17	SENT_64	[p2l1028t2325r1347b2404],
15	in	IN	O	in	_	0	SENT_64	[p2l1373t2326r1454b2403],
16	BCR	NN	ORGANIZATION	bcr	prep_in	14	SENT_64	[p2l1478t2331r1675b2409],
17	overcomes	VBZ	O	overcome	rcmod	8	SENT_64	[p2l1692t2351r2134b2405],
18	autoinhibition	NN	O	autoinhibition	dobj	17	SENT_64	[p2l10t2454r635b2533],
19	of	IN	O	of	_	0	SENT_64	[p2l681t2453r783b2532],
20	ABL	NNP	ORGANIZATION	ABL	nn	22	SENT_64	[p2l807t2460r989b2532],
21	catalytic	JJ	O	catalytic	amod	22	SENT_64	[p2l1034t2454r1389b2554],
22	activity	NN	O	activity	prep_of	18	SENT_64	[p2l1434t2454r1740b2554],
23	through	IN	O	through	_	0	SENT_64	[p2l1782t2454r2134b2554],
24	oligomerization	NN	O	oligomerization	prep_through	17	SENT_64	[p2l11t2582r709b2683],
25	and	CC	O	and	_	0	SENT_64	[p2l736t2583r894b2661],
26	autophosphorylationf	NN	O	autophosphorylationf	rcmod	8	SENT_64	[p2l919t2578r1899b2683],
27	‘	CD	NUMBER	‘	num	26	SENT_64	[p2l919t2578r1899b2683],
28	With	IN	O	with	dep	26	SENT_64	[p2l1921t2583r2134b2661],
29	some	DT	O	some	det	31	SENT_64	[p2l12t2736r240b2789],
30	receptor	NN	O	receptor	nn	31	SENT_64	[p2l264t2727r618b2811],
31	TKs	NN	O	tk	pobj	28	SENT_64	[p2l634t2716r827b2806],
32	,	,	O	,	_	0	SENT_64	[p2l634t2716r827b2806],
33	absence	NN	O	absence	nsubj	43	SENT_64	[p2l854t2711r1189b2789],
34	of	IN	O	of	_	0	SENT_64	[p2l1213t2710r1313b2789],
35	the	DT	O	the	det	38	SENT_64	[p2l1318t2711r1446b2789],
36	juxtamembrane	NN	O	juxtamembrane	nn	38	SENT_64	[p2l1456t2711r2135b2811],
37	inhibitory	JJ	O	inhibitory	amod	38	SENT_64	[p2l10t2839r439b2939],
38	domain	NN	O	domain	prep_of	33	SENT_64	[p2l473t2839r802b2917],
39	in	IN	O	in	_	0	SENT_64	[p2l839t2839r921b2916],
40	the	DT	O	the	det	42	SENT_64	[p2l960t2839r1091b2917],
41	fusion	NN	O	fusion	nn	42	SENT_64	[p2l1129t2838r1401b2918],
42	protein	NN	O	protein	prep_in	38	SENT_64	[p2l1438t2839r1751b2939],
43	contributes	VBZ	O	contribute	conj_and	17	SENT_64	[p2l1789t2839r2133b2917, p2l11t2984r183b3047],
44	to	TO	O	to	_	0	SENT_64	[p2l212t2984r292b3046],
45	activation	NN	O	activation	prep_to	43	SENT_64	[p2l320t2968r751b3047],
46	.	.	O	.	_	0	SENT_64	[p2l320t2968r751b3047],

1	A	DT	DURATION	a	det	4	SENT_65	[p2l136t3103r202b3173],
2	second	JJ	DURATION	second	amod	4	SENT_65	[p2l228t3095r529b3174],
3	important	JJ	O	important	amod	4	SENT_65	[p2l557t3096r999b3196],
4	mechanism	NN	O	mechanism	nsubj	12	SENT_65	[p2l1023t3096r1526b3174],
5	of	IN	O	of	_	0	SENT_65	[p2l1555t3095r1656b3174],
6	TK	NN	O	tk	nn	9	SENT_65	[p2l1664t3101r1793b3177],
7	dysreg	NN	O	dysreg	nn	9	SENT_65	[p2l1820t3096r2133b3196],
8	—	NN	O	—	nn	9	SENT_65	[p2l1820t3096r2133b3196],
9	ulation	NN	O	ulation	prep_of	4	SENT_65	[p2l11t3223r313b3303],
10	is	VBZ	O	be	cop	12	SENT_65	[p2l339t3224r405b3302],
11	a	DT	O	a	det	12	SENT_65	[p2l434t3250r478b3302],
12	mutation	NN	O	mutation	_	0	SENT_65	[p2l504t3224r900b3303],
13	that	WDT	O	that	nsubj	14	SENT_65	[p2l928t3223r1098b3302],
14	disrupts	VBZ	O	disrupt	rcmod	12	SENT_65	[p2l1121t3223r1470b3324],
15	autoregulation	NN	O	autoregulation	dobj	14	SENT_65	[p2l1499t3223r2134b3324],
16	of	IN	O	of	_	0	SENT_65	[p2l11t3351r113b3430],
17	the	DT	O	the	det	18	SENT_65	[p2l134t3352r265b3430],
18	kinase	NN	O	kinase	prep_of	15	SENT_65	[p2l305t3352r600b3431],
19	.	.	O	.	_	0	SENT_65	[p2l305t3352r600b3431],

1	Mutations	NNS	O	mutation	nsubj	5	SENT_66	[p2l639t3352r1073b3431],
2	in	IN	O	in	_	0	SENT_66	[p2l1111t3352r1192b3429],
3	the	DT	O	the	det	4	SENT_66	[p2l1229t3352r1358b3430],
4	Fms	NNS	O	fm	prep_in	1	SENT_66	[p2l1393t3352r1763b3431],
5	—	VBP	O	—	_	0	SENT_66	[p2l1393t3352r1763b3431],
6	lil	NN	O	lil	dobj	5	SENT_66	[p2l1393t3352r1763b3431],
7	8	CD	NUMBER	8	num	6	SENT_66	[p3l1975t540r2132b639, p3l11t664r419b769],
8	A	DT	O	a	det	10	SENT_66	[p3l441t676r507b746],
9	third	JJ	ORDINAL	third	amod	10	SENT_66	[p3l530t669r738b747],
10	mechanism	NN	O	mechanism	nsubjpass	15	SENT_66	[p3l762t669r1264b747],
11	of	IN	O	of	_	0	SENT_66	[p3l1290t668r1392b747],
12	TK	NN	O	tk	nn	13	SENT_66	[p3l1394t674r1525b750],
13	dysregulation	NN	O	dysregulation	prep_of	10	SENT_66	[p3l1547t669r2134b769],
14	is	VBZ	O	be	auxpass	15	SENT_66	[p3l10t797r76b875],
15	increased	VBN	O	increase	rcmod	6	SENT_66	[p3l113t797r523b875],
16	or	CC	O	or	_	0	SENT_66	[p3l560t822r650b875],
17	aberrant	JJ	O	aberrant	amod	18	SENT_66	[p3l682t797r1050b875],
18	expression	NN	O	expression	conj_or	6	SENT_66	[p3l1081t797r1544b897],
19	of	IN	O	of	_	0	SENT_66	[p3l1581t796r1682b875],
20	a	DT	O	a	det	22	SENT_66	[p3l1700t823r1744b875],
21	receptor	NN	O	receptor	nn	22	SENT_66	[p3l1778t813r2138b897],
22	TK	NN	O	tk	prep_of	18	SENT_66	[p3l7t930r158b1020],
23	,	,	O	,	_	0	SENT_66	[p3l7t930r158b1020],
24	its	PRP$	O	its	poss	25	SENT_66	[p3l194t925r293b1003],
25	ligand	NN	O	ligand	conj_or	22	SENT_66	[p3l324t925r620b1025],
26	,	,	O	,	_	0	SENT_66	[p3l324t925r620b1025],
27	or	CC	O	or	_	0	SENT_66	[p3l657t950r747b1003],
28	both	DT	O	both	conj_or	22	SENT_66	[p3l776t925r996b1003],
29	.	.	O	.	_	0	SENT_66	[p3l776t925r996b1003],

1	Examples	NNS	MISC	example	nsubj	2	SENT_67	[p3l1031t925r1445b1025],
2	include	VBP	O	include	_	0	SENT_67	[p3l1478t924r1793b1004],
3	overexpression	NN	O	overexpression	dobj	2	SENT_67	[p3l1825t950r2133b1004, p3l9t1053r379b1153],
4	of	IN	O	of	_	0	SENT_67	[p3l403t1052r504b1131],
5	the	DT	O	the	det	7	SENT_67	[p3l509t1053r638b1131],
6	receptor	NN	O	receptor	nn	7	SENT_67	[p3l662t1069r1014b1153],
7	TK	NN	O	tk	prep_of	3	SENT_67	[p3l1030t1058r1160b1134],
8	ERBB2	NN	O	erbb2	dep	2	SENT_67	[p3l1178t1058r1472b1136],
9	(	CD	NUMBER	(	num	10	SENT_67	[p3l1501t1058r2026b1144],
10	HER-2	NN	O	her-2	dep	8	SENT_67	[p3l1501t1058r2026b1144],
11	/	:	O	/	punct	8	SENT_67	[p3l1501t1058r2026b1144],
12	neu	NN	O	neu	nn	13	SENT_67	[p3l1501t1058r2026b1144],
13	)	NN	O	)	dep	8	SENT_67	[p3l1501t1058r2026b1144],
14	in	IN	O	in	_	0	SENT_67	[p3l2054t1053r2135b1130],
15	breast	NN	O	breast	nn	16	SENT_67	[p3l11t1180r271b1259],
16	cancer	NN	O	cancer	prep_in	13	SENT_67	[p3l291t1206r566b1259],
17	and	CC	O	and	_	0	SENT_67	[p3l586t1180r742b1259],
18	overexpression	NN	O	overexpression	nsubj	26	SENT_67	[p3l766t1181r1401b1281],
19	of	IN	O	of	_	0	SENT_67	[p3l1425t1180r1526b1259],
20	a	DT	O	a	det	22	SENT_67	[p3l1531t1207r1575b1259],
21	mutant	JJ	O	mutant	amod	22	SENT_67	[p3l1597t1197r1909b1260],
22	form	NN	O	form	prep_of	18	SENT_67	[p3l1928t1180r2135b1259],
23	of	IN	O	of	_	0	SENT_67	[p3l11t1308r113b1387],
24	platelet	NN	O	platelet	nn	25	SENT_67	[p3l118t1308r789b1409],
25	—	NN	O	—	prep_of	22	SENT_67	[p3l118t1308r789b1409],
26	derived	VBN	O	derive	conj_and	2	SENT_67	[p3l118t1308r789b1409],
27	growth	NN	O	growth	nn	28	SENT_67	[p3l814t1308r1122b1409],
28	factor	NN	O	factor	nsubj	31	SENT_67	[p3l1148t1308r1400b1387],
29	(	CD	NUMBER	(	num	31	SENT_67	[p3l1426t1314r1771b1404],
30	PDGF	NN	ORGANIZATION	pdgf	nn	31	SENT_67	[p3l1426t1314r1771b1404],
31	)	NN	O	)	xcomp	26	SENT_67	[p3l1426t1314r1771b1404],
32	,	,	O	,	_	0	SENT_67	[p3l1426t1314r1771b1404],
33	a	DT	O	a	det	36	SENT_67	[p3l1801t1335r1846b1387],
34	receptor	NN	O	receptor	nn	36	SENT_67	[p3l1869t1335r2133b1409, p3l11t1453r135b1515],
35	TK	NN	O	tk	nn	36	SENT_67	[p3l154t1442r285b1518],
36	ligand	NN	O	ligand	appos	31	SENT_67	[p3l305t1436r604b1537],
37	,	,	O	,	_	0	SENT_67	[p3l305t1436r604b1537],
38	in	IN	O	in	dep	31	SENT_67	[p3l634t1437r717b1514],
39	dermatoﬁbrosarcoma	NN	O	dermatoﬁbrosarcoma	nn	40	SENT_67	[p3l743t1436r1695b1515],
40	protuberans	NNS	O	protuberan	pobj	38	SENT_67	[p3l1718t1437r2133b1537, p3l10t1590r154b1643],
41	with	IN	O	with	_	0	SENT_67	[p3l176t1565r369b1644],
42	t	NN	O	t	prep_with	26	SENT_67	[p3l393t1570r761b1660],
43	(	CD	NUMBER	(	num	44	SENT_67	[p3l393t1570r761b1660],
44	11	CD	NUMBER	11	dep	42	SENT_67	[p3l393t1570r761b1660],
45	;	:	O	;	_	0	SENT_67	[p3l393t1570r761b1660],
46	17	CD	NUMBER	17	num	47	SENT_67	[p3l393t1570r761b1660],
47	)	NN	O	)	dep	42	SENT_67	[p3l393t1570r761b1660],
48	.	.	O	.	_	0	SENT_67	[p3l393t1570r761b1660],

1	Lastly	RB	O	lastly	advmod	37	SENT_68	[p3l790t1565r1054b1665],
2	,	,	O	,	_	0	SENT_68	[p3l790t1565r1054b1665],
3	increased	VBD	O	increase	parataxis	37	SENT_68	[p3l1083t1564r1493b1643],
4	TK	NN	O	tk	nn	5	SENT_68	[p3l1514t1570r1644b1646],
5	activity	NN	O	activity	nsubj	7	SENT_68	[p3l1664t1565r1967b1665],
6	can	MD	O	can	aux	7	SENT_68	[p3l1988t1590r2134b1643],
7	result	VB	O	result	ccomp	3	SENT_68	[p3l11t1692r257b1771],
8	from	IN	O	from	_	0	SENT_68	[p3l282t1692r493b1771],
9	a	DT	O	a	det	10	SENT_68	[p3l522t1719r566b1770],
10	decrease	NN	O	decrease	prep_from	7	SENT_68	[p3l596t1692r964b1771],
11	in	IN	O	in	_	0	SENT_68	[p3l994t1693r1076b1769],
12	factors	NNS	O	factor	prep_in	10	SENT_68	[p3l1106t1692r1397b1771],
13	that	WDT	O	that	nsubj	14	SENT_68	[p3l1430t1692r1600b1770],
14	limit	VBP	O	limit	rcmod	12	SENT_68	[p3l1624t1693r1832b1770],
15	T	NN	O	t	nn	17	SENT_68	[p3l1853t1698r1915b1769],
16	K	NN	O	k	nn	17	SENT_68	[p3l1917t1700r1984b1773],
17	activity	NN	O	activity	dobj	14	SENT_68	[p3l2010t1719r2133b1770, p3l11t1821r232b1921],
18	,	,	O	,	_	0	SENT_68	[p3l2010t1719r2133b1770, p3l11t1821r232b1921],
19	such	JJ	O	such	amod	24	SENT_68	[p3l273t1821r471b1900],
20	as	IN	O	as	dep	21	SENT_68	[p3l505t1847r591b1899],
21	impaired	JJ	O	impaired	amod	24	SENT_68	[p3l627t1821r1015b1921],
22	tyrosine	NN	O	tyrosine	nn	24	SENT_68	[p3l1050t1821r1392b1921],
23	phosphatase	NN	O	phosphatase	nn	24	SENT_68	[p3l1426t1821r1975b1921],
24	activity	NN	O	activity	conj_or	17	SENT_68	[p3l2010t1847r2133b1899, p3l11t1949r219b2049],
25	or	CC	O	or	_	0	SENT_68	[p3l241t1974r330b2027],
26	decreased	VBN	O	decrease	amod	27	SENT_68	[p3l353t1949r778b2027],
27	expression	NN	O	expression	conj_or	17	SENT_68	[p3l803t1949r1267b2049],
28	of	IN	O	of	_	0	SENT_68	[p3l1292t1948r1393b2027],
29	TK	NN	O	tk	nn	31	SENT_68	[p3l1397t1954r1527b2030],
30	inhibitor	NN	O	inhibitor	nn	31	SENT_68	[p3l1548t1949r1932b2027],
31	proteins	NNS	O	protein	prep_of	27	SENT_68	[p3l1953t1974r2133b2049, p3l11t2072r287b2155],
32	.9	CD	NUMBER	.9	num	35	SENT_68	[p3l1953t1974r2133b2049, p3l11t2072r287b2155],
33	Aberrant	JJ	O	aberrant	amod	35	SENT_68	[p3l334t2077r721b2155],
34	TK	NN	O	tk	nn	35	SENT_68	[p3l762t2082r891b2157],
35	activation	NN	O	activation	nsubj	3	SENT_68	[p3l937t2077r1354b2156],
36	can	MD	O	can	aux	37	SENT_68	[p3l1405t2102r1551b2154],
37	increase	VB	O	increase	_	0	SENT_68	[p3l1599t2077r1952b2155],
38	the	DT	O	the	det	39	SENT_68	[p3l2002t2077r2134b2155],
39	survival	NN	O	survival	dobj	37	SENT_68	[p3l12t2205r367b2300],
40	,	,	O	,	_	0	SENT_68	[p3l12t2205r367b2300],
41	proliferation	NN	O	proliferation	conj_and	39	SENT_68	[p3l407t2204r993b2305],
42	,	,	O	,	_	0	SENT_68	[p3l407t2204r993b2305],
43	and	CC	O	and	_	0	SENT_68	[p3l1034t2204r1193b2283],
44	cytotoxic	JJ	O	cytotoxic	amod	46	SENT_68	[p3l1230t2205r1621b2305],
45	drug	NN	O	drug	nn	46	SENT_68	[p3l1657t2205r1863b2305],
46	resistance	NN	O	resistance	conj_and	39	SENT_68	[p3l1895t2205r2131b2283, p3l11t2349r240b2411],
47	of	IN	O	of	_	0	SENT_68	[p3l273t2332r374b2411],
48	malignant	JJ	O	malignant	amod	49	SENT_68	[p3l387t2333r833b2433],
49	cells	NNS	O	cell	prep_of	46	SENT_68	[p3l860t2333r1073b2428],
50	,	,	O	,	_	0	SENT_68	[p3l860t2333r1073b2428],
51	and	CC	O	and	_	0	SENT_68	[p3l1110t2333r1268b2411],
52	in	IN	O	in	_	0	SENT_68	[p3l1299t2333r1381b2410],
53	tumors	NNS	O	tumor	prep_in	56	SENT_68	[p3l1412t2349r1719b2412],
54	it	PRP	O	it	nsubj	56	SENT_68	[p3l1752t2333r1813b2411],
55	can	MD	O	can	aux	56	SENT_68	[p3l1840t2358r1986b2411],
56	increase	VB	O	increase	conj_and	37	SENT_68	[p3l2016t2333r2133b2410, p3l11t2489r275b2541],
57	angiogenesis	NN	O	angiogenesis	dobj	56	SENT_68	[p3l298t2463r890b2563],
58	,	,	O	,	_	0	SENT_68	[p3l298t2463r890b2563],
59	invasiveness	NN	O	invasiveness	dobj	56	SENT_68	[p3l919t2463r1476b2558],
60	,	,	O	,	_	0	SENT_68	[p3l919t2463r1476b2558],
61	and	CC	O	and	_	0	SENT_68	[p3l1504t2462r1662b2541],
62	metastatic	JJ	O	metastatic	amod	63	SENT_68	[p3l1686t2463r2134b2541],
63	potential	NN	O	potential	dobj	56	SENT_68	[p3l9t2592r413b2691],
64	.	.	O	.	_	0	SENT_68	[p3l9t2592r413b2691],

1	STRATEGIES	NNS	O	strategy	nsubj	17	SENT_69	[p3l11t2875r505b2924],
2	To	TO	O	to	aux	3	SENT_69	[p3l542t2875r648b2924],
3	TARGET	VB	O	target	infmod	1	SENT_69	[p3l685t2875r1000b2924],
4	TKs	NNS	O	tk	dobj	3	SENT_69	[p3l1034t2875r1169b2924],
5	IN	IN	O	in	_	0	SENT_69	[p3l1212t2875r1292b2924],
6	CANCER	NNP	O	CANCER	nn	9	SENT_69	[p3l1338t2875r1664b2924],
7	TH	NN	O	th	nn	9	SENT_69	[p3l1702t2875r1805b2924],
8	ERAPY	NN	O	erapy	nn	9	SENT_69	[p3l1828t2875r2077b2924],
9	TKS	NN	O	tk	prep_in	3	SENT_69	[p3l7t2981r176b3057],
10	can	MD	O	can	aux	12	SENT_69	[p3l214t3001r360b3054],
11	be	VB	O	be	auxpass	12	SENT_69	[p3l395t2976r492b3054],
12	inhibited	VBN	O	inhibit	rcmod	9	SENT_69	[p3l526t2975r917b3054],
13	pharmacologically	RB	O	pharmacologically	advmod	12	SENT_69	[p3l950t2975r1755b3076],
14	through	IN	O	through	_	0	SENT_69	[p3l1785t2976r2133b3076],
15	multiple	JJ	O	multiple	amod	16	SENT_69	[p3l11t3104r375b3204],
16	mechanisms	NNS	O	mechanism	prep_through	12	SENT_69	[p3l417t3104r967b3182],
17	(	VBP	O	(	_	0	SENT_69	[p3l1015t3104r1205b3204],
18	Fig	NN	O	fig	dobj	17	SENT_69	[p3l1015t3104r1205b3204],
19	.	.	O	.	_	0	SENT_69	[p3l1015t3104r1205b3204],

1	2	CD	NUMBER	2	num	2	SENT_70	[p3l1253t3109r1362b3195],
2	)	CD	NUMBER	)	_	0	SENT_70	[p3l1253t3109r1362b3195],
3	.	.	O	.	_	0	SENT_70	[p3l1253t3109r1362b3195],

1	The	DT	O	the	det	2	SENT_71	[p3l1406t3104r1570b3182],
2	idea	NN	O	idea	_	0	SENT_71	[p3l1612t3103r1790b3182],
3	behind	RB	O	behind	advmod	4	SENT_71	[p3l1831t3103r2133b3182],
4	much	JJ	O	much	advmod	2	SENT_71	[p3l11t3232r247b3311],
5	of	IN	O	of	_	0	SENT_71	[p3l269t3231r368b3310],
6	anti	JJ	O	anti	prep_of	2	SENT_71	[p3l370t3232r617b3310],
7	.	.	O	.	_	0	SENT_71	[p3l370t3232r617b3310],

1	—	NN	O	—	_	0	SENT_72	[p3l370t3232r617b3310],
2	.	.	O	.	_	0	SENT_72	[p3l370t3232r617b3310],

1	T	NN	O	t	nn	2	SENT_73	[p3l370t3232r617b3310],
2	K	NN	O	k	nsubj	11	SENT_73	[p3l617t3239r684b3313],
3	drug	NN	O	drug	nn	4	SENT_73	[p3l702t3232r898b3332],
4	discovery	NN	O	discovery	nsubj	5	SENT_73	[p3l917t3232r1303b3332],
5	is	VBZ	O	be	rcmod	2	SENT_73	[p3l1319t3232r1382b3310],
6	to	TO	O	to	aux	7	SENT_73	[p3l1406t3248r1484b3310],
7	ﬁnd	VB	O	ﬁnd	xcomp	5	SENT_73	[p3l1506t3231r1672b3310],
8	small	JJ	O	small	amod	10	SENT_73	[p3l1694t3232r1919b3310],
9	mol	NN	O	mol	nn	10	SENT_73	[p3l1939t3232r2134b3310],
10	—	NN	O	—	dobj	7	SENT_73	[p3l1939t3232r2134b3310],
11	ecules	VBZ	O	ecule	_	0	SENT_73	[p3l11t3360r268b3439],
12	that	IN	O	that	complm	14	SENT_73	[p3l304t3359r474b3438],
13	directly	RB	O	directly	advmod	14	SENT_73	[p3l502t3359r821b3460],
14	inhibit	VBP	O	inhibit	ccomp	11	SENT_73	[p3l849t3360r1142b3438],
15	the	DT	O	the	det	17	SENT_73	[p3l1170t3359r1301b3438],
16	catalytic	JJ	O	catalytic	amod	17	SENT_73	[p3l1335t3360r1686b3460],
17	activity	NN	O	activity	dobj	14	SENT_73	[p3l1718t3360r2021b3460],
18	of	IN	O	of	_	0	SENT_73	[p3l2050t3359r2152b3438],
19	the	DT	O	the	det	20	SENT_73	[p3l11t3488r142b3566],
20	kinase	NN	O	kinase	prep_of	17	SENT_73	[p3l173t3488r449b3567],
21	by	IN	O	by	_	0	SENT_73	[p3l481t3488r579b3588],
22	interfering	VBG	O	interfere	prepc_by	14	SENT_73	[p3l605t3487r1070b3588],
23	With	IN	O	with	_	0	SENT_73	[p3l1093t3487r1286b3567],
24	the	DT	O	the	det	25	SENT_73	[p3l1317t3487r1449b3566],
25	binding	NN	O	binding	prep_with	22	SENT_73	[p3l1481t3487r1820b3588],
26	of	IN	O	of	_	0	SENT_73	[p3l1849t3487r1950b3566],
27	ATP	NN	O	atp	prep_of	25	SENT_73	[p3l1959t3493r2135b3565],
28	or	CC	O	or	_	0	SENT_73	[p3l11t3641r101b3694],
29	substrates	NNS	O	substrate	conj_or	27	SENT_73	[p3l124t3616r585b3695],
30	.	.	O	.	_	0	SENT_73	[p3l124t3616r585b3695],

1	Other	JJ	O	other	dep	2	SENT_74	[p3l616t3616r864b3694],
2	anti	JJ	O	anti	_	0	SENT_74	[p3l884t3616r1210b3697],
3	.	.	O	.	_	0	SENT_74	[p3l884t3616r1210b3697],

1	—	NN	O	—	_	0	SENT_75	[p3l884t3616r1210b3697],
2	.	.	O	.	_	0	SENT_75	[p3l884t3616r1210b3697],

1	TK	NN	O	tk	nn	2	SENT_76	[p3l884t3616r1210b3697],
2	drugs	NNS	O	drug	nsubj	4	SENT_76	[p3l1232t3616r1473b3716],
3	may	MD	O	may	aux	4	SENT_76	[p3l1500t3642r1679b3716],
4	inhibit	VB	O	inhibit	_	0	SENT_76	[p3l1698t3616r1990b3694],
5	activation	NN	O	activation	dobj	4	SENT_76	[p3l2009t3642r2132b3694, p4l11t21r327b100],

1	of	IN	O	of	_	0	SENT_77	[p4l360t20r461b99],
2	fusion	NN	O	fusion	nn	3	SENT_77	[p4l475t20r741b100],
3	TKs	NNS	O	tk	pobj	1	SENT_77	[p4l771t26r937b102],
4	by	IN	O	by	_	0	SENT_77	[p4l973t20r1070b121],
5	blocking	VBG	O	block	prepc_by	3	SENT_77	[p4l1098t20r1472b121],
6	their	PRP$	O	they	poss	9	SENT_77	[p4l1502t20r1699b99],
7	dimeriza	JJ	O	dimeriza	amod	9	SENT_77	[p4l1729t21r2133b99],
8	—	NN	O	—	nn	9	SENT_77	[p4l1729t21r2133b99],
9	tion	NN	O	tion	dobj	5	SENT_77	[p4l11t149r200b227],
10	.	.	O	.	_	0	SENT_77	[p4l11t149r200b227],

1	Antibodies	NNS	O	antibody	nsubj	8	SENT_78	[p4l243t149r702b227],
2	against	IN	O	against	_	0	SENT_78	[p4l745t149r1054b249],
3	receptor	NN	O	receptor	nn	4	SENT_78	[p4l1089t165r1441b249],
4	TKS	NN	O	tk	prep_against	1	SENT_78	[p4l1476t154r1643b230],
5	or	CC	O	or	_	0	SENT_78	[p4l1686t174r1775b227],
6	their	PRP$	O	they	poss	7	SENT_78	[p4l1814t148r2012b227],
7	ligands	NNS	O	ligand	prep_against	1	SENT_78	[p4l2048t149r2133b226, p4l10t276r256b377],
8	interrupt	VBP	O	interrupt	ccomp	28	SENT_78	[p4l276t277r647b377],
9	TK	NN	O	tk	nn	10	SENT_78	[p4l657t282r785b358],
10	signaling	NN	O	signaling	dobj	8	SENT_78	[p4l803t276r1186b377],
11	through	IN	O	through	_	0	SENT_78	[p4l1203t277r1537b377],
12	neutralization	NN	O	neutralization	prep_through	8	SENT_78	[p4l1556t277r2134b356],
13	of	IN	O	of	_	0	SENT_78	[p4l11t404r113b483],
14	ligand	NN	O	ligand	prep_of	12	SENT_78	[p4l121t405r411b505],
15	,	,	O	,	_	0	SENT_78	[p4l121t405r411b505],
16	blockade	NN	O	blockade	nsubj	28	SENT_78	[p4l445t404r823b484],
17	of	IN	O	of	_	0	SENT_78	[p4l853t404r953b483],
18	ligand	NN	O	ligand	nn	19	SENT_78	[p4l961t404r1227b505],
19	binding	NN	O	binding	prep_of	16	SENT_78	[p4l1257t404r1609b505],
20	,	,	O	,	_	0	SENT_78	[p4l1257t404r1609b505],
21	receptor	NN	O	receptor	nn	22	SENT_78	[p4l1643t421r1995b505],
22	internalization	NN	O	internalization	conj_and	19	SENT_78	[p4l2019t405r2133b482, p4l11t533r584b628],
23	,	,	O	,	_	0	SENT_78	[p4l2019t405r2133b482, p4l11t533r584b628],
24	and	CC	O	and	_	0	SENT_78	[p4l616t532r773b611],
25	perhaps	RB	O	perhaps	advmod	26	SENT_78	[p4l799t533r1144b633],
26	antibody	NN	O	antibody	conj_and	19	SENT_78	[p4l1173t533r1987b633],
27	—	RB	O	—	advmod	28	SENT_78	[p4l1173t533r1987b633],
28	mediated	VBD	O	mediate	_	0	SENT_78	[p4l1173t533r1987b633],
29	cytotoxicity	NN	O	cytotoxicity	dobj	28	SENT_78	[p4l2015t559r2132b633, p4l11t661r422b761],
30	.	.	O	.	_	0	SENT_78	[p4l2015t559r2132b633, p4l11t661r422b761],

1	The	DT	O	the	det	2	SENT_79	[p4l449t660r611b739],
2	stability	NN	O	stability	nsubjpass	7	SENT_79	[p4l635t660r971b761],
3	of	IN	O	of	_	0	SENT_79	[p4l990t660r1091b739],
4	some	DT	O	some	det	5	SENT_79	[p4l1097t686r1321b739],
5	TKS	NN	O	tk	prep_of	2	SENT_79	[p4l1342t666r1508b742],
6	is	VBZ	O	be	auxpass	7	SENT_79	[p4l1533t661r1598b739],
7	regulated	VBN	O	regulate	_	0	SENT_79	[p4l1623t660r2018b761],
8	by	IN	O	by	_	0	SENT_79	[p4l2042t661r2139b761],
9	binding	VBG	O	bind	agent	7	SENT_79	[p4l11t788r349b889],
10	to	TO	O	to	_	0	SENT_79	[p4l382t805r462b867],
11	heat	NN	O	heat	nn	13	SENT_79	[p4l499t788r978b868],
12	—	NN	O	—	nn	13	SENT_79	[p4l499t788r978b868],
13	shocl	NN	O	shocl	prep_to	9	SENT_79	[p4l499t788r978b868],
14	<	JJR	O	<	amod	15	SENT_79	[p4l499t788r978b868],
15	proteins	NNS	O	protein	dobj	9	SENT_79	[p4l1008t789r1363b889],
16	(	CD	NUMBER	(	nsubj	34	SENT_79	[p4l1406t796r1618b889],
17	e.g.	FW	O	e.g.	dep	16	SENT_79	[p4l1406t796r1618b889],
18	,	,	O	,	_	0	SENT_79	[p4l1406t796r1618b889],
19	heat	NN	O	heat	nn	22	SENT_79	[p4l1659t789r2138b868],
20	—	CD	NUMBER	—	num	22	SENT_79	[p4l1659t789r2138b868],
21	shock	NN	O	shock	nn	22	SENT_79	[p4l1659t789r2138b868],
22	protein	NN	O	protein	conj_and	16	SENT_79	[p4l9t917r322b1017],
23	90	CD	NUMBER	90	number	24	SENT_79	[p4l354t922r454b995],
24	[	CD	NUMBER	[	num	25	SENT_79	[p4l494t922r897b1017],
25	Hsp90	NN	O	hsp90	dep	22	SENT_79	[p4l494t922r897b1017],
26	]	CD	NUMBER	]	num	27	SENT_79	[p4l494t922r897b1017],
27	)	NN	O	)	dep	22	SENT_79	[p4l494t922r897b1017],
28	,	,	O	,	_	0	SENT_79	[p4l494t922r897b1017],
29	and	CC	O	and	_	0	SENT_79	[p4l933t917r1089b995],
30	inhibitors	NNS	O	inhibitor	conj_and	16	SENT_79	[p4l1120t917r1533b995],
31	of	IN	O	of	_	0	SENT_79	[p4l1567t916r1667b995],
32	Hsp9O	NN	O	hsp9o	prep_of	30	SENT_79	[p4l1680t922r1957b1017],
33	can	MD	O	can	aux	34	SENT_79	[p4l1991t942r2134b995],
34	disrupt	VB	O	disrupt	rcmod	15	SENT_79	[p4l11t1045r317b1145],
35	the	DT	O	the	det	36	SENT_79	[p4l337t1045r466b1123],
36	binding	NN	O	binding	dobj	34	SENT_79	[p4l493t1044r826b1145],
37	of	IN	O	of	_	0	SENT_79	[p4l849t1044r949b1123],
38	client	NN	O	client	nn	39	SENT_79	[p4l957t1044r1191b1123],
39	proteins	NNS	O	protein	prep_of	36	SENT_79	[p4l1210t1045r1559b1145],
40	such	JJ	O	such	_	0	SENT_79	[p4l1588t1045r1782b1124],
41	as	IN	O	as	_	0	SENT_79	[p4l1807t1071r1891b1123],
42	BCR	NN	O	bcr	nn	44	SENT_79	[p4l1917t1050r2133b1128],
43	—	CD	NUMBER	—	num	44	SENT_79	[p4l1917t1050r2133b1128],
44	ABL	NN	ORGANIZATION	abl	prep_such_as	39	SENT_79	[p4l7t1179r186b1251],
45	and	CC	O	and	_	0	SENT_79	[p4l208t1173r363b1251],
46	HER-2	NN	O	her-2	conj_and	44	SENT_79	[p4l387t1178r688b1268],
47	,	,	O	,	_	0	SENT_79	[p4l387t1178r688b1268],
48	causing	VBG	O	cause	partmod	34	SENT_79	[p4l719t1173r1047b1273],
49	their	PRP$	O	they	poss	50	SENT_79	[p4l1068t1172r1266b1251],
50	degradation	NN	O	degradation	dobj	48	SENT_79	[p4l1288t1172r1818b1273],
51	.	.	O	.	_	0	SENT_79	[p4l1288t1172r1818b1273],

1	An	DT	O	a	det	3	SENT_80	[p4l1845t1180r1965b1250],
2	important	JJ	O	important	amod	3	SENT_80	[p4l1989t1173r2133b1250, p4l9t1317r328b1401],
3	advantage	NN	O	advantage	nsubj	7	SENT_80	[p4l353t1300r779b1401],
4	of	IN	O	of	_	0	SENT_80	[p4l811t1300r911b1379],
5	TK	NN	O	tk	nn	6	SENT_80	[p4l920t1300r1417b1382],
6	—	NN	O	—	prep_of	3	SENT_80	[p4l920t1300r1417b1382],
7	directed	VBD	O	direct	_	0	SENT_80	[p4l920t1300r1417b1382],
8	therapy	NN	O	therapy	nsubj	9	SENT_80	[p4l1448t1300r1764b1401],
9	is	VBZ	O	be	ccomp	7	SENT_80	[p4l1790t1301r1854b1379],
10	that	IN	O	that	complm	13	SENT_80	[p4l1888t1301r2054b1379],
11	it	PRP	O	it	nsubj	13	SENT_80	[p4l2080t1301r2139b1379],
12	is	VBZ	O	be	cop	13	SENT_80	[p4l9t1429r74b1507],
13	possible	JJ	O	possible	ccomp	9	SENT_80	[p4l114t1428r465b1529],
14	to	TO	O	to	aux	15	SENT_80	[p4l505t1445r584b1507],
15	perform	VB	O	perform	xcomp	13	SENT_80	[p4l622t1428r970b1529],
16	pharmacodynamic	JJ	O	pharmacodynamic	amod	17	SENT_80	[p4l1008t1428r1799b1529],
17	studies	NNS	O	study	dobj	15	SENT_80	[p4l1839t1428r2133b1508],
18	that	WDT	O	that	nsubj	19	SENT_80	[p4l11t1557r177b1635],
19	correlate	VBP	O	correlate	rcmod	17	SENT_80	[p4l203t1557r568b1635],
20	inhibition	NN	O	inhibition	dobj	19	SENT_80	[p4l598t1557r1018b1635],
21	of	IN	O	of	_	0	SENT_80	[p4l1048t1556r1149b1635],
22	the	DT	O	the	det	24	SENT_80	[p4l1160t1557r1289b1635],
23	targeted	VBN	O	target	amod	24	SENT_80	[p4l1319t1556r1665b1657],
24	TK	NN	O	tk	prep_of	20	SENT_80	[p4l1690t1562r1819b1638],
25	in	IN	O	in	_	0	SENT_80	[p4l1845t1557r1926b1634],
26	cancer	NN	O	cancer	nn	27	SENT_80	[p4l1956t1582r2133b1635, p4l11t1711r136b1763],
27	cells	NNS	O	cell	prep_in	15	SENT_80	[p4l159t1684r342b1763],
28	With	IN	O	with	_	0	SENT_80	[p4l364t1685r554b1764],
29	clinical	JJ	O	clinical	amod	30	SENT_80	[p4l579t1684r880b1763],
30	responses	NNS	O	response	prep_with	27	SENT_80	[p4l905t1710r1325b1785],
31	to	TO	O	to	_	0	SENT_80	[p4l1353t1701r1431b1763],
32	the	DT	O	the	det	33	SENT_80	[p4l1458t1685r1587b1763],
33	drug	NN	O	drug	prep_to	15	SENT_80	[p4l1614t1685r1833b1785],
34	.	.	O	.	_	0	SENT_80	[p4l1614t1685r1833b1785],

1	TKS	NN	O	tk	_	0	SENT_81	[p4l390t2044r576b2105],
2	AS	JJ	O	as	amod	3	SENT_81	[p4l622t2044r741b2103],
3	TARGETS	NNS	O	target	dep	1	SENT_81	[p4l790t2044r1284b2104],
4	IN	IN	O	in	dep	3	SENT_81	[p4l1339t2044r1465b2104],
5	THE	DT	O	the	dep	4	SENT_81	[p4l1516t2044r1738b2102],

1	TREATMENT	NN	O	treatment	_	0	SENT_82	[p4l254t2166r945b2225],
2	OF	IN	O	of	_	0	SENT_82	[p4l993t2166r1128b2225],
3	MALIGNANT	JJ	O	malignant	prep_of	1	SENT_82	[p4l1179t2166r1877b2225],

1	HEMATOLOGIC	JJ	O	hematologic	amod	2	SENT_83	[p4l296t2287r1134b2346],
2	DISORDERS	NNS	O	disorder	_	0	SENT_83	[p4l1189t2287r1837b2346],

1	IMATINIB	NN	O	imatinib	nn	2	SENT_84	[p4l16t2516r407b2564],
2	MESYLATE2	NN	O	mesylate2	_	0	SENT_84	[p4l453t2515r894b2565],
3	THE	DT	O	the	det	8	SENT_84	[p4l931t2516r1091b2564],
4	FIRST	NNP	ORDINAL	FIRST	nn	8	SENT_84	[p4l1136t2515r1359b2565],
5	SUCCESSFUL	NNP	O	SUCCESSFUL	nn	8	SENT_84	[p4l1395t2515r1919b2565],
6	SMALL-MOLECULE	NN	O	small-molecule	nn	8	SENT_84	[p4l11t2599r768b2648],
7	TK	NN	O	tk	nn	8	SENT_84	[p4l805t2599r899b2648],
8	INHIBITOR	NN	O	inhibitor	dep	2	SENT_84	[p4l945t2599r1395b2648],
9	The	DT	O	the	det	11	SENT_84	[p4l7t2700r170b2778],
10	prime	JJ	O	prime	amod	11	SENT_84	[p4l209t2700r466b2800],
11	example	NN	O	example	nsubj	20	SENT_84	[p4l508t2700r869b2800],
12	of	IN	O	of	_	0	SENT_84	[p4l911t2699r1013b2778],
13	a	DT	O	a	prep_of	11	SENT_84	[p4l1035t2726r1079b2778],
14	dysregulated	VBN	O	dysregulate	partmod	13	SENT_84	[p4l1119t2699r1672b2800],
15	TK	NN	O	tk	dobj	14	SENT_84	[p4l1709t2705r1840b2781],
16	in	IN	O	in	_	0	SENT_84	[p4l1876t2700r1959b2777],
17	the	DT	O	the	det	19	SENT_84	[p4l2000t2700r2133b2778],
18	hematologic	JJ	O	hematologic	amod	19	SENT_84	[p4l11t2827r551b2928],
19	cancers	NNS	O	cancer	prep_in	15	SENT_84	[p4l577t2853r897b2906],
20	(	VBP	O	(	rcmod	2	SENT_84	[p4l930t2828r1190b2919],
21	Table	NNP	O	Table	dobj	20	SENT_84	[p4l930t2828r1190b2919],
22	1	CD	NUMBER	1	num	23	SENT_84	[p4l1220t2833r1295b2919],
23	)	NN	O	)	nsubj	25	SENT_84	[p4l1220t2833r1295b2919],
24	is	VBZ	O	be	cop	25	SENT_84	[p4l1325t2828r1391b2906],
25	BCR	NN	O	bcr	rcmod	21	SENT_84	[p4l1418t2833r1842b2923],
26	.	.	O	.	_	0	SENT_84	[p4l1418t2833r1842b2923],

1	—	NN	O	—	_	0	SENT_85	[p4l1418t2833r1842b2923],
2	.	.	O	.	_	0	SENT_85	[p4l1418t2833r1842b2923],

1	ABL	NNP	ORGANIZATION	ABL	_	0	SENT_86	[p4l1418t2833r1842b2923],
2	,	,	O	,	_	0	SENT_86	[p4l1418t2833r1842b2923],
3	which	WDT	O	which	nsubjpass	6	SENT_86	[p4l1868t2828r2133b2907],
4	has	VBZ	O	have	aux	6	SENT_86	[p4l11t2956r153b3034],
5	been	VBN	O	be	auxpass	6	SENT_86	[p4l184t2956r386b3034],
6	implicated	VBN	O	implicate	dep	1	SENT_86	[p4l413t2956r870b3056],
7	as	IN	O	as	_	0	SENT_86	[p4l897t2982r982b3034],
8	the	DT	O	the	det	10	SENT_86	[p4l1013t2956r1144b3034],
9	direct	JJ	O	direct	amod	10	SENT_86	[p4l1173t2956r1420b3034],
10	cause	NN	O	cause	prep_as	6	SENT_86	[p4l1444t2982r1678b3035],
11	of	IN	O	of	_	0	SENT_86	[p4l1707t2955r1808b3034],
12	CML	NN	ORGANIZATION	cml	prep_of	10	SENT_86	[p4l1818t2950r2133b3034],
13	.	.	O	.	_	0	SENT_86	[p4l1818t2950r2133b3034],

1	“	NN	O	“	nn	6	SENT_87	[p4l1818t2950r2133b3034],
2	Imatinib	NN	O	imatinib	nn	6	SENT_87	[p4l9t3084r379b3162],
3	mesylate	NN	O	mesylate	nn	6	SENT_87	[p4l408t3084r781b3184],
4	(	CD	NUMBER	(	num	6	SENT_87	[p4l814t3083r1236b3179],
5	Gleevec	NNP	O	Gleevec	nn	6	SENT_87	[p4l814t3083r1236b3179],
6	)	NN	O	)	_	0	SENT_87	[p4l814t3083r1236b3179],
7	,	,	O	,	_	0	SENT_87	[p4l814t3083r1236b3179],
8	a	DT	O	a	quantmod	9	SENT_87	[p4l1270t3110r1314b3162],
9	2	CD	NUMBER	2	num	14	SENT_87	[p4l1339t3084r2132b3184],
10	—	NN	O	—	nn	14	SENT_87	[p4l1339t3084r2132b3184],
11	phenylaminopy	NN	O	phenylaminopy	nn	14	SENT_87	[p4l1339t3084r2132b3184],
12	—	NN	O	—	nn	14	SENT_87	[p4l1339t3084r2132b3184],
13	rimidine	NN	O	rimidine	nn	14	SENT_87	[p4l11t3212r380b3290],
14	compound	NN	O	compound	nsubj	24	SENT_87	[p4l412t3212r879b3312],
15	that	WDT	O	that	nsubj	19	SENT_87	[p4l911t3212r1080b3290],
16	is	VBZ	O	be	cop	19	SENT_87	[p4l1106t3212r1172b3290],
17	a	DT	O	a	det	19	SENT_87	[p4l1205t3238r1249b3290],
18	speciﬁc	NN	O	speciﬁc	nn	19	SENT_87	[p4l1281t3211r1607b3312],
19	inhibitor	NN	O	inhibitor	rcmod	14	SENT_87	[p4l1637t3212r2021b3290],
20	of	IN	O	of	_	0	SENT_87	[p4l2050t3211r2152b3290],
21	several	JJ	O	several	amod	23	SENT_87	[p4l12t3340r289b3419],
22	T	NN	O	t	nn	23	SENT_87	[p4l307t3345r368b3417],
23	Ks	NNS	O	k	prep_of	19	SENT_87	[p4l369t3347r473b3421],
24	—	VBP	O	—	dep	6	SENT_87	[p4l493t3384r601b3392],
25	namely	RB	O	namely	advmod	24	SENT_87	[p4l619t3340r932b3440],
26	,	,	O	,	_	0	SENT_87	[p4l619t3340r932b3440],
27	ABL	NNP	ORGANIZATION	ABL	appos	6	SENT_87	[p4l956t3346r1153b3435],
28	,	,	O	,	_	0	SENT_87	[p4l956t3346r1153b3435],
29	ABL	NNP	O	ABL	appos	6	SENT_87	[p4l1177t3340r1667b3418],
30	—	CD	NUMBER	—	num	29	SENT_87	[p4l1177t3340r1667b3418],
31	related	JJ	O	related	amod	36	SENT_87	[p4l1177t3340r1667b3418],
32	gene	NN	O	gene	nn	36	SENT_87	[p4l1690t3365r1885b3440],
33	product	NN	O	product	nn	36	SENT_87	[p4l1907t3339r2134b3440, p4l10t3484r141b3547],
34	(	CD	NUMBER	(	num	36	SENT_87	[p4l167t3473r456b3563],
35	ARG	NN	O	arg	nn	36	SENT_87	[p4l167t3473r456b3563],
36	)	NN	O	)	dep	29	SENT_87	[p4l167t3473r456b3563],
37	,	,	O	,	_	0	SENT_87	[p4l167t3473r456b3563],
38	c	NN	O	c	appos	6	SENT_87	[p4l488t3473r743b3563],
39	.	.	O	.	_	0	SENT_87	[p4l488t3473r743b3563],

1	—	NN	O	—	_	0	SENT_88	[p4l488t3473r743b3563],
2	.	.	O	.	_	0	SENT_88	[p4l488t3473r743b3563],

1	KIT	NN	O	kit	nsubj	10	SENT_89	[p4l488t3473r743b3563],
2	,	,	O	,	_	0	SENT_89	[p4l488t3473r743b3563],
3	and	CC	O	and	_	0	SENT_89	[p4l773t3467r932b3546],
4	PDGF	NN	ORGANIZATION	pdgf	nn	7	SENT_89	[p4l955t3473r1209b3546],
5	receptor	NN	O	receptor	nn	7	SENT_89	[p4l1236t3484r1595b3568],
6	(	NN	O	(	nn	7	SENT_89	[p4l1622t3473r2003b3559],
7	PDGFR	NN	O	pdgfr	nsubj	10	SENT_89	[p4l1622t3473r2003b3559],
8	)	CD	NUMBER	)	num	9	SENT_89	[p4l1622t3473r2003b3559],
9	—	NN	O	—	dep	7	SENT_89	[p4l2030t3512r2138b3520],
10	induces	VBZ	O	induce	_	0	SENT_89	[p4l9t3595r343b3675],
11	complete	JJ	O	complete	amod	15	SENT_89	[p4l394t3595r793b3696],
12	hematologic	JJ	O	hematologic	amod	15	SENT_89	[p4l842t3595r1386b3696],
13	and	CC	O	and	_	0	SENT_89	[p4l1433t3596r1592b3674],
14	cytogenetic	JJ	O	cytogenetic	amod	15	SENT_89	[p4l1641t3596r2134b3696],
15	remissions	NNS	O	remission	dobj	10	SENT_89	[p5l11t21r482b99],
16	in	IN	O	in	_	0	SENT_89	[p5l524t21r607b98],
17	most	JJS	O	most	amod	18	SENT_89	[p5l647t37r867b99],
18	patients	NNS	O	patient	prep_in	15	SENT_89	[p5l902t21r1244b121],
19	with	IN	O	with	_	0	SENT_89	[p5l1282t21r1475b100],
20	chronic	JJ	O	chronic	amod	24	SENT_89	[p5l1516t20r2133b121],
21	—	NN	O	—	nn	24	SENT_89	[p5l1516t20r2133b121],
22	phase	NN	O	phase	nn	24	SENT_89	[p5l1516t20r2133b121],
23	CML1	NN	O	cml1	nn	24	SENT_89	[p5l11t143r296b227],
24	°	NN	O	°	prep_with	10	SENT_89	[p5l11t143r296b227],
25	but	CC	O	but	_	0	SENT_89	[p5l319t149r462b228],
26	is	VBZ	O	be	cop	37	SENT_89	[p5l479t149r545b227],
27	much	RB	O	much	advmod	29	SENT_89	[p5l570t149r813b228],
28	less	RBR	O	less	advmod	29	SENT_89	[p5l835t149r993b227],
29	effective	JJ	O	effective	amod	37	SENT_89	[p5l1018t148r1372b228],
30	in	IN	O	in	_	0	SENT_89	[p5l1394t150r1476b226],
31	the	DT	O	the	det	35	SENT_89	[p5l1499t149r1631b227],
32	accelerated	VBN	O	accelerate	nn	35	SENT_89	[p5l1653t148r2133b227],
33	and	CC	O	and	_	0	SENT_89	[p5l9t277r166b355],
34	blast	NN	O	blast	conj_and	32	SENT_89	[p5l189t277r646b355],
35	—	NN	O	—	prep_in	29	SENT_89	[p5l189t277r646b355],
36	crisis	NN	O	crisis	nn	37	SENT_89	[p5l189t277r646b355],
37	phases	NNS	O	phase	conj_but	10	SENT_89	[p5l670t277r958b377],
38	of	IN	O	of	_	0	SENT_89	[p5l983t276r1084b355],
39	the	DT	O	the	det	40	SENT_89	[p5l1089t277r1218b355],
40	disease	NN	O	disease	prep_of	37	SENT_89	[p5l1243t271r1656b355],
41	.	.	O	.	_	0	SENT_89	[p5l1243t271r1656b355],

1	“	NN	O	“	nn	2	SENT_90	[p5l1243t271r1656b355],
2	ABL	NN	ORGANIZATION	abl	nsubjpass	5	SENT_90	[p5l1676t284r1855b355],
3	is	VBZ	O	be	auxpass	5	SENT_90	[p5l1876t278r1941b355],
4	also	RB	O	also	advmod	5	SENT_90	[p5l1965t277r2133b355],
5	activated	VBN	O	activate	_	0	SENT_90	[p5l10t404r379b484],
6	by	IN	O	by	_	0	SENT_90	[p5l416t404r513b505],
7	fusion	NN	O	fusion	agent	5	SENT_90	[p5l545t404r812b484],
8	to	TO	O	to	_	0	SENT_90	[p5l849t421r928b483],
9	nucleoporin	NN	O	nucleoporin	prep_to	5	SENT_90	[p5l966t405r1480b505],
10	214	CD	NUMBER	214	number	11	SENT_90	[p5l1517t410r1671b483],
11	(	CD	NUMBER	(	num	13	SENT_90	[p5l1712t410r2128b496],
12	NUP214	NN	O	nup214	nn	13	SENT_90	[p5l1712t410r2128b496],
13	)	NN	O	)	nsubj	29	SENT_90	[p5l1712t410r2128b496],
14	in	IN	O	in	_	0	SENT_90	[p5l9t533r92b610],
15	5	CD	PERCENT	5	num	16	SENT_90	[p5l131t540r173b611],
16	percent	NN	PERCENT	percent	prep_in	13	SENT_90	[p5l212t549r539b633],
17	of	IN	O	of	_	0	SENT_90	[p5l571t532r672b611],
18	T	NN	O	t	nn	20	SENT_90	[p5l687t532r927b611],
19	—	NN	O	—	nn	20	SENT_90	[p5l687t532r927b611],
20	cell	NN	O	cell	prep_of	16	SENT_90	[p5l687t532r927b611],
21	acute	JJ	O	acute	amod	23	SENT_90	[p5l962t549r1186b612],
22	lymphoblastic	JJ	O	lymphoblastic	amod	23	SENT_90	[p5l1222t532r1835b633],
23	leukemias15	NN	O	leukemias15	dep	20	SENT_90	[p5l1869t532r2132b612, p5l11t655r287b739],
24	and	CC	O	and	_	0	SENT_90	[p5l311t661r465b739],
25	to	TO	O	to	_	0	SENT_90	[p5l488t677r566b739],
26	ETV6	NN	O	etv6	nn	27	SENT_90	[p5l587t667r811b739],
27	(	NN	O	(	prep_to	13	SENT_90	[p5l839t661r1031b752],
28	also	RB	O	also	advmod	29	SENT_90	[p5l839t661r1031b752],
29	known	VBN	O	know	rcmod	9	SENT_90	[p5l1054t661r1342b740],
30	as	IN	O	as	_	0	SENT_90	[p5l1363t687r1447b739],
31	TEL	NN	O	tel	prep_as	29	SENT_90	[p5l1467t667r1662b752],
32	)	CD	NUMBER	)	num	31	SENT_90	[p5l1467t667r1662b752],
33	in	IN	O	in	_	0	SENT_90	[p5l1689t662r1769b738],
34	rare	JJ	O	rare	amod	35	SENT_90	[p5l1791t687r1951b739],
35	cases	NNS	O	case	prep_in	29	SENT_90	[p5l1974t687r2134b739, p5l11t815r92b867],
36	of	IN	O	of	_	0	SENT_90	[p5l120t788r221b867],
37	atypical	JJ	O	atypical	amod	38	SENT_90	[p5l227t789r555b889],
38	CML	NN	ORGANIZATION	cml	prep_of	35	SENT_90	[p5l580t794r785b867],
39	and	CC	O	and	_	0	SENT_90	[p5l807t789r964b867],
40	acute	JJ	O	acute	amod	41	SENT_90	[p5l989t805r1213b868],
41	leukemia	NN	O	leukemia	prep_of	35	SENT_90	[p5l1237t783r1742b884],
42	,	,	O	,	_	0	SENT_90	[p5l1237t783r1742b884],
43	”	CD	NUMBER	”	prep_of	35	SENT_90	[p5l1237t783r1742b884],
44	both	CC	O	both	preconj	38	SENT_90	[p5l1770t789r1965b867],
45	potential	JJ	O	potential	amod	46	SENT_90	[p5l1989t814r2131b889, p5l11t917r281b995],
46	targets	NNS	O	target	conj_and	38	SENT_90	[p5l308t933r598b1017],
47	for	IN	O	for	_	0	SENT_90	[p5l625t916r748b995],
48	imatinib	NN	O	imatinib	prep_for	29	SENT_90	[p5l769t911r1238b995],
49	.	.	O	.	_	0	SENT_90	[p5l769t911r1238b995],

1	“	NN	O	“	_	0	SENT_91	[p5l769t911r1238b995],

1	Imatinib	NN	O	imatinib	nsubj	4	SENT_92	[p5l138t1045r508b1123],
2	should	MD	O	should	aux	4	SENT_92	[p5l555t1044r847b1124],
3	also	RB	O	also	advmod	4	SENT_92	[p5l890t1044r1061b1123],
4	have	VB	O	have	_	0	SENT_92	[p5l1107t1045r1298b1124],
5	activity	NN	O	activity	dobj	4	SENT_92	[p5l1342t1045r1645b1145],
6	in	IN	O	in	_	0	SENT_92	[p5l1684t1045r1766b1122],
7	cancers	NNS	O	cancer	prep_in	5	SENT_92	[p5l1811t1070r2131b1123],
8	caused	VBN	O	cause	partmod	7	SENT_92	[p5l11t1173r303b1252],
9	by	IN	O	by	_	0	SENT_92	[p5l335t1173r433b1273],
10	activated	VBN	O	activate	amod	11	SENT_92	[p5l460t1172r838b1252],
11	PDGFRS	NN	O	pdgfr	agent	8	SENT_92	[p5l867t1178r1231b1256],
12	and	CC	O	and	_	0	SENT_92	[p5l1265t1172r1422b1251],
13	c	NN	O	c	conj_and	11	SENT_92	[p5l1455t1178r1710b1254],
14	.	.	O	.	_	0	SENT_92	[p5l1455t1178r1710b1254],

1	—	NN	O	—	_	0	SENT_93	[p5l1455t1178r1710b1254],
2	.	.	O	.	_	0	SENT_93	[p5l1455t1178r1710b1254],

1	KIT	NN	O	kit	_	0	SENT_94	[p5l1455t1178r1710b1254],
2	.	.	O	.	_	0	SENT_94	[p5l1455t1178r1710b1254],

1	PDGFRoz	NNP	O	PDGFRoz	nsubjpass	3	SENT_95	[p5l1746t1178r2130b1256],
2	is	VBZ	O	be	auxpass	3	SENT_95	[p5l9t1301r77b1379],
3	activated	VBN	O	activate	_	0	SENT_95	[p5l131t1301r513b1380],
4	by	IN	O	by	_	0	SENT_95	[p5l565t1301r664b1401],
5	cryptic	JJ	O	cryptic	amod	7	SENT_95	[p5l713t1301r1003b1401],
6	interstitial	JJ	O	interstitial	amod	7	SENT_95	[p5l1054t1301r1504b1379],
7	chromosome	NN	O	chromosome	agent	3	SENT_95	[p5l1557t1301r2133b1379],
8	4	CD	NUMBER	4	num	9	SENT_95	[p5l8t1434r59b1507],
9	deletions	NNS	O	deletion	dobj	3	SENT_95	[p5l85t1428r474b1507],
10	that	WDT	O	that	nsubj	11	SENT_95	[p5l520t1428r691b1507],
11	generate	VBP	O	generate	rcmod	9	SENT_95	[p5l729t1445r1096b1529],
12	a	DT	O	a	det	13	SENT_95	[p5l1139t1455r1184b1507],
13	FIP1L1	NN	O	fip1l1	dobj	11	SENT_95	[p5l1224t1434r1967b1512],
14	.	.	O	.	_	0	SENT_95	[p5l1224t1434r1967b1512],

1	—	NN	O	—	_	0	SENT_96	[p5l1224t1434r1967b1512],
2	.	.	O	.	_	0	SENT_96	[p5l1224t1434r1967b1512],

1	PDGFR0z	NN	O	pdgfr0z	nn	3	SENT_97	[p5l1224t1434r1967b1512],
2	fusion	NN	O	fusion	nn	3	SENT_97	[p5l2013t1428r2131b1508, p5l12t1557r192b1635],
3	TK	NN	O	tk	_	0	SENT_97	[p5l222t1562r352b1638],
4	in	IN	O	in	_	0	SENT_97	[p5l381t1557r463b1634],
5	some	DT	O	some	det	6	SENT_97	[p5l498t1582r726b1635],
6	patients	NNS	O	patient	prep_in	3	SENT_97	[p5l758t1557r1100b1657],
7	with	IN	O	with	_	0	SENT_97	[p5l1130t1557r1323b1636],
8	hypereosinophilic	JJ	O	hypereosinophilic	prep_with	3	SENT_97	[p5l1356t1556r2134b1657],

1	N	NN	O	n	nn	3	SENT_98	[p5l527t1734r541b1749],
2	ENGLJ	NN	O	englj	nn	3	SENT_98	[p5l556t1733r640b1755],
3	MED	NN	O	med	_	0	SENT_98	[p5l655t1734r708b1749],
4	353	CD	NUMBER	353	dep	3	SENT_98	[p5l720t1733r784b1755],
5	;	:	O	;	_	0	SENT_98	[p5l720t1733r784b1755],
6	2	CD	NUMBER	2	num	7	SENT_98	[p5l720t1733r784b1755],
7	www	NN	O	www	dep	3	SENT_98	[p5l818t1734r893b1749],
8	.	.	O	.	_	0	SENT_98	[p5l818t1734r893b1749],

1	EJM.ORG	NN	O	ejm.org	nn	2	SENT_99	[p5l921t1733r1030b1755],
2	ULY14	NN	O	uly14	_	0	SENT_99	[p5l1079t1733r1170b1755],
3	,	,	O	,	_	0	SENT_99	[p5l1079t1733r1170b1755],
4	2005	CD	DATE	2005	num	5	SENT_99	[p5l1183t1733r1247b1755],
5	173	CD	NUMBER	173	appos	2	SENT_99	[p5l1961t1732r2016b1754],

1	The	DT	O	the	det	5	SENT_100	[p5l702t1766r753b1790],
2	New	NNP	O	New	nn	5	SENT_100	[p5l762t1767r824b1790],
3	England	NNP	O	England	nn	5	SENT_100	[p5l833t1766r944b1797],
4	Jouma	NNP	PERSON	Jouma	nn	5	SENT_100	[p5l953t1767r1042b1790],
5	o	NN	O	o	_	0	SENT_100	[p5l1060t1774r1075b1790],
6	Medicine	NN	O	medicine	dep	5	SENT_100	[p5l1096t1766r1221b1790],

1	Downloaded	VBN	O	download	_	0	SENT_101	[p5l144t1807r314b1830],
2	from	IN	O	from	_	0	SENT_101	[p5l323t1807r387b1830],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_101	[p5l396t1807r514b1837],
4	at	IN	O	at	_	0	SENT_101	[p5l525t1811r548b1830],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_101	[p5l556t1807r739b1830],
6	on	IN	O	on	_	0	SENT_101	[p5l748t1814r781b1830],
7	January	NNP	DATE	January	prep_on	1	SENT_101	[p5l789t1807r892b1837],
8	5	CD	DATE	5	num	7	SENT_101	[p5l902t1807r925b1834],
9	,	,	DATE	,	_	0	SENT_101	[p5l902t1807r925b1834],
10	2014	CD	DATE	2014	num	7	SENT_101	[p5l935t1807r1007b1830],
11	.	.	O	.	_	0	SENT_101	[p5l935t1807r1007b1830],

1	For	IN	O	for	_	0	SENT_102	[p5l1018t1807r1064b1830],
2	personal	JJ	O	personal	amod	3	SENT_102	[p5l1073t1807r1185b1837],
3	use	NN	O	use	pobj	1	SENT_102	[p5l1194t1814r1238b1830],
4	only	RB	O	only	advmod	3	SENT_102	[p5l1247t1807r1312b1837],
5	.	.	O	.	_	0	SENT_102	[p5l1247t1807r1312b1837],

1	No	DT	O	no	det	3	SENT_103	[p5l1323t1807r1363b1830],
2	other	JJ	O	other	amod	3	SENT_103	[p5l1373t1807r1441b1830],
3	uses	NNS	O	use	_	0	SENT_103	[p5l1449t1814r1505b1830],
4	without	IN	O	without	_	0	SENT_103	[p5l1515t1807r1616b1830],
5	permission	NN	O	permission	prep_without	3	SENT_103	[p5l1624t1807r1777b1837],
6	.	.	O	.	_	0	SENT_103	[p5l1624t1807r1777b1837],

1	Copyright	NN	O	copyright	_	0	SENT_104	[p5l494t1848r629b1879],
2	©	CD	NUMBER	©	num	6	SENT_104	[p5l638t1848r661b1872],
3	2005	CD	DATE	2005	num	6	SENT_104	[p5l672t1848r736b1872],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_104	[p5l746t1848r937b1872],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_104	[p5l947t1848r1055b1872],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_104	[p5l1066t1848r1171b1879],
7	.	.	O	.	_	0	SENT_104	[p5l1066t1848r1171b1879],

1	All	DT	O	all	det	2	SENT_105	[p5l1182t1848r1223b1872],
2	rights	NNS	O	rights	nsubj	3	SENT_105	[p5l1232t1848r1307b1879],
3	reserved	VBN	O	reserve	_	0	SENT_105	[p5l1317t1848r1436b1872],
4	.	.	O	.	_	0	SENT_105	[p5l1317t1848r1436b1872],

1	The	DT	O	the	det	4	SENT_106	[p5l715t1954r752b1975],
2	NEW	NNP	O	NEW	nn	4	SENT_106	[p5l764t1956r845b1975],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_106	[p5l859t1956r1034b1975],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_106	[p5l1048t1956r1214b1982],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_106	[p5l1228t1954r1444b1981],

1	syndrome	NN	O	syndrome	nsubj	36	SENT_107	[p5l12t2176r520b2281],
2	”	CD	NUMBER	”	num	1	SENT_107	[p5l12t2176r520b2281],
3	or	CC	O	or	_	0	SENT_107	[p5l554t2206r644b2259],
4	systemic	JJ	O	systemic	amod	5	SENT_107	[p5l676t2181r1045b2281],
5	mastocytosis	NN	O	mastocytosis	nsubj	36	SENT_107	[p5l1077t2176r1748b2281],
6	,	,	O	,	_	0	SENT_107	[p5l1077t2176r1748b2281],
7	”	CD	NUMBER	”	appos	5	SENT_107	[p5l1077t2176r1748b2281],
8	Whereas	IN	O	whereas	mark	11	SENT_107	[p5l1777t2181r2131b2260],
9	PDGFRB	NN	O	pdgfrb	nsubjpass	11	SENT_107	[p5l9t2312r393b2407],
10	is	VBZ	O	be	auxpass	11	SENT_107	[p5l419t2309r484b2386],
11	activated	VBN	O	activate	dep	36	SENT_107	[p5l508t2309r877b2387],
12	in	IN	O	in	_	0	SENT_107	[p5l898t2309r979b2385],
13	some	DT	O	some	det	14	SENT_107	[p5l1003t2333r1228b2386],
14	patients	NNS	O	patient	prep_in	11	SENT_107	[p5l1249t2309r1584b2408],
15	with	IN	O	with	_	0	SENT_107	[p5l1603t2309r1793b2387],
16	chronic	JJ	O	chronic	amod	18	SENT_107	[p5l1816t2309r2135b2386],
17	myelomonocytic	JJ	O	myelomonocytic	amod	18	SENT_107	[p5l10t2437r709b2537],
18	leukemia	NN	O	leukemia	prep_with	14	SENT_107	[p5l730t2437r1118b2516],
19	and	CC	O	and	_	0	SENT_107	[p5l1138t2436r1294b2515],
20	balanced	JJ	O	balanced	amod	23	SENT_107	[p5l1317t2437r1692b2515],
21	transloca	NN	O	transloca	nn	23	SENT_107	[p5l1715t2437r2133b2515],
22	—	NN	O	—	nn	23	SENT_107	[p5l1715t2437r2133b2515],
23	tions	NNS	O	tion	conj_and	18	SENT_107	[p5l11t2565r221b2643],
24	that	WDT	O	that	nsubj	25	SENT_107	[p5l259t2565r429b2642],
25	lead	VBP	O	lead	rcmod	14	SENT_107	[p5l459t2565r634b2643],
26	to	TO	O	to	_	0	SENT_107	[p5l670t2581r750b2643],
27	fusion	NN	O	fusion	prep_to	25	SENT_107	[p5l788t2564r1059b2644],
28	of	IN	O	of	_	0	SENT_107	[p5l1095t2564r1197b2643],
29	PDGFRB	NNP	O	PDGFRB	prep_of	27	SENT_107	[p5l1212t2568r1597b2663],
30	With	IN	O	with	_	0	SENT_107	[p5l1630t2565r1823b2644],
31	one	CD	NUMBER	one	prep_with	25	SENT_107	[p5l1860t2590r2014b2643],
32	of	IN	O	of	_	0	SENT_107	[p5l2050t2564r2152b2643],
33	several	JJ	O	several	amod	35	SENT_107	[p5l12t2693r303b2772],
34	partner	NN	O	partner	nn	35	SENT_107	[p5l336t2709r655b2793],
35	proteins	NNS	O	protein	prep_of	31	SENT_107	[p5l686t2687r1127b2793],
36	“	VBP	O	“	_	0	SENT_107	[p5l686t2687r1127b2793],
37	(	CD	NUMBER	(	num	38	SENT_107	[p5l1167t2693r1427b2784],
38	Table	NNP	O	Table	dobj	36	SENT_107	[p5l1167t2693r1427b2784],
39	1	CD	NUMBER	1	num	38	SENT_107	[p5l1465t2698r1570b2784],
40	)	CD	NUMBER	)	dep	38	SENT_107	[p5l1465t2698r1570b2784],
41	.	.	O	.	_	0	SENT_107	[p5l1465t2698r1570b2784],

1	Imatinib	NN	O	imatinib	nsubj	2	SENT_108	[p5l1610t2693r1980b2771],
2	induces	VBZ	O	induce	_	0	SENT_108	[p5l2016t2693r2132b2770, p5l11t2821r252b2900],
3	dramatic	JJ	O	dramatic	amod	4	SENT_108	[p5l289t2821r669b2899],
4	clinical	JJ	O	clinical	dobj	2	SENT_108	[p5l704t2821r1012b2899],
5	and	CC	O	and	_	0	SENT_108	[p5l1045t2821r1203b2899],
6	molecular	JJ	O	molecular	amod	7	SENT_108	[p5l1237t2821r1671b2900],
7	responses	NNS	O	response	dobj	2	SENT_108	[p5l1702t2846r2131b2921],
8	in	IN	O	in	prep	4	SENT_108	[p5l10t2950r92b3027],
9	both	CC	O	both	dep	4	SENT_108	[p5l113t2950r303b3028],
10	diseases	NNS	O	disease	conj_and	4	SENT_108	[p5l324t2945r875b3028],
11	.32	CD	NUMBER	.32	number	12	SENT_108	[p5l324t2945r875b3028],
12	’42	CD	NUMBER	’42	num	13	SENT_108	[p5l324t2945r875b3028],
13	c	NN	O	c	dep	10	SENT_108	[p5l896t2955r1130b3031],
14	.	.	O	.	_	0	SENT_108	[p5l896t2955r1130b3031],

1	—	NN	O	—	_	0	SENT_109	[p5l896t2955r1130b3031],
2	.	.	O	.	_	0	SENT_109	[p5l896t2955r1130b3031],

1	KIT	NN	O	kit	nsubjpass	3	SENT_110	[p5l896t2955r1130b3031],
2	is	VBZ	O	be	auxpass	3	SENT_110	[p5l1146t2950r1210b3028],
3	activated	VBN	O	activate	_	0	SENT_110	[p5l1232t2950r1594b3028],
4	by	IN	O	by	_	0	SENT_110	[p5l1615t2950r1711b3050],
5	point	NN	O	point	nn	6	SENT_110	[p5l1726t2950r1951b3050],
6	mutations	NNS	O	mutation	agent	3	SENT_110	[p5l1966t2976r2134b3029, p5l11t3078r294b3156],
7	in	IN	O	in	_	0	SENT_110	[p5l328t3078r409b3155],
8	many	JJ	O	many	amod	9	SENT_110	[p5l442t3103r676b3178],
9	cases	NNS	O	case	prep_in	6	SENT_110	[p5l705t3104r922b3156],
10	of	IN	O	of	_	0	SENT_110	[p5l959t3077r1059b3156],
11	systemic	JJ	O	systemic	amod	12	SENT_110	[p5l1075t3078r1436b3178],
12	mastocytosis	NN	O	mastocytosis	prep_of	6	SENT_110	[p5l1468t3078r2013b3178],
13	or	CC	O	or	_	0	SENT_110	[p5l2048t3103r2138b3156],
14	mast	NN	O	mast	nn	15	SENT_110	[p5l10t3206r396b3284],
15	—	NN	O	—	prep_of	6	SENT_110	[p5l10t3206r396b3284],
16	cell	NN	O	cell	nn	17	SENT_110	[p5l10t3206r396b3284],
17	leukemia	NN	O	leukemia	dep	6	SENT_110	[p5l415t3206r804b3285],
18	and	CC	O	and	_	0	SENT_110	[p5l823t3206r979b3284],
19	less	JJR	O	less	dep	6	SENT_110	[p5l998t3206r1153b3284],
20	frequently	RB	O	frequently	advmod	3	SENT_110	[p5l1177t3205r1608b3306],
21	in	IN	O	in	_	0	SENT_110	[p5l1624t3206r1705b3283],
22	AML	NN	ORGANIZATION	aml	prep_in	3	SENT_110	[p5l1723t3213r1949b3284],
23	.	.	O	.	_	0	SENT_110	[p5l1723t3213r1949b3284],

1	The	DT	O	the	det	4	SENT_111	[p5l1973t3206r2135b3284],
2	most	RBS	O	most	advmod	3	SENT_111	[p5l10t3350r230b3412],
3	common	JJ	O	common	amod	4	SENT_111	[p5l264t3359r650b3412],
4	c	NN	O	c	_	0	SENT_111	[p5l689t3339r930b3414],
5	.	.	O	.	_	0	SENT_111	[p5l689t3339r930b3414],

1	—	NN	O	—	_	0	SENT_112	[p5l689t3339r930b3414],
2	.	.	O	.	_	0	SENT_112	[p5l689t3339r930b3414],

1	KIT	NN	O	kit	nn	2	SENT_113	[p5l689t3339r930b3414],
2	mutation	NN	O	mutation	nsubj	3	SENT_113	[p5l966t3334r1362b3413],
3	involves	VBZ	O	involve	_	0	SENT_113	[p5l1400t3334r1744b3413],
4	D816	NN	O	d816	dobj	3	SENT_113	[p5l1783t3339r2013b3412],
5	in	IN	O	in	_	0	SENT_113	[p5l2052t3334r2134b3410],
6	the	DT	O	the	det	8	SENT_113	[p5l11t3462r142b3540],
7	activation	NN	O	activation	nn	8	SENT_113	[p5l177t3462r587b3540],
8	loop	NN	O	loop	prep_in	3	SENT_113	[p5l619t3462r806b3562],
9	of	IN	O	of	_	0	SENT_113	[p5l842t3461r943b3540],
10	the	DT	O	the	det	12	SENT_113	[p5l958t3462r1086b3540],
11	kinase	NN	O	kinase	nn	12	SENT_113	[p5l1119t3461r1390b3541],
12	domain	NN	O	domain	prep_of	8	SENT_113	[p5l1424t3462r1771b3557],
13	,	,	O	,	_	0	SENT_113	[p5l1424t3462r1771b3557],
14	but	CC	O	but	_	0	SENT_113	[p5l1811t3462r1952b3541],
15	this	DT	O	this	det	16	SENT_113	[p5l1980t3462r2133b3540],
16	mutant	NN	O	mutant	nsubjpass	19	SENT_113	[p5l10t3607r327b3670],
17	is	VBZ	O	be	auxpass	19	SENT_113	[p5l346t3591r412b3669],
18	not	RB	O	not	neg	19	SENT_113	[p5l438t3607r584b3669],
19	inhibited	VBN	O	inhibit	conj_but	3	SENT_113	[p5l602t3591r993b3669],
20	by	IN	O	by	_	0	SENT_113	[p5l1017t3591r1116b3691],
21	imatinib	NN	O	imatinib	agent	19	SENT_113	[p5l1135t3586r1611b3669],
22	.43	CD	NUMBER	.43	num	21	SENT_113	[p5l1135t3586r1611b3669],
23	The	DT	O	the	det	25	SENT_113	[p5l1633t3591r1797b3669],
24	normal	JJ	O	normal	amod	25	SENT_113	[p5l1821t3591r2134b3669],
25	c	NN	O	c	dep	21	SENT_113	[p6l11t26r254b102],
26	.	.	O	.	_	0	SENT_113	[p6l11t26r254b102],

1	—	NN	O	—	_	0	SENT_114	[p6l11t26r254b102],
2	.	.	O	.	_	0	SENT_114	[p6l11t26r254b102],

1	KIT	NN	O	kit	nn	2	SENT_115	[p6l11t26r254b102],
2	receptor	NN	O	receptor	nsubjpass	12	SENT_115	[p6l287t37r649b121],
3	is	VBZ	O	be	auxpass	4	SENT_115	[p6l681t21r747b99],
4	expressed	VBN	O	express	_	0	SENT_115	[p6l785t21r1214b121],
5	on	IN	O	on	_	0	SENT_115	[p6l1250t46r1357b99],
6	most	JJS	O	most	amod	8	SENT_115	[p6l1393t37r1614b99],
7	AML	NN	ORGANIZATION	aml	nn	8	SENT_115	[p6l1641t28r1849b99],
8	blasts	NNS	O	blast	prep_on	4	SENT_115	[p6l1883t21r2131b99],
9	and	CC	O	and	_	0	SENT_115	[p6l10t149r169b226],
10	may	MD	O	may	aux	12	SENT_115	[p6l210t174r389b248],
11	be	VB	O	be	auxpass	12	SENT_115	[p6l426t149r524b226],
12	overexpressed	VBN	O	overexpress	conj_and	4	SENT_115	[p6l561t149r1157b248],
13	and	CC	O	and	_	0	SENT_115	[p6l1193t149r1349b226],
14	activated	VBN	O	activate	conj_and	4	SENT_115	[p6l1385t149r1754b227],
15	in	IN	O	in	_	0	SENT_115	[p6l1790t149r1872b225],
16	some	DT	O	some	det	17	SENT_115	[p6l1910t173r2134b226],
17	patients	NNS	O	patient	prep_in	12	SENT_115	[p6l9t277r369b377],
18	,	,	O	,	_	0	SENT_115	[p6l9t277r369b377],
19	but	CC	O	but	_	0	SENT_115	[p6l403t277r544b356],
20	the	DT	O	the	det	21	SENT_115	[p6l568t277r697b355],
21	responses	NNS	O	response	nsubj	31	SENT_115	[p6l726t302r1147b377],
22	of	IN	O	of	_	0	SENT_115	[p6l1177t276r1278b355],
23	AML	NN	ORGANIZATION	aml	prep_of	21	SENT_115	[p6l1284t284r1489b355],
24	to	TO	O	to	_	0	SENT_115	[p6l1516t293r1595b355],
25	imatinib	NN	O	imatinib	prep_to	23	SENT_115	[p6l1624t277r1980b355],
26	are	VBP	O	be	cop	27	SENT_115	[p6l2009t303r2135b355],
27	variable	JJ	O	variable	conj_but	4	SENT_115	[p6l6t405r336b484],
28	and	CC	O	and	_	0	SENT_115	[p6l358t405r513b483],
29	do	VBP	O	do	aux	31	SENT_115	[p6l536t405r639b483],
30	not	RB	O	not	neg	31	SENT_115	[p6l662t421r806b483],
31	correlate	VB	O	correlate	conj_and	27	SENT_115	[p6l823t405r1189b483],
32	well	RB	O	well	advmod	31	SENT_115	[p6l1207t405r1382b484],
33	with	IN	O	with	_	0	SENT_115	[p6l1399t405r1588b484],
34	inhibition	NN	O	inhibition	prep_with	31	SENT_115	[p6l1610t405r2031b483],
35	of	IN	O	of	_	0	SENT_115	[p6l2053t404r2153b483],
36	KIT	NN	O	kit	nn	37	SENT_115	[p6l10t539r169b615],
37	signaling	NN	O	signaling	prep_of	34	SENT_115	[p6l192t529r694b634],
38	.44	CD	NUMBER	.44	num	37	SENT_115	[p6l192t529r694b634],

1	FLT3	NN	O	flt3	_	0	SENT_116	[p6l15t818r225b869],
2	:	:	O	:	_	0	SENT_116	[p6l15t818r225b869],
3	A	DT	O	a	det	5	SENT_116	[p6l263t818r309b867],
4	MAJOR	NN	O	major	nn	5	SENT_116	[p6l354t818r622b888],
5	TK	NN	O	tk	dep	1	SENT_116	[p6l660t818r754b867],
6	TARGET	NNP	O	TARGET	nsubj	14	SENT_116	[p6l791t818r1106b868],
7	IN	IN	O	in	_	0	SENT_116	[p6l1148t818r1228b867],
8	AM	NNP	O	AM	nn	10	SENT_116	[p6l1272t818r1388b867],
9	L	NNP	O	L	nn	10	SENT_116	[p6l1412t818r1444b867],
10	FLT3	NN	O	flt3	prep_in	6	SENT_116	[p6l9t924r214b997],
11	is	VBZ	O	be	cop	14	SENT_116	[p6l248t919r313b997],
12	a	DT	O	a	det	14	SENT_116	[p6l345t945r390b997],
13	receptor	NN	O	receptor	nn	14	SENT_116	[p6l419t935r771b1019],
14	TK	NN	O	tk	rcmod	5	SENT_116	[p6l795t924r925b1000],
15	expressed	VBN	O	express	partmod	14	SENT_116	[p6l953t919r1368b1019],
16	on	IN	O	on	_	0	SENT_116	[p6l1400t944r1507b997],
17	blasts	NNS	O	blast	prep_on	15	SENT_116	[p6l1539t919r1779b997],
18	in	IN	O	in	_	0	SENT_116	[p6l1811t919r1892b996],
19	most	JJS	O	most	amod	20	SENT_116	[p6l1923t935r2140b997],
20	cases	NNS	O	case	prep_in	17	SENT_116	[p6l11t1073r228b1125],
21	of	IN	O	of	_	0	SENT_116	[p6l273t1046r373b1125],
22	AML	NN	ORGANIZATION	aml	prep_of	20	SENT_116	[p6l393t1054r619b1142],
23	,	,	O	,	_	0	SENT_116	[p6l393t1054r619b1142],
24	and	CC	O	and	_	0	SENT_116	[p6l665t1047r822b1125],
25	it	PRP	O	it	nsubjpass	27	SENT_116	[p6l863t1047r922b1125],
26	is	VBZ	O	be	auxpass	27	SENT_116	[p6l958t1047r1023b1125],
27	activated	VBN	O	activate	rcmod	5	SENT_116	[p6l1066t1047r1436b1126],
28	by	IN	O	by	_	0	SENT_116	[p6l1477t1047r1574b1147],
29	duplications	NNS	O	duplication	agent	27	SENT_116	[p6l1612t1047r2133b1147],
30	within	IN	O	within	_	0	SENT_116	[p6l6t1176r277b1255],
31	the	DT	O	the	det	33	SENT_116	[p6l300t1176r428b1254],
32	juxtamembrane	NN	O	juxtamembrane	nn	33	SENT_116	[p6l437t1176r1110b1276],
33	domain5	NN	O	domain5	prep_within	29	SENT_116	[p6l1134t1171r1491b1254],
34	in	IN	O	in	_	0	SENT_116	[p6l1517t1176r1597b1253],
35	25	CD	NUMBER	25	number	37	SENT_116	[p6l1619t1181r1717b1254],
36	to	TO	O	to	dep	37	SENT_116	[p6l1743t1192r1821b1254],
37	30	CD	PERCENT	30	num	38	SENT_116	[p6l1846t1181r1944b1254],
38	percent	NN	PERCENT	percent	prep_in	27	SENT_116	[p6l1967t1202r2134b1276, p6l11t1320r192b1382],
39	of	IN	O	of	_	0	SENT_116	[p6l216t1303r317b1382],
40	patients	NNS	O	patient	prep_of	38	SENT_116	[p6l326t1305r668b1404],
41	and	CC	O	and	_	0	SENT_116	[p6l697t1304r855b1382],
42	point	NN	O	point	nn	43	SENT_116	[p6l882t1305r1116b1404],
43	mutations	NNS	O	mutation	nsubj	44	SENT_116	[p6l1139t1298r1663b1383],
44	”	VBP	O	”	rcmod	5	SENT_116	[p6l1139t1298r1663b1383],
45	at	IN	O	at	_	0	SENT_116	[p6l1691t1320r1770b1382],
46	D835	NN	O	d835	prep_at	44	SENT_116	[p6l1793t1309r2020b1382],
47	in	IN	O	in	_	0	SENT_116	[p6l2051t1305r2134b1381],
48	5	CD	NUMBER	5	number	50	SENT_116	[p6l12t1439r55b1510],
49	to	TO	O	to	dep	50	SENT_116	[p6l81t1448r158b1510],
50	7	CD	PERCENT	7	num	51	SENT_116	[p6l180t1439r226b1510],
51	percent	NN	PERCENT	percent	prep_in	44	SENT_116	[p6l245t1448r559b1532],
52	of	IN	O	of	_	0	SENT_116	[p6l574t1431r673b1510],
53	patients	NNS	O	patient	prep_of	51	SENT_116	[p6l673t1432r1000b1532],
54	(	RB	O	(	dep	55	SENT_116	[p6l1026t1432r1275b1523],
55	Table	NNP	O	Table	dep	53	SENT_116	[p6l1026t1432r1275b1523],
56	1	CD	NUMBER	1	number	57	SENT_116	[p6l1298t1437r1398b1523],
57	)	CD	NUMBER	)	num	55	SENT_116	[p6l1298t1437r1398b1523],
58	.	.	O	.	_	0	SENT_116	[p6l1298t1437r1398b1523],

1	Several	JJ	O	several	amod	2	SENT_117	[p6l1425t1432r1712b1511],
2	inhibitors	NNS	O	inhibitor	nsubj	7	SENT_117	[p6l1730t1432r2134b1510],
3	of	IN	O	of	_	0	SENT_117	[p6l11t1559r112b1638],
4	FLT3	NN	O	flt3	nn	6	SENT_117	[p6l123t1565r329b1638],
5	kinase	NN	O	kinase	nn	6	SENT_117	[p6l364t1560r634b1639],
6	activity	NN	O	activity	prep_of	2	SENT_117	[p6l666t1560r962b1660],
7	are	VBP	O	be	dep	39	SENT_117	[p6l989t1586r1115b1638],
8	in	IN	O	in	_	0	SENT_117	[p6l1146t1560r1227b1637],
9	various	JJ	O	various	amod	10	SENT_117	[p6l1255t1560r1560b1639],
10	stages	NNS	O	stage	prep_in	7	SENT_117	[p6l1596t1576r1855b1660],
11	of	IN	O	of	_	0	SENT_117	[p6l1890t1559r1991b1638],
12	development	NN	O	development	prep_of	10	SENT_117	[p6l2005t1560r2134b1638, p6l6t1684r561b1789],
13	.45	CD	NUMBER	.45	num	12	SENT_117	[p6l2005t1560r2134b1638, p6l6t1684r561b1789],
14	They	PRP	O	they	nsubj	18	SENT_117	[p6l588t1689r797b1789],
15	inhibit	VBP	O	inhibit	rcmod	12	SENT_117	[p6l819t1689r1105b1767],
16	growth	NN	O	growth	dobj	15	SENT_117	[p6l1127t1689r1430b1789],
17	and	CC	O	and	_	0	SENT_117	[p6l1456t1689r1612b1767],
18	induce	VB	O	induce	conj_and	15	SENT_117	[p6l1638t1689r1920b1768],
19	apo	NN	O	apo	nn	21	SENT_117	[p6l1947t1714r2134b1789],
20	—	NN	O	—	nn	21	SENT_117	[p6l1947t1714r2134b1789],
21	ptosis	NN	O	ptosis	dobj	18	SENT_117	[p6l9t1817r259b1916],
22	in	IN	O	in	_	0	SENT_117	[p6l296t1817r378b1893],
23	hematopoietic	JJ	O	hematopoietic	amod	25	SENT_117	[p6l413t1817r1020b1916],
24	cell	NN	O	cell	nn	25	SENT_117	[p6l1056t1817r1197b1894],
25	lines	NNS	O	line	prep_in	21	SENT_117	[p6l1231t1817r1428b1894],
26	expressing	VBG	O	express	xcomp	18	SENT_117	[p6l1466t1817r1922b1916],
27	activated	VBN	O	activate	amod	28	SENT_117	[p6l1954t1817r2134b1894, p6l6t1945r228b2024],
28	FLT3	NN	O	flt3	dobj	26	SENT_117	[p6l252t1950r458b2023],
29	and	CC	O	and	_	0	SENT_117	[p6l486t1944r641b2023],
30	have	VBP	O	have	conj_and	15	SENT_117	[p6l667t1945r855b2024],
31	therapeutic	JJ	O	therapeutic	amod	32	SENT_117	[p6l882t1945r1357b2045],
32	efﬁcacy	NN	O	efﬁcacy	dobj	30	SENT_117	[p6l1383t1944r1702b2045],
33	in	IN	O	in	_	0	SENT_117	[p6l1722t1945r1803b2022],
34	murine	JJ	O	murine	amod	35	SENT_117	[p6l1829t1945r2134b2024],
35	models	NNS	O	model	prep_in	32	SENT_117	[p6l10t2072r313b2150],
36	of	IN	O	of	_	0	SENT_117	[p6l339t2071r437b2150],
37	FLT3	NN	O	flt3	nn	38	SENT_117	[p6l440t2072r1015b2151],
38	—	NN	O	—	prep_of	35	SENT_117	[p6l440t2072r1015b2151],
39	induced	VBD	O	induce	_	0	SENT_117	[p6l440t2072r1015b2151],
40	leul	NN	O	leul	nsubj	41	SENT_117	[p6l1037t2065r1524b2151],
41	<	JJR	O	<	xcomp	39	SENT_117	[p6l1037t2065r1524b2151],
42	emia	CD	NUMBER	emia	num	43	SENT_117	[p6l1037t2065r1524b2151],
43	.46	CD	NUMBER	.46	npadvmod	51	SENT_117	[p6l1037t2065r1524b2151],
44	In	IN	O	in	_	0	SENT_117	[p6l1546t2079r1632b2149],
45	preliminary	JJ	O	preliminary	amod	47	SENT_117	[p6l1653t2072r2140b2172],
46	clinical	JJ	O	clinical	amod	47	SENT_117	[p6l11t2201r311b2279],
47	trials	NNS	O	trial	prep_in	51	SENT_117	[p6l332t2201r565b2296],
48	,	,	O	,	_	0	SENT_117	[p6l332t2201r565b2296],
49	the	DT	O	the	det	50	SENT_117	[p6l593t2201r722b2279],
50	drugs	NNS	O	drug	nsubj	51	SENT_117	[p6l744t2201r982b2301],
51	had	VBD	O	have	dep	41	SENT_117	[p6l1006t2201r1161b2279],
52	few	JJ	O	few	amod	54	SENT_117	[p6l1182t2200r1333b2280],
53	adverse	JJ	O	adverse	amod	54	SENT_117	[p6l1350t2201r1663b2280],
54	effects	NNS	O	effect	dobj	51	SENT_117	[p6l1686t2200r1956b2279],
55	and	CC	O	and	_	0	SENT_117	[p6l1979t2201r2135b2279],
56	reduced	VBN	O	reduce	conj_and	51	SENT_117	[p6l10t2329r345b2408],
57	circulating	VBG	O	circulate	xcomp	56	SENT_117	[p6l377t2328r831b2429],
58	and	CC	O	and	_	0	SENT_117	[p6l858t2329r1014b2407],
59	bone	NN	O	bone	nn	61	SENT_117	[p6l1046t2329r1253b2407],
60	marrow	NN	O	marrow	nn	61	SENT_117	[p6l1284t2354r1620b2408],
61	blasts	NNS	O	blast	conj_and	51	SENT_117	[p6l1648t2329r1889b2407],
62	in	IN	O	in	dep	61	SENT_117	[p6l1922t2329r2002b2406],
63	20	CD	NUMBER	20	number	65	SENT_117	[p6l2034t2334r2134b2407],
64	to	TO	O	to	dep	65	SENT_117	[p6l11t2473r90b2535],
65	50	CD	PERCENT	50	num	66	SENT_117	[p6l115t2462r214b2535],
66	percent	NN	PERCENT	percent	pobj	62	SENT_117	[p6l235t2473r556b2557],
67	of	IN	O	of	_	0	SENT_117	[p6l574t2456r674b2535],
68	patients	NNS	O	patient	prep_of	66	SENT_117	[p6l677t2457r1011b2557],
69	with	IN	O	with	_	0	SENT_117	[p6l1032t2456r1220b2536],
70	relapsed	VBN	O	relapse	prep_with	41	SENT_117	[p6l1243t2457r1597b2557],
71	or	CC	O	or	_	0	SENT_117	[p6l1620t2482r1709b2535],
72	refractory	JJ	O	refractory	amod	73	SENT_117	[p6l1728t2456r2139b2557],
73	AML	NN	ORGANIZATION	aml	prep_with	41	SENT_117	[p6l7t2581r429b2664],
74	.22	CD	NUMBER	.22	number	75	SENT_117	[p6l7t2581r429b2664],
75	'24	CD	NUMBER	'24	nsubj	39	SENT_117	[p6l7t2581r429b2664],
76	Whether	IN	O	whether	complm	80	SENT_117	[p6l448t2586r820b2664],
77	FLT3	NN	O	flt3	nn	78	SENT_117	[p6l839t2591r1045b2664],
78	inhibitors	NNS	O	inhibitor	nsubj	80	SENT_117	[p6l1071t2586r1485b2664],
79	will	MD	O	will	aux	80	SENT_117	[p6l1506t2586r1663b2665],
80	beneﬁt	VB	O	beneﬁt	ccomp	94	SENT_117	[p6l1687t2585r1984b2664],
81	patients	NNS	O	patient	dobj	80	SENT_117	[p6l2001t2612r2133b2686, p6l11t2714r241b2792],
82	with	IN	O	with	_	0	SENT_117	[p6l265t2714r455b2793],
83	AML	NN	ORGANIZATION	aml	prep_with	80	SENT_117	[p6l478t2721r684b2792],
84	whose	WP$	O	whose	poss	85	SENT_117	[p6l704t2714r978b2793],
85	blasts	NNS	O	blast	nsubj	86	SENT_117	[p6l1007t2714r1247b2792],
86	overexpress	VBP	O	overexpress	rcmod	83	SENT_117	[p6l1277t2739r1770b2814],
87	the	DT	O	the	acomp	86	SENT_117	[p6l1799t2714r1929b2792],
88	nor	CC	O	nor	_	0	SENT_117	[p6l1956t2739r2134b2792],
89	—	JJ	O	—	conj_nor	87	SENT_117	[p6l1956t2739r2134b2792],
90	mal	JJ	O	mal	amod	92	SENT_117	[p6l10t2842r170b2920],
91	FLT3	NN	O	flt3	nn	92	SENT_117	[p6l199t2847r407b2920],
92	receptor	NN	O	receptor	nsubj	94	SENT_117	[p6l442t2858r800b2942],
93	is	VBZ	O	be	cop	94	SENT_117	[p6l828t2842r894b2920],
94	unclear	JJ	O	unclear	rcmod	75	SENT_117	[p6l926t2842r1264b2921],
95	.	.	O	.	_	0	SENT_117	[p6l926t2842r1264b2921],

1	Such	JJ	O	such	amod	2	SENT_118	[p6l1302t2842r1508b2921],
2	patients	NNS	O	patient	nsubj	6	SENT_118	[p6l1537t2842r1880b2942],
3	often	RB	O	often	advmod	2	SENT_118	[p6l1913t2841r2134b2920],
4	do	VBP	O	do	aux	6	SENT_118	[p6l11t2970r115b3048],
5	not	RB	O	not	neg	6	SENT_118	[p6l156t2986r302b3048],
6	have	VB	O	have	_	0	SENT_118	[p6l336t2970r527b3049],
7	a	DT	O	a	det	8	SENT_118	[p6l567t2996r611b3048],
8	response	NN	O	response	dobj	6	SENT_118	[p6l650t2995r1036b3070],
9	to	TO	O	to	_	0	SENT_118	[p6l1077t2986r1157b3048],
10	FLT3	NN	O	flt3	nn	11	SENT_118	[p6l1197t2975r1405b3048],
11	inhibitors	NNS	O	inhibitor	prep_to	6	SENT_118	[p6l1447t2969r1898b3065],
12	,	,	O	,	_	0	SENT_118	[p6l1447t2969r1898b3065],
13	even	RB	O	even	advmod	19	SENT_118	[p6l1944t2995r2134b3049],
14	though	IN	O	though	dep	19	SENT_118	[p6l11t3098r316b3198],
15	an	DT	O	a	det	18	SENT_118	[p6l348t3123r447b3176],
16	autocrine	JJ	O	autocrine	amod	18	SENT_118	[p6l479t3098r876b3177],
17	FLT3	NN	O	flt3	nn	18	SENT_118	[p6l908t3103r1113b3176],
18	loop	NN	O	loop	nsubj	19	SENT_118	[p6l1148t3098r1335b3198],
19	promotes	VBZ	O	promote	dep	6	SENT_118	[p6l1368t3114r1773b3198],
20	the	DT	O	the	det	23	SENT_118	[p6l1808t3098r1936b3176],
21	sur	NN	O	sur	nn	23	SENT_118	[p6l1971t3124r2134b3177],
22	—	CD	NUMBER	—	num	23	SENT_118	[p6l1971t3124r2134b3177],
23	vival	NN	O	vival	dobj	19	SENT_118	[p6l6t3227r194b3306],
24	and	CC	O	and	_	0	SENT_118	[p6l218t3227r374b3305],
25	growth	NN	O	growth	dobj	19	SENT_118	[p6l398t3227r702b3327],
26	of	IN	O	of	_	0	SENT_118	[p6l727t3226r828b3305],
27	some	DT	O	some	det	29	SENT_118	[p6l836t3252r1060b3305],
28	AML	NN	ORGANIZATION	aml	nn	29	SENT_118	[p6l1082t3234r1287b3305],
29	blasts	NNS	O	blast	prep_of	25	SENT_118	[p6l1311t3227r1552b3305],
30	in	FW	O	in	nn	33	SENT_118	[p6l1578t3227r1659b3304],
31	vitro	FW	O	vitro	dep	33	SENT_118	[p6l1679t3222r2085b3306],
32	.47	CD	NUMBER	.47	num	33	SENT_118	[p6l1679t3222r2085b3306],
33	’48	CD	NUMBER	’48	advmod	19	SENT_118	[p6l1679t3222r2085b3306],

1	OTHER	JJ	O	other	amod	3	SENT_119	[p6l11t3521r290b3571],
2	TK	NN	O	tk	nn	3	SENT_119	[p6l327t3522r422b3570],
3	TARGETS	NNS	O	target	nsubj	23	SENT_119	[p6l459t3521r821b3571],
4	IN	IN	O	in	_	0	SENT_119	[p6l865t3522r946b3570],
5	MALIGNANT	JJ	O	malignant	amod	7	SENT_119	[p6l999t3521r1504b3571],
6	HEMATOLOGIC	JJ	O	hematologic	amod	7	SENT_119	[p6l17t3605r641b3654],
7	DISORDERS	NNS	O	disorder	prep_in	3	SENT_119	[p6l683t3605r1156b3654],
8	Other	JJ	O	other	amod	9	SENT_119	[p6l10t3706r259b3784],
9	TKS	NN	O	tk	nsubjpass	12	SENT_119	[p6l292t3711r461b3787],
10	have	VBP	O	have	aux	12	SENT_119	[p6l503t3706r694b3785],
11	been	VBN	O	be	auxpass	12	SENT_119	[p6l735t3706r938b3784],
12	implicated	VBN	O	implicate	rcmod	7	SENT_119	[p6l977t3706r1434b3806],
13	in	IN	O	in	_	0	SENT_119	[p6l1473t3706r1556b3783],
14	hematologic	JJ	O	hematologic	amod	15	SENT_119	[p6l1595t3705r2135b3806],
15	cancers	NNS	O	cancer	prep_in	12	SENT_119	[p7l11t46r357b116],
16	,	,	O	,	_	0	SENT_119	[p7l11t46r357b116],
17	but	CC	O	but	_	0	SENT_119	[p7l404t21r547b100],
18	targeted	VBN	O	target	conj_but	12	SENT_119	[p7l583t21r936b121],
19	therapeutics	NNS	O	therapeutics	dobj	18	SENT_119	[p7l977t21r1505b121],
20	for	IN	O	for	_	0	SENT_119	[p7l1548t20r1673b99],
21	these	DT	O	these	det	22	SENT_119	[p7l1711t21r1934b99],
22	diseases	NNS	O	disease	prep_for	19	SENT_119	[p7l1975t21r2132b99, p7l11t175r233b227],
23	are	VBP	O	be	_	0	SENT_119	[p7l270t175r397b227],
24	in	IN	O	in	_	0	SENT_119	[p7l429t149r511b226],
25	their	PRP$	O	they	poss	26	SENT_119	[p7l544t149r741b227],
26	infancy	NN	O	infancy	prep_in	23	SENT_119	[p7l770t148r1092b249],
27	.	.	O	.	_	0	SENT_119	[p7l770t148r1092b249],

1	Fusion	NN	O	fusion	dep	10	SENT_120	[p7l1129t149r1416b228],
2	of	IN	O	of	_	0	SENT_120	[p7l1450t148r1551b227],
3	the	DT	O	the	det	6	SENT_120	[p7l1565t149r1694b227],
4	ﬁbroblast	NN	O	ﬁbroblast	nn	6	SENT_120	[p7l1727t148r2140b227],
5	growth	NN	O	growth	nn	6	SENT_120	[p7l10t277r316b377],
6	factor	NN	O	factor	prep_of	1	SENT_120	[p7l347t276r598b355],
7	receptor	NN	O	receptor	dep	10	SENT_120	[p7l626t293r984b377],
8	1	CD	NUMBER	1	num	7	SENT_120	[p7l1015t282r1059b354],
9	(	CD	NUMBER	(	num	10	SENT_120	[p7l1095t282r1456b368],
10	FGFR1	NN	O	fgfr1	dep	31	SENT_120	[p7l1095t282r1456b368],
11	)	CD	NUMBER	)	num	12	SENT_120	[p7l1095t282r1456b368],
12	TK	NN	O	tk	dep	10	SENT_120	[p7l1489t282r1619b358],
13	With	IN	O	with	mark	18	SENT_120	[p7l1642t277r1834b356],
14	one	CD	NUMBER	one	nsubj	18	SENT_120	[p7l1865t302r2019b355],
15	of	IN	O	of	_	0	SENT_120	[p7l2051t276r2152b355],
16	several	JJ	O	several	amod	17	SENT_120	[p7l12t405r306b484],
17	partners	NNS	O	partner	prep_of	14	SENT_120	[p7l339t421r700b505],
18	occurs	VBZ	O	occur	advcl	31	SENT_120	[p7l739t430r1019b484],
19	in	IN	O	in	_	0	SENT_120	[p7l1056t405r1138b482],
20	the	DT	O	the	det	23	SENT_120	[p7l1174t405r1306b483],
21	8p11	NN	O	8p11	nn	23	SENT_120	[p7l1343t410r1556b505],
22	myeloprolif	JJ	O	myeloprolif	amod	23	SENT_120	[p7l1592t404r2132b505],
23	—	NN	O	—	prep_in	18	SENT_120	[p7l1592t404r2132b505],
24	erative	JJ	O	erative	amod	25	SENT_120	[p7l11t534r287b612],
25	syndrome	NN	O	syndrome	nsubjpass	31	SENT_120	[p7l334t527r871b633],
26	,	,	O	,	_	0	SENT_120	[p7l334t527r871b633],
27	”	NN	O	”	nsubjpass	31	SENT_120	[p7l334t527r871b633],
28	and	CC	O	and	_	0	SENT_120	[p7l916t533r1073b611],
29	FGFR3	NN	O	fgfr3	nsubjpass	31	SENT_120	[p7l1117t538r1415b616],
30	is	VBZ	O	be	auxpass	31	SENT_120	[p7l1462t534r1528b611],
31	mutated	VBN	O	mutate	dep	65	SENT_120	[p7l1575t533r1932b612],
32	and	CC	O	and	_	0	SENT_120	[p7l1976t533r2134b611],
33	overexpressed	VBN	O	overexpress	dep	65	SENT_120	[p7l11t662r608b762],
34	in	IN	O	in	_	0	SENT_120	[p7l637t662r717b739],
35	multiple	JJ	O	multiple	amod	36	SENT_120	[p7l746t662r1094b762],
36	myeloma	NN	O	myeloma	prep_in	31	SENT_120	[p7l1124t662r1508b762],
37	with	IN	O	with	_	0	SENT_120	[p7l1531t662r1718b741],
38	t	NN	O	t	prep_with	31	SENT_120	[p7l1748t657r2133b757],
39	(	CD	NUMBER	(	number	40	SENT_120	[p7l1748t657r2133b757],
40	4	CD	NUMBER	4	dep	38	SENT_120	[p7l1748t657r2133b757],
41	;	:	O	;	_	0	SENT_120	[p7l1748t657r2133b757],
42	14	CD	NUMBER	14	number	43	SENT_120	[p7l1748t657r2133b757],
43	)	CD	NUMBER	)	num	44	SENT_120	[p7l1748t657r2133b757],
44	.2	NN	NUMBER	.2	dep	38	SENT_120	[p7l1748t657r2133b757],
45	°	CD	NUMBER	°	num	46	SENT_120	[p7l1748t657r2133b757],
46	Translocations	NNS	O	translocation	dep	44	SENT_120	[p7l7t790r642b868],
47	involving	VBG	O	involve	xcomp	31	SENT_120	[p7l666t790r1059b890],
48	the	DT	O	the	det	53	SENT_120	[p7l1079t790r1207b868],
49	anaplastic	JJ	O	anaplastic	amod	53	SENT_120	[p7l1231t789r1657b890],
50	lymphoma	NN	O	lymphoma	nn	53	SENT_120	[p7l1678t790r2136b890],
51	kinase	NN	O	kinase	nn	53	SENT_120	[p7l10t918r282b997],
52	(	NN	O	(	nn	53	SENT_120	[p7l313t923r531b1009],
53	ALK	NN	O	alk	dobj	47	SENT_120	[p7l313t923r531b1009],
54	)	NN	O	)	nn	55	SENT_120	[p7l313t923r531b1009],
55	gene	NN	O	gene	nsubj	65	SENT_120	[p7l562t943r764b1018],
56	are	VBP	O	be	cop	65	SENT_120	[p7l789t944r917b996],
57	pathognomonic	JJ	O	pathognomonic	amod	65	SENT_120	[p7l942t918r1636b1018],
58	of	IN	O	of	_	0	SENT_120	[p7l1662t917r1764b996],
59	anaplas	FW	O	anaplas	nn	60	SENT_120	[p7l1770t918r2132b1018],
60	—	FW	O	—	prep_of	57	SENT_120	[p7l1770t918r2132b1018],
61	tic	JJ	O	tic	amod	65	SENT_120	[p7l11t1046r112b1124],
62	large	JJ	O	large	amod	65	SENT_120	[p7l137t1046r534b1146],
63	—	NN	O	—	nn	65	SENT_120	[p7l137t1046r534b1146],
64	cell	NN	O	cell	nn	65	SENT_120	[p7l137t1046r534b1146],
65	lymphoma	NN	O	lymphoma	_	0	SENT_120	[p7l558t1046r1016b1146],
66	and	CC	O	and	_	0	SENT_120	[p7l1039t1046r1195b1124],
67	generate	VB	O	generate	dep	74	SENT_120	[p7l1220t1062r1580b1146],
68	fusion	NN	O	fusion	dobj	67	SENT_120	[p7l1606t1045r1872b1125],
69	of	IN	O	of	_	0	SENT_120	[p7l1898t1045r1998b1124],
70	the	DT	O	the	det	73	SENT_120	[p7l2006t1046r2135b1124],
71	ALK	NN	O	alk	nn	73	SENT_120	[p7l7t1180r195b1254],
72	receptor	NN	O	receptor	nn	73	SENT_120	[p7l225t1189r588b1273],
73	TK	NN	O	tk	prep_of	68	SENT_120	[p7l615t1179r746b1254],
74	With	IN	O	with	conj_and	65	SENT_120	[p7l772t1173r966b1252],
75	several	JJ	O	several	amod	76	SENT_120	[p7l1001t1173r1295b1252],
76	partners	NNS	O	partner	pobj	74	SENT_120	[p7l1327t1166r1805b1273],
77	.	.	O	.	_	0	SENT_120	[p7l1327t1166r1805b1273],

1	“	NN	O	“	nn	2	SENT_121	[p7l1327t1166r1805b1273],
2	Fusion	NN	O	fusion	_	0	SENT_121	[p7l1837t1174r2133b1252],

1	Figure	NNP	O	Figure	_	0	SENT_122	[p8l83t202r301b285],
2	1	CD	NUMBER	1	number	3	SENT_122	[p8l328t207r360b264],
3	(	CD	NUMBER	(	dep	1	SENT_122	[p8l392t200r628b286],
4	facing	VBG	O	face	partmod	1	SENT_122	[p8l392t200r628b286],
5	page	NN	O	page	nn	6	SENT_122	[p8l654t207r865b286],
6	)	NN	O	)	dobj	4	SENT_122	[p8l654t207r865b286],
7	.	.	O	.	_	0	SENT_122	[p8l654t207r865b286],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_123	[p8l897t201r1346b266],
2	of	IN	O	of	_	0	SENT_123	[p8l1371t200r1451b266],
3	Activation	NN	O	activation	prep_of	1	SENT_123	[p8l1459t202r1811b266],
4	of	IN	O	of	_	0	SENT_123	[p8l77t307r158b373],
5	Normal	JJ	O	normal	amod	6	SENT_123	[p8l173t308r433b373],
6	TKs	NNS	O	tk	prep_of	1	SENT_123	[p8l458t314r610b373],
7	.	.	O	.	_	0	SENT_123	[p8l458t314r610b373],

1	A	DT	O	a	det	4	SENT_124	[p8l76t457r126b517],
2	typical	JJ	O	typical	amod	4	SENT_124	[p8l145t453r362b538],
3	receptor	NN	O	receptor	nn	4	SENT_124	[p8l392t465r676b538],
4	TK	NN	O	tk	nsubjpass	24	SENT_124	[p8l692t459r787b517],
5	(	CD	NUMBER	(	num	7	SENT_124	[p8l814t453r1365b538],
6	platelet-derived	JJ	O	platelet-derived	amod	7	SENT_124	[p8l814t453r1365b538],
7	growth	NN	O	growth	dep	4	SENT_124	[p8l1391t453r1626b539],
8	factor	NN	O	factor	nn	9	SENT_124	[p8l1651t452r1850b518],
9	receptor	NN	O	receptor	dep	4	SENT_124	[p8l1873t476r2078b538, p8l76t565r244b643],
10	,	,	O	,	_	0	SENT_124	[p8l1873t476r2078b538, p8l76t565r244b643],
11	B	NN	O	b	nn	14	SENT_124	[p8l1873t476r2078b538, p8l76t565r244b643],
12	[	CD	NUMBER	[	num	14	SENT_124	[p8l274t566r498b645],
13	PDFG	NN	O	pdfg	nn	14	SENT_124	[p8l274t566r498b645],
14	R	NN	O	r	dep	4	SENT_124	[p8l515t565r652b645],
15	,8	CD	NUMBER	,8	number	16	SENT_124	[p8l515t565r652b645],
16	]	CD	NUMBER	]	num	17	SENT_124	[p8l515t565r652b645],
17	)	NN	O	)	dep	14	SENT_124	[p8l515t565r652b645],
18	and	CC	O	and	_	0	SENT_124	[p8l687t561r810b626],
19	nonreceptorTK	JJ	O	nonreceptortk	amod	22	SENT_124	[p8l844t566r1389b645],
20	(	NN	O	(	nn	22	SENT_124	[p8l1421t565r1670b645],
21	c-ABL	NN	O	c-abl	nn	22	SENT_124	[p8l1421t565r1670b645],
22	)	NN	O	)	dep	4	SENT_124	[p8l1421t565r1670b645],
23	are	VBP	O	be	auxpass	24	SENT_124	[p8l1705t583r1808b626],
24	depicted	VBN	O	depict	ccomp	53	SENT_124	[p8l1834t561r2072b645, p8l79t668r178b744],
25	,	,	O	,	_	0	SENT_124	[p8l1834t561r2072b645, p8l79t668r178b744],
26	with	IN	O	with	_	0	SENT_124	[p8l205t668r349b733],
27	the	DT	O	the	det	31	SENT_124	[p8l377t668r487b732],
28	ATP-binding	JJ	O	atp-binding	amod	31	SENT_124	[p8l511t668r945b753],
29	(	CD	NUMBER	(	tmod	28	SENT_124	[p8l977t672r1159b753],
30	ATP	NN	ORGANIZATION	atp	nn	31	SENT_124	[p8l977t672r1159b753],
31	)	NN	O	)	prep_with	24	SENT_124	[p8l977t672r1159b753],
32	and	CC	O	and	_	0	SENT_124	[p8l1193t668r1317b732],
33	catalytic	JJ	O	catalytic	amod	35	SENT_124	[p8l1347t668r1631b753],
34	(	NN	O	(	nn	35	SENT_124	[p8l1663t673r1823b753],
35	Cat	NN	O	cat	conj_and	31	SENT_124	[p8l1663t673r1823b753],
36	)	CD	NUMBER	)	num	37	SENT_124	[p8l1663t673r1823b753],
37	lobes	NNS	O	lobe	npadvmod	38	SENT_124	[p8l1859t668r2039b732],
38	ofthe	JJ	O	ofthe	amod	40	SENT_124	[p8l78t775r277b840],
39	kinase	NN	O	kinase	nn	40	SENT_124	[p8l306t776r524b840],
40	domains	NNS	O	domain	dep	31	SENT_124	[p8l551t776r856b840],
41	and	CC	O	and	_	0	SENT_124	[p8l885t776r1009b840],
42	the	DT	O	the	det	47	SENT_124	[p8l1037t776r1147b840],
43	transmembrane	JJ	O	transmembrane	amod	47	SENT_124	[p8l1170t776r1739b840],
44	(	NN	O	(	nn	47	SENT_124	[p8l1773t781r1937b860],
45	TM	NN	MISC	tm	nn	47	SENT_124	[p8l1773t781r1937b860],
46	)	NN	O	)	nn	47	SENT_124	[p8l1773t781r1937b860],
47	region	NN	O	region	prep_with	24	SENT_124	[p8l1974t798r2057b840, p8l80t889r227b968],
48	of	IN	O	of	_	0	SENT_124	[p8l257t882r334b947],
49	PDG	NNP	O	PDG	nn	50	SENT_124	[p8l353t888r507b947],
50	FR	NN	O	fr	prep_of	47	SENT_124	[p8l524t887r659b964],
51	,	,	O	,	_	0	SENT_124	[p8l524t887r659b964],
52	B	NN	O	b	nsubj	53	SENT_124	[p8l524t887r659b964],
53	indicated	VBD	O	indicate	_	0	SENT_124	[p8l690t883r1029b947],
54	.	.	O	.	_	0	SENT_124	[p8l690t883r1029b947],

1	Panel	NN	O	panel	nn	2	SENT_125	[p8l1064t883r1245b947],
2	A	NN	O	a	nsubj	3	SENT_125	[p8l1272t887r1323b947],
3	shows	VBZ	O	show	_	0	SENT_125	[p8l1349t883r1565b947],
4	both	CC	O	both	prep	3	SENT_125	[p8l1597t883r1748b947],
5	kinases	NNS	O	kinase	dep	4	SENT_125	[p8l1782t883r2037b947],
6	in	IN	O	in	_	0	SENT_125	[p8l81t996r137b1053],
7	their	PRP$	O	they	poss	9	SENT_125	[p8l165t990r328b1055],
8	inactive	JJ	O	inactive	amod	9	SENT_125	[p8l354t996r620b1055],
9	states	NNS	O	state	prep_in	5	SENT_125	[p8l648t1002r871b1055],
10	.	.	O	.	_	0	SENT_125	[p8l648t1002r871b1055],

1	Inactive	JJ	O	inactive	amod	2	SENT_126	[p8l906t996r1173b1055],
2	PDGFRB	NN	O	pdgfrb	nsubj	6	SENT_126	[p8l1205t995r1511b1071],
3	is	VBZ	O	be	cop	4	SENT_126	[p8l1542t996r1591b1055],
4	monomeric	JJ	O	monomeric	_	0	SENT_126	[p8l1623t996r2021b1055],
5	and	CC	O	and	_	0	SENT_126	[p8l80t1097r201b1162],
6	unphosphorylated	JJ	O	unphosphorylated	conj_and	4	SENT_126	[p8l231t1097r869b1183],
7	,	,	O	,	_	0	SENT_126	[p8l231t1097r869b1183],
8	and	CC	O	and	_	0	SENT_126	[p8l896t1097r1017b1162],
9	the	DT	O	the	det	11	SENT_126	[p8l1042t1097r1148b1162],
10	catalytic	JJ	O	catalytic	amod	11	SENT_126	[p8l1171t1097r1446b1183],
11	domain	NN	O	domain	nsubjpass	13	SENT_126	[p8l1466t1097r1725b1162],
12	is	VBZ	O	be	auxpass	13	SENT_126	[p8l1754t1103r1804b1162],
13	inhibited	VBN	O	inhibit	conj_and	4	SENT_126	[p8l1833t1097r2077b1162, p8l79t1204r154b1269],
14	by	IN	O	by	_	0	SENT_126	[p8l184t1204r256b1290],
15	protrusion	NN	O	protrusion	agent	13	SENT_126	[p8l280t1211r629b1289],
16	of	IN	O	of	_	0	SENT_126	[p8l655t1204r730b1269],
17	a	DT	O	a	det	22	SENT_126	[p8l741t1228r774b1269],
18	regulatory	JJ	O	regulatory	amod	22	SENT_126	[p8l802t1204r1137b1290],
19	tyrosine	NN	O	tyrosine	nn	22	SENT_126	[p8l1156t1211r1424b1290],
20	(	JJ	O	(	amod	22	SENT_126	[p8l1454t1210r1593b1290],
21	Tyr	NN	O	tyr	nn	22	SENT_126	[p8l1454t1210r1593b1290],
22	)	NN	O	)	prep_of	15	SENT_126	[p8l1454t1210r1593b1290],
23	in	IN	O	in	_	0	SENT_126	[p8l1626t1211r1679b1268],
24	the	DT	O	the	det	26	SENT_126	[p8l1704t1204r1810b1269],
25	activation	NN	O	activation	nn	26	SENT_126	[p8l1834t1211r2047b1269, p8l76t1318r204b1377],
26	loop	NN	O	loop	prep_in	22	SENT_126	[p8l235t1312r379b1396],
27	into	IN	O	into	_	0	SENT_126	[p8l405t1318r532b1377],
28	the	DT	O	the	det	30	SENT_126	[p8l553t1312r659b1377],
29	substrate	NN	O	substrate	nn	30	SENT_126	[p8l683t1312r996b1377],
30	cleft	NN	O	cleft	prep_into	13	SENT_126	[p8l1018t1312r1157b1377],
31	and	CC	O	and	_	0	SENT_126	[p8l1179t1312r1300b1377],
32	by	IN	O	by	_	0	SENT_126	[p8l1330t1312r1401b1398],
33	an	DT	O	a	det	35	SENT_126	[p8l1423t1335r1498b1377],
34	intramolecular	JJ	O	intramolecular	amod	35	SENT_126	[p8l1528t1312r2021b1377],
35	interaction	NN	O	interaction	agent	13	SENT_126	[p8l81t1426r454b1484],
36	with	IN	O	with	_	0	SENT_126	[p8l481t1419r626b1484],
37	the	DT	O	the	det	38	SENT_126	[p8l653t1419r764b1484],
38	juxtamembrane	NN	O	juxtamembrane	prep_with	35	SENT_126	[p8l787t1419r1344b1505],
39	(	CD	NUMBER	(	num	42	SENT_126	[p8l1377t1425r1521b1504],
40	JM	NN	O	jm	nn	42	SENT_126	[p8l1377t1425r1521b1504],
41	)	NN	O	)	nn	42	SENT_126	[p8l1377t1425r1521b1504],
42	domain	NN	O	domain	dep	13	SENT_126	[p8l1555t1419r1842b1484],
43	.	.	O	.	_	0	SENT_126	[p8l1555t1419r1842b1484],

1	Inactive	JJ	O	inactive	amod	2	SENT_127	[p8l1877t1426r2041b1484, p8l76t1533r200b1592],
2	c-ABL	NN	O	c-abl	dep	4	SENT_127	[p8l223t1531r427b1592],
3	is	VBZ	O	be	auxpass	4	SENT_127	[p8l451t1533r500b1592],
4	associated	VBN	O	associate	_	0	SENT_127	[p8l527t1527r895b1592],
5	with	IN	O	with	_	0	SENT_127	[p8l920t1527r1064b1592],
6	the	DT	O	the	det	7	SENT_127	[p8l1090t1527r1199b1592],
7	membrane	NN	O	membrane	prep_with	4	SENT_127	[p8l1227t1527r1607b1592],
8	through	IN	O	through	_	0	SENT_127	[p8l1628t1527r1898b1613],
9	a	DT	O	a	det	13	SENT_127	[p8l1924t1550r1956b1592],
10	covalent	JJ	O	covalent	amod	13	SENT_127	[p8l1979t1550r2078b1592, p8l77t1634r282b1699],
11	N-terminal	JJ	MISC	n-terminal	amod	13	SENT_127	[p8l310t1634r672b1699],
12	myristate	NN	O	myristate	nn	13	SENT_127	[p8l703t1641r1015b1720],
13	group	NN	O	group	prep_through	4	SENT_127	[p8l1039t1657r1239b1720],
14	(	CD	NUMBER	(	num	16	SENT_127	[p8l1271t1639r1447b1720],
15	Myr	NN	O	myr	nn	16	SENT_127	[p8l1271t1639r1447b1720],
16	)	NN	O	)	nsubjpass	4	SENT_127	[p8l1271t1639r1447b1720],
17	and	CC	O	and	_	0	SENT_127	[p8l1479t1634r1600b1699],
18	is	VBZ	O	be	auxpass	19	SENT_127	[p8l1632t1641r1681b1699],
19	inhibited	VBN	O	inhibit	conj_and	4	SENT_127	[p8l1712t1634r2016b1699],
20	through	IN	O	through	_	0	SENT_127	[p8l76t1742r353b1827],
21	intramolecular	JJ	O	intramolecular	amod	29	SENT_127	[p8l382t1742r897b1807],
22	interaction	NN	O	interaction	nn	29	SENT_127	[p8l919t1747r1291b1807],
23	ofthe	NN	O	ofthe	nn	29	SENT_127	[p8l1317t1740r1510b1807],
24	Src	NN	O	src	nn	29	SENT_127	[p8l1533t1747r1641b1807],
25	homology-3	NN	O	homology-3	nn	29	SENT_127	[p8l1664t1742r2060b1827],
26	(	CD	NUMBER	(	num	29	SENT_127	[p8l86t1854r278b1934],
27	SH3	NN	O	sh3	nn	29	SENT_127	[p8l86t1854r278b1934],
28	)	NN	O	)	nn	29	SENT_127	[p8l86t1854r278b1934],
29	domain	NN	O	domain	prep_through	19	SENT_127	[p8l308t1849r566b1914],
30	with	IN	O	with	_	0	SENT_127	[p8l590t1849r730b1914],
31	an	DT	O	a	det	44	SENT_127	[p8l758t1871r834b1914],
32	adjacent	JJ	O	adjacent	amod	44	SENT_127	[p8l862t1849r1148b1934],
33	proline	NN	O	proline	nn	44	SENT_127	[p8l1173t1849r1405b1934],
34	(	CD	NUMBER	(	nn	44	SENT_127	[p8l1436t1854r1595b1934],
35	Pro	FW	O	pro	nn	37	SENT_127	[p8l1436t1854r1595b1934],
36	)	FW	O	)	nn	37	SENT_127	[p8l1436t1854r1595b1934],
37	residue	NN	O	residue	dep	34	SENT_127	[p8l1630t1849r1884b1914],
38	and	CC	O	and	_	0	SENT_127	[p8l1911t1849r2035b1914],
39	by	IN	O	by	conj_and	34	SENT_127	[p8l82t1956r154b2041],
40	direct	JJ	O	direct	amod	42	SENT_127	[p8l175t1956r367b2021],
41	interaction	NN	O	interaction	nn	42	SENT_127	[p8l392t1962r751b2021],
42	ofthe	NN	O	ofthe	pobj	39	SENT_127	[p8l779t1955r970b2021],
43	catalytic	JJ	O	catalytic	amod	44	SENT_127	[p8l994t1956r1268b2041],
44	domain	NN	O	domain	prep_with	29	SENT_127	[p8l1290t1956r1549b2021],
45	with	IN	O	with	_	0	SENT_127	[p8l1574t1956r1714b2021],
46	an	DT	O	a	det	49	SENT_127	[p8l1743t1979r1819b2021],
47	inhibitory	JJ	O	inhibitory	amod	49	SENT_127	[p8l1850t1956r2059b2021, p8l76t2076r208b2149],
48	membrane	NN	O	membrane	nn	49	SENT_127	[p8l235t2064r616b2128],
49	lipid	NN	O	lipid	prep_with	19	SENT_127	[p8l645t2064r810b2148],
50	,	,	O	,	_	0	SENT_127	[p8l645t2064r810b2148],
51	phosphatidylinosito	NN	O	phosphatidylinosito	nn	52	SENT_127	[p8l844t2064r2026b2149, p8l82t2171r266b2256],
52	|	NN	O	|	appos	49	SENT_127	[p8l844t2064r2026b2149, p8l82t2171r266b2256],
53	4,5	CD	NUMBER	4,5	num	54	SENT_127	[p8l844t2064r2026b2149, p8l82t2171r266b2256],
54	bisphosphate	NN	O	bisphosphate	dep	52	SENT_127	[p8l844t2064r2026b2149, p8l82t2171r266b2256],
55	(	CD	NUMBER	(	num	57	SENT_127	[p8l293t2176r506b2256],
56	PIPZ	NN	O	pipz	nn	57	SENT_127	[p8l293t2176r506b2256],
57	)	NN	O	)	nsubjpass	19	SENT_127	[p8l293t2176r506b2256],
58	.	.	O	.	_	0	SENT_127	[p8l293t2176r506b2256],

1	In	IN	O	in	_	0	SENT_128	[p8l534t2177r589b2234],
2	Panel	NN	O	panel	nn	3	SENT_128	[p8l618t2171r792b2235],
3	B	NN	O	b	prep_in	7	SENT_128	[p8l821t2177r876b2247],
4	,	,	O	,	_	0	SENT_128	[p8l821t2177r876b2247],
5	PDGFRB	NN	O	pdgfrb	nsubjpass	7	SENT_128	[p8l905t2175r1201b2252],
6	is	VBZ	O	be	auxpass	7	SENT_128	[p8l1225t2177r1272b2235],
7	activated	VBN	O	activate	_	0	SENT_128	[p8l1294t2171r1590b2235],
8	upon	IN	O	upon	_	0	SENT_128	[p8l1616t2194r1784b2255],
9	binding	NN	O	binding	nn	11	SENT_128	[p8l1810t2171r2064b2256],
10	ofthe	NN	O	ofthe	nn	11	SENT_128	[p8l79t2278r277b2343],
11	ligand	NN	O	ligand	prep_upon	7	SENT_128	[p8l306t2278r513b2364],
12	(	NN	O	(	nn	19	SENT_128	[p8l551t2278r840b2363],
13	dimeric	JJ	O	dimeric	amod	19	SENT_128	[p8l551t2278r840b2363],
14	platelet-derived	JJ	O	platelet-derived	amod	19	SENT_128	[p8l868t2278r1406b2362],
15	growth	NN	O	growth	nn	19	SENT_128	[p8l1436t2278r1675b2364],
16	factor	NN	O	factor	nn	19	SENT_128	[p8l1703t2278r1907b2343],
17	[	CD	NUMBER	[	num	19	SENT_128	[p8l81t2391r260b2471],
18	PDG	NN	O	pdg	nn	19	SENT_128	[p8l81t2391r260b2471],
19	F	NN	O	f	tmod	7	SENT_128	[p8l276t2391r381b2471],
20	]	CD	NUMBER	]	num	21	SENT_128	[p8l276t2391r381b2471],
21	)	NN	O	)	dep	19	SENT_128	[p8l276t2391r381b2471],
22	,	,	O	,	_	0	SENT_128	[p8l276t2391r381b2471],
23	which	WDT	O	which	nsubj	24	SENT_128	[p8l408t2385r611b2450],
24	induces	VBZ	O	induce	rcmod	19	SENT_128	[p8l643t2385r911b2450],
25	oligomerization	NN	O	oligomerization	nn	27	SENT_128	[p8l940t2385r1493b2471],
26	ofthe	NN	O	ofthe	nn	27	SENT_128	[p8l1523t2385r1721b2450],
27	receptor	NN	O	receptor	dobj	24	SENT_128	[p8l1751t2398r2041b2470],
28	and	CC	O	and	_	0	SENT_128	[p8l80t2493r204b2558],
29	intermolecular	JJ	O	intermolecular	amod	30	SENT_128	[p8l236t2493r751b2558],
30	phosphorylation	NN	O	phosphorylation	conj_and	27	SENT_128	[p8l778t2493r1348b2578],
31	(	CD	NUMBER	(	num	32	SENT_128	[p8l1386t2498r1470b2578],
32	P	NN	O	p	dep	30	SENT_128	[p8l1386t2498r1470b2578],
33	,	,	O	,	_	0	SENT_128	[p8l1386t2498r1470b2578],
34	in	IN	O	in	_	0	SENT_128	[p8l1502t2499r1558b2557],
35	yellow	JJ	O	yellow	amod	37	SENT_128	[p8l1585t2493r1826b2578],
36	)	NN	O	)	nn	37	SENT_128	[p8l1585t2493r1826b2578],
37	ofthe	NN	O	ofthe	prep_in	19	SENT_128	[p8l1859t2492r2057b2558],
38	activation-loop	JJ	O	activation-loop	amod	39	SENT_128	[p8l80t2600r604b2685],
39	tyrosine	NN	O	tyrosine	dep	19	SENT_128	[p8l628t2607r927b2686],
40	.	.	O	.	_	0	SENT_128	[p8l628t2607r927b2686],

1	This	DT	O	this	nsubj	12	SENT_129	[p8l954t2600r1101b2665],
2	leads	VBZ	O	lead	_	0	SENT_129	[p8l1132t2600r1308b2665],
3	to	TO	O	to	_	0	SENT_129	[p8l1334t2613r1402b2665],
4	a	DT	O	a	det	6	SENT_129	[p8l1430t2623r1463b2665],
5	conformational	JJ	O	conformational	amod	6	SENT_129	[p8l1490t2600r2029b2665],
6	change	NN	O	change	prep_to	2	SENT_129	[p8l79t2708r330b2793],
7	in	IN	O	in	_	0	SENT_129	[p8l359t2714r414b2771],
8	the	DT	O	the	det	10	SENT_129	[p8l442t2708r551b2773],
9	catalytic	JJ	O	catalytic	amod	10	SENT_129	[p8l578t2708r862b2793],
10	domain	NN	O	domain	prep_in	6	SENT_129	[p8l887t2708r1152b2773],
11	and	CC	O	and	_	0	SENT_129	[p8l1183t2708r1307b2773],
12	increased	VBD	O	increase	conj_and	2	SENT_129	[p8l1340t2708r1670b2773],
13	enzymatic	JJ	O	enzymatic	amod	14	SENT_129	[p8l1700t2714r2059b2793],
14	activity	NN	O	activity	dobj	12	SENT_129	[p8l80t2821r321b2901],
15	,	,	O	,	_	0	SENT_129	[p8l80t2821r321b2901],
16	while	IN	O	while	mark	26	SENT_129	[p8l344t2815r520b2880],
17	phosphorylation	NN	O	phosphorylation	nn	19	SENT_129	[p8l546t2815r1094b2901],
18	ofother	NN	O	ofother	nn	19	SENT_129	[p8l1120t2814r1384b2880],
19	tyrosines	NNS	O	tyrosine	nsubj	26	SENT_129	[p8l1400t2821r1705b2901],
20	within	IN	O	within	_	0	SENT_129	[p8l1727t2815r1932b2880],
21	the	DT	O	the	det	25	SENT_129	[p8l1955t2815r2061b2880],
22	intracellular	JJ	O	intracellular	amod	25	SENT_129	[p8l81t2922r480b2987],
23	domain	NN	O	domain	nn	25	SENT_129	[p8l500t2922r757b2987],
24	ofthe	NN	O	ofthe	nn	25	SENT_129	[p8l784t2921r975b2987],
25	receptor	NN	O	receptor	prep_within	19	SENT_129	[p8l1002t2934r1280b3007],
26	creates	VBZ	O	create	advcl	2	SENT_129	[p8l1304t2934r1551b2987],
27	binding	VBG	O	bind	amod	28	SENT_129	[p8l1582t2922r1847b3008],
28	sites	NNS	O	site	dobj	26	SENT_129	[p8l1873t2928r2029b2987],
29	for	IN	O	for	_	0	SENT_129	[p8l77t3029r172b3095],
30	SH2	NN	O	sh2	nn	32	SENT_129	[p8l193t3035r337b3095],
31	domain	NN	O	domain	nn	32	SENT_129	[p8l362t3030r1031b3116],
32	—	NN	O	—	prep_for	28	SENT_129	[p8l362t3030r1031b3116],
33	containing	VBG	O	contain	partmod	32	SENT_129	[p8l362t3030r1031b3116],
34	signaling	NN	O	signaling	nn	35	SENT_129	[p8l1054t3030r1360b3116],
35	proteins	NNS	O	protein	dobj	33	SENT_129	[p8l1385t3036r1677b3114],
36	,	,	O	,	_	0	SENT_129	[p8l1385t3036r1677b3114],
37	including	VBG	O	include	_	0	SENT_129	[p8l1707t3030r2020b3116],
38	c-SRC	NN	O	c-src	prep_including	26	SENT_129	[p8l78t3142r285b3202],
39	(	CD	NUMBER	(	num	42	SENT_129	[p8l317t3137r448b3222],
40	red	JJ	O	red	amod	42	SENT_129	[p8l317t3137r448b3222],
41	oval	JJ	O	oval	amod	42	SENT_129	[p8l477t3137r642b3222],
42	)	NN	O	)	dep	38	SENT_129	[p8l477t3137r642b3222],
43	and	CC	O	and	_	0	SENT_129	[p8l676t3137r800b3202],
44	phospholipase	NN	O	phospholipase	prep_including	26	SENT_129	[p8l833t3137r1349b3222],
45	Cy	NNP	O	Cy	nn	47	SENT_129	[p8l1376t3142r1476b3218],
46	(	CD	NUMBER	(	num	47	SENT_129	[p8l1505t3142r1738b3222],
47	PLC7	NN	O	plc7	dep	44	SENT_129	[p8l1505t3142r1738b3222],
48	/	:	O	/	punct	50	SENT_129	[p8l1505t3142r1738b3222],
49	)	CD	NUMBER	)	num	50	SENT_129	[p8l1505t3142r1738b3222],
50	(	CD	NUMBER	(	dep	47	SENT_129	[p8l1779t3143r1993b3223],
51	green	JJ	O	green	amod	53	SENT_129	[p8l1779t3143r1993b3223],
52	oval	JJ	O	oval	amod	53	SENT_129	[p8l79t3245r269b3329],
53	)	NN	O	)	dep	50	SENT_129	[p8l79t3245r269b3329],
54	.	.	O	.	_	0	SENT_129	[p8l79t3245r269b3329],

1	c-ABL	NN	O	c-abl	nsubjpass	3	SENT_130	[p8l298t3249r502b3309],
2	is	VBZ	O	be	auxpass	3	SENT_130	[p8l528t3250r577b3309],
3	activated	VBN	O	activate	_	0	SENT_130	[p8l607t3245r916b3309],
4	through	IN	O	through	_	0	SENT_130	[p8l944t3245r1221b3330],
5	the	DT	O	the	det	6	SENT_130	[p8l1249t3245r1358b3309],
6	phosphorylation	NN	O	phosphorylation	prep_through	3	SENT_130	[p8l1389t3245r1959b3330],
7	of	IN	O	of	_	0	SENT_130	[p8l1989t3244r2065b3309],
8	two	CD	NUMBER	two	num	10	SENT_130	[p8l76t3364r203b3416],
9	regulatory	JJ	O	regulatory	amod	10	SENT_130	[p8l233t3352r584b3437],
10	tyrosines	NNS	O	tyrosine	prep_of	6	SENT_130	[p8l605t3358r942b3437],
11	,	,	O	,	_	0	SENT_130	[p8l605t3358r942b3437],
12	one	CD	NUMBER	one	prep_through	3	SENT_130	[p8l972t3375r1100b3416],
13	in	IN	O	in	_	0	SENT_130	[p8l1129t3358r1185b3416],
14	the	DT	O	the	det	16	SENT_130	[p8l1212t3352r1322b3416],
15	activation	NN	O	activation	nn	16	SENT_130	[p8l1349t3358r1686b3416],
16	loop	NN	O	loop	prep_in	12	SENT_130	[p8l1719t3352r1869b3437],
17	and	CC	O	and	_	0	SENT_130	[p8l1897t3352r2021b3416],
18	the	DT	O	the	det	19	SENT_130	[p8l76t3459r186b3524],
19	other	JJ	O	other	conj_and	6	SENT_130	[p8l212t3459r398b3524],
20	near	IN	O	near	_	0	SENT_130	[p8l424t3482r576b3524],
21	the	DT	O	the	det	24	SENT_130	[p8l596t3459r706b3524],
22	SH3	NN	O	sh3	nn	24	SENT_130	[p8l733t3464r877b3524],
23	binding	NN	O	binding	nn	24	SENT_130	[p8l911t3459r1176b3544],
24	site	NN	O	site	prep_near	19	SENT_130	[p8l1202t3465r1340b3535],
25	,	,	O	,	_	0	SENT_130	[p8l1202t3465r1340b3535],
26	which	WDT	O	which	nsubjpass	29	SENT_130	[p8l1367t3459r1569b3524],
27	can	MD	O	can	aux	29	SENT_130	[p8l1600t3482r1716b3524],
28	be	VB	O	be	auxpass	29	SENT_130	[p8l1749t3459r1826b3524],
29	phosphorylated	VBN	O	phosphorylate	rcmod	24	SENT_130	[p8l1856t3459r2047b3543, p8l82t3566r448b3652],
30	by	IN	O	by	_	0	SENT_130	[p8l480t3566r554b3652],
31	another	DT	O	another	det	32	SENT_130	[p8l578t3566r850b3631],
32	TK	NN	O	tk	agent	29	SENT_130	[p8l870t3572r981b3643],
33	,	,	O	,	_	0	SENT_130	[p8l870t3572r981b3643],
34	such	JJ	O	such	_	0	SENT_130	[p8l1012t3566r1170b3631],
35	as	IN	O	as	_	0	SENT_130	[p8l1200t3589r1271b3631],
36	c-SRC	NN	O	c-src	prep_such_as	19	SENT_130	[p8l1298t3571r1522b3631],
37	.	.	O	.	_	0	SENT_130	[p8l1298t3571r1522b3631],

1	In	IN	O	in	_	0	SENT_131	[p8l1556t3572r1613b3630],
2	addition	NN	O	addition	pobj	1	SENT_131	[p8l1644t3566r1951b3643],
3	,	,	O	,	_	0	SENT_131	[p8l1644t3566r1951b3643],
4	activated	VBN	O	activate	partmod	2	SENT_131	[p8l1982t3589r2077b3631, p8l76t3674r310b3739],
5	PLCy	NN	O	plcy	nsubj	9	SENT_131	[p8l341t3679r525b3755],
6	can	MD	O	can	aux	7	SENT_131	[p8l542t3697r658b3739],
7	hydrolyze	VB	O	hydrolyze	ccomp	4	SENT_131	[p8l686t3674r1016b3759],
8	and	CC	O	and	_	0	SENT_131	[p8l1038t3674r1161b3739],
9	destroy	VB	O	destroy	conj_and	7	SENT_131	[p8l1187t3674r1445b3759],
10	the	DT	O	the	det	13	SENT_131	[p8l1461t3674r1572b3739],
11	lipid	NN	O	lipid	nn	13	SENT_131	[p8l1596t3674r1740b3758],
12	inhibitor	NN	O	inhibitor	nn	13	SENT_131	[p8l1767t3674r2065b3739],
13	PIP	NN	O	pip	dobj	7	SENT_131	[p8l85t3787r220b3834],
14	-	:	O	-	_	0	SENT_131	[p8l85t3787r220b3834],
15	l	NN	O	l	dep	13	SENT_131	[p8l273t3781r514b3834],
16	:	:	O	:	_	0	SENT_131	[p8l273t3781r514b3834],
17	llFl	NN	O	llfl	dep	13	SENT_131	[p8l273t3781r514b3834],
18	'	''	O	'	_	0	SENT_131	[p8l273t3781r514b3834],
19	l	NN	O	l	tmod	17	SENT_131	[p8l273t3781r514b3834],
20	"	''	O	"	punct	13	SENT_131	[p8l273t3781r514b3834],
21	IPr	NN	O	ipr	nn	23	SENT_131	[p8l273t3781r514b3834],
22	'	''	O	'	_	0	SENT_131	[p8l273t3781r514b3834],
23	rlptsiil	NN	O	rlptsiil	dep	13	SENT_131	[p8l534t3781r713b3834],
24	l	NN	O	l	tmod	23	SENT_131	[p8l743t3787r790b3834],
25	<	JJR	O	<	amod	2	SENT_131	[p8l743t3787r790b3834],
26	nrm/irlprl	CD	NUMBER	nrm/irlprl	dep	25	SENT_131	[p8l819t3781r1110b3834],
27	in	IN	O	in	dep	26	SENT_131	[p8l1140t3787r1194b3834],
28	the	DT	O	the	det	29	SENT_131	[p8l1218t3781r1325b3834],
29	rr	NN	O	rr	pobj	27	SENT_131	[p8l1352t3787r1564b3834],
30	=	JJ	O	=	amod	29	SENT_131	[p8l1352t3787r1564b3834],
31	\	CD	NUMBER	\	tmod	30	SENT_131	[p8l1352t3787r1564b3834],
32	/	:	O	/	punct	36	SENT_131	[p8l1352t3787r1564b3834],
33	ipw	NN	O	ipw	nn	36	SENT_131	[p8l1352t3787r1564b3834],
34	hv	NN	O	hv	nn	36	SENT_131	[p8l1588t3781r1660b3834],
35	Van	NNP	ORGANIZATION	Van	nn	36	SENT_131	[p8l1678t3787r1801b3834],
36	Fttpn	NNP	ORGANIZATION	Fttpn	dep	25	SENT_131	[p8l1833t3787r1999b3834],
37	1	CD	NUMBER	1	dep	36	SENT_131	[p8l2032t3781r2054b3814],

1	of	IN	O	of	_	0	SENT_132	[p9l10t278r111b357],
2	Janus	NN	O	janus	nn	3	SENT_132	[p9l115t286r356b370],
3	kinase	NN	O	kinase	prep_of	19	SENT_132	[p9l389t279r667b358],
4	2	CD	NUMBER	2	number	5	SENT_132	[p9l699t284r746b356],
5	(	CD	NUMBER	(	num	7	SENT_132	[p9l783t284r1092b374],
6	JAK2	NN	O	jak2	nn	7	SENT_132	[p9l783t284r1092b374],
7	)	NN	O	)	nsubjpass	19	SENT_132	[p9l783t284r1092b374],
8	,	,	O	,	_	0	SENT_132	[p9l783t284r1092b374],
9	a	DT	O	a	det	11	SENT_132	[p9l1129t305r1173b357],
10	nonreceptor	JJ	O	nonreceptor	amod	11	SENT_132	[p9l1204t295r1737b379],
11	TK	NN	O	tk	appos	7	SENT_132	[p9l1763t284r1915b374],
12	,	,	O	,	_	0	SENT_132	[p9l1763t284r1915b374],
13	with	IN	O	with	_	0	SENT_132	[p9l1947t279r2140b358],
14	TEL	NN	O	tel	prep_with	7	SENT_132	[p9l6t412r180b484],
15	or	CC	O	or	_	0	SENT_132	[p9l211t432r302b485],
16	BCR	NN	O	bcr	conj_or	14	SENT_132	[p9l329t412r532b490],
17	has	VBZ	O	have	aux	19	SENT_132	[p9l554t407r699b485],
18	been	VBN	O	be	auxpass	19	SENT_132	[p9l733t407r938b485],
19	described	VBN	O	describe	_	0	SENT_132	[p9l971t407r1391b485],
20	in	IN	O	in	_	0	SENT_132	[p9l1422t407r1506b484],
21	cases	NNS	O	case	prep_in	19	SENT_132	[p9l1538t433r1762b485],
22	of	IN	O	of	_	0	SENT_132	[p9l1797t406r1899b485],
23	acute	JJ	O	acute	amod	24	SENT_132	[p9l1912t423r2139b486],
24	leukemia	NN	O	leukemia	prep_of	21	SENT_132	[p9l8t534r406b613],
25	and	CC	O	and	_	0	SENT_132	[p9l432t534r590b612],
26	atypical	JJ	O	atypical	amod	27	SENT_132	[p9l617t534r949b634],
27	CML	NN	ORGANIZATION	cml	dep	28	SENT_132	[p9l976t527r1293b629],
28	,36	CD	NUMBER	,36	conj_and	19	SENT_132	[p9l976t527r1293b629],
29	Whereas	IN	O	whereas	mark	63	SENT_132	[p9l1316t534r1671b613],
30	an	DT	O	a	det	32	SENT_132	[p9l1701t559r1802b612],
31	activating	VBG	O	activate	amod	32	SENT_132	[p9l1829t535r2139b613, p9l8t663r150b763],
32	point	NN	O	point	nsubj	63	SENT_132	[p9l169t663r404b763],
33	mutation	NN	O	mutation	nn	36	SENT_132	[p9l425t663r825b742],
34	(	CD	NUMBER	(	num	36	SENT_132	[p9l853t668r1179b754],
35	V617F	NN	O	v617f	nn	36	SENT_132	[p9l853t668r1179b754],
36	)	NN	O	)	nsubjpass	40	SENT_132	[p9l853t668r1179b754],
37	in	IN	O	in	_	0	SENT_132	[p9l1207t663r1288b740],
38	JAK2	NN	O	jak2	prep_in	36	SENT_132	[p9l1301t668r1521b754],
39	is	VBZ	O	be	auxpass	40	SENT_132	[p9l1544t663r1609b741],
40	found	VBN	O	find	rcmod	32	SENT_132	[p9l1634t662r1885b742],
41	in	IN	O	in	_	0	SENT_132	[p9l1907t663r1989b740],
42	the	DT	O	the	det	43	SENT_132	[p9l2012t663r2141b741],
43	majority	NN	O	majority	prep_in	40	SENT_132	[p9l9t791r362b891],
44	of	IN	O	of	_	0	SENT_132	[p9l388t790r489b869],
45	patients	NNS	O	patient	prep_of	43	SENT_132	[p9l499t791r835b891],
46	with	IN	O	with	_	0	SENT_132	[p9l863t790r1053b870],
47	polycythemia	NN	O	polycythemia	nn	48	SENT_132	[p9l1082t791r1647b891],
48	Vera	NNP	PERSON	Vera	prep_with	45	SENT_132	[p9l1671t817r1846b870],
49	and	CC	O	and	_	0	SENT_132	[p9l1874t791r2030b869],
50	in	IN	O	in	_	0	SENT_132	[p9l2060t791r2141b868],
51	some	DT	O	some	det	52	SENT_132	[p9l11t944r239b997],
52	patients	NNS	O	patient	conj_and	43	SENT_132	[p9l270t919r613b1019],
53	With	IN	O	with	_	0	SENT_132	[p9l642t919r835b998],
54	essential	JJ	O	essential	amod	55	SENT_132	[p9l867t919r1243b997],
55	thrombocytosis	NN	O	thrombocytosis	prep_with	52	SENT_132	[p9l1275t919r1949b1019],
56	and	CC	O	and	_	0	SENT_132	[p9l1982t919r2140b997],
57	idiopathic	JJ	O	idiopathic	amod	58	SENT_132	[p9l8t1048r451b1148],
58	myelofibrosis	NN	O	myelofibrosis	conj_and	43	SENT_132	[p9l485t1043r1302b1148],
59	.34	CD	NUMBER	.34	number	60	SENT_132	[p9l485t1043r1302b1148],
60	’35	CD	NUMBER	’35	num	62	SENT_132	[p9l485t1043r1302b1148],
61	Preclinical	JJ	O	preclinical	amod	62	SENT_132	[p9l1339t1047r1797b1126],
62	studies	NNS	O	study	dep	58	SENT_132	[p9l1833t1048r2137b1127],
63	suggest	VBP	O	suggest	dep	19	SENT_132	[p9l11t1192r344b1276],
64	that	IN	O	that	complm	70	SENT_132	[p9l368t1175r536b1254],
65	many	JJ	O	many	nsubj	70	SENT_132	[p9l558t1201r793b1276],
66	of	IN	O	of	_	0	SENT_132	[p9l817t1175r918b1254],
67	these	DT	O	these	det	69	SENT_132	[p9l927t1176r1147b1254],
68	mutant	JJ	O	mutant	amod	69	SENT_132	[p9l1174t1192r1488b1255],
69	TKs	NN	O	tk	prep_of	65	SENT_132	[p9l1507t1181r1674b1257],
70	contribute	VBP	O	contribute	ccomp	63	SENT_132	[p9l1705t1175r2141b1255],
71	to	TO	O	to	_	0	SENT_132	[p9l10t1320r89b1382],
72	the	DT	O	the	det	73	SENT_132	[p9l116t1304r246b1382],
73	pathogenesis	NN	O	pathogenesis	prep_to	70	SENT_132	[p9l269t1304r830b1404],
74	of	IN	O	of	_	0	SENT_132	[p9l858t1303r959b1382],
75	the	DT	O	the	det	76	SENT_132	[p9l967t1304r1095b1382],
76	disease	NN	O	disease	prep_of	73	SENT_132	[p9l1122t1303r1450b1382],
77	.	.	O	.	_	0	SENT_132	[p9l1122t1303r1450b1382],

1	THE	DT	O	the	det	3	SENT_133	[p9l7t1599r168b1648],
2	DRAMATIC	NNP	O	DRAMATIC	nn	3	SENT_133	[p9l212t1598r643b1649],
3	RESPONSE	NNP	O	RESPONSE	_	0	SENT_133	[p9l685t1598r1115b1649],
4	OF	IN	O	of	_	0	SENT_133	[p9l1156t1598r1261b1649],
5	CML	NNP	O	CML	prep_of	3	SENT_133	[p9l1300t1598r1470b1649],
6	TO	TO	O	to	infmod	5	SENT_133	[p9l1505t1598r1612b1649],
7	KINASE	NNP	O	KINASE	nn	8	SENT_133	[p9l1657t1598r1955b1649],
8	INHIBITION	NNP	O	INHIBITION	dobj	6	SENT_133	[p9l15t1684r546b1735],
9	:	:	O	:	_	0	SENT_133	[p9l15t1684r546b1735],
10	THE	DT	O	the	det	12	SENT_133	[p9l583t1684r744b1734],
11	RULE	NN	O	rule	nn	12	SENT_133	[p9l788t1684r989b1734],
12	OR	NN	O	or	dep	3	SENT_133	[p9l1029t1684r1138b1734],
13	AN	DT	O	a	det	14	SENT_133	[p9l1176t1684r1284b1734],
14	EXCEPTION	NN	O	exception	dep	12	SENT_133	[p9l1334t1679r1845b1735],
15	?	.	O	?	_	0	SENT_133	[p9l1334t1679r1845b1735],

1	The	DT	O	the	det	3	SENT_134	[p9l6t1785r168b1863],
2	excellent	JJ	O	excellent	amod	3	SENT_134	[p9l191t1785r566b1863],
3	responses	NNS	O	response	nsubj	31	SENT_134	[p9l582t1810r1005b1885],
4	of	IN	O	of	_	0	SENT_134	[p9l1030t1784r1130b1863],
5	chronic	JJ	O	chronic	amod	8	SENT_134	[p9l1135t1785r1740b1885],
6	—	NN	O	—	nn	8	SENT_134	[p9l1135t1785r1740b1885],
7	phase	NN	O	phase	nn	8	SENT_134	[p9l1135t1785r1740b1885],
8	CML	NN	ORGANIZATION	cml	prep_of	3	SENT_134	[p9l1763t1790r1966b1863],
9	and	CC	O	and	_	0	SENT_134	[p9l1985t1785r2142b1863],
10	related	JJ	O	related	amod	11	SENT_134	[p9l9t1913r296b1991],
11	syndromes	NNS	O	syndrome	prep_of	3	SENT_134	[p9l321t1913r782b2013],
12	to	TO	O	to	_	0	SENT_134	[p9l809t1929r888b1991],
13	l	NN	O	l	dep	14	SENT_134	[p9l912t1912r1600b1992],
14	<	JJR	O	<	prep_to	8	SENT_134	[p9l912t1912r1600b1992],
15	inase	CD	NUMBER	inase	num	18	SENT_134	[p9l912t1912r1600b1992],
16	—	NN	O	—	nn	18	SENT_134	[p9l912t1912r1600b1992],
17	inhibitor	NN	O	inhibitor	nn	18	SENT_134	[p9l912t1912r1600b1992],
18	therapy	NN	O	therapy	nsubj	19	SENT_134	[p9l1621t1913r1939b2013],
19	suggest	VBP	O	suggest	rcmod	14	SENT_134	[p9l1960t1939r2140b2013, p9l9t2057r187b2141],
20	that	IN	O	that	complm	22	SENT_134	[p9l209t2041r379b2119],
21	a	DT	O	a	nsubj	22	SENT_134	[p9l401t2067r445b2119],
22	dysregulated	VBN	O	dysregulate	ccomp	19	SENT_134	[p9l472t2041r1021b2141],
23	TK	NN	O	tk	dobj	22	SENT_134	[p9l1045t2046r1176b2122],
24	is	VBZ	O	be	cop	31	SENT_134	[p9l1198t2041r1265b2119],
25	the	DT	O	the	det	31	SENT_134	[p9l1294t2041r1426b2119],
26	sole	JJ	O	sole	amod	31	SENT_134	[p9l1455t2041r1624b2119],
27	or	CC	O	or	_	0	SENT_134	[p9l1652t2066r1743b2119],
28	predominant	JJ	O	predominant	conj_or	26	SENT_134	[p9l1765t2041r2139b2141, p9l8t2170r235b2248],
29	somatic	JJ	O	somatic	amod	31	SENT_134	[p9l273t2170r611b2248],
30	genetic	JJ	O	genetic	amod	31	SENT_134	[p9l650t2170r962b2270],
31	abnormality	NN	O	abnormality	_	0	SENT_134	[p9l1000t2170r1529b2270],
32	in	IN	O	in	_	0	SENT_134	[p9l1565t2170r1647b2247],
33	the	DT	O	the	det	35	SENT_134	[p9l1688t2170r1819b2248],
34	malignant	JJ	O	malignant	amod	35	SENT_134	[p9l1860t2170r2139b2270, p9l9t2314r207b2376],
35	cells	NNS	O	cell	prep_in	31	SENT_134	[p9l256t2298r470b2376],
36	.	.	O	.	_	0	SENT_134	[p9l256t2298r470b2376],

1	In	IN	O	in	_	0	SENT_135	[p9l529t2305r617b2375],
2	contrast	NN	O	contrast	prep_in	11	SENT_135	[p9l672t2314r1042b2393],
3	,	,	O	,	_	0	SENT_135	[p9l672t2314r1042b2393],
4	one	CD	NUMBER	one	num	9	SENT_135	[p9l1100t2323r1252b2376],
5	or	CC	O	or	_	0	SENT_135	[p9l1305t2323r1393b2376],
6	more	JJR	O	more	num	9	SENT_135	[p9l1442t2323r1662b2376],
7	additional	JJ	O	additional	amod	9	SENT_135	[p9l1713t2298r2142b2376],
8	genetic	JJ	O	genetic	amod	9	SENT_135	[p9l9t2427r313b2527],
9	abnormalities	NNS	O	abnormality	nsubjpass	11	SENT_135	[p9l343t2427r923b2505],
10	are	VBP	O	be	auxpass	11	SENT_135	[p9l952t2453r1077b2505],
11	required	VBN	O	require	_	0	SENT_135	[p9l1106t2427r1456b2527],
12	for	IN	O	for	_	0	SENT_135	[p9l1485t2426r1606b2505],
13	the	DT	O	the	det	14	SENT_135	[p9l1632t2427r1760b2505],
14	development	NN	O	development	prep_for	11	SENT_135	[p9l1789t2427r2140b2527, p9l9t2572r229b2634],
15	of	IN	O	of	_	0	SENT_135	[p9l245t2555r344b2634],
16	AML	NN	ORGANIZATION	aml	prep_of	14	SENT_135	[p9l342t2551r652b2651],
17	,49	CD	NUMBER	,49	num	16	SENT_135	[p9l342t2551r652b2651],
18	which	WDT	O	which	nsubj	20	SENT_135	[p9l670t2556r935b2635],
19	may	MD	O	may	aux	20	SENT_135	[p9l958t2582r1137b2656],
20	explain	VB	O	explain	rcmod	14	SENT_135	[p9l1156t2556r1468b2656],
21	Why	WRB	O	why	advmod	32	SENT_135	[p9l1486t2556r1666b2656],
22	the	DT	O	the	det	23	SENT_135	[p9l1685t2556r1818b2634],
23	activity	NN	O	activity	nsubj	32	SENT_135	[p9l1841t2556r2144b2656],
24	of	IN	O	of	_	0	SENT_135	[p9l10t2683r111b2762],
25	FLT3	NN	O	flt3	nn	26	SENT_135	[p9l127t2689r336b2762],
26	inhibitors	NNS	O	inhibitor	prep_of	23	SENT_135	[p9l375t2684r800b2762],
27	in	IN	O	in	_	0	SENT_135	[p9l837t2684r919b2761],
28	that	DT	O	that	det	29	SENT_135	[p9l955t2684r1126b2762],
29	disease	NN	O	disease	prep_in	26	SENT_135	[p9l1157t2684r1468b2762],
30	is	VBZ	O	be	cop	32	SENT_135	[p9l1503t2684r1569b2762],
31	only	RB	O	only	advmod	32	SENT_135	[p9l1608t2683r1793b2784],
32	moderate	JJ	O	moderate	advcl	20	SENT_135	[p9l1824t2684r2139b2762, p9l8t2828r155b2890],
33	.	.	O	.	_	0	SENT_135	[p9l1824t2684r2139b2762, p9l8t2828r155b2890],

1	FLT3	NN	O	flt3	nn	2	SENT_136	[p9l204t2817r413b2890],
2	mutations	NNS	O	mutation	nsubjpass	5	SENT_136	[p9l460t2812r898b2891],
3	may	MD	O	may	aux	5	SENT_136	[p9l942t2838r1120b2912],
4	be	VB	O	be	auxpass	5	SENT_136	[p9l1157t2812r1253b2890],
5	acquired	VBN	O	acquire	_	0	SENT_136	[p9l1294t2812r1660b2912],
6	late	RB	O	late	advmod	5	SENT_136	[p9l1700t2812r1848b2890],
7	in	IN	O	in	_	0	SENT_136	[p9l1889t2812r1970b2889],
8	the	DT	O	the	prep_in	5	SENT_136	[p9l2012t2812r2140b2890],

1	174	CD	NUMBER	174	num	4	SENT_137	[p9l149t2987r205b3008],
2	N	NN	O	n	nn	4	SENT_137	[p9l918t2989r932b3004],
3	ENGLJ	NN	O	englj	nn	4	SENT_137	[p9l947t2988r1031b3010],
4	MED	NN	O	med	_	0	SENT_137	[p9l1046t2989r1099b3004],
5	35	CD	NUMBER	35	num	7	SENT_137	[p9l1111t2988r1136b3010],
6	;	:	O	;	_	0	SENT_137	[p9l1155t2988r1175b3008],
7	2	CD	NUMBER	2	dep	4	SENT_137	[p9l1155t2988r1175b3008],
8	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	9	SENT_137	[p9l1210t2988r1421b3010],
9	JULY	NNP	DATE	JULY	dep	4	SENT_137	[p9l1455t2989r1515b3010],
10	14	CD	DATE	14	num	9	SENT_137	[p9l1528t2988r1562b3010],
11	,	,	DATE	,	_	0	SENT_137	[p9l1528t2988r1562b3010],
12	2005	CD	DATE	2005	num	9	SENT_137	[p9l1575t2988r1638b3010],

1	The	DT	O	the	det	4	SENT_138	[p9l935t3021r986b3045],
2	New	NNP	O	New	nn	4	SENT_138	[p9l995t3022r1057b3045],
3	Englan	NNP	O	Englan	nn	4	SENT_138	[p9l1066t3021r1160b3052],
4	ournal	NN	O	ournal	_	0	SENT_138	[p9l1200t3021r1283b3045],
5	of	IN	O	of	_	0	SENT_138	[p9l1293t3021r1322b3045],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_138	[p9l1329t3021r1454b3045],

1	Downloaded	VBN	O	download	_	0	SENT_139	[p9l377t3062r547b3085],
2	from	IN	O	from	_	0	SENT_139	[p9l556t3062r620b3085],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_139	[p9l629t3062r747b3092],
4	at	IN	O	at	_	0	SENT_139	[p9l758t3066r781b3085],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_139	[p9l789t3062r972b3085],
6	on	IN	O	on	_	0	SENT_139	[p9l981t3069r1014b3085],
7	January	NNP	DATE	January	prep_on	1	SENT_139	[p9l1022t3062r1125b3092],
8	5	CD	DATE	5	num	7	SENT_139	[p9l1135t3062r1158b3089],
9	,	,	DATE	,	_	0	SENT_139	[p9l1135t3062r1158b3089],
10	2014	CD	DATE	2014	num	7	SENT_139	[p9l1169t3062r1241b3085],
11	.	.	O	.	_	0	SENT_139	[p9l1169t3062r1241b3085],

1	For	IN	O	for	_	0	SENT_140	[p9l1251t3062r1298b3085],
2	personal	JJ	O	personal	amod	3	SENT_140	[p9l1306t3062r1418b3092],
3	use	NN	O	use	pobj	1	SENT_140	[p9l1427t3069r1471b3085],
4	only	RB	O	only	advmod	3	SENT_140	[p9l1481t3062r1545b3092],
5	.	.	O	.	_	0	SENT_140	[p9l1481t3062r1545b3092],

1	No	DT	O	no	det	3	SENT_141	[p9l1556t3062r1596b3085],
2	other	JJ	O	other	amod	3	SENT_141	[p9l1606t3062r1674b3085],
3	uses	NNS	O	use	_	0	SENT_141	[p9l1682t3069r1738b3085],
4	without	IN	O	without	_	0	SENT_141	[p9l1748t3062r1849b3085],
5	permission	NN	O	permission	prep_without	3	SENT_141	[p9l1858t3062r2010b3092],
6	.	.	O	.	_	0	SENT_141	[p9l1858t3062r2010b3092],

1	Copyright	NN	O	copyright	_	0	SENT_142	[p9l727t3103r862b3134],
2	©	CD	NUMBER	©	num	6	SENT_142	[p9l871t3103r895b3127],
3	2005	CD	DATE	2005	num	6	SENT_142	[p9l905t3103r969b3127],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_142	[p9l979t3103r1170b3127],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_142	[p9l1180t3103r1288b3127],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_142	[p9l1299t3103r1404b3134],
7	.	.	O	.	_	0	SENT_142	[p9l1299t3103r1404b3134],

1	All	DT	O	all	det	2	SENT_143	[p9l1415t3103r1456b3127],
2	rights	NNS	O	rights	nsubj	3	SENT_143	[p9l1465t3103r1540b3134],
3	reserved	VBN	O	reserve	_	0	SENT_143	[p9l1550t3103r1669b3127],
4	.	.	O	.	_	0	SENT_143	[p9l1550t3103r1669b3127],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_144	[p9l717t3147r946b3166],
2	OF	IN	O	of	_	0	SENT_144	[p9l960t3147r1001b3166],
3	DISEASE	NN	O	disease	prep_of	1	SENT_144	[p9l1016t3147r1152b3166],

1	PDGFRﬂ	NN	O	pdgfrﬂ	_	0	SENT_145	[p10l792t84r912b115],

1	Extracellular	JJ	O	extracellular	amod	2	SENT_146	[p10l1742t476r1907b502],
2	region	NN	O	region	_	0	SENT_146	[p10l1918t479r2001b509],

1	Cell	NN	O	cell	nn	2	SENT_147	[p10l1767t809r1815b834],
2	membrane	NN	O	membrane	_	0	SENT_147	[p10l1828t809r1975b834],

1	B	NN	O	b	_	0	SENT_148	[p10l137t1158r155b1182],

1	PDGFRB	NN	O	pdgfrb	_	0	SENT_149	[p10l543t1485r664b1515],

1	evolution	NN	O	evolution	nsubj	20	SENT_150	[p10l93t2443r245b2475],
2	of	IN	O	of	_	0	SENT_150	[p10l259t2443r298b2474],
3	some	DT	O	some	det	5	SENT_150	[p10l304t2453r391b2474],
4	cases	NNS	O	case	nn	5	SENT_150	[p10l404t2453r490b2474],
5	ofAML	NN	O	ofaml	prep_of	1	SENT_150	[p10l505t2443r631b2474],
6	and	CC	O	and	_	0	SENT_150	[p10l643t2443r705b2474],
7	therefore	RB	O	therefore	advmod	1	SENT_150	[p10l719t2443r871b2474],
8	in	IN	O	in	_	0	SENT_150	[p10l885t2444r917b2474],
9	dence	NN	O	dence	prep_in	1	SENT_150	[p10l956t2443r1053b2474],
10	on	IN	O	on	_	0	SENT_150	[p10l1069t2453r1111b2474],
11	the	DT	O	the	det	14	SENT_150	[p10l1127t2443r1178b2474],
12	targeted	VBN	O	target	amod	14	SENT_150	[p10l1194t2443r1331b2483],
13	TK-signaling	NN	O	tk-signaling	nn	14	SENT_150	[p10l1346t2443r1565b2483],
14	pathway	NN	O	pathway	prep_on	9	SENT_150	[p10l1579t2443r1720b2483],
15	for	IN	O	for	_	0	SENT_150	[p10l1733t2443r1781b2474],
16	some	DT	O	some	det	17	SENT_150	[p10l94t2503r182b2524],
17	cases	NNS	O	case	prep_for	14	SENT_150	[p10l199t2503r285b2524],
18	are	VBP	O	be	cop	20	SENT_150	[p10l301t2503r351b2524],
19	not	RB	O	not	neg	20	SENT_150	[p10l367t2500r424b2524],
20	central	JJ	O	central	_	0	SENT_150	[p10l438t2493r552b2524],
21	to	TO	O	to	_	0	SENT_150	[p10l568t2500r599b2524],
22	the	DT	O	the	det	23	SENT_150	[p10l615t2493r666b2524],
23	origins	NNS	O	origin	prep_to	20	SENT_150	[p10l683t2494r800b2533],
24	of	IN	O	of	_	0	SENT_150	[p10l817t2493r856b2524],
25	the	DT	O	the	det	26	SENT_150	[p10l865t2493r916b2524],
26	survival	NN	O	survival	prep_of	23	SENT_150	[p10l956t2493r1092b2525],
27	.	.	O	.	_	0	SENT_150	[p10l956t2493r1092b2525],

1	This	DT	O	this	det	2	SENT_151	[p10l1107t2493r1180b2524],
2	phenomenon	NN	O	phenomenon	dep	8	SENT_151	[p10l1195t2493r1420b2533],
3	of	IN	O	of	_	0	SENT_151	[p10l1435t2493r1474b2524],
4	“	NN	O	“	nn	5	SENT_151	[p10l1483t2495r1662b2533],
5	oncogene	NN	O	oncogene	prep_of	2	SENT_151	[p10l1483t2495r1662b2533],
6	addicdisease	NN	O	addicdisease	dep	8	SENT_151	[p10l1676t2493r1779b2524, p10l93t2541r329b2574],
7	.5	CD	NUMBER	.5	num	6	SENT_151	[p10l1676t2493r1779b2524, p10l93t2541r329b2574],
8	°	CD	NUMBER	°	dep	14	SENT_151	[p10l1676t2493r1779b2524, p10l93t2541r329b2574],
9	The	DT	O	the	det	11	SENT_151	[p10l1676t2493r1779b2524, p10l93t2541r329b2574],
10	extreme	JJ	O	extreme	amod	11	SENT_151	[p10l338t2549r470b2574],
11	sensitivityof	NN	O	sensitivityof	dep	8	SENT_151	[p10l480t2542r694b2582],
12	some	DT	O	some	det	14	SENT_151	[p10l696t2553r784b2574],
13	cancers	NNS	O	cancer	nn	14	SENT_151	[p10l793t2553r916b2574],
14	tion	NN	O	tion	_	0	SENT_151	[p10l956t2541r1073b2574],
15	”	CD	NUMBER	”	num	16	SENT_151	[p10l956t2541r1073b2574],
16	51	CD	NUMBER	51	nsubjpass	19	SENT_151	[p10l956t2541r1073b2574],
17	can	MD	O	can	aux	19	SENT_151	[p10l1093t2553r1150b2574],
18	be	VB	O	be	auxpass	19	SENT_151	[p10l1170t2543r1208b2574],
19	seen	VBN	O	see	rcmod	14	SENT_151	[p10l1229t2553r1303b2574],
20	when	WRB	O	when	advmod	22	SENT_151	[p10l1321t2543r1413b2574],
21	imatinib	NN	O	imatinib	nsubj	22	SENT_151	[p10l1433t2543r1574b2574],
22	suppresses	VBZ	O	suppress	advcl	19	SENT_151	[p10l1596t2553r1778b2582],
23	to	TO	O	to	_	0	SENT_151	[p10l93t2599r124b2623],
24	TK	NN	O	tk	nn	25	SENT_151	[p10l135t2595r185b2624],
25	inhibition	NN	O	inhibition	prep_to	22	SENT_151	[p10l195t2592r359b2623],
26	may	MD	O	may	aux	27	SENT_151	[p10l370t2602r439b2631],
27	reﬂect	VB	O	reﬂect	rcmod	25	SENT_151	[p10l449t2592r552b2623],
28	their	PRP$	O	they	poss	34	SENT_151	[p10l562t2592r639b2623],
29	absolute	JJ	O	absolute	amod	34	SENT_151	[p10l649t2592r789b2623],
30	depen	NN	O	depen	nn	34	SENT_151	[p10l802t2592r916b2631],
31	—	NN	O	—	nn	34	SENT_151	[p10l802t2592r916b2631],
32	myeloid	JJ	O	myeloid	amod	34	SENT_151	[p10l956t2592r1086b2631],
33	colony	NN	O	colony	nn	34	SENT_151	[p10l1096t2592r1205b2631],
34	formation	NN	O	formation	dobj	27	SENT_151	[p10l1211t2592r1377b2623],
35	in	IN	O	in	_	0	SENT_151	[p10l1384t2593r1416b2622],
36	Philadelphia	NNP	LOCATION	Philadelphia	nn	37	SENT_151	[p10l1424t2592r1630b2631],
37	chromoN	NNP	O	chromoN	prep_in	27	SENT_151	[p10l1638t2592r1779b2623, p10l576t2708r590b2723],

1	ENGLJ	NNP	O	ENGLJ	nn	4	SENT_152	[p10l605t2707r689b2729],
2	MED	NNP	O	MED	nn	4	SENT_152	[p10l704t2708r757b2723],
3	353:2	CD	NUMBER	353:2	num	4	SENT_152	[p10l769t2707r833b2729],
4	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	_	0	SENT_152	[p10l868t2707r1080b2729],
5	JULY	NNP	DATE	JULY	dep	4	SENT_152	[p10l1113t2708r1173b2729],
6	14	CD	DATE	14	num	5	SENT_152	[p10l1185t2707r1220b2729],
7	,	,	DATE	,	_	0	SENT_152	[p10l1185t2707r1220b2729],
8	2005	CD	DATE	2005	num	5	SENT_152	[p10l1233t2707r1296b2729],
9	175	CD	NUMBER	175	dep	4	SENT_152	[p10l2010t2706r2065b2728],

1	The	DT	O	the	det	4	SENT_153	[p10l751t2804r802b2827],
2	New	NNP	O	New	nn	4	SENT_153	[p10l812t2804r873b2827],
3	England	NNP	O	England	nn	4	SENT_153	[p10l883t2804r994b2834],
4	Journal	NNP	O	Journal	_	0	SENT_153	[p10l1002t2804r1100b2827],
5	of	IN	O	of	_	0	SENT_153	[p10l1110t2804r1138b2827],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_153	[p10l1145t2804r1270b2827],

1	Downloaded	VBN	O	download	_	0	SENT_154	[p10l194t2844r364b2867],
2	from	IN	O	from	_	0	SENT_154	[p10l372t2844r437b2867],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_154	[p10l445t2844r564b2874],
4	at	IN	O	at	_	0	SENT_154	[p10l574t2848r597b2867],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_154	[p10l606t2844r788b2867],
6	on	IN	O	on	_	0	SENT_154	[p10l798t2851r830b2867],
7	January	NNP	DATE	January	prep_on	1	SENT_154	[p10l839t2844r942b2874],
8	5	CD	DATE	5	num	7	SENT_154	[p10l951t2844r974b2872],
9	,	,	DATE	,	_	0	SENT_154	[p10l951t2844r974b2872],
10	2014	CD	DATE	2014	num	7	SENT_154	[p10l985t2844r1057b2867],
11	.	.	O	.	_	0	SENT_154	[p10l985t2844r1057b2867],

1	For	IN	O	for	_	0	SENT_155	[p10l1068t2844r1114b2867],
2	personal	JJ	O	personal	amod	3	SENT_155	[p10l1122t2844r1235b2874],
3	use	NN	O	use	pobj	1	SENT_155	[p10l1244t2851r1287b2867],
4	only	RB	O	only	advmod	3	SENT_155	[p10l1297t2844r1362b2874],
5	.	.	O	.	_	0	SENT_155	[p10l1297t2844r1362b2874],

1	No	DT	O	no	det	3	SENT_156	[p10l1372t2844r1412b2867],
2	other	JJ	O	other	amod	3	SENT_156	[p10l1422t2844r1490b2867],
3	uses	NNS	O	use	_	0	SENT_156	[p10l1498t2851r1554b2867],
4	without	IN	O	without	_	0	SENT_156	[p10l1565t2844r1666b2867],
5	permission	NN	O	permission	prep_without	3	SENT_156	[p10l1674t2844r1827b2874],
6	.	.	O	.	_	0	SENT_156	[p10l1674t2844r1827b2874],

1	Copyright	NN	O	copyright	_	0	SENT_157	[p10l544t2885r678b2915],
2	©	CD	NUMBER	©	num	6	SENT_157	[p10l688t2885r711b2909],
3	2005	CD	DATE	2005	num	6	SENT_157	[p10l721t2885r785b2909],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_157	[p10l796t2885r987b2908],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_157	[p10l996t2885r1105b2908],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_157	[p10l1115t2885r1220b2915],
7	.	.	O	.	_	0	SENT_157	[p10l1115t2885r1220b2915],

1	All	DT	O	all	det	2	SENT_158	[p10l1231t2885r1273b2908],
2	rights	NNS	O	rights	nsubj	3	SENT_158	[p10l1282t2885r1357b2915],
3	reserved	VBN	O	reserve	_	0	SENT_158	[p10l1366t2885r1485b2908],
4	.	.	O	.	_	0	SENT_158	[p10l1366t2885r1485b2908],

1	The	DT	O	the	det	4	SENT_159	[p10l715t2990r752b3011],
2	NEW	NNP	O	NEW	nn	4	SENT_159	[p10l764t2992r845b3011],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_159	[p10l859t2992r1034b3011],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_159	[p10l1048t2992r1214b3018],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_159	[p10l1228t2990r1444b3017],

1	some	DT	O	some	det	5	SENT_160	[p10l12t3213r613b3313],
2	—	CD	NUMBER	—	num	5	SENT_160	[p10l12t3213r613b3313],
3	positive	JJ	O	positive	amod	5	SENT_160	[p10l12t3213r613b3313],
4	bone	NN	O	bone	nn	5	SENT_160	[p10l642t3212r849b3291],
5	marrow	NN	O	marrow	_	0	SENT_160	[p10l877t3238r1210b3292],
6	without	IN	O	without	_	0	SENT_160	[p10l1231t3213r1562b3292],
7	affecting	VBG	O	affect	prepc_without	5	SENT_160	[p10l1585t3212r1956b3313],
8	colonies	NNS	O	colony	dobj	7	SENT_160	[p10l1981t3213r2134b3291, p10l11t3342r231b3420],
9	from	IN	O	from	_	0	SENT_160	[p10l258t3341r464b3420],
10	normal	JJ	O	normal	amod	11	SENT_160	[p10l489t3342r796b3420],
11	progenitors	NNS	O	progenitor	prep_from	7	SENT_160	[p10l820t3337r1426b3442],
12	.	.	O	.	_	0	SENT_160	[p10l820t3337r1426b3442],

1	”	NN	O	”	_	0	SENT_161	[p10l820t3337r1426b3442],

1	The	DT	O	the	det	2	SENT_162	[p10l136t3469r298b3548],
2	responsiveness	NN	O	responsiveness	nsubj	17	SENT_162	[p10l334t3470r972b3570],
3	of	IN	O	of	_	0	SENT_162	[p10l1011t3469r1112b3548],
4	some	DT	O	some	det	6	SENT_162	[p10l1131t3495r1355b3548],
5	hematologic	JJ	O	hematologic	amod	6	SENT_162	[p10l1392t3469r1921b3570],
6	cancers	NNS	O	cancer	prep_of	2	SENT_162	[p10l1957t3495r2134b3548, p10l11t3624r175b3676],
7	to	TO	O	to	_	0	SENT_162	[p10l204t3614r283b3676],
8	l	NN	O	l	amod	13	SENT_162	[p10l311t3598r996b3677],
9	<	JJR	O	<	dep	8	SENT_162	[p10l311t3598r996b3677],
10	inase	CD	NUMBER	inase	num	13	SENT_162	[p10l311t3598r996b3677],
11	—	NN	O	—	nn	13	SENT_162	[p10l311t3598r996b3677],
12	inhibitor	NN	O	inhibitor	nn	13	SENT_162	[p10l311t3598r996b3677],
13	therapy	NN	O	therapy	prep_to	6	SENT_162	[p10l1020t3598r1338b3698],
14	may	MD	O	may	aux	17	SENT_162	[p10l1359t3624r1536b3698],
15	also	RB	O	also	advmod	17	SENT_162	[p10l1558t3598r1725b3676],
16	be	VB	O	be	cop	17	SENT_162	[p10l1754t3598r1849b3676],
17	due	JJ	O	due	_	0	SENT_162	[p10l1877t3597r2027b3677],
18	to	TO	O	to	_	0	SENT_162	[p10l2055t3614r2134b3676],
19	simultaneous	JJ	O	simultaneous	amod	20	SENT_162	[p10l12t3726r582b3805],
20	inhibition	NN	O	inhibition	prep_to	17	SENT_162	[p10l615t3726r1035b3804],
21	of	IN	O	of	_	0	SENT_162	[p10l1066t3725r1167b3804],
22	more	JJR	O	more	mwe	23	SENT_162	[p10l1180t3751r1400b3804],
23	than	IN	O	than	quantmod	24	SENT_162	[p10l1431t3726r1619b3804],
24	one	CD	NUMBER	one	num	26	SENT_162	[p10l1651t3751r1803b3804],
25	TK	NN	O	tk	nn	26	SENT_162	[p10l1830t3731r1960b3806],
26	target	NN	O	target	prep_of	20	SENT_162	[p10l1988t3742r2134b3804, p11l10t57r162b141],
27	.	.	O	.	_	0	SENT_162	[p10l1988t3742r2134b3804, p11l10t57r162b141],

1	Imatinib	NN	O	imatinib	nsubj	2	SENT_163	[p11l194t41r564b119],
2	inhibits	VBZ	O	inhibit	_	0	SENT_163	[p11l592t40r921b119],
3	both	CC	O	both	dep	4	SENT_163	[p11l952t41r1148b119],
4	BCR	NN	O	bcr	dobj	2	SENT_163	[p11l1174t46r1576b124],
5	.	.	O	.	_	0	SENT_163	[p11l1174t46r1576b124],

1	—	NN	O	—	_	0	SENT_164	[p11l1174t46r1576b124],
2	.	.	O	.	_	0	SENT_164	[p11l1174t46r1576b124],

1	ABL	NN	ORGANIZATION	abl	_	0	SENT_165	[p11l1174t46r1576b124],
2	and	CC	O	and	_	0	SENT_165	[p11l1601t41r1758b119],
3	c	NN	O	c	conj_and	1	SENT_165	[p11l1787t46r2028b122],
4	.	.	O	.	_	0	SENT_165	[p11l1787t46r2028b122],

1	—	NN	O	—	_	0	SENT_166	[p11l1787t46r2028b122],
2	.	.	O	.	_	0	SENT_166	[p11l1787t46r2028b122],

1	KIT	NN	O	kit	nsubj	20	SENT_167	[p11l1787t46r2028b122],
2	in	IN	O	in	_	0	SENT_167	[p11l2052t41r2134b118],
3	hematopoietic	JJ	O	hematopoietic	amod	4	SENT_167	[p11l10t169r631b269],
4	progenitors	NNS	O	progenitor	prep_in	1	SENT_167	[p11l663t169r1195b269],
5	,	,	O	,	_	0	SENT_167	[p11l663t169r1195b269],
6	and	CC	O	and	_	0	SENT_167	[p11l1234t169r1392b247],
7	this	DT	O	this	det	9	SENT_167	[p11l1426t169r1582b247],
8	dual	JJ	O	dual	amod	9	SENT_167	[p11l1619t169r1802b248],
9	activity	NN	O	activity	conj_and	4	SENT_167	[p11l1835t169r2139b269],
10	may	MD	O	may	aux	20	SENT_167	[p11l10t324r189b398],
11	in	IN	O	in	_	0	SENT_167	[p11l210t298r291b375],
12	part	NN	O	part	nn	13	SENT_167	[p11l314t314r487b398],
13	account	NN	O	account	prep_in	20	SENT_167	[p11l506t314r842b377],
14	for	IN	O	for	_	0	SENT_167	[p11l862t297r985b376],
15	its	PRP$	O	its	poss	16	SENT_167	[p11l1007t298r1103b376],
16	efficacy	NN	O	efficacy	prep_for	13	SENT_167	[p11l1130t297r1449b398],
17	in	IN	O	in	_	0	SENT_167	[p11l1469t298r1549b375],
18	CML	NNP	ORGANIZATION	CML	prep_in	16	SENT_167	[p11l1575t293r1882b376],
19	.53	CD	NUMBER	.53	num	18	SENT_167	[p11l1575t293r1882b376],
20	Simi	NNP	O	Simi	_	0	SENT_167	[p11l1912t298r2133b376],
21	—	CD	NUMBER	—	num	20	SENT_167	[p11l1912t298r2133b376],
22	larly	RB	O	larly	advmod	27	SENT_167	[p11l10t426r207b526],
23	,	,	O	,	_	0	SENT_167	[p11l10t426r207b526],
24	the	DT	O	the	det	26	SENT_167	[p11l245t426r376b504],
25	drug	NN	O	drug	nn	26	SENT_167	[p11l408t425r611b526],
26	SU5416	NN	O	su5416	nsubj	27	SENT_167	[p11l641t431r975b504],
27	inhibits	VBZ	O	inhibit	rcmod	20	SENT_167	[p11l1006t426r1336b504],
28	vascular	JJ	O	vascular	amod	32	SENT_167	[p11l1365t426r1720b505],
29	endothelial	JJ	O	endothelial	amod	32	SENT_167	[p11l1749t426r2133b504, p11l10t554r140b632],
30	growth	NN	O	growth	nn	32	SENT_167	[p11l164t554r472b654],
31	factor	NN	O	factor	nn	32	SENT_167	[p11l496t553r743b632],
32	receptors	NNS	O	receptor	nsubj	33	SENT_167	[p11l762t570r1152b654],
33	(	VBP	O	(	ccomp	27	SENT_167	[p11l1182t559r1548b645],
34	VEGFR	NN	O	vegfr	nn	35	SENT_167	[p11l1182t559r1548b645],
35	)	NN	O	)	dobj	33	SENT_167	[p11l1182t559r1548b645],
36	in	IN	O	in	_	0	SENT_167	[p11l1576t554r1656b631],
37	addition	NN	O	addition	prep_in	35	SENT_167	[p11l1679t554r2032b632],
38	to	TO	O	to	_	0	SENT_167	[p11l2055t570r2134b632],
39	FLT3	NN	O	flt3	prep_to	33	SENT_167	[p11l9t687r216b760],
40	and	CC	O	and	_	0	SENT_167	[p11l245t682r402b760],
41	c	NN	O	c	conj_and	39	SENT_167	[p11l429t687r687b777],
42	.	.	O	.	_	0	SENT_167	[p11l429t687r687b777],

1	—	NN	O	—	_	0	SENT_168	[p11l429t687r687b777],
2	.	.	O	.	_	0	SENT_168	[p11l429t687r687b777],

1	KIT	NN	O	kit	_	0	SENT_169	[p11l429t687r687b777],
2	;	:	O	;	_	0	SENT_169	[p11l429t687r687b777],
3	among	IN	O	among	_	0	SENT_169	[p11l717t707r1021b782],
4	patients	NNS	O	patient	prep_among	1	SENT_169	[p11l1042t682r1384b782],
5	with	IN	O	with	_	0	SENT_169	[p11l1407t682r1600b761],
6	c	NN	O	c	prep_with	4	SENT_169	[p11l1626t682r2133b782],
7	.	.	O	.	_	0	SENT_169	[p11l1626t682r2133b782],

1	—	NN	O	—	_	0	SENT_170	[p11l1626t682r2133b782],
2	.	.	O	.	_	0	SENT_170	[p11l1626t682r2133b782],

1	KIT	NN	O	kit	_	0	SENT_171	[p11l1626t682r2133b782],
2	.	.	O	.	_	0	SENT_171	[p11l1626t682r2133b782],

1	—	NN	O	—	_	0	SENT_172	[p11l1626t682r2133b782],
2	.	.	O	.	_	0	SENT_172	[p11l1626t682r2133b782],

1	posi	NN	O	posus	nn	3	SENT_173	[p11l1626t682r2133b782],
2	tive	JJ	O	tive	amod	3	SENT_173	[p11l11t810r154b889],
3	AML	NN	ORGANIZATION	aml	nsubj	13	SENT_173	[p11l173t817r400b905],
4	,	,	O	,	_	0	SENT_173	[p11l173t817r400b905],
5	those	DT	O	those	appos	3	SENT_173	[p11l428t810r655b888],
6	who	WP	O	who	nsubj	7	SENT_173	[p11l673t810r856b889],
7	had	VBD	O	have	rcmod	5	SENT_173	[p11l880t810r1035b888],
8	a	DT	O	a	det	9	SENT_173	[p11l1056t836r1101b888],
9	response	NN	O	response	dobj	7	SENT_173	[p11l1122t835r1501b910],
10	to	TO	O	to	_	0	SENT_173	[p11l1524t826r1602b888],
11	SU5416	NN	O	su5416	prep_to	9	SENT_173	[p11l1629t815r1957b888],
12	had	VBD	O	have	aux	13	SENT_173	[p11l1980t810r2135b888],
13	increased	VBN	O	increase	_	0	SENT_173	[p11l10t937r422b1016],
14	VEGF	NN	O	vegf	nn	15	SENT_173	[p11l458t943r707b1016],
15	levels	NNS	O	level	dobj	13	SENT_173	[p11l746t938r983b1017],
16	before	IN	O	before	_	0	SENT_173	[p11l1025t937r1299b1016],
17	treatment	NN	O	treatment	prep_before	13	SENT_173	[p11l1340t954r1767b1016],
18	and	CC	O	and	_	0	SENT_173	[p11l1801t937r1960b1016],
19	decreased	VBD	O	decrease	conj_and	13	SENT_173	[p11l2000t938r2131b1016, p11l11t1066r335b1144],
20	bone	NN	O	bone	nn	22	SENT_173	[p11l360t1066r567b1144],
21	marrow	NN	O	marrow	nn	22	SENT_173	[p11l593t1091r928b1145],
22	microvasculature	NN	O	microvasculature	dobj	19	SENT_173	[p11l949t1066r1673b1145],
23	after	IN	O	after	_	0	SENT_173	[p11l1697t1065r1891b1144],
24	treatment	NN	O	treatment	prep_after	19	SENT_173	[p11l1913t1082r2133b1144, p11l10t1190r338b1273],
25	.	.	O	.	_	0	SENT_173	[p11l1913t1082r2133b1144, p11l10t1190r338b1273],

1	“	NN	O	“	nsubjpass	10	SENT_174	[p11l1913t1082r2133b1144, p11l10t1190r338b1273],
2	The	DT	O	the	det	3	SENT_174	[p11l358t1195r520b1273],
3	response	NN	O	response	dep	1	SENT_174	[p11l544t1220r922b1295],
4	to	TO	O	to	_	0	SENT_174	[p11l947t1211r1026b1273],
5	this	DT	O	this	det	6	SENT_174	[p11l1051t1195r1204b1273],
6	drug	NN	O	drug	prep_to	1	SENT_174	[p11l1230t1195r1430b1295],
7	may	MD	O	may	aux	10	SENT_174	[p11l1450t1221r1627b1295],
8	thus	RB	O	thus	advmod	10	SENT_174	[p11l1647t1195r1826b1274],
9	be	VB	O	be	auxpass	10	SENT_174	[p11l1853t1195r1948b1273],
10	mediated	VBN	O	mediate	_	0	SENT_174	[p11l1972t1221r2134b1273, p11l11t1323r268b1401],
11	both	CC	O	both	dep	10	SENT_174	[p11l299t1323r491b1401],
12	by	IN	O	by	_	0	SENT_174	[p11l522t1322r619b1423],
13	inhibition	NN	O	inhibition	agent	10	SENT_174	[p11l644t1323r1064b1401],
14	of	IN	O	of	_	0	SENT_174	[p11l1095t1322r1196b1401],
15	c	NN	O	c	prep_of	13	SENT_174	[p11l1208t1328r1445b1404],
16	.	.	O	.	_	0	SENT_174	[p11l1208t1328r1445b1404],

1	—	NN	O	—	_	0	SENT_175	[p11l1208t1328r1445b1404],
2	.	.	O	.	_	0	SENT_175	[p11l1208t1328r1445b1404],

1	KIT	NN	O	kit	nn	2	SENT_176	[p11l1208t1328r1445b1404],
2	signaling	NN	O	signaling	conj_and	2	SENT_176	[p11l1473t1323r1868b1423],
3	in	IN	O	in	_	0	SENT_176	[p11l1894t1323r1975b1400],
4	the	DT	O	the	det	5	SENT_176	[p11l2006t1323r2135b1401],
5	blasts	NNS	O	blast	prep_in	2	SENT_176	[p11l11t1451r251b1529],
6	and	CC	O	and	_	0	SENT_176	[p11l283t1451r440b1529],
7	by	IN	O	by	_	0	SENT_176	[p11l471t1451r567b1551],
8	blockade	NN	O	blockade	nn	11	SENT_176	[p11l595t1451r973b1565],
9	_	CD	NUMBER	_	num	11	SENT_176	[p11l1004t1450r1436b1565],
10	ofVEGFR	NN	O	ofvegfr	nn	11	SENT_176	[p11l1004t1450r1436b1565],
11	activation	NN	O	activation	prep_by	2	SENT_176	[p11l1455t1451r1863b1529],
12	in	IN	O	in	_	0	SENT_176	[p11l1893t1451r1974b1528],
13	the	DT	O	the	det	18	SENT_176	[p11l2006t1451r2135b1529],
14	bone	NN	O	bone	nn	18	SENT_176	[p11l11t1552r218b1630],
15	marrow	NN	O	marrow	nn	18	SENT_176	[p11l243t1577r579b1631],
16	II1lCI	NN	O	ii1lcus	nn	18	SENT_176	[p11l601t1568r1416b1631],
17	'	''	O	'	_	0	SENT_176	[p11l601t1568r1416b1631],
18	O	NN	O	o	prep_in	11	SENT_176	[p11l601t1568r1416b1631],
19	€	CD	NUMBER	€	dep	2	SENT_176	[p11l601t1568r1416b1631],
20	I1Vl1	NN	O	i1vl1	nn	22	SENT_176	[p11l601t1568r1416b1631],
21	'	''	O	'	_	0	SENT_176	[p11l601t1568r1416b1631],
22	OI1In	NN	O	oi1in	dep	2	SENT_176	[p11l601t1568r1416b1631],
23	€	CD	NUMBER	€	num	24	SENT_176	[p11l601t1568r1416b1631],
24	I1t	NN	O	i1t	dep	22	SENT_176	[p11l601t1568r1416b1631],
25	.	.	O	.	_	0	SENT_176	[p11l601t1568r1416b1631],

1	TKS	NN	O	tk	_	0	SENT_177	[p11l205t1892r391b1952],
2	AS	JJ	O	as	amod	3	SENT_177	[p11l437t1891r556b1951],
3	TARGETS	NNS	O	target	dep	1	SENT_177	[p11l606t1891r1099b1951],
4	FOR	IN	O	for	_	0	SENT_177	[p11l1154t1891r1373b1951],
5	THERAPY	NN	O	therapy	prep_for	3	SENT_177	[p11l1415t1891r1928b1951],

1	OF	IN	O	of	_	0	SENT_178	[p11l546t2013r681b2073],
2	SOLID	JJ	O	solid	amod	3	SENT_178	[p11l734t2013r1069b2073],
3	TUMORS	NNS	O	tumor	pobj	1	SENT_178	[p11l1118t2013r1584b2074],

1	IMATINIB	NNP	O	IMATINIB	nsubj	2	SENT_179	[p11l16t2244r407b2292],
2	TARGETS	VBZ	O	target	_	0	SENT_179	[p11l443t2243r805b2293],
3	IN	IN	O	in	_	0	SENT_179	[p11l850t2244r930b2292],
4	SOLID	JJ	O	solid	amod	5	SENT_179	[p11l976t2243r1226b2293],
5	TUMORS	NNS	O	tumor	prep_in	2	SENT_179	[p11l1264t2243r1645b2293],
6	!	.	O	!	_	0	SENT_179	[p11l1264t2243r1645b2293],

1	GIST	NN	O	gist	nsubj	18	SENT_180	[p11l13t2327r199b2376],
2	AND	CC	O	and	_	0	SENT_180	[p11l234t2327r411b2376],
3	BEYOND	IN	O	beyond	dep	4	SENT_180	[p11l454t2327r793b2376],
4	Considerable	JJ	O	considerable	amod	6	SENT_180	[p11l10t2428r568b2506],
5	evidence	NN	O	evidence	nn	6	SENT_180	[p11l591t2428r951b2507],
6	points	NNS	O	point	conj_and	1	SENT_180	[p11l972t2428r1237b2528],
7	to	TO	O	to	_	0	SENT_180	[p11l1261t2444r1340b2506],
8	the	DT	O	the	det	9	SENT_180	[p11l1363t2428r1493b2506],
9	involvement	NN	O	involvement	prep_to	6	SENT_180	[p11l1514t2428r2036b2507],
10	of	IN	O	of	_	0	SENT_180	[p11l2053t2427r2153b2506],
11	TKs	NNS	O	tk	prep_of	1	SENT_180	[p11l7t2561r174b2637],
12	in	IN	O	in	_	0	SENT_180	[p11l197t2556r278b2633],
13	a	DT	O	a	det	14	SENT_180	[p11l300t2582r344b2634],
14	variety	NN	O	variety	prep_in	11	SENT_180	[p11l361t2556r639b2656],
15	of	IN	O	of	_	0	SENT_180	[p11l657t2555r757b2634],
16	solid	JJ	O	solid	amod	17	SENT_180	[p11l763t2555r965b2634],
17	tumors	NNS	O	tumor	prep_of	14	SENT_180	[p11l988t2572r1289b2635],
18	(	VBP	O	(	_	0	SENT_180	[p11l1318t2556r1571b2647],
19	Table	NNP	O	Table	nsubj	21	SENT_180	[p11l1318t2556r1571b2647],
20	2	CD	NUMBER	2	num	21	SENT_180	[p11l1594t2561r1700b2647],
21	)	CD	NUMBER	)	xcomp	18	SENT_180	[p11l1594t2561r1700b2647],
22	.	.	O	.	_	0	SENT_180	[p11l1594t2561r1700b2647],

1	Most	JJS	O	most	amod	4	SENT_181	[p11l1724t2563r1944b2634],
2	gastrointestinal	JJ	O	gastrointestinal	amod	4	SENT_181	[p11l1961t2582r2134b2656, p11l11t2684r544b2761],
3	stromal	JJ	O	stromal	amod	4	SENT_181	[p11l573t2684r905b2761],
4	tumors	NNS	O	tumor	nsubj	5	SENT_181	[p11l934t2700r1242b2762],
5	(	VBN	O	(	_	0	SENT_181	[p11l1278t2689r1602b2774],
6	GISTs	NNS	O	gist	dobj	5	SENT_181	[p11l1278t2689r1602b2774],
7	)	CD	NUMBER	)	nsubj	8	SENT_181	[p11l1278t2689r1602b2774],
8	carry	VBP	O	carry	rcmod	6	SENT_181	[p11l1637t2709r1851b2783],
9	mutations	NNS	O	mutation	dobj	8	SENT_181	[p11l1874t2699r2132b2762, p11l11t2812r223b2890],
10	in	IN	O	in	_	0	SENT_181	[p11l261t2812r344b2888],
11	c	NN	O	c	prep_in	9	SENT_181	[p11l383t2817r626b2892],
12	.	.	O	.	_	0	SENT_181	[p11l383t2817r626b2892],

1	—	NN	O	—	_	0	SENT_182	[p11l383t2817r626b2892],
2	.	.	O	.	_	0	SENT_182	[p11l383t2817r626b2892],

1	KIT	NN	O	kit	nsubj	14	SENT_183	[p11l383t2817r626b2892],
2	that	WDT	O	that	nsubjpass	4	SENT_183	[p11l661t2811r832b2889],
3	are	VBP	O	be	auxpass	4	SENT_183	[p11l864t2838r993b2890],
4	associated	VBN	O	associate	rcmod	1	SENT_183	[p11l1030t2811r1481b2890],
5	with	IN	O	with	_	0	SENT_183	[p11l1514t2812r1708b2891],
6	constitutive	JJ	O	constitutive	amod	7	SENT_183	[p11l1746t2812r2132b2890, p11l11t2940r156b3018],
7	activation	NN	O	activation	prep_with	4	SENT_183	[p11l184t2940r601b3018],
8	and	CC	O	and	_	0	SENT_183	[p11l628t2939r786b3017],
9	receptor	NN	O	receptor	nn	10	SENT_183	[p11l814t2955r1173b3039],
10	phosphorylation	NN	O	phosphorylation	prep_with	4	SENT_183	[p11l1197t2932r2133b3039],
11	.65	CD	NUMBER	.65	number	12	SENT_183	[p11l1197t2932r2133b3039],
12	’66	CD	NUMBER	’66	num	13	SENT_183	[p11l1197t2932r2133b3039],
13	GISTs	NNS	O	gist	dep	10	SENT_183	[p11l10t3073r271b3146],
14	develop	VBP	O	develop	_	0	SENT_183	[p11l316t3067r646b3168],
15	at	IN	O	at	_	0	SENT_183	[p11l690t3084r770b3146],
16	high	JJ	O	high	amod	17	SENT_183	[p11l807t3068r1005b3168],
17	frequency	NN	O	frequency	prep_at	14	SENT_183	[p11l1046t3067r1477b3168],
18	in	IN	O	in	_	0	SENT_183	[p11l1514t3068r1597b3145],
19	adults	NNS	O	adult	prep_in	17	SENT_183	[p11l1638t3067r1899b3147],
20	with	IN	O	with	_	0	SENT_183	[p11l1940t3068r2134b3147],
21	germ	NN	O	germ	prep_with	19	SENT_183	[p11l10t3196r418b3295],
22	—	CD	NUMBER	—	num	25	SENT_183	[p11l10t3196r418b3295],
23	line	NN	O	line	nn	25	SENT_183	[p11l10t3196r418b3295],
24	KIT	NN	O	kit	nn	25	SENT_183	[p11l444t3201r591b3273],
25	mutations	NNS	O	mutation	dobj	14	SENT_183	[p11l608t3196r1056b3290],
26	,	,	O	,	_	0	SENT_183	[p11l608t3196r1056b3290],
27	suggesting	VBG	O	suggest	partmod	25	SENT_183	[p11l1091t3196r1547b3295],
28	that	IN	O	that	complm	29	SENT_183	[p11l1571t3196r1735b3273],
29	c	NN	O	c	dep	27	SENT_183	[p11l1758t3201r1992b3276],
30	.	.	O	.	_	0	SENT_183	[p11l1758t3201r1992b3276],

1	—	NN	O	—	_	0	SENT_184	[p11l1758t3201r1992b3276],
2	.	.	O	.	_	0	SENT_184	[p11l1758t3201r1992b3276],

1	KIT	NN	O	kit	nn	2	SENT_185	[p11l1758t3201r1992b3276],
2	activation	NN	O	activation	nsubj	4	SENT_185	[p11l2015t3221r2134b3273, p11l11t3324r336b3403],
3	is	VBZ	O	be	cop	4	SENT_185	[p11l366t3325r432b3402],
4	insufﬁcient	JJ	O	insufﬁcient	_	0	SENT_185	[p11l464t3323r968b3403],
5	for	IN	O	for	_	0	SENT_185	[p11l993t3323r1120b3402],
6	tumorigenesis	NN	O	tumorigenesis	prep_for	4	SENT_185	[p11l1148t3318r1886b3424],
7	.	.	O	.	_	0	SENT_185	[p11l1148t3318r1886b3424],

1	”	NN	O	”	nsubj	29	SENT_186	[p11l1148t3318r1886b3424],
2	Most	JJS	O	most	amod	3	SENT_186	[p11l1914t3331r2138b3402],
3	patients	NNS	O	patient	nsubj	13	SENT_186	[p11l9t3452r342b3552],
4	with	IN	O	with	_	0	SENT_186	[p11l359t3452r547b3531],
5	a	DT	O	a	det	6	SENT_186	[p11l566t3478r611b3530],
6	GIST	NN	O	gist	prep_with	3	SENT_186	[p11l629t3457r846b3530],
7	who	WP	O	who	nsubj	10	SENT_186	[p11l859t3452r1041b3531],
8	do	VBP	O	do	aux	10	SENT_186	[p11l1064t3452r1166b3530],
9	not	RB	O	not	neg	10	SENT_186	[p11l1187t3468r1329b3530],
10	have	VB	O	have	rcmod	6	SENT_186	[p11l1344t3452r1531b3531],
11	KIT	NN	O	kit	nn	12	SENT_186	[p11l1549t3458r1696b3530],
12	mutations	NNS	O	mutation	dobj	10	SENT_186	[p11l1706t3452r2133b3531],
13	have	VBP	O	have	rcmod	1	SENT_186	[p11l10t3580r198b3659],
14	mutations	NNS	O	mutation	dobj	13	SENT_186	[p11l230t3580r661b3659],
15	in	IN	O	in	_	0	SENT_186	[p11l695t3580r775b3657],
16	PDGFRoz	NNP	O	PDGFRoz	nn	18	SENT_186	[p11l804t3575r1250b3659],
17	.85	CD	NUMBER	.85	num	18	SENT_186	[p11l804t3575r1250b3659],
18	Trials	NNS	O	trial	prep_in	14	SENT_186	[p11l1281t3580r1517b3658],
19	of	IN	O	of	_	0	SENT_186	[p11l1552t3579r1652b3658],
20	imatinib	NN	O	imatinib	prep_of	14	SENT_186	[p11l1665t3580r2021b3658],
21	in	IN	O	in	_	0	SENT_186	[p11l2053t3580r2135b3657],
22	GIST	NNP	O	GIST	prep_in	20	SENT_186	[p11l10t3713r229b3786],
23	that	WDT	O	that	nsubjpass	25	SENT_186	[p11l263t3708r429b3786],
24	were	VBD	O	be	auxpass	25	SENT_186	[p11l455t3734r656b3787],
25	prompted	VBN	O	prompt	rcmod	20	SENT_186	[p11l691t3707r1111b3808],
26	by	IN	O	by	_	0	SENT_186	[p11l1147t3708r1244b3808],
27	these	DT	O	these	det	28	SENT_186	[p11l1275t3707r1494b3786],
28	ﬁndings	NNS	O	ﬁndings	agent	25	SENT_186	[p11l1530t3707r1880b3808],
29	demonstrated	VBD	O	demonstrate	_	0	SENT_186	[p11l1918t3708r2134b3786, p12l11t21r409b100],

1	partial	JJ	O	partial	amod	2	SENT_187	[p12l444t22r716b122],
2	responses	NNS	O	response	nsubj	17	SENT_187	[p12l751t47r1171b122],
3	in	IN	O	in	_	0	SENT_187	[p12l1210t22r1290b99],
4	more	JJR	O	more	quantmod	6	SENT_187	[p12l1327t47r1547b100],
5	than	IN	O	than	quantmod	6	SENT_187	[p12l1584t22r1772b100],
6	half	PDT	O	half	num	8	SENT_187	[p12l1808t21r1987b100],
7	the	DT	O	the	det	8	SENT_187	[p12l2006t22r2135b100],
8	patients67	NN	O	patients67	prep_in	2	SENT_187	[p12l9t142r445b249],
9	;	:	O	;	_	0	SENT_187	[p12l9t142r445b249],
10	those	DT	O	those	dep	8	SENT_187	[p12l473t149r696b227],
11	with	IN	O	with	_	0	SENT_187	[p12l716t149r903b228],
12	KIT	NN	O	kit	nn	13	SENT_187	[p12l924t155r1071b227],
13	mutations	NNS	O	mutation	prep_with	10	SENT_187	[p12l1085t150r1508b228],
14	in	IN	O	in	_	0	SENT_187	[p12l1533t150r1614b226],
15	exon	NN	O	exon	prep_in	13	SENT_187	[p12l1638t174r1835b227],
16	11	CD	NUMBER	11	num	15	SENT_187	[p12l1862t155r1958b226],
17	had	VBD	O	have	_	0	SENT_187	[p12l1982t149r2135b227],
18	the	DT	O	the	det	20	SENT_187	[p12l11t278r140b356],
19	best	JJS	O	best	amod	20	SENT_187	[p12l170t277r348b356],
20	response	NN	O	response	dobj	17	SENT_187	[p12l372t303r784b378],
21	,	,	O	,	_	0	SENT_187	[p12l372t303r784b378],
22	whereas	IN	O	whereas	mark	34	SENT_187	[p12l814t278r1168b357],
23	the	DT	O	the	det	25	SENT_187	[p12l1199t278r1331b356],
24	few	JJ	O	few	amod	25	SENT_187	[p12l1360t277r1513b357],
25	patients	NNS	O	patient	nsubj	34	SENT_187	[p12l1537t278r1880b378],
26	without	IN	O	without	_	0	SENT_187	[p12l1906t278r2133b357, p12l11t422r154b485],
27	either	CC	O	either	preconj	28	SENT_187	[p12l180t406r432b484],
28	KIT	NN	O	kit	prep_without	25	SENT_187	[p12l457t412r609b483],
29	or	CC	O	or	_	0	SENT_187	[p12l632t431r722b484],
30	PDGFRoz	NN	O	pdgfroz	nn	31	SENT_187	[p12l748t412r1090b485],
31	mutations	NNS	O	mutation	prep_without	25	SENT_187	[p12l1123t406r1566b485],
32	did	VBD	O	do	aux	34	SENT_187	[p12l1601t405r1736b484],
33	not	RB	O	not	neg	34	SENT_187	[p12l1767t422r1914b484],
34	have	VB	O	have	advcl	17	SENT_187	[p12l1940t406r2133b485],
35	a	DT	O	a	det	36	SENT_187	[p12l10t561r54b613],
36	response	NN	O	response	dobj	34	SENT_187	[p12l84t530r580b635],
37	.	.	O	.	_	0	SENT_187	[p12l84t530r580b635],

1	”	NN	O	”	npadvmod	19	SENT_188	[p12l84t530r580b635],
2	In	IN	O	in	_	0	SENT_188	[p12l608t542r695b612],
3	contrast	NN	O	contrast	prep_in	19	SENT_188	[p12l724t551r1071b613],
4	to	TO	O	to	_	0	SENT_188	[p12l1095t551r1174b613],
5	patients	NNS	O	patient	prep_to	3	SENT_188	[p12l1202t535r1536b635],
6	with	IN	O	with	_	0	SENT_188	[p12l1563t535r1752b614],
7	chronic	JJ	O	chronic	amod	10	SENT_188	[p12l1781t535r2134b613],
8	—	NN	O	—	nn	10	SENT_188	[p12l1781t535r2134b613],
9	phase	NN	O	phase	nn	10	SENT_188	[p12l9t663r258b763],
10	CML	NN	ORGANIZATION	cml	prep_with	5	SENT_188	[p12l287t668r514b758],
11	,	,	O	,	_	0	SENT_188	[p12l287t668r514b758],
12	complete	JJ	O	complete	amod	13	SENT_188	[p12l550t663r946b763],
13	responses	NNS	O	response	nsubjpass	19	SENT_188	[p12l975t688r1405b763],
14	to	TO	O	to	_	0	SENT_188	[p12l1437t679r1517b741],
15	imatinib	NN	O	imatinib	prep_to	13	SENT_188	[p12l1548t663r1911b741],
16	have	VBP	O	have	aux	19	SENT_188	[p12l1942t663r2134b742],
17	not	RB	O	not	neg	19	SENT_188	[p12l10t806r154b868],
18	been	VBN	O	be	auxpass	19	SENT_188	[p12l172t790r370b868],
19	observed	VBN	O	observe	_	0	SENT_188	[p12l392t790r763b869],
20	in	IN	O	in	_	0	SENT_188	[p12l785t791r865b867],
21	patients	NNS	O	patient	prep_in	19	SENT_188	[p12l886t791r1216b890],
22	with	IN	O	with	_	0	SENT_188	[p12l1237t790r1424b869],
23	GISTs	NNS	O	gist	prep_with	19	SENT_188	[p12l1446t783r1808b885],
24	,67	CD	NUMBER	,67	num	23	SENT_188	[p12l1446t783r1808b885],
25	and	CC	O	and	_	0	SENT_188	[p12l1830t790r1984b868],
26	the	DT	O	the	det	28	SENT_188	[p12l2007t790r2135b868],
27	varying	VBG	O	vary	amod	28	SENT_188	[p12l6t919r318b1019],
28	responses	NNS	O	response	prep_with	19	SENT_188	[p12l348t944r768b1019],
29	of	IN	O	of	_	0	SENT_188	[p12l804t918r904b997],
30	patients	NNS	O	patient	prep_of	28	SENT_188	[p12l918t919r1252b1019],
31	With	IN	O	with	_	0	SENT_188	[p12l1283t919r1472b998],
32	different	JJ	O	different	amod	33	SENT_188	[p12l1506t918r1873b997],
33	c	NN	O	c	prep_with	30	SENT_188	[p12l1901t924r2138b1000],
34	.	.	O	.	_	0	SENT_188	[p12l1901t924r2138b1000],

1	—	NN	O	—	_	0	SENT_189	[p12l1901t924r2138b1000],
2	.	.	O	.	_	0	SENT_189	[p12l1901t924r2138b1000],

1	KIT	NN	O	kit	nn	2	SENT_190	[p12l1901t924r2138b1000],
2	mutations	NNS	O	mutation	nsubj	3	SENT_190	[p12l10t1047r449b1126],
3	contrasts	VBZ	O	contrast	_	0	SENT_190	[p12l475t1063r867b1125],
4	With	IN	O	with	_	0	SENT_190	[p12l887t1047r1080b1126],
5	the	DT	O	the	det	6	SENT_190	[p12l1103t1047r1234b1125],
6	uniform	NN	O	uniform	prep_with	3	SENT_190	[p12l1257t1046r1611b1126],
7	in	FW	O	in	nn	8	SENT_190	[p12l1633t1047r1716b1124],
8	vitro	FW	O	vitro	advmod	9	SENT_190	[p12l1734t1047r1930b1126],
9	sensitivity	NN	O	sensitivity	rcmod	6	SENT_190	[p12l1956t1072r2133b1125, p12l12t1175r281b1275],

1	of	IN	O	of	_	0	SENT_191	[p12l299t1174r398b1253],
2	these	DT	O	these	det	4	SENT_191	[p12l402t1175r616b1253],
3	mutant	JJ	O	mutant	amod	4	SENT_191	[p12l638t1191r946b1254],
4	receptors	NNS	O	receptor	pobj	1	SENT_191	[p12l962t1191r1345b1275],
5	to	TO	O	to	_	0	SENT_191	[p12l1370t1191r1447b1253],
6	the	DT	O	the	det	7	SENT_191	[p12l1471t1175r1598b1253],
7	drug	NN	O	drug	prep_to	4	SENT_191	[p12l1621t1175r1837b1275],
8	.	.	O	.	_	0	SENT_191	[p12l1621t1175r1837b1275],

1	Therefore	RB	O	therefore	dep	4	SENT_192	[p12l1861t1175r2134b1253, p12l10t1302r199b1398],
2	,	,	O	,	_	0	SENT_192	[p12l1861t1175r2134b1253, p12l10t1302r199b1398],
3	the	DT	O	the	det	4	SENT_192	[p12l237t1303r366b1381],
4	dependence	NN	O	dependence	_	0	SENT_192	[p12l398t1303r903b1403],
5	of	IN	O	of	_	0	SENT_192	[p12l936t1302r1036b1381],
6	GISTS	NN	O	gist	prep_of	4	SENT_192	[p12l1050t1308r1303b1381],
7	on	IN	O	on	_	0	SENT_192	[p12l1338t1328r1445b1381],
8	c	NN	O	c	prep_on	6	SENT_192	[p12l1477t1308r1713b1384],
9	.	.	O	.	_	0	SENT_192	[p12l1477t1308r1713b1384],

1	—	NN	O	—	_	0	SENT_193	[p12l1477t1308r1713b1384],
2	.	.	O	.	_	0	SENT_193	[p12l1477t1308r1713b1384],

1	KIT	NN	O	kit	nn	2	SENT_194	[p12l1477t1308r1713b1384],
2	signaling	NN	O	signaling	nsubj	9	SENT_194	[p12l1744t1303r2138b1403],
3	for	IN	O	for	_	0	SENT_194	[p12l10t1430r135b1509],
4	survival	NN	O	survival	prep_for	2	SENT_194	[p12l167t1431r496b1510],
5	and	CC	O	and	_	0	SENT_194	[p12l528t1431r687b1509],
6	proliferation	NN	O	proliferation	conj_and	4	SENT_194	[p12l719t1430r1273b1531],
7	is	VBZ	O	be	cop	9	SENT_194	[p12l1306t1431r1372b1509],
8	probably	RB	O	probably	advmod	9	SENT_194	[p12l1407t1431r1795b1531],
9	incomplete	JJ	O	incomplete	_	0	SENT_194	[p12l1823t1431r2132b1509, p12l9t1559r218b1658],
10	and	CC	O	and	_	0	SENT_194	[p12l246t1559r403b1636],
11	complex	NN	O	complex	conj_and	9	SENT_194	[p12l429t1559r810b1658],
12	.	.	O	.	_	0	SENT_194	[p12l429t1559r810b1658],

1	c	NN	O	c	_	0	SENT_195	[p12l140t1692r380b1768],
2	.	.	O	.	_	0	SENT_195	[p12l140t1692r380b1768],

1	—	NN	O	—	_	0	SENT_196	[p12l140t1692r380b1768],
2	.	.	O	.	_	0	SENT_196	[p12l140t1692r380b1768],

1	KIT	NN	O	kit	nsubjpass	7	SENT_197	[p12l140t1692r380b1768],
2	and	CC	O	and	_	0	SENT_197	[p12l402t1687r560b1765],
3	PDGFR	NN	O	pdgfr	conj_and	1	SENT_197	[p12l583t1692r915b1770],
4	have	VBP	O	have	aux	7	SENT_197	[p12l930t1687r1121b1766],
5	also	RB	O	also	advmod	7	SENT_197	[p12l1146t1687r1316b1765],
6	been	VBN	O	be	auxpass	7	SENT_197	[p12l1344t1687r1546b1765],
7	implicated	VBN	O	implicate	dep	12	SENT_197	[p12l1571t1686r2027b1787],
8	in	IN	O	in	_	0	SENT_197	[p12l2052t1687r2134b1764],
9	other	JJ	O	other	amod	11	SENT_197	[p12l11t1815r240b1893],
10	solid	JJ	O	solid	amod	11	SENT_197	[p12l267t1815r473b1893],
11	tumors	NNS	O	tumor	prep_in	7	SENT_197	[p12l502t1831r803b1894],
12	(	VBP	O	(	_	0	SENT_197	[p12l837t1814r1091b1906],
13	Table	NNP	O	Table	dobj	12	SENT_197	[p12l837t1814r1091b1906],
14	2	CD	NUMBER	2	num	15	SENT_197	[p12l1118t1820r1224b1910],
15	)	CD	NUMBER	)	nsubj	12	SENT_197	[p12l1118t1820r1224b1910],
16	,	,	O	,	_	0	SENT_197	[p12l1118t1820r1224b1910],
17	although	IN	O	although	mark	29	SENT_197	[p12l1256t1815r1637b1915],
18	evidence	NN	O	evidence	nsubjpass	29	SENT_197	[p12l1664t1814r2025b1894],
19	of	IN	O	of	_	0	SENT_197	[p12l2053t1814r2153b1893],
20	the	DT	O	the	det	21	SENT_197	[p12l11t1943r139b2021],
21	efficacy	NN	O	efficacy	prep_of	18	SENT_197	[p12l173t1942r499b2043],
22	of	IN	O	of	_	0	SENT_197	[p12l528t1942r629b2021],
23	kinase	NN	O	kinase	nn	24	SENT_197	[p12l643t1943r918b2022],
24	inhibitors	NNS	O	inhibitor	prep_of	21	SENT_197	[p12l950t1943r1374b2021],
25	in	IN	O	in	_	0	SENT_197	[p12l1408t1943r1490b2020],
26	these	DT	O	these	det	27	SENT_197	[p12l1523t1943r1746b2021],
27	diseases	NNS	O	disease	prep_in	24	SENT_197	[p12l1780t1943r2131b2021],
28	is	VBZ	O	be	auxpass	29	SENT_197	[p12l10t2071r76b2148],
29	limited	VBN	O	limit	dep	15	SENT_197	[p12l103t2071r429b2148],
30	.	.	O	.	_	0	SENT_197	[p12l103t2071r429b2148],

1	There	EX	O	there	expl	3	SENT_198	[p12l455t2071r700b2148],
2	are	VBP	O	be	aux	3	SENT_198	[p12l723t2096r849b2148],
3	activating	VBG	O	activate	_	0	SENT_198	[p12l873t2071r1284b2170],
4	kinase	NN	O	kinase	nn	5	SENT_198	[p12l1304t2071r1574b2150],
5	mutations	NNS	O	mutation	dobj	3	SENT_198	[p12l1598t2071r2028b2149],
6	in	IN	O	in	prep	3	SENT_198	[p12l2054t2071r2135b2147],

1	Figure	NN	O	figure	_	0	SENT_199	[p13l83t202r301b284],
2	2	CD	NUMBER	2	number	3	SENT_199	[p13l322t206r361b263],
3	(	CD	NUMBER	(	dep	1	SENT_199	[p13l389t200r625b285],
4	facing	VBG	O	face	partmod	1	SENT_199	[p13l389t200r625b285],
5	page	NN	O	page	nn	6	SENT_199	[p13l649t206r860b285],
6	)	NN	O	)	dobj	4	SENT_199	[p13l649t206r860b285],
7	.	.	O	.	_	0	SENT_199	[p13l649t206r860b285],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_200	[p13l890t200r1340b265],
2	of	IN	O	of	_	0	SENT_200	[p13l1363t199r1443b265],
3	TK	NN	O	tk	nn	4	SENT_200	[p13l1449t206r1545b264],
4	Dysregulation	NN	O	dysregulation	prep_of	1	SENT_200	[p13l1570t200r2056b285],
5	and	CC	O	and	_	0	SENT_200	[p13l78t308r204b372],
6	Therapeutic	JJ	O	therapeutic	amod	7	SENT_200	[p13l230t308r654b392],
7	Targeting	NN	O	targeting	prep_of	1	SENT_200	[p13l674t310r1005b393],
8	in	IN	O	in	_	0	SENT_200	[p13l1030t310r1089b372],
9	Cancer	NN	O	cancer	prep_in	1	SENT_200	[p13l1116t313r1370b372],
10	.	.	O	.	_	0	SENT_200	[p13l1116t313r1370b372],

1	In	IN	O	in	_	0	SENT_201	[p13l85t460r142b517],
2	each	DT	O	each	det	3	SENT_201	[p13l172t453r329b519],
3	case	NN	O	case	prep_in	15	SENT_201	[p13l358t477r529b530],
4	,	,	O	,	_	0	SENT_201	[p13l358t477r529b530],
5	the	DT	O	the	det	6	SENT_201	[p13l556t453r666b519],
6	TKs	NNS	O	tk	nsubjpass	15	SENT_201	[p13l689t460r818b519],
7	known	VBN	O	know	partmod	6	SENT_201	[p13l850t454r1073b519],
8	to	TO	O	to	aux	10	SENT_201	[p13l1101t466r1169b519],
9	be	VB	O	be	auxpass	10	SENT_201	[p13l1200t453r1276b519],
10	activated	VBN	O	activate	xcomp	7	SENT_201	[p13l1303t454r1613b519],
11	through	IN	O	through	_	0	SENT_201	[p13l1641t453r1918b539],
12	that	DT	O	that	det	13	SENT_201	[p13l76t559r215b623],
13	mechanism	NN	O	mechanism	prep_through	10	SENT_201	[p13l243t559r649b623],
14	are	VBP	O	be	auxpass	15	SENT_201	[p13l680t582r783b623],
15	listed	VBN	O	list	_	0	SENT_201	[p13l813t559r1016b623],
16	.	.	O	.	_	0	SENT_201	[p13l813t559r1016b623],

1	Overexpression	NN	O	overexpression	nn	2	SENT_202	[p13l1047t564r1593b643],
2	ofa	NN	O	ofa	nsubj	50	SENT_202	[p13l1623t558r1747b623],
3	normal	JJ	O	normal	amod	5	SENT_202	[p13l1779t559r2022b623],
4	receptor	NN	O	receptor	nn	5	SENT_202	[p13l82t676r373b749],
5	TK	NN	O	tk	tmod	2	SENT_202	[p13l393t670r488b728],
6	(	CD	NUMBER	(	npadvmod	7	SENT_202	[p13l519t664r712b749],
7	here	RB	O	here	advmod	5	SENT_202	[p13l519t664r712b749],
8	,	,	O	,	_	0	SENT_202	[p13l519t664r712b749],
9	epidermal	JJ	O	epidermal	amod	12	SENT_202	[p13l741t664r1091b749],
10	growth	NN	O	growth	nn	12	SENT_202	[p13l1122t664r1361b750],
11	factor	NN	O	factor	nn	12	SENT_202	[p13l1389t663r1593b729],
12	receptor	NN	O	receptor	nsubj	50	SENT_202	[p13l1620t676r1910b749],
13	[	CD	NUMBER	[	num	14	SENT_202	[p13l81t774r369b854],
14	EGFR	NN	O	egfr	dep	12	SENT_202	[p13l81t774r369b854],
15	]	CD	NUMBER	]	num	16	SENT_202	[p13l81t774r369b854],
16	)	NN	O	)	dep	12	SENT_202	[p13l81t774r369b854],
17	,	,	O	,	_	0	SENT_202	[p13l81t774r369b854],
18	its	PRP$	O	its	poss	19	SENT_202	[p13l401t776r476b834],
19	ligand	NN	O	ligand	appos	12	SENT_202	[p13l508t769r738b855],
20	,	,	O	,	_	0	SENT_202	[p13l508t769r738b855],
21	or	CC	O	or	_	0	SENT_202	[p13l767t792r839b834],
22	both	DT	O	both	nsubjpass	24	SENT_202	[p13l866t769r1017b834],
23	is	VBZ	O	be	auxpass	24	SENT_202	[p13l1050t776r1099b834],
24	depicted	VBN	O	depict	dep	32	SENT_202	[p13l1127t769r1424b854],
25	in	IN	O	in	_	0	SENT_202	[p13l1457t776r1512b833],
26	Panel	NNP	O	Panel	nn	27	SENT_202	[p13l1548t769r1730b834],
27	A.	NN	O	a.	prep_in	24	SENT_202	[p13l1757t773r1824b834],
28	In	IN	O	in	_	0	SENT_202	[p13l1859t776r1916b833],
29	Panel	NN	O	panel	nn	30	SENT_202	[p13l85t874r266b939],
30	B	NN	O	b	prep_in	24	SENT_202	[p13l302t881r360b951],
31	,	,	O	,	_	0	SENT_202	[p13l302t881r360b951],
32	mutations	NNS	O	mutation	nsubj	50	SENT_202	[p13l393t881r748b939],
33	that	WDT	O	that	nsubj	34	SENT_202	[p13l774t874r913b939],
34	render	VBP	O	render	rcmod	32	SENT_202	[p13l941t874r1166b939],
35	a	DT	O	a	det	37	SENT_202	[p13l1191t897r1223b939],
36	receptor	NN	O	receptor	nn	37	SENT_202	[p13l1255t887r1545b959],
37	TK	NN	O	tk	nsubjpass	45	SENT_202	[p13l1565t881r1660b938],
38	constitutively	RB	O	constitutively	advmod	39	SENT_202	[p13l1684t881r1993b939, p13l76t979r258b1065],
39	active	JJ	O	active	amod	37	SENT_202	[p13l283t986r482b1044],
40	in	IN	O	in	_	0	SENT_202	[p13l511t986r567b1043],
41	the	DT	O	the	det	43	SENT_202	[p13l594t979r704b1044],
42	absence	NN	O	absence	nn	43	SENT_202	[p13l731t979r1015b1044],
43	ofligand	NN	O	ofligand	prep_in	39	SENT_202	[p13l1042t979r1343b1065],
44	are	VBP	O	be	auxpass	45	SENT_202	[p13l1373t1002r1477b1044],
45	represented	VBN	O	represent	ccomp	34	SENT_202	[p13l1507t979r1919b1064],
46	by	IN	O	by	_	0	SENT_202	[p13l1952t979r2026b1065],
47	internal	JJ	O	internal	amod	49	SENT_202	[p13l81t1085r342b1150],
48	tandem	JJ	O	tandem	amod	49	SENT_202	[p13l370t1085r637b1150],
49	duplications	NNS	O	duplication	agent	45	SENT_202	[p13l667t1085r1100b1170],
50	(	VBP	O	(	dep	64	SENT_202	[p13l1136t1090r1350b1170],
51	|	CD	NUMBER	|	num	52	SENT_202	[p13l1136t1090r1350b1170],
52	TDs	NNS	O	td	dobj	50	SENT_202	[p13l1136t1090r1350b1170],
53	)	RB	O	)	advmod	50	SENT_202	[p13l1136t1090r1350b1170],
54	in	IN	O	in	_	0	SENT_202	[p13l1386t1091r1442b1149],
55	the	DT	O	the	det	60	SENT_202	[p13l1469t1085r1580b1150],
56	juxtamembrane	NN	O	juxtamembrane	nn	60	SENT_202	[p13l1602t1091r1980b1171, p13l82t1190r276b1255],
57	(	CD	NUMBER	(	num	60	SENT_202	[p13l310t1195r453b1275],
58	JM	NN	O	jm	nn	60	SENT_202	[p13l310t1195r453b1275],
59	)	NN	O	)	nn	60	SENT_202	[p13l310t1195r453b1275],
60	domain	NN	O	domain	prep_in	50	SENT_202	[p13l486t1190r752b1255],
61	and	CC	O	and	_	0	SENT_202	[p13l783t1190r906b1255],
62	point	NN	O	point	nn	63	SENT_202	[p13l940t1196r1120b1275],
63	mutations	NNS	O	mutation	conj_and	60	SENT_202	[p13l1148t1196r1503b1255],
64	(	VBP	O	(	_	0	SENT_202	[p13l1539t1194r1897b1275],
65	Asp835X	NN	O	asp835x	nn	66	SENT_202	[p13l1539t1194r1897b1275],
66	)	NN	O	)	dobj	64	SENT_202	[p13l1539t1194r1897b1275],
67	in	IN	O	in	_	0	SENT_202	[p13l1933t1196r1989b1254],
68	the	DT	O	the	det	70	SENT_202	[p13l76t1295r186b1360],
69	activation	NN	O	activation	nn	70	SENT_202	[p13l213t1301r550b1360],
70	loop	NN	O	loop	prep_in	64	SENT_202	[p13l584t1295r734b1380],
71	of	IN	O	of	_	0	SENT_202	[p13l760t1295r837b1360],
72	Fms-like	JJ	MISC	fms-like	amod	74	SENT_202	[p13l856t1295r1142b1360],
73	tyrosine	NN	O	tyrosine	nn	74	SENT_202	[p13l1165t1301r1446b1381],
74	kinase	NN	O	kinase	prep_of	70	SENT_202	[p13l1476t1295r1694b1360],
75	3	CD	NUMBER	3	num	78	SENT_202	[p13l1721t1300r1752b1360],
76	(	NN	O	(	nn	78	SENT_202	[p13l1790t1300r2027b1381],
77	FLT3	NN	O	flt3	nn	78	SENT_202	[p13l1790t1300r2027b1381],
78	)	NN	O	)	nsubj	64	SENT_202	[p13l1790t1300r2027b1381],
79	.	.	O	.	_	0	SENT_202	[p13l1790t1300r2027b1381],

1	In	IN	O	in	_	0	SENT_203	[p13l85t1406r142b1464],
2	Panel	NN	O	panel	nn	3	SENT_203	[p13l178t1400r360b1465],
3	C	NN	O	c	prep_in	6	SENT_203	[p13l390t1405r454b1477],
4	,	,	O	,	_	0	SENT_203	[p13l390t1405r454b1477],
5	BCR-ABL	NN	O	bcr-abl	nsubj	6	SENT_203	[p13l489t1405r802b1465],
6	exempliﬁes	VBZ	O	exempliﬁes	_	0	SENT_203	[p13l826t1400r1220b1485],
7	the	DT	O	the	det	8	SENT_203	[p13l1246t1400r1356b1465],
8	fusion	NN	O	fusion	dobj	6	SENT_203	[p13l1380t1400r1596b1465],
9	of	IN	O	of	_	0	SENT_203	[p13l1626t1400r1703b1465],
10	receptor	NN	O	receptor	prep_of	8	SENT_203	[p13l1720t1413r2011b1485],
11	and	CC	O	and	_	0	SENT_203	[p13l80t1506r204b1571],
12	nonreceptorTKs	NNS	O	nonreceptortk	conj_and	10	SENT_203	[p13l238t1512r817b1591],
13	to	TO	O	to	_	0	SENT_203	[p13l843t1518r911b1571],
14	various	JJ	O	various	amod	17	SENT_203	[p13l936t1512r1191b1571],
15	N-terminal	JJ	MISC	n-terminal	amod	17	SENT_203	[p13l1226t1506r1599b1571],
16	partner	NN	O	partner	nn	17	SENT_203	[p13l1632t1518r1885b1590],
17	proteins	NNS	O	protein	prep_to	6	SENT_203	[p13l1913t1528r2048b1590, p13l76t1617r245b1676],
18	as	IN	O	as	_	0	SENT_203	[p13l274t1634r344b1676],
19	a	DT	O	a	det	20	SENT_203	[p13l374t1634r406b1676],
20	consequence	NN	O	consequence	prep_as	17	SENT_203	[p13l434t1634r896b1695],
21	ofchromosomal	JJ	O	ofchromosomal	amod	22	SENT_203	[p13l923t1610r1501b1676],
22	translocations	NNS	O	translocation	dep	20	SENT_203	[p13l1529t1611r2031b1676],
23	and	CC	O	and	_	0	SENT_203	[p13l80t1716r204b1781],
24	deletions	NNS	O	deletion	dep	20	SENT_203	[p13l231t1716r571b1781],
25	.	.	O	.	_	0	SENT_203	[p13l231t1716r571b1781],

1	A	DT	O	a	det	6	SENT_204	[p13l595t1720r645b1780],
2	common	JJ	O	common	amod	6	SENT_204	[p13l666t1739r980b1781],
3	feature	NN	O	feature	nn	6	SENT_204	[p13l1006t1716r1251b1781],
4	ofthe	NN	O	ofthe	nn	6	SENT_204	[p13l1274t1716r1469b1781],
5	partner	NN	O	partner	nn	6	SENT_204	[p13l1496t1729r1749b1800],
6	proteins	NNS	O	protein	nsubj	9	SENT_204	[p13l1774t1722r2058b1800],
7	is	VBZ	O	be	cop	9	SENT_204	[p13l81t1827r131b1886],
8	a	DT	O	a	det	9	SENT_204	[p13l160t1844r192b1886],
9	domain	NN	O	domain	_	0	SENT_204	[p13l220t1821r485b1886],
10	that	WDT	O	that	nsubj	11	SENT_204	[p13l512t1821r651b1886],
11	mediates	VBZ	O	mediate	rcmod	9	SENT_204	[p13l679t1821r996b1886],
12	oligomerization	NN	O	oligomerization	dobj	11	SENT_204	[p13l1024t1821r1600b1907],
13	,	,	O	,	_	0	SENT_204	[p13l1024t1821r1600b1907],
14	such	JJ	O	such	_	0	SENT_204	[p13l1631t1821r1789b1886],
15	as	IN	O	as	_	0	SENT_204	[p13l1821t1844r1891b1886],
16	the	DT	O	the	det	21	SENT_204	[p13l1917t1821r2026b1886],
17	coiled-coil	JJ	O	coiled-coil	amod	21	SENT_204	[p13l79t1927r432b1992],
18	(	CD	NUMBER	(	num	21	SENT_204	[p13l467t1932r613b2011],
19	CC	NN	O	cc	nn	21	SENT_204	[p13l467t1932r613b2011],
20	)	NN	O	)	nn	21	SENT_204	[p13l467t1932r613b2011],
21	domain	NN	O	domain	prep_such_as	12	SENT_204	[p13l643t1927r909b1992],
22	of	IN	O	of	_	0	SENT_204	[p13l936t1926r1012b1992],
23	BCR	NN	O	bcr	prep_of	21	SENT_204	[p13l1029t1932r1190b1992],
24	.	.	O	.	_	0	SENT_204	[p13l1029t1932r1190b1992],

1	Examples	NNS	O	example	nsubjpass	7	SENT_205	[p13l1222t1927r1550b2011],
2	oftherapeutic	JJ	O	oftherapeutic	amod	3	SENT_205	[p13l1575t1926r2062b2011],
3	agents	NNS	O	agent	dep	1	SENT_205	[p13l80t2044r308b2118],
4	targeting	VBG	O	target	partmod	1	SENT_205	[p13l331t2038r649b2118],
5	TKs	NNS	O	tk	dobj	4	SENT_205	[p13l668t2038r797b2097],
6	are	VBP	O	be	auxpass	7	SENT_205	[p13l823t2055r927b2097],
7	listed	VBN	O	list	_	0	SENT_205	[p13l954t2032r1134b2097],
8	in	IN	O	in	_	0	SENT_205	[p13l1165t2038r1220b2096],
9	red	JJ	O	red	prep_in	7	SENT_205	[p13l1250t2032r1376b2097],
10	.	.	O	.	_	0	SENT_205	[p13l1250t2032r1376b2097],

1	Small-molecule	JJ	O	small-molecule	amod	3	SENT_206	[p13l1403t2032r1947b2097],
2	TK	NN	O	tk	nn	3	SENT_206	[p13l1968t2038r2062b2096],
3	inhibitors	NNS	O	inhibitor	nsubj	5	SENT_206	[p13l81t2137r414b2202],
4	usually	RB	O	usually	advmod	5	SENT_206	[p13l441t2137r682b2222],
5	act	VBP	O	act	_	0	SENT_206	[p13l703t2150r803b2202],
6	to	TO	O	to	aux	7	SENT_206	[p13l821t2150r889b2202],
7	block	VB	O	block	xcomp	5	SENT_206	[p13l915t2137r1097b2202],
8	binding	NN	O	binding	nn	9	SENT_206	[p13l1119t2137r1384b2222],
9	ofATP	NN	O	ofatp	dobj	7	SENT_206	[p13l1404t2136r1624b2202],
10	or	CC	O	or	_	0	SENT_206	[p13l1645t2160r1717b2202],
11	substrate	NN	O	substrate	dobj	7	SENT_206	[p13l1737t2137r2063b2202],
12	to	TO	O	to	_	0	SENT_206	[p13l76t2255r145b2307],
13	the	DT	O	the	det	17	SENT_206	[p13l169t2243r279b2307],
14	catalytic	JJ	O	catalytic	amod	17	SENT_206	[p13l305t2243r590b2327],
15	domain	NN	O	domain	nn	17	SENT_206	[p13l614t2243r880b2307],
16	ofthe	NN	O	ofthe	nn	17	SENT_206	[p13l910t2242r1107b2307],
17	TK	NN	O	tk	prep_to	7	SENT_206	[p13l1130t2248r1242b2307],
18	.	.	O	.	_	0	SENT_206	[p13l1130t2248r1242b2307],

1	BCR-ABL	NN	O	bcr-abl	nsubjpass	5	SENT_207	[p13l1277t2247r1590b2307],
2	may	MD	O	may	aux	5	SENT_207	[p13l1617t2265r1759b2327],
3	also	RB	O	also	advmod	5	SENT_207	[p13l1784t2243r1923b2307],
4	be	VB	O	be	auxpass	5	SENT_207	[p13l1952t2243r2029b2307],
5	targeted	VBN	O	target	_	0	SENT_207	[p13l76t2348r357b2433],
6	by	IN	O	by	_	0	SENT_207	[p13l388t2348r459b2432],
7	compounds	NNS	O	compound	agent	5	SENT_207	[p13l480t2348r889b2432],
8	such	JJ	O	such	_	0	SENT_207	[p13l916t2348r1069b2413],
9	as	IN	O	as	_	0	SENT_207	[p13l1097t2370r1166b2413],
10	17a	NN	O	17a	nn	13	SENT_207	[p13l1197t2348r2057b2433, p13l79t2453r660b2538],
11	|	CD	NUMBER	|	num	13	SENT_207	[p13l1197t2348r2057b2433, p13l79t2453r660b2538],
12	ly	NN	O	ly	nn	13	SENT_207	[p13l1197t2348r2057b2433, p13l79t2453r660b2538],
13	|	NN	O	|	prep_such_as	7	SENT_207	[p13l1197t2348r2057b2433, p13l79t2453r660b2538],
14	amino17demethoxygeldanamycin	NN	O	amino17demethoxygeldanamycin	nn	17	SENT_207	[p13l1197t2348r2057b2433, p13l79t2453r660b2538],
15	(	CD	NUMBER	(	num	17	SENT_207	[p13l697t2457r1013b2537],
16	17-AAG	NN	O	17-aag	nn	17	SENT_207	[p13l697t2457r1013b2537],
17	)	NN	O	)	dobj	5	SENT_207	[p13l697t2457r1013b2537],
18	that	WDT	O	that	nsubj	19	SENT_207	[p13l1044t2453r1182b2518],
19	interfere	VBP	O	interfere	rcmod	17	SENT_207	[p13l1210t2452r1500b2518],
20	with	IN	O	with	_	0	SENT_207	[p13l1524t2453r1669b2518],
21	binding	VBG	O	bind	prep_with	19	SENT_207	[p13l1702t2453r1967b2538],
22	to	TO	O	to	_	0	SENT_207	[p13l1988t2465r2057b2518],
23	cellular	JJ	O	cellular	amod	24	SENT_207	[p13l79t2558r334b2623],
24	chaperones	NNS	O	chaperone	prep_to	5	SENT_207	[p13l357t2558r762b2642],
25	such	JJ	O	such	_	0	SENT_207	[p13l792t2558r951b2623],
26	as	IN	O	as	_	0	SENT_207	[p13l982t2581r1052b2623],
27	Hsp90	NN	O	hsp90	prep_such_as	24	SENT_207	[p13l1086t2562r1331b2642],
28	,	,	O	,	_	0	SENT_207	[p13l1086t2562r1331b2642],
29	by	IN	O	by	_	0	SENT_207	[p13l1364t2558r1437b2643],
30	compounds	NNS	O	compound	prep_by	24	SENT_207	[p13l1461t2558r1883b2642],
31	that	WDT	O	that	nsubj	32	SENT_207	[p13l1908t2558r2047b2623],
32	block	VBP	O	block	rcmod	30	SENT_207	[p13l82t2663r264b2728],
33	oligomerization	NN	O	oligomerization	dobj	32	SENT_207	[p13l287t2663r862b2748],
34	,	,	O	,	_	0	SENT_207	[p13l287t2663r862b2748],
35	by	IN	O	by	_	0	SENT_207	[p13l894t2663r967b2748],
36	small	JJ	O	small	agent	5	SENT_207	[p13l991t2663r1173b2728],
37	interfering	VBG	O	interfere	partmod	36	SENT_207	[p13l1204t2662r1568b2748],
38	RNA	NN	O	rna	nn	41	SENT_207	[p13l1596t2667r1753b2727],
39	(	NN	O	(	nn	41	SENT_207	[p13l1783t2667r2052b2748],
40	siRNA	NN	O	sirna	nn	41	SENT_207	[p13l1783t2667r2052b2748],
41	)	NN	O	)	dobj	37	SENT_207	[p13l1783t2667r2052b2748],
42	that	WDT	O	that	nsubj	43	SENT_207	[p13l76t2768r215b2833],
43	induces	VBZ	O	induce	rcmod	41	SENT_207	[p13l240t2768r507b2833],
44	degradation	NN	O	degradation	dobj	43	SENT_207	[p13l533t2768r953b2854],
45	of	IN	O	of	_	0	SENT_207	[p13l981t2767r1058b2833],
46	BCR-ABL	NN	O	bcr-abl	nn	47	SENT_207	[p13l1073t2772r1387b2833],
47	mRNA	NN	O	mrna	prep_of	44	SENT_207	[p13l1413t2772r1662b2845],
48	,	,	O	,	_	0	SENT_207	[p13l1413t2772r1662b2845],
49	or	CC	O	or	_	0	SENT_207	[p13l1689t2791r1761b2833],
50	by	IN	O	by	_	0	SENT_207	[p13l1785t2768r1858b2853],
51	inhibitors	NNS	O	inhibitor	agent	5	SENT_207	[p13l1882t2768r2078b2833, p13l81t2880r233b2938],
52	of	IN	O	of	_	0	SENT_207	[p13l261t2872r338b2938],
53	BCR-ABL	NN	O	bcr-abl	nn	55	SENT_207	[p13l355t2877r669b2938],
54	gene	NN	O	gene	nn	55	SENT_207	[p13l695t2897r860b2959],
55	transcription	NN	O	transcription	prep_of	51	SENT_207	[p13l884t2880r1358b2958],
56	.	.	O	.	_	0	SENT_207	[p13l884t2880r1358b2958],

1	None	NN	O	none	nn	3	SENT_208	[p13l1393t2880r1580b2938],
2	ofthese	NN	O	ofthese	nn	3	SENT_208	[p13l1606t2872r1883b2938],
3	approaches	NNS	O	approach	nsubj	5	SENT_208	[p13l1910t2896r2015b2958, p13l82t2978r397b3063],
4	have	VBP	O	have	aux	5	SENT_208	[p13l429t2978r586b3043],
5	reached	VBN	O	reach	_	0	SENT_208	[p13l616t2978r884b3043],
6	clinical	JJ	O	clinical	amod	7	SENT_208	[p13l915t2978r1153b3043],
7	development	NN	O	development	dobj	5	SENT_208	[p13l1183t2978r1646b3063],
8	yet	RB	O	yet	advmod	5	SENT_208	[p13l1667t2991r1785b3064],
9	.	.	O	.	_	0	SENT_208	[p13l1667t2991r1785b3064],

1	Finally	RB	O	finally	advmod	11	SENT_209	[p13l1820t2978r2050b3064],
2	,	,	O	,	_	0	SENT_209	[p13l1820t2978r2050b3064],
3	receptor	NN	O	receptor	nn	4	SENT_209	[p13l82t3096r373b3169],
4	TKs	NNS	O	tk	nsubjpass	11	SENT_209	[p13l393t3090r522b3148],
5	and	CC	O	and	_	0	SENT_209	[p13l551t3084r676b3149],
6	their	PRP$	O	they	poss	7	SENT_209	[p13l703t3084r866b3149],
7	ligands	NNS	O	ligand	conj_and	4	SENT_209	[p13l893t3084r1140b3169],
8	can	MD	O	can	aux	11	SENT_209	[p13l1169t3107r1284b3148],
9	be	VB	O	be	auxpass	11	SENT_209	[p13l1318t3084r1394b3149],
10	specifically	RB	O	specifically	advmod	11	SENT_209	[p13l1422t3083r1804b3169],
11	targeted	VBN	O	target	_	0	SENT_209	[p13l1825t3096r2053b3169, p13l79t3189r155b3254],
12	by	IN	O	by	_	0	SENT_209	[p13l186t3189r259b3274],
13	monoclonal	JJ	O	monoclonal	amod	14	SENT_209	[p13l284t3189r689b3254],
14	antibodies	NNS	O	antibody	agent	11	SENT_209	[p13l717t3189r1075b3254],
15	(	VBP	O	(	rcmod	14	SENT_209	[p13l1108t3194r1242b3274],
16	top	JJ	O	top	amod	17	SENT_209	[p13l1108t3194r1242b3274],
17	area	NN	O	area	dobj	15	SENT_209	[p13l1267t3212r1409b3254],
18	of	IN	O	of	_	0	SENT_209	[p13l1434t3188r1510b3254],
19	Panel	NN	O	panel	nn	21	SENT_209	[p13l1526t3189r1705b3254],
20	A	NN	O	a	nn	21	SENT_209	[p13l1730t3193r1826b3274],
21	)	NN	O	)	prep_of	17	SENT_209	[p13l1730t3193r1826b3274],
22	.	.	O	.	_	0	SENT_209	[p13l1730t3193r1826b3274],

1	PDGF	NN	ORGANIZATION	pdgf	nsubj	2	SENT_210	[p13l1859t3194r2060b3254],
2	denotes	VBZ	O	denote	_	0	SENT_210	[p13l79t3294r357b3359],
3	platelet-derived	JJ	O	platelet-derived	amod	5	SENT_210	[p13l388t3294r925b3379],
4	growth	NN	O	growth	nn	5	SENT_210	[p13l956t3294r1195b3380],
5	factor	NN	O	factor	dobj	2	SENT_210	[p13l1223t3293r1436b3371],
6	,	,	O	,	_	0	SENT_210	[p13l1223t3293r1436b3371],
7	EGF	NN	ORGANIZATION	egf	appos	5	SENT_210	[p13l1471t3299r1612b3359],
8	epidermal	JJ	O	epidermal	amod	10	SENT_210	[p13l1638t3294r1988b3379],
9	growth	NN	O	growth	nn	10	SENT_210	[p13l80t3399r318b3485],
10	factor	NN	O	factor	dep	7	SENT_210	[p13l346t3399r559b3476],
11	,	,	O	,	_	0	SENT_210	[p13l346t3399r559b3476],
12	KL	NNP	O	KL	nn	14	SENT_210	[p13l593t3406r676b3463],
13	KIT	NNP	O	KIT	nn	14	SENT_210	[p13l705t3406r817b3463],
14	ligand	NN	O	ligand	appos	10	SENT_210	[p13l843t3399r1073b3485],
15	,	,	O	,	_	0	SENT_210	[p13l843t3399r1073b3485],
16	FL	NN	O	fl	nn	18	SENT_210	[p13l1107t3406r1186b3463],
17	FLIT3	NN	O	flit3	nn	18	SENT_210	[p13l1214t3404r1401b3464],
18	ligand	NN	O	ligand	appos	10	SENT_210	[p13l1435t3399r1664b3485],
19	,	,	O	,	_	0	SENT_210	[p13l1435t3399r1664b3485],
20	HGF	NN	O	hgf	nn	23	SENT_210	[p13l1698t3404r1859b3464],
21	hepatocyte	NN	O	hepatocyte	nn	23	SENT_210	[p13l1888t3399r2077b3484, p13l76t3517r286b3590],
22	growth	NN	O	growth	nn	23	SENT_210	[p13l313t3505r551b3590],
23	factor	NN	O	factor	appos	10	SENT_210	[p13l580t3504r792b3581],
24	,	,	O	,	_	0	SENT_210	[p13l580t3504r792b3581],
25	VEGF	NN	O	vegf	nn	29	SENT_210	[p13l819t3510r1019b3570],
26	vascular	JJ	O	vascular	amod	29	SENT_210	[p13l1043t3505r1336b3569],
27	endothelial	JJ	O	endothelial	amod	29	SENT_210	[p13l1359t3505r1747b3569],
28	growth	NN	O	growth	nn	29	SENT_210	[p13l1777t3505r2016b3590],
29	factor	NN	O	factor	appos	10	SENT_210	[p13l77t3609r290b3686],
30	,	,	O	,	_	0	SENT_210	[p13l77t3609r290b3686],
31	FGF	NN	ORGANIZATION	fgf	nn	34	SENT_210	[p13l325t3615r464b3675],
32	fibroblast	NN	O	fibroblast	nn	34	SENT_210	[p13l489t3609r825b3675],
33	growth	NN	O	growth	nn	34	SENT_210	[p13l850t3610r1089b3696],
34	factor	NN	O	factor	appos	10	SENT_210	[p13l1117t3609r1330b3686],
35	,	,	O	,	_	0	SENT_210	[p13l1117t3609r1330b3686],
36	PDG	NN	O	pdg	nn	37	SENT_210	[p13l1365t3615r1519b3675],
37	FR	NN	O	fr	appos	10	SENT_210	[p13l1535t3616r1620b3674],
38	plateletderived	JJ	O	plateletderived	amod	41	SENT_210	[p13l1649t3610r1926b3695, p13l78t3715r332b3780],
39	growth	NN	O	growth	nn	41	SENT_210	[p13l361t3715r600b3801],
40	factor	NN	O	factor	nn	41	SENT_210	[p13l626t3714r830b3780],
41	receptor	NN	O	receptor	dep	37	SENT_210	[p13l855t3728r1155b3800],
42	,	,	O	,	_	0	SENT_210	[p13l855t3728r1155b3800],
43	VEG	NNP	O	VEG	nn	44	SENT_210	[p13l1179t3720r1329b3780],
44	FR	NN	O	fr	appos	10	SENT_210	[p13l1346t3721r1429b3779],
45	vascular	JJ	O	vascular	amod	46	SENT_210	[p13l1452t3715r1745b3780],
46	endotheI	NN	O	endotheus	dep	44	SENT_210	[p13l1766t3715r2077b3780, p13l477t3820r503b3834],
47	'	''	O	'	_	0	SENT_210	[p13l1766t3715r2077b3780, p13l477t3820r503b3834],

1	,	,	O	,	_	0	SENT_211	[p13l1834t3833r1841b3834],
2	I	PRP	O	I	nsubj	4	SENT_211	[p13l1860t3820r1867b3834],
3	I	PRP	O	I	dep	2	SENT_211	[p13l1929t3820r1954b3834],
4	’	VBP	O	’	_	0	SENT_211	[p13l1929t3820r1954b3834],

1	Iial	JJ	O	iial	amod	4	SENT_212	[p14l82t6r173b57],
2	growth	NN	O	growth	nn	4	SENT_212	[p14l203t6r442b78],
3	factor	NN	O	factor	nn	4	SENT_212	[p14l471t6r674b57],
4	receptor	NN	O	receptor	_	0	SENT_212	[p14l701t6r1000b76],
5	,	,	O	,	_	0	SENT_212	[p14l701t6r1000b76],
6	I-GI-R3	NN	O	i-gi-r3	nn	10	SENT_212	[p14l1035t6r1264b57],
7	tibroblast	NN	O	tibroblast	nn	10	SENT_212	[p14l1293t6r1629b57],
8	growth	NN	O	growth	nn	10	SENT_212	[p14l1654t6r1893b78],
9	tactor	NN	O	tactor	nn	10	SENT_212	[p14l1921t6r2044b57, p14l76t110r177b162],
10	receptor	NN	O	receptor	appos	4	SENT_212	[p14l204t110r495b182],
11	3	CD	NUMBER	3	dep	10	SENT_212	[p14l519t103r573b174],
12	,	,	O	,	_	0	SENT_212	[p14l519t103r573b174],
13	ALK	NN	O	alk	appos	4	SENT_212	[p14l600t102r742b162],
14	anaplastic	JJ	O	anaplastic	amod	16	SENT_212	[p14l767t98r1125b182],
15	lymphoma	NN	O	lymphoma	nn	16	SENT_212	[p14l1152t98r1524b183],
16	kinase	NN	O	kinase	dep	13	SENT_212	[p14l1555t98r1791b174],
17	,	,	O	,	_	0	SENT_212	[p14l1555t98r1791b174],
18	mRNA	NN	O	mrna	nn	20	SENT_212	[p14l1824t102r2057b162],
19	messenger	NN	O	messenger	nn	20	SENT_212	[p14l82t225r467b289],
20	RNA	NN	MISC	rna	appos	4	SENT_212	[p14l496t207r670b279],
21	,	,	O	,	_	0	SENT_212	[p14l496t207r670b279],
22	and	CC	O	and	_	0	SENT_212	[p14l701t203r825b268],
23	Ph	NN	O	ph	nn	25	SENT_212	[p14l860t203r939b267],
24	Philadelphia	NN	LOCATION	philadelphium	nn	25	SENT_212	[p14l974t203r1402b287],
25	chromosome	NN	O	chromosome	conj_and	20	SENT_212	[p14l1429t203r1919b268],
26	.	.	O	.	_	0	SENT_212	[p14l1429t203r1919b268],

1	c	NN	O	c	_	0	SENT_213	[p14l10t554r251b629],
2	.	.	O	.	_	0	SENT_213	[p14l10t554r251b629],

1	—	NN	O	—	_	0	SENT_214	[p14l10t554r251b629],
2	.	.	O	.	_	0	SENT_214	[p14l10t554r251b629],

1	KIT	NN	O	kit	_	0	SENT_215	[p14l10t554r251b629],
2	in	IN	O	in	_	0	SENT_215	[p14l280t549r363b625],
3	some	DT	O	some	det	5	SENT_215	[p14l398t573r626b627],
4	testicular	JJ	O	testicular	amod	5	SENT_215	[p14l661t548r1062b627],
5	seminomas68	NN	O	seminomas68	prep_in	1	SENT_215	[p14l1094t541r1674b627],
6	and	CC	O	and	_	0	SENT_215	[p14l1708t548r1867b627],
7	c	NN	O	c	prep_in	1	SENT_215	[p14l1900t554r2143b629],
8	.	.	O	.	_	0	SENT_215	[p14l1900t554r2143b629],

1	—	NN	O	—	_	0	SENT_216	[p14l1900t554r2143b629],
2	.	.	O	.	_	0	SENT_216	[p14l1900t554r2143b629],

1	KIT	NN	O	kit	nn	2	SENT_217	[p14l1900t554r2143b629],
2	mutations	NNS	O	mutation	nsubj	25	SENT_217	[p14l9t677r449b755],
3	or	CC	O	or	_	0	SENT_217	[p14l486t701r577b754],
4	overeXpression69	NN	O	overexpression69	conj_or	2	SENT_217	[p14l608t669r1342b776],
5	in	IN	O	in	_	0	SENT_217	[p14l1376t677r1458b753],
6	small	JJ	O	small	amod	10	SENT_217	[p14l1494t676r1913b754],
7	—	JJ	O	—	amod	10	SENT_217	[p14l1494t676r1913b754],
8	cell	NN	O	cell	nn	10	SENT_217	[p14l1494t676r1913b754],
9	lung	NN	O	lung	nn	10	SENT_217	[p14l1946t676r2143b776],
10	cancer	NN	O	cancer	prep_in	4	SENT_217	[p14l10t830r309b900],
11	,	,	O	,	_	0	SENT_217	[p14l10t830r309b900],
12	but	CC	O	but	_	0	SENT_217	[p14l340t805r483b884],
13	a	DT	O	a	det	16	SENT_217	[p14l502t831r546b883],
14	phase	NN	O	phase	nn	16	SENT_217	[p14l568t805r819b905],
15	2	CD	NUMBER	2	num	16	SENT_217	[p14l845t810r892b882],
16	trial	NN	O	trial	conj_but	4	SENT_217	[p14l919t805r1090b883],
17	of	IN	O	of	_	0	SENT_217	[p14l1114t804r1217b883],
18	imatinib	NN	O	imatinib	prep_of	16	SENT_217	[p14l1222t805r1587b883],
19	in	IN	O	in	_	0	SENT_217	[p14l1613t805r1695b882],
20	small	JJ	O	small	amod	24	SENT_217	[p14l1722t805r2140b883],
21	—	JJ	O	—	amod	24	SENT_217	[p14l1722t805r2140b883],
22	cell	NN	O	cell	nn	24	SENT_217	[p14l1722t805r2140b883],
23	lung	NN	O	lung	nn	24	SENT_217	[p14l8t934r204b1034],
24	cancer	NN	O	cancer	prep_in	18	SENT_217	[p14l226t959r502b1012],
25	yielded	VBD	O	yield	_	0	SENT_217	[p14l520t933r822b1034],
26	equivocal	JJ	O	equivocal	amod	27	SENT_217	[p14l847t934r1244b1034],
27	results	NNS	O	result	dobj	25	SENT_217	[p14l1270t929r1660b1013],
28	.	.	O	.	_	0	SENT_217	[p14l1270t929r1660b1013],

1	”	NN	O	”	nsubj	9	SENT_218	[p14l1270t929r1660b1013],
2	Some	DT	O	some	det	7	SENT_218	[p14l1688t939r1921b1012],
3	glio	NN	O	glio	nn	7	SENT_218	[p14l1946t934r2139b1034],
4	—	NN	O	—	nn	7	SENT_218	[p14l1946t934r2139b1034],
5	blastoma	NN	O	blastoma	nn	7	SENT_218	[p14l10t1062r404b1140],
6	cell	NN	O	cell	nn	7	SENT_218	[p14l433t1061r579b1140],
7	lines	NNS	O	line	dep	1	SENT_218	[p14l608t1062r809b1140],
8	simultaneously	RB	O	simultaneously	advmod	9	SENT_218	[p14l844t1062r1507b1162],
9	express	VBP	O	express	_	0	SENT_218	[p14l1534t1088r1853b1162],
10	PDGF	NN	ORGANIZATION	pdgf	dobj	9	SENT_218	[p14l1885t1067r2139b1140],
11	and	CC	O	and	_	0	SENT_218	[p14l8t1190r164b1268],
12	its	PRP$	O	its	poss	13	SENT_218	[p14l193t1190r288b1268],
13	receptors	NNS	O	receptor	dobj	9	SENT_218	[p14l320t1206r707b1290],
14	and	CC	O	and	_	0	SENT_218	[p14l739t1190r894b1268],
15	display	VBP	O	display	conj_and	9	SENT_218	[p14l924t1190r1221b1290],
16	evidence	NN	O	evidence	dobj	15	SENT_218	[p14l1248t1190r1605b1269],
17	of	IN	O	of	_	0	SENT_218	[p14l1636t1189r1736b1268],
18	autocrine	JJ	O	autocrine	amod	20	SENT_218	[p14l1747t1190r2142b1269],
19	PDGFR	NN	O	pdgfr	nn	20	SENT_218	[p14l7t1323r336b1401],
20	signaling	NN	O	signaling	prep_of	16	SENT_218	[p14l365t1312r869b1418],
21	.	.	O	.	_	0	SENT_218	[p14l365t1312r869b1418],

1	“	NN	O	“	nn	2	SENT_219	[p14l365t1312r869b1418],
2	Imatinib	NN	O	imatinib	nsubj	10	SENT_219	[p14l904t1318r1268b1396],
3	inhibits	VBZ	O	inhibit	ccomp	48	SENT_219	[p14l1306t1318r1630b1396],
4	the	DT	O	the	det	5	SENT_219	[p14l1670t1318r1799b1396],
5	growth	NN	O	growth	dobj	3	SENT_219	[p14l1837t1318r2141b1418],
6	of	IN	O	of	_	0	SENT_219	[p14l10t1446r111b1525],
7	these	DT	O	these	det	8	SENT_219	[p14l134t1447r357b1525],
8	cells83	NNS	O	cells83	prep_of	5	SENT_219	[p14l398t1442r669b1525],
9	and	CC	O	and	_	0	SENT_219	[p14l711t1447r870b1525],
10	increases	VBZ	O	increase	ccomp	48	SENT_219	[p14l909t1447r1306b1525],
11	their	PRP$	O	they	poss	12	SENT_219	[p14l1349t1447r1551b1525],
12	sensitivity	NN	O	sensitivity	dobj	10	SENT_219	[p14l1590t1447r2022b1547],
13	to	TO	O	to	_	0	SENT_219	[p14l2058t1463r2139b1525],
14	ionizing	VBG	O	ionize	amod	15	SENT_219	[p14l8t1576r371b1676],
15	radiation	NN	O	radiation	prep_to	10	SENT_219	[p14l392t1571r893b1654],
16	.93	CD	NUMBER	.93	num	17	SENT_219	[p14l392t1571r893b1654],
17	Imatinib	NN	O	imatinib	nsubj	20	SENT_219	[p14l917t1576r1288b1654],
18	is	VBZ	O	be	cop	20	SENT_219	[p14l1312t1576r1379b1654],
19	also	RB	O	also	advmod	20	SENT_219	[p14l1403t1576r1574b1654],
20	active	JJ	O	active	ccomp	15	SENT_219	[p14l1598t1576r1840b1655],
21	in	IN	O	in	_	0	SENT_219	[p14l1863t1576r1945b1653],
22	dermatoﬂbrosarcoma	NN	O	dermatoﬂbrosarcoma	nn	23	SENT_219	[p14l1969t1576r2139b1654, p14l9t1704r814b1783],
23	protuberans	NNS	O	protuberan	prep_in	20	SENT_219	[p14l836t1700r1479b1805],
24	,87	CD	NUMBER	,87	dobj	34	SENT_219	[p14l836t1700r1479b1805],
25	in	IN	O	in	_	0	SENT_219	[p14l1503t1705r1586b1782],
26	which	WDT	O	which	prep_in	24	SENT_219	[p14l1606t1705r1871b1784],
27	platelet	NN	O	platelet	nn	28	SENT_219	[p14l1895t1705r2139b1805, p14l8t1833r467b1912],
28	—	NN	O	—	nsubjpass	34	SENT_219	[p14l1895t1705r2139b1805, p14l8t1833r467b1912],
29	derived	VBN	O	derive	partmod	28	SENT_219	[p14l1895t1705r2139b1805, p14l8t1833r467b1912],
30	growth	NN	O	growth	nn	32	SENT_219	[p14l511t1833r820b1933],
31	factor	NN	O	factor	nn	32	SENT_219	[p14l864t1832r1117b1911],
32	B	NN	O	b	dobj	29	SENT_219	[p14l1157t1839r1213b1911],
33	is	VBZ	O	be	auxpass	34	SENT_219	[p14l1259t1833r1326b1911],
34	fused	VBN	O	fuse	ccomp	20	SENT_219	[p14l1372t1832r1605b1912],
35	to	TO	O	to	_	0	SENT_219	[p14l1650t1849r1731b1911],
36	collagen	NN	O	collagen	nn	38	SENT_219	[p14l1777t1833r2140b1933],
37	type	NN	O	type	nn	38	SENT_219	[p14l10t1976r184b2060],
38	Ial	NN	O	ial	prep_to	34	SENT_219	[p14l206t1966r355b2037],
39	and	CC	O	and	_	0	SENT_219	[p14l379t1960r537b2038],
40	overeXpressed	JJ	O	overexpressed	amod	41	SENT_219	[p14l561t1953r1284b2060],
41	.86	CD	NUMBER	.86	conj_and	38	SENT_219	[p14l561t1953r1284b2060],
42	Finally	RB	O	finally	advmod	34	SENT_219	[p14l1307t1960r1612b2060],
43	,	,	O	,	_	0	SENT_219	[p14l1307t1960r1612b2060],
44	PDGFRa	NN	O	pdgfra	nsubjpass	48	SENT_219	[p14l1640t1966r2025b2043],
45	or	CC	O	or	_	0	SENT_219	[p14l2052t1985r2143b2038],
46	PDGFRB	NN	O	pdgfrb	nsubjpass	48	SENT_219	[p14l7t2092r393b2188],
47	is	VBZ	O	be	auxpass	48	SENT_219	[p14l441t2089r507b2167],
48	overexpressed	VBN	O	overexpress	_	0	SENT_219	[p14l555t2089r1166b2189],
49	in	IN	O	in	_	0	SENT_219	[p14l1210t2089r1293b2166],
50	a	DT	O	a	det	51	SENT_219	[p14l1338t2115r1383b2167],
51	subset	NN	O	subset	prep_in	48	SENT_219	[p14l1428t2089r1707b2168],
52	of	IN	O	of	_	0	SENT_219	[p14l1748t2088r1850b2167],
53	sarcomas72	NN	O	sarcomas72	prep_of	51	SENT_219	[p14l1878t2114r2139b2167, p14l9t2212r483b2295],
54	’	CD	NUMBER	’	number	55	SENT_219	[p14l1878t2114r2139b2167, p14l9t2212r483b2295],
55	82	CD	NUMBER	82	num	56	SENT_219	[p14l1878t2114r2139b2167, p14l9t2212r483b2295],
56	’84	NN	O	’84	dep	53	SENT_219	[p14l1878t2114r2139b2167, p14l9t2212r483b2295],
57	and	CC	O	and	_	0	SENT_219	[p14l516t2217r674b2295],
58	chordomas	NNS	O	chordoma	prep_of	51	SENT_219	[p14l709t2212r1310b2312],
59	,94	CD	NUMBER	,94	num	58	SENT_219	[p14l709t2212r1310b2312],
60	some	DT	O	some	nsubj	63	SENT_219	[p14l1346t2242r1574b2295],
61	of	IN	O	of	_	0	SENT_219	[p14l1610t2216r1712b2295],
62	which	WDT	O	which	prep_of	60	SENT_219	[p14l1724t2217r1990b2296],
63	respond	VBP	O	respond	rcmod	58	SENT_219	[p14l2025t2243r2139b2295, p14l11t2346r277b2446],
64	to	TO	O	to	aux	65	SENT_219	[p14l304t2362r384b2424],
65	imatinib	VB	O	imatinib	xcomp	63	SENT_219	[p14l412t2346r777b2424],
66	(	CD	NUMBER	(	num	67	SENT_219	[p14l810t2345r1071b2437],
67	Table	NNP	O	Table	dobj	65	SENT_219	[p14l810t2345r1071b2437],
68	2	CD	NUMBER	2	num	67	SENT_219	[p14l1098t2351r1207b2437],
69	)	CD	NUMBER	)	dep	67	SENT_219	[p14l1098t2351r1207b2437],
70	.	.	O	.	_	0	SENT_219	[p14l1098t2351r1207b2437],

1	SMALL-MOLECU	NNP	O	SMALL-MOLECU	nn	2	SENT_220	[p14l10t2631r667b2680],
2	LE	NNP	O	LE	nsubj	9	SENT_220	[p14l688t2631r769b2680],
3	IN	IN	O	in	_	0	SENT_220	[p14l815t2631r895b2680],
4	HIBITORS	NNP	O	HIBITORS	prep_in	2	SENT_220	[p14l920t2631r1317b2680],
5	or	CC	O	or	_	0	SENT_220	[p14l1357t2631r1462b2680],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_220	[p14l1505t2631r1709b2680],
7	EGFR	NN	ORGANIZATION	egfr	prep_in	2	SENT_220	[p14l7t2735r268b2813],
8	is	VBZ	O	be	aux	9	SENT_220	[p14l287t2730r352b2808],
9	overexpressed	VBN	O	overexpress	_	0	SENT_220	[p14l386t2729r1007b2830],
10	,	,	O	,	_	0	SENT_220	[p14l386t2729r1007b2830],
11	mutated	VBN	O	mutate	dep	9	SENT_220	[p14l1044t2729r1419b2825],
12	,	,	O	,	_	0	SENT_220	[p14l1044t2729r1419b2825],
13	or	CC	O	or	_	0	SENT_220	[p14l1457t2755r1546b2808],
14	both	DT	O	both	nsubj	19	SENT_220	[p14l1575t2730r1769b2808],
15	in	IN	O	in	_	0	SENT_220	[p14l1798t2730r1880b2807],
16	many	JJ	O	many	amod	18	SENT_220	[p14l1911t2755r2146b2830],
17	solid	JJ	O	solid	amod	18	SENT_220	[p14l11t2856r217b2934],
18	tumors	NNS	O	tumor	prep_in	14	SENT_220	[p14l241t2872r549b2935],
19	(	VBP	O	(	conj_or	9	SENT_220	[p14l579t2856r840b2947],
20	Table	NNP	O	Table	dobj	19	SENT_220	[p14l579t2856r840b2947],
21	2	CD	NUMBER	2	num	20	SENT_220	[p14l863t2861r942b2947],
22	)	CD	NUMBER	)	number	23	SENT_220	[p14l863t2861r942b2947],
23	.59	CD	NUMBER	.59	num	27	SENT_220	[p14l958t2851r1060b2934],
24	Geﬁtinib	NNP	O	Geﬁtinib	nn	27	SENT_220	[p14l1085t2855r1471b2934],
25	(	CD	NUMBER	(	num	27	SENT_220	[p14l1501t2862r1814b2947],
26	Iressa	NNP	O	Iressa	nn	27	SENT_220	[p14l1501t2862r1814b2947],
27	)	NN	O	)	dep	20	SENT_220	[p14l1501t2862r1814b2947],
28	and	CC	O	and	_	0	SENT_220	[p14l1842t2856r2001b2934],
29	er176	NN	O	er176	conj_and	20	SENT_220	[p14l2025t2882r2139b2934, p14l149t3022r205b3044],

1	N	NN	O	n	nn	2	SENT_221	[p14l918t3025r932b3040],
2	ENGLJ	NN	O	englj	_	0	SENT_221	[p14l947t3024r1031b3046],
3	MED	NN	O	med	nn	5	SENT_221	[p14l1046t3025r1099b3040],
4	o	NN	O	o	nn	5	SENT_221	[p14l1111t3024r1136b3046],
5	_	NN	O	_	dep	2	SENT_221	[p14l1111t3024r1136b3046],
6	+	CC	O	+	_	0	SENT_221	[p14l1111t3024r1136b3046],
7	l2	NN	O	l2	nn	8	SENT_221	[p14l1155t3024r1175b3044],
8	WWW	NN	O	www	dep	2	SENT_221	[p14l1210t3025r1322b3040],
9	.	.	O	.	_	0	SENT_221	[p14l1210t3025r1322b3040],

1	NE	NN	O	ne	nn	3	SENT_222	[p14l1210t3025r1322b3040],
2	M.ORG	NN	O	m.org	nn	3	SENT_222	[p14l1338t3024r1421b3040],
3	JULY	NN	DATE	july	_	0	SENT_222	[p14l1455t3025r1515b3046],
4	14,2005	CD	DATE	14,2005	dep	3	SENT_222	[p14l1528t3024r1638b3046],

1	The	DT	O	the	det	5	SENT_223	[p14l935t3057r986b3081],
2	New	NNP	O	New	nn	5	SENT_223	[p14l995t3058r1057b3081],
3	Englan	NNP	O	Englan	nn	5	SENT_223	[p14l1066t3057r1160b3088],
4	oumal	NN	O	oumal	nn	5	SENT_223	[p14l1200t3057r1283b3081],
5	o	NN	O	o	_	0	SENT_223	[p14l1293t3065r1308b3081],
6	edicine	NN	O	edicine	dep	5	SENT_223	[p14l1359t3057r1454b3081],

1	Downloaded	VBN	O	download	_	0	SENT_224	[p14l377t3098r547b3121],
2	from	IN	O	from	_	0	SENT_224	[p14l556t3098r620b3121],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_224	[p14l629t3098r747b3128],
4	at	IN	O	at	_	0	SENT_224	[p14l758t3102r781b3121],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_224	[p14l789t3098r972b3121],
6	on	IN	O	on	_	0	SENT_224	[p14l981t3105r1014b3121],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_224	[p14l1022t3098r1083b3121],
8	5	CD	DATE	5	num	7	SENT_224	[p14l1135t3098r1158b3125],
9	,	,	DATE	,	_	0	SENT_224	[p14l1135t3098r1158b3125],
10	2014	CD	DATE	2014	num	7	SENT_224	[p14l1169t3098r1241b3121],
11	.	.	O	.	_	0	SENT_224	[p14l1169t3098r1241b3121],

1	For	IN	O	for	_	0	SENT_225	[p14l1251t3098r1298b3121],
2	personal	JJ	O	personal	amod	3	SENT_225	[p14l1306t3098r1418b3128],
3	use	NN	O	use	pobj	1	SENT_225	[p14l1427t3105r1471b3121],
4	only	RB	O	only	advmod	3	SENT_225	[p14l1481t3098r1545b3128],
5	.	.	O	.	_	0	SENT_225	[p14l1481t3098r1545b3128],

1	No	DT	O	no	det	3	SENT_226	[p14l1556t3098r1596b3121],
2	other	JJ	O	other	amod	3	SENT_226	[p14l1606t3098r1674b3121],
3	uses	NNS	O	use	_	0	SENT_226	[p14l1682t3105r1738b3121],
4	without	IN	O	without	_	0	SENT_226	[p14l1748t3098r1849b3121],
5	permission	NN	O	permission	prep_without	3	SENT_226	[p14l1858t3098r2010b3128],
6	.	.	O	.	_	0	SENT_226	[p14l1858t3098r2010b3128],

1	Copyright	NN	O	copyright	nsubj	6	SENT_227	[p14l727t3139r862b3170],
2	©	CD	NUMBER	©	num	1	SENT_227	[p14l871t3139r895b3163],
3	2005	CD	DATE	2005	num	5	SENT_227	[p14l905t3139r969b3163],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_227	[p14l979t3140r1064b3163],
5	u	NN	O	u	dep	1	SENT_227	[p14l1096t3147r1112b3163],
6	etts	VBZ	O	ett	_	0	SENT_227	[p14l1126t3143r1170b3163],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_227	[p14l1180t3139r1288b3163],
8	Society	NNP	ORGANIZATION	Society	dobj	6	SENT_227	[p14l1299t3139r1404b3170],
9	.	.	O	.	_	0	SENT_227	[p14l1299t3139r1404b3170],

1	All	DT	O	all	det	2	SENT_228	[p14l1415t3139r1456b3163],
2	rights	NNS	O	rights	nsubj	3	SENT_228	[p14l1465t3139r1540b3170],
3	reserved	VBN	O	reserve	_	0	SENT_228	[p14l1550t3139r1669b3163],
4	.	.	O	.	_	0	SENT_228	[p14l1550t3139r1669b3163],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_229	[p14l718t3184r947b3203],
2	OF	IN	O	of	_	0	SENT_229	[p14l961t3184r1002b3203],
3	DISEASE	NN	O	disease	prep_of	1	SENT_229	[p14l1017t3184r1153b3203],

1	Antibody	NN	O	antibody	_	0	SENT_230	[p15l121t83r243b115],
2	to	TO	O	to	_	0	SENT_230	[p15l252t87r279b108],
3	receptor	NN	O	receptor	nn	4	SENT_230	[p15l291t87r403b115],
4	TK	NN	O	tk	prep_to	1	SENT_230	[p15l412t85r455b107],
5	:	:	O	:	_	0	SENT_230	[p15l412t85r455b107],
6	.	.	O	.	_	0	SENT_230	[p15l709t94r730b108],

1	?	.	O	?	_	0	SENT_231	[p15l1011t104r1015b118],

1	1	CD	NUMBER	1	_	0	SENT_232	[p15l1037t110r1043b122],

1	Cemximabi	NNP	PERSON	Cemximabi	_	0	SENT_233	[p15l211t122r357b152],
2	i	FW	O	i	dep	11	SENT_233	[p15l654t141r657b142],
3	@	IN	O	@	_	0	SENT_233	[p15l729t120r739b125],
4	t	NN	O	t	prep_@	2	SENT_233	[p15l729t120r739b125],
5	+	CC	O	+	_	0	SENT_233	[p15l729t120r739b125],
6	‘	CD	NUMBER	‘	number	7	SENT_233	[p15l957t120r1057b150],
7	*	CD	NUMBER	*	conj_+	4	SENT_233	[p15l957t120r1057b150],
8	9-9	CD	NUMBER	9-9	dep	7	SENT_233	[p15l957t120r1057b150],
9	‘	CD	NUMBER	‘	dep	11	SENT_233	[p15l957t120r1057b150],
10	le	DT	O	le	det	11	SENT_233	[p15l1067t127r1225b155],
11	Antibody	NN	O	antibody	dep	1	SENT_233	[p15l1235t136r1358b168],
12	to	TO	O	to	_	0	SENT_233	[p15l1367t140r1393b161],
13	ligand	NN	O	ligand	prep_to	11	SENT_233	[p15l1405t136r1494b169],
14	:	:	O	:	_	0	SENT_233	[p15l1405t136r1494b169],
15	poor	JJ	O	poor	amod	16	SENT_233	[p15l1640t147r1720b170],
16	tlastuzumab	NN	O	tlastuzumab	dep	1	SENT_233	[p15l201t162r375b187],
17	-	:	O	-	_	0	SENT_233	[p15l1123t188r1135b190],
18	iu	NN	O	iu	dep	16	SENT_233	[p15l1166t194r1177b200],
19	+	CC	O	+	_	0	SENT_233	[p15l1166t194r1177b200],
20	bevacizumab	NN	O	bevacizumab	nn	22	SENT_233	[p15l1277t175r1455b200],
21	EGF	NN	ORGANIZATION	egf	nn	22	SENT_233	[p15l1652t186r1708b209],
22	iu	NN	O	iu	dep	16	SENT_233	[p15l306t194r713b314],
23	+	CC	O	+	_	0	SENT_233	[p15l306t194r713b314],
24	it	PRP	O	it	dep	16	SENT_233	[p15l875t192r881b196],
25	A	DT	O	a	det	27	SENT_233	[p15l949t204r951b206],
26	p	NN	O	p	nn	27	SENT_233	[p15l1003t278r1007b279],
27	РKu	NN	O	рku	dep	24	SENT_233	[p15l1067t246r1108b309],
28	+	CC	O	+	_	0	SENT_233	[p15l1067t246r1108b309],
29	p	NN	O	p	nn	30	SENT_233	[p15l1159t290r1178b296],
30	Herﬁulin	NN	PERSON	herﬁulin	conj_+	27	SENT_233	[p15l1613t224r1746b288],

1	FL	NN	O	fl	nn	3	SENT_234	[p15l1665t305r1696b328],
2	HGF	NN	O	hgf	nn	3	SENT_234	[p15l1648t344r1712b368],
3	VEGF	NN	O	vegf	_	0	SENT_234	[p15l1640t384r1718b408],
4	,	,	O	,	_	0	SENT_234	[p15l1518t446r1522b450],
5	FGF	NN	O	fgf	appos	3	SENT_234	[p15l1653t424r1708b447],

1	Extracellular	JJ	O	extracellular	amod	2	SENT_235	[p15l1299t444r1464b469],
2	region	NN	O	region	_	0	SENT_235	[p15l1475t453r1558b477],

1	Cell	NN	O	cell	nn	2	SENT_236	[p15l1324t671r1371b697],
2	membrane	NN	O	membrane	_	0	SENT_236	[p15l1385t671r1532b697],

1	Geﬁntinib	NNP	MISC	Geﬁntinib	nn	2	SENT_237	[p15l1301t766r1436b791],
2	Erlotinib	NNP	MISC	Erlotinib	_	0	SENT_237	[p15l1313t806r1426b831],

1	Cytoplasm	NN	O	cytoplasm	_	0	SENT_238	[p15l1356t907r1498b940],

1	IT	PRP	O	it	_	0	SENT_239	[p15l798t1487r1045b1516],
2	PKC412	NN	O	pkc412	nn	3	SENT_239	[p15l1061t1491r1164b1514],
3	CEP-701	NN	O	cep-701	dep	1	SENT_239	[p15l1056t1530r1168b1553],
4	Asp835X	NN	O	asp835x	nn	6	SENT_239	[p15l839t1567r960b1598],
5	MLN5l8	NN	O	mln5l8	nn	6	SENT_239	[p15l1055t1569r1171b1593],
6	SU5416	NN	O	su5416	dep	1	SENT_239	[p15l1060t1609r1165b1633],

1	Fusion	NN	O	fusion	_	0	SENT_240	[p15l176t1890r263b1915],
2	of	IN	O	of	_	0	SENT_240	[p15l274t1889r346b1915],
3	'	''	O	'	_	0	SENT_240	[p15l274t1889r346b1915],
4	TK	NN	O	tk	prep_of	1	SENT_240	[p15l274t1889r346b1915],
5	to	TO	O	to	dep	1	SENT_240	[p15l354t1894r381b1915],
6	Partner	NNP	O	Partner	nn	7	SENT_240	[p15l393t1892r491b1915],
7	Proteins	NNS	O	protein	pobj	5	SENT_240	[p15l502t1890r612b1915],
8	with	IN	O	with	dep	1	SENT_240	[p15l248t1929r306b1966],
9	Oligomerization	NN	O	oligomerization	nn	12	SENT_240	[p15l317t1929r537b1962],
10	7	CD	NUMBER	7	num	12	SENT_240	[p15l549t1965r553b1966],
11	p	NN	O	p	nn	12	SENT_240	[p15l567t1962r569b1964],
12	p	NN	O	p	pobj	8	SENT_240	[p15l587t1960r589b1962],

1	Small-molecule	JJ	O	small-molecule	amod	3	SENT_241	[p15l730t1989r941b2014],
2	oligomerization	NN	O	oligomerization	nn	3	SENT_241	[p15l665t2028r878b2061],
3	inhibitor	NN	O	inhibitor	_	0	SENT_241	[p15l892t2028r1007b2053],

1	Hsp90	NN	O	hsp90	nn	2	SENT_242	[p15l1223t2061r1311b2092],
2	inhibitor	NN	O	inhibitor	_	0	SENT_242	[p15l1323t2059r1438b2085],
3	I	PRP	O	I	nsubj	4	SENT_242	[p15l1463t2038r1465b2042],
4	(	VBP	O	(	rcmod	2	SENT_242	[p15l1268t2101r1390b2132],
5	17-AAG	NN	O	17-aag	dobj	4	SENT_242	[p15l1268t2101r1390b2132],
6	)	CD	NUMBER	)	num	5	SENT_242	[p15l1268t2101r1390b2132],
7	/	:	O	/	punct	8	SENT_242	[p15l1246t2193r1435b2248],
8	iRNA	NN	O	irna	dep	5	SENT_242	[p15l1246t2193r1435b2248],

1	|	NN	O	|	_	0	SENT_243	[p15l1105t2313r1398b2338],
2	:	:	O	:	_	0	SENT_243	[p15l1105t2313r1398b2338],
3	AAA	NNP	O	AAA	nn	5	SENT_243	[p15l1411t2315r1470b2338],
4	BCR-ABL	NN	O	bcr-abl	nn	5	SENT_243	[p15l1149t2348r1255b2369],
5	mRNA	NN	O	mrna	dep	1	SENT_243	[p15l1265t2348r1344b2368],

1	BC	NN	O	bc	nn	2	SENT_244	[p15l509t2292r546b2315],
2	R-ABL	NN	O	r-abl	_	0	SENT_244	[p15l549t2292r631b2315],

1	Bl	NN	O	bl	_	0	SENT_245	[p15l156t2454r326b2477],
2	‘	CD	NUMBER	‘	dep	1	SENT_245	[p15l156t2454r326b2477],
3	/	:	O	/	punct	5	SENT_245	[p15l156t2454r326b2477],
4	ls	NNS	O	l	nsubj	5	SENT_245	[p15l156t2454r326b2477],
5	‘	VBP	O	‘	dep	1	SENT_245	[p15l156t2454r326b2477],
6	-354325	CD	NUMBER	-354325	num	9	SENT_245	[p15l156t2454r326b2477],
7	ljTranscription	NN	O	ljtranscription	nn	9	SENT_245	[p15l1249t2455r1529b2489],
8	AMN107	NN	O	amn107	nn	9	SENT_245	[p15l178t2493r301b2517],
9	o	NN	O	o	nsubj	11	SENT_245	[p15l677t2473r699b2513],
10	`	``	O	`	_	0	SENT_245	[p15l677t2473r699b2513],
11	u	FW	O	u	xcomp	5	SENT_245	[p15l677t2473r699b2513],
12	+	CC	O	+	_	0	SENT_245	[p15l677t2473r699b2513],
13	o	NN	O	o	conj_+	11	SENT_245	[p15l1011t2471r1075b2575],
14	`	``	O	`	_	0	SENT_245	[p15l1011t2471r1075b2575],
15	u	FW	O	u	dep	13	SENT_245	[p15l1011t2471r1075b2575],
16	+	CC	O	+	cc	17	SENT_245	[p15l1011t2471r1075b2575],
17	inhibitor	NN	O	inhibitor	dep	1	SENT_245	[p15l1352t2496r1467b2521],

1	P6	NN	O	p6	_	0	SENT_246	[p15l725t2537r737b2545],
2	|	CD	NUMBER	|	num	3	SENT_246	[p15l725t2537r737b2545],
3	q	NN	O	q	dep	1	SENT_246	[p15l725t2537r737b2545],
4	+	CC	O	+	_	0	SENT_246	[p15l725t2537r737b2545],
5	‘	NN	O	‘	nn	7	SENT_246	[p15l1073t2497r1111b2587],
6	Ph	NN	O	ph	nn	7	SENT_246	[p15l1124t2553r1154b2578],
7	chromosome	NN	O	chromosome	conj_+	3	SENT_246	[p15l1166t2553r1348b2578],

1	N	NN	O	n	nn	2	SENT_247	[p15l577t2707r591b2722],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_247	[p15l606t2706r690b2728],
3	MED	VBD	O	med	_	0	SENT_247	[p15l705t2707r758b2722],
4	353:2	CD	NUMBER	353:2	num	6	SENT_247	[p15l770t2706r834b2728],
5	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	6	SENT_247	[p15l869t2706r1081b2728],
6	JULY14	NN	O	july14	nsubj	8	SENT_247	[p15l1114t2706r1297b2728],
7	,2005	CD	NUMBER	,2005	num	8	SENT_247	[p15l1114t2706r1297b2728],
8	177	CD	NUMBER	177	xcomp	3	SENT_247	[p15l2011t2705r2067b2726],

1	The	DT	O	the	det	4	SENT_248	[p15l752t2738r803b2761],
2	New	NNP	O	New	nn	4	SENT_248	[p15l813t2738r874b2761],
3	England	NNP	O	England	nn	4	SENT_248	[p15l884t2738r995b2768],
4	Journal	NNP	O	Journal	_	0	SENT_248	[p15l1003t2738r1101b2761],
5	of	IN	O	of	_	0	SENT_248	[p15l1111t2738r1139b2761],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_248	[p15l1146t2738r1271b2761],

1	Downloaded	VBN	O	download	_	0	SENT_249	[p15l195t2777r365b2800],
2	from	IN	O	from	_	0	SENT_249	[p15l373t2777r438b2800],
3	nejmorg	NN	O	nejmorg	prep_from	1	SENT_249	[p15l446t2777r565b2807],
4	at	IN	O	at	_	0	SENT_249	[p15l575t2781r598b2800],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_249	[p15l607t2777r789b2800],
6	on	IN	O	on	_	0	SENT_249	[p15l799t2784r831b2800],
7	January	NNP	DATE	January	prep_on	1	SENT_249	[p15l840t2777r943b2807],
8	5	CD	DATE	5	num	7	SENT_249	[p15l952t2777r975b2805],
9	,	,	DATE	,	_	0	SENT_249	[p15l952t2777r975b2805],
10	2014	CD	DATE	2014	num	7	SENT_249	[p15l986t2777r1058b2800],
11	.	.	O	.	_	0	SENT_249	[p15l986t2777r1058b2800],

1	For	IN	O	for	_	0	SENT_250	[p15l1069t2777r1115b2800],
2	personal	JJ	O	personal	amod	3	SENT_250	[p15l1123t2777r1236b2807],
3	use	NN	O	use	pobj	1	SENT_250	[p15l1245t2784r1288b2800],
4	only	RB	O	only	advmod	3	SENT_250	[p15l1298t2777r1363b2807],
5	.	.	O	.	_	0	SENT_250	[p15l1298t2777r1363b2807],

1	No	DT	O	no	det	3	SENT_251	[p15l1373t2777r1413b2800],
2	other	JJ	O	other	amod	3	SENT_251	[p15l1423t2777r1491b2800],
3	uses	NNS	O	use	_	0	SENT_251	[p15l1499t2784r1555b2800],
4	without	IN	O	without	_	0	SENT_251	[p15l1566t2777r1667b2800],
5	permission	NN	O	permission	prep_without	3	SENT_251	[p15l1675t2777r1828b2807],
6	.	.	O	.	_	0	SENT_251	[p15l1675t2777r1828b2807],

1	Copyright	NN	O	copyright	_	0	SENT_252	[p15l545t2816r679b2846],
2	©	CD	NUMBER	©	num	6	SENT_252	[p15l689t2816r712b2840],
3	2005	CD	DATE	2005	num	6	SENT_252	[p15l722t2816r786b2840],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_252	[p15l797t2816r988b2839],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_252	[p15l997t2816r1106b2839],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_252	[p15l1116t2816r1221b2846],
7	.	.	O	.	_	0	SENT_252	[p15l1116t2816r1221b2846],

1	All	DT	O	all	det	2	SENT_253	[p15l1232t2816r1274b2839],
2	rights	NNS	O	rights	nsubj	3	SENT_253	[p15l1283t2816r1358b2846],
3	reserved	VBN	O	reserve	_	0	SENT_253	[p15l1367t2816r1486b2839],
4	.	.	O	.	_	0	SENT_253	[p15l1367t2816r1486b2839],

1	The	DT	O	the	det	4	SENT_254	[p15l857t2858r894b2880],
2	NEW	NNP	O	NEW	nn	4	SENT_254	[p15l906t2860r987b2880],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_254	[p15l1001t2860r1176b2880],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_254	[p15l1189t2860r1356b2887],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_254	[p15l1369t2858r1585b2886],

1	Table	NNP	O	Table	_	0	SENT_255	[p16l119t32r189b57],
2	1	CD	NUMBER	1	dep	1	SENT_255	[p16l200t34r221b57],
3	.	.	O	.	_	0	SENT_255	[p16l200t34r221b57],

1	Tyrosine	NN	O	tyrosine	nn	3	SENT_256	[p16l230t33r345b65],
2	Kinase	NN	O	kinase	nn	3	SENT_256	[p16l356t33r445b57],
3	Targets	NNS	O	target	_	0	SENT_256	[p16l453t34r551b65],
4	in	IN	O	in	_	0	SENT_256	[p16l562t33r584b57],
5	Malignant	JJ	O	malignant	amod	7	SENT_256	[p16l597t32r735b65],
6	Hematologic	JJ	O	hematologic	amod	7	SENT_256	[p16l745t32r920b65],
7	Disorders	NNS	O	disorder	prep_in	3	SENT_256	[p16l930t32r1087b57],
8	.	.	O	.	_	0	SENT_256	[p16l930t32r1087b57],

1	‘	SYM	O	‘	dep	3	SENT_257	[p16l930t32r1087b57],
2	-	:	O	-	_	0	SENT_257	[p16l930t32r1087b57],
3	"	``	O	"	_	0	SENT_257	[p16l930t32r1087b57],
4	‘	IN	O	‘	prep	3	SENT_257	[p16l930t32r1087b57],

1	Tyrosine	NN	O	tyrosine	_	0	SENT_258	[p16l118t104r233b136],
2	Kinase'i	NN	O	kinase'us	nsubj	7	SENT_258	[p16l244t104r350b136],
3	'	''	O	'	_	0	SENT_258	[p16l244t104r350b136],
4	Activating	VBG	O	activate	partmod	2	SENT_258	[p16l501t104r639b136],
5	Mechanisms	NNS	O	mechanism	nn	6	SENT_258	[p16l650t103r823b128],
6	Cancer	NN	O	cancer	dobj	4	SENT_258	[p16l957t105r1051b128],
7	Targeted	VBN	O	target	rcmod	1	SENT_258	[p16l1217t103r1333b136],
8	Therapy	NN	O	therapy	dobj	7	SENT_258	[p16l1342t103r1471b136],
9	:	:	O	:	_	0	SENT_258	[p16l1342t103r1471b136],
10	§	CD	NUMBER	§	dep	8	SENT_258	[p16l1342t103r1471b136],
11	:	:	O	:	_	0	SENT_258	[p16l1342t103r1471b136],
12	References	NNS	O	reference	dep	10	SENT_258	[p16l1735t103r1881b128],

1	ABL	NN	O	abl	_	0	SENT_259	[p16l118t171r174b194],
2	(	CD	NUMBER	(	num	4	SENT_259	[p16l185t171r268b202],
3	9q34	NN	O	9q34	nn	4	SENT_259	[p16l185t171r268b202],
4	)	NN	O	)	dep	1	SENT_259	[p16l185t171r268b202],

1	BCR-ABL	NN	O	bcr-abl	nn	2	SENT_260	[p16l172t224r293b248],
2	t	NN	O	t	_	0	SENT_260	[p16l617t225r705b256],
3	(	CD	NUMBER	(	number	4	SENT_260	[p16l617t225r705b256],
4	9	CD	NUMBER	9	dep	2	SENT_260	[p16l617t225r705b256],
5	;	:	O	;	_	0	SENT_260	[p16l617t225r705b256],
6	22	CD	NUMBER	22	number	7	SENT_260	[p16l617t225r705b256],
7	)	CD	NUMBER	)	num	11	SENT_260	[p16l617t225r705b256],
8	CM	NN	O	cm	nn	11	SENT_260	[p16l892t225r937b248],
9	L	NN	O	l	nn	11	SENT_260	[p16l944t225r963b252],
10	,	,	O	,	_	0	SENT_260	[p16l944t225r963b252],
11	ALL	NN	O	all	dep	2	SENT_260	[p16l973t224r1032b252],
12	,	,	O	,	_	0	SENT_260	[p16l973t224r1032b252],
13	AML	NN	ORGANIZATION	aml	nn	14	SENT_260	[p16l1042t224r1108b248],
14	lmatinib	NN	O	lmatinib	appos	11	SENT_260	[p16l1144t223r1256b248],
15	(	CD	NUMBER	(	npadvmod	16	SENT_260	[p16l1269t225r1323b256],
16	not	RB	O	not	advmod	14	SENT_260	[p16l1269t225r1323b256],
17	for	IN	O	for	_	0	SENT_260	[p16l1332t223r1370b248],
18	ALL	NN	O	all	nn	19	SENT_260	[p16l1378t224r1448b256],
19	)	NN	O	)	prep_for	14	SENT_260	[p16l1378t224r1448b256],
20	,	,	O	,	_	0	SENT_260	[p16l1378t224r1448b256],
21	SMS	NN	O	sm	appos	19	SENT_260	[p16l1460t225r1531b248],
22	-	:	O	-	_	0	SENT_260	[p16l1460t225r1531b248],
23	O'Brien	NNP	PERSON	O'Brien	dep	2	SENT_260	[p16l1575t225r1678b248],
24	et	FW	O	et	nn	26	SENT_260	[p16l1690t228r1714b248],
25	a	FW	O	a	nn	26	SENT_260	[p16l1724t223r1788b252],
26	|	NN	O	|	dep	23	SENT_260	[p16l1724t223r1788b252],
27	.	.	O	.	_	0	SENT_260	[p16l1724t223r1788b252],

1	,1	NN	O	,1	nn	3	SENT_261	[p16l1724t223r1788b252],
2	°	CD	NUMBER	°	num	3	SENT_261	[p16l1724t223r1788b252],
3	Druker	NNP	PERSON	Druker	_	0	SENT_261	[p16l1800t223r1891b248],
4	et	FW	O	et	nn	5	SENT_261	[p16l1900t228r1924b248],
5	aI.	FW	O	ai.	dep	3	SENT_261	[p16l1934t223r1997b252],
6	,11	CD	NUMBER	,11	dep	3	SENT_261	[p16l1934t223r1997b252],

1	354825	CD	NUMBER	354825	_	0	SENT_262	[p16l1193t262r1297b290],
2	,	,	O	,	_	0	SENT_262	[p16l1193t262r1297b290],
3	Shah	NNP	PERSON	Shah	appos	1	SENT_262	[p16l1625t260r1691b286],
4	et	FW	O	et	nn	5	SENT_262	[p16l1702t265r1726b286],
5	al.	FW	O	al.	dep	3	SENT_262	[p16l1736t260r1792b285],
6	12	CD	NUMBER	12	num	7	SENT_262	[p16l1736t260r1792b285],
7	NUP214-ABL	NN	O	nup214-abl	dep	1	SENT_262	[p16l172t316r351b340],
8	Episomal	JJ	MISC	episomal	amod	9	SENT_262	[p16l463t314r586b347],
9	fusion	NN	O	fusion	dep	7	SENT_262	[p16l597t314r681b340],
10	and	CC	O	and	_	0	SENT_262	[p16l692t314r740b340],
11	ampli	NN	O	amplus	dep	7	SENT_262	[p16l752t314r837b347],
12	-	:	O	-	_	0	SENT_262	[p16l752t314r837b347],
13	T-ALL	NN	O	t-all	dep	7	SENT_262	[p16l891t316r971b339],
14	lmatinib	NN	O	lmatinib	nn	16	SENT_262	[p16l1144t314r1269b347],
15	§	CD	NUMBER	§	num	16	SENT_262	[p16l1144t314r1269b347],
16	Graux	NNP	O	Graux	dep	13	SENT_262	[p16l1575t316r1656b340],
17	et	FW	O	et	dep	13	SENT_262	[p16l1665t319r1689b340],
18	al.	FW	O	al.	nn	19	SENT_262	[p16l1699t315r1753b340],
19	“	FW	O	“	dep	17	SENT_262	[p16l1699t315r1753b340],

1	ﬁcation	NN	O	ﬁcation	_	0	SENT_263	[p16l511t352r610b377],

1	ALK	NNP	O	ALK	_	0	SENT_264	[p16l118t409r174b431],
2	(	CD	NUMBER	(	num	1	SENT_264	[p16l184t408r268b439],
3	2p23	CD	NUMBER	2p23	num	4	SENT_264	[p16l184t408r268b439],
4	)	NN	O	)	dep	1	SENT_264	[p16l184t408r268b439],

1	NPM-ALK	NN	O	npm-alk	nn	3	SENT_265	[p16l172t462r306b485],
2	t	NN	O	t	nn	3	SENT_265	[p16l625t462r697b493],
3	(	NN	O	(	_	0	SENT_265	[p16l625t462r697b493],
4	2	CD	NUMBER	2	dep	3	SENT_265	[p16l625t462r697b493],
5	;	:	O	;	_	0	SENT_265	[p16l625t462r697b493],
6	5	CD	NUMBER	5	number	7	SENT_265	[p16l625t462r697b493],
7	)	CD	NUMBER	)	dep	4	SENT_265	[p16l625t462r697b493],
8	ALCL	NNP	ORGANIZATION	ALCL	nn	9	SENT_265	[p16l891t462r964b486],
9	Pulford	NNP	ORGANIZATION	Pulford	dep	14	SENT_265	[p16l1577t460r1672b486],
10	et	FW	O	et	nn	11	SENT_265	[p16l1684t465r1708b486],
11	al.	FW	O	al.	dep	9	SENT_265	[p16l1718t460r1773b486],
12	15	CD	NUMBER	15	num	13	SENT_265	[p16l1718t460r1773b486],
13	TPM3-ALK	NN	O	tpm3-alk	dep	14	SENT_265	[p16l169t516r315b540],
14	t	NN	O	t	dep	4	SENT_265	[p16l625t517r697b548],
15	(	CD	NUMBER	(	number	16	SENT_265	[p16l625t517r697b548],
16	1	CD	NUMBER	1	dep	14	SENT_265	[p16l625t517r697b548],
17	;	:	O	;	_	0	SENT_265	[p16l625t517r697b548],
18	2	CD	NUMBER	2	number	19	SENT_265	[p16l625t517r697b548],
19	)	CD	NUMBER	)	num	23	SENT_265	[p16l625t517r697b548],
20	ALCL	NN	ORGANIZATION	alcl	nn	23	SENT_265	[p16l891t516r964b540],
21	ATIC-ALK	NN	ORGANIZATION	atic-alk	nn	23	SENT_265	[p16l169t570r298b594],
22	inv	NN	O	inv	nn	23	SENT_265	[p16l624t571r700b602],
23	(	NN	O	(	dep	16	SENT_265	[p16l624t571r700b602],
24	2	CD	NUMBER	2	number	25	SENT_265	[p16l624t571r700b602],
25	)	CD	NUMBER	)	num	29	SENT_265	[p16l624t571r700b602],
26	ALCL	NN	O	alcl	nn	29	SENT_265	[p16l891t570r964b594],
27	CLTC-ALK	NN	O	cltc-alk	nn	29	SENT_265	[p16l170t625r304b648],
28	t	NN	O	t	nn	29	SENT_265	[p16l617t625r705b656],
29	(	NN	O	(	dep	23	SENT_265	[p16l617t625r705b656],
30	2	CD	NUMBER	2	num	32	SENT_265	[p16l617t625r705b656],
31	;	:	O	;	_	0	SENT_265	[p16l617t625r705b656],
32	l7	CD	NUMBER	l7	dep	4	SENT_265	[p16l617t625r705b656],
33	)	CD	NUMBER	)	num	34	SENT_265	[p16l617t625r705b656],
34	ALCL	NN	O	alcl	dep	3	SENT_265	[p16l891t625r964b648],

1	ARG	NN	O	arg	_	0	SENT_266	[p16l118t679r179b702],
2	(	CD	NUMBER	(	dep	1	SENT_266	[p16l192t679r274b710],
3	1q25	CD	NUMBER	1q25	num	4	SENT_266	[p16l192t679r274b710],
4	)	NN	O	)	dep	1	SENT_266	[p16l192t679r274b710],

1	TEL-ARG	NN	O	tel-arg	nn	2	SENT_267	[p16l169t733r290b757],
2	t	NN	O	t	dep	11	SENT_267	[p16l617t733r705b764],
3	(	CD	NUMBER	(	number	4	SENT_267	[p16l617t733r705b764],
4	1	CD	NUMBER	1	dep	2	SENT_267	[p16l617t733r705b764],
5	;	:	O	;	_	0	SENT_267	[p16l617t733r705b764],
6	12	CD	NUMBER	12	number	7	SENT_267	[p16l617t733r705b764],
7	)	CD	NUMBER	)	dep	4	SENT_267	[p16l617t733r705b764],
8	AML	NN	ORGANIZATION	aml	nn	9	SENT_267	[p16l891t733r956b756],
9	Imatiniblj	NN	O	imatiniblj	dep	7	SENT_267	[p16l1144t731r1269b764],
10	Cazzaniga	NNP	O	Cazzaniga	dep	11	SENT_267	[p16l1575t733r1713b765],
11	et	FW	O	et	dep	16	SENT_267	[p16l1724t736r1748b757],
12	al.	FW	O	al.	nn	14	SENT_267	[p16l1758t731r1813b757],
13	”	FW	O	”	nn	14	SENT_267	[p16l1758t731r1813b757],
14	FGFR1	NN	O	fgfr1	dep	11	SENT_267	[p16l121t787r211b811],
15	(	CD	NUMBER	(	num	16	SENT_267	[p16l223t787r307b819],
16	8p11	NN	O	8p11	dep	18	SENT_267	[p16l223t787r307b819],
17	)	CD	NUMBER	)	num	18	SENT_267	[p16l223t787r307b819],
18	ZN	NN	O	zn	dep	21	SENT_267	[p16l170t842r210b865],
19	F198-FG	NN	O	f198-fg	nn	21	SENT_267	[p16l217t841r328b865],
20	FR1	NN	O	fr1	nn	21	SENT_267	[p16l335t842r382b865],
21	t	NN	O	t	dep	34	SENT_267	[p16l617t841r705b873],
22	(	CD	NUMBER	(	num	23	SENT_267	[p16l617t841r705b873],
23	8	CD	NUMBER	8	dep	21	SENT_267	[p16l617t841r705b873],
24	'	''	DATE	'	_	0	SENT_267	[p16l617t841r705b873],
25	13	CD	DATE	13	dep	23	SENT_267	[p16l617t841r705b873],
26	)	CD	NUMBER	)	num	28	SENT_267	[p16l617t841r705b873],
27	EMS	NNP	ORGANIZATION	EMS	nn	28	SENT_267	[p16l894t842r954b865],
28	PKC412	NN	O	pkc412	dep	23	SENT_267	[p16l1144t842r1255b869],
29	,	,	O	,	_	0	SENT_267	[p16l1144t842r1255b869],
30	PDo173074g	NN	O	pdo173074g	nn	32	SENT_267	[p16l1268t840r1435b873],
31	§	CD	NUMBER	§	num	32	SENT_267	[p16l1268t840r1435b873],
32	Macdonald	NNP	PERSON	Macdonald	appos	28	SENT_267	[p16l1577t840r1727b865],
33	et	FW	O	et	nn	34	SENT_267	[p16l1738t844r1763b865],
34	aI.	FW	O	ai.	dep	38	SENT_267	[p16l1773t839r1837b869],
35	,18	CD	NUMBER	,18	num	36	SENT_267	[p16l1773t839r1837b869],
36	Chen	NNP	O	Chen	dep	34	SENT_267	[p16l1847t840r1915b865],
37	et	FW	O	et	nn	38	SENT_267	[p16l1926t844r1950b865],
38	aI	FW	O	ai	_	0	SENT_267	[p16l1960t839r2015b865],
39	.19	CD	NUMBER	.19	num	41	SENT_267	[p16l1960t839r2015b865],
40	FOP-FGFR1	NN	O	fop-fgfr1	nn	41	SENT_267	[p16l172t896r331b919],
41	t	NN	O	t	dep	38	SENT_267	[p16l625t896r697b927],
42	(	CD	NUMBER	(	number	43	SENT_267	[p16l625t896r697b927],
43	6	CD	NUMBER	6	dep	41	SENT_267	[p16l625t896r697b927],
44	;	:	O	;	_	0	SENT_267	[p16l625t896r697b927],
45	8	CD	NUMBER	8	dep	41	SENT_267	[p16l625t896r697b927],
46	)	CD	NUMBER	)	num	49	SENT_267	[p16l625t896r697b927],
47	EMS	NNP	ORGANIZATION	EMS	nn	49	SENT_267	[p16l894t896r954b919],
48	CEP110-FGFR1	NN	O	cep110-fgfr1	nn	49	SENT_267	[p16l170t950r376b973],
49	t	NN	O	t	dep	45	SENT_267	[p16l625t950r697b981],
50	(	CD	NUMBER	(	number	51	SENT_267	[p16l625t950r697b981],
51	8	CD	NUMBER	8	dep	49	SENT_267	[p16l625t950r697b981],
52	;	:	O	;	_	0	SENT_267	[p16l625t950r697b981],
53	9	CD	NUMBER	9	dep	41	SENT_267	[p16l625t950r697b981],
54	)	CD	NUMBER	)	num	57	SENT_267	[p16l625t950r697b981],
55	EMS	NNP	ORGANIZATION	EMS	nn	57	SENT_267	[p16l894t950r954b973],
56	HERVK-FGFR1	NN	O	hervk-fgfr1	nn	57	SENT_267	[p16l172t1004r371b1028],
57	t	NN	O	t	dep	53	SENT_267	[p16l617t1004r705b1035],
58	(	CD	NUMBER	(	number	59	SENT_267	[p16l617t1004r705b1035],
59	8	CD	NUMBER	8	dep	57	SENT_267	[p16l617t1004r705b1035],
60	;	:	O	;	_	0	SENT_267	[p16l617t1004r705b1035],
61	19	CD	NUMBER	19	dep	41	SENT_267	[p16l617t1004r705b1035],
62	)	CD	NUMBER	)	num	65	SENT_267	[p16l617t1004r705b1035],
63	EMS	NNP	ORGANIZATION	EMS	nn	65	SENT_267	[p16l894t1004r954b1027],
64	BCR-FGFR1	NN	O	bcr-fgfr1	nn	65	SENT_267	[p16l172t1058r329b1082],
65	t	NN	O	t	dep	61	SENT_267	[p16l617t1058r705b1090],
66	(	CD	NUMBER	(	number	67	SENT_267	[p16l617t1058r705b1090],
67	8	CD	NUMBER	8	dep	65	SENT_267	[p16l617t1058r705b1090],
68	;	:	O	;	_	0	SENT_267	[p16l617t1058r705b1090],
69	22	CD	NUMBER	22	number	70	SENT_267	[p16l617t1058r705b1090],
70	)	CD	NUMBER	)	dep	41	SENT_267	[p16l617t1058r705b1090],
71	aCML	NN	O	acml	dep	70	SENT_267	[p16l892t1058r973b1082],

1	FGFR3	NN	O	fgfr3	_	0	SENT_268	[p16l121t1113r211b1136],
2	(	CD	NUMBER	(	num	1	SENT_268	[p16l223t1113r307b1144],
3	4p16	CD	NUMBER	4p16	num	6	SENT_268	[p16l223t1113r307b1144],
4	)	NN	O	)	nn	6	SENT_268	[p16l223t1113r307b1144],
5	Overex	NN	O	overex	nn	6	SENT_268	[p16l461t1113r556b1136],
6	ssion	NN	O	ssion	dep	1	SENT_268	[p16l603t1113r673b1136],
7	with	IN	O	with	_	0	SENT_268	[p16l683t1111r739b1136],
8	t	NN	O	t	prep_with	6	SENT_268	[p16l749t1113r848b1144],
9	(	CD	NUMBER	(	number	10	SENT_268	[p16l749t1113r848b1144],
10	4	CD	NUMBER	4	dep	8	SENT_268	[p16l749t1113r848b1144],
11	;	:	O	;	_	0	SENT_268	[p16l749t1113r848b1144],
12	14	CD	NUMBER	14	num	13	SENT_268	[p16l749t1113r848b1144],
13	)	NN	O	)	dep	8	SENT_268	[p16l749t1113r848b1144],
14	;	:	O	;	_	0	SENT_268	[p16l749t1113r848b1144],
15	MM	NN	O	mm	nn	16	SENT_268	[p16l894t1113r946b1135],
16	PD0173074	NN	O	pd0173074	dep	8	SENT_268	[p16l1144t1110r1320b1143],
17	,	,	O	,	_	0	SENT_268	[p16l1144t1110r1320b1143],
18	§	CD	NUMBER	§	appos	8	SENT_268	[p16l1144t1110r1320b1143],
19	SU5402	NN	O	su5402	nn	21	SENT_268	[p16l1331t1110r1449b1143],
20	§	CD	NUMBER	§	num	21	SENT_268	[p16l1331t1110r1449b1143],
21	Chesi	NNP	O	Chesi	dep	18	SENT_268	[p16l1575t1111r1648b1136],
22	et	FW	O	et	nn	26	SENT_268	[p16l1660t1115r1684b1136],
23	a	FW	O	a	nn	26	SENT_268	[p16l1694t1110r1750b1136],
24	|	FW	O	|	nn	26	SENT_268	[p16l1694t1110r1750b1136],
25	.2	NN	NUMBER	.2	nn	26	SENT_268	[p16l1694t1110r1750b1136],
26	°	NN	O	°	dep	1	SENT_268	[p16l1694t1110r1750b1136],

1	K6	NN	O	k6	_	0	SENT_269	[p16l513t1150r544b1173],

1	TEL-FGFR3	NN	O	tel-fgfr3	nn	2	SENT_270	[p16l169t1204r322b1228],
2	t	NN	O	t	dep	20	SENT_270	[p16l617t1204r705b1235],
3	(	CD	NUMBER	(	number	4	SENT_270	[p16l617t1204r705b1235],
4	4	CD	NUMBER	4	dep	2	SENT_270	[p16l617t1204r705b1235],
5	;	:	O	;	_	0	SENT_270	[p16l617t1204r705b1235],
6	12	CD	NUMBER	12	number	7	SENT_270	[p16l617t1204r705b1235],
7	)	CD	NUMBER	)	dep	4	SENT_270	[p16l617t1204r705b1235],
8	T	NN	O	t	nn	10	SENT_270	[p16l891t1205r909b1227],
9	lymphoma	NN	O	lymphoma	nn	10	SENT_270	[p16l919t1202r1063b1235],
10	PDo173o74	NN	O	pdo173o74	dep	7	SENT_270	[p16l1144t1202r1320b1235],
11	,	,	O	,	_	0	SENT_270	[p16l1144t1202r1320b1235],
12	§	CD	NUMBER	§	num	13	SENT_270	[p16l1144t1202r1320b1235],
13	Su5402	NN	O	su5402	appos	7	SENT_270	[p16l1331t1202r1449b1235],
14	§	CD	NUMBER	§	num	15	SENT_270	[p16l1331t1202r1449b1235],
15	FLT3	NN	O	flt3	dep	13	SENT_270	[p16l121t1259r181b1282],
16	(	CD	NUMBER	(	num	17	SENT_270	[p16l194t1259r294b1290],
17	13q12	NN	O	13q12	dep	20	SENT_270	[p16l194t1259r294b1290],
18	)	CD	NUMBER	)	num	20	SENT_270	[p16l194t1259r294b1290],
19	juxt	NN	O	juxt	nn	20	SENT_270	[p16l457t1259r511b1289],
20	mbrane	NN	O	mbrane	dep	25	SENT_270	[p16l574t1257r677b1282],
21	internal	JJ	O	internal	amod	22	SENT_270	[p16l688t1257r789b1282],
22	tan	NN	O	tan	dep	20	SENT_270	[p16l799t1261r851b1282],
23	-	:	O	-	_	0	SENT_270	[p16l799t1261r851b1282],
24	AML	NN	ORGANIZATION	aml	nn	25	SENT_270	[p16l891t1258r956b1281],
25	PKC412	NN	O	pkc412	_	0	SENT_270	[p16l1144t1258r1255b1286],
26	,	,	O	,	_	0	SENT_270	[p16l1144t1258r1255b1286],
27	MLN518	NN	O	mln518	appos	25	SENT_270	[p16l1268t1258r1392b1286],
28	,	,	O	,	_	0	SENT_270	[p16l1268t1258r1392b1286],
29	CEP-701	NN	O	cep-701	appos	25	SENT_270	[p16l1403t1258r1524b1286],
30	,	,	O	,	_	0	SENT_270	[p16l1403t1258r1524b1286],
31	Nakao	NNP	PERSON	Nakao	nn	32	SENT_270	[p16l1577t1257r1663b1282],
32	et	NNP	O	et	appos	29	SENT_270	[p16l1673t1261r1697b1282],
33	.	.	O	.	_	0	SENT_270	[p16l1707t1257r1757b1286],

1	al.	FW	O	al.	_	0	SENT_271	[p16l1707t1257r1757b1286],
2	,5	CD	NUMBER	,5	dep	1	SENT_271	[p16l1707t1257r1757b1286],
3	Yamamoto	NNP	PERSON	Yamamoto	dep	2	SENT_271	[p16l1767t1259r1914b1282],
4	et	FW	O	et	nn	5	SENT_271	[p16l1925t1261r1949b1282],
5	aI.	FW	O	ai.	dep	1	SENT_271	[p16l1959t1256r2022b1286],
6	,	,	O	,	_	0	SENT_271	[p16l1959t1256r2022b1286],
7	“	CD	NUMBER	“	num	8	SENT_271	[p16l1959t1256r2022b1286],
8	duplication	NN	O	duplication	appos	5	SENT_271	[p16l581t1294r741b1327],
9	;	:	O	;	_	0	SENT_271	[p16l581t1294r741b1327],
10	D835X	NN	O	d835x	dep	5	SENT_271	[p16l754t1296r850b1324],
11	;	:	O	;	_	0	SENT_271	[p16l754t1296r850b1324],
12	SU5416	NNP	O	SU5416	nn	13	SENT_271	[p16l1193t1296r1298b1319],
13	Stone	NNP	O	Stone	dep	10	SENT_271	[p16l1625t1296r1703b1319],
14	et	FW	O	et	nn	15	SENT_271	[p16l1713t1299r1737b1319],
15	aI.	FW	O	ai.	dep	13	SENT_271	[p16l1747t1294r1810b1324],
16	,	,	O	,	_	0	SENT_271	[p16l1747t1294r1810b1324],
17	“	NNP	O	“	nn	18	SENT_271	[p16l1747t1294r1810b1324],
18	Smith	NNP	PERSON	Smith	appos	1	SENT_271	[p16l1821t1294r1899b1319],
19	et	FW	O	et	nn	21	SENT_271	[p16l1911t1299r1935b1319],
20	a	FW	O	a	nn	21	SENT_271	[p16l1945t1294r2008b1324],
21	|	NN	O	|	dep	18	SENT_271	[p16l1945t1294r2008b1324],
22	.	.	O	.	_	0	SENT_271	[p16l1945t1294r2008b1324],

1	,23	CD	NUMBER	,23	_	0	SENT_272	[p16l1945t1294r2008b1324],

1	overexpression	NN	O	overexpression	nn	2	SENT_273	[p16l511t1334r715b1364],
2	Fiedler	NNP	PERSON	Fiedler	_	0	SENT_273	[p16l1627t1332r1718b1357],
3	et	FW	O	et	dep	2	SENT_273	[p16l1727t1336r1751b1357],
4	al.	FW	O	al.	nn	5	SENT_273	[p16l1761t1331r1817b1357],
5	“	FW	O	“	dep	2	SENT_273	[p16l1761t1331r1817b1357],

1	C-FMS	NN	O	c-fm	dep	18	SENT_274	[p16l119t1388r206b1411],
2	(	CD	NUMBER	(	num	3	SENT_274	[p16l217t1388r300b1419],
3	5q33	NN	O	5q33	dep	1	SENT_274	[p16l217t1388r300b1419],
4	)	CD	NUMBER	)	num	5	SENT_274	[p16l217t1388r300b1419],
5	L301F/S	NN	O	l301f/s	dep	3	SENT_274	[p16l556t1387r674b1419],
6	;	:	O	;	_	0	SENT_274	[p16l556t1387r674b1419],
7	Y969C	NN	O	y969c	nn	8	SENT_274	[p16l685t1388r772b1411],
8	MDS	NN	O	md	dep	3	SENT_274	[p16l894t1388r968b1415],
9	,	,	O	,	_	0	SENT_274	[p16l894t1388r968b1415],
10	AML	NN	ORGANIZATION	aml	appos	8	SENT_274	[p16l978t1387r1043b1410],
11	Ridge	NNP	O	Ridge	dep	14	SENT_274	[p16l1577t1386r1651b1419],
12	et	FW	O	et	nn	14	SENT_274	[p16l1661t1390r1685b1411],
13	a	FW	O	a	nn	14	SENT_274	[p16l1695t1386r1749b1411],
14	|	FW	O	|	rcmod	10	SENT_274	[p16l1695t1386r1749b1411],
15	.25	CD	NUMBER	.25	num	16	SENT_274	[p16l1695t1386r1749b1411],
16	NTRK3	NN	O	ntrk3	dep	18	SENT_274	[p16l121t1442r215b1465],
17	(	CD	NUMBER	(	num	18	SENT_274	[p16l227t1442r327b1473],
18	15q25	CD	NUMBER	15q25	dep	28	SENT_274	[p16l227t1442r327b1473],
19	)	NN	O	)	nn	21	SENT_274	[p16l227t1442r327b1473],
20	TEL-NTRK3	NN	O	tel-ntrk3	nn	21	SENT_274	[p16l169t1496r326b1519],
21	t	NN	O	t	dep	18	SENT_274	[p16l608t1496r714b1527],
22	(	CD	NUMBER	(	number	23	SENT_274	[p16l608t1496r714b1527],
23	12	CD	NUMBER	12	num	27	SENT_274	[p16l608t1496r714b1527],
24	,	,	O	,	_	0	SENT_274	[p16l608t1496r714b1527],
25	l5	CD	NUMBER	l5	number	26	SENT_274	[p16l608t1496r714b1527],
26	)	CD	NUMBER	)	num	27	SENT_274	[p16l608t1496r714b1527],
27	AML	NN	ORGANIZATION	aml	dep	21	SENT_274	[p16l891t1496r956b1519],
28	Eguchi	NNP	ORGANIZATION	Eguchi	dep	32	SENT_274	[p16l1577t1494r1665b1527],
29	et	FW	O	et	nn	30	SENT_274	[p16l1677t1499r1701b1519],
30	al.	FW	O	al.	dep	28	SENT_274	[p16l1711t1493r1766b1519],
31	25	CD	NUMBER	25	num	32	SENT_274	[p16l1711t1493r1766b1519],
32	PDGFRa	NN	O	pdgfra	_	0	SENT_274	[p16l121t1550r243b1573],
33	(	CD	NUMBER	(	num	35	SENT_274	[p16l254t1550r337b1581],
34	4q12	NN	O	4q12	nn	35	SENT_274	[p16l254t1550r337b1581],
35	)	NN	O	)	dep	32	SENT_274	[p16l254t1550r337b1581],

1	F	NN	O	f	nsubj	16	SENT_275	[p16l172t1604r395b1628],
2	|	SYM	O	|	dep	3	SENT_275	[p16l172t1604r395b1628],
3	P1L1-PDGFRa	NN	O	p1l1-pdgfra	rcmod	1	SENT_275	[p16l172t1604r395b1628],
4	Interstitial	JJ	O	interstitial	amod	3	SENT_275	[p16l525t1602r660b1628],
5	de	IN	O	de	_	0	SENT_275	[p16l672t1602r800b1635],
6	|	CD	NUMBER	|	num	10	SENT_275	[p16l672t1602r800b1635],
7	(	CD	NUMBER	(	num	10	SENT_275	[p16l672t1602r800b1635],
8	4q12	NN	O	4q12	nn	10	SENT_275	[p16l672t1602r800b1635],
9	)	CD	NUMBER	)	num	10	SENT_275	[p16l672t1602r800b1635],
10	HES	NNS	ORGANIZATION	he	prep_de	1	SENT_275	[p16l894t1604r958b1632],
11	,	,	O	,	_	0	SENT_275	[p16l894t1604r958b1632],
12	SM	NNP	O	SM	nn	13	SENT_275	[p16l970t1604r1012b1628],
13	Imatinib	NNP	O	Imatinib	appos	10	SENT_275	[p16l1144t1602r1264b1632],
14	,	,	O	,	_	0	SENT_275	[p16l1144t1602r1264b1632],
15	PKC412	NN	O	pkc412	appos	13	SENT_275	[p16l1277t1604r1380b1628],
16	Cools	VBZ	O	cool	_	0	SENT_275	[p16l1575t1602r1650b1628],
17	et	FW	O	et	nn	19	SENT_275	[p16l1661t1607r1685b1628],
18	a	FW	O	a	nn	19	SENT_275	[p16l1695t1602r1791b1632],
19	|	NN	O	|	dep	16	SENT_275	[p16l1695t1602r1791b1632],
20	.	.	O	.	_	0	SENT_275	[p16l1695t1602r1791b1632],

1	,27	CD	NUMBER	,27	number	2	SENT_276	[p16l1695t1602r1791b1632],
2	'28	CD	NUMBER	'28	_	0	SENT_276	[p16l1695t1602r1791b1632],
3	Pardanani	NNP	O	Pardanani	dep	2	SENT_276	[p16l1803t1602r1937b1628],
4	et	FW	O	et	nn	8	SENT_276	[p16l1948t1607r1973b1628],
5	al.	FW	O	al.	nn	8	SENT_276	[p16l1982t1602r2038b1628],
6	”	FW	O	”	nn	8	SENT_276	[p16l1982t1602r2038b1628],
7	BCR-PDGFROz	NN	O	bcr-pdgfroz	nn	8	SENT_276	[p16l172t1659r359b1682],
8	t	NN	O	t	dep	2	SENT_276	[p16l617t1659r705b1690],
9	(	CD	NUMBER	(	number	10	SENT_276	[p16l617t1659r705b1690],
10	4	CD	NUMBER	4	dep	8	SENT_276	[p16l617t1659r705b1690],
11	;	:	O	;	_	0	SENT_276	[p16l617t1659r705b1690],
12	22	CD	NUMBER	22	number	13	SENT_276	[p16l617t1659r705b1690],
13	)	CD	NUMBER	)	num	15	SENT_276	[p16l617t1659r705b1690],
14	aCML	NN	O	acml	nn	15	SENT_276	[p16l893t1659r973b1682],
15	lmatinib	NN	O	lmatinib	dep	8	SENT_276	[p16l1144t1657r1256b1682],
16	Baxter	NNP	PERSON	Baxter	dep	15	SENT_276	[p16l1577t1659r1660b1682],
17	et	FW	O	et	nn	21	SENT_276	[p16l1669t1661r1693b1682],
18	a	FW	O	a	nn	21	SENT_276	[p16l1703t1656r1759b1682],
19	|	FW	O	|	nn	21	SENT_276	[p16l1703t1656r1759b1682],
20	.3	NN	NUMBER	.3	nn	21	SENT_276	[p16l1703t1656r1759b1682],
21	°	NN	O	°	dep	15	SENT_276	[p16l1703t1656r1759b1682],

1	lotinib	NN	O	lotinib	nsubj	6	SENT_277	[p16l8t1899r288b1978],
2	(	CD	NUMBER	(	num	4	SENT_277	[p16l337t1905r709b1991],
3	Tarceva	NNP	O	Tarceva	nn	4	SENT_277	[p16l337t1905r709b1991],
4	)	NN	O	)	dep	1	SENT_277	[p16l337t1905r709b1991],
5	are	VBP	O	be	cop	6	SENT_277	[p16l755t1926r881b1978],
6	anilinoquinazolines	NNS	O	anilinoquinazoline	_	0	SENT_277	[p16l922t1900r1764b2000],
7	that	WDT	O	that	nsubjpass	20	SENT_277	[p16l1808t1900r1975b1978],
8	are	VBP	O	be	cop	9	SENT_277	[p16l2010t1926r2136b1978],
9	speciﬁc	NN	O	speciﬁc	rcmod	6	SENT_277	[p16l11t2027r352b2128],
10	,	,	O	,	_	0	SENT_277	[p16l11t2027r352b2128],
11	competitive	JJ	O	competitive	amod	12	SENT_277	[p16l391t2028r881b2128],
12	inhibitors	NNS	O	inhibitor	appos	9	SENT_277	[p16l914t2028r1328b2106],
13	of	IN	O	of	_	0	SENT_277	[p16l1363t2027r1464b2106],
14	ATP	NN	O	atp	nn	15	SENT_277	[p16l1475t2033r1648b2105],
15	binding	NN	O	binding	prep_of	12	SENT_277	[p16l1680t2028r2014b2128],
16	by	IN	O	by	_	0	SENT_277	[p16l2044t2028r2140b2128],
17	EGFR	NN	ORGANIZATION	egfr	prep_by	15	SENT_277	[p16l7t2161r270b2239],
18	and	CC	O	and	_	0	SENT_277	[p16l295t2156r454b2234],
19	were	VBD	O	be	auxpass	20	SENT_277	[p16l486t2182r692b2235],
20	approved	VBN	O	approve	conj_and	9	SENT_277	[p16l728t2156r1131b2256],
21	by	IN	O	by	_	0	SENT_277	[p16l1168t2156r1267b2256],
22	the	DT	O	the	det	26	SENT_277	[p16l1299t2156r1431b2234],
23	Food	NNP	ORGANIZATION	Food	nn	26	SENT_277	[p16l1466t2156r1685b2234],
24	and	CC	ORGANIZATION	and	_	0	SENT_277	[p16l1720t2156r1879b2234],
25	Drug	NNP	ORGANIZATION	Drug	nn	26	SENT_277	[p16l1914t2162r2138b2256],
26	Administration	NNP	ORGANIZATION	Administration	agent	20	SENT_277	[p16l6t2283r665b2362],
27	(	CD	NUMBER	(	num	28	SENT_277	[p16l692t2290r934b2375],
28	FDA	NNP	ORGANIZATION	FDA	npadvmod	20	SENT_277	[p16l692t2290r934b2375],
29	)	CD	NUMBER	)	num	28	SENT_277	[p16l692t2290r934b2375],
30	in	IN	O	in	_	0	SENT_277	[p16l962t2284r1042b2361],
31	2004	CD	DATE	2004	prep_in	28	SENT_277	[p16l1065t2289r1273b2362],
32	for	IN	O	for	_	0	SENT_277	[p16l1295t2283r1418b2362],
33	refractory	JJ	O	refractory	amod	39	SENT_277	[p16l1438t2283r1850b2384],
34	locally	RB	O	locally	advmod	35	SENT_277	[p16l1867t2284r2140b2384],
35	advanced	JJ	O	advanced	amod	39	SENT_277	[p16l8t2411r400b2491],
36	or	CC	O	or	_	0	SENT_277	[p16l443t2437r532b2490],
37	metastatic	JJ	O	metastatic	amod	38	SENT_277	[p16l571t2412r1010b2490],
38	non	JJ	O	non	conj_or	35	SENT_277	[p16l1051t2411r1684b2490],
39	—	NN	O	—	prep_for	20	SENT_277	[p16l1051t2411r1684b2490],
40	small	JJ	O	small	amod	44	SENT_277	[p16l1051t2411r1684b2490],
41	—	NN	O	—	nn	44	SENT_277	[p16l1051t2411r1684b2490],
42	cell	NN	O	cell	nn	44	SENT_277	[p16l1051t2411r1684b2490],
43	lung	NN	O	lung	nn	44	SENT_277	[p16l1724t2411r1918b2512],
44	cancer	NN	O	cancer	dobj	9	SENT_277	[p16l1958t2437r2135b2490, p16l10t2566r156b2618],
45	.	.	O	.	_	0	SENT_277	[p16l1958t2437r2135b2490, p16l10t2566r156b2618],

1	Geﬁtinib	NNP	PERSON	Geﬁtinib	nsubj	2	SENT_278	[p16l194t2539r584b2618],
2	led	VBD	O	lead	_	0	SENT_278	[p16l616t2539r744b2618],
3	to	TO	O	to	_	0	SENT_278	[p16l776t2556r857b2618],
4	partial	JJ	O	partial	amod	5	SENT_278	[p16l888t2540r1170b2640],
5	responses	NNS	O	response	prep_to	2	SENT_278	[p16l1201t2565r1635b2640],
6	in	IN	O	in	_	0	SENT_278	[p16l1668t2540r1751b2617],
7	11	CD	NUMBER	11	number	9	SENT_278	[p16l1787t2545r1886b2617],
8	to	TO	O	to	dep	9	SENT_278	[p16l1918t2556r1998b2618],
9	19	CD	PERCENT	19	num	10	SENT_278	[p16l2035t2545r2134b2618],
10	percent	NN	PERCENT	percent	prep_in	5	SENT_278	[p16l7t2684r335b2768],
11	of	IN	O	of	_	0	SENT_278	[p16l354t2667r454b2746],
12	patients	NNS	O	patient	prep_of	10	SENT_278	[p16l458t2668r793b2768],
13	with	IN	O	with	_	0	SENT_278	[p16l815t2668r1005b2747],
14	refractory	JJ	O	refractory	amod	15	SENT_278	[p16l1028t2667r1439b2768],
15	disease	NN	O	disease	prep_with	12	SENT_278	[p16l1459t2667r1763b2746],
16	in	IN	O	in	_	0	SENT_278	[p16l1786t2668r1867b2745],
17	phase	NN	O	phase	prep_in	15	SENT_278	[p16l1889t2667r2136b2768],
18	2	CD	NUMBER	2	num	19	SENT_278	[p16l9t2802r56b2874],
19	trials	NNS	O	trial	dobj	2	SENT_278	[p16l83t2792r393b2892],
20	,55	CD	NUMBER	,55	nsubj	70	SENT_278	[p16l83t2792r393b2892],
21	whereas	IN	O	whereas	mark	23	SENT_278	[p16l418t2797r761b2876],
22	erlotinib	NN	O	erlotinib	nsubj	23	SENT_278	[p16l789t2797r1141b2875],
23	yielded	VBD	O	yield	dep	20	SENT_278	[p16l1163t2797r1459b2897],
24	partial	JJ	O	partial	amod	25	SENT_278	[p16l1483t2796r1750b2897],
25	responses	NNS	O	response	dobj	23	SENT_278	[p16l1774t2822r2135b2897, p16l10t2951r90b3003],
26	in	IN	O	in	_	0	SENT_278	[p16l132t2925r214b3002],
27	9	CD	PERCENT	9	num	28	SENT_278	[p16l255t2930r302b3003],
28	percent	NN	PERCENT	percent	prep_in	23	SENT_278	[p16l343t2941r664b3025],
29	of	IN	O	of	_	0	SENT_278	[p16l701t2924r802b3003],
30	similar	JJ	O	similar	amod	31	SENT_278	[p16l826t2925r1121b3003],
31	patients	NNS	O	patient	prep_of	28	SENT_278	[p16l1158t2925r1493b3025],
32	and	CC	O	and	_	0	SENT_278	[p16l1537t2924r1692b3003],
33	improved	VBN	O	improve	dep	20	SENT_278	[p16l1733t2925r2136b3025],
34	overall	JJ	O	overall	amod	39	SENT_278	[p16l10t3053r283b3132],
35	and	CC	O	and	_	0	SENT_278	[p16l302t3052r456b3131],
36	progression	NN	O	progression	conj_and	34	SENT_278	[p16l475t3052r1168b3153],
37	—	CD	NUMBER	—	num	39	SENT_278	[p16l475t3052r1168b3153],
38	free	JJ	O	free	amod	39	SENT_278	[p16l475t3052r1168b3153],
39	survival	NN	O	survival	dobj	33	SENT_278	[p16l1189t3052r1502b3132],
40	in	IN	O	in	_	0	SENT_278	[p16l1521t3053r1601b3130],
41	a	DT	O	a	det	44	SENT_278	[p16l1621t3079r1665b3131],
42	phase	NN	O	phase	nn	44	SENT_278	[p16l1682t3053r1925b3153],
43	3	CD	NUMBER	3	num	44	SENT_278	[p16l1946t3058r1990b3131],
44	trial	NN	O	trial	prep_in	33	SENT_278	[p16l2014t3053r2135b3131, p16l8t3173r186b3258],
45	.56	CD	NUMBER	.56	tmod	44	SENT_278	[p16l2014t3053r2135b3131, p16l8t3173r186b3258],
46	Disappointingly	RB	O	disappointingly	advmod	45	SENT_278	[p16l208t3180r892b3280],
47	,	,	O	,	_	0	SENT_278	[p16l208t3180r892b3280],
48	the	DT	O	the	det	49	SENT_278	[p16l921t3180r1049b3258],
49	addition	NN	O	addition	prep_in	33	SENT_278	[p16l1071t3180r1418b3258],
50	of	IN	O	of	_	0	SENT_278	[p16l1441t3179r1541b3258],
51	geﬁtinib	NN	O	geﬁtinib	prep_of	49	SENT_278	[p16l1544t3179r1893b3280],
52	or	CC	O	or	_	0	SENT_278	[p16l1918t3205r2006b3258],
53	erlotinib	NN	O	erlotinib	prep_in	33	SENT_278	[p16l2026t3206r2135b3258, p16l8t3308r289b3387],
54	to	TO	O	to	_	0	SENT_278	[p16l317t3325r397b3387],
55	chemotherapy	NN	O	chemotherapy	prep_to	53	SENT_278	[p16l426t3309r1045b3409],
56	in	IN	O	in	_	0	SENT_278	[p16l1065t3309r1148b3386],
57	the	DT	O	the	det	59	SENT_278	[p16l1174t3309r1306b3387],
58	initial	JJ	O	initial	amod	59	SENT_278	[p16l1331t3309r1581b3387],
59	treatment	NN	O	treatment	prep_in	33	SENT_278	[p16l1607t3325r2030b3387],
60	of	IN	O	of	_	0	SENT_278	[p16l2052t3308r2153b3387],
61	non	JJ	O	non	amod	67	SENT_278	[p16l9t3436r656b3515],
62	—	JJ	O	—	amod	67	SENT_278	[p16l9t3436r656b3515],
63	small	JJ	O	small	amod	67	SENT_278	[p16l9t3436r656b3515],
64	—	NN	O	—	nn	67	SENT_278	[p16l9t3436r656b3515],
65	cell	NN	O	cell	nn	67	SENT_278	[p16l9t3436r656b3515],
66	lung	NN	O	lung	nn	67	SENT_278	[p16l678t3437r876b3537],
67	cancer	NN	O	cancer	prep_of	59	SENT_278	[p16l897t3462r1178b3515],
68	did	VBD	O	do	aux	70	SENT_278	[p16l1200t3436r1335b3515],
69	not	RB	O	not	neg	70	SENT_278	[p16l1358t3453r1505b3515],
70	yield	VB	O	yield	rcmod	19	SENT_278	[p16l1519t3437r1723b3537],
71	any	DT	O	any	det	73	SENT_278	[p16l1746t3462r1896b3537],
72	additional	JJ	O	additional	amod	73	SENT_278	[p16l1915t3436r2134b3515, p16l10t3565r256b3643],
73	benefit	NN	O	benefit	iobj	70	SENT_278	[p16l284t3558r790b3643],
74	.95	CD	NUMBER	.95	number	75	SENT_278	[p16l284t3558r790b3643],
75	’96	CD	NUMBER	’96	dobj	70	SENT_278	[p16l284t3558r790b3643],

1	A	DT	O	a	det	3	SENT_279	[p16l135t3700r201b3770],
2	small	JJ	O	small	amod	3	SENT_279	[p16l241t3693r464b3771],
3	subgroup	NN	O	subgroup	_	0	SENT_279	[p16l507t3693r903b3793],
4	of	IN	O	of	_	0	SENT_279	[p16l946t3692r1046b3771],
5	patients	NNS	O	patient	prep_of	3	SENT_279	[p16l1067t3693r1395b3793],
6	with	IN	O	with	_	0	SENT_279	[p16l1434t3692r1620b3772],
7	non	JJ	O	non	amod	10	SENT_279	[p16l1662t3693r2136b3771],
8	—	JJ	O	—	amod	10	SENT_279	[p16l1662t3693r2136b3771],
9	small	JJ	O	small	amod	10	SENT_279	[p16l1662t3693r2136b3771],
10	—	NN	O	—	prep_with	3	SENT_279	[p16l1662t3693r2136b3771],

1	cell	NN	O	cell	nn	3	SENT_280	[p17l10t21r148b99],
2	lung	NN	O	lung	nn	3	SENT_280	[p17l179t21r370b121],
3	cancer	NN	O	cancer	nsubj	21	SENT_280	[p17l399t46r670b99],
4	who	WP	O	who	nsubj	6	SENT_280	[p17l693t20r875b100],
5	frequently	RB	O	frequently	advmod	6	SENT_280	[p17l908t20r1332b121],
6	had	VBD	O	have	rcmod	3	SENT_280	[p17l1358t21r1512b99],
7	adenocarcino	NN	O	adenocarcino	dobj	6	SENT_280	[p17l1543t20r2135b99],
8	—	CD	NUMBER	—	num	9	SENT_280	[p17l1543t20r2135b99],
9	mas	NNS	O	ma	nsubj	17	SENT_280	[p17l9t174r177b225],
10	and	CC	O	and	_	0	SENT_280	[p17l221t148r375b226],
11	most	JJS	O	most	conj_and	9	SENT_280	[p17l416t164r630b226],
12	of	IN	O	of	_	0	SENT_280	[p17l667t147r766b226],
13	whom	WP	O	whom	prep_of	9	SENT_280	[p17l785t148r1054b227],
14	were	VBD	O	be	cop	15	SENT_280	[p17l1091t174r1290b227],
15	Asian	JJ	MISC	asian	rcmod	7	SENT_280	[p17l1328t148r1586b242],
16	,	,	O	,	_	0	SENT_280	[p17l1328t148r1586b242],
17	female	JJ	O	female	rcmod	7	SENT_280	[p17l1633t147r1933b242],
18	,	,	O	,	_	0	SENT_280	[p17l1633t147r1933b242],
19	and	CC	O	and	_	0	SENT_280	[p17l1980t147r2134b226],
20	nonsmokers	NNS	O	nonsmoker	rcmod	7	SENT_280	[p17l8t276r528b355],
21	had	VBD	O	have	_	0	SENT_280	[p17l563t276r716b354],
22	dramatic	JJ	O	dramatic	amod	26	SENT_280	[p17l749t276r1115b354],
23	and	CC	O	and	cc	22	SENT_280	[p17l1147t276r1301b354],
24	sometimes	RB	O	sometimes	advmod	22	SENT_280	[p17l1335t276r1786b354],
25	durable	JJ	O	durable	amod	26	SENT_280	[p17l1821t275r2133b355],
26	responses	NNS	O	response	dobj	21	SENT_280	[p17l9t429r421b504],
27	to	TO	O	to	_	0	SENT_280	[p17l452t420r530b482],
28	geﬁtinib	JJ	O	geﬁtinib	amod	29	SENT_280	[p17l559t403r906b504],
29	monotherapy	NN	O	monotherapy	prep_to	21	SENT_280	[p17l935t404r1507b504],
30	.	.	O	.	_	0	SENT_280	[p17l935t404r1507b504],

1	Sequencing	NN	O	sequencing	nsubj	12	SENT_281	[p17l1543t404r2027b504],
2	of	IN	O	of	_	0	SENT_281	[p17l2053t403r2152b482],
3	the	DT	O	the	det	5	SENT_281	[p17l9t532r136b610],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_281	[p17l169t538r379b611],
5	gene	NN	O	gene	prep_of	1	SENT_281	[p17l407t557r603b632],
6	in	IN	O	in	_	0	SENT_281	[p17l637t532r718b609],
7	tumor	NN	O	tumor	nn	8	SENT_281	[p17l752t548r1012b611],
8	tissue	NN	O	tissue	prep_in	5	SENT_281	[p17l1044t532r1280b611],
9	from	IN	O	from	_	0	SENT_281	[p17l1315t531r1520b610],
10	these	DT	O	these	det	11	SENT_281	[p17l1555t532r1769b610],
11	patients	NNS	O	patient	prep_from	8	SENT_281	[p17l1803t532r2131b632],
12	revealed	VBD	O	reveal	_	0	SENT_281	[p17l9t659r345b739],
13	somatic	JJ	O	somatic	amod	15	SENT_281	[p17l381t660r706b738],
14	gain	NN	O	gain	nn	15	SENT_281	[p17l738t659r1427b760],
15	—	NN	O	—	nsubj	20	SENT_281	[p17l738t659r1427b760],
16	of	IN	O	of	_	0	SENT_281	[p17l738t659r1427b760],
17	—	CD	NUMBER	—	num	19	SENT_281	[p17l738t659r1427b760],
18	function	NN	O	function	nn	19	SENT_281	[p17l738t659r1427b760],
19	mutations	NNS	O	mutation	prep_of	15	SENT_281	[p17l1463t660r1894b739],
20	clus	VBP	O	clus	ccomp	12	SENT_281	[p17l1933t660r2131b739],
21	—	RB	O	—	advmod	20	SENT_281	[p17l1933t660r2131b739],
22	tered	VBN	O	ter	dep	20	SENT_281	[p17l9t788r220b866],
23	around	IN	O	around	_	0	SENT_281	[p17l244t788r547b867],
24	the	DT	O	the	det	28	SENT_281	[p17l573t788r702b866],
25	ATP	NN	O	atp	nn	28	SENT_281	[p17l724t788r1270b888],
26	—	NN	O	—	nn	28	SENT_281	[p17l724t788r1270b888],
27	binding	NN	O	binding	nn	28	SENT_281	[p17l724t788r1270b888],
28	pocket	NN	O	pocket	prep_around	22	SENT_281	[p17l1290t788r1578b888],
29	of	IN	O	of	_	0	SENT_281	[p17l1599t787r1699b866],
30	the	DT	O	the	det	32	SENT_281	[p17l1707t788r1836b866],
31	kinase	NN	O	kinase	nn	32	SENT_281	[p17l1862t787r2133b867],
32	domain	NN	O	domain	prep_of	28	SENT_281	[p17l9t915r333b993],
33	of	IN	O	of	_	0	SENT_281	[p17l375t914r475b993],
34	the	DT	O	the	det	36	SENT_281	[p17l498t915r627b993],
35	EGFR	NN	ORGANIZATION	egfr	nn	36	SENT_281	[p17l667t921r926b998],
36	protein	NN	O	protein	prep_of	32	SENT_281	[p17l955t916r1261b1015],
37	in	IN	O	in	_	0	SENT_281	[p17l1302t916r1383b992],
38	most	JJS	O	most	amod	39	SENT_281	[p17l1424t931r1640b993],
39	cases	NNS	O	case	prep_in	36	SENT_281	[p17l1676t908r2133b993],
40	.6754	CD	NUMBER	.6754	dep	22	SENT_281	[p17l1676t908r2133b993],
41	Unlike	IN	O	unlike	dep	40	SENT_281	[p17l8t1043r285b1122],
42	c	NN	O	c	pobj	41	SENT_281	[p17l310t1048r543b1123],
43	.	.	O	.	_	0	SENT_281	[p17l310t1048r543b1123],

1	—	NN	O	—	_	0	SENT_282	[p17l310t1048r543b1123],
2	.	.	O	.	_	0	SENT_282	[p17l310t1048r543b1123],

1	KIT	NN	O	kit	nn	2	SENT_283	[p17l310t1048r543b1123],
2	mutations	NNS	O	mutation	nsubj	40	SENT_283	[p17l564t1043r988b1122],
3	in	IN	O	in	_	0	SENT_283	[p17l1013t1043r1093b1119],
4	GIST	NNP	O	GIST	prep_in	2	SENT_283	[p17l1118t1048r1346b1137],
5	,	,	O	,	_	0	SENT_283	[p17l1118t1048r1346b1137],
6	these	DT	O	these	det	8	SENT_283	[p17l1377t1043r1591b1120],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_283	[p17l1614t1048r1871b1126],
8	mutations	NNS	O	mutation	appos	4	SENT_283	[p17l1885t1059r2132b1121, p17l9t1170r212b1248],
9	do	VBP	O	do	aux	11	SENT_283	[p17l261t1170r363b1248],
10	not	RB	O	not	neg	11	SENT_283	[p17l410t1186r552b1248],
11	cause	VB	O	cause	_	0	SENT_283	[p17l594t1196r820b1249],
12	constitutive	JJ	O	constitutive	amod	13	SENT_283	[p17l867t1170r1344b1248],
13	activation	NN	O	activation	dobj	11	SENT_283	[p17l1390t1170r1813b1264],
14	;	:	O	;	_	0	SENT_283	[p17l1390t1170r1813b1264],
15	rather	RB	O	rather	advmod	18	SENT_283	[p17l1863t1169r2128b1264],
16	,	,	O	,	_	0	SENT_283	[p17l1863t1169r2128b1264],
17	they	PRP	O	they	nsubj	18	SENT_283	[p17l9t1298r183b1398],
18	enhance	VBP	O	enhance	dep	13	SENT_283	[p17l211t1298r556b1376],
19	the	DT	O	the	det	20	SENT_283	[p17l588t1298r715b1376],
20	responsiveness	NN	O	responsiveness	dobj	18	SENT_283	[p17l747t1298r1373b1398],
21	of	IN	O	of	_	0	SENT_283	[p17l1408t1297r1507b1376],
22	the	DT	O	the	det	23	SENT_283	[p17l1521t1298r1648b1376],
23	receptor	NN	O	receptor	prep_of	20	SENT_283	[p17l1680t1314r2026b1398],
24	to	TO	O	to	_	0	SENT_283	[p17l2054t1314r2132b1376],
25	EGF	NN	ORGANIZATION	egf	nn	26	SENT_283	[p17l7t1431r187b1504],
26	ligand	NN	O	ligand	prep_to	18	SENT_283	[p17l216t1425r477b1526],
27	and	CC	O	and	_	0	SENT_283	[p17l505t1426r659b1504],
28	increase	VB	O	increase	conj_and	11	SENT_283	[p17l685t1426r1025b1504],
29	its	PRP$	O	its	poss	30	SENT_283	[p17l1053t1426r1147b1504],
30	sensitivity	NN	O	sensitivity	dobj	28	SENT_283	[p17l1179t1426r1590b1526],
31	to	TO	O	to	_	0	SENT_283	[p17l1614t1442r1692b1504],
32	inhibition	NN	O	inhibition	prep_to	28	SENT_283	[p17l1721t1425r2134b1504],
33	by	IN	O	by	_	0	SENT_283	[p17l9t1553r105b1653],
34	gefitinib6	NN	O	gefitinib6	nn	35	SENT_283	[p17l136t1546r586b1653],
35	’	NN	O	’	prep_by	28	SENT_283	[p17l136t1546r586b1653],
36	7	CD	NUMBER	7	num	35	SENT_283	[p17l136t1546r586b1653],
37	and	CC	O	and	_	0	SENT_283	[p17l622t1553r776b1631],
38	may	MD	O	may	aux	40	SENT_283	[p17l812t1579r986b1653],
39	preferentially	RB	O	preferentially	advmod	40	SENT_283	[p17l1017t1552r1569b1653],
40	activate	VB	O	activate	conj_and	11	SENT_283	[p17l1600t1554r1907b1632],
41	anti	JJ	O	anti	amod	45	SENT_283	[p17l1943t1554r2132b1631],
42	—	NN	O	—	nn	45	SENT_283	[p17l1943t1554r2132b1631],
43	apoptotic	JJ	O	apoptotic	amod	45	SENT_283	[p17l8t1681r401b1780],
44	signaling	NN	O	signaling	nn	45	SENT_283	[p17l425t1681r812b1780],
45	pathways	NNS	O	pathway	dobj	40	SENT_283	[p17l831t1681r1217b1780],
46	in	IN	O	in	_	0	SENT_283	[p17l1242t1681r1323b1757],
47	the	DT	O	the	det	49	SENT_283	[p17l1346t1680r1474b1758],
48	tumor	NN	O	tumor	nn	49	SENT_283	[p17l1498t1697r1756b1759],
49	cells	NNS	O	cell	prep_in	45	SENT_283	[p17l1778t1676r2025b1758],
50	.8	CD	NUMBER	.8	dobj	11	SENT_283	[p17l1778t1676r2025b1758],

1	Paradoxically	RB	O	paradoxically	advmod	25	SENT_284	[p17l136t1809r709b1909],
2	,	,	O	,	_	0	SENT_284	[p17l136t1809r709b1909],
3	in	IN	O	in	_	0	SENT_284	[p17l740t1809r821b1886],
4	the	DT	O	the	det	7	SENT_284	[p17l848t1809r977b1887],
5	Canadian	JJ	MISC	canadian	amod	7	SENT_284	[p17l1004t1808r1403b1887],
6	randomized	JJ	O	randomized	amod	7	SENT_284	[p17l1429t1808r1940b1887],
7	trial	NN	O	trial	prep_in	25	SENT_284	[p17l1966t1809r2133b1887],
8	of	IN	O	of	_	0	SENT_284	[p17l9t1936r110b2015],
9	erlotinib	NN	O	erlotinib	prep_of	7	SENT_284	[p17l122t1937r488b2015],
10	in	IN	O	in	_	0	SENT_284	[p17l520t1937r601b2014],
11	non	JJ	O	non	amod	17	SENT_284	[p17l631t1936r1262b2015],
12	—	JJ	O	—	amod	17	SENT_284	[p17l631t1936r1262b2015],
13	small	JJ	O	small	amod	17	SENT_284	[p17l631t1936r1262b2015],
14	—	NN	O	—	nn	17	SENT_284	[p17l631t1936r1262b2015],
15	cell	NN	O	cell	nn	17	SENT_284	[p17l631t1936r1262b2015],
16	lung	NN	O	lung	nn	17	SENT_284	[p17l1290t1937r1484b2037],
17	cancer	NN	O	cancer	prep_in	9	SENT_284	[p17l1512t1962r1803b2032],
18	,	,	O	,	_	0	SENT_284	[p17l1512t1962r1803b2032],
19	tumorcell	NN	O	tumorcell	nn	20	SENT_284	[p17l1838t1953r2131b2016, p17l9t2064r154b2143],
20	expression	NN	O	expression	nsubj	25	SENT_284	[p17l193t2065r656b2165],
21	of	IN	O	of	_	0	SENT_284	[p17l696t2064r798b2143],
22	EGFR	NN	ORGANIZATION	egfr	prep_of	20	SENT_284	[p17l817t2070r1079b2148],
23	was	VBD	O	be	cop	25	SENT_284	[p17l1103t2091r1266b2144],
24	signiﬁcantly	RB	O	signiﬁcantly	advmod	25	SENT_284	[p17l1308t2064r1843b2165],
25	corre17s	NNS	O	corre17	_	0	SENT_284	[p17l1877t2090r2130b2143, p17l149t2240r204b2261],

1	N	NN	O	n	nn	3	SENT_285	[p17l918t2242r932b2257],
2	ENGLJ	NN	O	englj	nn	3	SENT_285	[p17l947t2241r1031b2263],
3	MED	NN	O	med	_	0	SENT_285	[p17l1046t2242r1099b2257],
4	3	CD	NUMBER	3	dep	3	SENT_285	[p17l1111t2241r1122b2263],
5	;	:	O	;	_	0	SENT_285	[p17l1155t2242r1158b2261],
6	WWW	NNP	O	WWW	dep	3	SENT_285	[p17l1210t2242r1322b2257],
7	.	.	O	.	_	0	SENT_285	[p17l1210t2242r1322b2257],

1	NE	NN	O	ne	nn	3	SENT_286	[p17l1210t2242r1322b2257],
2	M.ORG	NN	O	m.org	nn	3	SENT_286	[p17l1338t2241r1421b2257],
3	JULY	NN	DATE	july	_	0	SENT_286	[p17l1455t2242r1515b2263],
4	14	CD	DATE	14	dep	3	SENT_286	[p17l1527t2241r1562b2263],
5	,	,	DATE	,	_	0	SENT_286	[p17l1527t2241r1562b2263],
6	2005	CD	DATE	2005	appos	4	SENT_286	[p17l1575t2241r1638b2263],

1	The	DT	O	the	det	4	SENT_287	[p17l935t2274r986b2298],
2	New	NNP	O	New	nn	4	SENT_287	[p17l995t2275r1057b2298],
3	Engl	NNP	O	Engl	nn	4	SENT_287	[p17l1066t2274r1129b2305],
4	Journal	NNP	O	Journal	_	0	SENT_287	[p17l1186t2274r1283b2298],
5	edicine	NN	O	edicine	dep	4	SENT_287	[p17l1359t2274r1454b2298],

1	Downloaded	VBN	O	download	_	0	SENT_288	[p17l377t2315r547b2338],
2	from	IN	O	from	_	0	SENT_288	[p17l556t2315r620b2338],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_288	[p17l629t2315r747b2345],
4	at	IN	O	at	_	0	SENT_288	[p17l758t2319r781b2338],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_288	[p17l789t2315r972b2338],
6	on	IN	O	on	_	0	SENT_288	[p17l981t2322r1014b2338],
7	January	NNP	DATE	January	prep_on	1	SENT_288	[p17l1022t2315r1125b2345],
8	5	CD	DATE	5	num	7	SENT_288	[p17l1135t2315r1158b2342],
9	,	,	DATE	,	_	0	SENT_288	[p17l1135t2315r1158b2342],
10	2014	CD	DATE	2014	num	7	SENT_288	[p17l1169t2315r1241b2338],
11	.	.	O	.	_	0	SENT_288	[p17l1169t2315r1241b2338],

1	For	IN	O	for	_	0	SENT_289	[p17l1251t2315r1298b2338],
2	personal	JJ	O	personal	amod	3	SENT_289	[p17l1306t2315r1418b2345],
3	use	NN	O	use	pobj	1	SENT_289	[p17l1427t2322r1471b2338],
4	only	RB	O	only	advmod	3	SENT_289	[p17l1481t2315r1545b2345],
5	.	.	O	.	_	0	SENT_289	[p17l1481t2315r1545b2345],

1	No	DT	O	no	det	3	SENT_290	[p17l1556t2315r1596b2338],
2	other	JJ	O	other	amod	3	SENT_290	[p17l1606t2315r1674b2338],
3	uses	NNS	O	use	_	0	SENT_290	[p17l1682t2322r1738b2338],
4	without	IN	O	without	_	0	SENT_290	[p17l1748t2315r1849b2338],
5	permission	NN	O	permission	prep_without	3	SENT_290	[p17l1858t2315r2010b2345],
6	.	.	O	.	_	0	SENT_290	[p17l1858t2315r2010b2345],

1	Copyri	NNP	O	Copyri	nn	5	SENT_291	[p17l727t2356r818b2387],
2	©	CD	NUMBER	©	num	5	SENT_291	[p17l871t2356r895b2380],
3	2005	CD	DATE	2005	num	5	SENT_291	[p17l905t2356r969b2380],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_291	[p17l979t2356r1170b2380],
5	Medical	NNP	ORGANIZATION	Medical	_	0	SENT_291	[p17l1180t2356r1288b2380],
6	Society	NNP	ORGANIZATION	Society	dep	5	SENT_291	[p17l1299t2356r1404b2387],
7	.	.	O	.	_	0	SENT_291	[p17l1299t2356r1404b2387],

1	All	DT	O	all	det	2	SENT_292	[p17l1415t2356r1456b2380],
2	rights	NNS	O	rights	nsubj	3	SENT_292	[p17l1465t2356r1540b2387],
3	reserved	VBN	O	reserve	_	0	SENT_292	[p17l1550t2356r1669b2380],
4	.	.	O	.	_	0	SENT_292	[p17l1550t2356r1669b2380],

1	MECH	NN	O	mech	nn	2	SENT_293	[p17l717t2400r813b2419],
2	SMS	NNS	O	sm	_	0	SENT_293	[p17l885t2400r946b2419],
3	OF	IN	O	of	_	0	SENT_293	[p17l960t2400r1001b2419],
4	DISEASE	NN	O	disease	prep_of	2	SENT_293	[p17l1016t2400r1152b2419],

1	Table	NNP	O	Table	_	0	SENT_294	[p17l119t2527r190b2552],
2	1	CD	NUMBER	1	dep	1	SENT_294	[p17l200t2529r222b2552],
3	.	.	O	.	_	0	SENT_294	[p17l200t2529r222b2552],

1	(	RB	O	(	advmod	2	SENT_295	[p17l233t2527r401b2560],
2	Continued	VBN	O	continue	_	0	SENT_295	[p17l233t2527r401b2560],
3	.	.	O	.	_	0	SENT_295	[p17l233t2527r401b2560],
4	)	SYM	O	)	dep	2	SENT_295	[p17l233t2527r401b2560],

1	Activating	VBG	O	activate	_	0	SENT_296	[p17l600t2599r738b2631],

1	Tyrosine	NN	O	tyrosine	nn	4	SENT_297	[p17l119t2636r234b2669],
2	Kinase'i	NN	O	kinase'us	nn	4	SENT_297	[p17l244t2636r351b2669],
3	'	''	O	'	_	0	SENT_297	[p17l244t2636r351b2669],
4	Mechanisms	NNS	O	mechanism	nsubj	5	SENT_297	[p17l583t2636r756b2661],
5	Targeted	VBN	O	target	_	0	SENT_297	[p17l1317t2636r1433b2669],
6	Therapy	NN	O	therapy	dobj	5	SENT_297	[p17l1442t2636r1571b2669],
7	:	:	O	:	_	0	SENT_297	[p17l1442t2636r1571b2669],
8	§	CD	NUMBER	§	dep	6	SENT_297	[p17l1442t2636r1571b2669],
9	:	:	O	:	_	0	SENT_297	[p17l1442t2636r1571b2669],
10	References	NNS	O	reference	dep	8	SENT_297	[p17l1753t2635r1900b2661],

1	PDGFRB	NN	O	pdgfrb	nn	3	SENT_298	[p17l122t2704r243b2734],
2	(	CD	NUMBER	(	num	3	SENT_298	[p17l254t2704r337b2736],
3	5q33	NN	O	5q33	_	0	SENT_298	[p17l254t2704r337b2736],
4	)	CD	NUMBER	)	num	5	SENT_298	[p17l254t2704r337b2736],
5	TEL-PDGFR	NN	O	tel-pdgfr	dep	3	SENT_298	[p17l169t2759r352b2789],
6	[	CD	NUMBER	[	number	7	SENT_298	[p17l169t2759r352b2789],
7	3	CD	NUMBER	3	num	8	SENT_298	[p17l169t2759r352b2789],
8	t	NN	O	t	dep	5	SENT_298	[p17l623t2759r711b2790],
9	(	CD	NUMBER	(	number	10	SENT_298	[p17l623t2759r711b2790],
10	5	CD	NUMBER	5	dep	3	SENT_298	[p17l623t2759r711b2790],
11	;	:	O	;	_	0	SENT_298	[p17l623t2759r711b2790],
12	12	CD	NUMBER	12	number	13	SENT_298	[p17l623t2759r711b2790],
13	)	CD	NUMBER	)	dep	10	SENT_298	[p17l623t2759r711b2790],
14	CMML	NN	O	cmml	dep	13	SENT_298	[p17l882t2759r976b2783],
15	Imatinib	NNP	O	Imatinib	nn	16	SENT_298	[p17l1320t2757r1432b2783],
16	Golub	NNP	PERSON	Golub	dep	3	SENT_298	[p17l1614t2757r1696b2783],
17	et	FW	O	et	nn	19	SENT_298	[p17l1706t2762r1731b2783],
18	a	FW	O	a	nn	19	SENT_298	[p17l1740t2757r1933b2790],
19	|	NN	O	|	dep	16	SENT_298	[p17l1740t2757r1933b2790],
20	.	.	O	.	_	0	SENT_298	[p17l1740t2757r1933b2790],

1	,31	CD	NUMBER	,31	num	3	SENT_299	[p17l1740t2757r1933b2790],
2	Apper	NN	O	apper	nn	3	SENT_299	[p17l1740t2757r1933b2790],
3	|	NN	O	|	dep	11	SENT_299	[p17l1740t2757r1933b2790],
4	ey	NN	O	ey	dep	3	SENT_299	[p17l1740t2757r1933b2790],
5	et	FW	O	et	nn	4	SENT_299	[p17l1942t2762r1966b2783],
6	al.	FW	O	al.	nn	4	SENT_299	[p17l1976t2757r2032b2783],
7	“	FW	O	“	dep	4	SENT_299	[p17l1976t2757r2032b2783],
8	HIP1-PDGFR	NN	O	hip1-pdgfr	dep	11	SENT_299	[p17l172t2814r371b2844],
9	[	CD	NUMBER	[	num	8	SENT_299	[p17l172t2814r371b2844],
10	3	CD	NUMBER	3	num	11	SENT_299	[p17l172t2814r371b2844],
11	t	NN	O	t	dep	60	SENT_299	[p17l631t2814r703b2845],
12	(	CD	NUMBER	(	num	13	SENT_299	[p17l631t2814r703b2845],
13	5	CD	NUMBER	5	dep	11	SENT_299	[p17l631t2814r703b2845],
14	;	:	O	;	_	0	SENT_299	[p17l631t2814r703b2845],
15	7	CD	NUMBER	7	number	16	SENT_299	[p17l631t2814r703b2845],
16	)	CD	NUMBER	)	dep	13	SENT_299	[p17l631t2814r703b2845],
17	CMML	NN	O	cmml	nn	19	SENT_299	[p17l882t2814r976b2838],
18	|	NN	O	|	nn	19	SENT_299	[p17l1320t2812r1445b2845],
19	matinib	NN	O	matinib	dep	33	SENT_299	[p17l1320t2812r1445b2845],
20	\	CD	NUMBER	\	number	21	SENT_299	[p17l1320t2812r1445b2845],
21	§	CD	NUMBER	§	num	23	SENT_299	[p17l1320t2812r1445b2845],
22	Rabaptin5-PDGFRB	NN	O	rabaptin5-pdgfrb	nn	23	SENT_299	[p17l172t2867r440b2900],
23	t	NN	O	t	dep	19	SENT_299	[p17l623t2869r711b2900],
24	(	CD	NUMBER	(	number	25	SENT_299	[p17l623t2869r711b2900],
25	5	CD	NUMBER	5	num	23	SENT_299	[p17l623t2869r711b2900],
26	;	:	O	;	_	0	SENT_299	[p17l623t2869r711b2900],
27	17	CD	NUMBER	17	number	28	SENT_299	[p17l623t2869r711b2900],
28	)	CD	NUMBER	)	dep	23	SENT_299	[p17l623t2869r711b2900],
29	CMML	NN	O	cmml	nn	31	SENT_299	[p17l882t2869r976b2893],
30	Imatinib	NNP	O	Imatinib	nn	31	SENT_299	[p17l1320t2867r1432b2893],
31	Magnusson	NNP	PERSON	Magnusson	dep	33	SENT_299	[p17l1616t2870r1774b2901],
32	et	FW	O	et	nn	33	SENT_299	[p17l1785t2872r1810b2893],
33	aI	FW	O	ai	dep	13	SENT_299	[p17l1820t2867r1875b2893],
34	.33	CD	NUMBER	.33	num	35	SENT_299	[p17l1820t2867r1875b2893],
35	H4-PDGFR	NN	O	h4-pdgfr	dep	33	SENT_299	[p17l173t2924r342b2954],
36	[	CD	NUMBER	[	number	37	SENT_299	[p17l173t2924r342b2954],
37	3	CD	NUMBER	3	num	38	SENT_299	[p17l173t2924r342b2954],
38	t	NN	O	t	dep	35	SENT_299	[p17l623t2924r711b2955],
39	(	CD	NUMBER	(	num	40	SENT_299	[p17l623t2924r711b2955],
40	5	CD	NUMBER	5	dep	13	SENT_299	[p17l623t2924r711b2955],
41	;	:	O	;	_	0	SENT_299	[p17l623t2924r711b2955],
42	10	CD	NUMBER	10	number	43	SENT_299	[p17l623t2924r711b2955],
43	)	CD	NUMBER	)	dep	13	SENT_299	[p17l623t2924r711b2955],
44	aCML	NN	O	acml	nn	46	SENT_299	[p17l883t2924r963b2948],
45	|	NN	O	|	nn	46	SENT_299	[p17l1320t2922r1445b2955],
46	matinib	NN	O	matinib	dep	43	SENT_299	[p17l1320t2922r1445b2955],
47	\	CD	NUMBER	\	number	48	SENT_299	[p17l1320t2922r1445b2955],
48	§	CD	NUMBER	§	num	50	SENT_299	[p17l1320t2922r1445b2955],
49	CEV14-PDGFR/3	NN	O	cev14-pdgfr/3	nn	50	SENT_299	[p17l171t2979r391b3009],
50	t	NN	O	t	dep	43	SENT_299	[p17l623t2980r711b3010],
51	(	CD	NUMBER	(	number	52	SENT_299	[p17l623t2980r711b3010],
52	5	CD	NUMBER	5	num	50	SENT_299	[p17l623t2980r711b3010],
53	;	:	O	;	_	0	SENT_299	[p17l623t2980r711b3010],
54	14	CD	NUMBER	14	number	55	SENT_299	[p17l623t2980r711b3010],
55	)	CD	NUMBER	)	dep	13	SENT_299	[p17l623t2980r711b3010],
56	AML	NN	ORGANIZATION	aml	dep	55	SENT_299	[p17l881t2979r947b3002],
57	|	NN	O	|	nn	60	SENT_299	[p17l1320t2977r1445b3010],
58	matinib	NN	O	matinib	nn	60	SENT_299	[p17l1320t2977r1445b3010],
59	\	NN	O	\	nn	60	SENT_299	[p17l1320t2977r1445b3010],
60	j	NN	O	j	_	0	SENT_299	[p17l1320t2977r1445b3010],

1	JAKZ	NN	O	jakz	nn	3	SENT_300	[p17l116t3035r184b3065],
2	(	CD	NUMBER	(	num	3	SENT_300	[p17l195t3035r279b3066],
3	9p24	NN	O	9p24	_	0	SENT_300	[p17l195t3035r279b3066],
4	)	CD	NUMBER	)	num	7	SENT_300	[p17l195t3035r279b3066],
5	V617F	NN	O	v617f	nn	7	SENT_300	[p17l626t3035r711b3058],
6	Poly	NN	O	poly	nn	7	SENT_300	[p17l884t3033r938b3065],
7	emia	NN	O	emium	dep	3	SENT_300	[p17l994t3035r1058b3058],
8	,	,	O	,	_	0	SENT_300	[p17l1125t3054r1129b3062],
9	essential	JJ	O	essential	amod	14	SENT_300	[p17l1140t3033r1255b3058],
10	James	NNP	PERSON	James	nn	14	SENT_300	[p17l1609t3035r1695b3065],
11	et	NNP	O	et	nn	14	SENT_300	[p17l1706t3037r1730b3058],
12	aI.	NNP	O	aI.	nn	14	SENT_300	[p17l1740t3033r1804b3062],
13	,34	CD	NUMBER	,34	num	14	SENT_300	[p17l1740t3033r1804b3062],
14	Kralovics	NNP	O	Kralovics	appos	7	SENT_300	[p17l1816t3032r1936b3058],
15	et	FW	O	et	nn	16	SENT_300	[p17l1946t3037r1971b3058],
16	aI	FW	O	ai	dep	14	SENT_300	[p17l1981t3032r2035b3058],
17	.35	CD	NUMBER	.35	dep	3	SENT_300	[p17l1981t3032r2035b3058],

1	mboc	NN	O	mboc	nn	3	SENT_301	[p17l989t3070r1064b3095],
2	mia	NN	O	mium	nn	3	SENT_301	[p17l1123t3072r1170b3095],
3	openia	NN	O	openia	_	0	SENT_301	[p17l1176t3072r1273b3103],
4	,	,	O	,	_	0	SENT_301	[p17l1176t3072r1273b3103],
5	idiopathic	JJ	O	idiopathic	amod	6	SENT_301	[p17l933t3108r1065b3140],
6	myeloﬁbrosis	NN	O	myeloﬁbrosis	appos	3	SENT_301	[p17l1075t3107r1252b3141],

1	TEL-JAKZ	NN	O	tel-jakz	_	0	SENT_302	[p17l169t3164r295b3195],
2	t	NN	O	t	dep	13	SENT_302	[p17l623t3165r711b3196],
3	(	CD	NUMBER	(	number	4	SENT_302	[p17l623t3165r711b3196],
4	9	CD	NUMBER	9	dep	2	SENT_302	[p17l623t3165r711b3196],
5	;	:	O	;	_	0	SENT_302	[p17l623t3165r711b3196],
6	12	CD	NUMBER	12	number	7	SENT_302	[p17l623t3165r711b3196],
7	)	CD	NUMBER	)	num	8	SENT_302	[p17l623t3165r711b3196],
8	AML	NN	ORGANIZATION	aml	dep	4	SENT_302	[p17l881t3164r953b3192],
9	,	,	O	,	_	0	SENT_302	[p17l881t3164r953b3192],
10	ALL	NN	O	all	appos	8	SENT_302	[p17l963t3164r1016b3187],
11	Lacronique	NN	O	lacronique	dep	13	SENT_302	[p17l1616t3165r1765b3195],
12	et	FW	O	et	nn	13	SENT_302	[p17l1775t3167r1799b3188],
13	aI	FW	O	ai	dep	1	SENT_302	[p17l1809t3162r1865b3188],
14	.35	CD	NUMBER	.35	num	16	SENT_302	[p17l1809t3162r1865b3188],
15	BCR-JAK2	NN	O	bcr-jak2	nn	16	SENT_302	[p17l173t3219r302b3250],
16	t	NN	O	t	dep	13	SENT_302	[p17l623t3220r711b3251],
17	(	CD	NUMBER	(	number	18	SENT_302	[p17l623t3220r711b3251],
18	9	CD	NUMBER	9	dep	16	SENT_302	[p17l623t3220r711b3251],
19	;	:	O	;	_	0	SENT_302	[p17l623t3220r711b3251],
20	22	CD	NUMBER	22	number	21	SENT_302	[p17l623t3220r711b3251],
21	)	CD	NUMBER	)	dep	1	SENT_302	[p17l623t3220r711b3251],
22	aCML	NN	O	acml	dep	21	SENT_302	[p17l883t3219r963b3243],

1	c-KIT	NN	O	c-kit	nsubj	15	SENT_303	[p17l120t3275r190b3298],
2	(	CD	NUMBER	(	num	3	SENT_303	[p17l200t3275r283b3306],
3	4q11	NN	O	4q11	dep	1	SENT_303	[p17l200t3275r283b3306],
4	)	CD	NUMBER	)	num	5	SENT_303	[p17l200t3275r283b3306],
5	D419X	NN	O	d419x	dep	3	SENT_303	[p17l495t3275r591b3302],
6	;	:	O	;	_	0	SENT_303	[p17l495t3275r591b3302],
7	V560X	NN	O	v560x	dep	3	SENT_303	[p17l601t3274r696b3302],
8	;	:	O	;	_	0	SENT_303	[p17l601t3274r696b3302],
9	D816X	NN	O	d816x	dep	7	SENT_303	[p17l709t3274r805b3302],
10	;	:	O	;	_	0	SENT_303	[p17l709t3274r805b3302],
11	AML	NN	ORGANIZATION	aml	dep	3	SENT_303	[p17l881t3274r953b3302],
12	,	,	O	,	_	0	SENT_303	[p17l881t3274r953b3302],
13	SM	NNP	O	SM	nn	14	SENT_303	[p17l965t3274r1006b3298],
14	Imatinib	NNP	O	Imatinib	appos	11	SENT_303	[p17l1320t3272r1432b3298],
15	(	VBD	O	(	_	0	SENT_303	[p17l1445t3275r1499b3306],
16	not	RB	O	not	neg	15	SENT_303	[p17l1445t3275r1499b3306],
17	for	IN	O	for	_	0	SENT_303	[p17l1508t3272r1545b3298],
18	Gari	NNP	PERSON	Gari	prep_for	15	SENT_303	[p17l1614t3274r1669b3298],
19	et	FW	O	et	nn	20	SENT_303	[p17l1680t3277r1705b3298],
20	aI.	FW	O	ai.	dep	18	SENT_303	[p17l1714t3272r1778b3302],
21	,37	CD	NUMBER	,37	num	22	SENT_303	[p17l1714t3272r1778b3302],
22	Furitsu	NNP	O	Furitsu	dep	18	SENT_303	[p17l1791t3275r1881b3298],
23	et	FW	O	et	nn	24	SENT_303	[p17l1893t3277r1917b3298],
24	aI.	FW	O	ai.	dep	22	SENT_303	[p17l1927t3272r1991b3302],
25	,	,	O	,	_	0	SENT_303	[p17l1927t3272r1991b3302],
26	”	IN	O	”	amod	18	SENT_303	[p17l1927t3272r1991b3302],

1	overexpression	NN	O	overexpression	nn	2	SENT_304	[p17l543t3312r747b3343],
2	D8	NN	O	d8	_	0	SENT_304	[p17l1370t3312r1405b3335],
3	,	,	O	,	_	0	SENT_304	[p17l1473t3331r1478b3340],
4	Zermati	NNP	O	Zermati	appos	2	SENT_304	[p17l1664t3312r1770b3335],
5	et	FW	O	et	tmod	4	SENT_304	[p17l1781t3315r1805b3335],
6	all	DT	O	all	advmod	5	SENT_304	[p17l1815t3310r1870b3335],
7	.	.	O	.	_	0	SENT_304	[p17l1815t3310r1870b3335],

1	”	NN	O	”	_	0	SENT_305	[p17l1815t3310r1870b3335],

1	SU	NNP	O	SU	_	0	SENT_306	[p17l1368t3350r1405b3373],
2	,	,	O	,	_	0	SENT_306	[p17l1476t3369r1480b3377],
3	PKC4l2	NN	O	pkc4l2	appos	1	SENT_306	[p17l1370t3387r1473b3410],

1	SYK	NN	O	syk	_	0	SENT_307	[p17l120t3442r174b3465],
2	(	CD	NUMBER	(	num	3	SENT_307	[p17l185t3442r268b3473],
3	9q22	NN	O	9q22	dep	1	SENT_307	[p17l185t3442r268b3473],
4	)	CD	NUMBER	)	num	5	SENT_307	[p17l185t3442r268b3473],
5	TEL-SYK	NN	O	tel-syk	dep	3	SENT_307	[p17l169t3497r286b3520],
6	;	:	O	;	_	0	SENT_307	[p17l663t3504r668b3525],
7	Kuno	NNP	PERSON	Kuno	dep	3	SENT_307	[p17l1616t3497r1684b3520],
8	et	FW	O	et	nn	12	SENT_307	[p17l1694t3500r1719b3520],
9	a	FW	O	a	nn	12	SENT_307	[p17l1729t3494r1785b3520],
10	|	FW	O	|	nn	12	SENT_307	[p17l1729t3494r1785b3520],
11	.4	FW	NUMBER	.4	nn	12	SENT_307	[p17l1729t3494r1785b3520],
12	°	FW	O	°	dep	7	SENT_307	[p17l1729t3494r1785b3520],

1	*	NN	O	*	nsubj	2	SENT_308	[p18l93t22r108b36],
2	denotes	VBZ	O	denote	_	0	SENT_308	[p18l191t19r298b44],
3	chronic	JJ	O	chronic	amod	5	SENT_308	[p18l308t19r410b44],
4	myeloid	JJ	O	myeloid	amod	5	SENT_308	[p18l419t19r524b52],
5	leukemia	NN	O	leukemia	dobj	2	SENT_308	[p18l535t19r664b49],
6	,	,	O	,	_	0	SENT_308	[p18l535t19r664b49],
7	ALL	NN	O	all	nn	10	SENT_308	[p18l673t21r726b44],
8	acute	JJ	O	acute	amod	10	SENT_308	[p18l734t24r806b44],
9	lymphoblastic	JJ	O	lymphoblastic	amod	10	SENT_308	[p18l817t19r1007b52],
10	leukemia	NN	O	leukemia	appos	5	SENT_308	[p18l1017t19r1145b49],
11	,	,	O	,	_	0	SENT_308	[p18l1017t19r1145b49],
12	AML	NN	ORGANIZATION	aml	nn	15	SENT_308	[p18l1154t21r1220b44],
13	acute	JJ	O	acute	amod	15	SENT_308	[p18l1228t24r1300b44],
14	myeloid	JJ	O	myeloid	amod	15	SENT_308	[p18l1311t19r1415b52],
15	leukemia	NN	O	leukemia	appos	5	SENT_308	[p18l1427t19r1555b49],
16	,	,	O	,	_	0	SENT_308	[p18l1427t19r1555b49],
17	aCML	NN	O	acml	nn	21	SENT_308	[p18l1566t21r1646b44],
18	atypical	JJ	O	atypical	amod	21	SENT_308	[p18l1655t19r1755b52],
19	chronic	JJ	O	chronic	amod	21	SENT_308	[p18l1766t19r1867b44],
20	myeloid	JJ	O	myeloid	amod	21	SENT_308	[p18l1877t19r1981b52],
21	leuemia	NN	O	leuemia	appos	5	SENT_308	[p18l1993t19r2040b44, p18l133t59r206b86],
22	,	,	O	,	_	0	SENT_308	[p18l1993t19r2040b44, p18l133t59r206b86],
23	T-ALLT-cell	JJ	O	t-allt-cell	amod	24	SENT_308	[p18l216t57r374b82],
24	acu	NN	O	acu	appos	5	SENT_308	[p18l385t66r430b82],
25	e	SYM	O	e	dep	28	SENT_308	[p18l444t66r457b82],
26	lymphoblastic	JJ	O	lymphoblastic	amod	28	SENT_308	[p18l468t57r658b90],
27	leuke	NN	O	leuke	nn	28	SENT_308	[p18l668t57r737b82],
28	ia	NN	O	ia	dep	45	SENT_308	[p18l769t59r797b86],
29	,	,	O	,	_	0	SENT_308	[p18l769t59r797b86],
30	NPM	NN	ORGANIZATION	npm	nn	31	SENT_308	[p18l810t59r876b82],
31	nucleophosmin	NN	O	nucleophosmin	appos	28	SENT_308	[p18l889t57r1108b90],
32	,	,	O	,	_	0	SENT_308	[p18l889t57r1108b90],
33	ALCL	NN	O	alcl	nn	41	SENT_308	[p18l1118t58r1191b82],
34	anaplastic	JJ	O	anaplastic	amod	41	SENT_308	[p18l1200t57r1337b90],
35	large-ce	JJ	O	large-ce	amod	41	SENT_308	[p18l1348t57r1452b90],
36	mphoma	NN	O	mphoma	nn	41	SENT_308	[p18l1500t57r1629b89],
37	,	,	O	,	_	0	SENT_308	[p18l1500t57r1629b89],
38	EMS	NNP	O	EMS	nn	41	SENT_308	[p18l1642t59r1702b82],
39	8p11myeloproliferative	JJ	O	8p11myeloproliferative	amod	41	SENT_308	[p18l1712t56r2033b90],
40	ndro	NN	O	ndro	nn	41	SENT_308	[p18l940t94r1001b119],
41	syndrome	NN	O	syndrome	appos	28	SENT_308	[p18l119t94r260b127],
42	,	,	O	,	_	0	SENT_308	[p18l119t94r260b127],
43	MM	NN	O	mm	nn	44	SENT_308	[p18l274t96r326b119],
44	mu	NN	O	mu	appos	28	SENT_308	[p18l340t103r381b119],
45	i	FW	O	i	dep	5	SENT_308	[p18l404t96r407b119],
46	e	LS	O	e	dep	47	SENT_308	[p18l437t103r450b119],
47	myeloma	NN	O	myeloma	dep	45	SENT_308	[p18l462t94r592b127],
48	,	,	O	,	_	0	SENT_308	[p18l462t94r592b127],
49	MDS	NN	O	md	nn	51	SENT_308	[p18l606t96r672b119],
50	myelodysplastic	JJ	O	myelodysplastic	amod	51	SENT_308	[p18l684t94r900b127],
51	sy	NN	O	sy	dep	59	SENT_308	[p18l910t103r937b127],
52	me	PRP	O	I	dep	51	SENT_308	[p18l1005t103r1052b123],
53	,	,	O	,	_	0	SENT_308	[p18l1005t103r1052b123],
54	HES	NNP	ORGANIZATION	HES	nn	57	SENT_308	[p18l1066t96r1122b119],
55	hypereosinophilic	JJ	O	hypereosinophilic	amod	57	SENT_308	[p18l1134t94r1375b127],
56	syn	NN	O	syn	nn	57	SENT_308	[p18l1385t103r1427b127],
57	rome	NN	O	rome	appos	51	SENT_308	[p18l1450t103r1527b123],
58	,	,	O	,	_	0	SENT_308	[p18l1450t103r1527b123],
59	SM	NN	O	sm	dep	65	SENT_308	[p18l1538t96r1580b119],
60	systemic	JJ	O	systemic	amod	61	SENT_308	[p18l1593t96r1712b127],
61	mastocytosis	NN	O	mastocytosis	dep	65	SENT_308	[p18l1723t96r1907b127],
62	,	,	O	,	_	0	SENT_308	[p18l1723t96r1907b127],
63	and	CC	O	and	dep	61	SENT_308	[p18l1919t94r1967b119],
64	CMML	NN	O	cmml	dep	63	SENT_308	[p18l118t133r212b156],
65	chronic	JJ	O	chronic	prep	47	SENT_308	[p18l221t131r323b156],
66	myelomonocytic	JJ	O	myelomonocytic	dep	65	SENT_308	[p18l333t131r557b164],
67	leukemia	NN	O	leukemia	dep	65	SENT_308	[p18l568t131r696b156],
68	.	.	O	.	_	0	SENT_308	[p18l568t131r696b156],

1	i	LS	O	i	dep	2	SENT_309	[p18l591t176r594b199],
2	1	CD	NUMBER	1	dep	7	SENT_309	[p18l94t176r109b207],
3	'	''	O	'	_	0	SENT_309	[p18l94t176r109b207],
4	Chromosomal	JJ	O	chromosomal	amod	5	SENT_309	[p18l118t174r312b199],
5	locations	NNS	O	location	nsubjpass	7	SENT_309	[p18l325t174r447b199],
6	are	VBP	O	be	auxpass	7	SENT_309	[p18l458t183r498b199],
7	given	VBN	O	give	_	0	SENT_309	[p18l508t176r578b207],
8	n	NN	O	n	nn	9	SENT_309	[p18l599t183r612b199],
9	parentheses	NNS	O	parenthesis	dobj	7	SENT_309	[p18l625t174r797b206],
10	.	.	O	.	_	0	SENT_309	[p18l625t174r797b206],

1	Ii	NN	O	ii	nsubjpass	13	SENT_310	[p18l94t213r109b244],
2	:	:	O	:	_	0	SENT_310	[p18l94t213r109b244],
3	Other	JJ	O	other	dep	1	SENT_310	[p18l118t211r197b236],
4	than	IN	O	than	_	0	SENT_310	[p18l205t211r265b236],
5	imatinib	NN	O	imatinib	prep_than	3	SENT_310	[p18l278t211r396b240],
6	,	,	O	,	_	0	SENT_310	[p18l278t211r396b240],
7	the	DT	O	the	det	8	SENT_310	[p18l406t211r449b236],
8	drugs	NNS	O	drug	appos	5	SENT_310	[p18l459t211r535b244],
9	listed	VBN	O	list	partmod	8	SENT_310	[p18l547t211r617b236],
10	have	VBP	O	have	aux	13	SENT_310	[p18l630t211r691b236],
11	not	RB	O	not	neg	13	SENT_310	[p18l702t216r745b236],
12	been	VBN	O	be	auxpass	13	SENT_310	[p18l756t211r818b236],
13	approved	VBN	O	approve	_	0	SENT_310	[p18l830t211r955b244],
14	by	IN	O	by	_	0	SENT_310	[p18l968t211r996b244],
15	the	DT	O	the	det	19	SENT_310	[p18l1005t211r1047b236],
16	Food	NNP	ORGANIZATION	Food	nn	19	SENT_310	[p18l1059t211r1123b236],
17	and	CC	ORGANIZATION	and	_	0	SENT_310	[p18l1135t211r1183b236],
18	Drug	NNP	ORGANIZATION	Drug	nn	19	SENT_310	[p18l1196t213r1263b244],
19	Administration	NNP	ORGANIZATION	Administration	agent	13	SENT_310	[p18l1271t211r1484b236],
20	.	.	O	.	_	0	SENT_310	[p18l1271t211r1484b236],

1	§	NN	O	§	nn	2	SENT_311	[p18l93t247r104b280],
2	A	NN	O	a	nsubjpass	19	SENT_311	[p18l117t249r137b272],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_311	[p18l145t247r300b280],
4	response	NN	O	response	dep	2	SENT_311	[p18l311t256r434b280],
5	is	VBZ	O	be	auxpass	6	SENT_311	[p18l445t250r464b272],
6	predicted	VBN	O	predict	_	0	SENT_311	[p18l476t247r601b280],
7	on	IN	O	on	_	0	SENT_311	[p18l612t256r644b272],
8	the	DT	O	the	det	14	SENT_311	[p18l655t247r698b272],
9	basis	NN	O	basis	nn	14	SENT_311	[p18l709t247r776b272],
10	ofthe	NN	O	ofthe	nn	14	SENT_311	[p18l787t247r863b272],
11	identity	NN	O	identity	nn	14	SENT_311	[p18l874t247r974b280],
12	ofthe	NN	O	ofthe	nn	14	SENT_311	[p18l983t247r1060b272],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_311	[p18l1069t250r1177b280],
14	kinase	NN	O	kinase	prep_on	6	SENT_311	[p18l1189t247r1273b272],
15	but	CC	O	but	_	0	SENT_311	[p18l1284t247r1327b272],
16	has	VBZ	O	have	aux	19	SENT_311	[p18l1338t247r1382b272],
17	not	RB	O	not	neg	19	SENT_311	[p18l1395t252r1438b272],
18	been	VBN	O	be	auxpass	19	SENT_311	[p18l1448t247r1510b272],
19	verified	VBN	O	verify	conj_but	6	SENT_311	[p18l1521t247r1620b272],
20	clinically	RB	O	clinically	advmod	19	SENT_311	[p18l1631t247r1751b280],
21	.	.	O	.	_	0	SENT_311	[p18l1631t247r1751b280],

1	lated	VBN	O	late	partmod	33	SENT_312	[p18l8t485r217b563],
2	with	IN	O	with	_	0	SENT_312	[p18l237t485r430b564],
3	the	DT	O	the	det	4	SENT_312	[p18l454t485r584b563],
4	response	NN	O	response	prep_with	1	SENT_312	[p18l607t510r989b585],
5	to	TO	O	to	_	0	SENT_312	[p18l1013t501r1092b563],
6	kinase	NN	O	kinase	nn	8	SENT_312	[p18l1116t485r1388b564],
7	inhibitor	NN	O	inhibitor	nn	8	SENT_312	[p18l1410t484r1788b563],
8	therapy	NN	O	therapy	prep_to	1	SENT_312	[p18l1809t484r2139b585],
9	,	,	O	,	_	0	SENT_312	[p18l1809t484r2139b585],
10	but	CC	O	but	cc	16	SENT_312	[p18l10t613r151b692],
11	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_312	[p18l174t619r387b693],
12	mutational	JJ	O	mutational	amod	13	SENT_312	[p18l411t613r877b692],
13	status	NN	O	status	nsubj	16	SENT_312	[p18l908t629r1155b692],
14	Was	VBD	O	be	cop	16	SENT_312	[p18l1182t639r1344b692],
15	not	RB	O	not	neg	16	SENT_312	[p18l1376t608r1625b691],
16	.97	CD	NUMBER	.97	ccomp	1	SENT_312	[p18l1376t608r1625b691],
17	In	IN	O	in	_	0	SENT_312	[p18l1654t620r1741b690],
18	contrast	NN	O	contrast	prep_in	16	SENT_312	[p18l1772t629r2139b708],
19	,	,	O	,	_	0	SENT_312	[p18l1772t629r2139b708],
20	studies	NNS	O	study	nsubj	33	SENT_312	[p18l11t742r305b821],
21	from	IN	O	from	_	0	SENT_312	[p18l339t741r548b820],
22	Asia	NNP	LOCATION	Asia	prep_from	20	SENT_312	[p18l575t742r781b837],
23	,	,	O	,	_	0	SENT_312	[p18l575t742r781b837],
24	Where	WRB	O	where	advmod	30	SENT_312	[p18l813t742r1073b822],
25	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_312	[p18l1103t748r1317b822],
26	mutant	JJ	O	mutant	amod	27	SENT_312	[p18l1341t758r1655b821],
27	tumors	NNS	O	tumor	nsubj	30	SENT_312	[p18l1682t758r1985b821],
28	are	VBP	O	be	cop	30	SENT_312	[p18l2017t768r2144b820],
29	more	RBR	O	more	advmod	30	SENT_312	[p18l9t896r233b949],
30	prevalent	JJ	O	prevalent	rcmod	20	SENT_312	[p18l267t871r690b971],
31	,	,	O	,	_	0	SENT_312	[p18l267t871r690b971],
32	have	VBP	O	have	aux	33	SENT_312	[p18l730t871r923b950],
33	found	VBN	O	find	_	0	SENT_312	[p18l958t870r1214b950],
34	signiﬁcant	JJ	O	signiﬁcant	amod	35	SENT_312	[p18l1250t870r1714b971],
35	increases	NNS	O	increase	dobj	33	SENT_312	[p18l1743t871r2141b949],
36	in	IN	O	in	_	0	SENT_312	[p18l8t999r91b1076],
37	response	NN	O	response	nn	38	SENT_312	[p18l126t1024r515b1099],
38	rates	NNS	O	rate	prep_in	33	SENT_312	[p18l551t1015r754b1077],
39	and	CC	O	and	_	0	SENT_312	[p18l791t998r950b1077],
40	overall	JJ	O	overall	amod	41	SENT_312	[p18l986t999r1272b1078],
41	survival	NN	O	survival	prep_in	33	SENT_312	[p18l1309t999r1636b1078],
42	among	IN	O	among	_	0	SENT_312	[p18l1670t1024r1976b1099],
43	patients	NNS	O	patient	prep_among	33	SENT_312	[p18l2006t1025r2142b1099, p18l9t1127r246b1205],
44	With	IN	O	with	_	0	SENT_312	[p18l269t1127r463b1206],
45	EGFR	NN	O	egfr	prep_with	59	SENT_312	[p18l487t1133r1052b1206],
46	—	CD	NUMBER	—	num	48	SENT_312	[p18l487t1133r1052b1206],
47	mutant	JJ	O	mutant	amod	48	SENT_312	[p18l487t1133r1052b1206],
48	tumors	NNS	O	tumor	nsubjpass	59	SENT_312	[p18l1073t1143r1382b1206],
49	treated	VBN	O	treat	partmod	48	SENT_312	[p18l1410t1127r1707b1205],
50	With	IN	O	with	_	0	SENT_312	[p18l1728t1127r1921b1206],
51	geﬁtinib	NN	O	geﬁtinib	prep_with	49	SENT_312	[p18l1947t1126r2142b1227, p18l9t1255r425b1333],
52	.98	CD	NUMBER	.98	number	53	SENT_312	[p18l1947t1126r2142b1227, p18l9t1255r425b1333],
53	»	CD	NUMBER	»	num	57	SENT_312	[p18l1947t1126r2142b1227, p18l9t1255r425b1333],
54	99	CD	NUMBER	99	num	57	SENT_312	[p18l1947t1126r2142b1227, p18l9t1255r425b1333],
55	Additional	JJ	O	additional	amod	57	SENT_312	[p18l448t1254r898b1333],
56	prospective	JJ	O	prospective	amod	57	SENT_312	[p18l922t1255r1406b1355],
57	studies	NNS	O	study	dep	49	SENT_312	[p18l1434t1255r1729b1334],
58	are	VBP	O	be	auxpass	59	SENT_312	[p18l1756t1281r1882b1333],
59	needed	VBN	O	need	rcmod	43	SENT_312	[p18l1909t1254r2143b1333, p18l10t1383r105b1461],
60	to	TO	O	to	aux	61	SENT_312	[p18l126t1399r204b1461],
61	determine	VB	O	determine	xcomp	59	SENT_312	[p18l227t1382r648b1461],
62	whether	IN	O	whether	complm	73	SENT_312	[p18l665t1383r1011b1462],
63	analysis	NN	O	analysis	nsubjpass	73	SENT_312	[p18l1028t1383r1352b1483],
64	of	IN	O	of	_	0	SENT_312	[p18l1375t1382r1475b1461],
65	EGFR	NN	ORGANIZATION	egfr	nn	66	SENT_312	[p18l1475t1389r1685b1462],
66	expression	NN	O	expression	prep_of	63	SENT_312	[p18l1700t1383r2145b1483],
67	and	CC	O	and	_	0	SENT_312	[p18l8t1510r167b1589],
68	mutation	NN	O	mutation	prep_of	63	SENT_312	[p18l199t1511r601b1590],
69	in	IN	O	in	_	0	SENT_312	[p18l632t1511r715b1588],
70	tumors	NNS	O	tumor	prep_in	66	SENT_312	[p18l747t1527r1058b1590],
71	should	MD	O	should	aux	73	SENT_312	[p18l1093t1510r1390b1590],
72	be	VB	O	be	auxpass	73	SENT_312	[p18l1423t1511r1520b1589],
73	used	VBN	O	use	ccomp	61	SENT_312	[p18l1552t1511r1753b1590],
74	to	TO	O	to	_	0	SENT_312	[p18l1785t1527r1866b1589],
75	select	JJ	O	select	amod	76	SENT_312	[p18l1901t1511r2148b1589],
76	patients	NNS	O	patient	prep_to	73	SENT_312	[p18l8t1639r340b1739],
77	with	IN	O	with	_	0	SENT_312	[p18l362t1639r550b1718],
78	non	JJ	O	non	amod	84	SENT_312	[p18l574t1639r1198b1717],
79	—	JJ	O	—	amod	84	SENT_312	[p18l574t1639r1198b1717],
80	small	JJ	O	small	amod	84	SENT_312	[p18l574t1639r1198b1717],
81	—	NN	O	—	nn	84	SENT_312	[p18l574t1639r1198b1717],
82	cell	NN	O	cell	nn	84	SENT_312	[p18l574t1639r1198b1717],
83	lung	NN	O	lung	nn	84	SENT_312	[p18l1221t1639r1413b1739],
84	cancer	NN	O	cancer	prep_with	73	SENT_312	[p18l1435t1664r1707b1717],
85	for	IN	O	for	_	0	SENT_312	[p18l1728t1638r1850b1717],
86	EGFRinhibitor	NN	O	egfrinhibitor	nn	87	SENT_312	[p18l1870t1644r2144b1722, p18l8t1767r385b1845],
87	therapy	NN	O	therapy	prep_for	84	SENT_312	[p18l408t1767r737b1867],
88	.	.	O	.	_	0	SENT_312	[p18l408t1767r737b1867],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_313	[p18l138t1900r398b1978],
2	kinase	NN	O	kinase	nn	3	SENT_313	[p18l432t1895r704b1974],
3	inhibitors	NNS	O	inhibitor	nsubj	19	SENT_313	[p18l749t1895r1165b1973],
4	are	VBP	O	be	cop	19	SENT_313	[p18l1211t1921r1338b1973],
5	in	IN	O	in	_	0	SENT_313	[p18l1383t1895r1465b1972],
6	phase	NN	O	phase	prep_in	19	SENT_313	[p18l1508t1895r1755b1995],
7	1	CD	NUMBER	1	num	6	SENT_313	[p18l1805t1900r1849b1972],
8	and	CC	O	and	_	0	SENT_313	[p18l1895t1894r2051b1973],
9	2	CD	NUMBER	2	num	10	SENT_313	[p18l2096t1900r2143b1972],
10	testing	NN	O	testing	conj_and	6	SENT_313	[p18l9t2024r305b2123],
11	in	IN	O	in	_	0	SENT_313	[p18l335t2024r417b2100],
12	a	DT	O	a	det	14	SENT_313	[p18l449t2049r493b2101],
13	wide	JJ	O	wide	amod	14	SENT_313	[p18l520t2023r726b2102],
14	range	NN	O	range	prep_in	10	SENT_313	[p18l759t2048r1001b2123],
15	of	IN	O	of	_	0	SENT_313	[p18l1035t2022r1137b2101],
16	solid	JJ	O	solid	amod	17	SENT_313	[p18l1152t2023r1361b2101],
17	tumors	NNS	O	tumor	prep_of	14	SENT_313	[p18l1393t2017r1859b2102],
18	.1	CD	NUMBER	.1	number	19	SENT_313	[p18l1393t2017r1859b2102],
19	°	CD	NUMBER	°	_	0	SENT_313	[p18l1393t2017r1859b2102],
20	°	CD	NUMBER	°	num	21	SENT_313	[p18l1393t2017r1859b2102],
21	EGFR	NN	ORGANIZATION	egfr	nsubjpass	34	SENT_313	[p18l1890t2028r2153b2106],
22	is	VBZ	O	be	auxpass	23	SENT_313	[p18l8t2151r75b2229],
23	overexpressed	VBN	O	overexpress	rcmod	19	SENT_313	[p18l112t2150r724b2251],
24	in	IN	O	in	_	0	SENT_313	[p18l758t2151r840b2228],
25	about	RB	O	about	quantmod	26	SENT_313	[p18l874t2150r1123b2230],
26	40	CD	PERCENT	40	num	27	SENT_313	[p18l1151t2156r1255b2229],
27	percent	NN	PERCENT	percent	prep_in	23	SENT_313	[p18l1288t2167r1617b2251],
28	of	IN	O	of	_	0	SENT_313	[p18l1647t2150r1750b2229],
29	glioblas	NNS	O	gliobla	prep_of	27	SENT_313	[p18l1765t2151r2142b2251],
30	—	CD	NUMBER	—	num	31	SENT_313	[p18l1765t2151r2142b2251],
31	tomas	NNS	O	toma	dep	29	SENT_313	[p18l9t2295r271b2357],
32	and	CC	O	and	_	0	SENT_313	[p18l302t2279r459b2357],
33	is	VBZ	O	be	auxpass	34	SENT_313	[p18l485t2279r551b2357],
34	activated	VBN	O	activate	conj_and	23	SENT_313	[p18l580t2279r951b2358],
35	by	IN	O	by	_	0	SENT_313	[p18l979t2279r1077b2379],
36	eXtracellular	JJ	O	extracellular	amod	39	SENT_313	[p18l1100t2278r1986b2358],
37	—	NN	O	—	nn	39	SENT_313	[p18l1100t2278r1986b2358],
38	domain	NN	O	domain	nn	39	SENT_313	[p18l1100t2278r1986b2358],
39	deletions	NNS	O	deletion	agent	34	SENT_313	[p18l2014t2279r2143b2357, p18l8t2407r298b2486],
40	in	IN	O	in	_	0	SENT_313	[p18l325t2408r408b2485],
41	a	DT	O	a	det	42	SENT_313	[p18l432t2434r478b2486],
42	subset	NN	O	subset	prep_in	34	SENT_313	[p18l502t2408r782b2487],
43	of	IN	O	of	_	0	SENT_313	[p18l803t2407r906b2486],
44	these	DT	O	these	det	45	SENT_313	[p18l913t2408r1137b2486],
45	tumors	NNS	O	tumor	prep_of	42	SENT_313	[p18l1163t2403r1586b2503],
46	,57	CD	NUMBER	,57	nsubj	49	SENT_313	[p18l1163t2403r1586b2503],
47	but	CC	O	but	prep	46	SENT_313	[p18l1612t2408r1756b2487],
48	geﬁtinib	NN	O	geﬁtinib	dep	47	SENT_313	[p18l1776t2407r2141b2508],
49	had	VBD	O	have	rcmod	45	SENT_313	[p18l9t2535r167b2614],
50	only	RB	O	only	advmod	52	SENT_313	[p18l199t2536r381b2636],
51	minimal	JJ	O	minimal	amod	52	SENT_313	[p18l405t2536r764b2614],
52	activity	NN	O	activity	dobj	49	SENT_313	[p18l792t2536r1089b2636],
53	in	IN	O	in	_	0	SENT_313	[p18l1113t2536r1194b2613],
54	a	DT	O	a	det	57	SENT_313	[p18l1222t2562r1266b2614],
55	phase	NN	O	phase	nn	57	SENT_313	[p18l1292t2536r1539b2636],
56	2	CD	NUMBER	2	num	57	SENT_313	[p18l1568t2541r1615b2613],
57	trial	NN	O	trial	prep_in	52	SENT_313	[p18l1645t2536r1812b2614],
58	in	IN	O	in	_	0	SENT_313	[p18l1839t2536r1921b2613],
59	glioblastoma	NN	O	glioblastoma	prep_in	57	SENT_313	[p18l1949t2536r2143b2636, p18l10t2660r510b2743],
60	.58	CD	NUMBER	.58	num	59	SENT_313	[p18l1949t2536r2143b2636, p18l10t2660r510b2743],

1	TARGETING	VBG	O	target	_	0	SENT_314	[p18l7t2938r488b2989],
2	RECEPTOR	NN	O	receptor	nn	3	SENT_314	[p18l535t2938r954b2989],
3	TKS	NNS	O	tk	dobj	1	SENT_314	[p18l991t2939r1127b2989],
4	AND	CC	O	and	_	0	SENT_314	[p18l1163t2939r1341b2988],
5	THEIR	NN	O	their	nn	6	SENT_314	[p18l1379t2939r1630b2988],
6	LIGANDS	NNS	O	ligand	dobj	1	SENT_314	[p18l1674t2938r2044b2989],

1	WITH	IN	O	with	_	0	SENT_315	[p18l7t3050r221b3099],
2	MONOCLONAL	JJ	O	monoclonal	amod	6	SENT_315	[p18l274t3050r884b3099],
3	ANTIBODIES	NNS	O	antibody	nn	6	SENT_315	[p18l920t3050r1439b3099],
4	Receptor	NN	O	receptor	nn	6	SENT_315	[p18l8t3150r402b3244],
5	TK	NN	O	tk	nn	6	SENT_315	[p18l439t3149r570b3225],
6	signaling	NN	O	signaling	prep_with	10	SENT_315	[p18l611t3144r1020b3244],
7	can	MD	O	can	aux	10	SENT_315	[p18l1060t3169r1208b3222],
8	also	RB	O	also	advmod	10	SENT_315	[p18l1250t3144r1423b3222],
9	be	VB	O	be	auxpass	10	SENT_315	[p18l1468t3144r1566b3222],
10	inhibited	VBN	O	inhibit	_	0	SENT_315	[p18l1608t3144r2005b3222],
11	by	IN	O	by	_	0	SENT_315	[p18l2048t3143r2147b3244],
12	monoclonal	JJ	O	monoclonal	amod	13	SENT_315	[p18l9t3264r531b3343],
13	antibodies	NNS	O	antibody	agent	10	SENT_315	[p18l558t3265r1009b3343],
14	against	IN	O	against	_	0	SENT_315	[p18l1039t3265r1356b3365],
15	the	DT	O	the	det	16	SENT_315	[p18l1380t3264r1511b3343],
16	receptor	NN	O	receptor	prep_against	13	SENT_315	[p18l1541t3281r1901b3365],
17	or	CC	O	or	_	0	SENT_315	[p18l1927t3290r2018b3343],
18	its	PRP$	O	its	poss	19	SENT_315	[p18l2043t3265r2141b3343],
19	ligand	NN	O	ligand	prep_against	13	SENT_315	[p18l11t3393r283b3493],
20	(	CD	NUMBER	(	num	21	SENT_315	[p18l317t3393r506b3493],
21	Fig	NN	O	fig	nsubjpass	10	SENT_315	[p18l317t3393r506b3493],
22	.	.	O	.	_	0	SENT_315	[p18l317t3393r506b3493],

1	2	CD	NUMBER	2	num	2	SENT_316	[p18l540t3398r649b3484],
2	)	CD	NUMBER	)	_	0	SENT_316	[p18l540t3398r649b3484],
3	.	.	O	.	_	0	SENT_316	[p18l540t3398r649b3484],

1	The	DT	O	the	det	2	SENT_317	[p18l680t3393r845b3471],
2	ERBB2	NN	O	erbb2	nsubjpass	10	SENT_317	[p18l873t3398r1173b3476],
3	or	CC	O	or	_	0	SENT_317	[p18l1203t3418r1294b3471],
4	HER	NN	O	her	nn	8	SENT_317	[p18l1320t3398r1603b3476],
5	—	NN	O	—	nn	8	SENT_317	[p18l1320t3398r1603b3476],
6	2	CD	NUMBER	2	num	8	SENT_317	[p18l1320t3398r1603b3476],
7	receptor	NN	O	receptor	nn	8	SENT_317	[p18l1633t3409r1993b3493],
8	TK	NN	O	tk	conj_or	2	SENT_317	[p18l2016t3398r2147b3474],
9	is	VBZ	O	be	auxpass	10	SENT_317	[p18l11t3521r77b3599],
10	overexpressed	VBN	O	overexpress	_	0	SENT_317	[p18l127t3520r739b3621],
11	through	IN	O	through	_	0	SENT_317	[p18l786t3521r1135b3621],
12	gene	NN	O	gene	nn	13	SENT_317	[p18l1183t3546r1385b3621],
13	ampliﬁcation	NN	O	ampliﬁcation	prep_through	10	SENT_317	[p18l1433t3520r2014b3621],
14	in	IN	O	in	_	0	SENT_317	[p18l2061t3521r2143b3598],
15	20	CD	NUMBER	20	number	17	SENT_317	[p18l12t3654r114b3727],
16	to	TO	O	to	dep	17	SENT_317	[p18l157t3665r239b3727],
17	25	CD	PERCENT	25	num	18	SENT_317	[p18l282t3654r381b3727],
18	percent	NN	PERCENT	percent	prep_in	13	SENT_317	[p18l426t3665r758b3749],
19	of	IN	O	of	_	0	SENT_317	[p18l796t3648r898b3727],
20	invasive	JJ	O	invasive	prep_of	18	SENT_317	[p18l921t3649r1264b3728],
21	primary	JJ	O	primary	amod	18	SENT_317	[p18l1306t3649r1653b3749],
22	and	CC	O	and	_	0	SENT_317	[p18l1690t3648r1850b3727],
23	metastatic	JJ	O	metastatic	amod	18	SENT_317	[p18l1892t3665r2142b3727, p19l13t21r244b99],

1	breast	NN	O	breast	nn	2	SENT_318	[p19l269t21r538b99],
2	cancers	NNS	O	cancer	nsubjpass	5	SENT_318	[p19l557t46r881b99],
3	and	CC	O	and	advmod	5	SENT_318	[p19l907t21r1067b99],
4	is	VBZ	O	be	auxpass	5	SENT_318	[p19l1090t21r1156b99],
5	associated	VBN	O	associate	_	0	SENT_318	[p19l1182t21r1635b99],
6	with	IN	O	with	_	0	SENT_318	[p19l1654t20r1849b100],
7	a	DT	O	a	det	9	SENT_318	[p19l1872t47r1917b99],
8	poor	JJ	O	poor	amod	9	SENT_318	[p19l1938t46r2145b121],
9	prognosis	NN	O	prognosis	prep_with	5	SENT_318	[p19l11t141r565b248],
10	.	.	O	.	_	0	SENT_318	[p19l11t141r565b248],

1	“	NN	O	“	dep	104	SENT_319	[p19l11t141r565b248],
2	Trastuzumab	NN	O	trastuzumab	dep	104	SENT_319	[p19l603t148r1166b227],
3	(	CD	NUMBER	(	dep	104	SENT_319	[p19l1210t149r1719b248],
4	Herceptin	NN	O	herceptin	dep	104	SENT_319	[p19l1210t149r1719b248],
5	)	NN	O	)	dep	104	SENT_319	[p19l1210t149r1719b248],
6	,	,	O	,	_	0	SENT_319	[p19l1210t149r1719b248],
7	a	DT	O	a	dep	104	SENT_319	[p19l1763t174r1807b226],
8	recombinant	JJ	O	recombinant	dep	104	SENT_319	[p19l1843t173r2143b226, p19l12t276r297b355],
9	humanized	JJ	O	humanized	dep	104	SENT_319	[p19l328t276r819b356],
10	monoclonal	JJ	O	monoclonal	dep	104	SENT_319	[p19l854t276r1380b355],
11	antibody	NN	O	antibody	dep	104	SENT_319	[p19l1413t277r1798b377],
12	against	IN	O	against	dep	104	SENT_319	[p19l1828t277r2148b377],
13	HER	NN	O	her	dep	104	SENT_319	[p19l11t410r311b500],
14	—	NN	O	—	dep	104	SENT_319	[p19l11t410r311b500],
15	2	CD	NUMBER	2	dep	104	SENT_319	[p19l11t410r311b500],
16	,	,	O	,	_	0	SENT_319	[p19l11t410r311b500],
17	increases	VBZ	O	increase	dep	104	SENT_319	[p19l343t405r727b483],
18	response	NN	O	response	dep	104	SENT_319	[p19l756t430r1133b505],
19	rates	NNS	O	rate	dep	104	SENT_319	[p19l1160t421r1356b483],
20	and	CC	O	and	dep	104	SENT_319	[p19l1385t405r1540b483],
21	improves	VBZ	O	improve	dep	104	SENT_319	[p19l1566t405r1952b505],
22	survival	NN	O	survival	dep	104	SENT_319	[p19l1982t431r2143b484, p19l7t532r196b612],
23	when	WRB	O	when	dep	104	SENT_319	[p19l232t533r470b612],
24	added	VBN	O	add	dep	104	SENT_319	[p19l510t532r764b611],
25	to	TO	O	to	dep	104	SENT_319	[p19l801t549r879b611],
26	chemotherapy	NN	O	chemotherapy	dep	104	SENT_319	[p19l919t532r1521b633],
27	for	IN	O	for	dep	104	SENT_319	[p19l1554t532r1677b611],
28	metastatic	JJ	O	metastatic	dep	104	SENT_319	[p19l1710t533r2145b611],
29	HER	NN	O	her	dep	104	SENT_319	[p19l11t661r972b760],
30	—	NN	O	—	dep	104	SENT_319	[p19l11t661r972b760],
31	2	CD	NUMBER	2	dep	104	SENT_319	[p19l11t661r972b760],
32	—	CD	NUMBER	—	dep	104	SENT_319	[p19l11t661r972b760],
33	overeXpressing	JJ	O	overexpressing	dep	104	SENT_319	[p19l11t661r972b760],
34	breast	NN	O	breast	dep	104	SENT_319	[p19l990t660r1247b738],
35	cancer	NN	O	cancer	dep	104	SENT_319	[p19l1263t653r1633b755],
36	,63	CD	NUMBER	,63	dep	104	SENT_319	[p19l1263t653r1633b755],
37	and	CC	O	and	dep	104	SENT_319	[p19l1655t660r1810b738],
38	in	IN	O	in	dep	104	SENT_319	[p19l1829t661r1910b737],
39	combination	NN	O	combination	dep	104	SENT_319	[p19l1931t685r2143b738, p19l12t788r366b867],
40	With	IN	O	with	dep	104	SENT_319	[p19l393t789r587b868],
41	adjuvant	JJ	O	adjuvant	dep	104	SENT_319	[p19l617t788r990b889],
42	chemotherapy	NN	O	chemotherapy	dep	104	SENT_319	[p19l1017t789r1657b889],
43	,	,	O	,	_	0	SENT_319	[p19l1017t789r1657b889],
44	it	PRP	O	it	dep	104	SENT_319	[p19l1693t789r1754b867],
45	decreases	VBZ	O	decrease	dep	104	SENT_319	[p19l1781t788r2141b867, p19l12t943r96b995],
46	recurrence	NN	O	recurrence	dep	104	SENT_319	[p19l119t942r560b996],
47	in	IN	O	in	dep	104	SENT_319	[p19l582t917r662b994],
48	Women	NNS	O	woman	dep	104	SENT_319	[p19l679t942r994b996],
49	Who	WP	O	who	dep	104	SENT_319	[p19l1011t917r1193b996],
50	have	VBP	O	have	dep	104	SENT_319	[p19l1216t916r1402b995],
51	early	JJ	O	early	dep	104	SENT_319	[p19l1424t917r1871b1017],
52	—	NN	O	—	dep	104	SENT_319	[p19l1424t917r1871b1017],
53	stage	NN	O	stage	dep	104	SENT_319	[p19l1424t917r1871b1017],
54	breast	NN	O	breast	dep	104	SENT_319	[p19l1894t917r2150b995],
55	cancer	NN	O	cancer	dep	104	SENT_319	[p19l12t1070r287b1123],
56	with	IN	O	with	dep	104	SENT_319	[p19l303t1045r493b1124],
57	HER	NN	O	her	dep	104	SENT_319	[p19l517t1050r795b1128],
58	—	NN	O	—	dep	104	SENT_319	[p19l517t1050r795b1128],
59	2	CD	NUMBER	2	dep	104	SENT_319	[p19l517t1050r795b1128],
60	overexpression	NN	O	overexpression	dep	104	SENT_319	[p19l821t1039r1609b1145],
61	.1	CD	NUMBER	.1	dep	104	SENT_319	[p19l821t1039r1609b1145],
62	°	NN	O	°	dep	104	SENT_319	[p19l821t1039r1609b1145],
63	1	CD	NUMBER	1	dep	104	SENT_319	[p19l821t1039r1609b1145],
64	Another	DT	O	another	dep	104	SENT_319	[p19l1629t1045r1981b1123],
65	humanized	JJ	O	humanized	dep	104	SENT_319	[p19l2001t1045r2142b1124, p19l12t1173r377b1251],
66	monoclonal	JJ	O	monoclonal	dep	104	SENT_319	[p19l399t1173r910b1251],
67	antibody	NN	O	antibody	dep	104	SENT_319	[p19l932t1172r1316b1273],
68	,	,	O	,	_	0	SENT_319	[p19l932t1172r1316b1273],
69	2C4	NN	O	2c4	dep	104	SENT_319	[p19l1343t1178r1534b1268],
70	,	,	O	,	_	0	SENT_319	[p19l1343t1178r1534b1268],
71	blocks	VBZ	O	block	dep	104	SENT_319	[p19l1563t1173r1836b1252],
72	dimerization	NN	O	dimerization	dep	104	SENT_319	[p19l1861t1173r2143b1251, p19l11t1301r301b1379],
73	of	IN	O	of	dep	104	SENT_319	[p19l334t1300r435b1379],
74	HER-2	NN	O	her-2	dep	104	SENT_319	[p19l447t1306r725b1384],
75	with	IN	O	with	dep	104	SENT_319	[p19l753t1301r943b1380],
76	other	JJ	O	other	dep	104	SENT_319	[p19l975t1301r1200b1379],
77	ErbB	NN	O	erbb	dep	104	SENT_319	[p19l1227t1301r1433b1379],
78	receptors	NNS	O	receptor	dep	104	SENT_319	[p19l1466t1317r1858b1401],
79	and	CC	O	and	dep	104	SENT_319	[p19l1890t1301r2047b1379],
80	is	VBZ	O	be	dep	104	SENT_319	[p19l2077t1301r2142b1379],
81	in	IN	O	in	dep	104	SENT_319	[p19l11t1430r93b1506],
82	phase	NN	O	phase	dep	104	SENT_319	[p19l118t1429r366b1529],
83	1	CD	NUMBER	1	dep	104	SENT_319	[p19l397t1434r441b1506],
84	studies	NNS	O	study	dep	104	SENT_319	[p19l470t1423r918b1508],
85	.1	CD	NUMBER	.1	dep	104	SENT_319	[p19l470t1423r918b1508],
86	°	NN	O	°	dep	104	SENT_319	[p19l470t1423r918b1508],
87	2	CD	NUMBER	2	dep	104	SENT_319	[p19l470t1423r918b1508],
88	HER-2	NN	O	her-2	dep	104	SENT_319	[p19l946t1434r1223b1512],
89	is	VBZ	O	be	dep	104	SENT_319	[p19l1251t1430r1317b1507],
90	mutated	VBN	O	mutate	dep	104	SENT_319	[p19l1346t1429r1698b1508],
91	or	CC	O	or	dep	104	SENT_319	[p19l1726t1454r1815b1507],
92	overexpressed	VBN	O	overexpress	dep	104	SENT_319	[p19l1841t1454r2143b1508, p19l11t1556r336b1656],
93	in	IN	O	in	dep	104	SENT_319	[p19l360t1557r441b1633],
94	other	JJ	O	other	dep	104	SENT_319	[p19l468t1556r692b1634],
95	cancers	NNS	O	cancer	dep	104	SENT_319	[p19l715t1549r1143b1651],
96	,	,	O	,	_	0	SENT_319	[p19l715t1549r1143b1651],
97	”	NN	O	”	dep	104	SENT_319	[p19l715t1549r1143b1651],
98	which	WDT	O	which	dep	104	SENT_319	[p19l1163t1556r1425b1635],
99	may	MD	O	may	dep	104	SENT_319	[p19l1451t1582r1627b1656],
100	also	RB	O	also	dep	104	SENT_319	[p19l1648t1556r1815b1634],
101	be	VB	O	be	dep	104	SENT_319	[p19l1843t1556r1938b1634],
102	candidates	NNS	O	candidate	dep	104	SENT_319	[p19l1965t1581r2143b1634, p19l12t1685r312b1763],
103	for	IN	O	for	dep	104	SENT_319	[p19l349t1684r472b1763],
104	anti	JJ	O	anti	_	0	SENT_319	[p19l503t1685r998b1768],
105	.	.	O	.	_	0	SENT_319	[p19l503t1685r998b1768],

1	—	NN	O	—	_	0	SENT_320	[p19l503t1685r998b1768],
2	.	.	O	.	_	0	SENT_320	[p19l503t1685r998b1768],

1	HER	NN	O	her	_	0	SENT_321	[p19l503t1685r998b1768],
2	.	.	O	.	_	0	SENT_321	[p19l503t1685r998b1768],

1	—	NN	O	—	_	0	SENT_322	[p19l503t1685r998b1768],
2	.	.	O	.	_	0	SENT_322	[p19l503t1685r998b1768],

1	2	CD	NUMBER	2	_	0	SENT_323	[p19l503t1685r998b1768],
2	therapy	NN	O	therapy	dep	1	SENT_323	[p19l1034t1685r1363b1785],
3	.	.	O	.	_	0	SENT_323	[p19l1034t1685r1363b1785],

1	A	DT	O	a	det	3	SENT_324	[p19l1400t1692r1467b1762],
2	direct	JJ	O	direct	amod	3	SENT_324	[p19l1499t1685r1741b1763],
3	inhibitor	NN	O	inhibitor	nsubj	12	SENT_324	[p19l1770t1685r2147b1763],
4	of	IN	O	of	_	0	SENT_324	[p19l12t1812r113b1891],
5	HER-2	NN	O	her-2	nn	6	SENT_324	[p19l119t1818r397b1896],
6	kinase	NN	O	kinase	prep_of	3	SENT_324	[p19l424t1813r695b1892],
7	(	CD	NUMBER	(	num	8	SENT_324	[p19l725t1818r1125b1904],
8	CI	NN	O	ci	dep	6	SENT_324	[p19l725t1818r1125b1904],
9	—	CD	NUMBER	—	number	10	SENT_324	[p19l725t1818r1125b1904],
10	1033	CD	DATE	1033	num	11	SENT_324	[p19l725t1818r1125b1904],
11	)	NN	O	)	dep	8	SENT_324	[p19l725t1818r1125b1904],
12	is	VBZ	O	be	_	0	SENT_324	[p19l1155t1813r1220b1891],
13	under	IN	O	under	_	0	SENT_324	[p19l1247t1813r1498b1892],
14	development	NN	O	development	prep_under	12	SENT_324	[p19l1521t1813r2091b1913],
15	.	.	O	.	_	0	SENT_324	[p19l1521t1813r2091b1913],

1	Several	JJ	O	several	amod	3	SENT_325	[p19l143t1941r447b2020],
2	monoclonal	JJ	O	monoclonal	amod	3	SENT_325	[p19l483t1941r1008b2019],
3	antibodies	NNS	O	antibody	nsubj	6	SENT_325	[p19l1044t1941r1500b2019],
4	against	IN	O	against	_	0	SENT_325	[p19l1538t1941r1858b2041],
5	EGFR	NN	ORGANIZATION	egfr	prep_against	3	SENT_325	[p19l1888t1946r2153b2024],
6	are	VBP	O	be	_	0	SENT_325	[p19l11t2095r141b2147],
7	also	RB	O	also	advmod	6	SENT_325	[p19l175t2069r348b2147],
8	in	IN	O	in	_	0	SENT_325	[p19l384t2069r467b2146],
9	development	NN	O	development	prep_in	6	SENT_325	[p19l499t2068r1069b2169],
10	.	.	O	.	_	0	SENT_325	[p19l499t2068r1069b2169],

1	Cetuximab	NNP	PERSON	Cetuximab	nn	4	SENT_326	[p19l1106t2069r1563b2148],
2	(	NNP	O	(	nn	4	SENT_326	[p19l1601t2069r1967b2160],
3	Erbitux	NNP	O	Erbitux	nn	4	SENT_326	[p19l1601t2069r1967b2160],
4	)	NN	O	)	nsubj	8	SENT_326	[p19l1601t2069r1967b2160],
5	is	VBZ	O	be	cop	8	SENT_326	[p19l2004t2069r2069b2147],
6	a	DT	O	a	det	8	SENT_326	[p19l2101t2095r2146b2147],
7	chimeric	JJ	O	chimeric	amod	8	SENT_326	[p19l12t2196r388b2275],
8	antibody	NN	O	antibody	_	0	SENT_326	[p19l428t2197r809b2297],
9	against	IN	O	against	_	0	SENT_326	[p19l845t2197r1161b2297],
10	EGFR	NN	ORGANIZATION	egfr	prep_against	8	SENT_326	[p19l1197t2202r1460b2280],
11	With	IN	O	with	_	0	SENT_326	[p19l1486t2197r1679b2276],
12	activity	NN	O	activity	prep_with	10	SENT_326	[p19l1720t2197r2025b2297],
13	in	IN	O	in	_	0	SENT_326	[p19l2061t2197r2143b2274],
14	combination	NN	O	combination	prep_in	12	SENT_326	[p19l12t2325r565b2403],
15	with	IN	O	with	_	0	SENT_326	[p19l609t2324r802b2404],
16	chemotherapy	NN	O	chemotherapy	prep_with	8	SENT_326	[p19l851t2324r1472b2425],
17	in	IN	O	in	_	0	SENT_326	[p19l1516t2325r1599b2402],
18	non	JJ	O	non	amod	24	SENT_326	[p19l1647t2325r2142b2403],
19	—	JJ	O	—	amod	24	SENT_326	[p19l1647t2325r2142b2403],
20	small	JJ	O	small	amod	24	SENT_326	[p19l1647t2325r2142b2403],
21	—	NN	O	—	nn	24	SENT_326	[p19l1647t2325r2142b2403],
22	cell	NN	O	cell	nn	24	SENT_326	[p19l12t2452r159b2531],
23	lung	NN	O	lung	nn	24	SENT_326	[p19l186t2453r385b2553],
24	cancer	NN	O	cancer	prep_in	16	SENT_326	[p19l410t2478r712b2548],
25	,	,	O	,	_	0	SENT_326	[p19l410t2478r712b2548],
26	squamous	JJ	O	squamous	amod	29	SENT_326	[p19l746t2453r1384b2553],
27	—	NN	O	—	nn	29	SENT_326	[p19l746t2453r1384b2553],
28	cell	NN	O	cell	nn	29	SENT_326	[p19l746t2453r1384b2553],
29	carcinoma	NN	O	carcinoma	attr	8	SENT_326	[p19l1412t2453r1871b2531],
30	of	IN	O	of	_	0	SENT_326	[p19l1898t2452r2000b2531],
31	the	DT	O	the	prep_of	29	SENT_326	[p19l2009t2453r2143b2531],

1	N	NN	O	n	nn	2	SENT_327	[p19l526t2630r540b2645],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_327	[p19l556t2629r639b2651],
3	MED	VBD	O	med	_	0	SENT_327	[p19l654t2630r707b2645],
4	353:2	CD	NUMBER	353:2	num	5	SENT_327	[p19l719t2629r783b2651],
5	WWW.NEjM.ORG	NN	O	www.nejm.org	dobj	3	SENT_327	[p19l818t2629r1029b2651],
6	ULY14	NN	O	uly14	dep	5	SENT_327	[p19l1078t2629r1246b2651],
7	,2005	CD	NUMBER	,2005	number	8	SENT_327	[p19l1078t2629r1246b2651],
8	179	CD	NUMBER	179	dep	6	SENT_327	[p19l1960t2628r2016b2650],

1	The	DT	O	the	det	5	SENT_328	[p19l702t2662r752b2686],
2	New	NNP	O	New	nn	5	SENT_328	[p19l762t2663r824b2686],
3	England	NNP	O	England	nn	5	SENT_328	[p19l833t2662r944b2693],
4	Jouma	NNP	PERSON	Jouma	nn	5	SENT_328	[p19l952t2663r1041b2686],
5	o	NN	O	o	_	0	SENT_328	[p19l1060t2670r1075b2686],
6	Medicine	NN	O	medicine	dep	5	SENT_328	[p19l1095t2662r1220b2686],

1	Downloaded	VBN	O	download	_	0	SENT_329	[p19l144t2703r314b2726],
2	from	IN	O	from	_	0	SENT_329	[p19l322t2703r387b2726],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_329	[p19l396t2703r514b2733],
4	at	IN	O	at	_	0	SENT_329	[p19l524t2707r547b2726],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_329	[p19l556t2703r738b2726],
6	on	IN	O	on	_	0	SENT_329	[p19l748t2710r780b2726],
7	January	NNP	DATE	January	prep_on	1	SENT_329	[p19l789t2703r891b2733],
8	5	CD	DATE	5	num	7	SENT_329	[p19l902t2703r924b2730],
9	,	,	DATE	,	_	0	SENT_329	[p19l902t2703r924b2730],
10	2014	CD	DATE	2014	num	7	SENT_329	[p19l935t2703r1007b2726],
11	.	.	O	.	_	0	SENT_329	[p19l935t2703r1007b2726],

1	For	IN	O	for	_	0	SENT_330	[p19l1018t2703r1064b2726],
2	personal	JJ	O	personal	amod	3	SENT_330	[p19l1072t2703r1184b2733],
3	use	NN	O	use	pobj	1	SENT_330	[p19l1194t2710r1237b2726],
4	only	RB	O	only	advmod	3	SENT_330	[p19l1247t2703r1312b2733],
5	.	.	O	.	_	0	SENT_330	[p19l1247t2703r1312b2733],

1	No	DT	O	no	det	3	SENT_331	[p19l1322t2703r1362b2726],
2	other	JJ	O	other	amod	3	SENT_331	[p19l1372t2703r1440b2726],
3	uses	NNS	O	use	_	0	SENT_331	[p19l1448t2710r1504b2726],
4	without	IN	O	without	_	0	SENT_331	[p19l1515t2703r1616b2726],
5	permission	NN	O	permission	prep_without	3	SENT_331	[p19l1624t2703r1777b2733],
6	.	.	O	.	_	0	SENT_331	[p19l1624t2703r1777b2733],

1	Copyright	NN	O	copyright	_	0	SENT_332	[p19l494t2744r628b2775],
2	©	CD	NUMBER	©	num	6	SENT_332	[p19l638t2744r661b2768],
3	2005	CD	DATE	2005	num	6	SENT_332	[p19l671t2744r735b2768],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_332	[p19l746t2744r937b2768],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_332	[p19l947t2744r1055b2768],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_332	[p19l1065t2744r1170b2775],
7	.	.	O	.	_	0	SENT_332	[p19l1065t2744r1170b2775],

1	All	DT	O	all	det	2	SENT_333	[p19l1181t2744r1222b2768],
2	rights	NNS	O	rights	nsubj	3	SENT_333	[p19l1232t2744r1306b2775],
3	reserved	VBN	O	reserve	_	0	SENT_333	[p19l1316t2744r1435b2768],
4	.	.	O	.	_	0	SENT_333	[p19l1316t2744r1435b2768],

1	The	DT	O	the	det	4	SENT_334	[p19l857t2786r894b2808],
2	NEW	NNP	O	NEW	nn	4	SENT_334	[p19l907t2788r987b2808],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_334	[p19l1001t2788r1176b2808],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_334	[p19l1190t2788r1356b2815],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_334	[p19l1370t2786r1586b2814],

1	Table	NNP	O	Table	_	0	SENT_335	[p20l119t35r189b60],
2	2	CD	NUMBER	2	dep	1	SENT_335	[p20l198t38r221b60],
3	.	.	O	.	_	0	SENT_335	[p20l198t38r221b60],

1	Tyrosine	NN	O	tyrosine	nn	3	SENT_336	[p20l230t36r345b68],
2	Kinase	NN	O	kinase	nn	3	SENT_336	[p20l356t36r445b60],
3	Targets	NNS	O	target	_	0	SENT_336	[p20l453t38r551b68],
4	in	IN	O	in	_	0	SENT_336	[p20l562t36r584b60],
5	Solid	JJ	O	solid	amod	6	SENT_336	[p20l595t35r661b60],
6	Tumors	NNS	O	tumor	prep_in	3	SENT_336	[p20l671t37r799b60],
7	.	.	O	.	_	0	SENT_336	[p20l671t37r799b60],

1	*	NN	O	*	_	0	SENT_337	[p20l671t37r799b60],

1	Tyrosine	NN	O	tyrosine	_	0	SENT_338	[p20l192t113r307b145],
2	Kinase	NN	O	kinase	nn	4	SENT_338	[p20l197t150r303b183],
3	'	''	O	'	_	0	SENT_338	[p20l197t150r303b183],
4	j'	NN	O	j'	dep	1	SENT_338	[p20l197t150r303b183],
5	ALK	NN	O	alk	dep	1	SENT_338	[p20l119t224r174b247],
6	(	CD	NUMBER	(	num	5	SENT_338	[p20l184t224r268b255],
7	2p23	NN	O	2p23	nn	10	SENT_338	[p20l184t224r268b255],
8	)	CD	NUMBER	)	num	10	SENT_338	[p20l184t224r268b255],
9	TM	NN	O	tm	nn	10	SENT_338	[p20l169t284r212b307],
10	P3	NN	O	p3	rcmod	5	SENT_338	[p20l219t284r259b307],
11	-	:	O	-	_	0	SENT_338	[p20l219t284r259b307],
12	or	CC	O	or	advmod	10	SENT_338	[p20l269t291r297b307],

1	TM	NN	MISC	tm	nn	5	SENT_339	[p20l219t322r262b345],
2	P4-ALK	NN	MISC	p4-alk	nn	5	SENT_339	[p20l269t321r365b345],
3	CLTC-ALK	NN	MISC	cltc-alk	nn	5	SENT_339	[p20l170t382r304b405],
4	CARS-ALK	NN	MISC	cars-alk	nn	5	SENT_339	[p20l170t442r310b466],
5	ERBB1	NN	MISC	erbb1	_	0	SENT_339	[p20l121t503r210b526],
6	(	CD	NUMBER	(	num	7	SENT_339	[p20l222t503r316b534],
7	EGFR	NN	ORGANIZATION	egfr	dep	5	SENT_339	[p20l222t503r316b534],
8	)	CD	NUMBER	)	num	10	SENT_339	[p20l222t503r316b534],
9	l7P12	NN	O	l7p12	nn	10	SENT_339	[p20l221t541r305b572],
10	)	NN	O	)	dep	5	SENT_339	[p20l221t541r305b572],

1	ERBB2	NN	O	erbb2	_	0	SENT_340	[p20l121t872r211b895],
2	(	CD	NUMBER	(	num	3	SENT_340	[p20l222t872r327b903],
3	HER-2	NN	O	her-2	dep	1	SENT_340	[p20l222t872r327b903],
4	)	CD	NUMBER	)	number	5	SENT_340	[p20l222t872r327b903],
5	(	CD	NUMBER	(	num	7	SENT_340	[p20l221t910r321b941],
6	17q21	NN	O	17q21	nn	7	SENT_340	[p20l221t910r321b941],
7	)	NN	O	)	dep	3	SENT_340	[p20l221t910r321b941],

1	ERBB3	NN	O	erbb3	nn	3	SENT_341	[p20l121t1008r210b1031],
2	(	CD	NUMBER	(	num	3	SENT_341	[p20l222t1008r322b1039],
3	12q13	NN	O	12q13	_	0	SENT_341	[p20l222t1008r322b1039],
4	)	CD	NUMBER	)	num	5	SENT_341	[p20l222t1008r322b1039],
5	c-KIT	NN	O	c-kit	dep	3	SENT_341	[p20l119t1068r189b1091],
6	(	CD	NUMBER	(	num	8	SENT_341	[p20l200t1068r283b1099],
7	4q11	NN	O	4q11	nn	8	SENT_341	[p20l200t1068r283b1099],
8	)	NN	O	)	dep	3	SENT_341	[p20l200t1068r283b1099],

1	c-MET	NN	O	c-met	_	0	SENT_342	[p20l119t1723r208b1746],
2	(	CD	NUMBER	(	dep	1	SENT_342	[p20l218t1723r301b1754],
3	7q31	CD	NUMBER	7q31	num	4	SENT_342	[p20l218t1723r301b1754],
4	)	NN	O	)	dep	1	SENT_342	[p20l218t1723r301b1754],

1	Activating	VBG	O	activate	_	0	SENT_343	[p20l438t151r576b183],
2	Mechanisms	NNS	O	mechanism	nn	3	SENT_343	[p20l587t150r760b175],
3	t	NN	O	t	dobj	1	SENT_343	[p20l562t284r634b315],
4	(	CD	NUMBER	(	number	5	SENT_343	[p20l562t284r634b315],
5	1	CD	NUMBER	1	dep	3	SENT_343	[p20l562t284r634b315],
6	;	:	O	;	_	0	SENT_343	[p20l562t284r634b315],
7	2	CD	NUMBER	2	num	8	SENT_343	[p20l562t284r634b315],
8	)	CD	NUMBER	)	dep	3	SENT_343	[p20l562t284r634b315],

1	t	NN	O	t	nn	2	SENT_344	[p20l550t385r559b405],
2	(	NN	O	(	_	0	SENT_344	[p20l572t382r646b413],
3	2	CD	NUMBER	2	dep	2	SENT_344	[p20l572t382r646b413],
4	;	:	O	;	_	0	SENT_344	[p20l572t382r646b413],
5	17	CD	NUMBER	17	number	6	SENT_344	[p20l572t382r646b413],
6	)	CD	NUMBER	)	num	8	SENT_344	[p20l572t382r646b413],
7	t	NN	O	t	nn	8	SENT_344	[p20l541t443r655b474],
8	(	NN	O	(	dep	3	SENT_344	[p20l541t443r655b474],
9	2	CD	NUMBER	2	num	11	SENT_344	[p20l541t443r655b474],
10	;	:	O	;	_	0	SENT_344	[p20l541t443r655b474],
11	11	CD	NUMBER	11	dep	8	SENT_344	[p20l541t443r655b474],
12	;	:	O	;	_	0	SENT_344	[p20l541t443r655b474],
13	2	CD	NUMBER	2	number	14	SENT_344	[p20l541t443r655b474],
14	)	CD	NUMBER	)	dep	8	SENT_344	[p20l541t443r655b474],
15	G7l9C/S	NN	O	g7l9c/s	dep	14	SENT_344	[p20l408t503r537b534],
16	;	:	O	;	_	0	SENT_344	[p20l408t503r537b534],
17	deletion	NN	O	deletion	dep	3	SENT_344	[p20l549t501r656b526],

1	LREA747_75O	NN	O	lrea747_75o	_	0	SENT_345	[p20l459t540r621b571],
2	;	:	O	;	_	0	SENT_345	[p20l459t540r621b571],
3	L858R	NN	O	l858r	dep	1	SENT_345	[p20l634t540r723b568],
4	,	,	O	,	_	0	SENT_345	[p20l634t540r723b568],
5	'	''	O	'	_	0	SENT_345	[p20l634t540r723b568],
6	L861Q	NN	O	l861q	appos	3	SENT_345	[p20l459t578r546b608],

1	Extracellular-domain	JJ	O	extracellular-domain	amod	2	SENT_346	[p20l409t637r687b662],
2	deletions	NNS	O	deletion	nsubj	3	SENT_346	[p20l699t637r763b662, p20l456t677r524b699],
3	vl	VBP	O	vl	_	0	SENT_346	[p20l534t676r616b699],
4	—	CD	NUMBER	—	dobj	3	SENT_346	[p20l534t676r616b699],
5	v	LS	O	v	dep	4	SENT_346	[p20l534t676r616b699],
6	|	CD	NUMBER	|	number	7	SENT_346	[p20l534t676r616b699],
7	|	CD	NUMBER	|	num	4	SENT_346	[p20l534t676r616b699],
8	|	IN	O	|	prep	3	SENT_346	[p20l534t676r616b699],

1	Glioblastoma	NN	O	glioblastoma	_	0	SENT_347	[p20l820t637r1011b666],
2	,	,	O	,	_	0	SENT_347	[p20l820t637r1011b666],
3	NSCLC	NN	O	nsclc	appos	1	SENT_347	[p20l1024t639r1120b662],

1	Overexpression	NN	O	overexpression	_	0	SENT_348	[p20l408t737r619b767],
2	rectal	JJ	O	rectal	amod	3	SENT_348	[p20l871t810r942b835],
3	cancer	NN	O	cancer	dep	1	SENT_348	[p20l953t818r1043b835],

1	Overexpression	NN	O	overexpression	_	0	SENT_349	[p20l408t872r627b903],
2	;	:	O	;	_	0	SENT_349	[p20l408t872r627b903],
3	kinasedomain	NN	O	kinasedomain	nn	4	SENT_349	[p20l640t870r733b895, p20l457t908r560b933],
4	mutations	NNS	O	mutation	dep	1	SENT_349	[p20l573t910r710b933],

1	Breast	NN	O	breast	nn	2	SENT_350	[p20l822t872r906b895],
2	cancer	NN	O	cancer	_	0	SENT_350	[p20l915t879r1008b900],
3	,	,	O	,	_	0	SENT_350	[p20l915t879r1008b900],
4	lung	NN	O	lung	nn	5	SENT_350	[p20l1021t870r1079b903],
5	cancer	NN	O	cancer	appos	2	SENT_350	[p20l1088t879r1177b895],

1	Soft-tissue	JJ	O	soft-tissue	amod	3	SENT_351	[p20l820t1005r964b1031],
2	clear-cell	JJ	O	clear-cell	amod	3	SENT_351	[p20l974t1006r1092b1031],
3	sarcoma	NN	O	sarcoma	_	0	SENT_351	[p20l1104t1014r1219b1031],
4	GIST	NN	O	gist	dep	3	SENT_351	[p20l820t1068r888b1091],

1	Overexpression	NN	O	overexpression	nn	2	SENT_352	[p20l408t1007r619b1038],
2	juxtamemebrane	NN	O	juxtamemebrane	_	0	SENT_352	[p20l403t1066r639b1098],
3	(	CD	NUMBER	(	num	4	SENT_352	[p20l652t1068r722b1099],
4	exon	NN	O	exon	dep	24	SENT_352	[p20l652t1068r722b1099],
5	11	CD	NUMBER	11	num	6	SENT_352	[p20l736t1068r774b1099],
6	)	NN	O	)	dep	4	SENT_352	[p20l736t1068r774b1099],
7	mutations	NNS	O	mutation	dep	6	SENT_352	[p20l459t1106r604b1129],
8	:	:	O	:	_	0	SENT_352	[p20l459t1106r604b1129],
9	deletions	NNS	O	deletion	dep	6	SENT_352	[p20l615t1103r747b1133],
10	,	,	O	,	_	0	SENT_352	[p20l615t1103r747b1133],
11	V56OD/A	NN	O	v56od/a	appos	9	SENT_352	[p20l456t1143r589b1174],
12	;	:	O	;	_	0	SENT_352	[p20l456t1143r589b1174],
13	extracellulardomain	NN	O	extracellulardomain	nn	15	SENT_352	[p20l600t1141r773b1166, p20l457t1178r560b1204],
14	(	CD	NUMBER	(	num	15	SENT_352	[p20l574t1181r645b1211],
15	exon	NN	O	exon	dep	6	SENT_352	[p20l574t1181r645b1211],
16	9	CD	NUMBER	9	num	19	SENT_352	[p20l656t1181r680b1211],
17	)	NN	O	)	nn	19	SENT_352	[p20l656t1181r680b1211],
18	mutatlonsz	NN	O	mutatlonsz	nn	19	SENT_352	[p20l694t1183r772b1204, p20l456t1218r532b1241],
19	dul3AY5o2-503	NN	O	dul3ay5o2-503	dep	15	SENT_352	[p20l543t1216r715b1249],
20	$	$	MONEY	$	dep	21	SENT_352	[p20l543t1216r715b1249],
21	kinase	NN	MONEY	kinase	dep	24	SENT_352	[p20l459t1254r543b1279],
22	domain	NN	O	domain	nn	24	SENT_352	[p20l553t1254r656b1279],
23	(	CD	NUMBER	(	num	24	SENT_352	[p20l670t1256r740b1287],
24	exon	NN	O	exon	dep	2	SENT_352	[p20l670t1256r740b1287],
25	13/17	CD	NUMBER	13/17	num	27	SENT_352	[p20l459t1293r545b1324],
26	)	NN	O	)	nn	27	SENT_352	[p20l459t1293r545b1324],
27	mutations	NNS	O	mutation	dep	24	SENT_352	[p20l559t1293r704b1316],
28	:	:	O	:	_	0	SENT_352	[p20l559t1293r704b1316],
29	K642E	NN	O	k642e	dep	2	SENT_352	[p20l459t1331r549b1358],
30	,	,	O	,	_	0	SENT_352	[p20l459t1331r549b1358],
31	D822K/H	NN	O	d822k/h	appos	29	SENT_352	[p20l563t1330r688b1362],

1	D816V/H	NN	O	d816v/h	_	0	SENT_353	[p20l409t1391r545b1422],
2	;	:	O	;	_	0	SENT_353	[p20l409t1391r545b1422],
3	N822K	NN	O	n822k	dep	1	SENT_353	[p20l558t1391r655b1419],
4	;	:	O	;	_	0	SENT_353	[p20l558t1391r655b1419],
5	Y823	NN	O	y823	nn	6	SENT_353	[p20l666t1391r731b1414],
6	D/C	NN	O	d/c	dep	3	SENT_353	[p20l737t1391r790b1422],
7	Seminoma	NN	O	seminoma	nn	8	SENT_353	[p20l820t1391r967b1414],
8	Overexpression	NN	O	overexpression	rcmod	6	SENT_353	[p20l408t1450r776b1482],
9	;	:	O	;	_	0	SENT_353	[p20l408t1450r776b1482],
10	extrace	FW	O	extrace	dep	8	SENT_353	[p20l408t1450r776b1482],
11	|	FW	O	|	nn	12	SENT_353	[p20l408t1450r776b1482],
12	|	FW	O	|	amod	10	SENT_353	[p20l408t1450r776b1482],
13	u	SYM	O	u	dep	8	SENT_353	[p20l408t1450r776b1482],
14	-	:	O	-	_	0	SENT_353	[p20l408t1450r776b1482],
15	SCLC	NN	ORGANIZATION	sclc	dep	1	SENT_353	[p20l820t1451r892b1475],

1	lar-domain	NN	O	lar-domain	_	0	SENT_354	[p20l459t1487r604b1512],
2	and	CC	O	and	_	0	SENT_354	[p20l616t1487r664b1512],
3	juxtamembrane	NN	O	juxtamembrane	nn	4	SENT_354	[p20l674t1489r748b1520, p20l459t1525r606b1550],
4	mutations	NNS	O	mutation	conj_and	1	SENT_354	[p20l617t1527r754b1550],

1	Overexpression	NN	O	overexpression	_	0	SENT_355	[p20l408t1585r776b1618],
2	;	:	O	;	_	0	SENT_355	[p20l408t1585r776b1618],
3	extracellu	SYM	O	extracellu	dep	1	SENT_355	[p20l408t1585r776b1618],
4	-	:	O	-	_	0	SENT_355	[p20l408t1585r776b1618],
5	Sarcomas	FW	O	sarcomas	dep	3	SENT_355	[p20l820t1587r953b1610],
6	lar-domain	NN	O	lar-domain	nn	9	SENT_355	[p20l459t1623r604b1648],
7	and	CC	O	and	_	0	SENT_355	[p20l616t1623r664b1648],
8	juxtamembrane	NN	O	juxtamembrane	nn	9	SENT_355	[p20l674t1625r748b1656, p20l459t1660r606b1685],
9	mutations	NNS	O	mutation	dep	5	SENT_355	[p20l617t1662r754b1685],

1	Musculoskeletal	JJ	O	musculoskeletal	amod	2	SENT_356	[p20l822t1720r1040b1746],
2	tumors	NNS	O	tumor	_	0	SENT_356	[p20l1051t1725r1149b1746],
3	SCLC	NN	ORGANIZATION	sclc	dep	2	SENT_356	[p20l820t1783r892b1806],

1	Overexpression	NN	O	overexpression	_	0	SENT_357	[p20l408t1722r628b1753],
2	;	:	O	;	_	0	SENT_357	[p20l408t1722r628b1753],
3	truncation	NN	O	truncation	nn	5	SENT_357	[p20l638t1723r778b1746],
4	juxtamembrane	NN	O	juxtamembrane	nn	5	SENT_357	[p20l403t1781r623b1813],
5	mutations	NNS	O	mutation	dep	1	SENT_357	[p20l635t1783r780b1806],
6	:	:	O	:	_	0	SENT_357	[p20l635t1783r780b1806],

1	R988C	NN	O	r988c	_	0	SENT_358	[p20l459t1820r552b1848],
2	,	,	O	,	_	0	SENT_358	[p20l459t1820r552b1848],
3	T1010	NN	TIME	t1010	nn	4	SENT_358	[p20l562t1820r653b1844],
4	|	NN	O	|	appos	1	SENT_358	[p20l562t1820r653b1844],

1	TPR-M	NN	O	tpr-m	nn	3	SENT_359	[p20l406t1881r497b1904],
2	ET	NNP	O	ET	nn	3	SENT_359	[p20l504t1881r536b1904],
3	fusion	NN	O	fusion	_	0	SENT_359	[p20l545t1879r628b1904],
4	Gastric	JJ	MISC	gastric	amod	7	SENT_359	[p20l820t1881r917b1904],
5	cancer	NN	O	cancer	nn	7	SENT_359	[p20l927t1888r1016b1904],
6	Kinase-domain	NN	O	kinase-domain	nn	7	SENT_359	[p20l409t1939r611b1965],
7	mutations	NNS	O	mutation	dep	3	SENT_359	[p20l624t1942r769b1965],
8	:	:	O	:	_	0	SENT_359	[p20l624t1942r769b1965],

1	M12681	NN	O	m12681	_	0	SENT_360	[p20l459t1979r572b2007],
2	"	''	O	"	punct	1	SENT_360	[p20l459t1979r572b2007],
3	,	,	O	,	_	0	SENT_360	[p20l459t1979r572b2007],
4	M1149T	NN	O	m1149t	appos	1	SENT_360	[p20l586t1979r696b2002],

1	Renal	JJ	O	renal	amod	3	SENT_361	[p20l822t1939r893b1965],
2	papillary	JJ	O	papillary	amod	3	SENT_361	[p20l906t1939r1020b1972],
3	carcinoma	NN	O	carcinoma	_	0	SENT_361	[p20l1029t1942r1172b1965],

1	Overexpression	NN	O	overexpression	_	0	SENT_362	[p20l408t2039r619b2070],

1	Malignant	JJ	O	malignant	amod	13	SENT_363	[p20l822t2037r959b2071],
2	melanoma	NN	O	melanoma	nn	13	SENT_363	[p20l970t2037r1113b2063],
3	SCCHN	NN	O	scchn	nn	13	SENT_363	[p20l820t737r934b764],
4	,	,	O	,	_	0	SENT_363	[p20l820t737r934b764],
5	NSCLC	NN	LOCATION	nsclc	dep	13	SENT_363	[p20l946t737r1049b764],
6	,	,	O	,	_	0	SENT_363	[p20l946t737r1049b764],
7	ovarian	JJ	O	ovarian	amod	13	SENT_363	[p20l1059t737r1157b760],
8	cancer	NN	O	cancer	nn	13	SENT_363	[p20l1167t743r1260b764],
9	,	,	O	,	_	0	SENT_363	[p20l1167t743r1260b764],
10	RCC	NN	ORGANIZATION	rcc	dep	13	SENT_363	[p20l872t774r934b802],
11	,	,	O	,	_	0	SENT_363	[p20l872t774r934b802],
12	pancreatic	JJ	O	pancreatic	amod	13	SENT_363	[p20l947t775r1087b805],
13	cancer	NN	O	cancer	_	0	SENT_363	[p20l1097t781r1189b802],
14	,	,	O	,	_	0	SENT_363	[p20l1097t781r1189b802],
15	coloTargeted	VBN	O	colotarget	partmod	13	SENT_363	[p20l1201t772r1266b797, p20l1325t150r1441b183],

1	Therapy	NN	O	therapy	_	0	SENT_364	[p20l1451t150r1579b183],
2	:	:	O	:	_	0	SENT_364	[p20l1451t150r1579b183],
3	§	CD	NUMBER	§	dep	1	SENT_364	[p20l1451t150r1579b183],
4	:	:	O	:	_	0	SENT_364	[p20l1451t150r1579b183],
5	References	NNS	O	reference	dep	3	SENT_364	[p20l1767t150r1914b175],

1	Pulford	NNP	PERSON	Pulford	nn	3	SENT_365	[p20l1641t282r1736b308],
2	et	NNP	O	et	nn	3	SENT_365	[p20l1748t287r1772b307],
3	aI	NNP	O	aI	_	0	SENT_365	[p20l1782t282r1837b307],
4	.15	CD	NUMBER	.15	dep	3	SENT_365	[p20l1782t282r1837b307],

1	Gefitinib	NNP	O	Gefitinib	nn	4	SENT_366	[p20l1295t501r1419b531],
2	,	,	O	,	_	0	SENT_366	[p20l1295t501r1419b531],
3	erlotinib	NNP	O	erlotinib	appos	4	SENT_366	[p20l1431t501r1543b526],
4	Lynch	NNP	PERSON	Lynch	_	0	SENT_366	[p20l1641t501r1715b534],
5	et	FW	O	et	nn	6	SENT_366	[p20l1726t506r1750b526],
6	al.	FW	O	al.	dep	4	SENT_366	[p20l1760t501r1811b531],
7	,	,	O	,	_	0	SENT_366	[p20l1760t501r1811b531],
8	'	''	O	'	_	0	SENT_366	[p20l1760t501r1811b531],
9	5	CD	NUMBER	5	num	10	SENT_366	[p20l1760t501r1811b531],
10	Pao	NNP	O	Pao	dep	4	SENT_366	[p20l1823t504r1871b526],
11	et	FW	O	et	nn	12	SENT_366	[p20l1881t506r1905b526],
12	al.	FW	O	al.	dep	4	SENT_366	[p20l1915t501r1966b531],
13	,7	CD	NUMBER	,7	dep	12	SENT_366	[p20l1915t501r1966b531],

1	Paez	NNP	PERSON	Paez	dep	5	SENT_367	[p20l1691t541r1752b564],
2	et	FW	O	et	nn	3	SENT_367	[p20l1762t544r1786b564],
3	al.	FW	O	al.	dep	1	SENT_367	[p20l1796t539r1860b568],
4	,54	CD	NUMBER	,54	dep	5	SENT_367	[p20l1796t539r1860b568],
5	Kris	NNP	PERSON	Kris	dep	9	SENT_367	[p20l1872t541r1920b564],
6	et	FW	O	et	nn	7	SENT_367	[p20l1931t543r1955b564],
7	al.	FW	O	al.	dep	5	SENT_367	[p20l1965t539r2028b568],
8	,55	CD	NUMBER	,55	num	9	SENT_367	[p20l1965t539r2028b568],
9	Shepherd	NNP	O	Shepherd	dep	12	SENT_367	[p20l1689t576r1817b609],
10	et	FW	O	et	nn	11	SENT_367	[p20l1829t581r1853b601],
11	al.	FW	O	al.	dep	9	SENT_367	[p20l1863t576r1918b601],
12	55	CD	NUMBER	55	_	0	SENT_367	[p20l1863t576r1918b601],

1	Geﬁtinib	NNP	O	Geﬁtinib	nn	5	SENT_368	[p20l1295t636r1419b666],
2	,	,	O	,	_	0	SENT_368	[p20l1295t636r1419b666],
3	erlotinib	JJ	O	erlotinib	amod	5	SENT_368	[p20l1431t637r1556b670],
4	§	NN	O	§	nn	5	SENT_368	[p20l1431t637r1556b670],
5	Frederick	NNP	PERSON	Frederick	dep	9	SENT_368	[p20l1641t637r1762b662],
6	et	FW	O	et	nn	7	SENT_368	[p20l1772t641r1796b662],
7	al.	FW	O	al.	dep	5	SENT_368	[p20l1806t637r1870b666],
8	,57	CD	NUMBER	,57	dep	9	SENT_368	[p20l1806t637r1870b666],
9	Rich	NNP	O	Rich	dep	12	SENT_368	[p20l1882t637r1937b662],
10	et	FW	O	et	nn	11	SENT_368	[p20l1948t641r1972b662],
11	al.	FW	O	al.	dep	9	SENT_368	[p20l1982t637r2038b662],
12	58	CD	NUMBER	58	_	0	SENT_368	[p20l1982t637r2038b662],

1	Geﬁtinib	NNP	O	Geﬁtinib	_	0	SENT_369	[p20l1295t734r1433b767],
2	,	,	O	,	_	0	SENT_369	[p20l1295t734r1433b767],
3	§	CD	NUMBER	§	num	4	SENT_369	[p20l1295t734r1433b767],
4	erlotinib	NN	O	erlotinib	appos	1	SENT_369	[p20l1444t734r1578b767],
5	,	,	O	,	_	0	SENT_369	[p20l1444t734r1578b767],
6	\	NN	O	\	nn	8	SENT_369	[p20l1444t734r1578b767],
7	j	NN	O	j	nn	8	SENT_369	[p20l1444t734r1578b767],
8	cetuximab	NN	O	cetuximab	appos	1	SENT_369	[p20l1345t772r1492b802],
9	,	,	O	,	_	0	SENT_369	[p20l1345t772r1492b802],
10	ABXEGF	NN	O	abxegf	appos	1	SENT_369	[p20l1502t774r1569b797, p20l1347t812r1402b835],

1	Trastuzumab	NNP	O	Trastuzumab	_	0	SENT_370	[p20l1294t870r1480b900],
2	,	,	O	,	_	0	SENT_370	[p20l1294t870r1480b900],
3	2C4	NN	O	2c4	appos	1	SENT_370	[p20l1491t872r1550b900],
4	,	,	O	,	_	0	SENT_370	[p20l1491t872r1550b900],

1	Cl-1033	NN	O	cl-1033	_	0	SENT_371	[p20l1345t909r1447b933],

1	Mendelsohn	NNP	PERSON	Mendelsohn	dep	7	SENT_372	[p20l1641t735r1809b760],
2	and	CC	O	and	_	0	SENT_372	[p20l1820t735r1868b760],
3	Base	NNP	O	Base	conj_and	1	SENT_372	[p20l1882t735r2019b768],
4	|	CD	NUMBER	|	num	3	SENT_372	[p20l1882t735r2019b768],
5	ga	NN	O	ga	dep	7	SENT_372	[p20l1882t735r2019b768],
6	,59	CD	NUMBER	,59	num	5	SENT_372	[p20l1882t735r2019b768],
7	Cunningham	NNP	O	Cunningham	dep	11	SENT_372	[p20l1689t772r1865b805],
8	et	FW	O	et	nn	9	SENT_372	[p20l1876t777r1901b797],
9	al.	FW	O	al.	dep	7	SENT_372	[p20l1910t772r1939b797],
10	5	CD	NUMBER	5	num	11	SENT_372	[p20l1950t775r1975b789],
11	°	NN	O	°	_	0	SENT_372	[p20l1950t775r1975b789],

1	Finn	NNP	PERSON	Finn	nn	5	SENT_373	[p20l1641t872r1697b895],
2	and	CC	O	and	_	0	SENT_373	[p20l1709t870r1757b895],
3	Slamon	NNP	PERSON	Slamon	conj_and	1	SENT_373	[p20l1769t870r1905b900],
4	,	,	O	,	_	0	SENT_373	[p20l1769t870r1905b900],
5	“	NNP	O	“	dep	15	SENT_373	[p20l1769t870r1905b900],
6	Stephens	NNP	PERSON	Stephens	dep	5	SENT_373	[p20l1689t908r1814b940],
7	et	FW	O	et	nn	8	SENT_373	[p20l1825t912r1849b933],
8	al.	FW	O	al.	dep	6	SENT_373	[p20l1859t908r1923b937],
9	,	,	O	,	_	0	SENT_373	[p20l1859t908r1923b937],
10	“	CD	NUMBER	“	num	11	SENT_373	[p20l1859t908r1923b937],
11	Slamon	NNP	PERSON	Slamon	appos	8	SENT_373	[p20l1689t945r1791b970],
12	et	FW	O	et	nn	13	SENT_373	[p20l1802t950r1827b970],
13	al.	FW	O	al.	dep	11	SENT_373	[p20l1836t945r1891b970],
14	53	CD	NUMBER	53	dep	15	SENT_373	[p20l1836t945r1891b970],
15	Schaefer	NNP	ORGANIZATION	Schaefer	dep	19	SENT_373	[p20l1639t1005r1756b1031],
16	et	FW	O	et	nn	17	SENT_373	[p20l1765t1010r1789b1031],
17	aI	FW	O	ai	dep	15	SENT_373	[p20l1799t1006r1855b1031],
18	.54	CD	NUMBER	.54	num	19	SENT_373	[p20l1799t1006r1855b1031],
19	Hirota	NNP	O	Hirota	dep	23	SENT_373	[p20l1641t1068r1725b1091],
20	et	FW	O	et	nn	21	SENT_373	[p20l1736t1071r1760b1091],
21	al.	FW	O	al.	dep	19	SENT_373	[p20l1770t1066r1833b1096],
22	,55	CD	NUMBER	,55	num	23	SENT_373	[p20l1770t1066r1833b1096],
23	Rubin	NNP	PERSON	Rubin	dep	26	SENT_373	[p20l1846t1066r1921b1091],
24	et	FW	O	et	nn	25	SENT_373	[p20l1933t1071r1957b1091],
25	al.	FW	O	al.	dep	23	SENT_373	[p20l1967t1066r2031b1096],
26	,55	CD	NUMBER	,55	_	0	SENT_373	[p20l1967t1066r2031b1096],

1	Demetri	NNP	PERSON	Demetri	_	0	SENT_374	[p20l1691t1106r1798b1129],
2	et	FW	O	et	nn	3	SENT_374	[p20l1810t1108r1834b1129],
3	al.	FW	O	al.	dep	1	SENT_374	[p20l1844t1103r1899b1129],
4	57	CD	NUMBER	57	dep	1	SENT_374	[p20l1844t1103r1899b1129],

1	Kemmer	NNP	PERSON	Kemmer	dep	7	SENT_375	[p20l1641t1391r1756b1414],
2	et	FW	O	et	dep	1	SENT_375	[p20l1765t1394r1789b1414],
3	al.	FW	O	al.	nn	4	SENT_375	[p20l1799t1389r1854b1414],
4	“	FW	O	“	dep	2	SENT_375	[p20l1799t1389r1854b1414],
5	Boldrini	NNP	PERSON	Boldrini	dep	7	SENT_375	[p20l1641t1446r1745b1471],
6	et	FW	O	et	nn	7	SENT_375	[p20l1756t1451r1780b1471],
7	al.	FW	O	al.	dep	9	SENT_375	[p20l1790t1446r1854b1476],
8	,59	CD	NUMBER	,59	dep	7	SENT_375	[p20l1790t1446r1854b1476],
9	Johnson	NNP	PERSON	Johnson	_	0	SENT_375	[p20l1684t1484r1800b1516],
10	et	FW	O	et	nn	14	SENT_375	[p20l1811t1488r1835b1509],
11	a	FW	O	a	nn	14	SENT_375	[p20l1845t1484r1902b1509],
12	|	FW	O	|	nn	14	SENT_375	[p20l1845t1484r1902b1509],
13	.7	FW	NUMBER	.7	nn	14	SENT_375	[p20l1845t1484r1902b1509],
14	°	FW	O	°	dep	9	SENT_375	[p20l1845t1484r1902b1509],

1	Imatinibﬁ	NNP	O	Imatinibﬁ	_	0	SENT_376	[p20l1297t1389r1422b1422],
2	(	CD	NUMBER	(	num	1	SENT_376	[p20l1435t1391r1489b1422],
3	not	RB	O	not	neg	4	SENT_376	[p20l1435t1391r1489b1422],
4	D816X	NN	O	d816x	dep	1	SENT_376	[p20l1501t1391r1598b1422],
5	)	CD	NUMBER	)	num	8	SENT_376	[p20l1501t1391r1598b1422],
6	|	NN	O	|	nn	8	SENT_376	[p20l1297t1449r1422b1482],
7	matinib	NN	O	matinib	nn	8	SENT_376	[p20l1297t1449r1422b1482],
8	§	NN	O	§	dep	1	SENT_376	[p20l1297t1449r1422b1482],

1	lmatinibﬁ	NN	O	lmatinibﬁ	nn	2	SENT_377	[p20l1297t1585r1422b1618],
2	Smithey	NNP	PERSON	Smithey	_	0	SENT_377	[p20l1639t1585r1749b1618],
3	et	FW	O	et	nn	4	SENT_377	[p20l1758t1590r1782b1610],
4	al.	FW	O	al.	dep	2	SENT_377	[p20l1792t1585r1855b1615],
5	,71	CD	NUMBER	,71	dep	2	SENT_377	[p20l1792t1585r1855b1615],

1	Tamborini	NNP	O	Tamborini	_	0	SENT_378	[p20l1688t1623r1825b1648],
2	et	FW	O	et	dep	1	SENT_378	[p20l1837t1627r1861b1648],
3	a	FW	O	a	nn	4	SENT_378	[p20l1871t1623r1926b1648],
4	|	FW	O	|	advmod	5	SENT_378	[p20l1871t1623r1926b1648],
5	.72	CD	NUMBER	.72	rcmod	2	SENT_378	[p20l1871t1623r1926b1648],

1	Wallenius	NNP	PERSON	Wallenius	dep	5	SENT_379	[p20l1638t1720r1769b1746],
2	et	FW	O	et	nn	3	SENT_379	[p20l1780t1725r1804b1746],
3	al.	FW	O	al.	dep	1	SENT_379	[p20l1814t1720r1869b1746],
4	73	CD	NUMBER	73	dep	5	SENT_379	[p20l1814t1720r1869b1746],
5	Ma	NNP	O	Ma	dep	8	SENT_379	[p20l1641t1783r1681b1806],
6	et	FW	O	et	nn	7	SENT_379	[p20l1692t1786r1716b1806],
7	al.	FW	O	al.	dep	5	SENT_379	[p20l1726t1781r1782b1806],
8	74	CD	NUMBER	74	_	0	SENT_379	[p20l1726t1781r1782b1806],

1	Soman	NNP	PERSON	Soman	dep	5	SENT_380	[p20l1639t1881r1733b1904],
2	et	FW	O	et	nn	3	SENT_380	[p20l1744t1884r1769b1904],
3	al.	FW	O	al.	dep	1	SENT_380	[p20l1779t1879r1833b1904],
4	75	CD	NUMBER	75	dep	5	SENT_380	[p20l1779t1879r1833b1904],
5	Schmidt	NNP	O	Schmidt	dep	8	SENT_380	[p20l1639t1936r1752b1961],
6	et	FW	O	et	nn	7	SENT_380	[p20l1762t1941r1786b1961],
7	al.	FW	O	al.	dep	5	SENT_380	[p20l1796t1936r1851b1961],
8	75	CD	NUMBER	75	_	0	SENT_380	[p20l1796t1936r1851b1961],

1	Cruz	NNP	PERSON	Cruz	_	0	SENT_381	[p20l1639t2039r1700b2063],
2	et	FW	O	et	nn	3	SENT_381	[p20l1710t2042r1734b2063],
3	al.	FW	O	al.	dep	1	SENT_381	[p20l1744t2037r1799b2062],
4	77	CD	NUMBER	77	dep	1	SENT_381	[p20l1744t2037r1799b2062],

1	head	NN	O	head	_	0	SENT_382	[p20l380t2194r460b2225],
2	and	CC	O	and	_	0	SENT_382	[p20l471t2194r532b2225],
3	neck	NN	O	neck	conj_and	1	SENT_382	[p20l542t2194r628b2231],
4	,	,	O	,	_	0	SENT_382	[p20l542t2194r628b2231],
5	and	CC	O	and	_	0	SENT_382	[p20l639t2194r700b2225],
6	colorectal	JJ	O	colorectal	amod	7	SENT_382	[p20l710t2194r871b2225],
7	cancer	NN	O	cancer	conj_and	1	SENT_382	[p20l880t2204r994b2225],
8	.	.	O	.	_	0	SENT_382	[p20l880t2204r994b2225],

1	In	IN	O	in	_	0	SENT_383	[p20l1005t2197r1039b2224],
2	metastatic	JJ	O	metastatic	amod	8	SENT_383	[p20l1049t2201r1203b2225, p20l380t2244r416b2280],
3	,	,	O	,	_	0	SENT_383	[p20l1049t2201r1203b2225, p20l380t2244r416b2280],
4	EGFR-positive	JJ	O	egfr-positive	amod	8	SENT_383	[p20l429t2244r679b2282],
5	,	,	O	,	_	0	SENT_383	[p20l429t2244r679b2282],
6	chemotherapy-refractory	JJ	O	chemotherapy-refractory	amod	8	SENT_383	[p20l693t2243r1110b2282],
7	colorectal	JJ	O	colorectal	amod	8	SENT_383	[p20l1120t2243r1203b2274, p20l380t2292r473b2323],
8	cancer	NN	O	cancer	prep_in	12	SENT_383	[p20l482t2302r598b2329],
9	,	,	O	,	_	0	SENT_383	[p20l482t2302r598b2329],
10	cetuximab	NN	O	cetuximab	nsubj	12	SENT_383	[p20l610t2292r782b2323],
11	alone	RB	O	alone	advmod	12	SENT_383	[p20l792t2292r883b2323],
12	had	VBD	O	have	_	0	SENT_383	[p20l893t2292r954b2323],
13	minimal	JJ	O	minimal	amod	14	SENT_383	[p20l963t2292r1105b2323],
14	activity	NN	O	activity	dobj	12	SENT_383	[p20l1114t2293r1203b2323, p20l380t2342r425b2380],
15	,	,	O	,	_	0	SENT_383	[p20l1114t2293r1203b2323, p20l380t2342r425b2380],
16	but	CC	O	but	_	0	SENT_383	[p20l437t2341r492b2372],
17	when	WRB	O	when	advmod	18	SENT_383	[p20l498t2341r590b2372],
18	combined	VBN	O	combine	advcl	22	SENT_383	[p20l600t2341r767b2372],
19	with	IN	O	with	_	0	SENT_383	[p20l774t2341r849b2372],
20	irinotecan	NN	O	irinotecan	prep_with	18	SENT_383	[p20l858t2342r1028b2372],
21	it	PRP	O	it	nsubj	30	SENT_383	[p20l1036t2342r1060b2372],
22	had	VBD	O	have	conj_but	12	SENT_383	[p20l1067t2341r1129b2372],
23	a	DT	O	a	det	27	SENT_383	[p20l1138t2351r1155b2372],
24	22	CD	PERCENT	22	num	27	SENT_383	[p20l1164t2343r1203b2371],
25	percent	NN	PERCENT	percent	nn	27	SENT_383	[p20l380t2397r506b2429],
26	response	NN	O	response	nn	27	SENT_383	[p20l514t2400r661b2429],
27	rate	NN	O	rate	dobj	22	SENT_383	[p20l671t2397r732b2421],
28	and	CC	O	and	_	0	SENT_383	[p20l741t2390r802b2421],
29	modestly	RB	O	modestly	advmod	30	SENT_383	[p20l811t2390r962b2429],
30	increased	VBD	O	increase	conj_and	22	SENT_383	[p20l969t2390r1125b2421],
31	progression-free	JJ	O	progression-free	amod	34	SENT_383	[p20l1134t2400r1203b2429, p20l380t2439r596b2479],
32	and	CC	O	and	_	0	SENT_383	[p20l604t2440r664b2471],
33	overall	JJ	O	overall	amod	34	SENT_383	[p20l673t2440r781b2471],
34	survival	NN	O	survival	dobj	30	SENT_383	[p20l790t2437r955b2477],
35	,	,	O	,	_	0	SENT_383	[p20l790t2437r955b2477],
36	“	CD	NUMBER	“	appos	34	SENT_383	[p20l790t2437r955b2477],
37	leading	VBG	O	lead	partmod	36	SENT_383	[p20l963t2440r1086b2479],
38	to	TO	O	to	_	0	SENT_383	[p20l1093t2446r1124b2471],
39	FDA	NNP	ORGANIZATION	FDA	nn	40	SENT_383	[p20l1132t2442r1205b2470],
40	approval	NN	O	approval	prep_to	37	SENT_383	[p20l380t2489r525b2528],
41	for	IN	O	for	_	0	SENT_383	[p20l537t2489r586b2520],
42	this	DT	O	this	det	43	SENT_383	[p20l598t2489r659b2520],
43	indication	NN	O	indication	prep_for	37	SENT_383	[p20l672t2489r843b2520],
44	in	IN	O	in	_	0	SENT_383	[p20l855t2490r888b2519],
45	2004	CD	DATE	2004	prep_in	43	SENT_383	[p20l900t2491r992b2520],
46	.	.	O	.	_	0	SENT_383	[p20l900t2491r992b2520],

1	ABX-EGF	NN	O	abx-egf	nsubj	7	SENT_384	[p20l1005t2491r1164b2520],
2	is	VBZ	O	be	cop	7	SENT_384	[p20l1177t2490r1203b2520],
3	a	DT	O	a	det	7	SENT_384	[p20l380t2548r397b2568],
4	humanized	JJ	O	humanized	amod	7	SENT_384	[p20l406t2538r590b2569],
5	anti-EGFR	JJ	O	anti-egfr	amod	7	SENT_384	[p20l598t2539r774b2571],
6	monoclonal	JJ	O	monoclonal	amod	7	SENT_384	[p20l779t2538r974b2569],
7	antibody	NN	O	antibody	_	0	SENT_384	[p20l983t2538r1126b2577],
8	with	IN	O	with	prep	7	SENT_384	[p20l1131t2538r1204b2569],

1	N	NN	O	n	nn	2	SENT_385	[p20l863t2654r877b2669],
2	ENGLJ	NN	O	englj	dep	3	SENT_385	[p20l892t2653r976b2675],
3	MED	VBD	O	med	_	0	SENT_385	[p20l991t2654r1044b2669],
4	353:2	CD	NUMBER	353:2	num	5	SENT_385	[p20l1056t2653r1120b2675],
5	WWW.NEjM.ORG	NN	O	www.nejm.org	nsubj	3	SENT_385	[p20l1155t2653r1366b2675],

1	activity	NN	O	activity	nsubj	27	SENT_386	[p20l1243t2195r1360b2233],
2	as	IN	O	as	_	0	SENT_386	[p20l1368t2204r1402b2225],
3	a	DT	O	a	det	5	SENT_386	[p20l1413t2204r1430b2225],
4	single	JJ	O	single	amod	5	SENT_386	[p20l1441t2194r1540b2233],
5	agent	NN	O	agent	prep_as	1	SENT_386	[p20l1551t2201r1644b2233],
6	in	IN	O	in	_	0	SENT_386	[p20l1653t2195r1685b2224],
7	phase	NN	O	phase	prep_in	5	SENT_386	[p20l1695t2194r1793b2233],
8	2	CD	NUMBER	2	num	9	SENT_386	[p20l1803t2196r1822b2224],
9	trials	NNS	O	trial	dep	5	SENT_386	[p20l1833t2194r1916b2225],
10	in	IN	O	in	_	0	SENT_386	[p20l1927t2195r1959b2224],
11	metastatic	JJ	O	metastatic	amod	12	SENT_386	[p20l1970t2201r2066b2225, p20l1244t2244r1332b2274],
12	renal-cell	NN	O	renal-cell	prep_in	9	SENT_386	[p20l1342t2243r1495b2274],
13	and	CC	O	and	_	0	SENT_386	[p20l1504t2243r1565b2274],
14	colorectal	JJ	O	colorectal	amod	16	SENT_386	[p20l1575t2243r1735b2274],
15	carcinoma	NN	O	carcinoma	nn	16	SENT_386	[p20l1745t2241r1974b2274],
16	.1	NN	NUMBER	.1	conj_and	5	SENT_386	[p20l1745t2241r1974b2274],
17	°	CD	NUMBER	°	number	18	SENT_386	[p20l1745t2241r1974b2274],
18	3	CD	NUMBER	3	num	25	SENT_386	[p20l1745t2241r1974b2274],
19	Vascular	JJ	O	vascular	amod	25	SENT_386	[p20l1291t2292r1434b2323],
20	endothelial	JJ	O	endothelial	amod	25	SENT_386	[p20l1449t2292r1637b2323],
21	growth	NN	O	growth	nn	25	SENT_386	[p20l1653t2292r1772b2331],
22	factor	NN	O	factor	nn	25	SENT_386	[p20l1788t2292r1886b2323],
23	(	CD	NUMBER	(	num	25	SENT_386	[p20l1903t2294r2022b2327],
24	VEGF	NN	O	vegf	nn	25	SENT_386	[p20l1903t2294r2022b2327],
25	)	NN	O	)	dep	16	SENT_386	[p20l1903t2294r2022b2327],
26	is	VBZ	O	be	cop	27	SENT_386	[p20l2039t2293r2065b2323],
27	essential	JJ	O	essential	_	0	SENT_386	[p20l1243t2341r1388b2372],
28	for	IN	O	for	_	0	SENT_386	[p20l1399t2341r1448b2372],
29	angiogenesis	NN	O	angiogenesis	prep_for	27	SENT_386	[p20l1457t2342r1687b2380],
30	,	,	O	,	_	0	SENT_386	[p20l1457t2342r1687b2380],
31	and	CC	O	and	_	0	SENT_386	[p20l1699t2341r1761b2372],
32	either	CC	O	either	preconj	33	SENT_386	[p20l1772t2341r1868b2372],
33	it	PRP	O	it	nsubjpass	45	SENT_386	[p20l1878t2342r1902b2372],
34	or	CC	O	or	_	0	SENT_386	[p20l1911t2351r1946b2372],
35	its	PRP$	O	its	poss	40	SENT_386	[p20l1956t2342r1994b2372],
36	two	CD	NUMBER	two	amod	40	SENT_386	[p20l2006t2348r2066b2372],
37	receptor	NN	O	receptor	nn	40	SENT_386	[p20l1243t2397r1382b2429],
38	TKs	NN	O	tk	nn	40	SENT_386	[p20l1389t2393r1454b2421],
39	(	CD	NUMBER	(	num	40	SENT_386	[p20l1466t2392r1632b2425],
40	VEGFR-1	NN	O	vegfr-1	conj_or	33	SENT_386	[p20l1466t2392r1632b2425],
41	and	CC	O	and	_	0	SENT_386	[p20l1640t2390r1702b2421],
42	VEGFR-2	NN	O	vegfr-2	nn	43	SENT_386	[p20l1709t2392r1876b2425],
43	)	NN	O	)	conj_or	33	SENT_386	[p20l1709t2392r1876b2425],
44	are	VBP	O	be	auxpass	45	SENT_386	[p20l1887t2400r1937b2421],
45	overexpressed	VBN	O	overexpress	conj_and	27	SENT_386	[p20l1946t2400r2065b2421, p20l1242t2440r1371b2479],
46	in	IN	O	in	advcl	45	SENT_386	[p20l1381t2440r1413b2470],
47	many	JJ	O	many	amod	52	SENT_386	[p20l1423t2450r1515b2479],
48	non	JJ	O	non	amod	52	SENT_386	[p20l1524t2440r1774b2471],
49	—	NN	O	—	nn	52	SENT_386	[p20l1524t2440r1774b2471],
50	small-cell	NN	O	small-cell	nn	52	SENT_386	[p20l1524t2440r1774b2471],
51	lung	NN	O	lung	nn	52	SENT_386	[p20l1784t2440r1861b2479],
52	cancers	NNS	O	cancer	dep	70	SENT_386	[p20l1870t2450r1994b2470],
53	and	CC	O	and	_	0	SENT_386	[p20l2005t2440r2066b2471],
54	breast	NN	O	breast	nn	58	SENT_386	[p20l1243t2489r1352b2526],
55	,	,	O	,	_	0	SENT_386	[p20l1243t2489r1352b2526],
56	prostate	NN	O	prostate	dep	58	SENT_386	[p20l1374t2496r1521b2528],
57	,	,	O	,	_	0	SENT_386	[p20l1374t2496r1521b2528],
58	renal-cell	NN	O	renal-cell	conj_and	52	SENT_386	[p20l1543t2489r1708b2526],
59	,	,	O	,	_	0	SENT_386	[p20l1543t2489r1708b2526],
60	and	CC	O	and	_	0	SENT_386	[p20l1730t2489r1791b2520],
61	colorectal	JJ	O	colorectal	amod	62	SENT_386	[p20l1811t2489r1976b2520],
62	cancers	NNS	O	cancer	dep	70	SENT_386	[p20l1996t2499r2066b2520, p20l1243t2536r1369b2569],
63	.1	CD	NUMBER	.1	number	64	SENT_386	[p20l1996t2499r2066b2520, p20l1243t2536r1369b2569],
64	°	CD	NUMBER	°	num	65	SENT_386	[p20l1996t2499r2066b2520, p20l1243t2536r1369b2569],
65	“	NN	O	“	dep	62	SENT_386	[p20l1996t2499r2066b2520, p20l1243t2536r1369b2569],
66	A	DT	O	a	det	68	SENT_386	[p20l1380t2541r1406b2568],
67	pivotal	JJ	O	pivotal	amod	68	SENT_386	[p20l1417t2538r1531b2577],
68	phase	NN	O	phase	dep	70	SENT_386	[p20l1543t2538r1640b2577],
69	3	CD	NUMBER	3	num	70	SENT_386	[p20l1653t2540r1670b2569],
70	study	NN	O	study	dep	46	SENT_386	[p20l1685t2538r1774b2577],
71	in	IN	O	in	_	0	SENT_386	[p20l1784t2539r1816b2568],
72	metastatic	JJ	O	metastatic	amod	73	SENT_386	[p20l1829t2539r2003b2569],
73	coJULY14	NN	O	cojuly14	prep_in	70	SENT_386	[p20l2016t2548r2066b2569, p20l1400t2653r1507b2675],
74	,	,	O	,	_	0	SENT_386	[p20l2016t2548r2066b2569, p20l1400t2653r1507b2675],

1	2005	CD	DATE	2005	_	0	SENT_387	[p20l1520t2653r1583b2675],

1	The	DT	O	the	det	4	SENT_388	[p20l880t2750r931b2774],
2	New	NNP	O	New	nn	4	SENT_388	[p20l940t2751r1002b2774],
3	England	NNP	O	England	nn	4	SENT_388	[p20l1011t2750r1122b2781],
4	Journal	NNP	O	Journal	_	0	SENT_388	[p20l1131t2750r1228b2774],
5	of	IN	O	of	_	0	SENT_388	[p20l1238t2750r1267b2774],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_388	[p20l1274t2750r1399b2774],

1	Downloaded	VBN	O	download	_	0	SENT_389	[p20l322t2791r492b2814],
2	from	IN	O	from	_	0	SENT_389	[p20l501t2791r565b2814],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_389	[p20l574t2791r692b2821],
4	at	IN	O	at	_	0	SENT_389	[p20l703t2795r726b2814],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_389	[p20l734t2791r917b2814],
6	on	IN	O	on	_	0	SENT_389	[p20l926t2798r959b2814],
7	January	NNP	DATE	January	prep_on	1	SENT_389	[p20l967t2791r1070b2821],
8	5	CD	DATE	5	num	7	SENT_389	[p20l1080t2791r1103b2818],
9	,	,	DATE	,	_	0	SENT_389	[p20l1080t2791r1103b2818],
10	2014	CD	DATE	2014	num	7	SENT_389	[p20l1113t2791r1186b2814],
11	.	.	O	.	_	0	SENT_389	[p20l1113t2791r1186b2814],

1	For	IN	O	for	_	0	SENT_390	[p20l1196t2791r1243b2814],
2	personal	JJ	O	personal	amod	3	SENT_390	[p20l1251t2791r1363b2821],
3	use	NN	O	use	pobj	1	SENT_390	[p20l1372t2798r1416b2814],
4	only	RB	O	only	advmod	3	SENT_390	[p20l1426t2791r1490b2821],
5	.	.	O	.	_	0	SENT_390	[p20l1426t2791r1490b2821],

1	No	DT	O	no	det	3	SENT_391	[p20l1501t2791r1541b2814],
2	other	JJ	O	other	amod	3	SENT_391	[p20l1551t2791r1619b2814],
3	uses	NNS	O	use	_	0	SENT_391	[p20l1627t2798r1683b2814],
4	without	IN	O	without	_	0	SENT_391	[p20l1693t2791r1794b2814],
5	permission	NN	O	permission	prep_without	3	SENT_391	[p20l1803t2791r1955b2821],
6	.	.	O	.	_	0	SENT_391	[p20l1803t2791r1955b2821],

1	Copyright	NN	O	copyright	_	0	SENT_392	[p20l672t2832r807b2863],
2	©	CD	NUMBER	©	num	6	SENT_392	[p20l816t2832r840b2856],
3	2005	CD	DATE	2005	num	6	SENT_392	[p20l850t2832r914b2856],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_392	[p20l924t2832r1115b2856],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_392	[p20l1125t2832r1233b2856],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_392	[p20l1244t2832r1349b2863],
7	.	.	O	.	_	0	SENT_392	[p20l1244t2832r1349b2863],

1	All	DT	O	all	det	2	SENT_393	[p20l1360t2832r1401b2856],
2	rights	NNS	O	rights	nsubj	3	SENT_393	[p20l1410t2832r1485b2863],
3	reserved	VBN	O	reserve	_	0	SENT_393	[p20l1495t2832r1614b2856],
4	.	.	O	.	_	0	SENT_393	[p20l1495t2832r1614b2856],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_394	[p20l708t2876r936b2895],
2	OF	IN	O	of	_	0	SENT_394	[p20l951t2876r992b2895],
3	DISEASE	NN	O	disease	prep_of	1	SENT_394	[p20l1006t2876r1143b2895],

1	Table	NNP	O	Table	_	0	SENT_395	[p21l110t34r181b59],
2	2	CD	NUMBER	2	dep	1	SENT_395	[p21l190t37r213b59],
3	.	.	O	.	_	0	SENT_395	[p21l190t37r213b59],

1	(	RB	O	(	advmod	2	SENT_396	[p21l224t34r391b67],
2	Continued	VBN	O	continue	_	0	SENT_396	[p21l224t34r391b67],
3	.	.	O	.	_	0	SENT_396	[p21l224t34r391b67],
4	)	SYM	O	)	dep	2	SENT_396	[p21l224t34r391b67],

1	Tyrosine	NN	O	tyrosine	_	0	SENT_397	[p21l180t110r294b142],
2	Kinase'i	NN	O	kinase'us	nsubj	6	SENT_397	[p21l184t147r291b180],
3	'	''	O	'	_	0	SENT_397	[p21l184t147r291b180],
4	Activating	VBG	O	activate	partmod	2	SENT_397	[p21l421t147r559b180],
5	Mechanisms	NNS	O	mechanism	dobj	4	SENT_397	[p21l570t147r743b172],
6	Targeted	VBN	O	target	rcmod	1	SENT_397	[p21l1336t147r1452b180],
7	Therapy	NN	O	therapy	dobj	6	SENT_397	[p21l1462t147r1590b180],
8	:	:	O	:	_	0	SENT_397	[p21l1462t147r1590b180],
9	§	CD	NUMBER	§	dep	7	SENT_397	[p21l1462t147r1590b180],
10	:	:	O	:	_	0	SENT_397	[p21l1462t147r1590b180],
11	References	NNS	O	reference	dep	9	SENT_397	[p21l1781t146r1928b172],

1	NTRK1	NN	O	ntrk1	nn	3	SENT_398	[p21l113t219r206b242],
2	(	CD	NUMBER	(	num	3	SENT_398	[p21l219t219r302b250],
3	1q21	NN	O	1q21	_	0	SENT_398	[p21l219t219r302b250],
4	)	CD	NUMBER	)	num	7	SENT_398	[p21l219t219r302b250],
5	Tropomyosin	NN	O	tropomyosin	nn	7	SENT_398	[p21l160t277r357b308],
6	—	NN	O	—	nn	7	SENT_398	[p21l160t277r357b308],
7	t	NN	O	t	dep	3	SENT_398	[p21l390t277r462b308],
8	(	CD	NUMBER	(	number	9	SENT_398	[p21l390t277r462b308],
9	1	CD	NUMBER	1	dep	7	SENT_398	[p21l390t277r462b308],
10	;	:	O	;	_	0	SENT_398	[p21l390t277r462b308],
11	1	CD	NUMBER	1	number	12	SENT_398	[p21l390t277r462b308],
12	)	CD	NUMBER	)	num	14	SENT_398	[p21l390t277r462b308],
13	PTC	NN	O	ptc	nn	14	SENT_398	[p21l805t277r858b300],
14	GYECO	NN	O	gyeco	dep	7	SENT_398	[p21l1659t274r1740b297],
15	et	FW	O	et	nn	16	SENT_398	[p21l1750t276r1774b297],
16	al.	FW	O	al.	dep	14	SENT_398	[p21l1784t272r1840b297],
17	78	CD	NUMBER	78	dep	3	SENT_398	[p21l1784t272r1840b297],

1	NTRK1	NN	O	ntrk1	_	0	SENT_399	[p21l213t315r306b337],

1	TPR-NTRK1	NN	O	tpr-ntrk1	nn	2	SENT_400	[p21l160t373r321b396],
2	t	NN	O	t	_	0	SENT_400	[p21l390t373r462b404],
3	(	CD	NUMBER	(	number	4	SENT_400	[p21l390t373r462b404],
4	1	CD	NUMBER	1	dep	2	SENT_400	[p21l390t373r462b404],
5	;	:	O	;	_	0	SENT_400	[p21l390t373r462b404],
6	1	CD	NUMBER	1	number	7	SENT_400	[p21l390t373r462b404],
7	)	CD	NUMBER	)	dep	4	SENT_400	[p21l390t373r462b404],
8	PTC	NN	ORGANIZATION	ptc	nn	10	SENT_400	[p21l805t373r858b396],
9	TFG-NTRK1	NN	O	tfg-ntrk1	nn	10	SENT_400	[p21l160t431r324b454],
10	t	NN	O	t	dep	7	SENT_400	[p21l390t431r462b462],
11	(	CD	NUMBER	(	number	12	SENT_400	[p21l390t431r462b462],
12	1	CD	NUMBER	1	dep	2	SENT_400	[p21l390t431r462b462],
13	;	:	O	;	_	0	SENT_400	[p21l390t431r462b462],
14	3	CD	NUMBER	3	number	15	SENT_400	[p21l390t431r462b462],
15	)	CD	NUMBER	)	num	17	SENT_400	[p21l390t431r462b462],
16	PTC	NN	ORGANIZATION	ptc	nn	17	SENT_400	[p21l805t431r858b454],
17	NTRK3	NN	O	ntrk3	dep	12	SENT_400	[p21l113t490r206b513],
18	(	CD	NUMBER	(	num	19	SENT_400	[p21l219t490r318b521],
19	15q25	CD	NUMBER	15q25	dep	17	SENT_400	[p21l219t490r318b521],
20	)	NN	O	)	nn	22	SENT_400	[p21l219t490r318b521],
21	TEL-NTRK3	NN	O	tel-ntrk3	nn	22	SENT_400	[p21l160t548r317b571],
22	t	NN	O	t	dep	2	SENT_400	[p21l390t548r495b579],
23	(	CD	NUMBER	(	number	24	SENT_400	[p21l390t548r495b579],
24	12	CD	NUMBER	12	dep	22	SENT_400	[p21l390t548r495b579],
25	;	:	O	;	_	0	SENT_400	[p21l390t548r495b579],
26	15	CD	NUMBER	15	number	27	SENT_400	[p21l390t548r495b579],
27	)	CD	NUMBER	)	num	29	SENT_400	[p21l390t548r495b579],
28	Congenital	JJ	O	congenital	amod	29	SENT_400	[p21l803t546r948b579],
29	ﬁbrosarcoma	NN	O	ﬁbrosarcoma	dep	22	SENT_400	[p21l958t546r1147b576],
30	,	,	O	,	_	0	SENT_400	[p21l958t546r1147b576],
31	meso	NN	O	meso	appos	29	SENT_400	[p21l1160t555r1241b571],
32	-	:	O	-	_	0	SENT_400	[p21l1160t555r1241b571],
33	K	NNP	O	K	dep	22	SENT_400	[p21l1661t542r1795b568],
34	|	CD	NUMBER	|	number	35	SENT_400	[p21l1661t542r1795b568],
35	’	CD	NUMBER	’	num	36	SENT_400	[p21l1661t542r1795b568],
36	16Z	NN	O	16z	dep	33	SENT_400	[p21l1661t542r1795b568],
37	€	CD	NUMBER	€	num	38	SENT_400	[p21l1661t542r1795b568],
38	ViCl1	NN	O	vicl1	dep	2	SENT_400	[p21l1661t542r1795b568],
39	et	FW	O	et	dep	38	SENT_400	[p21l1807t547r1831b568],
40	-	:	O	-	_	0	SENT_400	[p21l1841t542r1905b572],
41	‘	CD	NUMBER	‘	dep	38	SENT_400	[p21l1841t542r1905b572],
42	all	DT	O	all	det	44	SENT_400	[p21l1841t542r1905b572],
43	-,7	CD	NUMBER	-,7	num	44	SENT_400	[p21l1841t542r1905b572],
44	‘	NN	O	‘	dep	41	SENT_400	[p21l1841t542r1905b572],
45	?	.	O	?	_	0	SENT_400	[p21l1841t542r1905b572],

1	blastic	JJ	O	blastic	amod	7	SENT_401	[p21l854t583r941b609],
2	nephroma	NN	O	nephroma	nn	7	SENT_401	[p21l952t583r1098b616],
3	,	,	O	,	_	0	SENT_401	[p21l952t583r1098b616],
4	secretory	JJ	O	secretory	amod	7	SENT_401	[p21l1110t588r1233b616],
5	Toghoh	NNP	O	Toghoh	nn	7	SENT_401	[p21l1708t582r1809b613],
6	ef	NN	O	ef	nn	7	SENT_401	[p21l1820t585r1845b605],
7	3l	NN	O	3l	_	0	SENT_401	[p21l1855t580r1911b605],
8	.3	NN	NUMBER	.3	nn	11	SENT_401	[p21l1855t580r1911b605],
9	°	CD	NUMBER	°	num	11	SENT_401	[p21l1855t580r1911b605],
10	breast	NN	O	breast	nn	11	SENT_401	[p21l854t621r937b646],
11	carcinoma	NN	O	carcinoma	dep	7	SENT_401	[p21l946t623r1088b646],

1	Overexpression	NN	O	overexpression	_	0	SENT_402	[p21l391t681r602b712],
2	Glioblastoma	NN	O	glioblastoma	dep	13	SENT_402	[p21l803t679r994b709],
3	,	,	O	,	_	0	SENT_402	[p21l803t679r994b709],
4	osteosarcoma	NN	O	osteosarcoma	nn	6	SENT_402	[p21l1005t684r1197b704],
5	|	NN	O	|	nn	6	SENT_402	[p21l1299t679r1432b712],
6	matinib	NN	O	matinib	appos	2	SENT_402	[p21l1299t679r1432b712],
7	,	,	O	,	_	0	SENT_402	[p21l1299t679r1432b712],
8	\	CD	NUMBER	\	num	10	SENT_402	[p21l1299t679r1432b712],
9	]	CD	NUMBER	]	num	10	SENT_402	[p21l1299t679r1432b712],
10	CT52923	NN	O	ct52923	appos	2	SENT_402	[p21l1443t681r1560b705],
11	Hermanson	NNP	PERSON	Hermanson	dep	13	SENT_402	[p21l1661t681r1821b704],
12	et	FW	O	et	nn	13	SENT_402	[p21l1833t684r1857b704],
13	al.	FW	O	al.	dep	15	SENT_402	[p21l1867t679r1930b709],
14	,31	CD	NUMBER	,31	dep	13	SENT_402	[p21l1867t679r1930b709],
15	McGary	NNP	O	McGary	dep	19	SENT_402	[p21l1711t719r1816b750],
16	et	FW	O	et	nn	17	SENT_402	[p21l1825t721r1849b742],
17	al.	FW	O	al.	dep	15	SENT_402	[p21l1859t717r1923b746],
18	,32	CD	NUMBER	,32	num	19	SENT_402	[p21l1859t717r1923b746],
19	Kilic	NNP	PERSON	Kilic	dep	24	SENT_402	[p21l1711t754r1766b779],
20	et	FW	O	et	nn	21	SENT_402	[p21l1775t759r1799b779],
21	aI	FW	O	ai	dep	19	SENT_402	[p21l1809t754r1864b779],
22	.83	CD	NUMBER	.83	num	24	SENT_402	[p21l1809t754r1864b779],
23	Overexpression	NN	O	overexpression	nn	24	SENT_402	[p21l391t815r602b845],
24	|	NN	O	|	dep	32	SENT_402	[p21l1299t812r1424b845],
25	matinib	NN	O	matinib	nn	27	SENT_402	[p21l1299t812r1424b845],
26	§	CD	NUMBER	§	num	27	SENT_402	[p21l1299t812r1424b845],
27	Zhao	NNP	PERSON	Zhao	dep	24	SENT_402	[p21l1659t813r1728b838],
28	et	FW	O	et	nn	32	SENT_402	[p21l1738t817r1763b838],
29	a	FW	O	a	nn	32	SENT_402	[p21l1772t813r1828b838],
30	|	FW	O	|	nn	32	SENT_402	[p21l1772t813r1828b838],
31	.84	NN	NUMBER	.84	nn	32	SENT_402	[p21l1772t813r1828b838],
32	Kinase-domain	NN	O	kinase-domain	dep	1	SENT_402	[p21l393t871r594b896],
33	mutations	NNS	O	mutation	dep	32	SENT_402	[p21l607t873r752b896],
34	:	:	O	:	_	0	SENT_402	[p21l607t873r752b896],
35	|	NN	O	|	dep	1	SENT_402	[p21l1299t871r1424b904],
36	matinib	NN	O	matinib	nn	38	SENT_402	[p21l1299t871r1424b904],
37	§	CD	NUMBER	§	num	38	SENT_402	[p21l1299t871r1424b904],
38	Heinrich	NNP	PERSON	Heinrich	dep	35	SENT_402	[p21l1661t871r1775b896],
39	et	FW	O	et	nn	42	SENT_402	[p21l1787t876r1811b896],
40	a	FW	O	a	nn	42	SENT_402	[p21l1821t871r1875b896],
41	|	FW	O	|	nn	42	SENT_402	[p21l1821t871r1875b896],
42	.85	FW	NUMBER	.85	dep	35	SENT_402	[p21l1821t871r1875b896],

1	D842V/Y	NN	O	d842v/y	_	0	SENT_403	[p21l443t910r566b942],
2	,	,	O	,	_	0	SENT_403	[p21l443t910r566b942],
3	deletion	NN	O	deletion	nn	5	SENT_403	[p21l577t908r685b934],
4	Dllvl	NN	O	dllvl	nn	5	SENT_403	[p21l443t948r499b971],
5	N842-845	NN	O	n842-845	appos	1	SENT_403	[p21l506t948r618b978],
6	?	.	O	?	_	0	SENT_403	[p21l506t948r618b978],

1	luxta	NN	O	luxta	_	0	SENT_404	[p21l628t948r702b979],
2	‘	CD	NUMBER	‘	num	4	SENT_404	[p21l628t948r702b979],
3	membrane	NN	O	membrane	nn	4	SENT_404	[p21l442t984r589b1009],
4	mutations	NNS	O	mutation	dep	1	SENT_404	[p21l600t986r746b1009],
5	:	:	O	:	_	0	SENT_404	[p21l600t986r746b1009],
6	deletion	NN	O	deletion	nn	7	SENT_404	[p21l441t1021r548b1046],
7	RV	NN	O	rv	dep	1	SENT_404	[p21l562t1023r734b1053],
8	|	CD	NUMBER	|	num	9	SENT_404	[p21l562t1023r734b1053],
9	ES550_554	NN	O	es550_554	dep	7	SENT_404	[p21l562t1023r734b1053],
10	,	,	O	,	_	0	SENT_404	[p21l562t1023r734b1053],
11	V561D	NN	O	v561d	nn	12	SENT_404	[p21l440t1061r531b1084],
12	t	NN	O	t	appos	9	SENT_404	[p21l397t1119r503b1150],
13	(	CD	NUMBER	(	number	14	SENT_404	[p21l397t1119r503b1150],
14	17	CD	NUMBER	17	dep	12	SENT_404	[p21l397t1119r503b1150],
15	;	:	O	;	_	0	SENT_404	[p21l397t1119r503b1150],
16	22	CD	NUMBER	22	num	17	SENT_404	[p21l397t1119r503b1150],
17	)	NN	O	)	dep	1	SENT_404	[p21l397t1119r503b1150],
18	and	CC	O	and	_	0	SENT_404	[p21l516t1117r564b1142],
19	overexpres	NNS	O	overexpre	conj_and	17	SENT_404	[p21l575t1126r731b1150],
20	-	:	O	-	_	0	SENT_404	[p21l575t1126r731b1150],
21	Simon	NNP	PERSON	Simon	nn	23	SENT_404	[p21l1660t1119r1746b1142],
22	et	NNP	O	et	nn	23	SENT_404	[p21l1757t1122r1781b1142],
23	aI.	NNP	O	aI.	dep	1	SENT_404	[p21l1791t1117r1855b1147],
24	,	,	O	,	_	0	SENT_404	[p21l1791t1117r1855b1147],
25	*	CD	NUMBER	*	number	26	SENT_404	[p21l1791t1117r1855b1147],
26	36	CD	NUMBER	36	num	30	SENT_404	[p21l1791t1117r1855b1147],
27	sion	NN	O	sion	nn	30	SENT_404	[p21l441t1157r496b1180],
28	ofCOL	NN	O	ofcol	nn	30	SENT_404	[p21l507t1154r767b1180],
29	|	CD	NUMBER	|	num	30	SENT_404	[p21l507t1154r767b1180],
30	a1	NN	O	a1	appos	23	SENT_404	[p21l507t1154r767b1180],
31	.	.	O	.	_	0	SENT_404	[p21l507t1154r767b1180],

1	—	NN	O	—	_	0	SENT_405	[p21l507t1154r767b1180],
2	.	.	O	.	_	0	SENT_405	[p21l507t1154r767b1180],

1	PDGFB	NN	O	pdgfb	_	0	SENT_406	[p21l507t1154r767b1180],
2	McArthur37	NN	O	mcarthur37	nn	3	SENT_406	[p21l1711t1154r1865b1180],
3	Hgand	NN	O	hgand	dep	1	SENT_406	[p21l442t1192r522b1225],

1	RET	NNP	O	RET	nn	3	SENT_407	[p21l113t1252r165b1275],
2	(	CD	NUMBER	(	num	3	SENT_407	[p21l176t1252r275b1283],
3	10q11	NN	O	10q11	_	0	SENT_407	[p21l176t1252r275b1283],
4	)	CD	NUMBER	)	num	7	SENT_407	[p21l176t1252r275b1283],
5	Cysteine	NN	MISC	cysteine	nn	7	SENT_407	[p21l391t1252r504b1283],
6	point	NN	O	point	nn	7	SENT_407	[p21l515t1253r585b1283],
7	mutations	NNS	O	mutation	dep	3	SENT_407	[p21l596t1253r733b1275],
8	MEN-2A	NN	O	men-2a	dep	3	SENT_407	[p21l805t1252r926b1280],
9	,	,	O	,	_	0	SENT_407	[p21l805t1252r926b1280],
10	FMTC	NNP	O	FMTC	nn	11	SENT_407	[p21l940t1252r1020b1275],
11	Santoro	NNP	PERSON	Santoro	appos	8	SENT_407	[p21l1660t1252r1766b1275],
12	et	FW	O	et	dep	11	SENT_407	[p21l1776t1255r1800b1275],
13	a	FW	O	a	nn	14	SENT_407	[p21l1810t1250r1866b1275],
14	|	FW	O	|	advmod	15	SENT_407	[p21l1810t1250r1866b1275],
15	.33	CD	NUMBER	.33	rcmod	12	SENT_407	[p21l1810t1250r1866b1275],

1	in	IN	O	in	dep	7	SENT_408	[p21l442t1290r463b1313],
2	exons	NNS	O	exon	pobj	1	SENT_408	[p21l475t1297r552b1313],
3	7	CD	NUMBER	7	num	2	SENT_408	[p21l564t1290r577b1313],
4	and	CC	O	and	_	0	SENT_408	[p21l587t1288r635b1313],
5	8	CD	NUMBER	8	conj_and	2	SENT_408	[p21l647t1289r660b1313],
6	Kinase-domain	NN	O	kinase-domain	nn	7	SENT_408	[p21l393t1346r594b1371],
7	mutation	NN	O	mutation	_	0	SENT_408	[p21l607t1348r737b1371],
8	:	:	O	:	_	0	SENT_408	[p21l607t1348r737b1371],
9	MEN-2B	NN	O	men-2b	dep	7	SENT_408	[p21l805t1348r918b1371],

1	M918T	NN	O	m918t	_	0	SENT_409	[p21l443t1385r536b1409],

1	RET	NNP	O	RET	_	0	SENT_410	[p21l393t1444r517b1467],
2	.	.	O	.	_	0	SENT_410	[p21l393t1444r517b1467],

1	—	NN	O	—	_	0	SENT_411	[p21l393t1444r517b1467],
2	.	.	O	.	_	0	SENT_411	[p21l393t1444r517b1467],

1	PTC	NN	O	ptc	nn	3	SENT_412	[p21l393t1444r517b1467],
2	gene	NN	O	gene	nn	3	SENT_412	[p21l527t1451r591b1475],
3	fusions	NNS	O	fusion	_	0	SENT_412	[p21l600t1442r699b1467],
4	Radiation-associated	JJ	O	radiation-associated	amod	5	SENT_412	[p21l805t1442r1087b1467],
5	PTC	NN	O	ptc	dep	3	SENT_412	[p21l1100t1444r1153b1467],

1	ROS	NN	O	ro	_	0	SENT_413	[p21l113t1502r172b1525],
2	(	CD	NUMBER	(	num	4	SENT_413	[p21l183t1502r266b1533],
3	6q22	NN	O	6q22	nn	4	SENT_413	[p21l183t1502r266b1533],
4	)	NN	O	)	dep	1	SENT_413	[p21l183t1502r266b1533],

1	FIG-ROS	NNP	O	FIG-ROS	dep	9	SENT_414	[p21l163t1561r281b1584],
2	de	IN	O	de	_	0	SENT_414	[p21l391t1559r538b1592],
3	|	CD	NUMBER	|	num	5	SENT_414	[p21l391t1559r538b1592],
4	etion	NN	O	etion	nn	5	SENT_414	[p21l391t1559r538b1592],
5	(	NN	O	(	prep_de	1	SENT_414	[p21l391t1559r538b1592],
6	6	CD	NUMBER	6	num	7	SENT_414	[p21l391t1559r538b1592],
7	)	NN	O	)	dep	9	SENT_414	[p21l391t1559r538b1592],
8	(	CD	NUMBER	(	num	9	SENT_414	[p21l546t1561r672b1592],
9	q21	NN	O	q21	dep	36	SENT_414	[p21l546t1561r672b1592],
10	;	:	O	;	_	0	SENT_414	[p21l546t1561r672b1592],
11	q21	NN	O	q21	nn	13	SENT_414	[p21l546t1561r672b1592],
12	)	CD	NUMBER	)	num	13	SENT_414	[p21l546t1561r672b1592],
13	Glioblastoma	NNP	ORGANIZATION	Glioblastoma	dep	9	SENT_414	[p21l803t1559r994b1588],
14	,	,	O	,	_	0	SENT_414	[p21l803t1559r994b1588],
15	astrocytoma	NN	O	astrocytoma	nn	16	SENT_414	[p21l1006t1563r1173b1592],
16	Charest	NNP	PERSON	Charest	dep	9	SENT_414	[p21l1659t1559r1763b1584],
17	et	FW	O	et	nn	18	SENT_414	[p21l1773t1563r1797b1584],
18	al.	FW	O	al.	dep	16	SENT_414	[p21l1807t1559r1862b1584],
19	89	CD	NUMBER	89	num	20	SENT_414	[p21l1807t1559r1862b1584],
20	VEGFR-1	NN	O	vegfr-1	dep	16	SENT_414	[p21l110t1619r232b1642],
21	and	CC	O	and	_	0	SENT_414	[p21l243t1617r291b1642],
22	Overexpression	NN	O	overexpression	nn	24	SENT_414	[p21l391t1619r602b1650],
23	ofVEGF	NN	O	ofvegf	nn	24	SENT_414	[p21l613t1617r724b1642],
24	NSCLC	NN	O	nsclc	dep	9	SENT_414	[p21l805t1619r901b1642],
25	and	CC	O	and	_	0	SENT_414	[p21l911t1617r959b1642],
26	breast	NN	O	breast	conj_and	9	SENT_414	[p21l972t1617r1061b1647],
27	,	,	O	,	_	0	SENT_414	[p21l972t1617r1061b1647],
28	prostate	NN	O	prostate	appos	26	SENT_414	[p21l1074t1622r1191b1650],
29	,	,	O	,	_	0	SENT_414	[p21l1074t1622r1191b1650],
30	Bevacizumab	NNP	PERSON	Bevacizumab	appos	26	SENT_414	[p21l1299t1617r1486b1647],
31	,	,	O	,	_	0	SENT_414	[p21l1299t1617r1486b1647],
32	HUrWltZ	NNP	O	HUrWltZ	appos	26	SENT_414	[p21l1661t1616r1768b1639],
33	et	FW	O	et	nn	34	SENT_414	[p21l1778t1618r1802b1639],
34	al.	FW	O	al.	dep	32	SENT_414	[p21l1812t1614r1868b1639],
35	9	CD	NUMBER	9	num	36	SENT_414	[p21l1812t1614r1868b1639],
36	°	NN	O	°	_	0	SENT_414	[p21l1812t1614r1868b1639],

1	VEGFR-2	NN	MISC	vegfr-2	_	0	SENT_415	[p21l210t1656r333b1680],
2	ligand	NN	O	ligand	dep	1	SENT_415	[p21l442t1654r522b1688],
3	renal	JJ	O	renal	dep	2	SENT_415	[p21l854t1654r927b1684],
4	,	,	O	,	_	0	SENT_415	[p21l854t1654r927b1684],
5	colorectal	JJ	O	colorectal	amod	6	SENT_415	[p21l938t1654r1068b1680],
6	cancers	NNS	O	cancer	appos	3	SENT_415	[p21l1080t1663r1182b1680],
7	anti-VEG	JJ	O	anti-veg	amod	8	SENT_415	[p21l1347t1656r1465b1680],
8	FR	NN	O	fr	dep	6	SENT_415	[p21l1472t1657r1511b1684],
9	,	,	O	,	_	0	SENT_415	[p21l1472t1657r1511b1684],

1	VEGFR	NN	O	vegfr	nn	2	SENT_416	[p21l1346t1694r1442b1717],
2	inhibitor	NN	O	inhibitor	_	0	SENT_416	[p21l1453t1692r1569b1717],

1	*	NN	O	*	nn	2	SENT_417	[p21l84t1788r99b1803],
2	IMT	NN	O	imt	nsubj	3	SENT_417	[p21l111t1788r165b1811],
3	denotes	VBZ	O	denote	_	0	SENT_417	[p21l174t1786r282b1811],
4	inﬂammatory	JJ	O	inﬂammatory	amod	6	SENT_417	[p21l293t1785r476b1819],
5	myoﬁbroblastic	JJ	O	myoﬁbroblastic	amod	6	SENT_417	[p21l486t1785r696b1819],
6	tumor	NN	O	tumor	nsubj	59	SENT_417	[p21l705t1791r794b1815],
7	,	,	O	,	_	0	SENT_417	[p21l705t1791r794b1815],
8	NSCLC	NNP	O	NSCLC	appos	6	SENT_417	[p21l807t1788r903b1811],
9	non	JJ	O	non	amod	13	SENT_417	[p21l914t1786r1110b1811],
10	—	NN	O	—	nn	13	SENT_417	[p21l914t1786r1110b1811],
11	small-cell	NN	O	small-cell	nn	13	SENT_417	[p21l914t1786r1110b1811],
12	lung	NN	O	lung	nn	13	SENT_417	[p21l1123t1786r1181b1819],
13	cancer	NN	O	cancer	dep	8	SENT_417	[p21l1191t1795r1283b1815],
14	,	,	O	,	_	0	SENT_417	[p21l1191t1795r1283b1815],
15	SSCHN	NNP	O	SSCHN	nn	18	SENT_417	[p21l1295t1788r1397b1811],
16	squamous-cell	JJ	O	squamous-cell	amod	18	SENT_417	[p21l1410t1786r1606b1819],
17	carcinoma	NN	O	carcinoma	nn	18	SENT_417	[p21l1617t1788r1759b1811],
18	ofhead	NN	O	ofhead	appos	6	SENT_417	[p21l1770t1785r1869b1811],
19	and	CC	O	and	_	0	SENT_417	[p21l1881t1786r1928b1811],
20	neck	NN	O	neck	conj_and	18	SENT_417	[p21l1941t1786r2008b1815],
21	,	,	O	,	_	0	SENT_417	[p21l1941t1786r2008b1815],
22	RCC	NN	O	rcc	nn	24	SENT_417	[p21l111t1825r167b1848],
23	renal-cell	JJ	O	renal-cell	amod	24	SENT_417	[p21l177t1823r296b1848],
24	carcinoma	NN	O	carcinoma	appos	6	SENT_417	[p21l306t1825r455b1852],
25	,	,	O	,	_	0	SENT_417	[p21l306t1825r455b1852],
26	GIST	NN	O	gist	nn	34	SENT_417	[p21l465t1825r533b1848],
27	gastrointestinal	JJ	O	gastrointestinal	amod	34	SENT_417	[p21l541t1823r751b1856],
28	stromal	JJ	O	stromal	amod	34	SENT_417	[p21l762t1823r864b1848],
29	tumor	NN	O	tumor	nn	34	SENT_417	[p21l873t1828r961b1852],
30	,	,	O	,	_	0	SENT_417	[p21l873t1828r961b1852],
31	SCLC	NNP	ORGANIZATION	SCLC	nn	34	SENT_417	[p21l971t1825r1044b1848],
32	small	JJ	O	small	amod	34	SENT_417	[p21l1052t1823r1179b1848],
33	—	NN	O	—	nn	34	SENT_417	[p21l1052t1823r1179b1848],
34	cell	NN	O	cell	appos	6	SENT_417	[p21l1052t1823r1179b1848],
35	lung	NN	O	lung	nn	36	SENT_417	[p21l1189t1823r1248b1856],
36	cancer	NN	O	cancer	dep	34	SENT_417	[p21l1255t1832r1348b1852],
37	,	,	O	,	_	0	SENT_417	[p21l1255t1832r1348b1852],
38	PTC	NN	O	ptc	nn	40	SENT_417	[p21l1360t1825r1412b1848],
39	papillarythyroid	JJ	O	papillarythyroid	amod	40	SENT_417	[p21l1422t1823r1637b1856],
40	carcinoma	NN	O	carcinoma	appos	6	SENT_417	[p21l1646t1825r1796b1852],
41	,	,	O	,	_	0	SENT_417	[p21l1646t1825r1796b1852],
42	PAIS	NN	O	pai	nn	44	SENT_417	[p21l1808t1824r1869b1848],
43	pulmonary	JJ	O	pulmonary	amod	44	SENT_417	[p21l1879t1823r2025b1856],
44	artery	NN	O	artery	appos	6	SENT_417	[p21l110t1864r185b1893],
45	intimal	JJ	O	intimal	amod	46	SENT_417	[p21l196t1859r288b1885],
46	sarcoma	NN	O	sarcoma	dep	44	SENT_417	[p21l300t1868r423b1889],
47	,	,	O	,	_	0	SENT_417	[p21l300t1868r423b1889],
48	DFSP	NN	O	dfsp	nn	50	SENT_417	[p21l436t1861r510b1885],
49	dermatoﬁbrosarcoma	NN	O	dermatoﬁbrosarcoma	nn	50	SENT_417	[p21l520t1859r816b1885],
50	protuberans	NNS	O	protuberan	appos	6	SENT_417	[p21l829t1859r1001b1893],
51	,	,	O	,	_	0	SENT_417	[p21l829t1859r1001b1893],
52	COL	NNP	O	COL	nn	54	SENT_417	[p21l1012t1861r1118b1885],
53	|	CD	NUMBER	|	num	54	SENT_417	[p21l1012t1861r1118b1885],
54	a1	NN	O	a1	appos	6	SENT_417	[p21l1012t1861r1118b1885],
55	collagen	NN	O	collagen	nn	57	SENT_417	[p21l1130t1859r1241b1893],
56	type	NN	O	type	nn	57	SENT_417	[p21l1252t1864r1308b1893],
57	Ial	NN	O	ial	dep	54	SENT_417	[p21l1320t1862r1370b1889],
58	,	,	O	,	_	0	SENT_417	[p21l1320t1862r1370b1889],
59	MEN-2A	NN	O	men-2a	xcomp	3	SENT_417	[p21l1383t1861r1498b1885],
60	and	CC	O	and	_	0	SENT_417	[p21l1507t1859r1555b1885],
61	MEN-2B	NN	O	men-2b	conj_and	59	SENT_417	[p21l1569t1862r1682b1885],
62	multiple	JJ	O	multiple	amod	65	SENT_417	[p21l1694t1859r1805b1893],
63	endocrine	JJ	O	endocrine	amod	65	SENT_417	[p21l1815t1859r1950b1885],
64	neoplasia	NN	O	neoplasium	nn	65	SENT_417	[p21l1962t1868r2019b1885, p21l111t1896r187b1930],
65	types	NNS	O	type	dep	59	SENT_417	[p21l197t1901r267b1930],
66	2A	NN	O	2a	dep	59	SENT_417	[p21l278t1898r313b1921],
67	and	CC	O	and	_	0	SENT_417	[p21l323t1896r371b1922],
68	2B	NN	O	2b	conj_and	66	SENT_417	[p21l382t1899r423b1926],
69	,	,	O	,	_	0	SENT_417	[p21l382t1899r423b1926],
70	FMTC	NN	O	fmtc	nn	74	SENT_417	[p21l437t1898r517b1922],
71	familial	JJ	O	familial	amod	74	SENT_417	[p21l527t1896r625b1922],
72	medullary	JJ	O	medullary	amod	74	SENT_417	[p21l638t1896r772b1930],
73	thyroid	NN	O	thyroid	nn	74	SENT_417	[p21l780t1896r874b1930],
74	carcinoma	NN	O	carcinoma	conj_and	66	SENT_417	[p21l886t1899r1035b1926],
75	,	,	O	,	_	0	SENT_417	[p21l886t1899r1035b1926],
76	and	CC	O	and	_	0	SENT_417	[p21l1047t1896r1095b1922],
77	VEGF	NN	O	vegf	nn	81	SENT_417	[p21l1105t1898r1182b1922],
78	vascular	JJ	O	vascular	amod	81	SENT_417	[p21l1192t1896r1305b1922],
79	endothelial	JJ	O	endothelial	amod	81	SENT_417	[p21l1314t1896r1463b1922],
80	growth	NN	O	growth	nn	81	SENT_417	[p21l1475t1896r1568b1930],
81	factor	NN	O	factor	dep	59	SENT_417	[p21l1578t1896r1661b1922],
82	.	.	O	.	_	0	SENT_417	[p21l1578t1896r1661b1922],

1	1	CD	NUMBER	1	dep	6	SENT_418	[p21l85t1936r100b1967],
2	'	''	O	'	_	0	SENT_418	[p21l85t1936r100b1967],
3	Chromosomal	JJ	O	chromosomal	amod	4	SENT_418	[p21l109t1934r303b1959],
4	locations	NNS	O	location	nsubjpass	6	SENT_418	[p21l316t1934r438b1959],
5	are	VBP	O	be	auxpass	6	SENT_418	[p21l449t1943r489b1959],
6	given	VBN	O	give	_	0	SENT_418	[p21l499t1936r569b1967],
7	in	IN	O	in	_	0	SENT_418	[p21l581t1936r603b1959],
8	parentheses	NNS	O	parenthesis	prep_in	6	SENT_418	[p21l616t1934r788b1967],
9	.	.	O	.	_	0	SENT_418	[p21l616t1934r788b1967],

1	:3	CD	NUMBER	:3	_	0	SENT_419	[p21l85t1973r100b2004],
2	:	:	O	:	_	0	SENT_419	[p21l85t1973r100b2004],
3	Geﬁtinib	NNP	O	Geﬁtinib	nsubjpass	17	SENT_419	[p21l109t1970r233b2000],
4	,	,	O	,	_	0	SENT_419	[p21l109t1970r233b2000],
5	erlotinib	NN	O	erlotinib	appos	3	SENT_419	[p21l244t1970r364b2000],
6	,	,	O	,	_	0	SENT_419	[p21l244t1970r364b2000],
7	cetuximab	NN	O	cetuximab	conj_and	5	SENT_419	[p21l374t1970r521b2000],
8	,	,	O	,	_	0	SENT_419	[p21l374t1970r521b2000],
9	trastuzumab	NN	O	trastuzumab	conj_and	5	SENT_419	[p21l530t1970r712b2000],
10	,	,	O	,	_	0	SENT_419	[p21l530t1970r712b2000],
11	imatinib	NN	O	imatinib	conj_and	5	SENT_419	[p21l723t1970r842b2000],
12	,	,	O	,	_	0	SENT_419	[p21l723t1970r842b2000],
13	and	CC	O	and	_	0	SENT_419	[p21l852t1970r900b1996],
14	bevacizumab	NN	O	bevacizumab	conj_and	5	SENT_419	[p21l912t1970r1090b1996],
15	have	VBP	O	have	aux	17	SENT_419	[p21l1100t1970r1161b1996],
16	been	VBN	O	be	auxpass	17	SENT_419	[p21l1172t1970r1234b1996],
17	approved	VBN	O	approve	dep	1	SENT_419	[p21l1244t1970r1370b2004],
18	by	IN	O	by	_	0	SENT_419	[p21l1382t1970r1410b2004],
19	the	DT	O	the	det	23	SENT_419	[p21l1417t1970r1460b1996],
20	Food	NNP	ORGANIZATION	Food	nn	23	SENT_419	[p21l1471t1970r1534b1996],
21	and	CC	ORGANIZATION	and	_	0	SENT_419	[p21l1545t1970r1593b1996],
22	Drug	NNP	ORGANIZATION	Drug	nn	23	SENT_419	[p21l1606t1973r1672b2004],
23	Administration	NNP	ORGANIZATION	Administration	agent	17	SENT_419	[p21l1679t1970r1893b2000],
24	;	:	O	;	_	0	SENT_419	[p21l1679t1970r1893b2000],
25	the	DT	O	the	det	27	SENT_419	[p21l1902t1970r1944b1996],
26	other	JJ	O	other	amod	27	SENT_419	[p21l1953t1970r2025b1996],
27	drugs	NNS	O	drug	nsubjpass	32	SENT_419	[p21l109t2008r185b2041],
28	listed	VBN	O	list	partmod	27	SENT_419	[p21l197t2008r267b2033],
29	have	VBP	O	have	aux	32	SENT_419	[p21l280t2008r341b2033],
30	not	RB	O	not	neg	32	SENT_419	[p21l352t2013r395b2033],
31	been	VBN	O	be	auxpass	32	SENT_419	[p21l406t2008r468b2033],
32	approved	VBN	O	approve	parataxis	17	SENT_419	[p21l480t2008r614b2041],
33	.	.	O	.	_	0	SENT_419	[p21l480t2008r614b2041],

1	§	NN	O	§	nn	2	SENT_420	[p21l84t2044r95b2077],
2	A	NN	O	a	nsubjpass	19	SENT_420	[p21l108t2046r128b2069],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_420	[p21l136t2044r291b2077],
4	response	NN	O	response	dep	2	SENT_420	[p21l302t2053r425b2077],
5	is	VBZ	O	be	auxpass	6	SENT_420	[p21l436t2047r455b2069],
6	predicted	VBN	O	predict	_	0	SENT_420	[p21l467t2044r592b2077],
7	on	IN	O	on	_	0	SENT_420	[p21l603t2053r635b2069],
8	the	DT	O	the	det	14	SENT_420	[p21l646t2044r688b2069],
9	basis	NN	O	basis	nn	14	SENT_420	[p21l700t2044r767b2069],
10	ofthe	NN	O	ofthe	nn	14	SENT_420	[p21l778t2044r854b2069],
11	identity	NN	O	identity	nn	14	SENT_420	[p21l865t2044r965b2077],
12	ofthe	NN	O	ofthe	nn	14	SENT_420	[p21l974t2044r1051b2069],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_420	[p21l1060t2047r1168b2077],
14	kinase	NN	O	kinase	prep_on	6	SENT_420	[p21l1179t2044r1264b2069],
15	but	CC	O	but	_	0	SENT_420	[p21l1275t2044r1318b2069],
16	has	VBZ	O	have	aux	19	SENT_420	[p21l1329t2044r1373b2069],
17	not	RB	O	not	neg	19	SENT_420	[p21l1385t2049r1428b2069],
18	been	VBN	O	be	auxpass	19	SENT_420	[p21l1439t2044r1501b2069],
19	veriﬁed	VBN	O	veriﬁed	conj_but	6	SENT_420	[p21l1512t2044r1610b2069],
20	clinically	RB	O	clinically	advmod	19	SENT_420	[p21l1622t2044r1741b2077],
21	.	.	O	.	_	0	SENT_420	[p21l1622t2044r1741b2077],

1	lorectal	JJ	O	lorectal	amod	2	SENT_421	[p21l84t2143r212b2174],
2	cancer	NN	O	cancer	_	0	SENT_421	[p21l221t2153r332b2174],
3	demonstrated	VBD	O	demonstrate	partmod	2	SENT_421	[p21l341t2143r577b2174],
4	that	IN	O	that	complm	14	SENT_421	[p21l587t2143r654b2174],
5	the	DT	O	the	det	6	SENT_421	[p21l662t2143r714b2174],
6	addition	NN	O	addition	nsubj	14	SENT_421	[p21l723t2143r865b2174],
7	of	IN	O	of	prep	6	SENT_421	[p21l875t2143r915b2174],
8	not	RB	O	not	dep	7	SENT_421	[p21l947t2150r1003b2174],
9	yet	RB	O	yet	dep	8	SENT_421	[p21l1013t2150r1062b2182],
10	available	JJ	O	available	dep	8	SENT_421	[p21l1073t2143r1215b2174],
11	(	CD	NUMBER	(	tmod	10	SENT_421	[p21l1230t2143r1328b2178],
12	Table	NNP	O	Table	dep	14	SENT_421	[p21l1230t2143r1328b2178],
13	2	CD	NUMBER	2	num	14	SENT_421	[p21l1341t2145r1382b2178],
14	)	CD	NUMBER	)	ccomp	3	SENT_421	[p21l1341t2145r1382b2178],
15	.	.	O	.	_	0	SENT_421	[p21l1341t2145r1382b2178],

1	Activating	VBG	O	activate	amod	6	SENT_422	[p21l1395t2144r1562b2182],
2	point	NN	O	point	nn	6	SENT_422	[p21l1573t2144r1662b2182],
3	mutabevacizumab	NN	O	mutabevacizumab	nn	6	SENT_422	[p21l1672t2150r1770b2174, p21l84t2192r305b2223],
4	(	CD	NUMBER	(	num	6	SENT_422	[p21l320t2193r482b2229],
5	Avastin	NNP	O	Avastin	nn	6	SENT_422	[p21l320t2193r482b2229],
6	)	NN	O	)	_	0	SENT_422	[p21l320t2193r482b2229],
7	,	,	O	,	_	0	SENT_422	[p21l320t2193r482b2229],
8	a	DT	O	a	det	10	SENT_422	[p21l497t2202r514b2223],
9	humanized	JJ	O	humanized	amod	10	SENT_422	[p21l527t2192r718b2223],
10	anti	JJ	O	anti	appos	6	SENT_422	[p21l731t2193r906b2223],
11	.	.	O	.	_	0	SENT_422	[p21l731t2193r906b2223],

1	—	NN	O	—	_	0	SENT_423	[p21l731t2193r906b2223],
2	.	.	O	.	_	0	SENT_423	[p21l731t2193r906b2223],

1	VEGF	NN	ORGANIZATION	vegf	nn	2	SENT_424	[p21l731t2193r906b2223],
2	tions	NNS	O	tion	nsubj	10	SENT_424	[p21l947t2193r1027b2223],
3	and	CC	O	and	_	0	SENT_424	[p21l1040t2192r1100b2223],
4	fusions	NNS	O	fusion	nsubj	10	SENT_424	[p21l1112t2192r1231b2223],
5	of	IN	O	of	_	0	SENT_424	[p21l1244t2192r1283b2223],
6	the	DT	O	the	det	9	SENT_424	[p21l1288t2192r1338b2223],
7	receptor	NN	O	receptor	nn	9	SENT_424	[p21l1350t2199r1486b2231],
8	TK	NN	O	tk	nn	9	SENT_424	[p21l1496t2194r1546b2223],
9	RET	NNP	O	RET	prep_of	2	SENT_424	[p21l1556t2194r1627b2225],
10	occur	VB	O	occur	_	0	SENT_424	[p21l1638t2202r1728b2223],
11	in	IN	O	in	_	0	SENT_424	[p21l1739t2193r1770b2222],
12	monoclonal	JJ	O	monoclonal	amod	13	SENT_424	[p21l84t2241r287b2272],
13	antibody	NN	O	antibody	prep_in	10	SENT_424	[p21l296t2241r450b2280],
14	,	,	O	,	_	0	SENT_424	[p21l296t2241r450b2280],
15	to	TO	O	to	_	0	SENT_424	[p21l462t2248r493b2272],
16	irinotecan	NN	O	irinotecan	prep_to	10	SENT_424	[p21l503t2242r684b2278],
17	,	,	O	,	_	0	SENT_424	[p21l503t2242r684b2278],
18	ﬂuorouracil	NN	O	ﬂuorouracil	conj_and	16	SENT_424	[p21l696t2241r905b2278],
19	,	,	O	,	_	0	SENT_424	[p21l696t2241r905b2278],
20	multiple	JJ	O	multiple	amod	22	SENT_424	[p21l947t2241r1087b2280],
21	endocrine	JJ	O	endocrine	amod	22	SENT_424	[p21l1098t2241r1264b2272],
22	neoplasia	NN	O	neoplasium	prep_to	10	SENT_424	[p21l1275t2241r1435b2280],
23	and	CC	O	and	_	0	SENT_424	[p21l1445t2241r1506b2272],
24	radiation	NN	O	radiation	nn	27	SENT_424	[p21l1517t2241r1769b2272],
25	—	CD	NUMBER	—	num	27	SENT_424	[p21l1517t2241r1769b2272],
26	asso	NN	O	asso	nn	27	SENT_424	[p21l1517t2241r1769b2272],
27	—	NN	O	—	prep_to	10	SENT_424	[p21l1517t2241r1769b2272],
28	and	CC	O	and	_	0	SENT_424	[p21l84t2291r146b2322],
29	leucovorin	NN	O	leucovorin	nsubj	30	SENT_424	[p21l161t2291r335b2322],
30	led	VBD	O	lead	conj_and	10	SENT_424	[p21l349t2291r398b2322],
31	to	TO	O	to	_	0	SENT_424	[p21l412t2297r443b2322],
32	signiﬁcant	JJ	O	signiﬁcant	amod	33	SENT_424	[p21l459t2290r634b2330],
33	prolongation	NN	O	prolongation	prep_to	30	SENT_424	[p21l645t2291r861b2330],
34	of	IN	O	of	_	0	SENT_424	[p21l876t2290r915b2322],
35	ciated	VBN	O	ciate	prepc_of	33	SENT_424	[p21l947t2291r1044b2322],
36	thyroid	NN	O	thyroid	nn	37	SENT_424	[p21l1057t2291r1174b2330],
37	cancer	NN	O	cancer	dobj	35	SENT_424	[p21l1187t2289r1333b2322],
38	.	.	O	.	_	0	SENT_424	[p21l1187t2289r1333b2322],

1	”	NN	O	”	ccomp	12	SENT_425	[p21l1187t2289r1333b2322],
2	Similarly	RB	O	similarly	advmod	1	SENT_425	[p21l1347t2291r1497b2330],
3	,	,	O	,	_	0	SENT_425	[p21l1347t2291r1497b2330],
4	the	DT	O	the	det	7	SENT_425	[p21l1512t2291r1562b2321],
5	receptor	NN	O	receptor	nn	7	SENT_425	[p21l1575t2297r1711b2330],
6	TK	NN	O	tk	nn	7	SENT_425	[p21l1721t2293r1771b2322],
7	survival	NN	O	survival	nsubjpass	56	SENT_425	[p21l85t2339r251b2372],
8	.9	CD	NUMBER	.9	num	10	SENT_425	[p21l85t2339r251b2372],
9	°	CD	NUMBER	°	num	10	SENT_425	[p21l85t2339r251b2372],
10	MET	NN	O	met	dep	7	SENT_425	[p21l946t2343r1025b2371],
11	is	VBZ	O	be	auxpass	12	SENT_425	[p21l1035t2341r1061b2371],
12	overexpressed	VBN	O	overexpress	_	0	SENT_425	[p21l1073t2341r1304b2380],
13	in	IN	O	in	_	0	SENT_425	[p21l1315t2341r1347b2371],
14	melanoma	NN	O	melanoma	nn	17	SENT_425	[p21l1358t2341r1533b2372],
15	and	CC	O	and	_	0	SENT_425	[p21l1544t2341r1605b2372],
16	musculoskeletal	JJ	O	musculoskeletal	nn	17	SENT_425	[p21l1616t2341r1770b2372, p21l947t2390r1074b2421],
17	tumors	NNS	O	tumor	prep_in	12	SENT_425	[p21l1089t2397r1218b2427],
18	,	,	O	,	_	0	SENT_425	[p21l1089t2397r1218b2427],
19	activated	VBN	O	activate	conj_and	12	SENT_425	[p21l1235t2390r1382b2421],
20	by	IN	O	by	_	0	SENT_425	[p21l1397t2390r1435b2429],
21	point	NN	O	point	nn	22	SENT_425	[p21l1448t2391r1539b2429],
22	mutations	NNS	O	mutation	prep_by	19	SENT_425	[p21l1552t2391r1722b2421],
23	in	IN	O	in	_	0	SENT_425	[p21l1738t2391r1770b2420],
24	OTH	NNP	O	OTH	prep_in	19	SENT_425	[p21l85t2449r150b2469],
25	an	DT	O	a	det	27	SENT_425	[p21l159t2450r193b2468],
26	TK	NN	O	tk	nn	27	SENT_425	[p21l207t2450r244b2468],
27	mac	NN	O	mac	dep	24	SENT_425	[p21l258t2449r340b2469],
28	:	:	O	:	_	0	SENT_425	[p21l258t2449r340b2469],
29	ETS	NN	O	et	dep	24	SENT_425	[p21l347t2449r399b2469],
30	IN	IN	O	in	_	0	SENT_425	[p21l416t2450r447b2468],
31	so	RB	O	so	advmod	32	SENT_425	[p21l465t2449r505b2469],
32	LID	JJ	O	lid	amod	36	SENT_425	[p21l512t2450r562b2468],
33	TU	NN	O	tu	nn	36	SENT_425	[p21l576t2450r614b2469],
34	M	NN	O	m	nn	36	SENT_425	[p21l623t2450r644b2469],
35	o	NN	O	o	nn	36	SENT_425	[p21l651t2449r672b2469],
36	RS	NN	O	r	prep_in	29	SENT_425	[p21l679t2449r713b2469],
37	small	JJ	O	small	amod	41	SENT_425	[p21l947t2439r1110b2470],
38	—	NN	O	—	nn	41	SENT_425	[p21l947t2439r1110b2470],
39	cell	NN	O	cell	nn	41	SENT_425	[p21l947t2439r1110b2470],
40	lung	NN	O	lung	nn	41	SENT_425	[p21l1120t2439r1195b2478],
41	cancer	NN	O	cancer	dep	29	SENT_425	[p21l1205t2449r1312b2470],
42	and	CC	O	and	_	0	SENT_425	[p21l1321t2439r1382b2470],
43	renal	JJ	O	renal	amod	45	SENT_425	[p21l1392t2439r1474b2470],
44	papillary	JJ	O	papillary	amod	45	SENT_425	[p21l1484t2439r1628b2478],
45	carcinoSeveral	NN	O	carcinoseveral	prep_in	19	SENT_425	[p21l1637t2440r1770b2470, p21l85t2488r201b2519],
46	other	JJ	O	other	amod	47	SENT_425	[p21l217t2488r305b2519],
47	TKs	NNS	O	tk	nsubjpass	50	SENT_425	[p21l319t2490r384b2519],
48	have	VBP	O	have	aux	50	SENT_425	[p21l401t2488r475b2519],
49	been	VBN	O	be	auxpass	50	SENT_425	[p21l492t2488r570b2519],
50	implicated	VBN	O	implicate	rcmod	45	SENT_425	[p21l586t2488r763b2527],
51	in	IN	O	in	_	0	SENT_425	[p21l778t2489r811b2518],
52	solid	JJ	O	solid	amod	53	SENT_425	[p21l827t2488r907b2519],
53	ma	NN	O	ma	prep_in	50	SENT_425	[p21l947t2498r1006b2525],
54	,	,	O	,	_	0	SENT_425	[p21l947t2498r1006b2525],
55	and	CC	O	and	_	0	SENT_425	[p21l1017t2488r1078b2519],
56	dysregulated	VBN	O	dysregulate	conj_and	12	SENT_425	[p21l1087t2488r1295b2527],
57	by	IN	O	by	_	0	SENT_425	[p21l1305t2488r1342b2527],
58	fusion	NN	O	fusion	prep_by	56	SENT_425	[p21l1350t2488r1453b2519],
59	with	IN	O	with	_	0	SENT_425	[p21l1461t2488r1534b2519],
60	TPRin	NN	O	tprin	nn	62	SENT_425	[p21l1542t2489r1652b2521],
61	gastric	JJ	O	gastric	amod	62	SENT_425	[p21l1661t2489r1771b2527],
62	tumors	NNS	O	tumor	prep_with	56	SENT_425	[p21l84t2544r214b2574],
63	,	,	O	,	_	0	SENT_425	[p21l84t2544r214b2574],
64	but	CC	O	but	_	0	SENT_425	[p21l231t2537r287b2568],
65	targeted	VBN	O	target	csubj	70	SENT_425	[p21l300t2537r437b2576],
66	therapies	NNS	O	therapy	dobj	65	SENT_425	[p21l453t2537r605b2576],
67	against	IN	O	against	_	0	SENT_425	[p21l621t2538r744b2576],
68	them	PRP	O	they	prep_against	66	SENT_425	[p21l757t2537r842b2568],
69	are	VBP	O	be	cop	70	SENT_425	[p21l857t2547r907b2568],
70	carcinoma	NN	O	carcinoma	conj_but	12	SENT_425	[p21l947t2538r1128b2568],
71	.	.	O	.	_	0	SENT_425	[p21l947t2538r1128b2568],

1	The	DT	O	the	det	4	SENT_426	[p21l1142t2537r1205b2568],
2	receptor	NN	O	receptor	nn	4	SENT_426	[p21l1219t2544r1355b2576],
3	TKs	NN	O	tk	nn	4	SENT_426	[p21l1366t2540r1431b2568],
4	ROS	NN	O	ro	_	0	SENT_426	[p21l1445t2539r1526b2574],
5	,	,	O	,	_	0	SENT_426	[p21l1445t2539r1526b2574],
6	ALK	NNP	O	ALK	dep	4	SENT_426	[p21l1540t2540r1620b2574],
7	,	,	O	,	_	0	SENT_426	[p21l1540t2540r1620b2574],
8	NTRK1	NN	O	ntrk1	appos	6	SENT_426	[p21l1635t2539r1768b2574],
9	,	,	O	,	_	0	SENT_426	[p21l1635t2539r1768b2574],

1	N	NN	O	n	nn	3	SENT_427	[p21l567t2653r581b2668],
2	ENGLJ	NN	O	englj	nn	3	SENT_427	[p21l596t2652r680b2674],
3	MED	NN	O	med	_	0	SENT_427	[p21l695t2653r748b2668],
4	353	CD	NUMBER	353	dep	3	SENT_427	[p21l760t2652r824b2674],
5	;	:	O	;	_	0	SENT_427	[p21l760t2652r824b2674],
6	2	CD	NUMBER	2	num	8	SENT_427	[p21l760t2652r824b2674],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	8	SENT_427	[p21l859t2652r1070b2674],
8	JULY14	NN	O	july14	dep	4	SENT_427	[p21l1103t2652r1210b2674],
9	,	,	O	,	_	0	SENT_427	[p21l1103t2652r1210b2674],
10	2005	CD	DATE	2005	num	11	SENT_427	[p21l1224t2652r1287b2674],
11	181	CD	NUMBER	181	appos	8	SENT_427	[p21l2001t2651r2057b2672],

1	The	DT	O	the	det	4	SENT_428	[p21l742t2749r793b2773],
2	New	NNP	O	New	nn	4	SENT_428	[p21l802t2750r864b2773],
3	England	NNP	O	England	nn	4	SENT_428	[p21l874t2749r984b2780],
4	Journal	NNP	O	Journal	_	0	SENT_428	[p21l993t2749r1090b2773],
5	of	IN	O	of	_	0	SENT_428	[p21l1100t2749r1129b2773],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_428	[p21l1136t2749r1261b2773],

1	Downloaded	VBN	O	download	_	0	SENT_429	[p21l185t2790r354b2813],
2	from	IN	O	from	_	0	SENT_429	[p21l363t2790r428b2813],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_429	[p21l437t2790r555b2820],
4	at	IN	O	at	_	0	SENT_429	[p21l565t2794r588b2813],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_429	[p21l597t2790r779b2813],
6	on	IN	O	on	_	0	SENT_429	[p21l789t2797r821b2813],
7	January	NNP	DATE	January	prep_on	1	SENT_429	[p21l830t2790r932b2820],
8	5	CD	DATE	5	num	7	SENT_429	[p21l942t2790r965b2817],
9	,	,	DATE	,	_	0	SENT_429	[p21l942t2790r965b2817],
10	2014	CD	DATE	2014	num	7	SENT_429	[p21l976t2790r1048b2813],
11	.	.	O	.	_	0	SENT_429	[p21l976t2790r1048b2813],

1	For	IN	O	for	_	0	SENT_430	[p21l1058t2790r1105b2813],
2	personal	JJ	O	personal	amod	3	SENT_430	[p21l1113t2790r1225b2820],
3	use	NN	O	use	pobj	1	SENT_430	[p21l1235t2797r1278b2813],
4	only	RB	O	only	advmod	3	SENT_430	[p21l1288t2790r1352b2820],
5	.	.	O	.	_	0	SENT_430	[p21l1288t2790r1352b2820],

1	No	DT	O	no	det	3	SENT_431	[p21l1363t2790r1403b2813],
2	other	JJ	O	other	amod	3	SENT_431	[p21l1413t2790r1481b2813],
3	uses	NNS	O	use	_	0	SENT_431	[p21l1489t2797r1545b2813],
4	without	IN	O	without	_	0	SENT_431	[p21l1555t2790r1656b2813],
5	permission	NN	O	permission	prep_without	3	SENT_431	[p21l1665t2790r1817b2820],
6	.	.	O	.	_	0	SENT_431	[p21l1665t2790r1817b2820],

1	Copyright	NN	O	copyright	_	0	SENT_432	[p21l535t2831r669b2862],
2	©	CD	NUMBER	©	num	6	SENT_432	[p21l679t2831r702b2855],
3	2005	CD	DATE	2005	num	6	SENT_432	[p21l712t2831r776b2855],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_432	[p21l787t2831r978b2855],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_432	[p21l988t2831r1096b2855],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_432	[p21l1106t2831r1211b2862],
7	.	.	O	.	_	0	SENT_432	[p21l1106t2831r1211b2862],

1	All	DT	O	all	det	2	SENT_433	[p21l1222t2831r1263b2855],
2	rights	NNS	O	rights	nsubj	3	SENT_433	[p21l1272t2831r1347b2862],
3	reserved	VBN	O	reserve	_	0	SENT_433	[p21l1357t2831r1476b2855],
4	.	.	O	.	_	0	SENT_433	[p21l1357t2831r1476b2855],

1	The	DT	O	the	det	4	SENT_434	[p21l715t2937r752b2958],
2	NEW	NNP	O	NEW	nn	4	SENT_434	[p21l764t2939r845b2958],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_434	[p21l859t2939r1034b2958],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_434	[p21l1048t2939r1214b2965],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_434	[p21l1228t2937r1444b2964],

1	and	CC	O	and	cc	4	SENT_435	[p21l10t3159r166b3238],
2	NTRK3	NN	O	ntrk3	nsubjpass	4	SENT_435	[p21l197t3165r517b3243],
3	are	VBP	O	be	auxpass	4	SENT_435	[p21l553t3186r681b3238],
4	activated	VBN	O	activate	_	0	SENT_435	[p21l713t3159r1091b3239],
5	through	IN	O	through	_	0	SENT_435	[p21l1124t3160r1472b3260],
6	the	DT	O	the	det	7	SENT_435	[p21l1505t3159r1637b3238],
7	generation	NN	O	generation	prep_through	4	SENT_435	[p21l1669t3160r2134b3260],
8	of	IN	O	of	_	0	SENT_435	[p21l11t3287r112b3366],
9	fusion	NN	O	fusion	nn	10	SENT_435	[p21l130t3287r402b3367],
10	proteins	NNS	O	protein	prep_of	7	SENT_435	[p21l437t3288r792b3388],
11	in	IN	O	in	_	0	SENT_435	[p21l830t3288r912b3365],
12	a	DT	O	a	det	14	SENT_435	[p21l948t3314r992b3366],
13	diverse	JJ	O	diverse	amod	14	SENT_435	[p21l1028t3287r1326b3367],
14	set	NN	O	set	prep_in	4	SENT_435	[p21l1365t3304r1486b3366],
15	of	IN	O	of	_	0	SENT_435	[p21l1518t3287r1619b3366],
16	carcinomas	NNS	O	carcinoma	prep_of	14	SENT_435	[p21l1638t3288r2131b3366],
17	and	CC	O	and	_	0	SENT_435	[p21l10t3416r167b3494],
18	sarcomas	NNS	O	sarcoma	prep_of	14	SENT_435	[p21l209t3441r640b3494],
19	.	.	O	.	_	0	SENT_435	[p21l209t3441r640b3494],

1	ALK	NN	O	alk	nn	5	SENT_436	[p21l682t3423r871b3497],
2	and	CC	O	and	_	0	SENT_436	[p21l906t3415r1064b3494],
3	NTRK3	NN	O	ntrk3	conj_and	1	SENT_436	[p21l1102t3421r1422b3499],
4	fusion	NN	O	fusion	nn	5	SENT_436	[p21l1465t3415r1738b3495],
5	proteins	NNS	O	protein	nsubjpass	8	SENT_436	[p21l1776t3416r2131b3516],
6	are	VBP	O	be	auxpass	8	SENT_436	[p21l10t3570r135b3622],
7	also	RB	O	also	advmod	8	SENT_436	[p21l162t3543r329b3622],
8	found	VBN	O	find	_	0	SENT_436	[p21l357t3543r608b3623],
9	in	IN	O	in	_	0	SENT_436	[p21l634t3544r716b3621],
10	hematologic	JJ	O	hematologic	amod	11	SENT_436	[p21l742t3543r1271b3644],
11	cancers	NNS	O	cancer	prep_in	8	SENT_436	[p21l1298t3569r1637b3622],
12	.	.	O	.	_	0	SENT_436	[p21l1298t3569r1637b3622],

1	The	DT	O	the	det	2	SENT_437	[p21l1665t3543r1827b3622],
2	type	NN	O	type	nsubjpass	6	SENT_437	[p21l1855t3560r2025b3644],
3	of	IN	O	of	_	0	SENT_437	[p21l2053t3543r2153b3622],
4	disease	NN	O	disease	prep_of	2	SENT_437	[p21l11t3672r317b3750],
5	is	VBZ	O	be	auxpass	6	SENT_437	[p21l345t3672r411b3750],
6	dictated	VBN	O	dictate	_	0	SENT_437	[p21l443t3671r787b3750],
7	by	IN	O	by	_	0	SENT_437	[p21l816t3672r913b3772],
8	the	DT	O	the	det	9	SENT_437	[p21l939t3672r1070b3750],
9	tissue	NN	O	tissue	agent	6	SENT_437	[p21l1100t3672r1347b3751],
10	of	IN	O	of	_	0	SENT_437	[p21l1376t3671r1478b3750],
11	expression	NN	O	expression	prep_of	9	SENT_437	[p21l1489t3672r1979b3772],
12	;	:	O	;	_	0	SENT_437	[p21l1489t3672r1979b3772],
13	for	IN	O	for	_	0	SENT_437	[p21l2012t3671r2136b3750],
14	example	NN	O	example	prep_for	6	SENT_437	[p22l11t21r397b121],
15	,	,	O	,	_	0	SENT_437	[p22l11t21r397b121],
16	T	NN	O	t	nn	17	SENT_437	[p22l430t26r491b98],
17	EL	NN	O	el	appos	14	SENT_437	[p22l494t26r965b104],
18	.	.	O	.	_	0	SENT_437	[p22l494t26r965b104],

1	—	NN	O	—	_	0	SENT_438	[p22l494t26r965b104],
2	.	.	O	.	_	0	SENT_438	[p22l494t26r965b104],

1	NTRK3	NN	O	ntrk3	nn	2	SENT_439	[p22l494t26r965b104],
2	fusions	NNS	O	fusion	nsubj	8	SENT_439	[p22l999t20r1316b100],
3	found	VBN	O	find	partmod	2	SENT_439	[p22l1349t20r1606b100],
4	in	IN	O	in	_	0	SENT_439	[p22l1637t21r1719b98],
5	congenital	JJ	O	congenital	amod	6	SENT_439	[p22l1751t21r2132b121, p22l11t149r117b227],
6	ﬁbrosarcoma	NN	O	ﬁbrosarcoma	prep_in	3	SENT_439	[p22l155t148r733b227],
7	can	MD	O	can	aux	8	SENT_439	[p22l770t174r916b227],
8	induce	VB	O	induce	_	0	SENT_439	[p22l953t149r1241b228],
9	hematologic	JJ	O	hematologic	amod	10	SENT_439	[p22l1279t148r1818b249],
10	cancer	NN	O	cancer	dobj	8	SENT_439	[p22l1856t174r2136b227],
11	when	WRB	O	when	advmod	12	SENT_439	[p22l6t277r243b356],
12	expressed	VBN	O	express	advcl	8	SENT_439	[p22l271t277r687b377],
13	directly	RB	O	directly	advmod	12	SENT_439	[p22l713t277r1024b377],
14	in	IN	O	in	_	0	SENT_439	[p22l1044t278r1125b354],
15	bone	NN	O	bone	nn	16	SENT_439	[p22l1151t277r1358b355],
16	marroW	NN	O	marrow	prep_in	12	SENT_439	[p22l1384t271r1855b356],
17	.1	CD	NUMBER	.1	num	18	SENT_439	[p22l1384t271r1855b356],
18	°	NN	O	°	dep	16	SENT_439	[p22l1384t271r1855b356],
19	5	CD	NUMBER	5	dep	18	SENT_439	[p22l1384t271r1855b356],

1	CURRENT	JJ	DATE	current	amod	2	SENT_440	[p22l397t624r939b683],
2	CHALLENGES	NNS	O	challenge	_	0	SENT_440	[p22l988t624r1734b683],

1	AND	CC	O	and	_	0	SENT_441	[p22l312t746r552b804],
2	FUTURE	JJ	DATE	future	amod	3	SENT_441	[p22l607t746r1048b804],
3	DIRECTIONS	NNS	O	direction	dep	1	SENT_441	[p22l1103t745r1815b804],

1	LIMITATIONS	NNS	O	limitation	nsubj	14	SENT_442	[p22l15t973r566b1023],
2	OF	IN	O	of	_	0	SENT_442	[p22l606t973r711b1023],
3	TK-TARGETED	NN	O	tk-targeted	nn	5	SENT_442	[p22l747t973r1310b1023],
4	THERAPIES2	NN	O	therapies2	nn	5	SENT_442	[p22l1347t973r1834b1023],
5	TOXICITY	NN	O	toxicity	prep_of	1	SENT_442	[p22l8t1057r392b1106],
6	AND	CC	O	and	_	0	SENT_442	[p22l428t1057r605b1106],
7	RESISTANCE	NN	O	resistance	prep_of	1	SENT_442	[p22l650t1057r1150b1106],
8	Targeted	VBN	O	target	partmod	7	SENT_442	[p22l7t1157r375b1258],
9	cancer	NN	O	cancer	nn	10	SENT_442	[p22l401t1183r676b1236],
10	therapies	NNS	O	therapy	dobj	8	SENT_442	[p22l697t1157r1082b1258],
11	should	MD	O	should	aux	14	SENT_442	[p22l1110t1157r1397b1237],
12	be	VB	O	be	cop	14	SENT_442	[p22l1422t1158r1517b1236],
13	less	RBR	O	less	advmod	14	SENT_442	[p22l1540t1158r1695b1236],
14	toxic	JJ	O	toxic	_	0	SENT_442	[p22l1722t1158r1923b1236],
15	than	IN	O	than	_	0	SENT_442	[p22l1947t1158r2135b1236],
16	conventional	JJ	O	conventional	amod	17	SENT_442	[p22l11t1286r565b1365],
17	chemotherapy	NN	O	chemotherapy	prep_than	14	SENT_442	[p22l592t1285r1210b1386],
18	because	IN	O	because	mark	21	SENT_442	[p22l1233t1285r1571b1365],
19	they	PRP	O	they	nsubj	21	SENT_442	[p22l1599t1285r1779b1386],
20	are	VBP	O	be	cop	21	SENT_442	[p22l1801t1312r1929b1364],
21	speciﬁc	NN	O	speciﬁc	advcl	14	SENT_442	[p22l1957t1312r2132b1386, p22l11t1413r189b1492],
22	for	IN	O	for	_	0	SENT_442	[p22l213t1413r338b1492],
23	tumor	NN	O	tumor	nn	24	SENT_442	[p22l360t1430r627b1493],
24	cells	NNS	O	cell	prep_for	21	SENT_442	[p22l650t1413r863b1492],
25	.	.	O	.	_	0	SENT_442	[p22l650t1413r863b1492],

1	Consistent	JJ	O	consistent	ccomp	8	SENT_443	[p22l893t1414r1361b1492],
2	With	IN	O	with	dep	1	SENT_443	[p22l1376t1414r1568b1493],
3	this	DT	O	this	det	4	SENT_443	[p22l1593t1414r1749b1492],
4	expectation	NN	O	expectation	pobj	2	SENT_443	[p22l1777t1430r2133b1514, p22l11t1541r204b1635],
5	,	,	O	,	_	0	SENT_443	[p22l1777t1430r2133b1514, p22l11t1541r204b1635],
6	a	DT	O	a	det	7	SENT_443	[p22l247t1567r291b1618],
7	maximum	NN	O	maximum	nsubj	8	SENT_443	[p22l326t1541r759b1620],
8	tolerated	VBD	O	tolerate	dep	14	SENT_443	[p22l794t1540r1166b1619],
9	dose	NN	O	dose	dobj	8	SENT_443	[p22l1201t1540r1394b1619],
10	for	IN	O	for	_	0	SENT_443	[p22l1429t1540r1552b1619],
11	imatinib	NN	O	imatinib	prep_for	8	SENT_443	[p22l1584t1541r1940b1619],
12	was	VBD	O	be	auxpass	14	SENT_443	[p22l1972t1567r2133b1619],
13	never	RB	O	never	neg	14	SENT_443	[p22l10t1694r241b1748],
14	reached	VBN	O	reach	_	0	SENT_443	[p22l274t1668r610b1747],
15	in	IN	O	in	_	0	SENT_443	[p22l646t1669r728b1746],
16	the	DT	O	the	det	17	SENT_443	[p22l765t1668r895b1747],
17	phase	NN	O	phase	prep_in	14	SENT_443	[p22l931t1669r1182b1769],
18	1	CD	NUMBER	1	num	19	SENT_443	[p22l1221t1674r1265b1746],
19	trials	NNS	O	trial	nsubjpass	14	SENT_443	[p22l1303t1669r1516b1747],
20	of	IN	O	of	_	0	SENT_443	[p22l1554t1668r1656b1747],
21	this	DT	O	this	det	22	SENT_443	[p22l1674t1668r1830b1747],
22	agent	NN	O	agent	prep_of	19	SENT_443	[p22l1868t1685r2128b1769],
23	.	.	O	.	_	0	SENT_443	[p22l1868t1685r2128b1769],

1	However	RB	O	however	advmod	13	SENT_444	[p22l10t1804r409b1892],
2	,	,	O	,	_	0	SENT_444	[p22l10t1804r409b1892],
3	some	DT	O	some	det	5	SENT_444	[p22l442t1822r670b1875],
4	toxic	JJ	O	toxic	amod	5	SENT_444	[p22l697t1797r902b1875],
5	effects	NNS	O	effect	nsubj	23	SENT_444	[p22l928t1796r1205b1875],
6	of	IN	O	of	_	0	SENT_444	[p22l1234t1796r1335b1875],
7	TK	NN	O	tk	prep_of	5	SENT_444	[p22l1340t1797r1854b1897],
8	—	CD	NUMBER	—	num	7	SENT_444	[p22l1340t1797r1854b1897],
9	targeted	VBN	O	target	partmod	7	SENT_444	[p22l1340t1797r1854b1897],
10	therapies	NNS	O	therapy	dobj	9	SENT_444	[p22l1880t1797r2132b1875, p22l9t1925r179b2025],
11	may	MD	O	may	aux	13	SENT_444	[p22l213t1951r389b2025],
12	be	VB	O	be	auxpass	13	SENT_444	[p22l415t1925r510b2003],
13	related	VBN	O	relate	_	0	SENT_444	[p22l539t1924r826b2003],
14	to	TO	O	to	_	0	SENT_444	[p22l855t1941r934b2003],
15	inhibition	NN	O	inhibition	prep_to	13	SENT_444	[p22l963t1924r1384b2003],
16	of	IN	O	of	_	0	SENT_444	[p22l1413t1924r1514b2003],
17	TKs	NNS	O	tk	prep_of	15	SENT_444	[p22l1521t1930r1688b2006],
18	in	IN	O	in	_	0	SENT_444	[p22l1718t1925r1800b2002],
19	normal	JJ	O	normal	amod	20	SENT_444	[p22l1828t1925r2135b2003],
20	tissues	NNS	O	tissue	prep_in	17	SENT_444	[p22l11t2053r294b2132],
21	and	CC	O	and	_	0	SENT_444	[p22l321t2052r476b2131],
22	therefore	RB	O	therefore	advmod	23	SENT_444	[p22l502t2052r886b2131],
23	difficult	JJ	O	difficult	conj_and	13	SENT_444	[p22l912t2052r1248b2132],
24	to	TO	O	to	aux	25	SENT_444	[p22l1269t2069r1348b2131],
25	eliminate	VB	O	eliminate	xcomp	23	SENT_444	[p22l1375t2053r1792b2131],
26	.	.	O	.	_	0	SENT_444	[p22l1375t2053r1792b2131],

1	Defects	NNS	O	defect	nsubj	5	SENT_445	[p22l1821t2052r2133b2131],
2	in	IN	O	in	_	0	SENT_445	[p22l10t2181r92b2258],
3	cell	NN	O	cell	nn	4	SENT_445	[p22l125t2180r709b2259],
4	—	NN	O	—	prep_in	1	SENT_445	[p22l125t2180r709b2259],
5	mediated	VBD	O	mediate	_	0	SENT_445	[p22l125t2180r709b2259],
6	immunity	NN	O	immunity	nsubjpass	9	SENT_445	[p22l741t2181r1165b2281],
7	have	VBP	O	have	aux	9	SENT_445	[p22l1193t2181r1384b2260],
8	been	VBN	O	be	auxpass	9	SENT_445	[p22l1419t2181r1621b2259],
9	reported	VBN	O	report	ccomp	5	SENT_445	[p22l1653t2180r2020b2281],
10	in	IN	O	in	_	0	SENT_445	[p22l2052t2181r2134b2258],
11	patients	NNS	O	patient	prep_in	9	SENT_445	[p22l9t2309r351b2409],
12	with	IN	O	with	_	0	SENT_445	[p22l380t2309r573b2388],
13	imatinib	NN	O	imatinib	nn	14	SENT_445	[p22l603t2308r1305b2387],
14	—	NN	O	—	prep_with	9	SENT_445	[p22l603t2308r1305b2387],
15	treated	VBN	O	treat	partmod	14	SENT_445	[p22l603t2308r1305b2387],
16	CML	NN	ORGANIZATION	cml	dobj	15	SENT_445	[p22l1336t2314r1540b2387],
17	and	CC	O	and	_	0	SENT_445	[p22l1569t2309r1727b2387],
18	may	MD	O	may	aux	21	SENT_445	[p22l1758t2335r1936b2409],
19	be	VB	O	be	cop	21	SENT_445	[p22l1963t2309r2060b2387],
20	a	DT	O	a	det	21	SENT_445	[p22l2091t2335r2135b2387],
21	consequence	NN	O	consequence	conj_and	5	SENT_445	[p22l11t2462r572b2537],
22	of	IN	O	of	_	0	SENT_445	[p22l616t2436r718b2515],
23	blockade	NN	O	blockade	prep_of	21	SENT_445	[p22l743t2436r1133b2516],
24	of	IN	O	of	_	0	SENT_445	[p22l1177t2436r1279b2515],
25	c	NN	O	c	prep_of	23	SENT_445	[p22l1304t2443r1562b2515],
26	.	.	O	.	_	0	SENT_445	[p22l1304t2443r1562b2515],

1	—	NN	O	—	_	0	SENT_446	[p22l1304t2443r1562b2515],
2	.	.	O	.	_	0	SENT_446	[p22l1304t2443r1562b2515],

1	ABL	NN	ORGANIZATION	abl	nn	2	SENT_447	[p22l1304t2443r1562b2515],
2	signaling	NN	O	signaling	dep	10	SENT_447	[p22l1605t2437r2012b2537],
3	in	IN	O	in	_	0	SENT_447	[p22l2051t2437r2134b2514],
4	T	NN	O	t	nn	5	SENT_447	[p22l7t2570r68b2641],
5	lymphocytes	NNS	O	lymphocyte	prep_in	2	SENT_447	[p22l92t2557r788b2664],
6	.1	CD	NUMBER	.1	dep	10	SENT_447	[p22l92t2557r788b2664],
7	°	CD	NUMBER	°	number	8	SENT_447	[p22l92t2557r788b2664],
8	6	CD	NUMBER	6	num	10	SENT_447	[p22l92t2557r788b2664],
9	The	DT	O	the	det	10	SENT_447	[p22l817t2564r981b2642],
10	cardiotoxicity	NN	O	cardiotoxicity	dep	16	SENT_447	[p22l1015t2564r1602b2664],
11	of	IN	O	of	_	0	SENT_447	[p22l1632t2563r1733b2642],
12	trastuzu	FW	O	trastuzu	nn	13	SENT_447	[p22l1748t2580r2132b2643],
13	—	FW	O	—	prep_of	10	SENT_447	[p22l1748t2580r2132b2643],
14	mab	FW	O	mab	nsubj	16	SENT_447	[p22l10t2693r196b2771],
15	may	MD	O	may	aux	16	SENT_447	[p22l220t2719r397b2793],
16	reﬂect	VB	O	reﬂect	_	0	SENT_447	[p22l414t2692r680b2771],
17	a	DT	O	a	det	18	SENT_447	[p22l695t2719r740b2771],
18	requirement	NN	O	requirement	dobj	16	SENT_447	[p22l759t2693r1286b2793],
19	for	IN	O	for	_	0	SENT_447	[p22l1302t2692r1425b2771],
20	HER-2	NN	MISC	her-2	nn	21	SENT_447	[p22l1442t2698r1720b2776],
21	signaling	NN	O	signaling	prep_for	18	SENT_447	[p22l1744t2693r2138b2793],
22	in	IN	O	in	_	0	SENT_447	[p22l10t2821r91b2898],
23	cardiomyocytes	NNS	O	cardiomyocyte	prep_in	16	SENT_447	[p22l113t2820r790b2921],
24	,	,	O	,	_	0	SENT_447	[p22l113t2820r790b2921],
25	Whereas	IN	O	whereas	mark	42	SENT_447	[p22l812t2821r1161b2900],
26	the	DT	O	the	det	28	SENT_447	[p22l1184t2821r1313b2899],
27	acneiform	NN	O	acneiform	nn	28	SENT_447	[p22l1335t2820r1766b2899],
28	rash	NN	O	rash	nsubj	42	SENT_447	[p22l1787t2820r1967b2899],
29	frequently	RB	O	frequently	advmod	30	SENT_447	[p22l1989t2820r2134b2899, p22l11t2949r326b3048],
30	seen	VBN	O	see	partmod	28	SENT_447	[p22l345t2973r532b3026],
31	in	IN	O	in	_	0	SENT_447	[p22l554t2949r636b3025],
32	patients	NNS	O	patient	prep_in	30	SENT_447	[p22l658t2949r992b3048],
33	who	WP	O	who	nsubj	34	SENT_447	[p22l1013t2949r1197b3027],
34	have	VBP	O	have	rcmod	32	SENT_447	[p22l1221t2949r1410b3027],
35	a	DT	O	a	det	36	SENT_447	[p22l1433t2974r1477b3026],
36	response	NN	O	response	dobj	34	SENT_447	[p22l1499t2973r1878b3048],
37	to	TO	O	to	_	0	SENT_447	[p22l1901t2964r1980b3026],
38	gefitinib	NN	O	gefitinib	prep_to	34	SENT_447	[p22l2005t2974r2134b3048, p22l10t3076r264b3155],
39	and	CC	O	and	_	0	SENT_447	[p22l287t3077r443b3155],
40	cetuximab	NN	O	cetuximab	prep_to	34	SENT_447	[p22l466t3077r900b3156],
41	may	MD	O	may	aux	42	SENT_447	[p22l924t3103r1101b3177],
42	correlate	VB	O	correlate	dep	16	SENT_447	[p22l1119t3076r1485b3155],
43	with	IN	O	with	_	0	SENT_447	[p22l1504t3076r1693b3156],
44	inhibition	NN	O	inhibition	prep_with	42	SENT_447	[p22l1714t3076r2135b3155],
45	of	IN	O	of	_	0	SENT_447	[p22l11t3204r112b3283],
46	EGFR	NN	ORGANIZATION	egfr	nn	47	SENT_447	[p22l117t3210r375b3288],
47	signaling	NN	O	signaling	prep_of	44	SENT_447	[p22l392t3205r787b3305],
48	in	IN	O	in	_	0	SENT_447	[p22l807t3205r889b3282],
49	skin	NN	O	skin	prep_in	42	SENT_447	[p22l915t3205r1114b3284],
50	.	.	O	.	_	0	SENT_447	[p22l915t3205r1114b3284],

1	Resistance	NN	O	resistance	nsubj	20	SENT_448	[p22l138t3333r605b3416],
2	to	TO	O	to	_	0	SENT_448	[p22l633t3349r713b3411],
3	TK	NN	O	tk	nn	4	SENT_448	[p22l739t3332r1258b3433],
4	—	NN	O	—	prep_to	1	SENT_448	[p22l739t3332r1258b3433],
5	targeted	VBN	O	target	dep	4	SENT_448	[p22l739t3332r1258b3433],
6	therapies	NNS	O	therapy	nsubj	10	SENT_448	[p22l1286t3333r1684b3433],
7	is	VBZ	O	be	cop	10	SENT_448	[p22l1713t3333r1779b3411],
8	a	DT	O	a	det	10	SENT_448	[p22l1808t3359r1853b3411],
9	growing	VBG	O	grow	amod	10	SENT_448	[p22l1878t3358r2131b3433, p22l10t3461r149b3561],
10	problem	NN	O	problem	ccomp	5	SENT_448	[p22l166t3460r524b3561],
11	and	CC	O	and	_	0	SENT_448	[p22l544t3461r699b3539],
12	may	MD	O	may	aux	14	SENT_448	[p22l720t3487r895b3561],
13	be	VB	O	be	cop	14	SENT_448	[p22l913t3461r1008b3539],
14	due	JJ	O	due	conj_and	5	SENT_448	[p22l1030t3460r1179b3540],
15	to	TO	O	to	_	0	SENT_448	[p22l1202t3477r1280b3539],
16	any	DT	O	any	prep_to	14	SENT_448	[p22l1302t3486r1449b3561],
17	of	IN	O	of	_	0	SENT_448	[p22l1466t3460r1566b3539],
18	several	JJ	O	several	amod	19	SENT_448	[p22l1570t3461r1851b3540],
19	mechanisms	NNS	O	mechanism	prep_of	16	SENT_448	[p22l1873t3460r2134b3539, p22l10t3589r313b3667],
20	(	VBP	O	(	_	0	SENT_448	[p22l357t3589r544b3689],
21	Fig	NN	O	fig	dobj	20	SENT_448	[p22l357t3589r544b3689],
22	.	.	O	.	_	0	SENT_448	[p22l357t3589r544b3689],

1	3	CD	NUMBER	3	_	0	SENT_449	[p22l587t3594r695b3680],
2	)	NN	O	)	dep	1	SENT_449	[p22l587t3594r695b3680],
3	.	.	O	.	_	0	SENT_449	[p22l587t3594r695b3680],

1	Resistance	NN	O	resistance	nsubjpass	7	SENT_450	[p22l735t3589r1197b3672],
2	to	TO	O	to	_	0	SENT_450	[p22l1234t3605r1314b3667],
3	TK	NN	O	tk	nn	4	SENT_450	[p22l1348t3594r1478b3670],
4	inhibitors	NNS	O	inhibitor	prep_to	1	SENT_450	[p22l1510t3588r1934b3667],
5	was	VBD	O	be	auxpass	7	SENT_450	[p22l1968t3615r2131b3668],
6	first	JJ	ORDINAL	first	advmod	7	SENT_450	[p23l10t20r188b99],
7	identiﬁed	VBN	O	identiﬁed	_	0	SENT_450	[p23l208t20r616b99],
8	in	IN	O	in	_	0	SENT_450	[p23l640t21r721b98],
9	patients	NNS	O	patient	prep_in	7	SENT_450	[p23l744t21r1079b121],
10	with	IN	O	with	_	0	SENT_450	[p23l1101t21r1290b100],
11	advanced	JJ	O	advanced	amod	12	SENT_450	[p23l1314t21r1706b100],
12	CML	NN	ORGANIZATION	cml	prep_with	7	SENT_450	[p23l1730t26r1933b99],
13	who	WP	O	who	nsubj	14	SENT_450	[p23l1950t21r2134b100],
14	had	VBD	O	have	rcmod	12	SENT_450	[p23l10t148r165b227],
15	a	DT	O	a	det	16	SENT_450	[p23l193t175r238b227],
16	relapse	NN	O	relapse	dobj	14	SENT_450	[p23l265t149r564b249],
17	While	IN	O	while	mark	18	SENT_450	[p23l588t148r820b228],
18	receiving	VBG	O	receive	dep	7	SENT_450	[p23l849t149r1232b249],
19	imatinib	NN	O	imatinib	dobj	18	SENT_450	[p23l1257t149r1613b227],
20	and	CC	O	and	_	0	SENT_450	[p23l1643t149r1798b227],
21	was	VBD	O	be	auxpass	22	SENT_450	[p23l1823t175r1984b228],
22	associated	VBN	O	associate	conj_and	18	SENT_450	[p23l2015t175r2134b227, p23l12t277r364b355],
23	With	IN	O	with	_	0	SENT_450	[p23l398t277r590b356],
24	point	NN	O	point	nn	25	SENT_450	[p23l628t277r860b377],
25	mutations	NNS	O	mutation	prep_with	22	SENT_450	[p23l895t277r1334b356],
26	that	WDT	O	that	nsubj	27	SENT_450	[p23l1376t277r1545b355],
27	rendered	VBD	O	render	rcmod	25	SENT_450	[p23l1580t276r1963b355],
28	the	DT	O	the	det	30	SENT_450	[p23l2002t277r2134b355],
29	ABL	NN	ORGANIZATION	abl	nn	30	SENT_450	[p23l7t411r188b483],
30	kinase	NN	O	kinase	nsubj	31	SENT_450	[p23l215t405r488b484],
31	resistant	JJ	O	resistant	xcomp	27	SENT_450	[p23l516t405r884b483],
32	to	TO	O	to	_	0	SENT_450	[p23l907t421r986b483],
33	the	DT	O	the	det	34	SENT_450	[p23l1015t405r1144b483],
34	drug	NN	O	drug	prep_to	31	SENT_450	[p23l1173t404r1373b505],
35	or	CC	O	or	_	0	SENT_450	[p23l1398t430r1503b500],
36	,	,	O	,	_	0	SENT_450	[p23l1398t430r1503b500],
37	less	JJR	O	less	dep	27	SENT_450	[p23l1535t405r1690b483],
38	commonly	RB	O	commonly	advmod	37	SENT_450	[p23l1721t430r2134b483, p23l9t533r92b633],
39	,	,	O	,	_	0	SENT_450	[p23l1721t430r2134b483, p23l9t533r92b633],
40	was	VBD	O	be	auxpass	41	SENT_450	[p23l135t559r298b612],
41	associated	VBN	O	associate	rcmod	25	SENT_450	[p23l341t532r787b611],
42	With	IN	O	with	_	0	SENT_450	[p23l824t532r1016b612],
43	BCR	NN	O	bcr	prep_with	41	SENT_450	[p23l1056t538r1414b612],
44	.	.	O	.	_	0	SENT_450	[p23l1056t538r1414b612],

1	—	NN	O	—	_	0	SENT_451	[p23l1056t538r1414b612],
2	.	.	O	.	_	0	SENT_451	[p23l1056t538r1414b612],

1	ABL	NN	ORGANIZATION	abl	nn	3	SENT_452	[p23l1056t538r1414b612],
2	gene	NN	O	gene	nn	3	SENT_452	[p23l1451t558r1654b633],
3	ampliﬁcation	NN	O	ampliﬁcation	_	0	SENT_452	[p23l1695t532r2132b633, p23l11t655r334b739],
4	.1	CD	NUMBER	.1	num	5	SENT_452	[p23l1695t532r2132b633, p23l11t655r334b739],
5	°	NN	O	°	dep	3	SENT_452	[p23l1695t532r2132b633, p23l11t655r334b739],
6	7	CD	NUMBER	7	dep	5	SENT_452	[p23l1695t532r2132b633, p23l11t655r334b739],
7	A	DT	O	a	det	9	SENT_452	[p23l365t668r431b738],
8	long	JJ	O	long	amod	9	SENT_452	[p23l459t661r652b761],
9	list	NN	O	list	dep	3	SENT_452	[p23l679t660r811b739],
10	of	IN	O	of	_	0	SENT_452	[p23l838t660r939b739],
11	imatinib	NN	O	imatinib	npadvmod	13	SENT_452	[p23l952t661r1716b739],
12	—	CD	NUMBER	—	num	11	SENT_452	[p23l952t661r1716b739],
13	resistant	JJ	O	resistant	amod	14	SENT_452	[p23l952t661r1716b739],
14	BCR	NN	O	bcr	prep_of	9	SENT_452	[p23l1741t666r2138b744],
15	.	.	O	.	_	0	SENT_452	[p23l1741t666r2138b744],

1	—	NN	O	—	_	0	SENT_453	[p23l1741t666r2138b744],
2	.	.	O	.	_	0	SENT_453	[p23l1741t666r2138b744],

1	ABL	NN	ORGANIZATION	abl	dep	106	SENT_454	[p23l1741t666r2138b744],
2	mutants	NNS	O	mutant	dep	106	SENT_454	[p23l10t805r358b868],
3	has	VBZ	O	have	dep	106	SENT_454	[p23l384t789r525b867],
4	been	VBN	O	be	dep	106	SENT_454	[p23l550t789r750b867],
5	linked	VBN	O	link	dep	106	SENT_454	[p23l772t789r1036b868],
6	to	TO	O	to	dep	106	SENT_454	[p23l1060t805r1139b867],
7	drug	NN	O	drug	dep	106	SENT_454	[p23l1163t789r1363b889],
8	resistancelos	NNS	O	resistancelo	dep	106	SENT_454	[p23l1383t783r1926b867],
9	and	CC	O	and	dep	106	SENT_454	[p23l1950t789r2129b884],
10	,	,	O	,	_	0	SENT_454	[p23l1950t789r2129b884],
11	in	IN	O	in	dep	106	SENT_454	[p23l10t918r92b994],
12	some	DT	O	some	dep	106	SENT_454	[p23l127t942r355b995],
13	cases	NNS	O	case	dep	106	SENT_454	[p23l389t943r637b1012],
14	,	,	O	,	_	0	SENT_454	[p23l389t943r637b1012],
15	to	TO	O	to	dep	106	SENT_454	[p23l678t933r757b995],
16	disease	NN	O	disease	dep	106	SENT_454	[p23l793t917r1103b995],
17	progression	NN	O	progression	dep	106	SENT_454	[p23l1136t911r1809b1017],
18	.1	CD	NUMBER	.1	dep	106	SENT_454	[p23l1136t911r1809b1017],
19	°	CD	NUMBER	°	dep	106	SENT_454	[p23l1136t911r1809b1017],
20	9	CD	NUMBER	9	dep	106	SENT_454	[p23l1136t911r1809b1017],
21	Kinase	NN	O	kinase	dep	106	SENT_454	[p23l1843t918r2133b998],
22	mutations	NNS	O	mutation	dep	106	SENT_454	[p23l10t1045r443b1124],
23	also	RB	O	also	dep	106	SENT_454	[p23l470t1045r637b1123],
24	play	VBP	O	play	dep	106	SENT_454	[p23l663t1045r837b1145],
25	a	DT	O	a	dep	106	SENT_454	[p23l857t1071r902b1123],
26	role	NN	O	role	dep	106	SENT_454	[p23l925t1044r1086b1123],
27	in	IN	O	in	dep	106	SENT_454	[p23l1110t1045r1192b1122],
28	acquired	VBN	O	acquire	dep	106	SENT_454	[p23l1216t1045r1581b1145],
29	resistance	NN	O	resistance	dep	106	SENT_454	[p23l1606t1045r2028b1123],
30	to	TO	O	to	dep	106	SENT_454	[p23l2055t1061r2134b1123],
31	TK	NN	O	tk	dep	106	SENT_454	[p23l7t1173r539b1254],
32	—	NN	O	—	dep	106	SENT_454	[p23l7t1173r539b1254],
33	inhibitor	NN	O	inhibitor	dep	106	SENT_454	[p23l7t1173r539b1254],
34	therapy	NN	O	therapy	dep	106	SENT_454	[p23l577t1172r894b1273],
35	in	IN	O	in	dep	106	SENT_454	[p23l930t1173r1011b1250],
36	GIST	NNP	O	GIST	dep	106	SENT_454	[p23l1051t1178r1271b1251],
37	and	CC	O	and	dep	106	SENT_454	[p23l1307t1172r1463b1251],
38	non	JJ	O	non	dep	106	SENT_454	[p23l1504t1172r2135b1251],
39	—	JJ	O	—	dep	106	SENT_454	[p23l1504t1172r2135b1251],
40	small	JJ	O	small	dep	106	SENT_454	[p23l1504t1172r2135b1251],
41	—	NN	O	—	dep	106	SENT_454	[p23l1504t1172r2135b1251],
42	cell	NN	O	cell	dep	106	SENT_454	[p23l1504t1172r2135b1251],
43	lung	NN	O	lung	dep	106	SENT_454	[p23l10t1301r203b1401],
44	cancer	NN	O	cancer	dep	106	SENT_454	[p23l228t1295r791b1379],
45	.11	CD	NUMBER	.11	dep	106	SENT_454	[p23l228t1295r791b1379],
46	°	CD	NUMBER	°	dep	106	SENT_454	[p23l228t1295r791b1379],
47	’“	NN	O	’“	dep	106	SENT_454	[p23l228t1295r791b1379],
48	1	CD	NUMBER	1	dep	106	SENT_454	[p23l228t1295r791b1379],
49	A	DT	O	a	dep	106	SENT_454	[p23l815t1308r881b1378],
50	proportion	NN	O	proportion	dep	106	SENT_454	[p23l903t1302r1366b1401],
51	of	IN	O	of	dep	106	SENT_454	[p23l1393t1300r1494b1379],
52	the	DT	O	the	dep	106	SENT_454	[p23l1503t1301r1632b1379],
53	most	RBS	O	most	dep	106	SENT_454	[p23l1659t1317r1875b1379],
54	primitive	JJ	O	primitive	dep	106	SENT_454	[p23l1896t1302r2134b1401, p23l10t1429r187b1508],
55	cancer	NN	O	cancer	dep	106	SENT_454	[p23l221t1454r507b1507],
56	stem	NN	O	stem	dep	106	SENT_454	[p23l538t1445r746b1507],
57	cells	NNS	O	cell	dep	106	SENT_454	[p23l780t1429r970b1507],
58	or	CC	O	or	dep	106	SENT_454	[p23l1006t1454r1098b1507],
59	initiating	VBG	O	initiate	dep	106	SENT_454	[p23l1126t1429r1535b1529],
60	cells	NNS	O	cell	dep	106	SENT_454	[p23l1565t1429r1784b1524],
61	,	,	O	,	_	0	SENT_454	[p23l1565t1429r1784b1524],
62	including	VBG	O	include	dep	106	SENT_454	[p23l1821t1428r2131b1508, p23l10t1557r150b1657],
63	quiescent	JJ	O	quiescent	dep	106	SENT_454	[p23l193t1557r595b1657],
64	Philadelphia	NN	LOCATION	philadelphium	dep	106	SENT_454	[p23l633t1556r1157b1657],
65	chromosome	NN	O	chromosome	dep	106	SENT_454	[p23l1202t1557r2135b1657],
66	—	CD	NUMBER	—	dep	106	SENT_454	[p23l1202t1557r2135b1657],
67	positive	JJ	O	positive	dep	106	SENT_454	[p23l1202t1557r2135b1657],
68	CD34	NN	O	cd34	dep	106	SENT_454	[p23l10t1690r310b1763],
69	+	CC	O	+	dep	106	SENT_454	[p23l10t1690r310b1763],
70	cells	NNS	O	cell	dep	106	SENT_454	[p23l337t1685r521b1763],
71	in	IN	O	in	dep	106	SENT_454	[p23l545t1686r627b1762],
72	CML	NN	ORGANIZATION	cml	dep	106	SENT_454	[p23l651t1679r1002b1780],
73	,112	CD	NUMBER	,112	dep	106	SENT_454	[p23l651t1679r1002b1780],
74	may	MD	O	may	dep	106	SENT_454	[p23l1026t1711r1202b1785],
75	be	VB	O	be	dep	106	SENT_454	[p23l1223t1685r1317b1763],
76	resistant	JJ	O	resistant	dep	106	SENT_454	[p23l1341t1686r1709b1763],
77	to	TO	O	to	dep	106	SENT_454	[p23l1728t1701r1807b1763],
78	TK	NN	O	tk	dep	106	SENT_454	[p23l1829t1690r2134b1766],
79	—	CD	NUMBER	—	dep	106	SENT_454	[p23l1829t1690r2134b1766],
80	tar	NN	O	tar	dep	106	SENT_454	[p23l1829t1690r2134b1766],
81	—	NN	O	—	dep	106	SENT_454	[p23l1829t1690r2134b1766],
82	geted	VBN	O	gete	dep	106	SENT_454	[p23l10t1813r238b1913],
83	therapy	NN	O	therapy	dep	106	SENT_454	[p23l263t1813r580b1913],
84	—	CD	NUMBER	—	dep	106	SENT_454	[p23l596t1857r704b1865],
85	a	DT	O	a	dep	106	SENT_454	[p23l723t1839r767b1891],
86	ﬁnding	NN	O	ﬁnding	dep	106	SENT_454	[p23l790t1812r1102b1913],
87	that	WDT	O	that	dep	106	SENT_454	[p23l1123t1813r1290b1891],
88	may	MD	O	may	dep	106	SENT_454	[p23l1309t1839r1486b1913],
89	account	VB	O	account	dep	106	SENT_454	[p23l1505t1829r1841b1892],
90	for	IN	O	for	dep	106	SENT_454	[p23l1860t1812r1984b1891],
91	the	DT	O	the	dep	106	SENT_454	[p23l2006t1812r2134b1891],
92	relatively	RB	O	relatively	dep	106	SENT_454	[p23l10t1941r387b2041],
93	low	JJ	O	low	dep	106	SENT_454	[p23l421t1940r577b2020],
94	frequency	NN	O	frequency	dep	106	SENT_454	[p23l614t1940r1031b2041],
95	of	IN	O	of	dep	106	SENT_454	[p23l1068t1940r1168b2019],
96	imatinib	NN	O	imatinib	dep	106	SENT_454	[p23l1189t1941r1923b2020],
97	—	NN	O	—	dep	106	SENT_454	[p23l1189t1941r1923b2020],
98	induced	VBD	O	induce	dep	106	SENT_454	[p23l1189t1941r1923b2020],
99	molecular	JJ	O	molecular	dep	106	SENT_454	[p23l1963t1966r2134b2019, p23l9t2069r294b2148],
100	remissions	NNS	O	remission	dep	106	SENT_454	[p23l327t2069r788b2147],
101	in	IN	O	in	dep	106	SENT_454	[p23l826t2070r907b2146],
102	CML	NN	O	cml	dep	106	SENT_454	[p23l943t2063r1292b2147],
103	.113	CD	NUMBER	.113	dep	106	SENT_454	[p23l943t2063r1292b2147],
104	Mechanisms	NNS	O	mechanism	dep	106	SENT_454	[p23l1327t2069r1865b2147],
105	of	IN	O	of	dep	106	SENT_454	[p23l1904t2068r2005b2147],
106	resistance	NN	O	resistance	_	0	SENT_454	[p23l2021t2095r2133b2147, p23l12t2197r349b2275],

1	to	TO	O	to	_	0	SENT_455	[p23l381t2213r460b2275],
2	monoclonal	JJ	O	monoclonal	amod	5	SENT_455	[p23l492t2196r1410b2297],
3	—	NN	O	—	nn	5	SENT_455	[p23l492t2196r1410b2297],
4	antibody	NN	O	antibody	nn	5	SENT_455	[p23l492t2196r1410b2297],
5	therapies	NNS	O	therapy	prep_to	11	SENT_455	[p23l1437t2196r1822b2297],
6	targeting	VBG	O	target	amod	8	SENT_455	[p23l1855t2213r2133b2297, p23l9t2325r148b2425],
7	receptor	NN	O	receptor	nn	8	SENT_455	[p23l173t2341r535b2425],
8	TKs	NNS	O	tk	nsubjpass	11	SENT_455	[p23l559t2330r729b2406],
9	are	VBP	O	be	auxpass	11	SENT_455	[p23l760t2351r889b2403],
10	poorly	RB	O	poorly	advmod	11	SENT_455	[p23l919t2325r1200b2425],
11	understood	VBN	O	understand	_	0	SENT_455	[p23l1226t2324r1750b2420],
12	,	,	O	,	_	0	SENT_455	[p23l1226t2324r1750b2420],
13	but	CC	O	but	_	0	SENT_455	[p23l1786t2324r1930b2404],
14	they	PRP	O	they	nsubjpass	16	SENT_455	[p23l1956t2325r2137b2425],
15	are	VBP	O	be	auxpass	16	SENT_455	[p23l9t2479r137b2531],
16	thought	VBN	O	think	conj_but	11	SENT_455	[p23l173t2452r520b2553],
17	to	TO	O	to	aux	18	SENT_455	[p23l551t2469r631b2531],
18	include	VB	O	include	xcomp	16	SENT_455	[p23l667t2452r983b2532],
19	receptor	NN	O	receptor	nn	22	SENT_455	[p23l1018t2469r1377b2553],
20	doWn	NN	O	down	nn	22	SENT_455	[p23l1410t2452r2133b2553],
21	—	NN	O	—	nn	22	SENT_455	[p23l1410t2452r2133b2553],
22	regulation	NN	O	regulation	dobj	18	SENT_455	[p23l1410t2452r2133b2553],
23	and	CC	O	and	_	0	SENT_455	[p23l9t2581r168b2659],
24	loss	NN	O	loss	dobj	18	SENT_455	[p23l195t2580r359b2659],
25	of	IN	O	of	_	0	SENT_455	[p23l386t2580r486b2659],
26	TK	NN	O	tk	npadvmod	28	SENT_455	[p23l489t2581r1065b2681],
27	—	CD	NUMBER	—	num	26	SENT_455	[p23l489t2581r1065b2681],
28	inhibitory	JJ	O	inhibitory	amod	29	SENT_455	[p23l489t2581r1065b2681],
29	pathways	NNS	O	pathway	prep_of	22	SENT_455	[p23l1084t2575r1630b2681],
30	?	.	O	?	_	0	SENT_455	[p23l1084t2575r1630b2681],

1	“	NN	O	“	_	0	SENT_456	[p23l1084t2575r1630b2681],

1	Several	JJ	O	several	amod	2	SENT_457	[p23l141t2710r439b2789],
2	strategies	NNS	O	strategy	nsubj	6	SENT_457	[p23l469t2710r878b2810],
3	may	MD	O	may	aux	4	SENT_457	[p23l908t2736r1087b2810],
4	prevent	VB	O	prevent	_	0	SENT_457	[p23l1109t2726r1434b2810],
5	or	CC	O	or	_	0	SENT_457	[p23l1458t2735r1548b2788],
6	overcome	VB	O	overcome	conj_or	4	SENT_457	[p23l1574t2735r1989b2789],
7	resistance	NN	O	resistance	dobj	4	SENT_457	[p23l2018t2736r2131b2788, p23l12t2838r356b2916],
8	to	TO	O	to	_	0	SENT_457	[p23l394t2854r474b2916],
9	TK	NN	O	tk	nn	10	SENT_457	[p23l509t2838r1023b2938],
10	—	NN	O	—	prep_to	4	SENT_457	[p23l509t2838r1023b2938],
11	targeted	VBN	O	target	partmod	10	SENT_457	[p23l509t2838r1023b2938],
12	therapies	NNS	O	therapy	dobj	11	SENT_457	[p23l1060t2838r1480b2938],
13	.	.	O	.	_	0	SENT_457	[p23l1060t2838r1480b2938],

1	In	IN	O	in	_	0	SENT_458	[p23l1521t2845r1609b2915],
2	CML	NN	ORGANIZATION	cml	prep_in	5	SENT_458	[p23l1646t2843r1873b2933],
3	,	,	O	,	_	0	SENT_458	[p23l1646t2843r1873b2933],
4	there	EX	O	there	expl	5	SENT_458	[p23l1916t2838r2133b2916],
5	are	VBP	O	be	_	0	SENT_458	[p23l9t2992r137b3044],
6	several	JJ	DURATION	several	amod	12	SENT_458	[p23l171t2965r461b3045],
7	second	JJ	DURATION	second	amod	12	SENT_458	[p23l493t2966r1299b3066],
8	—	NN	O	—	nn	12	SENT_458	[p23l493t2966r1299b3066],
9	generation	NN	O	generation	nn	12	SENT_458	[p23l493t2966r1299b3066],
10	ABL	NN	ORGANIZATION	abl	nn	12	SENT_458	[p23l1326t2972r1507b3044],
11	kinase	NN	O	kinase	nn	12	SENT_458	[p23l1536t2966r1812b3045],
12	inhibitors	NNS	O	inhibitor	nsubj	5	SENT_458	[p23l1842t2965r2131b3044, p23l11t3110r172b3172],
13	With	IN	O	with	_	0	SENT_458	[p23l214t3094r406b3173],
14	increased	VBN	O	increase	amod	15	SENT_458	[p23l449t3094r859b3172],
15	potency	NN	O	potency	prep_with	12	SENT_458	[p23l901t3110r1242b3194],
16	and	CC	O	and	_	0	SENT_458	[p23l1280t3093r1438b3172],
17	activity	NN	O	activity	conj_and	15	SENT_458	[p23l1481t3094r1784b3194],
18	against	IN	O	against	_	0	SENT_458	[p23l1823t3094r2138b3194],
19	most	JJS	O	most	dep	20	SENT_458	[p23l10t3238r224b3300],
20	imatinib	JJ	O	imatinib	amod	23	SENT_458	[p23l238t3222r987b3300],
21	—	NN	O	—	npadvmod	22	SENT_458	[p23l238t3222r987b3300],
22	resistant	JJ	O	resistant	amod	23	SENT_458	[p23l238t3222r987b3300],
23	BCR	NN	O	bcr	prep_against	15	SENT_458	[p23l1000t3227r1391b3305],
24	.	.	O	.	_	0	SENT_458	[p23l1000t3227r1391b3305],

1	—	NN	O	—	_	0	SENT_459	[p23l1000t3227r1391b3305],
2	.	.	O	.	_	0	SENT_459	[p23l1000t3227r1391b3305],

1	ABL	NN	ORGANIZATION	abl	nn	2	SENT_460	[p23l1000t3227r1391b3305],
2	mutants	NNS	O	mutant	_	0	SENT_460	[p23l1408t3216r1861b3301],
3	.	.	O	.	_	0	SENT_460	[p23l1408t3216r1861b3301],

1	”	NN	O	”	nn	2	SENT_461	[p23l1408t3216r1861b3301],
2	Drugs	NNS	O	drug	nsubj	16	SENT_461	[p23l1879t3229r2132b3322],
3	that	WDT	O	that	nsubj	5	SENT_461	[p23l11t3350r182b3428],
4	irreversibly	RB	O	irreversibly	advmod	5	SENT_461	[p23l221t3350r710b3450],
5	inactivate	VBP	O	inactivate	rcmod	2	SENT_461	[p23l749t3350r1162b3429],
6	the	DT	O	the	det	7	SENT_461	[p23l1207t3350r1340b3428],
7	l	NN	O	l	dobj	5	SENT_461	[p23l1383t3350r1785b3429],
8	<	JJR	O	<	dep	7	SENT_461	[p23l1383t3350r1785b3429],
9	inase115	CD	NUMBER	inase115	num	7	SENT_461	[p23l1383t3350r1785b3429],
10	or	CC	O	or	_	0	SENT_461	[p23l1833t3375r1924b3428],
11	that	DT	O	that	det	14	SENT_461	[p23l1965t3349r2137b3428],
12	block	NN	O	block	nn	14	SENT_461	[p23l11t3477r250b3557],
13	substrate	NN	O	substrate	nn	14	SENT_461	[p23l283t3478r675b3557],
14	binding115	NN	O	binding115	conj_or	7	SENT_461	[p23l712t3478r1173b3578],
15	may	MD	O	may	aux	16	SENT_461	[p23l1209t3504r1388b3578],
16	overcome	VB	O	overcome	_	0	SENT_461	[p23l1421t3503r1836b3557],
17	“	RB	O	“	advmod	16	SENT_461	[p23l1876t3482r2131b3578],
18	gate	NN	O	gate	dobj	16	SENT_461	[p23l1876t3482r2131b3578],
19	—	CD	NUMBER	—	num	22	SENT_461	[p23l1876t3482r2131b3578],
20	keeper	NN	O	keeper	nn	22	SENT_461	[p23l9t3605r339b3706],
21	”	NN	O	”	nn	22	SENT_461	[p23l9t3605r339b3706],
22	mutations	NNS	O	mutation	nsubj	23	SENT_461	[p23l371t3606r810b3685],
23	(	VBP	O	(	rcmod	18	SENT_461	[p23l844t3606r1074b3697],
24	such	JJ	O	such	_	0	SENT_461	[p23l844t3606r1074b3697],
25	as	IN	O	as	_	0	SENT_461	[p23l1101t3632r1186b3684],
26	T3151	NN	O	t3151	prep_such_as	18	SENT_461	[p23l1213t3611r1468b3684],
27	in	IN	O	in	_	0	SENT_461	[p23l1494t3606r1576b3683],
28	ABL	NNP	ORGANIZATION	ABL	prep_in	26	SENT_461	[p23l1600t3612r1840b3701],
29	)	CD	NUMBER	)	num	28	SENT_461	[p23l1600t3612r1840b3701],
30	,	,	O	,	_	0	SENT_461	[p23l1600t3612r1840b3701],
31	which	WDT	O	which	nsubj	32	SENT_461	[p23l1868t3606r2133b3685],
32	cause	VBP	O	cause	rcmod	18	SENT_461	[p24l11t47r246b100],
33	resistance	NN	O	resistance	dobj	32	SENT_461	[p24l275t21r697b99],
34	to	TO	O	to	_	0	SENT_461	[p24l727t37r806b99],
35	all	DT	O	all	det	39	SENT_461	[p24l836t21r935b99],
36	ATP	NN	O	atp	nn	39	SENT_461	[p24l959t21r1661b121],
37	—	NN	O	—	nn	39	SENT_461	[p24l959t21r1661b121],
38	competitive	JJ	O	competitive	amod	39	SENT_461	[p24l959t21r1661b121],
39	inhibitors	NNS	O	inhibitor	prep_to	32	SENT_461	[p24l1689t21r2129b99],
40	.	.	O	.	_	0	SENT_461	[p24l1689t21r2129b99],

1	Combinations	NNS	O	combination	nsubj	22	SENT_462	[p24l10t149r612b227],
2	of	IN	O	of	_	0	SENT_462	[p24l661t148r761b227],
3	monoclonal	JJ	O	monoclonal	amod	4	SENT_462	[p24l789t148r1298b227],
4	antibodies	NNS	O	antibody	prep_of	1	SENT_462	[p24l1343t149r1782b227],
5	against	IN	O	against	_	0	SENT_462	[p24l1830t149r2139b249],
6	receptor	NN	O	receptor	nn	8	SENT_462	[p24l10t293r361b377],
7	T	NN	O	t	nn	8	SENT_462	[p24l385t282r447b354],
8	Ks	NNS	O	k	prep_against	4	SENT_462	[p24l448t284r553b358],
9	and	CC	O	and	_	0	SENT_462	[p24l584t276r740b355],
10	small	JJ	O	small	amod	15	SENT_462	[p24l772t276r1422b356],
11	—	NN	O	—	nn	15	SENT_462	[p24l772t276r1422b356],
12	molecule	NN	O	molecule	nn	15	SENT_462	[p24l772t276r1422b356],
13	T	NN	O	t	nn	15	SENT_462	[p24l1449t282r1511b354],
14	K	NN	O	k	nn	15	SENT_462	[p24l1512t284r1578b358],
15	inhibitors	NNS	O	inhibitor	conj_and	4	SENT_462	[p24l1605t276r2018b355],
16	of	IN	O	of	_	0	SENT_462	[p24l2052t276r2152b355],
17	the	DT	O	the	det	18	SENT_462	[p24l11t404r140b483],
18	receptor	NN	O	receptor	prep_of	15	SENT_462	[p24l176t421r534b505],
19	in	IN	O	in	_	0	SENT_462	[p24l565t405r647b482],
20	solid	JJ	O	solid	amod	21	SENT_462	[p24l684t405r891b483],
21	tumors	NNS	O	tumor	prep_in	18	SENT_462	[p24l925t421r1231b484],
22	are	VBP	O	be	_	0	SENT_462	[p24l1268t431r1396b483],
23	under	IN	O	under	_	0	SENT_462	[p24l1431t405r1684b484],
24	investigation	NN	O	investigation	prep_under	22	SENT_462	[p24l1716t405r2132b505, p24l11t533r203b611],
25	.	.	O	.	_	0	SENT_462	[p24l1716t405r2132b505, p24l11t533r203b611],

1	Another	DT	O	another	det	2	SENT_463	[p24l235t532r585b611],
2	approach	NN	O	approach	nsubj	3	SENT_463	[p24l609t532r1006b633],
3	is	VBZ	O	be	_	0	SENT_463	[p24l1032t533r1097b611],
4	to	TO	O	to	aux	5	SENT_463	[p24l1128t549r1206b611],
5	combine	VB	O	combine	xcomp	3	SENT_463	[p24l1236t533r1603b611],
6	a	DT	O	a	det	8	SENT_463	[p24l1631t559r1675b611],
7	TK	NN	O	tk	nn	8	SENT_463	[p24l1698t538r1827b614],
8	inhibitor	NN	O	inhibitor	dobj	5	SENT_463	[p24l1850t532r2133b611, p24l11t677r131b739],
9	with	IN	O	with	_	0	SENT_463	[p24l150t661r339b740],
10	cytotoxic	JJ	O	cytotoxic	amod	11	SENT_463	[p24l367t661r740b761],
11	chemotherapy	NN	O	chemotherapy	prep_with	5	SENT_463	[p24l767t660r1373b761],
12	or	CC	O	or	_	0	SENT_463	[p24l1396t686r1485b739],
13	with	IN	O	with	_	0	SENT_463	[p24l1504t661r1693b740],
14	drugs	NNS	O	drug	prep_with	5	SENT_463	[p24l1720t661r1957b761],
15	targeting	VBG	O	target	partmod	14	SENT_463	[p24l1987t677r2133b739, p24l10t789r279b889],
16	other	JJ	O	other	amod	18	SENT_463	[p24l305t789r528b867],
17	signaling	NN	O	signaling	nn	18	SENT_463	[p24l555t789r950b889],
18	pathways	NNS	O	pathway	dobj	15	SENT_463	[p24l973t789r1365b889],
19	in	IN	O	in	_	0	SENT_463	[p24l1395t789r1476b866],
20	the	DT	O	the	det	22	SENT_463	[p24l1504t789r1634b867],
21	cancer	NN	O	cancer	nn	22	SENT_463	[p24l1663t814r1938b867],
22	cell	NN	O	cell	prep_in	15	SENT_463	[p24l1964t789r2128b867],
23	.	.	O	.	_	0	SENT_463	[p24l1964t789r2128b867],

1	In	IN	O	in	_	0	SENT_464	[p24l8t923r96b992],
2	colorectal	JJ	O	colorectal	amod	3	SENT_464	[p24l133t916r547b994],
3	cancer	NN	O	cancer	prep_in	8	SENT_464	[p24l584t941r875b1010],
4	,	,	O	,	_	0	SENT_464	[p24l584t941r875b1010],
5	cetuximab	NN	O	cetuximab	nsubj	8	SENT_464	[p24l919t916r1353b994],
6	and	CC	O	and	_	0	SENT_464	[p24l1391t916r1546b994],
7	bevacizumab	NN	O	bevacizumab	conj_and	5	SENT_464	[p24l1583t915r2132b994],
8	show	VBP	O	show	_	0	SENT_464	[p24l12t1044r239b1123],
9	beneﬁt	NN	O	beneﬁt	dobj	8	SENT_464	[p24l277t1043r580b1122],
10	only	RB	O	only	advmod	12	SENT_464	[p24l616t1044r800b1144],
11	when	WRB	O	when	advmod	12	SENT_464	[p24l831t1044r1068b1123],
12	combined	VBN	O	combine	dep	8	SENT_464	[p24l1109t1044r1539b1122],
13	with	IN	O	with	_	0	SENT_464	[p24l1575t1044r1768b1123],
14	chemotherapy	NN	O	chemotherapy	prep_with	12	SENT_464	[p24l1809t1044r2131b1122, p24l11t1172r346b1272],
15	,	,	O	,	_	0	SENT_464	[p24l1809t1044r2131b1122, p24l11t1172r346b1272],
16	but	CC	O	but	_	0	SENT_464	[p24l382t1172r524b1251],
17	the	DT	O	the	det	18	SENT_464	[p24l546t1172r675b1250],
18	mechanism	NN	O	mechanism	nsubjpass	21	SENT_464	[p24l703t1171r1197b1250],
19	is	VBZ	O	be	auxpass	21	SENT_464	[p24l1223t1172r1288b1250],
20	not	RB	O	not	neg	21	SENT_464	[p24l1317t1188r1461b1250],
21	understood	VBN	O	understand	conj_but	8	SENT_464	[p24l1483t1171r1992b1251],
22	.	.	O	.	_	0	SENT_464	[p24l1483t1171r1992b1251],

1	Finally	RB	O	finally	advmod	6	SENT_465	[p24l2023t1172r2133b1249, p24l10t1300r224b1400],
2	,	,	O	,	_	0	SENT_465	[p24l2023t1172r2133b1249, p24l10t1300r224b1400],
3	immune	JJ	O	immune	amod	4	SENT_465	[p24l254t1300r611b1379],
4	mechanisms	NNS	O	mechanism	nsubj	6	SENT_465	[p24l636t1300r1171b1378],
5	may	MD	O	may	aux	6	SENT_465	[p24l1199t1326r1375b1400],
6	eradicate	VB	O	eradicate	_	0	SENT_465	[p24l1396t1300r1773b1378],
7	residual	JJ	O	residual	amod	9	SENT_465	[p24l1799t1299r2134b1379],
8	malignant	JJ	O	malignant	amod	9	SENT_465	[p24l10t1428r447b1528],
9	disease	NN	O	disease	dobj	6	SENT_465	[p24l485t1428r812b1523],
10	,	,	O	,	_	0	SENT_465	[p24l485t1428r812b1523],
11	and	CC	O	and	_	0	SENT_465	[p24l858t1428r1015b1506],
12	trials	NNS	O	trial	nsubjpass	27	SENT_465	[p24l1057t1428r1264b1506],
13	of	IN	O	of	_	0	SENT_465	[p24l1308t1427r1409b1506],
14	TK	NN	O	tk	nn	15	SENT_465	[p24l1429t1433r1558b1509],
15	inhibitors	NNS	O	inhibitor	prep_of	12	SENT_465	[p24l1596t1427r2009b1506],
16	in	IN	O	in	_	0	SENT_465	[p24l2053t1428r2134b1505],
17	combination	NN	O	combination	prep_in	15	SENT_465	[p24l11t1556r550b1634],
18	with	IN	O	with	_	0	SENT_465	[p24l578t1556r767b1635],
19	adoptive	JJ	O	adoptive	amod	20	SENT_465	[p24l798t1555r1154b1656],
20	immunotherapy	NN	O	immunotherapy	prep_with	17	SENT_465	[p24l1185t1556r1872b1656],
21	or	CC	O	or	_	0	SENT_465	[p24l1900t1581r1990b1634],
22	tumor	NN	O	tumor	nn	25	SENT_465	[p24l2019t1572r2133b1635, p24l10t1684r366b1762],
23	—	JJ	O	—	amod	25	SENT_465	[p24l2019t1572r2133b1635, p24l10t1684r366b1762],
24	cell	NN	O	cell	nn	25	SENT_465	[p24l2019t1572r2133b1635, p24l10t1684r366b1762],
25	vaccines	NNS	O	vaccine	conj_or	20	SENT_465	[p24l386t1684r737b1763],
26	are	VBP	O	be	auxpass	27	SENT_465	[p24l764t1710r890b1762],
27	warranted	VBN	O	warrant	conj_and	6	SENT_465	[p24l911t1684r1365b1763],
28	.	.	O	.	_	0	SENT_465	[p24l911t1684r1365b1763],

1	STRATEGIES	NNS	O	strategy	nsubj	27	SENT_466	[p24l10t1957r505b2007],
2	TO	TO	O	to	aux	4	SENT_466	[p24l542t1957r647b2007],
3	IDENTIFY	NNP	O	IDENTIFY	nn	4	SENT_466	[p24l692t1958r1079b2006],
4	NEW	NNP	O	NEW	infmod	1	SENT_466	[p24l1124t1958r1303b2007],
5	TK	NN	O	tk	nsubj	6	SENT_466	[p24l1337t1958r1431b2006],
6	TARGETS	VBZ	O	target	rcmod	4	SENT_466	[p24l1469t1957r1831b2007],
7	IN	IN	O	in	_	0	SENT_466	[p24l16t2041r96b2090],
8	CANCER	NNP	O	CANCER	nn	10	SENT_466	[p24l142t2041r468b2090],
9	Constitutive	JJ	O	constitutive	amod	10	SENT_466	[p24l10t2142r512b2221],
10	activation	NN	O	activation	prep_in	4	SENT_466	[p24l532t2142r935b2220],
11	of	IN	O	of	_	0	SENT_466	[p24l956t2141r1056b2220],
12	one	CD	NUMBER	one	num	15	SENT_466	[p24l1058t2167r1209b2220],
13	or	CC	O	or	_	0	SENT_466	[p24l1231t2167r1319b2220],
14	more	JJR	O	more	conj_or	12	SENT_466	[p24l1337t2167r1555b2220],
15	TKs	NNS	O	tk	prep_of	4	SENT_466	[p24l1572t2147r1738b2222],
16	or	CC	O	or	_	0	SENT_466	[p24l1761t2167r1849b2220],
17	downstream	JJ	O	downstream	amod	19	SENT_466	[p24l1868t2142r2133b2221, p24l12t2286r301b2348],
18	signaling	NN	O	signaling	nn	19	SENT_466	[p24l331t2270r733b2370],
19	pathways	NNS	O	pathway	prep_of	4	SENT_466	[p24l757t2270r1156b2370],
20	is	VBZ	O	be	cop	27	SENT_466	[p24l1187t2270r1252b2348],
21	likely	JJ	O	likely	amod	27	SENT_466	[p24l1281t2269r1513b2370],
22	in	IN	O	in	_	0	SENT_466	[p24l1536t2270r1618b2347],
23	many	JJ	O	many	prep_in	21	SENT_466	[p24l1646t2295r1884b2370],
24	if	IN	O	if	_	0	SENT_466	[p24l1907t2269r1983b2347],
25	not	RB	O	not	_	0	SENT_466	[p24l1992t2286r2138b2348],
26	most	RBS	O	most	prep_in	21	SENT_466	[p24l10t2414r230b2476],
27	cancers	NNS	O	cancer	_	0	SENT_466	[p24l255t2423r602b2493],
28	,	,	O	,	_	0	SENT_466	[p24l255t2423r602b2493],
29	and	CC	O	and	_	0	SENT_466	[p24l636t2398r794b2476],
30	we	PRP	O	we	nsubj	33	SENT_466	[p24l819t2424r938b2477],
31	have	VBP	O	have	aux	33	SENT_466	[p24l968t2398r1160b2477],
32	only	RB	O	only	advmod	33	SENT_466	[p24l1191t2397r1375b2498],
33	begun	VBN	O	begin	conj_and	27	SENT_466	[p24l1401t2398r1667b2498],
34	to	TO	O	to	aux	35	SENT_466	[p24l1698t2414r1778b2476],
35	identify	VB	O	identify	xcomp	33	SENT_466	[p24l1808t2397r2137b2498],
36	them	PRP	O	they	dobj	35	SENT_466	[p24l11t2526r255b2604],
37	.	.	O	.	_	0	SENT_466	[p24l11t2526r255b2604],

1	Modern	NNP	MISC	Modern	nn	2	SENT_467	[p24l285t2525r623b2604],
2	cytogenetics	NNS	O	cytogenetic	nsubj	5	SENT_467	[p24l649t2526r1166b2626],
3	may	MD	O	may	aux	5	SENT_467	[p24l1194t2552r1371b2626],
4	be	VB	O	be	cop	5	SENT_467	[p24l1392t2526r1488b2604],
5	able	JJ	O	able	_	0	SENT_467	[p24l1513t2525r1685b2604],
6	to	TO	O	to	aux	7	SENT_467	[p24l1711t2542r1790b2604],
7	identify	VB	O	identify	xcomp	5	SENT_467	[p24l1817t2525r2138b2626],
8	additional	JJ	O	additional	amod	9	SENT_467	[p24l9t2654r446b2732],
9	TKs	NNS	O	tk	dobj	7	SENT_467	[p24l490t2659r659b2735],
10	activated	VBN	O	activate	partmod	9	SENT_467	[p24l709t2653r1087b2733],
11	through	IN	O	through	_	0	SENT_467	[p24l1134t2654r1483b2754],
12	chromosomal	JJ	O	chromosomal	amod	13	SENT_467	[p24l1532t2654r2133b2732],
13	translocations	NNS	O	translocation	prep_through	10	SENT_467	[p24l11t2782r642b2877],
14	,	,	O	,	_	0	SENT_467	[p24l11t2782r642b2877],
15	rearrangements	NNS	O	rearrangement	prep_through	10	SENT_467	[p24l689t2798r1383b2882],
16	,	,	O	,	_	0	SENT_467	[p24l689t2798r1383b2882],
17	and	CC	O	and	_	0	SENT_467	[p24l1430t2781r1586b2860],
18	deletions	NNS	O	deletion	prep_through	10	SENT_467	[p24l1628t2782r2009b2860],
19	in	IN	O	in	_	0	SENT_467	[p24l2053t2782r2134b2859],
20	cancer	NN	O	cancer	nn	21	SENT_467	[p24l11t2935r286b2988],
21	cells	NNS	O	cell	prep_in	10	SENT_467	[p24l310t2909r518b2988],
22	.	.	O	.	_	0	SENT_467	[p24l310t2909r518b2988],

1	FISH	NN	O	fish	nn	2	SENT_468	[p24l549t2915r760b2988],
2	analysis	NN	O	analysis	nsubj	3	SENT_468	[p24l787t2909r1117b3010],
3	revealed	VBD	O	reveal	_	0	SENT_468	[p24l1146t2910r1489b2989],
4	ABL1	NN	O	abl1	nn	6	SENT_468	[p24l1509t2915r1715b2987],
5	gene	NN	O	gene	nn	6	SENT_468	[p24l1744t2935r1943b3010],
6	ampliﬁcation	NN	O	ampliﬁcation	nsubj	16	SENT_468	[p24l1969t2936r2133b2988, p24l8t3037r452b3138],
7	in	IN	O	in	_	0	SENT_468	[p24l479t3038r562b3115],
8	a	DT	O	a	det	9	SENT_468	[p24l590t3064r634b3116],
9	subset	NN	O	subset	prep_in	6	SENT_468	[p24l663t3038r941b3117],
10	of	IN	O	of	_	0	SENT_468	[p24l965t3037r1066b3116],
11	T	NN	O	t	nn	15	SENT_468	[p24l1074t3037r1314b3116],
12	—	NN	O	—	nn	15	SENT_468	[p24l1074t3037r1314b3116],
13	cell	NN	O	cell	nn	15	SENT_468	[p24l1074t3037r1314b3116],
14	acute	JJ	O	acute	amod	15	SENT_468	[p24l1341t3054r1564b3117],
15	lymphoblas	NNS	O	lymphobla	prep_of	9	SENT_468	[p24l1592t3037r2132b3138],
16	—	VBP	O	—	ccomp	3	SENT_468	[p24l1592t3037r2132b3138],
17	tic	JJ	O	tic	amod	18	SENT_468	[p24l11t3167r112b3244],
18	leukemia117	NN	O	leukemia117	dobj	16	SENT_468	[p24l142t3160r656b3245],
19	and	CC	O	and	_	0	SENT_468	[p24l686t3166r842b3244],
20	led	VBD	O	lead	ccomp	3	SENT_468	[p24l871t3166r996b3244],
21	to	TO	O	to	_	0	SENT_468	[p24l1026t3182r1105b3244],
22	the	DT	O	the	det	23	SENT_468	[p24l1137t3166r1266b3244],
23	identiﬁcation	NN	O	identiﬁcation	prep_to	20	SENT_468	[p24l1296t3165r1861b3244],
24	of	IN	O	of	_	0	SENT_468	[p24l1892t3165r1992b3244],
25	the	DT	O	the	det	27	SENT_468	[p24l2005t3166r2133b3244],
26	N	NN	O	n	nn	27	SENT_468	[p24l8t3301r83b3372],
27	UP214	NN	O	up214	prep_of	23	SENT_468	[p24l85t3299r604b3372],
28	.	.	O	.	_	0	SENT_468	[p24l85t3299r604b3372],

1	—	NN	O	—	_	0	SENT_469	[p24l85t3299r604b3372],
2	.	.	O	.	_	0	SENT_469	[p24l85t3299r604b3372],

1	ABL	NN	ORGANIZATION	abl	_	0	SENT_470	[p24l85t3299r604b3372],
2	fusion	NN	O	fusion	nn	3	SENT_470	[p24l650t3293r922b3373],
3	protein	NN	O	protein	dep	1	SENT_470	[p24l968t3288r1391b3394],
4	.	.	O	.	_	0	SENT_470	[p24l968t3288r1391b3394],

1	”	NN	O	”	_	0	SENT_471	[p24l968t3288r1391b3394],
2	In	IN	O	in	dep	1	SENT_471	[p24l1440t3301r1528b3371],
3	the	DT	O	the	det	5	SENT_471	[p24l1577t3294r1707b3372],
4	hypereo	NN	O	hypereo	nn	5	SENT_471	[p24l1756t3294r2131b3394],
5	—	NN	O	—	pobj	2	SENT_471	[p24l1756t3294r2131b3394],
6	sinophilic	JJ	O	sinophilic	amod	7	SENT_471	[p24l12t3422r441b3522],
7	syndrome	NN	O	syndrome	nsubjpass	22	SENT_471	[p24l476t3422r901b3522],
8	and	CC	O	and	_	0	SENT_471	[p24l934t3421r1092b3500],
9	glioblastoma	NN	O	glioblastoma	nsubjpass	22	SENT_471	[p24l1126t3422r1716b3522],
10	,	,	O	,	_	0	SENT_471	[p24l1126t3422r1716b3522],
11	activated	VBN	O	activate	amod	13	SENT_471	[p24l1756t3421r2133b3501],
12	fusion	NN	O	fusion	nn	13	SENT_471	[p24l10t3549r282b3629],
13	proteins	NNS	O	protein	appos	7	SENT_471	[p24l303t3550r651b3650],
14	involving	VBG	O	involve	_	0	SENT_471	[p24l675t3550r1066b3650],
15	the	DT	O	the	det	16	SENT_471	[p24l1085t3550r1214b3628],
16	PDGFRcr	NN	O	pdgfrcr	prep_involving	13	SENT_471	[p24l1235t3555r1614b3633],
17	and	CC	O	and	_	0	SENT_471	[p24l1639t3549r1795b3628],
18	ROS	NN	O	ro	nn	20	SENT_471	[p24l1815t3555r1996b3633],
19	receptor	NN	O	receptor	nn	20	SENT_471	[p24l2020t3576r2132b3628, p24l11t3694r278b3778],
20	TKs	NNS	O	tk	prep_involving	13	SENT_471	[p24l297t3683r464b3759],
21	are	VBP	O	be	auxpass	22	SENT_471	[p24l492t3704r617b3756],
22	generated	VBN	O	generate	rcmod	5	SENT_471	[p24l643t3678r1060b3778],
23	through	IN	O	through	_	0	SENT_471	[p24l1085t3677r1427b3778],
24	interstitial	JJ	O	interstitial	amod	25	SENT_471	[p24l1453t3677r1885b3756],
25	chromosomal	JJ	O	chromosomal	prep_through	22	SENT_471	[p24l1911t3677r2133b3756, p25l10t21r407b99],

1	deletions	NNS	O	deletion	nsubjpass	6	SENT_472	[p25l430t20r812b99],
2	too	RB	O	too	advmod	3	SENT_472	[p25l837t37r971b99],
3	small	JJ	O	small	amod	1	SENT_472	[p25l996t20r1224b99],
4	to	TO	O	to	aux	6	SENT_472	[p25l1246t37r1325b99],
5	be	VB	O	be	auxpass	6	SENT_472	[p25l1350t20r1445b99],
6	detected	VBN	O	detect	_	0	SENT_472	[p25l1469t20r1819b99],
7	by	IN	O	by	_	0	SENT_472	[p25l1843t21r1939b121],
8	routine	JJ	O	routine	amod	9	SENT_472	[p25l1957t46r2133b100, p25l11t148r170b225],
9	cytogenetics	NNS	O	cytogenetic	agent	6	SENT_472	[p25l203t143r952b247],
10	,27	CD	NUMBER	,27	number	11	SENT_472	[p25l203t143r952b247],
11	’89	CD	NUMBER	’89	dep	9	SENT_472	[p25l203t143r952b247],
12	but	CC	O	but	_	0	SENT_472	[p25l986t148r1128b226],
13	they	PRP	O	they	nsubjpass	16	SENT_472	[p25l1156t148r1336b247],
14	might	MD	O	might	aux	16	SENT_472	[p25l1363t148r1626b247],
15	be	VB	O	be	auxpass	16	SENT_472	[p25l1653t147r1750b225],
16	revealed	VBN	O	reveal	conj_but	6	SENT_472	[p25l1782t147r2133b226],
17	through	IN	O	through	_	0	SENT_472	[p25l11t275r355b376],
18	array	NN	O	array	nn	21	SENT_472	[p25l379t302r590b376],
19	comparative	JJ	O	comparative	amod	21	SENT_472	[p25l610t276r1126b376],
20	genomic	JJ	O	genomic	amod	21	SENT_472	[p25l1149t276r1518b376],
21	hybridization	NN	O	hybridization	prep_through	16	SENT_472	[p25l1540t275r2128b376],
22	.	.	O	.	_	0	SENT_472	[p25l1540t275r2128b376],

1	A	DT	O	a	det	3	SENT_473	[p25l7t411r73b481],
2	serendipitous	JJ	O	serendipitous	amod	3	SENT_473	[p25l94t403r660b504],
3	approach	NN	O	approach	_	0	SENT_473	[p25l685t404r1100b504],
4	,	,	O	,	_	0	SENT_473	[p25l685t404r1100b504],
5	illustrated	VBN	O	illustrate	partmod	3	SENT_473	[p25l1128t403r1549b483],
6	by	IN	O	by	_	0	SENT_473	[p25l1573t403r1669b504],
7	the	DT	O	the	det	8	SENT_473	[p25l1688t403r1816b482],
8	discovery	NN	O	discovery	agent	5	SENT_473	[p25l1840t403r2133b483, p25l11t558r136b632],
9	of	IN	O	of	_	0	SENT_473	[p25l158t531r258b610],
10	the	DT	O	the	det	11	SENT_473	[p25l266t532r394b610],
11	FIP1L1	NN	O	fip1l1	prep_of	8	SENT_473	[p25l419t537r1148b615],
12	.	.	O	.	_	0	SENT_473	[p25l419t537r1148b615],

1	—	NN	O	—	_	0	SENT_474	[p25l419t537r1148b615],
2	.	.	O	.	_	0	SENT_474	[p25l419t537r1148b615],

1	PDGFRa	NN	O	pdgfra	nn	2	SENT_475	[p25l419t537r1148b615],
2	kinase	NN	O	kinase	ccomp	10	SENT_475	[p25l1178t532r1448b611],
3	in	IN	O	in	_	0	SENT_475	[p25l1473t532r1555b609],
4	hypereosino	NN	O	hypereosino	nn	7	SENT_475	[p25l1581t532r2133b632],
5	—	NN	O	—	nn	7	SENT_475	[p25l1581t532r2133b632],
6	philic	JJ	O	philic	amod	7	SENT_475	[p25l8t659r254b758],
7	syndrome	NN	O	syndrome	prep_in	2	SENT_475	[p25l285t654r829b758],
8	,	,	O	,	_	0	SENT_475	[p25l285t654r829b758],
9	“	NN	O	“	nsubj	10	SENT_475	[p25l285t654r829b758],
10	is	VBZ	O	be	_	0	SENT_475	[p25l858t659r925b736],
11	to	TO	O	to	aux	12	SENT_475	[p25l959t675r1039b736],
12	test	VB	O	test	ccomp	10	SENT_475	[p25l1071t674r1227b736],
13	each	DT	O	each	det	16	SENT_475	[p25l1254t659r1449b736],
14	new	JJ	O	new	amod	16	SENT_475	[p25l1479t684r1658b738],
15	TK	NN	O	tk	nn	16	SENT_475	[p25l1681t664r1812b739],
16	inhibitor	NN	O	inhibitor	dobj	12	SENT_475	[p25l1838t659r2130b736, p25l11t803r133b865],
17	in	IN	O	in	_	0	SENT_475	[p25l160t787r242b864],
18	a	DT	O	a	det	20	SENT_475	[p25l272t813r317b865],
19	wide	JJ	O	wide	amod	20	SENT_475	[p25l341t786r546b866],
20	range	NN	O	range	prep_in	12	SENT_475	[p25l577t812r817b887],
21	of	IN	O	of	_	0	SENT_475	[p25l849t786r950b865],
22	patients	NNS	O	patient	prep_of	20	SENT_475	[p25l961t787r1303b887],
23	with	IN	O	with	_	0	SENT_475	[p25l1331t787r1524b866],
24	cancer	NN	O	cancer	prep_with	22	SENT_475	[p25l1555t812r1836b865],
25	and	CC	O	and	_	0	SENT_475	[p25l1863t786r2021b865],
26	to	TO	O	to	aux	27	SENT_475	[p25l2051t803r2131b865],
27	investigate	VB	O	investigate	conj_and	12	SENT_475	[p25l9t915r455b1015],
28	the	DT	O	the	det	29	SENT_475	[p25l480t915r607b993],
29	identity	NN	O	identity	dobj	27	SENT_475	[p25l631t914r945b1015],
30	of	IN	O	of	_	0	SENT_475	[p25l965t914r1065b993],
31	the	DT	O	the	det	33	SENT_475	[p25l1071t914r1198b993],
32	sensitive	JJ	O	sensitive	amod	33	SENT_475	[p25l1224t915r1576b994],
33	kinase	NN	O	kinase	prep_of	29	SENT_475	[p25l1600t914r1866b994],
34	in	IN	O	in	_	0	SENT_475	[p25l1890t915r1970b992],
35	any	DT	O	any	det	36	SENT_475	[p25l1993t940r2139b1015],
36	patient	NN	O	patient	prep_in	27	SENT_475	[p25l8t1043r304b1143],
37	who	WP	O	who	nsubj	38	SENT_475	[p25l323t1042r506b1122],
38	has	VBZ	O	have	rcmod	36	SENT_475	[p25l534t1043r676b1121],
39	a	DT	O	a	det	40	SENT_475	[p25l705t1069r749b1121],
40	response	NN	O	response	dobj	38	SENT_475	[p25l775t1068r1178b1143],
41	.	.	O	.	_	0	SENT_475	[p25l775t1068r1178b1143],

1	Flow	NN	O	flow	nn	2	SENT_476	[p25l1210t1042r1898b1143],
2	—	NN	O	—	_	0	SENT_476	[p25l1210t1042r1898b1143],
3	cytometric	JJ	O	cytometric	amod	4	SENT_476	[p25l1210t1042r1898b1143],
4	tech132	NN	O	tech132	dep	2	SENT_476	[p25l1925t1042r2133b1121, p25l149t1218r205b1239],

1	N	NN	O	n	nn	2	SENT_477	[p25l918t1220r932b1235],
2	ENGL	NN	ORGANIZATION	engl	_	0	SENT_477	[p25l947t1219r1031b1241],
3	)	CD	NUMBER	)	num	4	SENT_477	[p25l947t1219r1031b1241],
4	MED	NN	O	med	dep	2	SENT_477	[p25l1046t1220r1099b1235],
5	353:2	CD	NUMBER	353:2	num	7	SENT_477	[p25l1111t1219r1175b1241],
6	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	7	SENT_477	[p25l1210t1219r1422b1241],
7	JULY14	NN	O	july14	dep	2	SENT_477	[p25l1455t1219r1562b1241],
8	,	,	O	,	_	0	SENT_477	[p25l1455t1219r1562b1241],
9	2005	CD	DATE	2005	appos	7	SENT_477	[p25l1575t1219r1638b1241],

1	The	DT	O	the	det	4	SENT_478	[p25l935t1252r986b1276],
2	New	NNP	O	New	nn	4	SENT_478	[p25l995t1253r1057b1276],
3	England	NNP	O	England	nn	4	SENT_478	[p25l1066t1252r1177b1283],
4	Journal	NNP	O	Journal	_	0	SENT_478	[p25l1186t1252r1283b1276],
5	of	IN	O	of	_	0	SENT_478	[p25l1293t1252r1322b1276],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_478	[p25l1329t1252r1454b1276],

1	Downloaded	VBN	O	download	_	0	SENT_479	[p25l377t1293r547b1316],
2	from	IN	O	from	_	0	SENT_479	[p25l556t1293r620b1316],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_479	[p25l629t1293r748b1323],
4	at	IN	O	at	_	0	SENT_479	[p25l758t1297r781b1316],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_479	[p25l789t1293r972b1316],
6	on	IN	O	on	_	0	SENT_479	[p25l981t1300r1014b1316],
7	January	NNP	DATE	January	prep_on	1	SENT_479	[p25l1022t1293r1125b1323],
8	5	CD	DATE	5	num	7	SENT_479	[p25l1135t1293r1158b1320],
9	,	,	DATE	,	_	0	SENT_479	[p25l1135t1293r1158b1320],
10	2014	CD	DATE	2014	num	7	SENT_479	[p25l1168t1293r1241b1316],
11	.	.	O	.	_	0	SENT_479	[p25l1168t1293r1241b1316],

1	For	IN	O	for	_	0	SENT_480	[p25l1251t1293r1298b1316],
2	personal	JJ	O	personal	amod	3	SENT_480	[p25l1306t1293r1418b1323],
3	use	NN	O	use	pobj	1	SENT_480	[p25l1427t1300r1471b1316],
4	only	RB	O	only	advmod	3	SENT_480	[p25l1481t1293r1545b1323],
5	.	.	O	.	_	0	SENT_480	[p25l1481t1293r1545b1323],

1	No	DT	O	no	det	3	SENT_481	[p25l1556t1293r1596b1316],
2	other	JJ	O	other	amod	3	SENT_481	[p25l1606t1293r1674b1316],
3	uses	NNS	O	use	_	0	SENT_481	[p25l1682t1300r1738b1316],
4	without	IN	O	without	_	0	SENT_481	[p25l1748t1293r1849b1316],
5	permission	NN	O	permission	prep_without	3	SENT_481	[p25l1857t1293r2010b1323],
6	.	.	O	.	_	0	SENT_481	[p25l1857t1293r2010b1323],

1	Copyright	NN	O	copyright	_	0	SENT_482	[p25l727t1334r862b1365],
2	©	CD	NUMBER	©	num	6	SENT_482	[p25l871t1334r895b1358],
3	2005	CD	DATE	2005	num	6	SENT_482	[p25l905t1334r969b1358],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_482	[p25l979t1334r1171b1358],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_482	[p25l1180t1334r1288b1358],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_482	[p25l1299t1334r1404b1365],
7	.	.	O	.	_	0	SENT_482	[p25l1299t1334r1404b1365],

1	All	DT	O	all	det	2	SENT_483	[p25l1415t1334r1456b1358],
2	rights	NNS	O	rights	nsubj	3	SENT_483	[p25l1465t1334r1540b1365],
3	reserved	VBN	O	reserve	_	0	SENT_483	[p25l1550t1334r1669b1358],
4	.	.	O	.	_	0	SENT_483	[p25l1550t1334r1669b1358],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_484	[p25l717t1378r946b1397],
2	OF	IN	O	of	_	0	SENT_484	[p25l960t1378r1001b1397],
3	DISEASE	NN	O	disease	prep_of	1	SENT_484	[p25l1016t1378r1152b1397],

1	N	NN	O	n	_	0	SENT_485	[p25l930t1614r942b1628],
2	©	CD	NUMBER	©	num	4	SENT_485	[p25l973t1624r1027b1686],
3	1-Acidic	JJ	O	1-acidic	amod	4	SENT_485	[p25l1035t1545r1363b1664],
4	glycoprotein	NN	O	glycoprotein	dep	1	SENT_485	[p25l1373t1591r1540b1625],

1	N	NN	O	n	nn	2	SENT_486	[p25l774t1639r786b1654],
2	N	NN	O	n	_	0	SENT_486	[p25l861t1639r873b1653],

1	B	NN	O	b	_	0	SENT_487	[p25l1436t1659r1454b1683],
2	. . .	CD	NUMBER	. . .	num	1	SENT_487	[p25l1761t1681r1766b1686],[p25l1663t1681r1668b1686],

1	NNo	SYM	MISC	nno	dep	2	SENT_488	[p25l772t1603r1212b1761],
2	Plasma-Protein	NN	MISC	plasma-protein	dep	3	SENT_488	[p25l1481t1680r1685b1705],
3	Binding	NN	MISC	binding	dep	5	SENT_488	[p25l1698t1680r1803b1713],
4	(	CD	NUMBER	(	num	3	SENT_488	[p25l1814t1680r1843b1713],
5	P	NN	O	p	_	0	SENT_488	[p25l1814t1680r1843b1713],
6	)	CD	NUMBER	)	num	5	SENT_488	[p25l1814t1680r1843b1713],

1	o	NN	O	o	nn	5	SENT_489	[p25l991t1735r1005b1750],
2	N	NN	O	n	nn	5	SENT_489	[p25l1215t1741r1227b1755],
3	A	NN	O	a	nn	5	SENT_489	[p25l617t1744r638b1768],
4	Drug	NN	O	drug	nn	5	SENT_489	[p25l659t1768r726b1799],
5	Efﬂux	NN	O	efﬂux	_	0	SENT_489	[p25l737t1765r813b1791],
6	(	CD	NUMBER	(	num	7	SENT_489	[p25l824t1766r854b1799],
7	.3	NN	NUMBER	.3	dep	5	SENT_489	[p25l824t1766r854b1799],
8	)	CD	NUMBER	)	dep	7	SENT_489	[p25l824t1766r854b1799],
9	\	NN	O	\	dep	5	SENT_489	[p25l1229t1754r1250b1767],
10	'	''	O	'	_	0	SENT_489	[p25l757t1887r764b1897],

1	:	:	O	:	_	0	SENT_490	[p25l819t1879r823b1890],
2	I	PRP	O	I	nsubj	3	SENT_490	[p25l857t1859r875b1879],
3	‘	VBP	O	‘	_	0	SENT_490	[p25l857t1859r875b1879],
4	,	,	O	,	_	0	SENT_490	[p25l995t1857r1013b1911],
5	l	NN	O	l	nn	6	SENT_490	[p25l995t1857r1013b1911],
6	il	NN	O	il	dobj	3	SENT_490	[p25l1033t1873r1043b1905],
7	in	IN	O	in	_	0	SENT_490	[p25l1071t1871r1087b1905],
8	i	FW	O	i	prep_in	6	SENT_490	[p25l1129t1892r1130b1899],
9	'	''	O	'	_	0	SENT_490	[p25l1181t1877r1185b1887],

1	‘	NN	O	‘	_	0	SENT_491	[p25l621t1925r622b1933],
2	‘	CD	NUMBER	‘	num	1	SENT_491	[p25l739t1905r741b1913],
3	l	NN	O	l	nn	7	SENT_491	[p25l799t1909r802b1923],
4	J	NN	O	j	nn	7	SENT_491	[p25l821t1914r839b1925],
5	»	NN	O	»	nn	7	SENT_491	[p25l821t1914r839b1925],
6	'	''	O	'	_	0	SENT_491	[p25l863t1913r866b1921],
7	rl	NN	O	rl	dep	1	SENT_491	[p25l883t1906r891b1927],
8	‘	NN	O	‘	dep	1	SENT_491	[p25l1009t1909r1013b1917],

1	_	SYM	O	_	dep	5	SENT_492	[p25l168t2377r188b2399],
2	-	:	O	-	_	0	SENT_492	[p25l168t2377r188b2399],
3	‘	NN	O	‘	nn	5	SENT_492	[p25l168t2377r188b2399],
4	l	NN	O	l	nn	5	SENT_492	[p25l168t2377r188b2399],
5	l	NN	O	l	_	0	SENT_492	[p25l643t2386r644b2397],
6	.	.	O	.	_	0	SENT_492	[p25l159t2435r161b2439],

1	C	NN	O	c	_	0	SENT_493	[p25l231t2414r252b2440],
2	,	,	O	,	_	0	SENT_493	[p25l484t2437r489b2443],
3	BCR-ABL	NN	MISC	bcr-abl	nn	4	SENT_493	[p25l268t2438r390b2461],
4	Mutation	NN	MISC	mutation	appos	1	SENT_493	[p25l401t2439r524b2462],

1	y	NN	O	y	_	0	SENT_494	[p25l229t2577r246b2593],
2	|	CD	NUMBER	|	dep	1	SENT_494	[p25l229t2577r246b2593],
3	+	CC	O	+	_	0	SENT_494	[p25l229t2577r246b2593],
4	AB	NNP	O	AB	nn	5	SENT_494	[p25l409t2564r447b2587],
5	L	NN	O	l	dep	1	SENT_494	[p25l452t2565r465b2587],

1	Figure	NNP	O	Figure	_	0	SENT_495	[p25l122t2930r203b2962],
2	3	CD	NUMBER	3	dep	1	SENT_495	[p25l211t2932r233b2955],
3	.	.	O	.	_	0	SENT_495	[p25l211t2932r233b2955],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_496	[p25l243t2930r411b2955],
2	of	IN	O	of	_	0	SENT_496	[p25l419t2929r450b2955],
3	Resistance	NN	O	resistance	prep_of	1	SENT_496	[p25l454t2930r593b2955],
4	to	TO	O	to	_	0	SENT_496	[p25l599t2934r626b2955],
5	TK-Inhibitor	NN	O	tk-inhibitor	nn	6	SENT_496	[p25l633t2930r791b2955],
6	Therapy	NN	O	therapy	prep_to	1	SENT_496	[p25l797t2930r908b2963],
7	.	.	O	.	_	0	SENT_496	[p25l797t2930r908b2963],

1	Although	IN	O	although	mark	10	SENT_497	[p25l119t2980r238b3013],
2	causes	NNS	O	cause	nn	4	SENT_497	[p25l248t2988r336b3005],
3	ofimatinib	JJ	O	ofimatinib	amod	4	SENT_497	[p25l345t2979r485b3005],
4	resistance	NN	O	resistance	nsubjpass	10	SENT_497	[p25l495t2982r625b3005],
5	in	IN	O	in	_	0	SENT_497	[p25l634t2982r655b3004],
6	chronic	JJ	O	chronic	amod	8	SENT_497	[p25l665t2980r762b3005],
7	myeloid	JJ	O	myeloid	amod	8	SENT_497	[p25l771t2980r872b3013],
8	leukemia	NN	O	leukemia	prep_in	4	SENT_497	[p25l882t2980r998b3005],
9	are	VBP	O	be	auxpass	10	SENT_497	[p25l1008t2988r1047b3005],
10	depicted	VBN	O	depict	advcl	16	SENT_497	[p25l1055t2980r1165b3012],
11	here	RB	O	here	advmod	10	SENT_497	[p25l1176t2980r1237b3009],
12	,	,	O	,	_	0	SENT_497	[p25l1176t2980r1237b3009],
13	these	DT	O	these	det	14	SENT_497	[p25l1246t2980r1316b3005],
14	mechanisms	NNS	O	mechanism	nsubj	16	SENT_497	[p25l1326t2980r1492b3005],
15	are	VBP	O	be	cop	16	SENT_497	[p25l1502t2988r1541b3005],
16	applicable	JJ	O	applicable	_	0	SENT_497	[p25l1549t2980r1681b3012],
17	to	TO	O	to	_	0	SENT_497	[p25l1688t2984r1714b3005],
18	both	DT	O	both	det	21	SENT_497	[p25l1724t2980r1780b3005],
19	small-molecule	JJ	O	small-molecule	amod	21	SENT_497	[p25l1790t2980r1989b3005],
20	TK	NN	O	tk	nn	21	SENT_497	[p25l1996t2982r2032b3004],
21	inhibitors	NNS	O	inhibitor	prep_to	16	SENT_497	[p25l121t3021r244b3047],
22	and	CC	O	and	_	0	SENT_497	[p25l253t3021r300b3047],
23	monoclonal	JJ	O	monoclonal	amod	24	SENT_497	[p25l311t3021r464b3047],
24	antibodies	NNS	O	antibody	prep_to	16	SENT_497	[p25l474t3021r609b3047],
25	against	IN	O	against	_	0	SENT_497	[p25l619t3024r713b3055],
26	receptor	NN	O	receptor	nn	27	SENT_497	[p25l722t3026r829b3054],
27	TKs	NNS	O	tk	prep_against	16	SENT_497	[p25l835t3024r891b3047],
28	.	.	O	.	_	0	SENT_497	[p25l835t3024r891b3047],

1	Increased	VBN	O	increase	amod	3	SENT_498	[p25l903t3021r1026b3047],
2	efﬂux	NN	O	efﬂux	nn	3	SENT_498	[p25l1035t3021r1105b3047],
3	ofdrug	NN	O	ofdrug	nsubj	25	SENT_498	[p25l1112t3021r1205b3055],
4	from	IN	O	from	_	0	SENT_498	[p25l1212t3021r1274b3047],
5	the	DT	O	the	det	7	SENT_498	[p25l1282t3021r1323b3047],
6	cancer	NN	O	cancer	nn	7	SENT_498	[p25l1332t3030r1418b3047],
7	cell	NN	O	cell	prep_from	3	SENT_498	[p25l1425t3021r1473b3051],
8	,	,	O	,	_	0	SENT_498	[p25l1425t3021r1473b3051],
9	mediated	VBN	O	mediate	partmod	3	SENT_498	[p25l1484t3021r1604b3047],
10	by	IN	O	by	_	0	SENT_498	[p25l1615t3021r1643b3054],
11	membrane	NN	O	membrane	nn	12	SENT_498	[p25l1652t3021r1794b3047],
12	transporters	NNS	O	transporter	agent	9	SENT_498	[p25l1801t3026r1961b3054],
13	such	JJ	O	such	_	0	SENT_498	[p25l1971t3021r2030b3047],
14	as	IN	O	as	_	0	SENT_498	[p25l121t3072r147b3088],
15	multidrug-resistance	JJ	O	multidrug-resistance	amod	18	SENT_498	[p25l158t3063r428b3096],
16	gene	NN	O	gene	nn	18	SENT_498	[p25l437t3072r499b3096],
17	1	CD	NUMBER	1	num	18	SENT_498	[p25l509t3065r520b3088],
18	protein	NN	O	protein	prep_such_as	12	SENT_498	[p25l532t3065r622b3096],
19	(	CD	NUMBER	(	num	22	SENT_498	[p25l635t3065r668b3096],
20	M	NN	O	m	nn	22	SENT_498	[p25l635t3065r668b3096],
21	DR-1	NN	O	dr-1	nn	22	SENT_498	[p25l674t3065r755b3096],
22	)	NN	O	)	dobj	9	SENT_498	[p25l674t3065r755b3096],
23	,	,	O	,	_	0	SENT_498	[p25l674t3065r755b3096],
24	can	MD	O	can	aux	25	SENT_498	[p25l765t3072r809b3088],
25	decrease	VB	O	decrease	dep	28	SENT_498	[p25l819t3063r934b3088],
26	intracellular	JJ	O	intracellular	amod	27	SENT_498	[p25l943t3063r1097b3088],
27	concentrations	NNS	O	concentration	dobj	25	SENT_498	[p25l1104t3065r1299b3088],
28	ofthe	VBP	O	ofthe	_	0	SENT_498	[p25l1308t3063r1381b3088],
29	drug	NN	O	drug	nn	31	SENT_498	[p25l1390t3063r1451b3096],
30	(	CD	NUMBER	(	num	31	SENT_498	[p25l1462t3063r1623b3096],
31	mechanism	NN	O	mechanism	dobj	28	SENT_498	[p25l1462t3063r1623b3096],
32	A	DT	O	a	det	33	SENT_498	[p25l1632t3065r1669b3096],
33	)	NN	O	)	nsubj	28	SENT_498	[p25l1632t3065r1669b3096],
34	.	.	O	.	_	0	SENT_498	[p25l1632t3065r1669b3096],

1	Increased	VBN	O	increase	amod	3	SENT_499	[p25l1681t3063r1804b3088],
2	drug	NN	O	drug	nn	3	SENT_499	[p25l1814t3063r1875b3096],
3	binding	NN	O	binding	nsubj	12	SENT_499	[p25l1884t3063r1982b3096],
4	by	IN	O	by	_	0	SENT_499	[p25l1992t3063r2019b3096],
5	plasma	NN	O	plasma	nn	6	SENT_499	[p25l122t3105r215b3137],
6	proteins	NNS	O	protein	prep_by	3	SENT_499	[p25l226t3107r331b3137],
7	such	JJ	O	such	_	0	SENT_499	[p25l341t3105r400b3130],
8	as	IN	O	as	_	0	SENT_499	[p25l411t3113r438b3130],
9	al-acidic	JJ	O	al-acidic	amod	10	SENT_499	[p25l447t3105r563b3135],
10	glycoprotein	NN	O	glycoprotein	prep_such_as	6	SENT_499	[p25l571t3105r730b3138],
11	can	MD	O	can	aux	12	SENT_499	[p25l740t3113r784b3130],
12	decrease	VB	O	decrease	_	0	SENT_499	[p25l795t3105r909b3130],
13	the	DT	O	the	det	21	SENT_499	[p25l917t3105r958b3130],
14	drug	NN	O	drug	poss	19	SENT_499	[p25l967t3105r1048b3138],
15	's	POS	O	's	_	0	SENT_499	[p25l967t3105r1048b3138],
16	effective	JJ	O	effective	amod	19	SENT_499	[p25l1058t3104r1164b3130],
17	concentration	NN	O	concentration	nn	19	SENT_499	[p25l1173t3107r1352b3130],
18	(	NN	O	(	nn	19	SENT_499	[p25l1365t3105r1527b3138],
19	mechanism	NN	O	mechanism	nn	21	SENT_499	[p25l1365t3105r1527b3138],
20	B	NN	O	b	nn	21	SENT_499	[p25l1539t3107r1573b3138],
21	)	NN	O	)	dobj	12	SENT_499	[p25l1539t3107r1573b3138],
22	.	.	O	.	_	0	SENT_499	[p25l1539t3107r1573b3138],

1	Mutations	NNS	O	mutation	_	0	SENT_500	[p25l1584t3107r1717b3130],
2	in	IN	O	in	_	0	SENT_500	[p25l1727t3107r1748b3129],
3	the	DT	O	the	det	6	SENT_500	[p25l1757t3105r1799b3130],
4	BCR-ABL	NN	MISC	bcr-abl	nn	6	SENT_500	[p25l1810t3106r1927b3130],
5	kinase	NN	O	kinase	nn	6	SENT_500	[p25l1936t3105r2017b3130],
6	domain	NN	O	domain	prep_in	1	SENT_500	[p25l120t3146r227b3176],
7	,	,	O	,	_	0	SENT_500	[p25l120t3146r227b3176],
8	including	VBG	O	include	_	0	SENT_500	[p25l238t3146r358b3180],
9	Thr315I	NNP	O	Thr315I	prep_including	1	SENT_500	[p25l365t3146r496b3176],
10	|	CD	NUMBER	|	num	9	SENT_500	[p25l365t3146r496b3176],
11	e	LS	O	e	dep	14	SENT_500	[p25l365t3146r496b3176],
12	,	,	O	,	_	0	SENT_500	[p25l365t3146r496b3176],
13	can	MD	O	can	aux	14	SENT_500	[p25l505t3155r549b3172],
14	decrease	VB	O	decrease	dep	1	SENT_500	[p25l559t3146r673b3172],
15	or	CC	O	or	_	0	SENT_500	[p25l682t3155r709b3172],
16	abolish	VB	O	abolish	conj_or	14	SENT_500	[p25l716t3146r809b3172],
17	the	DT	O	the	det	18	SENT_500	[p25l817t3146r859b3172],
18	inhibitory	JJ	O	inhibitory	dep	20	SENT_500	[p25l868t3146r990b3179],
19	effect	NN	O	effect	nsubj	20	SENT_500	[p25l998t3146r1068b3172],
20	ofthe	NN	O	ofthe	dep	14	SENT_500	[p25l1076t3146r1149b3172],
21	drug	NN	O	drug	dobj	20	SENT_500	[p25l1157t3146r1217b3180],
22	(	CD	NUMBER	(	tmod	21	SENT_500	[p25l1228t3146r1389b3179],
23	mechanism	NN	O	mechanism	prep	21	SENT_500	[p25l1228t3146r1389b3179],
24	C	NN	O	c	dep	23	SENT_500	[p25l1399t3148r1435b3179],
25	)	NN	O	)	advmod	21	SENT_500	[p25l1399t3148r1435b3179],
26	.	.	O	.	_	0	SENT_500	[p25l1399t3148r1435b3179],

1	Constitutive	JJ	O	constitutive	amod	8	SENT_501	[p25l1445t3148r1601b3172],
2	activation	NN	O	activation	nn	8	SENT_501	[p25l1609t3149r1734b3172],
3	ofa	NN	O	ofa	nn	8	SENT_501	[p25l1744t3146r1789b3172],
4	signaling	NN	O	signaling	nn	8	SENT_501	[p25l1799t3146r1916b3180],
5	pathway	NN	O	pathway	nn	8	SENT_501	[p25l1925t3146r2032b3179],
6	downstream	JJ	O	downstream	amod	8	SENT_501	[p25l120t3188r283b3213],
7	ofa	NN	O	ofa	nn	8	SENT_501	[p25l293t3188r339b3213],
8	TK	NN	O	tk	nsubj	18	SENT_501	[p25l347t3190r389b3218],
9	,	,	O	,	_	0	SENT_501	[p25l347t3190r389b3218],
10	such	JJ	O	such	_	0	SENT_501	[p25l399t3188r459b3213],
11	as	IN	O	as	_	0	SENT_501	[p25l469t3197r496b3213],
12	a	DT	O	a	det	15	SENT_501	[p25l505t3197r518b3213],
13	SRC	NN	O	src	nn	15	SENT_501	[p25l528t3190r581b3213],
14	family	NN	O	family	nn	15	SENT_501	[p25l589t3188r668b3221],
15	member	NN	O	member	prep_such_as	8	SENT_501	[p25l677t3188r791b3218],
16	,	,	O	,	_	0	SENT_501	[p25l677t3188r791b3218],
17	can	MD	O	can	aux	18	SENT_501	[p25l801t3197r844b3213],
18	alleviate	VB	O	alleviate	_	0	SENT_501	[p25l855t3188r959b3213],
19	the	DT	O	the	det	22	SENT_501	[p25l967t3188r1008b3213],
20	dependence	NN	O	dependence	nn	22	SENT_501	[p25l1017t3188r1176b3221],
21	ofthe	NN	O	ofthe	nn	22	SENT_501	[p25l1185t3188r1258b3213],
22	cancer	NN	O	cancer	dobj	18	SENT_501	[p25l1267t3197r1353b3213],
23	on	IN	O	on	_	0	SENT_501	[p25l1360t3197r1392b3213],
24	the	DT	O	the	det	30	SENT_501	[p25l1401t3188r1442b3213],
25	original	JJ	O	original	amod	30	SENT_501	[p25l1451t3188r1547b3221],
26	TK	NN	O	tk	nn	30	SENT_501	[p25l1556t3190r1592b3213],
27	target	NN	O	target	nn	30	SENT_501	[p25l1599t3193r1675b3221],
28	(	CD	NUMBER	(	num	30	SENT_501	[p25l1686t3188r1847b3221],
29	mechanism	NN	O	mechanism	nn	30	SENT_501	[p25l1686t3188r1847b3221],
30	D	NN	O	d	prep_on	18	SENT_501	[p25l1859t3190r1897b3221],
31	)	CD	NUMBER	)	dep	30	SENT_501	[p25l1859t3190r1897b3221],
32	.	.	O	.	_	0	SENT_501	[p25l1859t3190r1897b3221],

1	Ampliﬁcation	NN	O	ampliﬁcation	nn	4	SENT_502	[p25l1905t3188r2038b3221, p25l119t3232r169b3255],
2	ofthe	NN	O	ofthe	nn	4	SENT_502	[p25l179t3229r252b3255],
3	BCR-ABL	NN	O	bcr-abl	nn	4	SENT_502	[p25l263t3231r380b3255],
4	gene	NN	O	gene	nsubj	11	SENT_502	[p25l389t3238r451b3263],
5	leading	VBG	O	lead	partmod	4	SENT_502	[p25l460t3230r554b3263],
6	to	TO	O	to	_	0	SENT_502	[p25l561t3234r587b3255],
7	overproduction	NN	O	overproduction	nn	9	SENT_502	[p25l596t3230r796b3262],
8	ofthe	NN	O	ofthe	nn	9	SENT_502	[p25l806t3229r879b3255],
9	TK	NN	O	tk	prep_to	5	SENT_502	[p25l887t3232r923b3254],
10	can	MD	O	can	aux	11	SENT_502	[p25l931t3238r975b3255],
11	confer	VB	O	confer	_	0	SENT_502	[p25l985t3229r1067b3255],
12	relative	JJ	O	relative	amod	13	SENT_502	[p25l1076t3230r1168b3255],
13	resistance	NN	O	resistance	dobj	11	SENT_502	[p25l1178t3232r1308b3255],
14	to	TO	O	to	_	0	SENT_502	[p25l1316t3234r1342b3255],
15	an	DT	O	a	det	18	SENT_502	[p25l1351t3238r1380b3255],
16	inhibitor	NN	O	inhibitor	nn	18	SENT_502	[p25l1391t3230r1501b3255],
17	(	NN	O	(	nn	18	SENT_502	[p25l1512t3230r1674b3263],
18	mechanism	NN	O	mechanism	prep_to	11	SENT_502	[p25l1512t3230r1674b3263],
19	E	NN	O	e	dep	18	SENT_502	[p25l1686t3232r1718b3263],
20	)	CD	NUMBER	)	num	19	SENT_502	[p25l1686t3232r1718b3263],
21	.	.	O	.	_	0	SENT_502	[p25l1686t3232r1718b3263],

1	For	IN	O	for	_	0	SENT_503	[p25l1729t3232r1770b3255],
2	imatinib	NN	O	imatinib	prep_for	15	SENT_503	[p25l1779t3230r1892b3259],
3	,	,	O	,	_	0	SENT_503	[p25l1779t3230r1892b3259],
4	mechanisms	NNS	O	mechanism	nsubjpass	15	SENT_503	[p25l1903t3230r1998b3255, p25l122t3274r199b3297],
5	A	DT	O	a	amod	4	SENT_503	[p25l207t3273r233b3301],
6	,	,	O	,	_	0	SENT_503	[p25l207t3273r233b3301],
7	B	NN	O	b	dep	5	SENT_503	[p25l245t3274r266b3301],
8	,	,	O	,	_	0	SENT_503	[p25l245t3274r266b3301],
9	and	CC	O	and	_	0	SENT_503	[p25l277t3271r323b3297],
10	D	NN	O	d	nsubjpass	15	SENT_503	[p25l336t3274r355b3296],
11	have	VBP	O	have	aux	15	SENT_503	[p25l365t3271r424b3297],
12	not	RB	O	not	neg	15	SENT_503	[p25l434t3276r476b3297],
13	yet	RB	O	yet	advmod	15	SENT_503	[p25l483t3276r520b3304],
14	been	VBN	O	be	auxpass	15	SENT_503	[p25l530t3271r590b3297],
15	identiﬁed	VBN	O	identiﬁed	_	0	SENT_503	[p25l601t3271r720b3297],
16	in	IN	O	in	_	0	SENT_503	[p25l731t3274r752b3296],
17	patients	NNS	O	patient	prep_in	15	SENT_503	[p25l764t3274r866b3304],
18	with	IN	O	with	_	0	SENT_503	[p25l875t3271r929b3297],
19	drug-resistant	JJ	O	drug-resistant	amod	21	SENT_503	[p25l939t3271r1121b3305],
20	CM	NN	O	cm	nn	21	SENT_503	[p25l1130t3273r1174b3297],
21	L.	NN	O	l.	prep_with	17	SENT_503	[p25l1180t3274r1199b3296],

1	niques	NNS	O	nique	nsubj	15	SENT_504	[p25l11t3539r287b3639],
2	to	TO	O	to	_	0	SENT_504	[p25l315t3555r393b3618],
3	identity	NN	O	identity	prep_to	1	SENT_504	[p25l420t3537r737b3639],
4	activated	VBN	O	activate	partmod	3	SENT_504	[p25l757t3538r1121b3618],
5	T	NN	O	t	nn	6	SENT_504	[p25l1143t3545r1204b3616],
6	Ks	NNS	O	k	dobj	4	SENT_504	[p25l1205t3546r1310b3619],
7	and	CC	O	and	_	0	SENT_504	[p25l1336t3538r1491b3618],
8	signaling	NN	O	signaling	nn	9	SENT_504	[p25l1518t3538r1908b3640],
9	pathways	NNS	O	pathway	dobj	4	SENT_504	[p25l1928t3538r2148b3639, p25l6t3693r213b3767],
10	in	IN	O	in	_	0	SENT_504	[p25l252t3668r336b3745],
11	primary	JJ	O	primary	amod	13	SENT_504	[p25l372t3668r718b3767],
12	cancer	NN	O	cancer	nn	13	SENT_504	[p25l752t3693r1034b3745],
13	cells	NNS	O	cell	prep_in	4	SENT_504	[p25l1070t3667r1259b3745],
14	are	VBP	O	be	aux	15	SENT_504	[p25l1299t3693r1428b3745],
15	showing	VBG	O	show	_	0	SENT_504	[p25l1468t3667r1842b3768],
16	promise	NN	O	promise	dobj	15	SENT_504	[p25l1875t3693r2145b3767, p26l10t18r280b102],
17	.118	CD	NUMBER	.118	num	16	SENT_504	[p25l1875t3693r2145b3767, p26l10t18r280b102],

1	Finally	RB	O	finally	advmod	9	SENT_505	[p26l314t23r619b123],
2	,	,	O	,	_	0	SENT_505	[p26l314t23r619b123],
3	a	DT	O	a	det	6	SENT_505	[p26l659t49r703b101],
4	direct	JJ	O	direct	amod	6	SENT_505	[p26l738t23r986b102],
5	genomic	JJ	O	genomic	amod	6	SENT_505	[p26l1016t24r1393b124],
6	approach	NN	O	approach	nsubjpass	9	SENT_505	[p26l1426t23r1832b123],
7	can	MD	O	can	aux	9	SENT_505	[p26l1867t49r2014b101],
8	be	VB	O	be	auxpass	9	SENT_505	[p26l2050t23r2147b102],
9	pursued	VBN	O	pursue	_	0	SENT_505	[p26l10t150r387b250],
10	,	,	O	,	_	0	SENT_505	[p26l10t150r387b250],
11	Where	WRB	O	where	advmod	18	SENT_505	[p26l412t150r676b230],
12	each	DT	O	each	det	13	SENT_505	[p26l702t150r895b228],
13	exon	NN	O	exon	nsubjpass	28	SENT_505	[p26l920t176r1124b229],
14	of	IN	O	of	_	0	SENT_505	[p26l1148t149r1250b229],
15	every	DT	O	every	det	16	SENT_505	[p26l1256t176r1474b250],
16	TK	NN	O	tk	prep_of	13	SENT_505	[p26l1491t156r1621b231],
17	is	VBZ	O	be	auxpass	18	SENT_505	[p26l1640t151r1707b228],
18	ampliﬁed	VBN	O	ampliﬁed	advcl	9	SENT_505	[p26l1732t149r2147b250],
19	by	IN	O	by	_	0	SENT_505	[p26l11t278r110b378],
20	the	DT	O	the	det	23	SENT_505	[p26l128t278r257b356],
21	polymerase	NN	O	polymerase	nn	23	SENT_505	[p26l278t278r760b378],
22	chain	NN	O	chain	nn	23	SENT_505	[p26l784t278r1012b356],
23	reaction	NN	O	reaction	agent	18	SENT_505	[p26l1035t279r1374b357],
24	from	IN	O	from	_	0	SENT_505	[p26l1397t277r1604b357],
25	tumor	NN	O	tumor	nn	26	SENT_505	[p26l1627t295r1888b357],
26	tissue	NN	O	tissue	prep_from	18	SENT_505	[p26l1909t279r2148b357],
27	and	CC	O	and	_	0	SENT_505	[p26l10t407r169b487],
28	analyzed	VBN	O	analyze	conj_and	18	SENT_505	[p26l193t407r570b508],
29	by	IN	O	by	_	0	SENT_505	[p26l594t407r693b508],
30	DNA	NN	O	dna	nn	31	SENT_505	[p26l711t414r926b487],
31	sequencing	NN	O	sequencing	prep_by	28	SENT_505	[p26l948t408r1446b509],
32	for	IN	O	for	_	0	SENT_505	[p26l1466t406r1592b487],
33	potential	JJ	O	potential	amod	35	SENT_505	[p26l1612t407r1999b508],
34	activating	VBG	O	activate	amod	35	SENT_505	[p26l2022t434r2145b486, p26l11t537r342b638],
35	mutations	NNS	O	mutation	prep_for	31	SENT_505	[p26l367t537r840b616],
36	.	.	O	.	_	0	SENT_505	[p26l367t537r840b616],

1	This	DT	O	this	det	2	SENT_506	[p26l870t536r1061b615],
2	technique	NN	O	technique	nsubj	4	SENT_506	[p26l1092t536r1523b637],
3	has	VBZ	O	have	aux	4	SENT_506	[p26l1552t536r1696b615],
4	identiﬁed	VBN	O	identiﬁed	_	0	SENT_506	[p26l1726t535r2147b616],
5	several	JJ	O	several	amod	6	SENT_506	[p26l12t665r308b744],
6	potential	JJ	O	potential	nsubj	8	SENT_506	[p26l342t665r729b765],
7	new	JJ	O	new	dep	8	SENT_506	[p26l763t691r942b744],
8	activating	VBG	O	activate	xcomp	4	SENT_506	[p26l973t666r1395b766],
9	TK	NN	O	tk	nn	10	SENT_506	[p26l1423t671r1555b746],
10	mutations	NNS	O	mutation	dobj	8	SENT_506	[p26l1586t666r2028b744],
11	in	IN	O	in	_	0	SENT_506	[p26l2065t666r2147b743],
12	colorectal	JJ	O	colorectal	amod	13	SENT_506	[p26l11t793r437b872],
13	cancer	NN	O	cancer	prep_in	8	SENT_506	[p26l464t788r894b889],
14	,119	CD	NUMBER	,119	dep	13	SENT_506	[p26l464t788r894b889],
15	but	CC	O	but	_	0	SENT_506	[p26l922t793r1067b872],
16	it	PRP	O	it	nsubj	17	SENT_506	[p26l1087t794r1148b871],
17	has	VBZ	O	have	conj_but	4	SENT_506	[p26l1170t793r1314b871],
18	a	DT	O	a	det	20	SENT_506	[p26l1343t819r1387b871],
19	low	JJ	O	low	amod	20	SENT_506	[p26l1411t793r1569b872],
20	yield	NN	O	yield	dobj	17	SENT_506	[p26l1588t793r1817b893],
21	.	.	O	.	_	0	SENT_506	[p26l1588t793r1817b893],

1	In	IN	O	in	_	0	SENT_507	[p26l1848t801r1937b871],
2	cancers	NNS	O	cancer	nn	11	SENT_507	[p26l1965t819r2145b871, p26l11t948r180b1000],
3	other	JJ	O	other	amod	11	SENT_507	[p26l216t922r442b1001],
4	than	IN	O	than	_	0	SENT_507	[p26l470t922r659b1000],
5	non	JJ	O	non	amod	9	SENT_507	[p26l690t922r1326b1001],
6	—	JJ	O	—	amod	9	SENT_507	[p26l690t922r1326b1001],
7	small	JJ	O	small	amod	9	SENT_507	[p26l690t922r1326b1001],
8	—	NN	O	—	nn	9	SENT_507	[p26l690t922r1326b1001],
9	cell	NN	O	cell	prep_than	3	SENT_507	[p26l690t922r1326b1001],
10	lung	NN	O	lung	nn	11	SENT_507	[p26l1356t922r1551b1023],
11	cancer	NN	O	cancer	prep_in	43	SENT_507	[p26l1579t948r1873b1018],
12	,	,	O	,	_	0	SENT_507	[p26l1579t948r1873b1018],
13	direct	JJ	O	direct	amod	14	SENT_507	[p26l1910t922r2153b1001],
14	sequencing	NN	O	sequencing	nsubj	43	SENT_507	[p26l12t1051r500b1152],
15	identiﬁed	VBN	O	identiﬁed	partmod	14	SENT_507	[p26l533t1049r939b1130],
16	ERBB2	NN	O	erbb2	nn	19	SENT_507	[p26l974t1057r1239b1130],
17	and	CC	O	and	_	0	SENT_507	[p26l1277t1050r1434b1130],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_507	[p26l1469t1057r1682b1131],
19	mutations	NNS	O	mutation	dobj	15	SENT_507	[p26l1713t1051r2145b1130],
20	in	IN	O	in	_	0	SENT_507	[p26l10t1179r92b1256],
21	only	RB	O	only	quantmod	24	SENT_507	[p26l114t1178r296b1278],
22	3	CD	NUMBER	3	number	24	SENT_507	[p26l313t1185r357b1257],
23	of	IN	O	of	quantmod	24	SENT_507	[p26l382t1177r484b1257],
24	303	CD	NUMBER	303	num	26	SENT_507	[p26l487t1185r637b1257],
25	primary	JJ	O	primary	amod	26	SENT_507	[p26l660t1179r999b1278],
26	tumors	NNS	O	tumor	prep_in	15	SENT_507	[p26l1016t1195r1319b1257],
27	and	CC	O	and	_	0	SENT_507	[p26l1341t1178r1498b1257],
28	none	NN	O	none	prep_in	15	SENT_507	[p26l1519t1204r1730b1257],
29	of	IN	O	of	_	0	SENT_507	[p26l1752t1177r1853b1257],
30	203	CD	NUMBER	203	num	33	SENT_507	[p26l1856t1185r2008b1257],
31	tumor	NN	O	tumor	nn	33	SENT_507	[p26l2032t1195r2147b1257, p26l11t1333r189b1387],
32	cell	NN	O	cell	nn	33	SENT_507	[p26l212t1307r354b1386],
33	lines	NNS	O	line	prep_of	28	SENT_507	[p26l377t1301r752b1387],
34	.6	CD	NUMBER	.6	num	35	SENT_507	[p26l377t1301r752b1387],
35	’62	CD	NUMBER	’62	nsubj	37	SENT_507	[p26l377t1301r752b1387],
36	ARE	VBP	O	be	cop	37	SENT_507	[p26l8t1418r158b1467],
37	CHANGES	NNS	O	change	rcmod	33	SENT_507	[p26l199t1417r606b1468],
38	IN	IN	O	in	_	0	SENT_507	[p26l651t1418r732b1467],
39	THE	DT	O	the	det	42	SENT_507	[p26l775t1418r937b1467],
40	DRUG-DEVELOPMENT	JJ	O	drug-development	amod	42	SENT_507	[p26l981t1417r1888b1468],
41	pnocess	NN	O	pnocess	nn	42	SENT_507	[p26l15t1503r380b1553],
42	N	NN	O	n	prep_in	37	SENT_507	[p26l427t1503r470b1553],
43	EEDED	VBD	O	eed	_	0	SENT_507	[p26l495t1503r760b1553],
44	FOR	IN	O	for	_	0	SENT_507	[p26l805t1503r960b1553],
45	TK-TARGETED	JJ	O	tk-targeted	amod	46	SENT_507	[p26l998t1503r1565b1553],
46	THERAPIES	NNS	O	therapy	prep_for	43	SENT_507	[p26l1602t1498r2107b1554],
47	?	.	O	?	_	0	SENT_507	[p26l1602t1498r2107b1554],

1	The	DT	DATE	the	det	2	SENT_508	[p26l6t1604r169b1682],
2	future	NN	DATE	future	nsubj	11	SENT_508	[p26l197t1603r451b1683],
3	of	IN	O	of	_	0	SENT_508	[p26l480t1603r581b1682],
4	TK	NN	O	tk	prep_of	2	SENT_508	[p26l587t1604r1094b1704],
5	—	CD	NUMBER	—	num	4	SENT_508	[p26l587t1604r1094b1704],
6	targeted	VBN	O	target	partmod	4	SENT_508	[p26l587t1604r1094b1704],
7	therapeutics	NNS	O	therapeutics	dobj	6	SENT_508	[p26l1122t1604r1642b1704],
8	in	IN	O	in	_	0	SENT_508	[p26l1671t1604r1753b1681],
9	cancer	NN	O	cancer	prep_in	7	SENT_508	[p26l1782t1629r2059b1682],
10	is	VBZ	O	be	cop	11	SENT_508	[p26l2083t1604r2148b1682],
11	promising	JJ	O	promising	_	0	SENT_508	[p26l8t1733r477b1833],
12	,	,	O	,	_	0	SENT_508	[p26l8t1733r477b1833],
13	but	CC	O	but	_	0	SENT_508	[p26l519t1733r662b1812],
14	some	DT	O	some	det	15	SENT_508	[p26l694t1758r919b1811],
15	changes	NNS	O	change	nsubjpass	27	SENT_508	[p26l956t1733r1301b1833],
16	in	IN	O	in	_	0	SENT_508	[p26l1339t1733r1421b1810],
17	our	PRP$	O	we	poss	18	SENT_508	[p26l1457t1758r1602b1812],
18	approach	NN	O	approach	prep_in	15	SENT_508	[p26l1634t1733r2033b1833],
19	to	TO	O	to	_	0	SENT_508	[p26l2069t1749r2149b1811],
20	the	DT	O	the	det	21	SENT_508	[p26l10t1861r140b1939],
21	development	NN	O	development	prep_to	18	SENT_508	[p26l173t1861r727b1961],
22	of	IN	O	of	_	0	SENT_508	[p26l755t1860r855b1939],
23	these	DT	O	these	det	24	SENT_508	[p26l869t1861r1089b1939],
24	drugs	NNS	O	drug	prep_of	21	SENT_508	[p26l1123t1861r1362b1961],
25	may	MD	O	may	aux	27	SENT_508	[p26l1396t1887r1574b1961],
26	be	VB	O	be	auxpass	27	SENT_508	[p26l1602t1861r1698b1939],
27	indicated	VBN	O	indicate	conj_but	11	SENT_508	[p26l1730t1861r2145b1939],
28	.	.	O	.	_	0	SENT_508	[p26l1730t1861r2145b1939],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_509	[p26l6t1989r529b2089],
2	agents	NNS	O	agent	nsubj	7	SENT_509	[p26l565t2005r845b2089],
3	targeting	VBG	O	target	partmod	2	SENT_509	[p26l885t1989r1284b2089],
4	TKs	NNS	O	tk	dobj	3	SENT_509	[p26l1314t1994r1485b2070],
5	do	VBP	O	do	aux	7	SENT_509	[p26l1526t1989r1630b2067],
6	not	RB	O	not	neg	7	SENT_509	[p26l1669t2005r1815b2067],
7	ﬁt	VB	O	ﬁt	_	0	SENT_509	[p26l1847t1988r1942b2067],
8	Well	UH	O	well	dep	7	SENT_509	[p26l1970t1989r2150b2068],
9	into	IN	O	into	_	0	SENT_509	[p26l8t2118r179b2196],
10	traditional	JJ	O	traditional	amod	11	SENT_509	[p26l205t2118r659b2196],
11	phase	NN	O	phase	prep_into	7	SENT_509	[p26l680t2118r932b2218],
12	1	CD	NUMBER	1	num	11	SENT_509	[p26l960t2123r1030b2213],
13	,	,	O	,	_	0	SENT_509	[p26l960t2123r1030b2213],
14	2	CD	NUMBER	2	appos	11	SENT_509	[p26l1059t2123r1132b2213],
15	,	,	O	,	_	0	SENT_509	[p26l1059t2123r1132b2213],
16	or	CC	O	or	_	0	SENT_509	[p26l1162t2143r1253b2196],
17	3	CD	NUMBER	3	num	18	SENT_509	[p26l1275t2123r1318b2196],
18	drug	NN	O	drug	conj_or	11	SENT_509	[p26l1346t2118r2154b2218],
19	—	CD	NUMBER	—	num	21	SENT_509	[p26l1346t2118r2154b2218],
20	development	NN	O	development	nn	21	SENT_509	[p26l1346t2118r2154b2218],
21	programs	NNS	O	program	dep	18	SENT_509	[p26l8t2271r427b2346],
22	because	IN	O	because	mark	28	SENT_509	[p26l460t2246r794b2325],
23	their	PRP$	O	they	poss	25	SENT_509	[p26l825t2246r1024b2324],
24	toxicity	NN	O	toxicity	nn	25	SENT_509	[p26l1051t2246r1360b2346],
25	proﬁle	NN	O	proﬁle	nsubj	28	SENT_509	[p26l1384t2245r1665b2346],
26	can	MD	O	can	aux	28	SENT_509	[p26l1696t2271r1842b2324],
27	be	VB	O	be	cop	28	SENT_509	[p26l1872t2246r1968b2324],
28	low	JJ	O	low	dep	11	SENT_509	[p26l1998t2246r2154b2325],
29	and	CC	O	and	_	0	SENT_509	[p26l8t2375r166b2453],
30	because	IN	O	because	mark	36	SENT_509	[p26l190t2375r525b2454],
31	the	DT	O	the	det	33	SENT_509	[p26l550t2375r680b2453],
32	therapeutic	JJ	O	therapeutic	amod	33	SENT_509	[p26l705t2375r1184b2475],
33	responses	NNS	O	response	nsubjpass	36	SENT_509	[p26l1207t2400r1632b2475],
34	may	MD	O	may	aux	36	SENT_509	[p26l1658t2401r1836b2475],
35	be	VB	O	be	auxpass	36	SENT_509	[p26l1856t2375r1952b2453],
36	limited	VBN	O	limit	conj_and	28	SENT_509	[p26l1976t2375r2149b2452, p26l8t2503r168b2581],
37	to	TO	O	to	_	0	SENT_509	[p26l201t2519r283b2581],
38	a	DT	O	a	det	40	SENT_509	[p26l317t2529r361b2581],
39	small	JJ	O	small	amod	40	SENT_509	[p26l395t2503r630b2581],
40	subgroup	NN	O	subgroup	prep_to	36	SENT_509	[p26l665t2503r1082b2603],
41	of	IN	O	of	_	0	SENT_509	[p26l1117t2502r1220b2581],
42	patients	NNS	O	patient	prep_of	40	SENT_509	[p26l1233t2503r1582b2603],
43	with	IN	O	with	_	0	SENT_509	[p26l1613t2503r1808b2582],
44	a	DT	O	a	det	46	SENT_509	[p26l1841t2529r1885b2581],
45	given	VBN	O	give	amod	46	SENT_509	[p26l1917t2503r2149b2603],
46	cancer	NN	O	cancer	prep_with	36	SENT_509	[p26l10t2656r313b2710],
47	.	.	O	.	_	0	SENT_509	[p26l10t2656r313b2710],

1	12	CD	NUMBER	12	num	2	SENT_510	[p26l326t2625r442b2671],
2	°	CD	NUMBER	°	npadvmod	13	SENT_510	[p26l326t2625r442b2671],
3	In	IN	O	in	_	0	SENT_510	[p26l470t2638r558b2709],
4	phase	NN	O	phase	prep_in	13	SENT_510	[p26l586t2631r833b2732],
5	2	CD	NUMBER	2	num	4	SENT_510	[p26l863t2637r910b2709],
6	or	CC	O	or	_	0	SENT_510	[p26l941t2656r1031b2710],
7	3	CD	NUMBER	3	num	8	SENT_510	[p26l1058t2637r1102b2710],
8	studies	NNS	O	study	conj_or	4	SENT_510	[p26l1136t2631r1457b2727],
9	,	,	O	,	_	0	SENT_510	[p26l1136t2631r1457b2727],
10	patients	NNS	O	patient	nsubjpass	13	SENT_510	[p26l1491t2632r1828b2732],
11	should	MD	O	should	aux	13	SENT_510	[p26l1861t2631r2150b2711],
12	be	VB	O	be	auxpass	13	SENT_510	[p26l10t2761r106b2839],
13	selected	VBN	O	select	_	0	SENT_510	[p26l142t2761r487b2839],
14	on	IN	O	on	_	0	SENT_510	[p26l522t2786r630b2839],
15	the	DT	O	the	det	16	SENT_510	[p26l665t2761r798b2839],
16	basis	NN	O	basis	prep_on	13	SENT_510	[p26l833t2761r1049b2839],
17	of	IN	O	of	_	0	SENT_510	[p26l1086t2760r1188b2839],
18	evidence	NN	O	evidence	prep_of	16	SENT_510	[p26l1205t2761r1576b2839],
19	of	IN	O	of	_	0	SENT_510	[p26l1612t2760r1713b2839],
20	activation	NN	O	activation	prep_of	18	SENT_510	[p26l1729t2761r2149b2839],
21	of	IN	O	of	_	0	SENT_510	[p26l10t2888r113b2967],
22	the	DT	O	the	det	25	SENT_510	[p26l123t2889r255b2967],
23	T	NN	O	t	nn	25	SENT_510	[p26l280t2894r342b2966],
24	K	NN	O	k	nn	25	SENT_510	[p26l344t2896r412b2970],
25	target	NN	O	target	prep_of	20	SENT_510	[p26l437t2905r694b2989],
26	in	IN	O	in	_	0	SENT_510	[p26l717t2889r799b2966],
27	their	PRP$	O	they	poss	28	SENT_510	[p26l829t2889r1032b2967],
28	tumors	NNS	O	tumor	prep_in	25	SENT_510	[p26l1058t2905r1393b2984],
29	,	,	O	,	_	0	SENT_510	[p26l1058t2905r1393b2984],
30	and	CC	O	and	_	0	SENT_510	[p26l1427t2889r1586b2967],
31	such	JJ	O	such	amod	32	SENT_510	[p26l1616t2889r1815b2968],
32	studies	NNS	O	study	conj_and	25	SENT_510	[p26l1845t2889r2148b2968],

1	N	NN	O	n	nn	3	SENT_511	[p26l526t3066r540b3081],
2	ENGLJ	NN	O	englj	nn	3	SENT_511	[p26l555t3065r639b3087],
3	MED	NN	O	med	_	0	SENT_511	[p26l654t3066r707b3081],
4	353	CD	NUMBER	353	dep	3	SENT_511	[p26l719t3065r783b3087],
5	;	:	O	;	_	0	SENT_511	[p26l719t3065r783b3087],
6	2	CD	NUMBER	2	num	8	SENT_511	[p26l719t3065r783b3087],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	8	SENT_511	[p26l818t3065r1029b3087],
8	ULY14	NN	O	uly14	dep	4	SENT_511	[p26l1078t3065r1169b3087],
9	,	,	O	,	_	0	SENT_511	[p26l1078t3065r1169b3087],
10	2005	CD	DATE	2005	number	11	SENT_511	[p26l1183t3065r1246b3087],
11	133	CD	NUMBER	133	appos	8	SENT_511	[p26l1960t3064r2015b3086],

1	The	DT	O	the	det	6	SENT_512	[p26l701t3099r752b3122],
2	New	NNP	O	New	nn	6	SENT_512	[p26l762t3099r823b3122],
3	England	NNP	O	England	nn	6	SENT_512	[p26l833t3099r943b3129],
4	J	NNP	O	J	nn	6	SENT_512	[p26l952t3099r964b3122],
5	oum	NN	O	oum	nn	6	SENT_512	[p26l966t3106r1026b3122],
6	o	NN	O	o	_	0	SENT_512	[p26l1059t3106r1074b3122],
7	Medicine	NN	O	medicine	dep	6	SENT_512	[p26l1095t3099r1220b3122],

1	Downloaded	VBN	O	download	_	0	SENT_513	[p26l144t3139r314b3162],
2	from	IN	O	from	_	0	SENT_513	[p26l322t3139r387b3162],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_513	[p26l395t3139r514b3169],
4	at	IN	O	at	_	0	SENT_513	[p26l524t3143r547b3162],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_513	[p26l556t3139r738b3162],
6	on	IN	O	on	_	0	SENT_513	[p26l748t3146r780b3162],
7	Janua	NNP	DATE	Janua	prep_on	1	SENT_513	[p26l789t3139r864b3162],
8	5	CD	DATE	5	num	7	SENT_513	[p26l901t3139r924b3166],
9	,	,	DATE	,	_	0	SENT_513	[p26l901t3139r924b3166],
10	2014	CD	DATE	2014	num	7	SENT_513	[p26l935t3139r1007b3162],
11	.	.	O	.	_	0	SENT_513	[p26l935t3139r1007b3162],

1	For	IN	O	for	_	0	SENT_514	[p26l1017t3139r1064b3162],
2	personal	JJ	O	personal	amod	3	SENT_514	[p26l1072t3139r1184b3169],
3	use	NN	O	use	pobj	1	SENT_514	[p26l1194t3146r1237b3162],
4	only	RB	O	only	advmod	3	SENT_514	[p26l1247t3139r1311b3169],
5	.	.	O	.	_	0	SENT_514	[p26l1247t3139r1311b3169],

1	No	DT	O	no	det	3	SENT_515	[p26l1322t3139r1362b3162],
2	other	JJ	O	other	amod	3	SENT_515	[p26l1372t3139r1440b3162],
3	uses	NNS	O	use	_	0	SENT_515	[p26l1448t3146r1504b3162],
4	without	IN	O	without	_	0	SENT_515	[p26l1514t3139r1615b3162],
5	permission	NN	O	permission	prep_without	3	SENT_515	[p26l1624t3139r1776b3169],
6	.	.	O	.	_	0	SENT_515	[p26l1624t3139r1776b3169],

1	Copyright	NN	O	copyright	nn	5	SENT_516	[p26l494t3180r628b3210],
2	©	CD	NUMBER	©	num	5	SENT_516	[p26l638t3180r661b3204],
3	2005	CD	DATE	2005	num	5	SENT_516	[p26l671t3180r735b3204],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_516	[p26l745t3181r844b3203],
5	usetts	NNP	O	usetts	_	0	SENT_516	[p26l862t3184r937b3203],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_516	[p26l946t3180r1055b3203],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_516	[p26l1065t3180r1170b3210],
8	.	.	O	.	_	0	SENT_516	[p26l1065t3180r1170b3210],

1	All	DT	O	all	det	2	SENT_517	[p26l1181t3180r1222b3203],
2	rights	NNS	O	rights	nsubj	3	SENT_517	[p26l1231t3180r1306b3210],
3	reserved	VBN	O	reserve	_	0	SENT_517	[p26l1316t3180r1435b3203],
4	.	.	O	.	_	0	SENT_517	[p26l1316t3180r1435b3203],

1	The	DT	O	the	det	4	SENT_518	[p26l715t3285r752b3306],
2	NEW	NNP	O	NEW	nn	4	SENT_518	[p26l764t3287r845b3306],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_518	[p26l859t3287r1034b3306],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_518	[p26l1048t3287r1214b3313],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_518	[p26l1228t3285r1444b3312],

1	should	MD	O	should	aux	2	SENT_519	[p26l13t3508r304b3588],
2	include	VB	O	include	_	0	SENT_519	[p26l338t3508r650b3588],
3	pharmacodynamic	JJ	O	pharmacodynamic	amod	4	SENT_519	[p26l683t3508r1479b3609],
4	analysis	NN	O	analysis	dobj	2	SENT_519	[p26l1513t3509r1845b3609],
5	of	IN	O	of	_	0	SENT_519	[p26l1883t3508r1984b3587],
6	tar	NN	O	tar	prep_of	4	SENT_519	[p26l2001t3525r2148b3587],
7	—	CD	NUMBER	—	nsubj	2	SENT_519	[p26l2001t3525r2148b3587],
8	get	VBP	O	get	rcmod	7	SENT_519	[p26l11t3653r141b3737],
9	inhibition	NN	O	inhibition	dobj	8	SENT_519	[p26l163t3637r575b3715],
10	to	TO	O	to	aux	11	SENT_519	[p26l603t3653r681b3715],
11	avoid	VB	O	avoid	xcomp	8	SENT_519	[p26l709t3636r929b3716],
12	discarding	VBG	O	discard	xcomp	11	SENT_519	[p26l956t3636r1396b3737],
13	a	DT	O	a	det	15	SENT_519	[p26l1419t3663r1464b3715],
14	potentially	RB	O	potentially	advmod	15	SENT_519	[p26l1488t3636r1930b3737],
15	valuable	JJ	O	valuable	dobj	12	SENT_519	[p26l1948t3637r2149b3716, p27l11t21r186b99],

1	therapeutic	JJ	O	therapeutic	amod	2	SENT_520	[p27l225t21r715b121],
2	agent	NN	O	agent	_	0	SENT_520	[p27l751t37r994b121],
3	because	IN	O	because	mark	34	SENT_520	[p27l1027t21r1368b100],
4	of	IN	O	of	_	0	SENT_520	[p27l1407t20r1509b99],
5	perceived	VBN	O	perceive	amod	7	SENT_520	[p27l1527t21r1938b121],
6	lack	NN	O	lack	nn	7	SENT_520	[p27l1974t20r2152b100],
7	ofefficacy	NN	O	ofefficacy	prep_of	34	SENT_520	[p27l12t143r592b249],
8	.121	CD	NUMBER	.121	nsubj	34	SENT_520	[p27l12t143r592b249],
9	The	DT	DATE	the	det	10	SENT_520	[p27l612t149r777b227],
10	future	NN	DATE	future	nsubj	13	SENT_520	[p27l800t148r1060b228],
11	of	IN	O	of	_	0	SENT_520	[p27l1085t148r1187b227],
12	gefitinib	NN	O	gefitinib	prep_of	10	SENT_520	[p27l1192t148r1557b249],
13	is	VBZ	O	be	rcmod	8	SENT_520	[p27l1582t150r1648b227],
14	in	IN	O	in	_	0	SENT_520	[p27l1674t150r1756b226],
15	jeopardy	NN	O	jeopardy	prep_in	13	SENT_520	[p27l1766t149r2153b249],
16	after	IN	O	after	_	0	SENT_520	[p27l11t276r208b355],
17	a	DT	O	a	det	22	SENT_520	[p27l237t303r281b355],
18	recent	JJ	O	recent	amod	22	SENT_520	[p27l311t293r576b355],
19	large	JJ	O	large	amod	22	SENT_520	[p27l600t277r809b377],
20	phase	NN	O	phase	nn	22	SENT_520	[p27l838t276r1086b377],
21	3	CD	NUMBER	3	num	22	SENT_520	[p27l1117t282r1161b355],
22	trial	NN	O	trial	prep_after	13	SENT_520	[p27l1195t277r1362b355],
23	involving	VBG	O	involve	partmod	8	SENT_520	[p27l1391t277r1785b377],
24	patients	NNS	O	patient	dobj	23	SENT_520	[p27l1810t277r2147b377],
25	with	IN	O	with	_	0	SENT_520	[p27l7t404r197b484],
26	refractory	JJ	O	refractory	amod	28	SENT_520	[p27l220t404r634b505],
27	non	JJ	O	non	amod	28	SENT_520	[p27l652t404r1288b483],
28	—	NN	O	—	prep_with	23	SENT_520	[p27l652t404r1288b483],
29	small	JJ	O	small	amod	33	SENT_520	[p27l652t404r1288b483],
30	—	NN	O	—	nn	33	SENT_520	[p27l652t404r1288b483],
31	cell	NN	O	cell	nn	33	SENT_520	[p27l652t404r1288b483],
32	lung	NN	O	lung	nn	33	SENT_520	[p27l1309t405r1505b505],
33	cancer	NN	O	cancer	dep	28	SENT_520	[p27l1525t430r1802b483],
34	showed	VBD	O	show	dep	2	SENT_520	[p27l1823t405r2149b484],
35	that	IN	O	that	complm	38	SENT_520	[p27l12t532r180b611],
36	the	DT	O	the	det	37	SENT_520	[p27l215t533r345b611],
37	drug	NN	O	drug	nsubj	38	SENT_520	[p27l386t533r587b633],
38	conferred	VBD	O	confer	ccomp	34	SENT_520	[p27l625t532r1034b611],
39	no	DT	O	no	det	41	SENT_520	[p27l1074t558r1181b611],
40	survival	NN	O	survival	nn	41	SENT_520	[p27l1224t532r1544b612],
41	benefit	NN	O	benefit	dobj	38	SENT_520	[p27l1585t532r1883b611],
42	when	WRB	O	when	advmod	43	SENT_520	[p27l1914t533r2149b612],
43	compared	VBN	O	compare	advcl	38	SENT_520	[p27l12t661r438b761],
44	with	IN	O	with	_	0	SENT_520	[p27l459t660r649b740],
45	placebo122	NN	O	placebo122	prep_with	43	SENT_520	[p27l673t655r1126b761],
46	—	CD	NUMBER	—	num	45	SENT_520	[p27l1148t706r1256b713],
47	a	DT	O	a	det	49	SENT_520	[p27l1278t687r1322b739],
48	surprising	JJ	O	surprising	amod	49	SENT_520	[p27l1348t662r1787b761],
49	ﬁnding	NN	O	ﬁnding	dep	2	SENT_520	[p27l1809t660r2143b761],
50	,	,	O	,	_	0	SENT_520	[p27l1809t660r2143b761],
51	given	VBN	O	give	dep	49	SENT_520	[p27l11t789r236b889],
52	that	IN	O	that	complm	65	SENT_520	[p27l273t789r441b867],
53	the	DT	O	the	det	55	SENT_520	[p27l474t789r603b867],
54	expected	JJ	O	expected	amod	55	SENT_520	[p27l642t788r1011b889],
55	frequency	NN	O	frequency	nsubj	65	SENT_520	[p27l1048t788r1468b889],
56	of	IN	O	of	_	0	SENT_520	[p27l1501t788r1602b867],
57	tumors	NNS	O	tumor	prep_of	55	SENT_520	[p27l1621t805r1924b868],
58	with	IN	O	with	_	0	SENT_520	[p27l1958t789r2149b868],
59	responsive	JJ	O	responsive	amod	60	SENT_520	[p27l11t917r456b1017],
60	EGFRmutations	NNS	O	egfrmutation	prep_with	57	SENT_520	[p27l475t917r1170b1000],
61	was	VBD	O	be	cop	65	SENT_520	[p27l1189t943r1349b996],
62	8	CD	NUMBER	8	number	64	SENT_520	[p27l1373t922r1418b995],
63	to	TO	O	to	dep	64	SENT_520	[p27l1441t933r1520b995],
64	10	CD	PERCENT	10	num	65	SENT_520	[p27l1546t922r1643b995],
65	percent	NN	PERCENT	percent	ccomp	51	SENT_520	[p27l1662t933r1980b1017],
66	and	CC	O	and	_	0	SENT_520	[p27l1995t917r2150b995],
67	given	VBN	O	give	conj_and	51	SENT_520	[p27l11t1045r236b1145],
68	that	IN	O	that	complm	72	SENT_520	[p27l258t1045r425b1123],
69	the	DT	O	the	det	70	SENT_520	[p27l443t1044r572b1123],
70	study	NN	O	study	nsubjpass	72	SENT_520	[p27l596t1045r823b1145],
71	was	VBD	O	be	auxpass	72	SENT_520	[p27l835t1071r997b1124],
72	powered	VBN	O	power	ccomp	67	SENT_520	[p27l1020t1045r1387b1145],
73	to	TO	O	to	aux	74	SENT_520	[p27l1409t1061r1488b1123],
74	detect	VB	O	detect	xcomp	72	SENT_520	[p27l1512t1045r1767b1123],
75	such	JJ	O	such	amod	76	SENT_520	[p27l1785t1044r1981b1124],
76	differences	NNS	O	difference	dobj	74	SENT_520	[p27l2003t1044r2148b1123, p27l11t1173r386b1252],
77	.	.	O	.	_	0	SENT_520	[p27l2003t1044r2148b1123, p27l11t1173r386b1252],

1	Patient	NN	O	patient	nn	2	SENT_521	[p27l139t1302r438b1380],
2	stratiﬁcation	NN	O	stratiﬁcation	nsubj	4	SENT_521	[p27l464t1301r1003b1380],
3	will	MD	O	will	aux	4	SENT_521	[p27l1028t1302r1186b1381],
4	lead	VB	O	lead	dep	17	SENT_521	[p27l1214t1301r1388b1380],
5	to	TO	O	to	_	0	SENT_521	[p27l1418t1318r1498b1380],
6	smaller	JJR	O	smaller	amod	8	SENT_521	[p27l1531t1302r1846b1380],
7	potential	JJ	O	potential	amod	8	SENT_521	[p27l1871t1318r2148b1402, p27l12t1429r146b1508],
8	markets	NNS	O	market	prep_to	4	SENT_521	[p27l180t1430r533b1509],
9	for	IN	O	for	_	0	SENT_521	[p27l570t1429r699b1508],
10	each	DT	O	each	det	14	SENT_521	[p27l730t1429r928b1508],
11	newly	RB	O	newly	advmod	12	SENT_521	[p27l962t1430r1220b1530],
12	approved	VBN	O	approve	amod	14	SENT_521	[p27l1249t1430r1657b1530],
13	TK	NN	O	tk	nn	14	SENT_521	[p27l1688t1435r2145b1530],
14	—	NN	O	—	prep_for	8	SENT_521	[p27l1688t1435r2145b1530],
15	target	NN	O	target	nsubj	17	SENT_521	[p27l1688t1435r2145b1530],
16	—	CD	NUMBER	—	num	15	SENT_521	[p27l1688t1435r2145b1530],
17	ed	VBD	O	ed	_	0	SENT_521	[p27l12t1557r111b1636],
18	cancer	NN	O	cancer	nn	19	SENT_521	[p27l143t1583r431b1636],
19	therapy	NN	O	therapy	dobj	17	SENT_521	[p27l459t1558r789b1658],
20	,	,	O	,	_	0	SENT_521	[p27l459t1558r789b1658],
21	a	DT	O	a	det	22	SENT_521	[p27l822t1584r867b1636],
22	situation	NN	O	situation	appos	19	SENT_521	[p27l895t1558r1265b1637],
23	that	WDT	O	that	nsubj	25	SENT_521	[p27l1294t1558r1462b1636],
24	may	MD	O	may	aux	25	SENT_521	[p27l1484t1584r1662b1658],
25	discourage	VB	O	discourage	rcmod	22	SENT_521	[p27l1687t1558r2148b1658],
26	the	DT	O	the	det	30	SENT_521	[p27l12t1685r141b1764],
27	drug	NN	O	drug	nn	30	SENT_521	[p27l167t1685r958b1786],
28	—	NN	O	—	nn	30	SENT_521	[p27l167t1685r958b1786],
29	development	NN	O	development	nn	30	SENT_521	[p27l167t1685r958b1786],
30	process	NN	O	process	dobj	25	SENT_521	[p27l975t1711r1297b1786],
31	at	IN	O	at	_	0	SENT_521	[p27l1323t1702r1403b1764],
32	a	DT	O	a	det	35	SENT_521	[p27l1421t1712r1465b1764],
33	very	RB	O	very	advmod	34	SENT_521	[p27l1484t1712r1657b1786],
34	early	JJ	O	early	amod	35	SENT_521	[p27l1678t1686r1879b1786],
35	stage	NN	O	stage	prep_at	25	SENT_521	[p27l1900t1702r2143b1786],
36	.	.	O	.	_	0	SENT_521	[p27l1900t1702r2143b1786],

1	Clinical	JJ	O	clinical	amod	2	SENT_522	[p27l11t1814r335b1892],
2	development	NN	O	development	nsubj	8	SENT_522	[p27l364t1814r917b1914],
3	of	IN	O	of	_	0	SENT_522	[p27l940t1813r1042b1892],
4	imatinib	NN	O	imatinib	prep_of	2	SENT_522	[p27l1051t1813r1409b1892],
5	was	VBD	O	be	cop	8	SENT_522	[p27l1435t1840r1596b1893],
6	nearly	RB	O	nearly	advmod	8	SENT_522	[p27l1627t1813r1887b1914],
7	aban	JJ	O	aban	amod	8	SENT_522	[p27l1910t1814r2148b1892],
8	—	NN	O	—	_	0	SENT_522	[p27l1910t1814r2148b1892],
9	doned	VBN	O	don	partmod	8	SENT_522	[p27l12t1941r277b2020],
10	because	IN	O	because	mark	19	SENT_522	[p27l307t1941r641b2021],
11	the	DT	O	the	det	12	SENT_522	[p27l671t1942r800b2020],
12	market	NN	O	market	nsubjpass	19	SENT_522	[p27l830t1941r1134b2021],
13	for	IN	O	for	_	0	SENT_522	[p27l1159t1941r1282b2020],
14	a	DT	O	a	det	15	SENT_522	[p27l1309t1968r1353b2020],
15	drug	NN	O	drug	prep_for	12	SENT_522	[p27l1382t1942r1582b2042],
16	for	IN	O	for	_	0	SENT_522	[p27l1608t1941r1732b2020],
17	CML	NN	ORGANIZATION	cml	prep_for	15	SENT_522	[p27l1758t1947r1962b2020],
18	was	VBD	O	be	auxpass	19	SENT_522	[p27l1985t1968r2147b2021],
19	perceived	VBN	O	perceive	advcl	9	SENT_522	[p27l10t2069r411b2170],
20	to	TO	O	to	aux	23	SENT_522	[p27l443t2086r523b2148],
21	be	VB	O	be	cop	23	SENT_522	[p27l556t2070r652b2148],
22	too	RB	O	too	advmod	23	SENT_522	[p27l685t2086r819b2148],
23	small	JJ	O	small	xcomp	19	SENT_522	[p27l854t2070r1106b2165],
24	,	,	O	,	_	0	SENT_522	[p27l854t2070r1106b2165],
25	but	CC	O	but	_	0	SENT_522	[p27l1144t2070r1286b2149],
26	the	DT	O	the	det	28	SENT_522	[p27l1313t2070r1443b2148],
27	high	JJ	O	high	amod	28	SENT_522	[p27l1474t2069r1668b2170],
28	prevalence	NN	O	prevalence	nsubj	39	SENT_522	[p27l1698t2070r2149b2170],
29	of	IN	O	of	_	0	SENT_522	[p27l12t2197r113b2276],
30	the	DT	O	the	det	31	SENT_522	[p27l116t2198r246b2276],
31	disease	NN	O	disease	prep_of	28	SENT_522	[p27l268t2198r573b2276],
32	and	CC	O	and	_	0	SENT_522	[p27l595t2197r751b2276],
33	the	DT	O	the	det	34	SENT_522	[p27l773t2198r903b2276],
34	durability	NN	O	durability	prep_of	28	SENT_522	[p27l925t2197r1334b2298],
35	of	IN	O	of	_	0	SENT_522	[p27l1351t2197r1452b2276],
36	clinical	JJ	O	clinical	amod	37	SENT_522	[p27l1456t2198r1758b2276],
37	responses	NNS	O	response	prep_of	34	SENT_522	[p27l1779t2223r2148b2298, p27l12t2353r94b2405],
38	have	VBP	O	have	aux	39	SENT_522	[p27l120t2326r308b2406],
39	driven	VBN	O	drive	conj_but	8	SENT_522	[p27l333t2326r595b2406],
40	annual	JJ	SET	annual	amod	41	SENT_522	[p27l618t2326r908b2406],
41	sales	NNS	O	sale	dobj	39	SENT_522	[p27l932t2326r1133b2405],
42	to	TO	O	to	_	0	SENT_522	[p27l1158t2343r1238b2405],
43	more	JJR	O	more	quantmod	45	SENT_522	[p27l1262t2352r1483b2405],
44	than	IN	O	than	quantmod	45	SENT_522	[p27l1508t2326r1696b2405],
45	$	$	MONEY	$	prep_to	39	SENT_522	[p27l1722t2323r1821b2415],
46	1	CD	MONEY	1	number	45	SENT_522	[p27l1722t2323r1821b2415],
47	billion	CD	MONEY	billion	number	45	SENT_522	[p27l1845t2326r2144b2405],
48	.	.	O	.	_	0	SENT_522	[p27l1845t2326r2144b2405],

1	However	RB	O	however	_	0	SENT_523	[p27l11t2462r415b2550],
2	,	,	O	,	_	0	SENT_523	[p27l11t2462r415b2550],
3	the	DT	O	the	det	4	SENT_523	[p27l450t2455r583b2533],
4	prevalence	NN	O	prevalence	dep	5	SENT_523	[p27l611t2455r1076b2555],
5	of	IN	O	of	dep	1	SENT_523	[p27l1106t2454r1208b2533],
6	the	DT	O	the	det	8	SENT_523	[p27l1219t2455r1352b2533],
7	other	JJ	O	other	amod	8	SENT_523	[p27l1383t2455r1614b2533],
8	hematologREFERENCES	NN	O	hematologreference	pobj	5	SENT_523	[p27l1640t2455r2146b2555, p27l15t2750r487b2792],

1	1	LS	NUMBER	1	_	0	SENT_524	[p27l16t2912r89b2989],
2	.	.	O	.	_	0	SENT_524	[p27l16t2912r89b2989],

1	Van	NNP	PERSON	Van	nn	2	SENT_525	[p27l205t2908r387b2989],
2	Etten	NNP	PERSON	Etten	nsubj	3	SENT_525	[p27l419t2908r672b2989],
3	RA	NN	O	ra	_	0	SENT_525	[p27l704t2908r876b2995],
4	.	.	O	.	_	0	SENT_525	[p27l704t2908r876b2995],

1	c	NN	O	c	_	0	SENT_526	[p27l917t2900r1169b2990],
2	.	.	O	.	_	0	SENT_526	[p27l917t2900r1169b2990],

1	—	NN	O	—	_	0	SENT_527	[p27l917t2900r1169b2990],
2	.	.	O	.	_	0	SENT_527	[p27l917t2900r1169b2990],

1	Abl	NN	PERSON	abl	nn	2	SENT_528	[p27l917t2900r1169b2990],
2	regulation	NN	O	regulation	_	0	SENT_528	[p27l1202t2900r1730b3015],
3	:	:	O	:	_	0	SENT_528	[p27l1202t2900r1730b3015],
4	a	DT	O	a	det	5	SENT_528	[p27l1767t2930r1819b2989],
5	tail	NN	O	tail	dep	2	SENT_528	[p27l1852t2900r2003b2989],
6	of	IN	O	of	_	0	SENT_528	[p27l2036t2898r2153b2990],
7	two	CD	NUMBER	two	num	8	SENT_528	[p27l12t3068r186b3140],
8	lipids	NNS	O	lipid	prep_of	5	SENT_528	[p27l215t3049r512b3164],
9	.	.	O	.	_	0	SENT_528	[p27l215t3049r512b3164],

1	Curr	NNP	O	Curr	nn	2	SENT_529	[p27l548t3055r769b3140],
2	Biol	NNP	O	Biol	_	0	SENT_529	[p27l793t3049r987b3139],
3	2003	CD	DATE	2003	num	5	SENT_529	[p27l1014t3055r2025b3158],
4	;	:	O	;	_	0	SENT_529	[p27l1014t3055r2025b3158],
5	13	CD	NUMBER	13	dep	2	SENT_529	[p27l1014t3055r2025b3158],
6	:	:	O	:	_	0	SENT_529	[p27l1014t3055r2025b3158],
7	R608-R610	NN	O	r608-r610	dep	2	SENT_529	[p27l1014t3055r2025b3158],
8	.	.	O	.	_	0	SENT_529	[p27l1014t3055r2025b3158],

1	2	LS	NUMBER	2	_	0	SENT_530	[p27l10t3208r89b3287],
2	.	.	O	.	_	0	SENT_530	[p27l10t3208r89b3287],

1	Griffith	NNP	PERSON	Griffith	nn	2	SENT_531	[p27l209t3196r576b3288],
2	J	NNP	PERSON	J	_	0	SENT_531	[p27l597t3206r664b3307],
3	,	,	O	,	_	0	SENT_531	[p27l597t3206r664b3307],
4	Black	NNP	O	Black	appos	2	SENT_531	[p27l702t3198r1056b3307],
5	]	CD	NUMBER	]	num	4	SENT_531	[p27l702t3198r1056b3307],
6	,	,	O	,	_	0	SENT_531	[p27l702t3198r1056b3307],
7	Faerman	NNP	O	Faerman	nn	8	SENT_531	[p27l1093t3206r1521b3287],
8	C	NNP	O	C	appos	2	SENT_531	[p27l1554t3204r1649b3307],
9	,	,	O	,	_	0	SENT_531	[p27l1554t3204r1649b3307],
10	et	FW	O	et	nn	11	SENT_531	[p27l1689t3217r1778b3287],
11	al.	FW	O	al.	appos	2	SENT_531	[p27l1803t3198r1912b3288],
12	.	.	O	.	_	0	SENT_531	[p27l1803t3198r1912b3288],

1	The	DT	O	the	det	3	SENT_532	[p27l1947t3198r2132b3287],
2	structural	JJ	O	structural	amod	3	SENT_532	[p27l14t3346r488b3437],
3	basis	NN	O	basis	_	0	SENT_532	[p27l528t3346r773b3435],
4	for	IN	O	for	_	0	SENT_532	[p27l816t3344r961b3435],
5	autoinhibition	NN	O	autoinhibition	prep_for	3	SENT_532	[p27l996t3346r1712b3437],
6	of	IN	O	of	_	0	SENT_532	[p27l1753t3344r1870b3435],
7	FLT3	NN	O	flt3	prep_of	3	SENT_532	[p27l1888t3352r2126b3437],
8	by	IN	O	by	_	0	SENT_532	[p27l12t3495r125b3610],
9	the	DT	O	the	det	11	SENT_532	[p27l176t3495r328b3584],
10	juxtamembrane	NN	O	juxtamembrane	nn	11	SENT_532	[p27l369t3495r1165b3610],
11	domain	NN	O	domain	prep_by	3	SENT_532	[p27l1222t3495r1629b3585],
12	.	.	O	.	_	0	SENT_532	[p27l1222t3495r1629b3585],

1	Mol	NNP	O	Mol	nn	2	SENT_533	[p27l1688t3495r1884b3585],
2	Cell	NNP	O	Cell	_	0	SENT_533	[p27l1941t3495r2131b3585],
3	2004	CD	DATE	2004	num	2	SENT_533	[p27l12t3650r819b3753],
4	;	:	O	;	_	0	SENT_533	[p27l12t3650r819b3753],
5	13:169	CD	NUMBER	13:169	num	6	SENT_533	[p27l12t3650r819b3753],
6	—	NN	O	—	dep	2	SENT_533	[p27l12t3650r819b3753],
7	78	CD	NUMBER	78	dep	6	SENT_533	[p27l12t3650r819b3753],
8	.	.	O	.	_	0	SENT_533	[p27l12t3650r819b3753],

1	3	LS	NUMBER	3	_	0	SENT_534	[p28l12t37r89b116],
2	.	.	O	.	_	0	SENT_534	[p28l12t37r89b116],

1	Schlessinger	NNP	O	Schlessinger	nn	3	SENT_535	[p28l212t27r838b142],
2	J.	NNP	O	J.	nn	3	SENT_535	[p28l858t35r925b132],
3	Cell	NNP	O	Cell	nsubj	4	SENT_535	[p28l965t27r1157b117],
4	signaling	NN	O	signaling	_	0	SENT_535	[p28l1192t27r1655b142],
5	by	IN	O	by	_	0	SENT_535	[p28l1684t27r1797b142],
6	receptor	NN	O	receptor	nn	8	SENT_535	[p28l1827t57r2129b142, p28l12t195r152b266],
7	tyrosine	NN	O	tyrosine	nn	8	SENT_535	[p28l180t178r573b291],
8	kinases	NNS	O	kinase	prep_by	4	SENT_535	[p28l603t176r991b267],
9	.	.	O	.	_	0	SENT_535	[p28l603t176r991b267],

1	Cell	NN	O	cell	_	0	SENT_536	[p28l1026t176r1212b266],
2	2000	CD	DATE	2000	num	1	SENT_536	[p28l1241t182r2039b285],
3	;	:	O	;	_	0	SENT_536	[p28l1241t182r2039b285],
4	13:211	CD	NUMBER	13:211	number	5	SENT_536	[p28l1241t182r2039b285],
5	—	CD	NUMBER	—	dep	1	SENT_536	[p28l1241t182r2039b285],
6	25	CD	NUMBER	25	dep	5	SENT_536	[p28l1241t182r2039b285],
7	.	.	O	.	_	0	SENT_536	[p28l1241t182r2039b285],

1	4	LS	NUMBER	4	_	0	SENT_537	[p28l8t337r89b414],
2	.	.	O	.	_	0	SENT_537	[p28l8t337r89b414],

1	Smith	NNP	PERSON	Smith	nn	2	SENT_538	[p28l212t325r508b415],
2	KM	NNP	O	KM	_	0	SENT_538	[p28l565t333r771b434],
3	,	,	O	,	_	0	SENT_538	[p28l565t333r771b434],
4	Yacobi	NNP	PERSON	Yacobi	nn	5	SENT_538	[p28l832t325r1165b415],
5	R	NNP	PERSON	R	appos	2	SENT_538	[p28l1220t333r1321b434],
6	,	,	O	,	_	0	SENT_538	[p28l1220t333r1321b434],
7	Van	NNP	PERSON	Van	nn	9	SENT_538	[p28l1382t333r1568b414],
8	Etten	NNP	PERSON	Etten	nn	9	SENT_538	[p28l1625t333r1888b414],
9	RA	NN	O	ra	appos	5	SENT_538	[p28l1945t333r2122b420],
10	.	.	O	.	_	0	SENT_538	[p28l1945t333r2122b420],

1	Autoinhibition	NN	O	autoinhibition	_	0	SENT_539	[p28l8t474r746b565],
2	of	IN	O	of	_	0	SENT_539	[p28l785t472r902b564],
3	Bcr-Abl	NNP	O	Bcr-Abl	prep_of	1	SENT_539	[p28l917t474r1293b564],
4	through	IN	O	through	_	0	SENT_539	[p28l1331t474r1732b589],
5	its	PRP$	O	its	poss	7	SENT_539	[p28l1769t474r1882b563],
6	SH3	NN	O	sh3	nn	7	SENT_539	[p28l1926t480r2127b565],
7	domain	NN	O	domain	prep_through	1	SENT_539	[p28l12t623r419b713],
8	.	.	O	.	_	0	SENT_539	[p28l12t623r419b713],

1	Mol	NNP	O	Mol	nn	2	SENT_540	[p28l453t623r649b713],
2	Cell	NNP	O	Cell	_	0	SENT_540	[p28l678t623r864b713],
3	2003	CD	DATE	2003	num	2	SENT_540	[p28l892t629r1629b732],
4	;	:	O	;	_	0	SENT_540	[p28l892t629r1629b732],
5	12:27	CD	TIME	12:27	number	6	SENT_540	[p28l892t629r1629b732],
6	—	CD	NUMBER	—	dep	2	SENT_540	[p28l892t629r1629b732],
7	37	CD	NUMBER	37	dep	6	SENT_540	[p28l892t629r1629b732],
8	.	.	O	.	_	0	SENT_540	[p28l892t629r1629b732],

1	5	CD	NUMBER	5	_	0	SENT_541	[p28l12t784r89b861],
2	.	.	O	.	_	0	SENT_541	[p28l12t784r89b861],

1	N	NN	O	n	nn	3	SENT_542	[p28l206t780r293b863],
2	akao	NN	O	akao	nn	3	SENT_542	[p28l296t772r522b863],
3	M	NN	O	m	_	0	SENT_542	[p28l544t780r670b881],
4	,	,	O	,	_	0	SENT_542	[p28l544t780r670b881],
5	Yokota	NNP	PERSON	Yokota	nn	6	SENT_542	[p28l696t772r1030b863],
6	S	NNP	O	S	appos	3	SENT_542	[p28l1055t778r1133b881],
7	,	,	O	,	_	0	SENT_542	[p28l1055t778r1133b881],
8	Iwai	NNP	ORGANIZATION	Iwai	nn	9	SENT_542	[p28l1163t772r1368b863],
9	T	NN	ORGANIZATION	t	appos	3	SENT_542	[p28l1388t778r1473b881],
10	,	,	O	,	_	0	SENT_542	[p28l1388t778r1473b881],
11	et	FW	O	et	nn	12	SENT_542	[p28l1504t790r1592b861],
12	al.	FW	O	al.	appos	3	SENT_542	[p28l1609t772r1718b862],
13	.	.	O	.	_	0	SENT_542	[p28l1609t772r1718b862],

1	Internal	JJ	O	internal	amod	3	SENT_543	[p28l1748t772r2132b861],
2	tandem	JJ	O	tandem	amod	3	SENT_543	[p28l12t921r382b1011],
3	duplication	NN	O	duplication	nsubj	8	SENT_543	[p28l409t921r961b1036],
4	of	IN	O	of	_	0	SENT_543	[p28l987t919r1103b1011],
5	the	DT	O	the	det	7	SENT_543	[p28l1109t921r1257b1010],
6	ﬂt3	NN	O	ﬂt3	nn	7	SENT_543	[p28l1283t919r1441b1012],
7	gene	NN	O	gene	prep_of	3	SENT_543	[p28l1471t951r1699b1036],
8	found	VBN	O	find	_	0	SENT_543	[p28l1726t919r2015b1012],
9	in	IN	O	in	_	0	SENT_543	[p28l2040t921r2133b1010],
10	acute	JJ	O	acute	amod	12	SENT_543	[p28l10t1088r263b1161],
11	myeloid	JJ	O	myeloid	amod	12	SENT_543	[p28l290t1070r678b1185],
12	leukemia	NN	O	leukemia	prep_in	8	SENT_543	[p28l702t1070r1174b1161],
13	.	.	O	.	_	0	SENT_543	[p28l702t1070r1174b1161],

1	Leukemia	NN	O	leukemia	_	0	SENT_544	[p28l1206t1070r1681b1161],
2	1996	CD	DATE	1996	num	1	SENT_544	[p28l1710t1076r2127b1179],
3	;	:	O	;	_	0	SENT_544	[p28l1710t1076r2127b1179],
4	10	CD	NUMBER	10	num	6	SENT_544	[p28l1710t1076r2127b1179],
5	:	:	O	:	_	0	SENT_544	[p28l1710t1076r2127b1179],
6	1911-8	CD	NUMBER	1911-8	dep	1	SENT_544	[p28l16t1224r376b1307],
7	.	.	O	.	_	0	SENT_544	[p28l16t1224r376b1307],

1	6	CD	NUMBER	6	_	0	SENT_545	[p28l12t1377r89b1457],
2	.	.	O	.	_	0	SENT_545	[p28l12t1377r89b1457],

1	Lynch	NNP	PERSON	Lynch	nn	2	SENT_546	[p28l207t1367r498b1482],
2	T	NN	PERSON	t	_	0	SENT_546	[p28l524t1373r609b1476],
3	,	,	O	,	_	0	SENT_546	[p28l524t1373r609b1476],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_546	[p28l643t1367r827b1456],
5	DW	NNP	ORGANIZATION	DW	appos	2	SENT_546	[p28l854t1375r1054b1476],
6	,	,	O	,	_	0	SENT_546	[p28l854t1375r1054b1476],
7	Sordella	NNP	PERSON	Sordella	nn	8	SENT_546	[p28l1093t1367r1487b1457],
8	R	NNP	PERSON	R	appos	2	SENT_546	[p28l1512t1375r1611b1476],
9	,	,	O	,	_	0	SENT_546	[p28l1512t1375r1611b1476],
10	et	FW	O	et	nn	11	SENT_546	[p28l1649t1385r1736b1456],
11	al.	FW	O	al.	appos	2	SENT_546	[p28l1760t1367r1868b1457],
12	.	.	O	.	_	0	SENT_546	[p28l1760t1367r1868b1457],

1	Activating	VBG	O	activate	amod	2	SENT_547	[p28l1900t1367r2130b1456, p28l6t1518r309b1631],
2	mutations	NNS	O	mutation	_	0	SENT_547	[p28l356t1518r850b1607],
3	in	IN	O	in	_	0	SENT_547	[p28l901t1516r995b1605],
4	the	DT	O	the	det	7	SENT_547	[p28l1046t1516r1194b1605],
5	epidermal	JJ	O	epidermal	amod	7	SENT_547	[p28l1245t1516r1734b1631],
6	growth	NN	O	growth	nn	7	SENT_547	[p28l1783t1516r2133b1631],
7	factor	NN	O	factor	prep_in	2	SENT_547	[p28l12t1663r299b1755],
8	receptor	NN	O	receptor	nn	10	SENT_547	[p28l342t1683r754b1780],
9	underlying	VBG	O	underlie	amod	10	SENT_547	[p28l797t1665r1337b1780],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_547	[p28l1380t1667r2129b1780],
11	of	IN	O	of	_	0	SENT_547	[p28l12t1812r129b1904],
12	non	JJ	O	non	amod	16	SENT_547	[p28l156t1814r884b1904],
13	—	JJ	O	—	amod	16	SENT_547	[p28l156t1814r884b1904],
14	small-cell	NN	O	small-cell	nn	16	SENT_547	[p28l156t1814r884b1904],
15	lung	NN	O	lung	nn	16	SENT_547	[p28l929t1814r1151b1929],
16	cancer	NN	O	cancer	prep_of	10	SENT_547	[p28l1194t1844r1510b1903],
17	to	TO	O	to	_	0	SENT_547	[p28l1552t1832r1643b1904],
18	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_547	[p28l1690t1812r2126b1929],
19	.	.	O	.	_	0	SENT_547	[p28l1690t1812r2126b1929],

1	N	NN	O	n	nn	2	SENT_548	[p28l8t1971r95b2054],
2	EnglJ	NN	O	englj	nsubj	3	SENT_548	[p28l121t1963r404b2078],
3	Med	VBD	O	med	_	0	SENT_548	[p28l427t1963r641b2053],
4	2004	CD	DATE	2004	dobj	3	SENT_548	[p28l670t1969r1590b2072],
5	;	:	O	;	_	0	SENT_548	[p28l670t1969r1590b2072],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_548	[p28l670t1969r1590b2072],
7	—	CD	NUMBER	—	dep	4	SENT_548	[p28l670t1969r1590b2072],
8	39	CD	NUMBER	39	dep	7	SENT_548	[p28l670t1969r1590b2072],
9	.	.	O	.	_	0	SENT_548	[p28l670t1969r1590b2072],

1	7	CD	NUMBER	7	_	0	SENT_549	[p28l14t2124r89b2201],
2	.	.	O	.	_	0	SENT_549	[p28l14t2124r89b2201],

1	Pao	NNP	O	Pao	nn	2	SENT_550	[p28l207t2120r380b2202],
2	W	NNP	O	W	_	0	SENT_550	[p28l409t2120r530b2221],
3	,	,	O	,	_	0	SENT_550	[p28l409t2120r530b2221],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_550	[p28l565t2112r858b2201],
5	V	NNP	O	V	appos	2	SENT_550	[p28l884t2120r965b2221],
6	,	,	O	,	_	0	SENT_550	[p28l884t2120r965b2221],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_550	[p28l1000t2112r1469b2203],
8	M	NNP	O	M	appos	2	SENT_550	[p28l1497t2120r1623b2221],
9	,	,	O	,	_	0	SENT_550	[p28l1497t2120r1623b2221],
10	et	FW	O	et	nn	11	SENT_550	[p28l1662t2130r1750b2201],
11	al.	FW	O	al.	appos	2	SENT_550	[p28l1775t2112r1884b2202],
12	.	.	O	.	_	0	SENT_550	[p28l1775t2112r1884b2202],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_551	[p28l1921t2118r2130b2203],
2	receptor	NN	O	receptor	nn	4	SENT_551	[p28l12t2279r427b2376],
3	gene	NN	O	gene	nn	4	SENT_551	[p28l476t2291r712b2376],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_551	[p28l765t2263r1275b2352],
5	are	VBP	O	be	cop	6	SENT_551	[p28l1331t2291r1479b2350],
6	common	JJ	O	common	_	0	SENT_551	[p28l1534t2290r1981b2351],
7	in	IN	O	in	_	0	SENT_551	[p28l2034t2261r2130b2350],
8	lung	NN	O	lung	nn	9	SENT_551	[p28l10t2410r230b2525],
9	cancers	NNS	O	cancer	prep_in	6	SENT_551	[p28l265t2439r619b2499],
10	from	IN	O	from	_	0	SENT_551	[p28l659t2408r896b2500],
11	“	CD	NUMBER	“	prep_from	9	SENT_551	[p28l937t2414r1244b2501],
12	never	RB	O	never	advmod	9	SENT_551	[p28l937t2414r1244b2501],
13	smokers	NNS	O	smoker	dep	9	SENT_551	[p28l1279t2410r1734b2501],
14	”	CD	NUMBER	”	tmod	6	SENT_551	[p28l1279t2410r1734b2501],
15	and	CC	O	and	_	0	SENT_551	[p28l1777t2410r1954b2500],
16	are	VBP	O	be	auxpass	17	SENT_551	[p28l1991t2440r2133b2499],
17	associated	VBN	O	associate	conj_and	6	SENT_551	[p28l10t2559r512b2649],
18	With	IN	O	with	_	0	SENT_551	[p28l536t2559r753b2650],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_551	[p28l783t2559r1266b2674],
20	of	IN	O	of	_	0	SENT_551	[p28l1291t2557r1406b2649],
21	tumors	NNS	O	tumor	prep_of	19	SENT_551	[p28l1414t2577r1760b2650],
22	to	TO	O	to	aux	23	SENT_551	[p28l1793t2577r1882b2649],
23	geﬁ	VB	O	geﬁ	xcomp	17	SENT_551	[p28l1914t2557r2131b2674],
24	tinib	NN	O	tinib	dobj	23	SENT_551	[p28l12t2707r234b2796],
25	and	CC	O	and	_	0	SENT_551	[p28l265t2707r447b2796],
26	erlotinib	NN	O	erlotinib	conj_and	24	SENT_551	[p28l478t2707r918b2796],
27	.	.	O	.	_	0	SENT_551	[p28l478t2707r918b2796],

1	Proc	NNP	O	Proc	nn	7	SENT_552	[p28l953t2715r1170b2796],
2	Natl	NNP	O	Natl	nn	7	SENT_552	[p28l1196t2707r1404b2798],
3	Acad	NNP	O	Acad	nn	7	SENT_552	[p28l1429t2707r1673b2796],
4	Sci	NNP	O	Sci	nn	7	SENT_552	[p28l1706t2707r1842b2796],
5	U	NNP	O	U	nn	7	SENT_552	[p28l1870t2715r1950b2798],
6	S	NNP	O	S	nn	7	SENT_552	[p28l1981t2713r2031b2798],
7	A	NNP	O	A	_	0	SENT_552	[p28l2060t2715r2137b2796],

1	2004	CD	DATE	2004	_	0	SENT_553	[p28l12t2862r993b2965],
2	;	:	O	;	_	0	SENT_553	[p28l12t2862r993b2965],
3	101:13306	CD	NUMBER	101:13306	number	4	SENT_553	[p28l12t2862r993b2965],
4	—	CD	NUMBER	—	dep	1	SENT_553	[p28l12t2862r993b2965],
5	11	CD	NUMBER	11	dep	4	SENT_553	[p28l12t2862r993b2965],
6	.	.	O	.	_	0	SENT_553	[p28l12t2862r993b2965],

1	8	CD	NUMBER	8	_	0	SENT_554	[p28l10t3013r89b3096],
2	.	.	O	.	_	0	SENT_554	[p28l10t3013r89b3096],

1	Sordella	NN	O	sordellum	nn	2	SENT_555	[p28l212t3005r613b3095],
2	R	NN	O	r	nsubj	18	SENT_555	[p28l647t3013r747b3114],
3	,	,	O	,	_	0	SENT_555	[p28l647t3013r747b3114],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_555	[p28l789t3005r977b3094],
5	DW	NNP	ORGANIZATION	DW	appos	2	SENT_555	[p28l1012t3013r1212b3114],
6	,	,	O	,	_	0	SENT_555	[p28l1012t3013r1212b3114],
7	Haber	NNP	ORGANIZATION	Haber	nn	8	SENT_555	[p28l1255t3005r1562b3095],
8	DA	NNP	ORGANIZATION	DA	appos	2	SENT_555	[p28l1595t3013r1775b3114],
9	,	,	O	,	_	0	SENT_555	[p28l1595t3013r1775b3114],
10	Settleman	NNP	O	Settleman	nn	11	SENT_555	[p28l1821t3005r2129b3095, p28l12t3183r229b3243],
11	J.	NNP	O	J.	appos	2	SENT_555	[p28l273t3162r342b3259],
12	Geﬁtinib-sensitizing	JJ	O	geﬁtinib-sensitizing	amod	14	SENT_555	[p28l403t3152r1441b3269],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_555	[p28l1491t3160r1792b3249],
14	mutations	NNS	O	mutation	dep	11	SENT_555	[p28l1836t3172r2128b3245, p28l12t3303r257b3393],
15	in	IN	O	in	_	0	SENT_555	[p28l287t3303r384b3392],
16	lung	NN	O	lung	nn	17	SENT_555	[p28l411t3303r641b3418],
17	cancer	NN	O	cancer	prep_in	14	SENT_555	[p28l666t3332r993b3392],
18	activate	VBP	O	activate	_	0	SENT_555	[p28l1018t3303r1390b3394],
19	anti	JJ	O	anti	amod	22	SENT_555	[p28l1420t3305r2131b3418],
20	—	NN	O	—	nn	22	SENT_555	[p28l1420t3305r2131b3418],
21	apoptotic	JJ	O	apoptotic	amod	22	SENT_555	[p28l1420t3305r2131b3418],
22	pathways	NNS	O	pathway	dobj	18	SENT_555	[p28l10t3452r499b3567],
23	.	.	O	.	_	0	SENT_555	[p28l10t3452r499b3567],

1	Science	NNP	O	Science	_	0	SENT_556	[p28l538t3452r896b3542],
2	2004	CD	DATE	2004	num	1	SENT_556	[p28l925t3458r1784b3561],
3	;	:	O	;	_	0	SENT_556	[p28l925t3458r1784b3561],
4	305:1163	CD	NUMBER	305:1163	num	5	SENT_556	[p28l925t3458r1784b3561],
5	—	NN	O	—	dep	1	SENT_556	[p28l925t3458r1784b3561],
6	7	CD	NUMBER	7	dep	5	SENT_556	[p28l925t3458r1784b3561],
7	.	.	O	.	_	0	SENT_556	[p28l925t3458r1784b3561],

1	9	CD	NUMBER	9	_	0	SENT_557	[p28l10t3611r89b3690],
2	.	.	O	.	_	0	SENT_557	[p28l10t3611r89b3690],

1	Watanabe	NNP	PERSON	Watanabe	nn	2	SENT_558	[p28l205t3601r698b3691],
2	D	NNP	PERSON	D	_	0	SENT_558	[p28l728t3609r831b3710],
3	,	,	O	,	_	0	SENT_558	[p28l728t3609r831b3710],
4	Ezoe	NNP	PERSON	Ezoe	nn	5	SENT_558	[p28l868t3609r1105b3691],
5	S	NNP	O	S	appos	2	SENT_558	[p28l1139t3607r1220b3710],
6	,	,	O	,	_	0	SENT_558	[p28l1139t3607r1220b3710],
7	Fujimoto	NNP	PERSON	Fujimoto	nn	8	SENT_558	[p28l1255t3603r1704b3716],
8	M	NNP	O	M	appos	2	SENT_558	[p28l1734t3609r1860b3710],
9	,	,	O	,	_	0	SENT_558	[p28l1734t3609r1860b3710],
10	et	FW	O	et	nn	11	SENT_558	[p28l1900t3619r1989b3690],
11	al.	FW	O	al.	appos	2	SENT_558	[p28l2014t3601r2124b3691],
12	.	.	O	.	_	0	SENT_558	[p28l2014t3601r2124b3691],

1	Suppressor	NN	O	suppressor	_	0	SENT_559	[p29l14t31r574b140],
2	of	IN	O	of	_	0	SENT_559	[p29l627t23r743b115],
3	cytokine	NN	O	cytokine	nn	8	SENT_559	[p29l777t25r1191b140],
4	signalling	NN	O	signalling	nn	8	SENT_559	[p29l1248t25r1843b140],
5	—	NN	O	—	nn	8	SENT_559	[p29l1248t25r1843b140],
6	1	CD	NUMBER	1	num	8	SENT_559	[p29l1248t25r1843b140],
7	gene	NN	O	gene	nn	8	SENT_559	[p29l1898t54r2131b140],
8	silencing	NN	O	silencing	prep_of	1	SENT_559	[p29l14t174r465b289],
9	in	IN	O	in	_	0	SENT_559	[p29l514t174r607b263],
10	acute	JJ	O	acute	amod	12	SENT_559	[p29l660t192r918b265],
11	myeloid	JJ	O	myeloid	amod	12	SENT_559	[p29l970t174r1358b289],
12	leukaemia	NN	O	leukaemia	prep_in	8	SENT_559	[p29l1405t174r1906b265],
13	and	CC	O	and	_	0	SENT_559	[p29l1953t174r2132b264],
14	human	JJ	O	human	amod	17	SENT_559	[p29l12t323r356b414],
15	haematopoietic	JJ	O	haematopoietic	amod	17	SENT_559	[p29l394t323r1147b438],
16	cell	NN	O	cell	nn	17	SENT_559	[p29l1186t323r1350b412],
17	lines	NNS	O	line	prep_in	8	SENT_559	[p29l1386t323r1643b413],
18	.	.	O	.	_	0	SENT_559	[p29l1386t323r1643b413],

1	Br	NN	O	br	_	0	SENT_560	[p29l1686t331r1866b428],
2	]	CD	NUMBER	]	num	1	SENT_560	[p29l1686t331r1866b428],
3	Haematol	NNP	O	Haematol	dep	1	SENT_560	[p29l1902t331r2131b412, p29l12t472r291b562],
4	2004	CD	DATE	2004	num	3	SENT_560	[p29l320t478r1179b581],
5	;	:	O	;	_	0	SENT_560	[p29l320t478r1179b581],
6	126:726	CD	NUMBER	126:726	num	7	SENT_560	[p29l320t478r1179b581],
7	-35	CD	NUMBER	-35	dep	1	SENT_560	[p29l320t478r1179b581],
8	.	.	O	.	_	0	SENT_560	[p29l320t478r1179b581],

1	10	CD	NUMBER	10	_	0	SENT_561	[p29l16t629r147b711],
2	.	.	O	.	_	0	SENT_561	[p29l16t629r147b711],

1	O	NN	O	o	nn	5	SENT_562	[p29l209t621r589b711],
2	’	CD	NUMBER	’	num	5	SENT_562	[p29l209t621r589b711],
3	]	CD	NUMBER	]	num	5	SENT_562	[p29l209t621r589b711],
4	Brien	NNP	PERSON	Brien	nn	5	SENT_562	[p29l209t621r589b711],
5	SG	NNP	O	SG	nsubjpass	49	SENT_562	[p29l640t627r809b730],
6	,	,	O	,	_	0	SENT_562	[p29l640t627r809b730],
7	Guilhot	NNP	O	Guilhot	nn	8	SENT_562	[p29l866t621r1256b712],
8	F	NN	O	f	appos	5	SENT_562	[p29l1297t629r1370b730],
9	,	,	O	,	_	0	SENT_562	[p29l1297t629r1370b730],
10	Larson	NNP	PERSON	Larson	nn	11	SENT_562	[p29l1424t629r1766b711],
11	RA	NN	O	ra	appos	8	SENT_562	[p29l1813t629r1989b730],
12	,	,	O	,	_	0	SENT_562	[p29l1813t629r1989b730],
13	et	FW	O	et	nn	15	SENT_562	[p29l2046t639r2135b710],
14	al.	FW	O	al.	nn	15	SENT_562	[p29l10t770r123b860],
15	lmatinib	NN	O	lmatinib	appos	8	SENT_562	[p29l162t770r591b860],
16	compared	VBN	O	compare	_	0	SENT_562	[p29l627t770r1125b885],
17	with	IN	O	with	prepc_compared_with	15	SENT_562	[p29l1154t770r1378b861],
18	interferon	NN	O	interferon	pobj	15	SENT_562	[p29l1411t768r1916b860],
19	and	CC	O	and	_	0	SENT_562	[p29l1947t770r2131b860],
20	ic	JJ	O	ic	amod	21	SENT_562	[p29l14t1079r84b1157],
21	cancers	NNS	O	cancer	appos	8	SENT_562	[p29l114t1104r433b1157],
22	caused	VBN	O	cause	partmod	21	SENT_562	[p29l466t1079r757b1158],
23	by	IN	O	by	_	0	SENT_562	[p29l788t1079r885b1179],
24	activated	VBN	O	activate	amod	25	SENT_562	[p29l910t1078r1288b1158],
25	TKS	NN	O	tk	agent	22	SENT_562	[p29l1314t1084r1483b1160],
26	(	CD	NUMBER	(	num	29	SENT_562	[p29l1520t1079r1779b1170],
27	Table	NNP	O	Table	nn	29	SENT_562	[p29l1520t1079r1779b1170],
28	1	CD	NUMBER	1	num	29	SENT_562	[p29l1812t1084r1887b1170],
29	)	NN	O	)	nsubj	32	SENT_562	[p29l1812t1084r1887b1170],
30	is	VBZ	O	be	cop	32	SENT_562	[p29l1922t1079r1988b1157],
31	far	RB	O	far	advmod	32	SENT_562	[p29l2020t1078r2138b1157],
32	lower	JJR	O	lower	rcmod	25	SENT_562	[p29l13t1207r265b1302],
33	,	,	O	,	_	0	SENT_562	[p29l13t1207r265b1302],
34	and	CC	O	and	_	0	SENT_562	[p29l293t1206r447b1285],
35	strategies	NNS	O	strategy	appos	8	SENT_562	[p29l471t1207r864b1307],
36	to	TO	O	to	aux	37	SENT_562	[p29l890t1223r968b1285],
37	encourage	VB	O	encourage	infmod	35	SENT_562	[p29l992t1232r1424b1307],
38	the	DT	O	the	det	39	SENT_562	[p29l1447t1206r1574b1285],
39	development	NN	O	development	dobj	37	SENT_562	[p29l1598t1207r2141b1307],
40	of	IN	O	of	_	0	SENT_562	[p29l15t1334r117b1413],
41	therapeutic	JJ	O	therapeutic	amod	42	SENT_562	[p29l133t1335r625b1435],
42	agents	NNS	O	agent	prep_of	39	SENT_562	[p29l658t1351r939b1435],
43	targeting	VBG	O	target	partmod	42	SENT_562	[p29l976t1335r1376b1435],
44	uncommon	JJ	O	uncommon	amod	45	SENT_562	[p29l1408t1360r1912b1414],
45	subtypes	NNS	O	subtype	dobj	43	SENT_562	[p29l1948t1335r2132b1414, p29l15t1479r233b1563],
46	of	IN	O	of	_	0	SENT_562	[p29l264t1462r366b1541],
47	cancer	NN	O	cancer	prep_of	45	SENT_562	[p29l372t1488r646b1541],
48	are	VBP	O	be	auxpass	49	SENT_562	[p29l667t1489r793b1541],
49	needed	VBN	O	need	_	0	SENT_562	[p29l819t1462r1143b1541],
50	.	.	O	.	_	0	SENT_562	[p29l819t1462r1143b1541],

1	Finally	RB	O	finally	advmod	19	SENT_563	[p29l141t1590r438b1691],
2	,	,	O	,	_	0	SENT_563	[p29l141t1590r438b1691],
3	some	DT	O	some	det	4	SENT_563	[p29l474t1616r698b1669],
4	compromise	NN	O	compromise	nsubj	19	SENT_563	[p29l729t1591r1261b1691],
5	among	IN	O	among	_	0	SENT_563	[p29l1290t1616r1590b1691],
6	the	DT	O	the	det	8	SENT_563	[p29l1616t1591r1744b1669],
7	pharmaceutical	JJ	O	pharmaceutical	amod	8	SENT_563	[p29l1773t1591r2135b1691, p29l15t1719r334b1798],
8	industry	NN	O	industry	prep_among	4	SENT_563	[p29l356t1718r718b1819],
9	,	,	O	,	_	0	SENT_563	[p29l356t1718r718b1819],
10	government	NN	O	government	prep_among	4	SENT_563	[p29l746t1735r1278b1819],
11	,	,	O	,	_	0	SENT_563	[p29l746t1735r1278b1819],
12	and	CC	O	and	_	0	SENT_563	[p29l1306t1719r1462b1797],
13	third	JJ	ORDINAL	third	amod	16	SENT_563	[p29l1485t1718r1942b1819],
14	—	NN	O	—	nn	16	SENT_563	[p29l1485t1718r1942b1819],
15	party	NN	O	party	nn	16	SENT_563	[p29l1485t1718r1942b1819],
16	payers	NNS	O	payer	prep_among	4	SENT_563	[p29l1959t1745r2135b1819, p29l15t1873r134b1925],
17	Will	MD	O	will	aux	19	SENT_563	[p29l158t1846r314b1926],
18	be	VB	O	be	cop	19	SENT_563	[p29l341t1847r435b1925],
19	necessary	JJ	O	necessary	_	0	SENT_563	[p29l462t1872r870b1947],
20	with	IN	O	with	_	0	SENT_563	[p29l887t1847r1076b1926],
21	respect	NN	O	respect	prep_with	19	SENT_563	[p29l1102t1863r1407b1947],
22	to	TO	O	to	_	0	SENT_563	[p29l1428t1863r1507b1925],
23	the	DT	O	the	det	24	SENT_563	[p29l1535t1846r1664b1925],
24	expense	NN	O	expense	prep_to	19	SENT_563	[p29l1691t1872r2027b1947],
25	of	IN	O	of	_	0	SENT_563	[p29l2054t1846r2154b1925],
26	TK	NN	O	tk	prep_of	24	SENT_563	[p29l11t1975r514b2075],
27	—	CD	NUMBER	—	num	26	SENT_563	[p29l11t1975r514b2075],
28	targeted	VBN	O	target	partmod	26	SENT_563	[p29l11t1975r514b2075],
29	therapies	NNS	O	therapy	dobj	28	SENT_563	[p29l552t1975r962b2075],
30	,	,	O	,	_	0	SENT_563	[p29l552t1975r962b2075],
31	each	DT	O	each	nsubjpass	35	SENT_563	[p29l1007t1975r1197b2053],
32	of	IN	O	of	_	0	SENT_563	[p29l1236t1974r1336b2053],
33	which	WDT	O	which	prep_of	31	SENT_563	[p29l1351t1974r1612b2054],
34	is	VBZ	O	be	auxpass	35	SENT_563	[p29l1650t1975r1715b2053],
35	priced	VBN	O	price	rcmod	29	SENT_563	[p29l1753t1975r2017b2075],
36	to	TO	O	to	aux	37	SENT_563	[p29l2056t1991r2135b2053],
37	generate	VB	O	generate	xcomp	35	SENT_563	[p29l14t2118r381b2202],
38	annual	JJ	SET	annual	amod	39	SENT_563	[p29l418t2102r711b2181],
39	revenues	NNS	O	revenue	dobj	37	SENT_563	[p29l748t2128r1122b2181],
40	of	IN	O	of	_	0	SENT_563	[p29l1162t2101r1264b2180],
41	$	$	MONEY	$	dep	44	SENT_563	[p29l1285t2099r1630b2197],
42	20,000	CD	MONEY	20,000	number	44	SENT_563	[p29l1285t2099r1630b2197],
43	to	TO	O	to	dep	44	SENT_563	[p29l1668t2118r1748b2180],
44	$	$	MONEY	$	prep_of	39	SENT_563	[p29l1789t2099r2134b2197],
45	30,000	CD	MONEY	30,000	number	44	SENT_563	[p29l1789t2099r2134b2197],
46	per	IN	O	per	_	0	SENT_563	[p29l13t2257r153b2331],
47	patient	NN	O	patient	prep_per	44	SENT_563	[p29l177t2231r494b2331],
48	.	.	O	.	_	0	SENT_563	[p29l177t2231r494b2331],

1	Limiting	VBG	O	limit	csubj	18	SENT_564	[p29l524t2231r890b2331],
2	targeted	VBN	O	target	dep	1	SENT_564	[p29l912t2231r1257b2331],
3	therapies	NNS	O	therapy	dobj	2	SENT_564	[p29l1283t2231r1667b2331],
4	to	TO	O	to	_	0	SENT_564	[p29l1695t2247r1774b2309],
5	patients	NNS	O	patient	prep_to	2	SENT_564	[p29l1800t2231r2134b2331],
6	identiﬁed	VBN	O	identiﬁed	partmod	5	SENT_564	[p29l14t2358r417b2437],
7	by	IN	O	by	_	0	SENT_564	[p29l441t2359r538b2459],
8	molecular	JJ	O	molecular	amod	9	SENT_564	[p29l557t2359r983b2438],
9	profiling	NN	O	profiling	agent	6	SENT_564	[p29l1003t2358r1378b2459],
10	as	IN	O	as	_	0	SENT_564	[p29l1399t2385r1483b2437],
11	those	DT	O	those	prep_as	6	SENT_564	[p29l1509t2359r1735b2437],
12	who	WP	O	who	nsubj	14	SENT_564	[p29l1756t2359r1939b2438],
13	may	MD	O	may	aux	14	SENT_564	[p29l1964t2385r2140b2459],
14	have	VB	O	have	rcmod	11	SENT_564	[p29l14t2486r202b2566],
15	a	DT	O	a	det	16	SENT_564	[p29l229t2513r273b2565],
16	response	NN	O	response	dobj	14	SENT_564	[p29l299t2512r678b2587],
17	would	MD	O	would	aux	18	SENT_564	[p29l701t2486r966b2566],
18	help	VB	O	help	_	0	SENT_564	[p29l993t2487r1174b2587],
19	control	VB	O	control	xcomp	18	SENT_564	[p29l1203t2486r1506b2565],
20	costs	NNS	O	cost	dobj	19	SENT_564	[p29l1533t2503r1769b2582],
21	,	,	O	,	_	0	SENT_564	[p29l1533t2503r1769b2582],
22	but	CC	O	but	_	0	SENT_564	[p29l1802t2487r1943b2566],
23	ultimately	RB	O	ultimately	advmod	28	SENT_564	[p29l1965t2487r2135b2566, p29l14t2614r300b2715],
24	We	PRP	O	we	nsubj	28	SENT_564	[p29l315t2641r435b2694],
25	may	MD	O	may	aux	28	SENT_564	[p29l460t2641r639b2715],
26	not	RB	O	not	neg	28	SENT_564	[p29l659t2631r804b2693],
27	be	VB	O	be	cop	28	SENT_564	[p29l824t2614r921b2693],
28	able	JJ	O	able	conj_but	18	SENT_564	[p29l945t2614r1121b2693],
29	to	TO	O	to	aux	30	SENT_564	[p29l1146t2631r1225b2693],
30	afford	VB	O	afford	xcomp	28	SENT_564	[p29l1252t2614r1513b2693],
31	a	DT	O	a	det	32	SENT_564	[p29l1537t2641r1581b2693],
32	pharmacy	NN	O	pharmacy	dobj	30	SENT_564	[p29l1603t2615r2031b2715],
33	of	IN	O	of	_	0	SENT_564	[p29l2052t2614r2153b2693],
34	such	JJ	O	such	amod	35	SENT_564	[p29l16t2743r213b2822],
35	drugs	NNS	O	drug	prep_of	32	SENT_564	[p29l247t2743r515b2843],
36	,	,	O	,	_	0	SENT_564	[p29l247t2743r515b2843],
37	which	WDT	O	which	nsubjpass	41	SENT_564	[p29l550t2742r814b2822],
38	often	RB	O	often	advmod	41	SENT_564	[p29l849t2742r1069b2821],
39	must	MD	O	must	aux	41	SENT_564	[p29l1103t2759r1323b2822],
40	be	VB	O	be	auxpass	41	SENT_564	[p29l1352t2743r1449b2821],
41	combined	VBN	O	combine	dep	28	SENT_564	[p29l1484t2742r1913b2821],
42	with	IN	O	with	_	0	SENT_564	[p29l1943t2743r2135b2822],
43	other	JJ	O	other	amod	45	SENT_564	[p29l15t2871r238b2949],
44	expensive	JJ	O	expensive	amod	45	SENT_564	[p29l264t2871r670b2971],
45	treatments	NNS	O	treatment	prep_with	41	SENT_564	[p29l698t2887r1148b2949],
46	and	CC	O	and	_	0	SENT_564	[p29l1177t2870r1332b2949],
47	which	WDT	O	which	nsubj	54	SENT_564	[p29l1355t2871r1615b2950],
48	in	IN	O	in	_	0	SENT_564	[p29l1642t2871r1723b2948],
49	some	DT	O	some	det	50	SENT_564	[p29l1752t2896r1976b2949],
50	patients	NNS	O	patient	prep_in	54	SENT_564	[p29l2002t2897r2135b2971, p29l15t2999r244b3077],
51	with	IN	O	with	_	0	SENT_564	[p29l278t2999r467b3078],
52	cancer	NN	O	cancer	prep_with	50	SENT_564	[p29l504t3024r778b3077],
53	may	MD	O	may	aux	54	SENT_564	[p29l812t3025r988b3099],
54	offer	VB	O	offer	dep	28	SENT_564	[p29l1021t2998r1222b3077],
55	only	RB	O	only	advmod	58	SENT_564	[p29l1256t2999r1437b3099],
56	modest	JJ	O	modest	amod	58	SENT_564	[p29l1468t2998r1786b3077],
57	survival	NN	O	survival	nn	58	SENT_564	[p29l1819t2999r2136b3078],
58	beneﬁts	NNS	O	beneﬁts	dobj	54	SENT_564	[p29l15t3127r372b3206],
59	.	.	O	.	_	0	SENT_564	[p29l15t3127r372b3206],

1	Supported	VBN	O	support	_	0	SENT_565	[p30l101t33r428b108],
2	in	IN	O	in	_	0	SENT_565	[p30l455t34r516b91],
3	part	NN	O	part	prep_in	1	SENT_565	[p30l543t46r673b108],
4	by	IN	O	by	_	0	SENT_565	[p30l697t33r770b108],
5	grants	NNS	O	grant	prep_by	1	SENT_565	[p30l794t46r992b109],
6	(	VBP	O	(	dep	1	SENT_565	[p30l1025t38r1338b101],
7	CA90576	NN	O	ca90576	dobj	6	SENT_565	[p30l1025t38r1338b101],
8	and	CC	O	and	_	0	SENT_565	[p30l1366t33r1483b92],
9	HL56949	NN	O	hl56949	dobj	6	SENT_565	[p30l1510t38r1825b101],
10	)	CD	NUMBER	)	nsubj	1	SENT_565	[p30l1510t38r1825b101],
11	from	IN	O	from	_	0	SENT_565	[p30l1857t33r2012b92],
12	the	DT	O	the	det	23	SENT_565	[p30l2040t33r2137b92],
13	National	NNP	ORGANIZATION	National	dep	23	SENT_565	[p30l11t119r287b178],
14	Institutes	NNPS	ORGANIZATION	Institutes	dep	13	SENT_565	[p30l310t119r605b178],
15	of	IN	ORGANIZATION	of	_	0	SENT_565	[p30l632t118r707b177],
16	Health	NNP	ORGANIZATION	Health	prep_of	13	SENT_565	[p30l717t119r930b177],
17	and	CC	O	and	_	0	SENT_565	[p30l953t118r1070b177],
18	a	DT	O	a	det	20	SENT_565	[p30l1094t138r1127b177],
19	Specialized	NNP	O	Specialized	nn	20	SENT_565	[p30l1153t118r1506b194],
20	Center	NNP	O	Center	prep_of	13	SENT_565	[p30l1530t123r1742b177],
21	of	IN	O	of	_	0	SENT_565	[p30l1764t118r1840b177],
22	Research	NNP	O	Research	prep_of	20	SENT_565	[p30l1849t118r2137b181],
23	grant	NN	O	grant	prep_from	10	SENT_565	[p30l13t216r184b279],
24	from	IN	O	from	_	0	SENT_565	[p30l198t203r354b262],
25	the	DT	O	the	det	29	SENT_565	[p30l373t203r470b262],
26	Leukemia	NN	O	leukemia	nn	29	SENT_565	[p30l488t203r798b263],
27	and	CC	O	and	_	0	SENT_565	[p30l815t203r931b262],
28	Lymphoma	NN	ORGANIZATION	lymphoma	nn	29	SENT_565	[p30l949t203r1311b279],
29	Society	NN	ORGANIZATION	society	prep_from	23	SENT_565	[p30l1331t204r1560b279],
30	.	.	O	.	_	0	SENT_565	[p30l1331t204r1560b279],

1	We	PRP	O	we	nsubj	3	SENT_566	[p30l96t294r197b347],
2	are	VBP	O	be	cop	3	SENT_566	[p30l224t308r318b347],
3	indebted	JJ	O	indebted	_	0	SENT_566	[p30l346t288r623b347],
4	to	TO	O	to	_	0	SENT_566	[p30l651t301r711b347],
5	Drs.	NNP	O	Drs.	nn	8	SENT_566	[p30l739t293r868b347],
6	Nicholas	NNP	PERSON	Nicholas	nn	8	SENT_566	[p30l899t288r1180b347],
7	C.P.	NNP	PERSON	C.P.	nn	8	SENT_566	[p30l1209t293r1326b347],
8	Cross	NNP	PERSON	Cross	prep_to	3	SENT_566	[p30l1358t293r1555b360],
9	,	,	O	,	_	0	SENT_566	[p30l1358t293r1555b360],
10	James	NNP	PERSON	James	nn	12	SENT_566	[p30l1579t294r1772b356],
11	D.	NNP	PERSON	D.	nn	12	SENT_566	[p30l1800t293r1867b347],
12	Grifﬁn	NNP	PERSON	Grifﬁn	prep_to	3	SENT_566	[p30l1899t288r2132b360],
13	,	,	O	,	_	0	SENT_566	[p30l1899t288r2132b360],
14	John	NNP	PERSON	John	nn	16	SENT_566	[p30l6t374r160b442],
15	M.	NNP	PERSON	M.	nn	16	SENT_566	[p30l172t379r255b432],
16	Goldman	NNP	PERSON	Goldman	conj_and	8	SENT_566	[p30l274t373r592b445],
17	,	,	O	,	_	0	SENT_566	[p30l274t373r592b445],
18	and	CC	O	and	_	0	SENT_566	[p30l611t373r728b432],
19	Daniel	NNP	PERSON	Daniel	nn	20	SENT_566	[p30l743t373r949b432],
20	Haber	NNP	PERSON	Haber	conj_and	8	SENT_566	[p30l964t373r1161b432],
21	for	IN	O	for	_	0	SENT_566	[p30l1174t373r1266b432],
22	critically	RB	O	critically	advmod	23	SENT_566	[p30l1280t373r1549b449],
23	reading	VBG	O	read	prepc_for	3	SENT_566	[p30l1561t373r1804b449],
24	the	DT	O	the	det	25	SENT_566	[p30l1818t374r1914b432],
25	manuscript	NN	O	manuscript	dobj	23	SENT_566	[p30l1930t393r2136b433, p30l15t459r207b534],
26	.	.	O	.	_	0	SENT_566	[p30l1930t393r2136b433, p30l15t459r207b534],

1	Because	IN	O	because	_	0	SENT_567	[p30l235t463r491b518],
2	of	IN	O	of	prepc_because_of	8	SENT_567	[p30l516t458r591b517],
3	space	NN	O	space	nn	4	SENT_567	[p30l604t478r777b534],
4	constraints	NNS	O	constraint	pobj	8	SENT_567	[p30l802t459r1172b530],
5	,	,	O	,	_	0	SENT_567	[p30l802t459r1172b530],
6	we	PRP	O	we	nsubj	8	SENT_567	[p30l1198t478r1287b518],
7	were	VBD	O	be	cop	8	SENT_567	[p30l1309t478r1460b518],
8	unable	JJ	O	unable	_	0	SENT_567	[p30l1485t458r1698b518],
9	to	TO	O	to	aux	10	SENT_567	[p30l1723t471r1782b517],
10	cite	VB	O	cite	xcomp	8	SENT_567	[p30l1809t459r1917b517],
11	all	PDT	O	all	predet	14	SENT_567	[p30l1941t458r2016b517],
12	the	DT	O	the	det	14	SENT_567	[p30l2040t458r2137b517],
13	relevant	JJ	O	relevant	amod	14	SENT_567	[p30l13t544r265b603],
14	articles	NNS	O	article	dobj	10	SENT_567	[p30l279t545r504b603],
15	in	IN	O	in	_	0	SENT_567	[p30l524t545r585b602],
16	this	DT	O	this	det	17	SENT_567	[p30l604t544r718b603],
17	ﬁeld	NN	O	ﬁeld	prep_in	10	SENT_567	[p30l738t544r894b603],
18	.	.	O	.	_	0	SENT_567	[p30l738t544r894b603],

1	low-dose	JJ	O	low-dose	amod	2	SENT_568	[p30l12t748r233b792],
2	cytarabine	NN	O	cytarabine	nsubj	5	SENT_568	[p30l259t748r509b804],
3	for	IN	O	for	prep	2	SENT_568	[p30l534t747r605b792],
4	newly	RB	O	newly	pcomp	3	SENT_568	[p30l628t748r770b804],
5	diagnosed	VBN	O	diagnose	_	0	SENT_568	[p30l792t748r1043b804],
6	chronic-phase	JJ	O	chronic-phase	amod	8	SENT_568	[p30l13t819r361b875],
7	myeloid	JJ	O	myeloid	amod	8	SENT_568	[p30l386t819r580b875],
8	leukemia	NN	O	leukemia	dobj	5	SENT_568	[p30l604t819r840b863],
9	.	.	O	.	_	0	SENT_568	[p30l604t819r840b863],

1	N	NN	O	n	nn	3	SENT_569	[p30l867t823r909b863],
2	Engl	NNP	O	Engl	nn	3	SENT_569	[p30l932t819r1043b875],
3	J	NNP	O	J	nsubj	4	SENT_569	[p30l7t894r28b941],
4	Med	VBD	O	med	_	0	SENT_569	[p30l41t890r148b934],
5	2003	CD	DATE	2003	dobj	4	SENT_569	[p30l163t893r651b943],
6	;	:	O	;	_	0	SENT_569	[p30l163t893r651b943],
7	348:994	CD	NUMBER	348:994	num	8	SENT_569	[p30l163t893r651b943],
8	-1004	CD	NUMBER	-1004	dep	5	SENT_569	[p30l163t893r651b943],
9	.	.	O	.	_	0	SENT_569	[p30l163t893r651b943],

1	11	CD	NUMBER	11	_	0	SENT_570	[p30l14t966r78b1005],
2	.	.	O	.	_	0	SENT_570	[p30l14t966r78b1005],

1	Druker	NNP	PERSON	Druker	nn	2	SENT_571	[p30l108t961r280b1006],
2	BJ	NNP	O	BJ	_	0	SENT_571	[p30l299t965r363b1014],
3	,	,	O	,	_	0	SENT_571	[p30l299t965r363b1014],
4	Sawyers	NNP	ORGANIZATION	Sawyers	nn	5	SENT_571	[p30l390t964r581b1017],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_571	[p30l605t964r683b1014],
6	,	,	O	,	_	0	SENT_571	[p30l605t964r683b1014],
7	Kantarjian	JJ	O	kantarjian	amod	8	SENT_571	[p30l708t961r963b1017],
8	H	NN	O	h	appos	2	SENT_571	[p30l985t965r1040b1014],
9	,	,	O	,	_	0	SENT_571	[p30l985t965r1040b1014],
10	et	FW	O	et	nn	11	SENT_571	[p30l13t1041r56b1076],
11	al.	FW	O	al.	appos	2	SENT_571	[p30l74t1032r128b1076],
12	.	.	O	.	_	0	SENT_571	[p30l74t1032r128b1076],

1	Activity	NN	O	activity	_	0	SENT_572	[p30l151t1032r331b1088],
2	of	IN	O	of	_	0	SENT_572	[p30l350t1031r407b1076],
3	a	DT	O	a	det	5	SENT_572	[p30l418t1046r443b1076],
4	speciﬁc	NN	O	speciﬁc	nn	5	SENT_572	[p30l464t1031r647b1088],
5	inhibitor	NN	O	inhibitor	prep_of	1	SENT_572	[p30l667t1032r882b1076],
6	of	IN	O	of	_	0	SENT_572	[p30l902t1031r959b1076],
7	the	DT	O	the	det	8	SENT_572	[p30l970t1032r1044b1076],
8	BCR	NN	O	bcr	prep_of	1	SENT_572	[p30l12t1106r235b1150],
9	.	.	O	.	_	0	SENT_572	[p30l12t1106r235b1150],

1	—	NN	O	—	_	0	SENT_573	[p30l12t1106r235b1150],
2	.	.	O	.	_	0	SENT_573	[p30l12t1106r235b1150],

1	ABL	NN	ORGANIZATION	abl	nn	3	SENT_574	[p30l12t1106r235b1150],
2	tyrosine	NN	O	tyrosine	nn	3	SENT_574	[p30l254t1103r441b1159],
3	kinase	NN	O	kinase	_	0	SENT_574	[p30l461t1103r613b1147],
4	in	IN	O	in	_	0	SENT_574	[p30l632t1103r677b1146],
5	the	DT	O	the	det	7	SENT_574	[p30l697t1103r770b1147],
6	blast	NN	O	blast	nn	7	SENT_574	[p30l790t1103r904b1147],
7	crisis	NN	O	crisis	prep_in	3	SENT_574	[p30l921t1103r1043b1147],
8	of	IN	O	of	_	0	SENT_574	[p30l13t1173r69b1218],
9	chronic	JJ	O	chronic	amod	11	SENT_574	[p30l74t1174r253b1218],
10	myeloid	JJ	O	myeloid	amod	11	SENT_574	[p30l267t1174r455b1230],
11	leukemia	NN	O	leukemia	prep_of	3	SENT_574	[p30l469t1174r687b1219],
12	and	CC	O	and	_	0	SENT_574	[p30l700t1174r787b1218],
13	acute	JJ	O	acute	amod	15	SENT_574	[p30l801t1183r924b1218],
14	lymphoblastic	JJ	O	lymphoblastic	amod	15	SENT_574	[p30l939t1174r1044b1230, p30l12t1245r259b1301],
15	leukemia	NN	O	leukemia	conj_and	11	SENT_574	[p30l283t1245r500b1290],
16	with	IN	O	with	_	0	SENT_574	[p30l521t1245r627b1289],
17	the	DT	O	the	det	19	SENT_574	[p30l652t1245r724b1289],
18	Philadelphia	NNP	LOCATION	Philadelphia	nn	19	SENT_574	[p30l749t1245r1045b1301],
19	chromosome	NN	O	chromosome	prep_with	3	SENT_574	[p30l13t1316r340b1360],
20	.	.	O	.	_	0	SENT_574	[p30l13t1316r340b1360],

1	N	NN	O	n	nsubj	2	SENT_575	[p30l354t1320r396b1360],
2	EnglJMed	VBD	O	engljm	_	0	SENT_575	[p30l407t1316r657b1372],
3	2001	CD	DATE	2001	dobj	2	SENT_575	[p30l669t1319r1044b1369, p30l12t1390r82b1431],
4	;	:	O	;	_	0	SENT_575	[p30l669t1319r1044b1369, p30l12t1390r82b1431],
5	344:103842	CD	NUMBER	344:103842	dep	3	SENT_575	[p30l669t1319r1044b1369, p30l12t1390r82b1431],
6	.	.	O	.	_	0	SENT_575	[p30l669t1319r1044b1369, p30l12t1390r82b1431],

1	[	NNP	O	[	_	0	SENT_576	[p30l104t1391r328b1440],
2	Erratum	NNP	O	Erratum	nn	5	SENT_576	[p30l104t1391r328b1440],
3	,	,	O	,	_	0	SENT_576	[p30l104t1391r328b1440],
4	N	NNP	O	N	appos	5	SENT_576	[p30l343t1391r385b1431],
5	EnglJMed	NNP	O	EnglJMed	dep	1	SENT_576	[p30l398t1387r651b1443],
6	2001	CD	DATE	2001	rcmod	5	SENT_576	[p30l665t1390r1023b1440],
7	;	:	O	;	_	0	SENT_576	[p30l665t1390r1023b1440],
8	345:232	CD	NUMBER	345:232	dep	6	SENT_576	[p30l665t1390r1023b1440],
9	.	.	O	.	_	0	SENT_576	[p30l665t1390r1023b1440],
10	]	SYM	O	]	dep	6	SENT_576	[p30l665t1390r1023b1440],

1	12	CD	NUMBER	12	_	0	SENT_577	[p30l14t1463r78b1502],
2	.	.	O	.	_	0	SENT_577	[p30l14t1463r78b1502],

1	Shah	NNP	O	Shah	nn	2	SENT_578	[p30l110t1458r227b1502],
2	NP	NNP	O	NP	_	0	SENT_578	[p30l239t1462r319b1511],
3	,	,	O	,	_	0	SENT_578	[p30l239t1462r319b1511],
4	Tran	NNP	ORGANIZATION	Tran	nn	5	SENT_578	[p30l333t1461r445b1502],
5	C	NNP	ORGANIZATION	C	appos	2	SENT_578	[p30l458t1461r505b1511],
6	,	,	O	,	_	0	SENT_578	[p30l458t1461r505b1511],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_578	[p30l521t1462r601b1502],
8	FY	NNP	O	FY	appos	5	SENT_578	[p30l614t1462r681b1511],
9	,	,	O	,	_	0	SENT_578	[p30l614t1462r681b1511],
10	Chen	NNP	PERSON	Chen	nn	11	SENT_578	[p30l697t1458r823b1502],
11	P	NN	PERSON	p	appos	5	SENT_578	[p30l836t1462r872b1511],
12	,	,	O	,	_	0	SENT_578	[p30l836t1462r872b1511],
13	Norris	NNP	ORGANIZATION	Norris	nn	14	SENT_578	[p30l887t1458r1042b1502],
14	D	NNP	ORGANIZATION	D	appos	5	SENT_578	[p30l12t1533r63b1582],
15	,	,	O	,	_	0	SENT_578	[p30l12t1533r63b1582],
16	Sawyers	NNP	ORGANIZATION	Sawyers	nn	17	SENT_578	[p30l86t1532r279b1585],
17	CL	NN	ORGANIZATION	cl	appos	5	SENT_578	[p30l298t1532r377b1573],
18	.	.	O	.	_	0	SENT_578	[p30l298t1532r377b1573],

1	Overriding	JJ	O	overriding	amod	3	SENT_579	[p30l399t1529r667b1585],
2	imatinib	NN	O	imatinib	nn	3	SENT_579	[p30l683t1529r890b1573],
3	resistance	NN	O	resistance	_	0	SENT_579	[p30l910t1530r1042b1573, p30l13t1609r138b1644],
4	with	IN	O	with	_	0	SENT_579	[p30l151t1600r255b1645],
5	a	DT	O	a	det	9	SENT_579	[p30l271t1614r296b1644],
6	novel	JJ	O	novel	amod	9	SENT_579	[p30l311t1600r434b1644],
7	ABL	NN	ORGANIZATION	abl	nn	9	SENT_579	[p30l447t1604r547b1644],
8	kinase	NN	O	kinase	nn	9	SENT_579	[p30l561t1600r710b1644],
9	inhibitor	NN	O	inhibitor	prep_with	3	SENT_579	[p30l726t1600r940b1644],
10	.	.	O	.	_	0	SENT_579	[p30l726t1600r940b1644],

1	Science	NNP	O	Science	_	0	SENT_580	[p30l960t1600r1043b1644, p30l13t1685r117b1715],
2	2004	CD	DATE	2004	num	1	SENT_580	[p30l130t1674r576b1724],
3	;	:	O	;	_	0	SENT_580	[p30l130t1674r576b1724],
4	305:399	CD	NUMBER	305:399	number	5	SENT_580	[p30l130t1674r576b1724],
5	-401	CD	NUMBER	-401	dep	1	SENT_580	[p30l130t1674r576b1724],
6	.	.	O	.	_	0	SENT_580	[p30l130t1674r576b1724],

1	13	CD	NUMBER	13	_	0	SENT_581	[p30l14t1747r78b1786],
2	.	.	O	.	_	0	SENT_581	[p30l14t1747r78b1786],

1	Golub	NNP	ORGANIZATION	Golub	nn	2	SENT_582	[p30l109t1742r255b1786],
2	TR	NN	ORGANIZATION	tr	_	0	SENT_582	[p30l267t1745r350b1795],
3	,	,	O	,	_	0	SENT_582	[p30l267t1745r350b1795],
4	Goga	NNP	PERSON	Goga	nn	5	SENT_582	[p30l366t1745r494b1798],
5	A	NNP	O	A	appos	2	SENT_582	[p30l505t1746r553b1795],
6	,	,	O	,	_	0	SENT_582	[p30l505t1746r553b1795],
7	Barker	NNP	PERSON	Barker	nn	8	SENT_582	[p30l569t1742r727b1787],
8	GF	NN	O	gf	appos	2	SENT_582	[p30l739t1745r815b1795],
9	,	,	O	,	_	0	SENT_582	[p30l739t1745r815b1795],
10	et	FW	O	et	nn	11	SENT_582	[p30l832t1751r875b1786],
11	al.	FW	O	al.	appos	2	SENT_582	[p30l885t1742r938b1786],
12	.	.	O	.	_	0	SENT_582	[p30l885t1742r938b1786],

1	Oligomerization	NN	O	oligomerization	_	0	SENT_583	[p30l955t1742r1043b1786, p30l12t1813r336b1869],
2	of	IN	O	of	_	0	SENT_583	[p30l351t1812r408b1857],
3	the	DT	O	the	det	6	SENT_583	[p30l413t1813r487b1857],
4	ABL	NNP	ORGANIZATION	ABL	nn	6	SENT_583	[p30l500t1817r601b1857],
5	tyrosine	NN	O	tyrosine	nn	6	SENT_583	[p30l615t1813r807b1869],
6	kinase	NN	O	kinase	prep_of	1	SENT_583	[p30l821t1813r976b1858],
7	by	IN	O	by	_	0	SENT_583	[p30l991t1813r1046b1869],
8	the	DT	O	the	det	11	SENT_583	[p30l13t1884r86b1928],
9	Ets	NN	O	et	nn	11	SENT_583	[p30l98t1888r171b1928],
10	protein	NN	O	protein	nn	11	SENT_583	[p30l184t1884r356b1940],
11	TEL	NN	O	tel	prep_by	1	SENT_583	[p30l366t1887r461b1927],
12	in	IN	O	in	_	0	SENT_583	[p30l471t1884r517b1927],
13	human	JJ	O	human	amod	14	SENT_583	[p30l529t1884r696b1928],
14	leukemia	NN	O	leukemia	prep_in	1	SENT_583	[p30l708t1884r937b1928],
15	.	.	O	.	_	0	SENT_583	[p30l708t1884r937b1928],

1	Mol	NNP	O	Mol	nn	3	SENT_584	[p30l950t1884r1044b1928],
2	Cell	NNP	O	Cell	nn	3	SENT_584	[p30l13t1955r103b1999],
3	Biol	NNP	O	Biol	_	0	SENT_584	[p30l116t1955r210b1999],
4	1996	CD	DATE	1996	num	3	SENT_584	[p30l226t1958r642b2008],
5	;	:	O	;	_	0	SENT_584	[p30l226t1958r642b2008],
6	16:4107	CD	NUMBER	16:4107	number	7	SENT_584	[p30l226t1958r642b2008],
7	-16	CD	NUMBER	-16	dep	3	SENT_584	[p30l226t1958r642b2008],
8	.	.	O	.	_	0	SENT_584	[p30l226t1958r642b2008],

1	14	CD	NUMBER	14	_	0	SENT_585	[p30l14t2031r78b2070],
2	.	.	O	.	_	0	SENT_585	[p30l14t2031r78b2070],

1	O’Brien	NNP	O	O’Brien	nn	2	SENT_586	[p30l109t2026r295b2070],
2	SG	NNP	O	SG	_	0	SENT_586	[p30l310t2029r392b2079],
3	,	,	O	,	_	0	SENT_586	[p30l310t2029r392b2079],
4	Vieira	NNP	ORGANIZATION	Vieira	nn	5	SENT_586	[p30l407t2026r547b2070],
5	SA	NNP	ORGANIZATION	SA	appos	2	SENT_586	[p30l562t2029r637b2079],
6	,	,	O	,	_	0	SENT_586	[p30l562t2029r637b2079],
7	Connors	NNP	PERSON	Connors	nn	8	SENT_586	[p30l654t2029r860b2070],
8	S	NNP	O	S	appos	2	SENT_586	[p30l876t2029r916b2079],
9	,	,	O	,	_	0	SENT_586	[p30l876t2029r916b2079],
10	et	FW	O	et	nn	11	SENT_586	[p30l933t2035r976b2070],
11	al.	FW	O	al.	appos	2	SENT_586	[p30l987t2026r1041b2070],
12	.	.	O	.	_	0	SENT_586	[p30l987t2026r1041b2070],

1	Transient	JJ	O	transient	amod	2	SENT_587	[p30l11t2097r243b2141],
2	response	NN	O	response	_	0	SENT_587	[p30l272t2111r489b2153],
3	to	TO	O	to	_	0	SENT_587	[p30l521t2106r566b2141],
4	imatinib	NN	O	imatinib	nn	5	SENT_587	[p30l598t2097r802b2141],
5	mesylate	NN	O	mesylate	prep_to	2	SENT_587	[p30l834t2097r1043b2153],
6	(	CD	NUMBER	(	num	8	SENT_587	[p30l15t2171r222b2219],
7	STI571	NN	O	sti571	nn	8	SENT_587	[p30l15t2171r222b2219],
8	)	NN	O	)	npadvmod	2	SENT_587	[p30l15t2171r222b2219],
9	in	IN	O	in	_	0	SENT_587	[p30l249t2168r296b2211],
10	a	DT	O	a	det	11	SENT_587	[p30l320t2182r345b2212],
11	patient	NN	O	patient	prep_in	8	SENT_587	[p30l368t2168r541b2224],
12	with	IN	O	with	_	0	SENT_587	[p30l560t2168r669b2212],
13	the	DT	O	the	det	15	SENT_587	[p30l694t2168r768b2212],
14	ETV6-ABL	NN	O	etv6-abl	nn	15	SENT_587	[p30l792t2171r1044b2212],
15	t	NN	O	t	prep_with	2	SENT_587	[p30l13t2242r172b2292],
16	(	CD	NUMBER	(	number	17	SENT_587	[p30l13t2242r172b2292],
17	9	CD	NUMBER	9	num	15	SENT_587	[p30l13t2242r172b2292],
18	;	:	O	;	_	0	SENT_587	[p30l13t2242r172b2292],
19	12	CD	NUMBER	12	number	20	SENT_587	[p30l13t2242r172b2292],
20	)	CD	NUMBER	)	dep	2	SENT_587	[p30l13t2242r172b2292],
21	translocation	NN	O	translocation	dep	20	SENT_587	[p30l194t2239r520b2283],
22	.	.	O	.	_	0	SENT_587	[p30l194t2239r520b2283],

1	Blood	NN	O	blood	_	0	SENT_588	[p30l540t2239r680b2283],
2	2002	CD	DATE	2002	num	1	SENT_588	[p30l699t2242r1043b2292, p30l13t2314r52b2354],
3	;	:	O	;	_	0	SENT_588	[p30l699t2242r1043b2292, p30l13t2314r52b2354],
4	99:34657	CD	NUMBER	99:34657	dep	1	SENT_588	[p30l699t2242r1043b2292, p30l13t2314r52b2354],
5	.	.	O	.	_	0	SENT_588	[p30l699t2242r1043b2292, p30l13t2314r52b2354],

1	15	CD	NUMBER	15	_	0	SENT_589	[p30l14t2386r78b2425],
2	.	.	O	.	_	0	SENT_589	[p30l14t2386r78b2425],

1	Graux	NN	O	graux	nn	2	SENT_590	[p30l109t2384r252b2425],
2	C	NN	O	c	dep	4	SENT_590	[p30l264t2384r310b2434],
3	,	,	O	,	_	0	SENT_590	[p30l264t2384r310b2434],
4	Cools	VBZ	O	cool	_	0	SENT_590	[p30l327t2381r458b2425],
5	J	NN	O	j	nsubj	4	SENT_590	[p30l467t2385r499b2434],
6	,	,	O	,	_	0	SENT_590	[p30l467t2385r499b2434],
7	Melotte	NN	O	melotte	nn	8	SENT_590	[p30l514t2381r690b2425],
8	C	NN	O	c	appos	5	SENT_590	[p30l704t2384r750b2434],
9	,	,	O	,	_	0	SENT_590	[p30l704t2384r750b2434],
10	et	FW	O	et	nn	11	SENT_590	[p30l767t2390r809b2425],
11	al.	FW	O	al.	appos	8	SENT_590	[p30l820t2381r871b2425],
12	.	.	O	.	_	0	SENT_590	[p30l820t2381r871b2425],

1	Fusion	NN	O	fusion	_	0	SENT_591	[p30l887t2381r1045b2425],
2	of	IN	O	of	_	0	SENT_591	[p30l13t2451r69b2496],
3	NUP214	NN	O	nup214	prep_of	1	SENT_591	[p30l73t2455r273b2496],
4	to	TO	O	to	_	0	SENT_591	[p30l291t2461r335b2496],
5	ABL1	NN	O	abl1	prep_to	1	SENT_591	[p30l352t2455r480b2496],
6	on	IN	O	on	_	0	SENT_591	[p30l499t2466r559b2496],
7	ampliﬁed	JJ	O	ampliﬁed	amod	8	SENT_591	[p30l576t2451r803b2508],
8	episomes	NNS	O	episome	prep_on	1	SENT_591	[p30l821t2452r1043b2508],
9	in	IN	O	in	_	0	SENT_591	[p30l12t2523r57b2566],
10	T-cell	NN	MISC	t-cell	nn	13	SENT_591	[p30l72t2523r203b2567],
11	acute	JJ	O	acute	amod	13	SENT_591	[p30l220t2532r343b2567],
12	lymphoblastic	JJ	O	lymphoblastic	amod	13	SENT_591	[p30l359t2523r695b2579],
13	leukemia	NN	O	leukemia	prep_in	8	SENT_591	[p30l711t2523r940b2568],
14	.	.	O	.	_	0	SENT_591	[p30l711t2523r940b2568],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_592	[p30l959t2527r1047b2567],
2	Genet	NNP	PERSON	Genet	_	0	SENT_592	[p30l13t2597r156b2638],
3	2004	CD	DATE	2004	num	2	SENT_592	[p30l167t2597r555b2647],
4	;	:	O	;	_	0	SENT_592	[p30l167t2597r555b2647],
5	36:1084	CD	NUMBER	36:1084	number	6	SENT_592	[p30l167t2597r555b2647],
6	-9	CD	NUMBER	-9	dep	2	SENT_592	[p30l167t2597r555b2647],
7	.	.	O	.	_	0	SENT_592	[p30l167t2597r555b2647],

1	16	CD	NUMBER	16	_	0	SENT_593	[p30l14t2670r78b2709],
2	.	.	O	.	_	0	SENT_593	[p30l14t2670r78b2709],

1	Pulford	NNP	PERSON	Pulford	nn	2	SENT_594	[p30l108t2664r286b2709],
2	K	NNP	PERSON	K	_	0	SENT_594	[p30l306t2669r355b2718],
3	,	,	O	,	_	0	SENT_594	[p30l306t2669r355b2718],
4	Lamant	NNP	O	Lamant	nn	5	SENT_594	[p30l379t2669r563b2709],
5	L	NNP	O	L	appos	2	SENT_594	[p30l581t2669r622b2718],
6	,	,	O	,	_	0	SENT_594	[p30l581t2669r622b2718],
7	Espinos	NNP	O	Espinos	nn	8	SENT_594	[p30l645t2665r836b2721],
8	E	NNP	O	E	appos	2	SENT_594	[p30l857t2669r901b2718],
9	,	,	O	,	_	0	SENT_594	[p30l857t2669r901b2718],
10	et	FW	O	et	nn	11	SENT_594	[p30l925t2674r969b2709],
11	al.	FW	O	al.	appos	2	SENT_594	[p30l987t2665r1040b2709],
12	.	.	O	.	_	0	SENT_594	[p30l987t2665r1040b2709],

1	The	DT	O	the	_	0	SENT_595	[p30l11t2736r103b2780],
2	emerging	VBG	O	emerge	amod	1	SENT_595	[p30l123t2736r357b2792],
3	normal	JJ	O	normal	amod	6	SENT_595	[p30l375t2736r551b2780],
4	and	CC	O	and	_	0	SENT_595	[p30l570t2736r659b2780],
5	disease-related	JJ	O	disease-related	amod	6	SENT_595	[p30l679t2736r1044b2780],
6	roles	NNS	O	role	npadvmod	1	SENT_595	[p30l13t2807r128b2851],
7	of	IN	O	of	_	0	SENT_595	[p30l150t2806r207b2851],
8	anaplastic	JJ	O	anaplastic	amod	10	SENT_595	[p30l216t2807r460b2863],
9	lymphoma	NN	O	lymphoma	nn	10	SENT_595	[p30l480t2807r740b2863],
10	kinase	NN	O	kinase	prep_of	1	SENT_595	[p30l760t2807r928b2851],
11	.	.	O	.	_	0	SENT_595	[p30l760t2807r928b2851],

1	Cell	NN	O	cell	_	0	SENT_596	[p30l951t2807r1044b2851],
2	Mol	NNP	O	Mol	nn	4	SENT_596	[p30l11t2878r106b2922],
3	Life	NNP	O	Life	nn	4	SENT_596	[p30l120t2877r207b2922],
4	Sci	NNP	O	Sci	dep	1	SENT_596	[p30l223t2878r289b2922],
5	2004	CD	DATE	2004	num	4	SENT_596	[p30l303t2881r721b2931],
6	;	:	O	;	_	0	SENT_596	[p30l303t2881r721b2931],
7	61:2939	CD	NUMBER	61:2939	num	8	SENT_596	[p30l303t2881r721b2931],
8	-53	CD	NUMBER	-53	dep	1	SENT_596	[p30l303t2881r721b2931],
9	.	.	O	.	_	0	SENT_596	[p30l303t2881r721b2931],

1	17	CD	NUMBER	17	_	0	SENT_597	[p30l14t2954r78b2993],
2	.	.	O	.	_	0	SENT_597	[p30l14t2954r78b2993],

1	Cazzaniga	NNP	O	Cazzaniga	nn	2	SENT_598	[p30l109t2949r358b3005],
2	G	NNP	O	G	_	0	SENT_598	[p30l371t2952r424b3002],
3	,	,	O	,	_	0	SENT_598	[p30l371t2952r424b3002],
4	Tosi	NNP	PERSON	Tosi	nn	5	SENT_598	[p30l439t2949r541b2993],
5	S	NNP	O	S	appos	2	SENT_598	[p30l556t2952r595b3002],
6	,	,	O	,	_	0	SENT_598	[p30l556t2952r595b3002],
7	Aloisi	NNP	PERSON	Aloisi	nn	8	SENT_598	[p30l610t2949r750b2993],
8	A	NNP	O	A	appos	2	SENT_598	[p30l762t2953r811b3002],
9	,	,	O	,	_	0	SENT_598	[p30l762t2953r811b3002],
10	et	FW	O	et	nn	11	SENT_598	[p30l828t2958r872b2993],
11	al.	FW	O	al.	appos	2	SENT_598	[p30l883t2949r936b2993],
12	.	.	O	.	_	0	SENT_598	[p30l883t2949r936b2993],

1	The	DT	O	the	det	3	SENT_599	[p30l952t2949r1043b2993],
2	tyrosine	NN	O	tyrosine	nn	3	SENT_599	[p30l13t3020r208b3076],
3	kinase	NN	O	kinase	_	0	SENT_599	[p30l238t3020r395b3064],
4	abl-related	JJ	O	abl-related	amod	6	SENT_599	[p30l425t3020r689b3064],
5	gene	NN	O	gene	nn	6	SENT_599	[p30l718t3034r833b3076],
6	ARG	NN	O	arg	nsubjpass	8	SENT_599	[p30l861t3023r974b3067],
7	is	VBZ	O	be	auxpass	8	SENT_599	[p30l1004t3020r1041b3064],
8	fused	VBN	O	fuse	rcmod	3	SENT_599	[p30l13t3090r142b3135],
9	to	TO	O	to	_	0	SENT_599	[p30l155t3100r200b3135],
10	ETV6	NN	O	etv6	prep_to	8	SENT_599	[p30l214t3094r342b3135],
11	in	IN	O	in	_	0	SENT_599	[p30l355t3091r400b3134],
12	an	DT	O	a	det	14	SENT_599	[p30l413t3105r469b3135],
13	AML-M4Eo	JJ	O	aml-m4eo	amod	14	SENT_599	[p30l479t3094r752b3135],
14	patient	NN	O	patient	prep_in	10	SENT_599	[p30l764t3091r931b3147],
15	with	IN	O	with	_	0	SENT_599	[p30l938t3091r1044b3135],
16	a	DT	O	a	det	18	SENT_599	[p30l12t3176r37b3206],
17	t	NN	O	t	nn	18	SENT_599	[p30l65t3165r483b3218],
18	(	NN	O	(	prep_with	8	SENT_599	[p30l65t3165r483b3218],
19	1	CD	NUMBER	1	dep	18	SENT_599	[p30l65t3165r483b3218],
20	;	:	O	;	_	0	SENT_599	[p30l65t3165r483b3218],
21	12	CD	NUMBER	12	number	22	SENT_599	[p30l65t3165r483b3218],
22	)	CD	NUMBER	)	dep	3	SENT_599	[p30l65t3165r483b3218],
23	(	CD	NUMBER	(	num	24	SENT_599	[p30l65t3165r483b3218],
24	q25	NN	O	q25	dep	22	SENT_599	[p30l65t3165r483b3218],
25	;	:	O	;	_	0	SENT_599	[p30l65t3165r483b3218],
26	p13	NN	O	p13	dep	3	SENT_599	[p30l65t3165r483b3218],
27	)	CD	NUMBER	)	dep	26	SENT_599	[p30l65t3165r483b3218],
28	:	:	O	:	_	0	SENT_599	[p30l65t3165r483b3218],
29	molecular	JJ	O	molecular	amod	30	SENT_599	[p30l515t3162r757b3206],
30	cloning	NN	O	cloning	dep	3	SENT_599	[p30l786t3162r969b3218],
31	of	IN	O	of	_	0	SENT_599	[p30l997t3161r1054b3206],
32	both	DT	O	both	det	34	SENT_599	[p30l13t3233r123b3277],
33	reciprocal	JJ	O	reciprocal	amod	34	SENT_599	[p30l141t3233r376b3289],
34	transcripts	NNS	O	transcript	prep_of	30	SENT_599	[p30l394t3233r660b3289],
35	.	.	O	.	_	0	SENT_599	[p30l394t3233r660b3289],

1	Blood	NN	O	blood	_	0	SENT_600	[p30l679t3233r819b3277],
2	1999	CD	DATE	1999	num	1	SENT_600	[p30l838t3236r1042b3286],
3	;	:	O	;	_	0	SENT_600	[p30l838t3236r1042b3286],
4	94	CD	NUMBER	94	num	6	SENT_600	[p30l838t3236r1042b3286],
5	:	:	O	:	_	0	SENT_600	[p30l838t3236r1042b3286],
6	4370-3	CD	NUMBER	4370-3	dep	1	SENT_600	[p30l12t3307r190b3348],
7	.	.	O	.	_	0	SENT_600	[p30l12t3307r190b3348],

1	18	CD	NUMBER	18	_	0	SENT_601	[p30l1120t752r1184b792],
2	.	.	O	.	_	0	SENT_601	[p30l1120t752r1184b792],

1	Macdonald	NNP	PERSON	Macdonald	nn	2	SENT_602	[p30l1213t748r1478b792],
2	D	NNP	PERSON	D	_	0	SENT_602	[p30l1492t752r1542b801],
3	,	,	O	,	_	0	SENT_602	[p30l1492t752r1542b801],
4	Reiter	NNP	PERSON	Reiter	nn	5	SENT_602	[p30l1560t748r1702b795],
5	A	NNP	O	A	appos	2	SENT_602	[p30l1713t752r1762b801],
6	,	,	O	,	_	0	SENT_602	[p30l1713t752r1762b801],
7	Cross	NNP	O	Cross	nn	8	SENT_602	[p30l1780t751r1912b792],
8	NCP	NNP	O	NCP	appos	5	SENT_602	[p30l1928t751r2042b792],
9	.	.	O	.	_	0	SENT_602	[p30l1928t751r2042b792],

1	The	DT	O	the	det	4	SENT_603	[p30l2059t748r2149b792],
2	8p11	NN	O	8p11	nn	4	SENT_603	[p30l1118t822r1234b875],
3	myeloproliferative	JJ	O	myeloproliferative	amod	4	SENT_603	[p30l1246t818r1670b875],
4	syndrome	NN	O	syndrome	_	0	SENT_603	[p30l1683t819r1928b875],
5	:	:	O	:	_	0	SENT_603	[p30l1683t819r1928b875],
6	a	DT	O	a	det	9	SENT_603	[p30l1941t833r1966b863],
7	distinct	JJ	O	distinct	amod	9	SENT_603	[p30l1977t819r2153b863],
8	clinical	JJ	O	clinical	amod	9	SENT_603	[p30l1118t890r1294b934],
9	entity	NN	O	entity	dep	4	SENT_603	[p30l1315t890r1453b946],
10	caused	VBN	O	cause	partmod	9	SENT_603	[p30l1472t890r1639b934],
11	by	IN	O	by	_	0	SENT_603	[p30l1660t890r1716b946],
12	constitutive	JJ	O	constitutive	amod	13	SENT_603	[p30l1735t890r2021b934],
13	activation	NN	O	activation	agent	10	SENT_603	[p30l2042t890r2148b934, p30l1116t961r1267b1005],
14	of	IN	O	of	_	0	SENT_603	[p30l1285t960r1343b1005],
15	FGFR1	NN	O	fgfr1	prep_of	13	SENT_603	[p30l1349t964r1529b1008],
16	.	.	O	.	_	0	SENT_603	[p30l1349t964r1529b1008],

1	Acta	NNP	O	Acta	nn	2	SENT_604	[p30l1545t965r1651b1005],
2	Haematol	NNP	O	Haematol	_	0	SENT_604	[p30l1665t961r1897b1005],
3	2002	CD	DATE	2002	num	2	SENT_604	[p30l1912t964r2147b1014],
4	;	:	O	;	_	0	SENT_604	[p30l1912t964r2147b1014],
5	107	CD	NUMBER	107	num	7	SENT_604	[p30l1912t964r2147b1014],
6	:	:	O	:	_	0	SENT_604	[p30l1912t964r2147b1014],
7	101-7	CD	NUMBER	101-7	dep	2	SENT_604	[p30l1120t1035r1266b1076],
8	.	.	O	.	_	0	SENT_604	[p30l1120t1035r1266b1076],

1	19	CD	NUMBER	19	_	0	SENT_605	[p30l1120t1108r1184b1147],
2	.	.	O	.	_	0	SENT_605	[p30l1120t1108r1184b1147],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_606	[p30l1214t1103r1339b1147],
2	J	NNP	PERSON	J	_	0	SENT_606	[p30l1358t1107r1391b1156],
3	,	,	O	,	_	0	SENT_606	[p30l1358t1107r1391b1156],
4	Deangelo	NNP	PERSON	Deangelo	nn	5	SENT_606	[p30l1418t1103r1647b1159],
5	DJ	NNP	PERSON	DJ	appos	2	SENT_606	[p30l1672t1107r1742b1156],
6	,	,	O	,	_	0	SENT_606	[p30l1672t1107r1742b1156],
7	Kutok	NNP	PERSON	Kutok	nn	8	SENT_606	[p30l1769t1103r1918b1148],
8	JL	NNP	O	JL	appos	2	SENT_606	[p30l1935t1107r1998b1156],
9	,	,	O	,	_	0	SENT_606	[p30l1935t1107r1998b1156],
10	et	FW	O	et	nn	11	SENT_606	[p30l2027t1112r2070b1147],
11	al.	FW	O	al.	appos	2	SENT_606	[p30l2092t1103r2146b1147],
12	.	.	O	.	_	0	SENT_606	[p30l2092t1103r2146b1147],

1	PKC412	NN	O	pkc412	nsubj	2	SENT_607	[p30l1117t1177r1308b1219],
2	inhibits	VBZ	O	inhibit	_	0	SENT_607	[p30l1327t1174r1512b1218],
3	the	DT	O	the	det	9	SENT_607	[p30l1532t1174r1605b1218],
4	zinc	NN	O	zinc	nn	9	SENT_607	[p30l1623t1174r1723b1218],
5	ﬁnger	NN	O	ﬁnger	nn	9	SENT_607	[p30l1741t1173r1886b1230],
6	198ﬁbroblast	CD	NUMBER	198ﬁbroblast	num	9	SENT_607	[p30l1905t1173r2148b1218, p30l1118t1245r1235b1289],
7	growth	NN	O	growth	nn	9	SENT_607	[p30l1255t1245r1427b1301],
8	factor	NN	O	factor	nn	9	SENT_607	[p30l1448t1244r1586b1289],
9	receptor	NN	O	receptor	nsubj	13	SENT_607	[p30l1606t1254r1802b1301],
10	1	CD	NUMBER	1	num	13	SENT_607	[p30l1824t1248r1848b1288],
11	ﬁision	NN	O	ﬁision	nn	13	SENT_607	[p30l1870t1244r2019b1289],
12	tyrosine	NN	O	tyrosine	nn	13	SENT_607	[p30l2040t1254r2149b1301, p30l1119t1316r1213b1360],
13	kinase	NN	O	kinase	xcomp	2	SENT_607	[p30l1225t1316r1376b1361],
14	and	CC	O	and	_	0	SENT_607	[p30l1388t1316r1475b1360],
15	is	VBZ	O	be	cop	16	SENT_607	[p30l1487t1316r1523b1360],
16	active	JJ	O	active	conj_and	2	SENT_607	[p30l1536t1316r1668b1361],
17	in	IN	O	in	_	0	SENT_607	[p30l1680t1316r1725b1359],
18	treatment	NN	O	treatment	prep_in	16	SENT_607	[p30l1737t1325r1969b1360],
19	of	IN	O	of	_	0	SENT_607	[p30l1979t1315r2035b1360],
20	stem	NN	O	stem	nn	23	SENT_607	[p30l2037t1325r2150b1360],
21	cell	NN	O	cell	nn	23	SENT_607	[p30l1118t1387r1198b1431],
22	myeloproliferative	JJ	O	myeloproliferative	amod	23	SENT_607	[p30l1225t1386r1654b1443],
23	disorder	NN	O	disorder	prep_of	18	SENT_607	[p30l1682t1387r1889b1431],
24	.	.	O	.	_	0	SENT_607	[p30l1682t1387r1889b1431],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_608	[p30l1918t1391r2023b1431],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_608	[p30l2049t1387r2149b1431],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_608	[p30l1116t1458r1234b1502],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_608	[p30l1249t1458r1315b1502],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_608	[p30l1329t1462r1367b1502],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_608	[p30l1381t1461r1405b1502],
7	A	NNP	O	A	_	0	SENT_608	[p30l1419t1462r1455b1501],
8	2004	CD	DATE	2004	num	7	SENT_608	[p30l1468t1461r1945b1511],
9	;	:	O	;	_	0	SENT_608	[p30l1468t1461r1945b1511],
10	101:14479	CD	NUMBER	101:14479	number	11	SENT_608	[p30l1468t1461r1945b1511],
11	-84	CD	NUMBER	-84	dep	7	SENT_608	[p30l1468t1461r1945b1511],
12	.	.	O	.	_	0	SENT_608	[p30l1468t1461r1945b1511],

1	20	CD	NUMBER	20	_	0	SENT_609	[p30l1117t1533r1184b1573],
2	.	.	O	.	_	0	SENT_609	[p30l1117t1533r1184b1573],

1	Chesi	NN	MISC	chesus	nn	2	SENT_610	[p30l1214t1529r1347b1573],
2	M	NN	O	m	_	0	SENT_610	[p30l1370t1533r1431b1582],
3	,	,	O	,	_	0	SENT_610	[p30l1370t1533r1431b1582],
4	Nardini	NNP	PERSON	Nardini	nn	5	SENT_610	[p30l1458t1529r1645b1573],
5	E	NNP	O	E	appos	2	SENT_610	[p30l1668t1533r1712b1582],
6	,	,	O	,	_	0	SENT_610	[p30l1668t1533r1712b1582],
7	Brents	NNP	ORGANIZATION	Brents	nn	8	SENT_610	[p30l1740t1533r1895b1573],
8	LA	NNP	ORGANIZATION	LA	appos	2	SENT_610	[p30l1920t1533r1998b1582],
9	,	,	O	,	_	0	SENT_610	[p30l1920t1533r1998b1582],
10	et	FW	O	et	nn	11	SENT_610	[p30l2027t1538r2070b1573],
11	al.	FW	O	al.	appos	2	SENT_610	[p30l2092t1529r2146b1573],
12	.	.	O	.	_	0	SENT_610	[p30l2092t1529r2146b1573],

1	Frequent	JJ	O	frequent	amod	3	SENT_611	[p30l1117t1604r1331b1656],
2	translocation	NN	O	translocation	nn	3	SENT_611	[p30l1341t1600r1652b1644],
3	t	NN	O	t	_	0	SENT_611	[p30l1664t1603r1820b1653],
4	(	CD	NUMBER	(	number	5	SENT_611	[p30l1664t1603r1820b1653],
5	4	CD	NUMBER	4	dep	3	SENT_611	[p30l1664t1603r1820b1653],
6	;	:	O	;	_	0	SENT_611	[p30l1664t1603r1820b1653],
7	14	CD	NUMBER	14	number	8	SENT_611	[p30l1664t1603r1820b1653],
8	)	CD	NUMBER	)	dep	3	SENT_611	[p30l1664t1603r1820b1653],
9	(	NN	O	(	nn	11	SENT_611	[p30l1828t1603r1976b1656],
10	p16	NN	O	p16	nn	11	SENT_611	[p30l1828t1603r1976b1656],
11	.3	NN	NUMBER	.3	dep	8	SENT_611	[p30l1828t1603r1976b1656],
12	;	:	O	;	_	0	SENT_611	[p30l1984t1603r2147b1656],
13	q32	NN	O	q32	nn	15	SENT_611	[p30l1984t1603r2147b1656],
14	.3	NN	NUMBER	.3	nn	15	SENT_611	[p30l1984t1603r2147b1656],
15	)	NN	O	)	dep	3	SENT_611	[p30l1984t1603r2147b1656],
16	in	IN	O	in	_	0	SENT_611	[p30l1118t1672r1164b1714],
17	multiple	JJ	O	multiple	amod	18	SENT_611	[p30l1179t1671r1386b1727],
18	myeloma	NN	O	myeloma	prep_in	15	SENT_611	[p30l1401t1671r1625b1727],
19	is	VBZ	O	be	auxpass	20	SENT_611	[p30l1639t1671r1677b1715],
20	associated	VBN	O	associate	rcmod	3	SENT_611	[p30l1692t1671r1948b1715],
21	with	IN	O	with	_	0	SENT_611	[p30l1960t1671r2069b1715],
22	increased	VBN	O	increase	amod	23	SENT_611	[p30l2083t1672r2148b1714, p30l1118t1742r1298b1786],
23	expression	NN	O	expression	prep_with	20	SENT_611	[p30l1330t1742r1589b1798],
24	and	CC	O	and	_	0	SENT_611	[p30l1621t1742r1709b1786],
25	activating	VBG	O	activate	amod	26	SENT_611	[p30l1740t1742r1975b1798],
26	mutations	NNS	O	mutation	conj_and	23	SENT_611	[p30l2005t1751r2148b1786, p30l1118t1813r1236b1857],
27	of	IN	O	of	_	0	SENT_611	[p30l1254t1812r1311b1857],
28	ﬁbroblast	NN	O	ﬁbroblast	nn	31	SENT_611	[p30l1316t1812r1547b1857],
29	growth	NN	O	growth	nn	31	SENT_611	[p30l1560t1813r1729b1869],
30	factor	NN	O	factor	nn	31	SENT_611	[p30l1745t1812r1883b1857],
31	receptor	NN	O	receptor	prep_of	23	SENT_611	[p30l1896t1822r2093b1869],
32	3	CD	NUMBER	3	dep	31	SENT_611	[p30l2107t1816r2146b1857],
33	.	.	O	.	_	0	SENT_611	[p30l2107t1816r2146b1857],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_612	[p30l1117t1888r1204b1928],
2	Genet	NNP	PERSON	Genet	_	0	SENT_612	[p30l1216t1887r1359b1928],
3	1997	CD	DATE	1997	num	2	SENT_612	[p30l1372t1887r1729b1937],
4	;	:	O	;	_	0	SENT_612	[p30l1372t1887r1729b1937],
5	16:260	CD	NUMBER	16:260	number	6	SENT_612	[p30l1372t1887r1729b1937],
6	-4	CD	NUMBER	-4	dep	2	SENT_612	[p30l1372t1887r1729b1937],
7	.	.	O	.	_	0	SENT_612	[p30l1372t1887r1729b1937],

1	21	CD	NUMBER	21	_	0	SENT_613	[p30l1117t1960r1184b1999],
2	.	.	O	.	_	0	SENT_613	[p30l1117t1960r1184b1999],

1	Yamamoto	NNP	PERSON	Yamamoto	nn	2	SENT_614	[p30l1212t1959r1467b1999],
2	Y	NN	PERSON	y	_	0	SENT_614	[p30l1487t1959r1524b2008],
3	,	,	O	,	_	0	SENT_614	[p30l1487t1959r1524b2008],
4	Kiyoi	NN	PERSON	kiyous	nn	5	SENT_614	[p30l1548t1955r1669b2011],
5	H	NN	PERSON	h	appos	2	SENT_614	[p30l1689t1959r1743b2008],
6	,	,	O	,	_	0	SENT_614	[p30l1689t1959r1743b2008],
7	Nakano	NNP	PERSON	Nakano	nn	8	SENT_614	[p30l1766t1955r1951b2000],
8	Y	NN	PERSON	y	appos	2	SENT_614	[p30l1971t1959r2009b2008],
9	,	,	O	,	_	0	SENT_614	[p30l1971t1959r2009b2008],
10	et	FW	O	et	nn	11	SENT_614	[p30l2033t1964r2076b1999],
11	al.	FW	O	al.	appos	2	SENT_614	[p30l2093t1955r2146b1999],
12	.	.	O	.	_	0	SENT_614	[p30l2093t1955r2146b1999],

1	Activating	VBG	O	activate	amod	2	SENT_615	[p30l1116t2026r1357b2082],
2	mutation	NN	O	mutation	_	0	SENT_615	[p30l1368t2026r1586b2070],
3	of	IN	O	of	_	0	SENT_615	[p30l1599t2025r1656b2070],
4	D835	NN	O	d835	prep_of	2	SENT_615	[p30l1658t2029r1783b2070],
5	within	IN	O	within	_	0	SENT_615	[p30l1796t2026r1949b2070],
6	the	DT	O	the	det	8	SENT_615	[p30l1963t2026r2035b2070],
7	activation	NN	O	activation	nn	8	SENT_615	[p30l2048t2026r2149b2070, p30l1116t2097r1261b2141],
8	loop	NN	O	loop	prep_within	4	SENT_615	[p30l1280t2097r1385b2153],
9	of	IN	O	of	_	0	SENT_615	[p30l1405t2096r1461b2141],
10	FLT3	NN	O	flt3	prep_of	8	SENT_615	[p30l1469t2100r1583b2141],
11	in	IN	O	in	_	0	SENT_615	[p30l1604t2097r1649b2140],
12	human	JJ	O	human	amod	14	SENT_615	[p30l1668t2097r1835b2141],
13	hematologic	JJ	O	hematologic	amod	14	SENT_615	[p30l1854t2097r2150b2153],
14	malignancies	NNS	O	malignancy	prep_in	10	SENT_615	[p30l1118t2168r1446b2224],
15	.	.	O	.	_	0	SENT_615	[p30l1118t2168r1446b2224],

1	Blood	NN	O	blood	_	0	SENT_616	[p30l1463t2168r1603b2212],
2	2001	CD	DATE	2001	num	1	SENT_616	[p30l1616t2171r2005b2221],
3	;	:	O	;	_	0	SENT_616	[p30l1616t2171r2005b2221],
4	97:2434	CD	NUMBER	97:2434	number	5	SENT_616	[p30l1616t2171r2005b2221],
5	-9	CD	NUMBER	-9	dep	1	SENT_616	[p30l1616t2171r2005b2221],
6	.	.	O	.	_	0	SENT_616	[p30l1616t2171r2005b2221],

1	22	CD	NUMBER	22	_	0	SENT_617	[p30l1117t2244r1184b2283],
2	.	.	O	.	_	0	SENT_617	[p30l1117t2244r1184b2283],

1	Stone	NNP	O	Stone	nn	2	SENT_618	[p30l1215t2242r1346b2283],
2	RM	NN	O	rm	_	0	SENT_618	[p30l1359t2243r1456b2292],
3	,	,	O	,	_	0	SENT_618	[p30l1359t2243r1456b2292],
4	beAngelo	NN	O	beangelo	nn	5	SENT_618	[p30l1471t2239r1705b2295],
5	DJ	NNP	O	DJ	appos	2	SENT_618	[p30l1718t2243r1787b2292],
6	,	,	O	,	_	0	SENT_618	[p30l1718t2243r1787b2292],
7	Klimek	NNP	PERSON	Klimek	nn	8	SENT_618	[p30l1803t2239r1976b2284],
8	V	NNP	O	V	appos	2	SENT_618	[p30l1985t2243r2024b2292],
9	,	,	O	,	_	0	SENT_618	[p30l1985t2243r2024b2292],
10	et	FW	O	et	nn	11	SENT_618	[p30l2040t2248r2083b2283],
11	al.	FW	O	al.	appos	2	SENT_618	[p30l2093t2239r2146b2283],
12	.	.	O	.	_	0	SENT_618	[p30l2093t2239r2146b2283],

1	Patients	NNS	O	patient	nsubj	12	SENT_619	[p30l1117t2310r1303b2354],
2	with	IN	O	with	_	0	SENT_619	[p30l1314t2310r1420b2354],
3	acute	JJ	O	acute	amod	5	SENT_619	[p30l1432t2319r1555b2354],
4	myeloid	JJ	O	myeloid	amod	5	SENT_619	[p30l1567t2310r1755b2366],
5	leukemia	NN	O	leukemia	prep_with	1	SENT_619	[p30l1767t2310r1984b2355],
6	and	CC	O	and	_	0	SENT_619	[p30l1995t2310r2082b2354],
7	an	DT	O	a	det	9	SENT_619	[p30l2094t2324r2150b2354],
8	activating	VBG	O	activate	amod	9	SENT_619	[p30l1118t2381r1348b2437],
9	mutation	NN	O	mutation	conj_and	5	SENT_619	[p30l1373t2381r1590b2425],
10	in	IN	O	in	_	0	SENT_619	[p30l1617t2381r1663b2424],
11	FLT3	NN	O	flt3	prep_in	9	SENT_619	[p30l1689t2384r1804b2425],
12	respond	VBP	O	respond	_	0	SENT_619	[p30l1833t2381r2026b2437],
13	to	TO	O	to	_	0	SENT_619	[p30l2054t2390r2098b2425],
14	a	DT	O	a	det	19	SENT_619	[p30l2125t2395r2150b2425],
15	small-molecule	JJ	O	small-molecule	amod	19	SENT_619	[p30l1119t2452r1483b2496],
16	FLT3	NN	O	flt3	nn	19	SENT_619	[p30l1495t2455r1610b2496],
17	tyrosine	NN	O	tyrosine	nn	19	SENT_619	[p30l1625t2452r1813b2508],
18	kinase	NN	O	kinase	nn	19	SENT_619	[p30l1826t2452r1977b2497],
19	inhibitor	NN	O	inhibitor	prep_to	12	SENT_619	[p30l1991t2452r2149b2496, p30l1118t2532r1195b2576],
20	,	,	O	,	_	0	SENT_619	[p30l1991t2452r2149b2496, p30l1118t2532r1195b2576],
21	PKC412	NN	O	pkc412	appos	19	SENT_619	[p30l1211t2526r1413b2568],
22	.	.	O	.	_	0	SENT_619	[p30l1211t2526r1413b2568],

1	Blood	NN	O	blood	_	0	SENT_620	[p30l1429t2523r1569b2567],
2	2005	CD	DATE	2005	num	1	SENT_620	[p30l1583t2526r1971b2576],
3	;	:	O	;	_	0	SENT_620	[p30l1583t2526r1971b2576],
4	105:54	CD	NUMBER	105:54	number	5	SENT_620	[p30l1583t2526r1971b2576],
5	-60	CD	NUMBER	-60	dep	1	SENT_620	[p30l1583t2526r1971b2576],
6	.	.	O	.	_	0	SENT_620	[p30l1583t2526r1971b2576],

1	23	CD	NUMBER	23	_	0	SENT_621	[p30l1117t2599r1184b2638],
2	.	.	O	.	_	0	SENT_621	[p30l1117t2599r1184b2638],

1	Smith	NNP	PERSON	Smith	nn	2	SENT_622	[p30l1215t2594r1355b2638],
2	BD	NNP	O	BD	_	0	SENT_622	[p30l1372t2598r1455b2647],
3	,	,	O	,	_	0	SENT_622	[p30l1372t2598r1455b2647],
4	Levis	NNP	PERSON	Levis	nn	5	SENT_622	[p30l1476t2594r1592b2638],
5	M	NNP	O	M	appos	2	SENT_622	[p30l1609t2598r1670b2647],
6	,	,	O	,	_	0	SENT_622	[p30l1609t2598r1670b2647],
7	Beran	NNP	PERSON	Beran	nn	8	SENT_622	[p30l1690t2598r1827b2638],
8	M	NNP	O	M	appos	2	SENT_622	[p30l1843t2598r1904b2647],
9	,	,	O	,	_	0	SENT_622	[p30l1843t2598r1904b2647],
10	et	FW	O	et	nn	11	SENT_622	[p30l1925t2603r1968b2638],
11	al.	FW	O	al.	appos	2	SENT_622	[p30l1983t2594r2035b2638],
12	.	.	O	.	_	0	SENT_622	[p30l1983t2594r2035b2638],

1	Single-agent	JJ	O	single-agent	amod	2	SENT_623	[p30l2058t2594r2149b2638, p30l1118t2665r1341b2721],
2	CEP-701	NN	O	cep-701	nsubj	9	SENT_623	[p30l1359t2668r1576b2718],
3	,	,	O	,	_	0	SENT_623	[p30l1359t2668r1576b2718],
4	a	DT	O	a	det	7	SENT_623	[p30l1600t2679r1625b2709],
5	novel	JJ	O	novel	amod	7	SENT_623	[p30l1645t2665r1770b2709],
6	FLT3	NN	O	flt3	nn	7	SENT_623	[p30l1790t2668r1904b2709],
7	inhibitor	NN	O	inhibitor	appos	2	SENT_623	[p30l1927t2665r2146b2718],
8	,	,	O	,	_	0	SENT_623	[p30l1927t2665r2146b2718],
9	shows	VBZ	O	show	_	0	SENT_623	[p30l1119t2736r1264b2781],
10	biologic	JJ	O	biologic	amod	13	SENT_623	[p30l1277t2736r1463b2792],
11	and	CC	O	and	_	0	SENT_623	[p30l1473t2736r1559b2780],
12	clinical	JJ	O	clinical	conj_and	10	SENT_623	[p30l1570t2736r1734b2780],
13	activity	NN	O	activity	dobj	9	SENT_623	[p30l1744t2736r1904b2792],
14	in	IN	O	in	_	0	SENT_623	[p30l1912t2736r1957b2779],
15	patients	NNS	O	patient	prep_in	13	SENT_623	[p30l1967t2736r2149b2792],
16	with	IN	O	with	_	0	SENT_623	[p30l1116t2807r1223b2851],
17	relapsed	VBN	O	relapse	prep_with	15	SENT_623	[p30l1248t2807r1450b2863],
18	or	CC	O	or	_	0	SENT_623	[p30l1476t2821r1526b2851],
19	refractory	JJ	O	refractory	amod	22	SENT_623	[p30l1550t2806r1785b2863],
20	acute	JJ	O	acute	amod	22	SENT_623	[p30l1807t2816r1932b2851],
21	myeloid	JJ	O	myeloid	amod	22	SENT_623	[p30l1957t2807r2149b2863],
22	leukemia	NN	O	leukemia	prep_with	15	SENT_623	[p30l1117t2878r1350b2922],
23	.	.	O	.	_	0	SENT_623	[p30l1117t2878r1350b2922],

1	Blood	NN	O	blood	_	0	SENT_624	[p30l1367t2878r1506b2922],
2	2004	CD	DATE	2004	num	1	SENT_624	[p30l1520t2881r1968b2931],
3	;	:	O	;	_	0	SENT_624	[p30l1520t2881r1968b2931],
4	103:3669	CD	NUMBER	103:3669	number	5	SENT_624	[p30l1520t2881r1968b2931],
5	-76	CD	NUMBER	-76	dep	1	SENT_624	[p30l1520t2881r1968b2931],
6	.	.	O	.	_	0	SENT_624	[p30l1520t2881r1968b2931],

1	24	CD	NUMBER	24	_	0	SENT_625	[p30l1117t2954r1184b2993],
2	.	.	O	.	_	0	SENT_625	[p30l1117t2954r1184b2993],

1	Fiedler	NNP	PERSON	Fiedler	nn	2	SENT_626	[p30l1214t2949r1377b2993],
2	W	NNP	O	W	_	0	SENT_626	[p30l1388t2953r1446b3002],
3	,	,	O	,	_	0	SENT_626	[p30l1388t2953r1446b3002],
4	Mesters	NNP	O	Mesters	nn	5	SENT_626	[p30l1462t2953r1647b2993],
5	R	NNP	O	R	appos	2	SENT_626	[p30l1662t2953r1709b3002],
6	,	,	O	,	_	0	SENT_626	[p30l1662t2953r1709b3002],
7	Tinnefeld	NNP	O	Tinnefeld	nn	8	SENT_626	[p30l1725t2948r1954b2993],
8	H	NNP	O	H	appos	2	SENT_626	[p30l1968t2953r2022b3002],
9	,	,	O	,	_	0	SENT_626	[p30l1968t2953r2022b3002],
10	et	FW	O	et	nn	11	SENT_626	[p30l2039t2958r2083b2993],
11	al.	FW	O	al.	appos	2	SENT_626	[p30l2094t2949r2146b2993],
12	.	.	O	.	_	0	SENT_626	[p30l2094t2949r2146b2993],

1	A	DT	O	a	det	5	SENT_627	[p30l1116t3024r1153b3063],
2	phase	NN	O	phase	nn	5	SENT_627	[p30l1162t3020r1298b3076],
3	2	CD	NUMBER	2	num	5	SENT_627	[p30l1310t3023r1336b3063],
4	clinical	JJ	O	clinical	amod	5	SENT_627	[p30l1348t3020r1513b3064],
5	study	NN	O	study	_	0	SENT_627	[p30l1525t3020r1649b3076],
6	of	IN	O	of	_	0	SENT_627	[p30l1659t3019r1715b3064],
7	SU5416	NN	O	su5416	prep_of	5	SENT_627	[p30l1717t3023r1898b3064],
8	in	IN	O	in	_	0	SENT_627	[p30l1910t3020r1955b3063],
9	patients	NNS	O	patient	prep_in	5	SENT_627	[p30l1965t3020r2149b3076],
10	with	IN	O	with	_	0	SENT_627	[p30l1116t3091r1225b3135],
11	refractory	JJ	O	refractory	amod	14	SENT_627	[p30l1255t3090r1496b3147],
12	acute	JJ	O	acute	amod	14	SENT_627	[p30l1523t3100r1651b3135],
13	myeloid	JJ	O	myeloid	amod	14	SENT_627	[p30l1681t3091r1877b3147],
14	leukemia	NN	O	leukemia	prep_with	9	SENT_627	[p30l1907t3091r2145b3135],
15	.	.	O	.	_	0	SENT_627	[p30l1907t3091r2145b3135],

1	Blood	NN	O	blood	_	0	SENT_628	[p30l1117t3162r1260b3206],
2	2003	CD	DATE	2003	num	1	SENT_628	[p30l1274t3165r1693b3215],
3	;	:	O	;	_	0	SENT_628	[p30l1274t3165r1693b3215],
4	102:2763	CD	NUMBER	102:2763	number	5	SENT_628	[p30l1274t3165r1693b3215],
5	-7	CD	NUMBER	-7	dep	1	SENT_628	[p30l1274t3165r1693b3215],
6	.	.	O	.	_	0	SENT_628	[p30l1274t3165r1693b3215],

1	25	CD	NUMBER	25	_	0	SENT_629	[p30l1117t3238r1184b3277],
2	.	.	O	.	_	0	SENT_629	[p30l1117t3238r1184b3277],

1	Ridge	NNP	O	Ridge	nn	2	SENT_630	[p30l1214t3233r1351b3289],
2	SA	NNP	O	SA	_	0	SENT_630	[p30l1364t3236r1439b3286],
3	,	,	O	,	_	0	SENT_630	[p30l1364t3236r1439b3286],
4	Worwood	NNP	O	Worwood	nn	5	SENT_630	[p30l1452t3233r1685b3278],
5	M	NNP	O	M	appos	2	SENT_630	[p30l1695t3237r1756b3286],
6	,	,	O	,	_	0	SENT_630	[p30l1695t3237r1756b3286],
7	Oscier	NNP	PERSON	Oscier	nn	8	SENT_630	[p30l1771t3234r1923b3277],
8	D	NNP	PERSON	D	appos	2	SENT_630	[p30l1933t3237r1983b3286],
9	,	,	O	,	_	0	SENT_630	[p30l1933t3237r1983b3286],
10	Jacobs	NNP	PERSON	Jacobs	nn	11	SENT_630	[p30l1992t3233r2148b3284],
11	A	NNP	O	A	appos	2	SENT_630	[p30l1116t3308r1164b3357],
12	,	,	O	,	_	0	SENT_630	[p30l1116t3308r1164b3357],
13	Padua	NNP	LOCATION	Padua	nn	14	SENT_630	[p30l1187t3304r1330b3348],
14	RA	NN	O	ra	appos	2	SENT_630	[p30l1349t3308r1433b3351],
15	.	.	O	.	_	0	SENT_630	[p30l1349t3308r1433b3351],

1	FMS	NN	O	fm	nn	2	SENT_631	[p30l1456t3307r1560b3348],
2	mutations	NNS	O	mutation	_	0	SENT_631	[p30l1582t3304r1822b3348],
3	in	IN	O	in	_	0	SENT_631	[p30l1843t3304r1889b3347],
4	myelodys	JJ	O	myelodys	amod	5	SENT_631	[p30l1910t3304r2149b3360, p30l149t3435r205b3456],
5	*	NN	O	*	prep_in	2	SENT_631	[p30l1910t3304r2149b3360, p30l149t3435r205b3456],

1	N	NN	O	n	nn	2	SENT_632	[p30l918t3437r932b3452],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_632	[p30l947t3436r1031b3458],
3	MED	VBD	O	med	_	0	SENT_632	[p30l1046t3437r1099b3452],
4	3532	CD	NUMBER	3532	num	6	SENT_632	[p30l1111t3436r1175b3458],
5	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	6	SENT_632	[p30l1210t3436r1421b3458],
6	jULY14.	NNP	O	jULY14.	dobj	3	SENT_632	[p30l1455t3436r1638b3458],
7	,2005	CD	NUMBER	,2005	dep	6	SENT_632	[p30l1455t3436r1638b3458],

1	The	DT	O	the	det	4	SENT_633	[p30l935t3469r986b3493],
2	New	NNP	O	New	nn	4	SENT_633	[p30l995t3470r1057b3493],
3	England	NNP	O	England	nn	4	SENT_633	[p30l1066t3469r1177b3500],
4	Journal	NNP	O	Journal	_	0	SENT_633	[p30l1186t3469r1283b3493],
5	of	IN	O	of	_	0	SENT_633	[p30l1293t3469r1322b3493],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_633	[p30l1329t3469r1454b3493],

1	Downloaded	VBN	O	download	_	0	SENT_634	[p30l377t3510r547b3533],
2	from	IN	O	from	_	0	SENT_634	[p30l556t3510r620b3533],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_634	[p30l629t3510r747b3540],
4	at	IN	O	at	_	0	SENT_634	[p30l758t3514r781b3533],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_634	[p30l789t3510r972b3533],
6	on	IN	O	on	_	0	SENT_634	[p30l981t3517r1014b3533],
7	January	NNP	DATE	January	prep_on	1	SENT_634	[p30l1022t3510r1125b3540],
8	5	CD	DATE	5	num	7	SENT_634	[p30l1135t3510r1158b3537],
9	,	,	DATE	,	_	0	SENT_634	[p30l1135t3510r1158b3537],
10	2014	CD	DATE	2014	num	7	SENT_634	[p30l1169t3510r1241b3533],
11	.	.	O	.	_	0	SENT_634	[p30l1169t3510r1241b3533],

1	For	IN	O	for	_	0	SENT_635	[p30l1251t3510r1298b3533],
2	personal	JJ	O	personal	amod	3	SENT_635	[p30l1306t3510r1418b3540],
3	use	NN	O	use	pobj	1	SENT_635	[p30l1427t3517r1471b3533],
4	only	RB	O	only	advmod	3	SENT_635	[p30l1481t3510r1545b3540],
5	.	.	O	.	_	0	SENT_635	[p30l1481t3510r1545b3540],

1	No	DT	O	no	det	3	SENT_636	[p30l1556t3510r1596b3533],
2	other	JJ	O	other	amod	3	SENT_636	[p30l1606t3510r1674b3533],
3	uses	NNS	O	use	_	0	SENT_636	[p30l1682t3517r1738b3533],
4	without	IN	O	without	_	0	SENT_636	[p30l1748t3510r1849b3533],
5	permission	NN	O	permission	prep_without	3	SENT_636	[p30l1858t3510r2010b3540],
6	.	.	O	.	_	0	SENT_636	[p30l1858t3510r2010b3540],

1	Copyright	NN	O	copyright	_	0	SENT_637	[p30l727t3551r862b3582],
2	©	CD	NUMBER	©	num	6	SENT_637	[p30l871t3551r895b3575],
3	2005	CD	DATE	2005	num	6	SENT_637	[p30l905t3551r969b3575],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_637	[p30l979t3551r1170b3575],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_637	[p30l1180t3551r1288b3575],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_637	[p30l1299t3551r1404b3582],
7	.	.	O	.	_	0	SENT_637	[p30l1299t3551r1404b3582],

1	All	DT	O	all	det	2	SENT_638	[p30l1415t3551r1456b3575],
2	rights	NNS	O	rights	nsubj	3	SENT_638	[p30l1465t3551r1540b3582],
3	reserved	VBN	O	reserve	_	0	SENT_638	[p30l1550t3551r1669b3575],
4	.	.	O	.	_	0	SENT_638	[p30l1550t3551r1669b3575],

1	MECHANISMS	NNS	O	mechanism	_	0	SENT_639	[p30l1207t3726r1646b3762],
2	OF	IN	O	of	_	0	SENT_639	[p30l1674t3726r1752b3762],
3	DISEASE	NN	O	disease	prep_of	1	SENT_639	[p30l1780t3726r2043b3762],

1	plastic	NN	O	plastic	_	0	SENT_640	[p31l8t115r175b171],
2	,	,	O	,	_	0	SENT_640	[p31l8t115r175b171],
3	leukemic	JJ	O	leukemic	appos	1	SENT_640	[p31l190t115r418b169],
4	,	,	O	,	_	0	SENT_640	[p31l190t115r418b169],
5	and	CC	O	and	_	0	SENT_640	[p31l433t115r521b159],
6	normal	JJ	O	normal	amod	7	SENT_640	[p31l533t115r705b159],
7	subjects	NNS	O	subject	appos	1	SENT_640	[p31l718t115r919b171],
8	.	.	O	.	_	0	SENT_640	[p31l718t115r919b171],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_641	[p31l935t119r1040b160],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_641	[p31l8t186r108b231],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_641	[p31l120t186r237b231],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_641	[p31l252t187r319b231],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_641	[p31l332t191r370b231],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_641	[p31l385t190r408b231],
7	A	NNP	O	A	_	0	SENT_641	[p31l422t191r459b230],
8	1990	CD	DATE	1990	num	7	SENT_641	[p31l473t190r888b240],
9	;	:	O	;	_	0	SENT_641	[p31l473t190r888b240],
10	87:1377	CD	NUMBER	87:1377	number	11	SENT_641	[p31l473t190r888b240],
11	—	CD	NUMBER	—	dep	7	SENT_641	[p31l473t190r888b240],
12	80	CD	NUMBER	80	dep	11	SENT_641	[p31l473t190r888b240],
13	.	.	O	.	_	0	SENT_641	[p31l473t190r888b240],

1	26	CD	NUMBER	26	_	0	SENT_642	[p31l8t263r75b301],
2	.	.	O	.	_	0	SENT_642	[p31l8t263r75b301],

1	Eguchi	NNP	PERSON	Eguchi	nn	2	SENT_643	[p31l104t257r268b314],
2	M	NNP	O	M	_	0	SENT_643	[p31l280t261r341b311],
3	,	,	O	,	_	0	SENT_643	[p31l280t261r341b311],
4	Eguchi-Ishimae	NNP	O	Eguchi-Ishimae	nn	5	SENT_643	[p31l357t257r731b314],
5	M	NNP	O	M	appos	2	SENT_643	[p31l743t261r804b311],
6	,	,	O	,	_	0	SENT_643	[p31l743t261r804b311],
7	Tojo	NNP	PERSON	Tojo	nn	8	SENT_643	[p31l819t258r921b313],
8	A	NNP	O	A	appos	2	SENT_643	[p31l933t261r981b311],
9	,	,	O	,	_	0	SENT_643	[p31l933t261r981b311],
10	et	FW	O	et	nn	11	SENT_643	[p31l999t266r1041b301],
11	al.	FW	O	al.	appos	2	SENT_643	[p31l9t328r61b373],
12	.	.	O	.	_	0	SENT_643	[p31l9t328r61b373],

1	Fusion	NN	O	fusion	dep	9	SENT_644	[p31l78t329r239b373],
2	of	IN	O	of	_	0	SENT_644	[p31l254t328r310b373],
3	ETV6	NN	O	etv6	prep_of	1	SENT_644	[p31l313t332r439b373],
4	to	TO	O	to	_	0	SENT_644	[p31l455t338r499b373],
5	neurotrophin	NN	O	neurotrophin	prep_to	3	SENT_644	[p31l514t329r878b385],
6	—	NN	O	—	dep	9	SENT_644	[p31l514t329r878b385],
7	3	CD	NUMBER	3	num	6	SENT_644	[p31l514t329r878b385],
8	receptor	NN	O	receptor	nn	9	SENT_644	[p31l894t343r1038b385, p31l9t409r77b444],
9	TRKC	NN	O	trkc	dep	17	SENT_644	[p31l96t403r238b446],
10	in	IN	O	in	_	0	SENT_644	[p31l261t400r307b443],
11	acute	JJ	O	acute	amod	13	SENT_644	[p31l329t409r454b444],
12	myeloid	JJ	O	myeloid	amod	13	SENT_644	[p31l477t399r669b456],
13	leukemia	NN	O	leukemia	prep_in	9	SENT_644	[p31l691t399r912b444],
14	with	IN	O	with	_	0	SENT_644	[p31l931t399r1039b444],
15	t	NN	O	t	prep_with	13	SENT_644	[p31l9t474r451b527],
16	(	CD	NUMBER	(	num	17	SENT_644	[p31l9t474r451b527],
17	12	CD	NUMBER	12	_	0	SENT_644	[p31l9t474r451b527],
18	;	:	O	;	_	0	SENT_644	[p31l9t474r451b527],
19	15	CD	NUMBER	15	num	20	SENT_644	[p31l9t474r451b527],
20	)	CD	NUMBER	)	dep	17	SENT_644	[p31l9t474r451b527],
21	(	NN	O	(	nn	22	SENT_644	[p31l9t474r451b527],
22	p13	NN	O	p13	dep	20	SENT_644	[p31l9t474r451b527],
23	;	:	O	;	_	0	SENT_644	[p31l9t474r451b527],
24	q25	CD	NUMBER	q25	num	25	SENT_644	[p31l9t474r451b527],
25	)	NN	O	)	dep	22	SENT_644	[p31l9t474r451b527],
26	.	.	O	.	_	0	SENT_644	[p31l9t474r451b527],

1	Blood	NN	O	blood	_	0	SENT_645	[p31l466t470r606b515],
2	1999	CD	DATE	1999	num	1	SENT_645	[p31l620t474r1036b524],
3	;	:	O	;	_	0	SENT_645	[p31l620t474r1036b524],
4	93:1355	CD	NUMBER	93:1355	number	5	SENT_645	[p31l620t474r1036b524],
5	—	CD	NUMBER	—	dep	1	SENT_645	[p31l620t474r1036b524],
6	63	CD	NUMBER	63	dep	5	SENT_645	[p31l620t474r1036b524],
7	.	.	O	.	_	0	SENT_645	[p31l620t474r1036b524],

1	27	CD	NUMBER	27	_	0	SENT_646	[p31l8t547r75b585],
2	.	.	O	.	_	0	SENT_646	[p31l8t547r75b585],

1	Cools	VBZ	O	cool	_	0	SENT_647	[p31l105t541r239b585],
2	J	NNP	O	J	dobj	1	SENT_647	[p31l260t545r293b595],
3	,	,	O	,	_	0	SENT_647	[p31l260t545r293b595],
4	DeAngelo	NNP	O	DeAngelo	nn	5	SENT_647	[p31l321t541r558b598],
5	DJ	NNP	O	DJ	appos	2	SENT_647	[p31l584t545r653b595],
6	,	,	O	,	_	0	SENT_647	[p31l584t545r653b595],
7	Gotlib	NNP	O	Gotlib	nn	8	SENT_647	[p31l682t541r834b585],
8	J	NNP	O	J	appos	2	SENT_647	[p31l854t545r888b595],
9	,	,	O	,	_	0	SENT_647	[p31l854t545r888b595],
10	et	FW	O	et	nn	11	SENT_647	[p31l916t550r960b585],
11	al.	FW	O	al.	appos	2	SENT_647	[p31l982t541r1035b585],
12	.	.	O	.	_	0	SENT_647	[p31l982t541r1035b585],

1	A	DT	O	a	det	3	SENT_648	[p31l7t617r44b656],
2	tyrosine	NN	O	tyrosine	nn	3	SENT_648	[p31l58t613r249b669],
3	kinase	NN	O	kinase	nsubj	4	SENT_648	[p31l272t613r426b657],
4	created	VBN	O	create	_	0	SENT_648	[p31l449t612r622b657],
5	by	IN	O	by	_	0	SENT_648	[p31l645t612r700b669],
6	fusion	NN	O	fusion	prep_by	4	SENT_648	[p31l720t612r872b657],
7	of	IN	O	of	_	0	SENT_648	[p31l895t612r952b657],
8	the	DT	O	the	det	12	SENT_648	[p31l965t612r1038b657],
9	PDGFA	NN	O	pdgfa	nn	12	SENT_648	[p31l8t687r162b727],
10	and	CC	O	and	_	0	SENT_648	[p31l185t683r273b728],
11	FIP1Ll	NN	O	fip1ll	nn	12	SENT_648	[p31l298t687r453b727],
12	genes	NNS	O	gene	prep_of	6	SENT_648	[p31l480t698r617b740],
13	as	IN	O	as	_	0	SENT_648	[p31l643t698r691b727],
14	a	DT	O	a	det	16	SENT_648	[p31l717t698r742b727],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_648	[p31l767t684r1039b740],
16	target	NN	O	target	prep_as	4	SENT_648	[p31l9t764r152b811],
17	of	IN	O	of	_	0	SENT_648	[p31l176t754r233b799],
18	imatinib	NN	O	imatinib	prep_of	16	SENT_648	[p31l249t754r454b799],
19	in	IN	O	in	_	0	SENT_648	[p31l481t755r527b798],
20	idiopathic	JJ	O	idiopathic	amod	22	SENT_648	[p31l553t754r799b811],
21	hypereosinophilic	JJ	O	hypereosinophilic	amod	22	SENT_648	[p31l826t755r1037b811, p31l10t825r250b882],
22	syndrome	NN	O	syndrome	prep_in	4	SENT_648	[p31l272t825r524b882],
23	.	.	O	.	_	0	SENT_648	[p31l272t825r524b882],

1	N	NN	O	n	nn	3	SENT_649	[p31l547t830r589b870],
2	Engl	NNP	O	Engl	nn	3	SENT_649	[p31l610t826r720b882],
3	J	NNP	O	J	nsubj	4	SENT_649	[p31l736t830r757b876],
4	Med	VBD	O	med	_	0	SENT_649	[p31l776t825r882b870],
5	2003	CD	DATE	2003	dobj	4	SENT_649	[p31l904t829r1036b879],
6	;	:	O	;	_	0	SENT_649	[p31l904t829r1036b879],
7	348:1201	CD	NUMBER	348:1201	number	8	SENT_649	[p31l9t900r325b941],
8	—	CD	NUMBER	—	dep	5	SENT_649	[p31l9t900r325b941],
9	14	CD	NUMBER	14	dep	8	SENT_649	[p31l9t900r325b941],
10	.	.	O	.	_	0	SENT_649	[p31l9t900r325b941],

1	28	CD	NUMBER	28	_	0	SENT_650	[p31l8t972r75b1012],
2	.	.	O	.	_	0	SENT_650	[p31l8t972r75b1012],

1	Cools	VBZ	O	cool	_	0	SENT_651	[p31l105t967r238b1012],
2	J	NNP	O	J	dobj	1	SENT_651	[p31l258t971r291b1021],
3	,	,	O	,	_	0	SENT_651	[p31l258t971r291b1021],
4	Stover	NNP	PERSON	Stover	nn	5	SENT_651	[p31l320t971r465b1012],
5	EH	NNP	O	EH	appos	2	SENT_651	[p31l488t971r574b1021],
6	,	,	O	,	_	0	SENT_651	[p31l488t971r574b1021],
7	Boulton	NNP	PERSON	Boulton	nn	8	SENT_651	[p31l601t967r790b1012],
8	CL	NN	O	cl	appos	2	SENT_651	[p31l815t971r891b1021],
9	,	,	O	,	_	0	SENT_651	[p31l815t971r891b1021],
10	et	FW	O	et	nn	11	SENT_651	[p31l919t976r962b1011],
11	al.	FW	O	al.	appos	2	SENT_651	[p31l983t967r1036b1011],
12	.	.	O	.	_	0	SENT_651	[p31l983t967r1036b1011],

1	PKC412	NN	O	pkc412	nsubj	2	SENT_652	[p31l8t1042r198b1084],
2	overcomes	VBZ	O	overcome	_	0	SENT_652	[p31l222t1053r477b1083],
3	resistance	NN	O	resistance	dobj	2	SENT_652	[p31l501t1039r743b1083],
4	to	TO	O	to	_	0	SENT_652	[p31l766t1048r811b1083],
5	imatinib	NN	O	imatinib	prep_to	2	SENT_652	[p31l834t1038r1037b1083],
6	in	IN	O	in	_	0	SENT_652	[p31l8t1110r54b1153],
7	a	DT	O	a	det	9	SENT_652	[p31l71t1124r96b1153],
8	murine	JJ	O	murine	amod	9	SENT_652	[p31l111t1110r284b1154],
9	model	NN	O	model	prep_in	5	SENT_652	[p31l300t1109r449b1154],
10	of	IN	O	of	_	0	SENT_652	[p31l465t1109r521b1154],
11	FIP1L1	NN	O	fip1l1	prep_of	9	SENT_652	[p31l525t1109r1038b1166],
12	.	.	O	.	_	0	SENT_652	[p31l525t1109r1038b1166],

1	—	NN	O	—	_	0	SENT_653	[p31l525t1109r1038b1166],
2	.	.	O	.	_	0	SENT_653	[p31l525t1109r1038b1166],

1	PDGFRalpha	NN	O	pdgfralpha	nsubj	2	SENT_654	[p31l525t1109r1038b1166],
2	induced	VBD	O	induce	_	0	SENT_654	[p31l8t1180r199b1225],
3	myeloproliferative	JJ	O	myeloproliferative	amod	4	SENT_654	[p31l213t1180r653b1237],
4	disease	NN	O	disease	dobj	2	SENT_654	[p31l668t1180r855b1225],
5	.	.	O	.	_	0	SENT_654	[p31l668t1180r855b1225],

1	Cancer	NN	O	cancer	nn	2	SENT_655	[p31l872t1184r1040b1225],
2	Cell	NN	O	cell	_	0	SENT_655	[p31l9t1252r101b1297],
3	2003	CD	DATE	2003	dep	2	SENT_655	[p31l116t1256r476b1306],
4	;	:	O	;	_	0	SENT_655	[p31l116t1256r476b1306],
5	3:459	CD	NUMBER	3:459	number	6	SENT_655	[p31l116t1256r476b1306],
6	—	CD	NUMBER	—	dep	2	SENT_655	[p31l116t1256r476b1306],
7	69	CD	NUMBER	69	dep	6	SENT_655	[p31l116t1256r476b1306],
8	.	.	O	.	_	0	SENT_655	[p31l116t1256r476b1306],

1	29	CD	NUMBER	29	_	0	SENT_656	[p31l8t1327r75b1366],
2	.	.	O	.	_	0	SENT_656	[p31l8t1327r75b1366],

1	Pardanani	NNP	MISC	Pardanani	nn	2	SENT_657	[p31l104t1322r347b1367],
2	A	NNP	MISC	A	_	0	SENT_657	[p31l363t1326r412b1376],
3	,	,	O	,	_	0	SENT_657	[p31l363t1326r412b1376],
4	Ketterling	NNP	O	Ketterling	nn	5	SENT_657	[p31l434t1322r677b1379],
5	RP	NNP	O	RP	appos	2	SENT_657	[p31l693t1326r767b1376],
6	,	,	O	,	_	0	SENT_657	[p31l693t1326r767b1376],
7	Brockman	NNP	PERSON	Brockman	nn	8	SENT_657	[p31l788t1322r1038b1367],
8	SR	NN	O	sr	appos	2	SENT_657	[p31l10t1397r88b1447],
9	,	,	O	,	_	0	SENT_657	[p31l10t1397r88b1447],
10	et	FW	O	et	nn	11	SENT_657	[p31l111t1403r155b1437],
11	al.	FW	O	al.	appos	2	SENT_657	[p31l172t1394r227b1438],
12	.	.	O	.	_	0	SENT_657	[p31l172t1394r227b1438],

1	CHIC2	NN	O	chic2	nn	2	SENT_658	[p31l250t1397r415b1438],
2	deletion	NN	O	deletion	_	0	SENT_658	[p31l436t1393r649b1447],
3	,	,	O	,	_	0	SENT_658	[p31l436t1393r649b1447],
4	a	DT	O	a	det	5	SENT_658	[p31l671t1408r696b1437],
5	surrogate	NN	O	surrogate	appos	2	SENT_658	[p31l716t1403r949b1450],
6	for	IN	O	for	_	0	SENT_658	[p31l969t1393r1040b1438],
7	FIP1L1	NN	O	fip1l1	prep_for	5	SENT_658	[p31l8t1468r413b1511],
8	.	.	O	.	_	0	SENT_658	[p31l8t1468r413b1511],

1	—	NN	O	—	_	0	SENT_659	[p31l8t1468r413b1511],
2	.	.	O	.	_	0	SENT_659	[p31l8t1468r413b1511],

1	PDGFRA	NN	O	pdgfra	nn	2	SENT_660	[p31l8t1468r413b1511],
2	fusion	NN	O	fusion	nsubj	12	SENT_660	[p31l427t1464r589b1518],
3	,	,	O	,	_	0	SENT_660	[p31l427t1464r589b1518],
4	occurs	VBZ	O	occur	_	0	SENT_660	[p31l608t1479r760b1509],
5	in	IN	O	in	_	0	SENT_660	[p31l776t1465r822b1508],
6	systemic	JJ	O	systemic	amod	7	SENT_660	[p31l837t1465r1039b1521],
7	mastocytosis	NN	O	mastocytosis	prep_in	4	SENT_660	[p31l9t1536r319b1592],
8	associated	VBN	O	associate	partmod	7	SENT_660	[p31l342t1535r592b1580],
9	with	IN	O	with	_	0	SENT_660	[p31l611t1536r718b1580],
10	eosinophilia	NN	O	eosinophilia	prep_with	8	SENT_660	[p31l740t1535r1039b1592],
11	and	CC	O	and	_	0	SENT_660	[p31l9t1606r97b1651],
12	predicts	VBZ	O	predict	conj_and	4	SENT_660	[p31l115t1606r304b1663],
13	response	NN	O	response	dobj	12	SENT_660	[p31l323t1621r535b1663],
14	to	TO	O	to	_	0	SENT_660	[p31l554t1615r598b1651],
15	imatinib	NN	O	imatinib	nn	17	SENT_660	[p31l616t1606r815b1651],
16	mesylate	NN	O	mesylate	nn	17	SENT_660	[p31l834t1606r1039b1663],
17	therapy	NN	O	therapy	prep_to	12	SENT_660	[p31l9t1678r192b1734],
18	.	.	O	.	_	0	SENT_660	[p31l9t1678r192b1734],

1	Blood	NN	O	blood	_	0	SENT_661	[p31l209t1677r348b1722],
2	2003	CD	DATE	2003	num	1	SENT_661	[p31l362t1681r779b1731],
3	;	:	O	;	_	0	SENT_661	[p31l362t1681r779b1731],
4	102:3093	CD	NUMBER	102:3093	number	5	SENT_661	[p31l362t1681r779b1731],
5	—	CD	NUMBER	—	dep	1	SENT_661	[p31l362t1681r779b1731],
6	6	CD	NUMBER	6	dep	5	SENT_661	[p31l362t1681r779b1731],
7	.	.	O	.	_	0	SENT_661	[p31l362t1681r779b1731],

1	30	CD	NUMBER	30	_	0	SENT_662	[p31l9t1753r75b1792],
2	.	.	O	.	_	0	SENT_662	[p31l9t1753r75b1792],

1	Baxter	NNP	PERSON	Baxter	nn	2	SENT_663	[p31l104t1752r256b1792],
2	EJ	NNP	O	EJ	_	0	SENT_663	[p31l270t1752r331b1802],
3	,	,	O	,	_	0	SENT_663	[p31l270t1752r331b1802],
4	Hochhaus	NNP	O	Hochhaus	nn	5	SENT_663	[p31l350t1748r595b1793],
5	A	NNP	O	A	appos	2	SENT_663	[p31l610t1752r659b1802],
6	,	,	O	,	_	0	SENT_663	[p31l610t1752r659b1802],
7	Bolufer	NNP	O	Bolufer	nn	8	SENT_663	[p31l677t1748r856b1793],
8	P	NN	O	p	appos	2	SENT_663	[p31l870t1752r906b1802],
9	,	,	O	,	_	0	SENT_663	[p31l870t1752r906b1802],
10	et	FW	O	et	nn	11	SENT_663	[p31l925t1757r968b1792],
11	al.	FW	O	al.	appos	2	SENT_663	[p31l981t1748r1035b1792],
12	.	.	O	.	_	0	SENT_663	[p31l981t1748r1035b1792],

1	The	DT	O	the	det	2	SENT_664	[p31l7t1819r100b1864],
2	t	NN	O	t	_	0	SENT_664	[p31l127t1823r535b1876],
3	(	CD	NUMBER	(	number	4	SENT_664	[p31l127t1823r535b1876],
4	4	CD	NUMBER	4	num	2	SENT_664	[p31l127t1823r535b1876],
5	;	:	O	;	_	0	SENT_664	[p31l127t1823r535b1876],
6	22	CD	NUMBER	22	number	7	SENT_664	[p31l127t1823r535b1876],
7	)	CD	NUMBER	)	dep	2	SENT_664	[p31l127t1823r535b1876],
8	(	NN	O	(	nn	9	SENT_664	[p31l127t1823r535b1876],
9	q12	NN	O	q12	dep	7	SENT_664	[p31l127t1823r535b1876],
10	;	:	O	;	_	0	SENT_664	[p31l127t1823r535b1876],
11	q11	NN	O	q11	nn	12	SENT_664	[p31l127t1823r535b1876],
12	)	NN	O	)	nsubj	18	SENT_664	[p31l127t1823r535b1876],
13	in	IN	O	in	_	0	SENT_664	[p31l565t1820r611b1863],
14	atypical	JJ	O	atypical	amod	17	SENT_664	[p31l638t1819r825b1876],
15	chronic	JJ	O	chronic	amod	17	SENT_664	[p31l853t1820r1038b1864],
16	myeloid	JJ	O	myeloid	amod	17	SENT_664	[p31l9t1890r204b1947],
17	leukaemia	NN	O	leukaemia	prep_in	12	SENT_664	[p31l223t1890r471b1935],
18	fuses	VBZ	O	fuse	dep	7	SENT_664	[p31l488t1890r607b1935],
19	BCR	NN	O	bcr	dobj	18	SENT_664	[p31l625t1894r736b1937],
20	to	TO	O	to	_	0	SENT_664	[p31l748t1900r792b1935],
21	PDGFRA	NNP	O	PDGFRA	prep_to	18	SENT_664	[p31l810t1894r1036b1937],
22	.	.	O	.	_	0	SENT_664	[p31l810t1894r1036b1937],

1	Hum	NNP	O	Hum	nn	3	SENT_665	[p31l8t1966r129b2006],
2	Mol	NNP	O	Mol	nn	3	SENT_665	[p31l141t1961r235b2006],
3	Genet	NNP	O	Genet	_	0	SENT_665	[p31l249t1965r392b2006],
4	2002	CD	DATE	2002	num	3	SENT_665	[p31l403t1965r791b2015],
5	;	:	O	;	_	0	SENT_665	[p31l403t1965r791b2015],
6	11:1391	CD	NUMBER	11:1391	num	7	SENT_665	[p31l403t1965r791b2015],
7	—	NN	O	—	dep	3	SENT_665	[p31l403t1965r791b2015],
8	7	CD	NUMBER	7	dep	7	SENT_665	[p31l403t1965r791b2015],
9	.	.	O	.	_	0	SENT_665	[p31l403t1965r791b2015],

1	31	CD	NUMBER	31	_	0	SENT_666	[p31l9t2038r75b2076],
2	.	.	O	.	_	0	SENT_666	[p31l9t2038r75b2076],

1	Golub	NNP	ORGANIZATION	Golub	nn	2	SENT_667	[p31l105t2032r254b2077],
2	TR	NN	ORGANIZATION	tr	_	0	SENT_667	[p31l272t2036r357b2086],
3	,	,	O	,	_	0	SENT_667	[p31l272t2036r357b2086],
4	Barker	NNP	PERSON	Barker	nn	5	SENT_667	[p31l379t2032r542b2077],
5	GF	NN	O	gf	appos	2	SENT_667	[p31l560t2036r639b2086],
6	,	,	O	,	_	0	SENT_667	[p31l560t2036r639b2086],
7	Lovett	NNP	PERSON	Lovett	nn	8	SENT_667	[p31l661t2036r812b2077],
8	M	NNP	O	M	appos	2	SENT_667	[p31l827t2036r889b2086],
9	,	,	O	,	_	0	SENT_667	[p31l827t2036r889b2086],
10	Gilliland	NNP	PERSON	Gilliland	nn	11	SENT_667	[p31l911t2032r1038b2077, p31l8t2103r112b2148],
11	DG	NNS	O	dg	appos	2	SENT_667	[p31l143t2107r240b2148],
12	.	.	O	.	_	0	SENT_667	[p31l143t2107r240b2148],

1	Fusion	NN	O	fusion	_	0	SENT_668	[p31l274t2104r441b2148],
2	of	IN	O	of	_	0	SENT_668	[p31l473t2103r531b2148],
3	the	DT	O	the	det	6	SENT_668	[p31l553t2103r627b2147],
4	PDGF	NN	ORGANIZATION	pdgf	nn	6	SENT_668	[p31l659t2107r802b2148],
5	receptor	NN	O	receptor	nn	6	SENT_668	[p31l835t2113r1040b2160],
6	beta	NN	O	beta	prep_of	1	SENT_668	[p31l9t2175r112b2219],
7	to	TO	O	to	_	0	SENT_668	[p31l128t2184r173b2219],
8	a	DT	O	a	det	10	SENT_668	[p31l190t2189r215b2218],
9	novel	JJ	O	novel	amod	10	SENT_668	[p31l230t2175r358b2219],
10	ets	NN	O	et	prep_to	6	SENT_668	[p31l373t2174r547b2219],
11	—	CD	NUMBER	—	npadvmod	6	SENT_668	[p31l373t2174r547b2219],
12	like	IN	O	like	_	0	SENT_668	[p31l373t2174r547b2219],
13	gene	NN	O	gene	prep_like	11	SENT_668	[p31l562t2189r689b2231],
14	,	,	O	,	_	0	SENT_668	[p31l562t2189r689b2231],
15	tel	NN	O	tel	appos	13	SENT_668	[p31l707t2174r777b2228],
16	,	,	O	,	_	0	SENT_668	[p31l707t2174r777b2228],
17	in	IN	O	in	_	0	SENT_668	[p31l795t2175r841b2218],
18	chronic	JJ	O	chronic	amod	20	SENT_668	[p31l857t2174r1039b2219],
19	myelomonocytic	JJ	O	myelomonocytic	amod	20	SENT_668	[p31l9t2246r393b2302],
20	leukemia	NN	O	leukemia	prep_in	13	SENT_668	[p31l406t2245r619b2290],
21	with	IN	O	with	_	0	SENT_668	[p31l630t2246r734b2290],
22	t	NN	O	t	prep_with	6	SENT_668	[p31l748t2249r900b2299],
23	(	CD	NUMBER	(	number	24	SENT_668	[p31l748t2249r900b2299],
24	5	CD	NUMBER	5	num	22	SENT_668	[p31l748t2249r900b2299],
25	;	:	O	;	_	0	SENT_668	[p31l748t2249r900b2299],
26	12	CD	NUMBER	12	number	27	SENT_668	[p31l748t2249r900b2299],
27	)	CD	NUMBER	)	dep	1	SENT_668	[p31l748t2249r900b2299],
28	chromosomal	JJ	O	chromosomal	amod	29	SENT_668	[p31l917t2245r1039b2290, p31l9t2316r228b2361],
29	translocation	NN	O	translocation	dep	27	SENT_668	[p31l254t2317r578b2361],
30	.	.	O	.	_	0	SENT_668	[p31l254t2317r578b2361],

1	Cell	NN	O	cell	_	0	SENT_669	[p31l607t2316r698b2361],
2	1994	CD	DATE	1994	num	1	SENT_669	[p31l726t2320r1038b2370, p31l11t2391r78b2432],
3	;	:	O	;	_	0	SENT_669	[p31l726t2320r1038b2370, p31l11t2391r78b2432],
4	77:30716	CD	NUMBER	77:30716	dep	1	SENT_669	[p31l726t2320r1038b2370, p31l11t2391r78b2432],
5	.	.	O	.	_	0	SENT_669	[p31l726t2320r1038b2370, p31l11t2391r78b2432],

1	32	CD	NUMBER	32	_	0	SENT_670	[p31l9t2464r75b2502],
2	.	.	O	.	_	0	SENT_670	[p31l9t2464r75b2502],

1	Apperley	NNP	O	Apperley	nn	2	SENT_671	[p31l103t2458r315b2514],
2	JF	NNP	O	JF	_	0	SENT_671	[p31l327t2462r384b2512],
3	,	,	O	,	_	0	SENT_671	[p31l327t2462r384b2512],
4	Gardembas	NNP	O	Gardembas	nn	5	SENT_671	[p31l407t2458r679b2503],
5	M	NNP	O	M	appos	2	SENT_671	[p31l699t2462r760b2512],
6	,	,	O	,	_	0	SENT_671	[p31l699t2462r760b2512],
7	Melo	NNP	PERSON	Melo	nn	8	SENT_671	[p31l782t2458r900b2503],
8	JV	NNP	O	JV	appos	2	SENT_671	[p31l915t2462r975b2512],
9	,	,	O	,	_	0	SENT_671	[p31l915t2462r975b2512],
10	et	FW	O	et	nn	11	SENT_671	[p31l998t2468r1041b2502],
11	al.	FW	O	al.	appos	2	SENT_671	[p31l8t2530r61b2574],
12	.	.	O	.	_	0	SENT_671	[p31l8t2530r61b2574],

1	Response	NN	O	response	_	0	SENT_672	[p31l77t2533r302b2586],
2	to	TO	O	to	_	0	SENT_672	[p31l316t2539r359b2574],
3	imatinib	NN	O	imatinib	nn	4	SENT_672	[p31l373t2530r569b2574],
4	mesylate	NN	O	mesylate	prep_to	1	SENT_672	[p31l583t2530r784b2586],
5	in	IN	O	in	_	0	SENT_672	[p31l797t2530r842b2573],
6	patients	NNS	O	patient	prep_in	1	SENT_672	[p31l855t2530r1038b2586],
7	with	IN	O	with	_	0	SENT_672	[p31l6t2600r115b2645],
8	chronic	JJ	O	chronic	amod	10	SENT_672	[p31l147t2601r331b2645],
9	myeloproliferative	JJ	O	myeloproliferative	amod	10	SENT_672	[p31l362t2600r806b2657],
10	diseases	NNS	O	disease	prep_with	1	SENT_672	[p31l838t2600r1037b2645],
11	with	IN	O	with	_	0	SENT_672	[p31l6t2672r114b2716],
12	rearrangements	NNS	O	rearrangement	prep_with	1	SENT_672	[p31l132t2681r505b2728],
13	of	IN	O	of	_	0	SENT_672	[p31l523t2671r579b2716],
14	the	DT	O	the	det	16	SENT_672	[p31l586t2671r658b2716],
15	platelet	NN	O	platelet	nn	16	SENT_672	[p31l673t2671r1039b2728],
16	—	NN	O	—	prep_of	1	SENT_672	[p31l673t2671r1039b2728],
17	derived	VBN	O	derive	partmod	1	SENT_672	[p31l673t2671r1039b2728],
18	growth	NN	O	growth	nn	21	SENT_672	[p31l9t2742r178b2799],
19	factor	NN	O	factor	nn	21	SENT_672	[p31l201t2742r338b2787],
20	receptor	NN	O	receptor	nn	21	SENT_672	[p31l359t2752r556b2799],
21	beta	NN	O	beta	dobj	17	SENT_672	[p31l577t2742r689b2787],
22	.	.	O	.	_	0	SENT_672	[p31l577t2742r689b2787],

1	N	NN	O	n	nn	3	SENT_673	[p31l714t2747r755b2787],
2	Engl	NNP	O	Engl	nn	3	SENT_673	[p31l768t2742r876b2799],
3	J	NNP	O	J	nsubj	4	SENT_673	[p31l893t2747r915b2793],
4	Med	VBD	O	med	_	0	SENT_673	[p31l934t2742r1039b2787],
5	2002	CD	DATE	2002	dobj	4	SENT_673	[p31l9t2817r397b2867],
6	;	:	O	;	_	0	SENT_673	[p31l9t2817r397b2867],
7	347:481	CD	NUMBER	347:481	num	8	SENT_673	[p31l9t2817r397b2867],
8	—	NN	O	—	dep	5	SENT_673	[p31l9t2817r397b2867],
9	7	CD	NUMBER	7	dep	8	SENT_673	[p31l9t2817r397b2867],
10	.	.	O	.	_	0	SENT_673	[p31l9t2817r397b2867],

1	33	CD	NUMBER	33	_	0	SENT_674	[p31l9t2890r75b2928],
2	.	.	O	.	_	0	SENT_674	[p31l9t2890r75b2928],

1	Magnusson	NNP	ORGANIZATION	Magnusson	nn	2	SENT_675	[p31l103t2888r382b2941],
2	MK	NNP	ORGANIZATION	MK	_	0	SENT_675	[p31l398t2888r496b2938],
3	,	,	O	,	_	0	SENT_675	[p31l398t2888r496b2938],
4	Meade	NNP	PERSON	Meade	nn	5	SENT_675	[p31l515t2884r671b2928],
5	KE	NNP	PERSON	KE	appos	2	SENT_675	[p31l689t2888r770b2938],
6	,	,	O	,	_	0	SENT_675	[p31l689t2888r770b2938],
7	N	NNP	O	N	nn	9	SENT_675	[p31l789t2888r831b2929],
8	akamura	NN	O	akamura	nn	9	SENT_675	[p31l833t2884r1040b2929],
9	R	NN	O	r	appos	2	SENT_675	[p31l8t2959r56b3009],
10	,	,	O	,	_	0	SENT_675	[p31l8t2959r56b3009],
11	BarrettJ	NN	O	barrettj	appos	2	SENT_675	[p31l70t2959r271b3009],
12	,	,	O	,	_	0	SENT_675	[p31l70t2959r271b3009],
13	Dunbar	NNP	PERSON	Dunbar	nn	14	SENT_675	[p31l286t2955r467b3000],
14	CE	NNP	O	CE	appos	2	SENT_675	[p31l477t2959r556b3000],
15	.	.	O	.	_	0	SENT_675	[p31l477t2959r556b3000],

1	Activity	NN	O	activity	nsubj	13	SENT_676	[p31l570t2956r746b3012],
2	of	IN	O	of	_	0	SENT_676	[p31l756t2955r813b3000],
3	STI5	NN	O	sti5	prep_of	1	SENT_676	[p31l816t2959r921b3000],
4	71	CD	NUMBER	71	num	3	SENT_676	[p31l926t2959r982b2999],
5	in	IN	O	in	_	0	SENT_676	[p31l994t2956r1039b2999],
6	chronic	JJ	O	chronic	amod	8	SENT_676	[p31l9t3027r188b3071],
7	myelomonocytic	JJ	O	myelomonocytic	amod	8	SENT_676	[p31l217t3027r608b3083],
8	leukemia	NN	O	leukemia	prep_in	3	SENT_676	[p31l637t3026r853b3071],
9	with	IN	O	with	_	0	SENT_676	[p31l880t3026r986b3071],
10	a	DT	O	a	det	12	SENT_676	[p31l1015t3041r1040b3070],
11	platelet	NN	O	platelet	nn	12	SENT_676	[p31l8t3097r374b3154],
12	—	NN	O	—	prep_with	8	SENT_676	[p31l8t3097r374b3154],
13	derived	VBN	O	derive	_	0	SENT_676	[p31l8t3097r374b3154],
14	growth	NN	O	growth	nn	16	SENT_676	[p31l390t3097r560b3154],
15	factor	NN	O	factor	nn	16	SENT_676	[p31l576t3097r714b3142],
16	beta	NN	O	beta	tmod	13	SENT_676	[p31l729t3098r828b3142],
17	receptor	NN	O	receptor	nn	19	SENT_676	[p31l844t3107r1040b3154],
18	ﬁision	NN	O	ﬁision	nn	19	SENT_676	[p31l9t3168r158b3213],
19	oncogene	NN	O	oncogene	dep	16	SENT_676	[p31l172t3183r414b3225],
20	.	.	O	.	_	0	SENT_676	[p31l172t3183r414b3225],

1	Blood	NN	O	blood	_	0	SENT_677	[p31l430t3168r570b3213],
2	2002	CD	DATE	2002	num	1	SENT_677	[p31l584t3172r1031b3222],
3	;	:	O	;	_	0	SENT_677	[p31l584t3172r1031b3222],
4	100:1088	CD	NUMBER	100:1088	number	5	SENT_677	[p31l584t3172r1031b3222],
5	—	CD	NUMBER	—	dep	1	SENT_677	[p31l584t3172r1031b3222],
6	91	CD	NUMBER	91	dep	5	SENT_677	[p31l584t3172r1031b3222],
7	.	.	O	.	_	0	SENT_677	[p31l584t3172r1031b3222],

1	34	CD	NUMBER	34	_	0	SENT_678	[p31l9t3245r75b3283],
2	.	.	O	.	_	0	SENT_678	[p31l9t3245r75b3283],

1	James	NNP	PERSON	James	nn	2	SENT_679	[p31l99t3243r243b3290],
2	C	NNP	PERSON	C	_	0	SENT_679	[p31l270t3243r317b3293],
3	,	,	O	,	_	0	SENT_679	[p31l270t3243r317b3293],
4	Ugo	NNP	PERSON	Ugo	nn	5	SENT_679	[p31l346t3243r444b3296],
5	V	NNP	PERSON	V	appos	2	SENT_679	[p31l469t3243r508b3293],
6	,	,	O	,	_	0	SENT_679	[p31l469t3243r508b3293],
7	Le	NNP	PERSON	Le	nn	9	SENT_679	[p31l537t3243r590b3283],
8	Couedic	NNP	PERSON	Couedic	nn	9	SENT_679	[p31l617t3239r809b3284],
9	JP	NNP	O	JP	appos	2	SENT_679	[p31l830t3243r887b3293],
10	,	,	O	,	_	0	SENT_679	[p31l830t3243r887b3293],
11	et	FW	O	et	nn	12	SENT_679	[p31l917t3248r960b3283],
12	al.	FW	O	al.	appos	2	SENT_679	[p31l983t3239r1035b3283],
13	.	.	O	.	_	0	SENT_679	[p31l983t3239r1035b3283],

1	Aunique	JJ	MISC	aunique	amod	4	SENT_680	[p31l7t3311r219b3367],
2	clonal	JJ	O	clonal	amod	4	SENT_680	[p31l245t3310r387b3355],
3	JAK2	NN	O	jak2	nn	4	SENT_680	[p31l405t3314r528b3361],
4	mutation	NN	O	mutation	nsubj	9	SENT_680	[p31l553t3311r770b3355],
5	leading	VBG	O	lead	partmod	4	SENT_680	[p31l794t3310r971b3367],
6	to	TO	O	to	_	0	SENT_680	[p31l994t3320r1038b3355],
7	constitutive	JJ	O	constitutive	amod	8	SENT_680	[p31l9t3382r277b3426],
8	signalling	NN	O	signalling	prep_to	5	SENT_680	[p31l294t3381r525b3438],
9	causes	VBZ	O	cause	_	0	SENT_680	[p31l540t3396r689b3426],
10	polycythaemia	NN	O	polycythaemia	nn	11	SENT_680	[p31l705t3381r1040b3438],
11	vera	NN	O	vera	dobj	9	SENT_680	[p31l6t3467r116b3497],
12	.	.	O	.	_	0	SENT_680	[p31l6t3467r116b3497],

1	Nature	NNP	O	Nature	_	0	SENT_681	[p31l132t3457r294b3497],
2	2005	CD	DATE	2005	num	1	SENT_681	[p31l308t3456r725b3506],
3	;	:	O	;	_	0	SENT_681	[p31l308t3456r725b3506],
4	434:1144	CD	NUMBER	434:1144	number	5	SENT_681	[p31l308t3456r725b3506],
5	—	CD	NUMBER	—	dep	1	SENT_681	[p31l308t3456r725b3506],
6	8	CD	NUMBER	8	dep	5	SENT_681	[p31l308t3456r725b3506],
7	.	.	O	.	_	0	SENT_681	[p31l308t3456r725b3506],

1	35	CD	NUMBER	35	_	0	SENT_682	[p31l9t3530r75b3568],
2	.	.	O	.	_	0	SENT_682	[p31l9t3530r75b3568],

1	Kralovics	NNS	O	kralovic	nn	2	SENT_683	[p31l105t3524r320b3569],
2	R	NN	O	r	_	0	SENT_683	[p31l338t3528r386b3578],
3	,	,	O	,	_	0	SENT_683	[p31l338t3528r386b3578],
4	Passamonti	NN	O	passamontus	nn	5	SENT_683	[p31l406t3525r680b3568],
5	F	NN	O	f	appos	2	SENT_683	[p31l696t3528r731b3578],
6	,	,	O	,	_	0	SENT_683	[p31l696t3528r731b3578],
7	Buser	NNP	ORGANIZATION	Buser	nn	8	SENT_683	[p31l751t3528r887b3569],
8	AS	NNP	ORGANIZATION	AS	appos	2	SENT_683	[p31l900t3528r978b3578],
9	,	,	O	,	_	0	SENT_683	[p31l900t3528r978b3578],
10	et	FW	O	et	nn	11	SENT_683	[p31l999t3533r1041b3568],
11	al.	FW	O	al.	appos	2	SENT_683	[p31l9t3594r61b3639],
12	.	.	O	.	_	0	SENT_683	[p31l9t3594r61b3639],

1	A	DT	O	a	det	3	SENT_684	[p31l85t3599r122b3638],
2	gain	NN	O	gain	nn	3	SENT_684	[p31l142t3594r533b3651],
3	—	NN	O	—	_	0	SENT_684	[p31l142t3594r533b3651],
4	of	IN	O	of	_	0	SENT_684	[p31l142t3594r533b3651],
5	—	CD	NUMBER	—	num	7	SENT_684	[p31l142t3594r533b3651],
6	ﬁ1nction	NN	O	ﬁ1nction	nn	7	SENT_684	[p31l142t3594r533b3651],
7	mutation	NN	O	mutation	prep_of	3	SENT_684	[p31l556t3595r773b3639],
8	of	IN	O	of	_	0	SENT_684	[p31l795t3594r852b3639],
9	]	CD	NUMBER	]	num	10	SENT_684	[p31l855t3598r970b3651],
10	AK2	NN	O	ak2	prep_of	7	SENT_684	[p31l855t3598r970b3651],
11	in	IN	O	in	_	0	SENT_684	[p31l993t3595r1038b3638],
12	myeloproliferative	JJ	O	myeloproliferative	amod	13	SENT_684	[p31l9t3665r438b3722],
13	disorders	NNS	O	disorder	prep_in	3	SENT_684	[p31l458t3665r692b3710],
14	.	.	O	.	_	0	SENT_684	[p31l458t3665r692b3710],

1	N	NN	O	n	nn	2	SENT_685	[p31l714t3670r756b3710],
2	EnglJ	NN	O	englj	nsubj	3	SENT_685	[p31l774t3666r918b3722],
3	Med	VBD	O	med	_	0	SENT_685	[p31l935t3665r1039b3710],
4	2005	CD	DATE	2005	dobj	3	SENT_685	[p31l9t3740r456b3790],
5	;	:	O	;	_	0	SENT_685	[p31l9t3740r456b3790],
6	352:1779	CD	NUMBER	352:1779	number	7	SENT_685	[p31l9t3740r456b3790],
7	—	CD	NUMBER	—	dep	4	SENT_685	[p31l9t3740r456b3790],
8	90	CD	NUMBER	90	dep	7	SENT_685	[p31l9t3740r456b3790],
9	.	.	O	.	_	0	SENT_685	[p31l9t3740r456b3790],

1	mutated	VBN	O	mutate	csubj	6	SENT_686	[p31l1113t115r1309b160],
2	c	NN	O	c	prep	1	SENT_686	[p31l1331t115r1439b160],
3	—	CD	NUMBER	—	num	5	SENT_686	[p31l1331t115r1439b160],
4	kit	NN	O	kit	nn	5	SENT_686	[p31l1331t115r1439b160],
5	receptors	NNS	O	receptor	dep	2	SENT_686	[p31l1458t125r1675b172],
6	found	VBN	O	find	_	0	SENT_686	[p31l1699t115r1839b160],
7	in	IN	O	in	_	0	SENT_686	[p31l1860t116r1906b159],
8	mast	NN	O	mast	nn	10	SENT_686	[p31l1928t125r2045b159],
9	cell	NN	O	cell	nn	10	SENT_686	[p31l2065t116r2144b160],
10	neoplasms	NNS	O	neoplasm	prep_in	6	SENT_686	[p31l1113t186r1382b243],
11	.	.	O	.	_	0	SENT_686	[p31l1113t186r1382b243],

1	Oncogene	NN	O	oncogene	_	0	SENT_687	[p31l1399t190r1639b243],
2	2003	CD	DATE	2003	num	1	SENT_687	[p31l1653t190r2011b240],
3	;	:	O	;	_	0	SENT_687	[p31l1653t190r2011b240],
4	22:660	CD	NUMBER	22:660	number	5	SENT_687	[p31l1653t190r2011b240],
5	-4	CD	NUMBER	-4	dep	1	SENT_687	[p31l1653t190r2011b240],
6	.	.	O	.	_	0	SENT_687	[p31l1653t190r2011b240],

1	40	CD	NUMBER	40	_	0	SENT_688	[p31l1112t262r1179b301],
2	.	.	O	.	_	0	SENT_688	[p31l1112t262r1179b301],

1	Kuno	NNP	PERSON	Kuno	nn	2	SENT_689	[p31l1209t261r1339b303],
2	Y	NN	PERSON	y	_	0	SENT_689	[p31l1356t261r1395b311],
3	,	,	O	,	_	0	SENT_689	[p31l1356t261r1395b311],
4	Abe	NN	O	abe	nn	5	SENT_689	[p31l1414t257r1508b301],
5	A	NN	O	a	appos	2	SENT_689	[p31l1523t261r1572b311],
6	,	,	O	,	_	0	SENT_689	[p31l1523t261r1572b311],
7	Emi	NNP	ORGANIZATION	Emi	nn	8	SENT_689	[p31l1593t258r1690b301],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_689	[p31l1706t261r1759b311],
9	,	,	O	,	_	0	SENT_689	[p31l1706t261r1759b311],
10	et	FW	O	et	nn	11	SENT_689	[p31l1780t266r1824b301],
11	al.	FW	O	al.	appos	2	SENT_689	[p31l1839t257r1893b301],
12	.	.	O	.	_	0	SENT_689	[p31l1839t257r1893b301],

1	Constitutive	JJ	O	constitutive	amod	3	SENT_690	[p31l1914t258r2142b302, p31l1113t329r1196b373],
2	kinase	NN	O	kinase	nn	3	SENT_690	[p31l1209t329r1365b373],
3	activation	NN	O	activation	_	0	SENT_690	[p31l1378t329r1614b373],
4	of	IN	O	of	_	0	SENT_690	[p31l1628t328r1685b373],
5	the	DT	O	the	det	6	SENT_690	[p31l1688t328r1762b372],
6	TEL	NN	O	tel	prep_of	3	SENT_690	[p31l1774t328r1978b385],
7	.	.	O	.	_	0	SENT_690	[p31l1774t328r1978b385],

1	—	NN	O	—	_	0	SENT_691	[p31l1774t328r1978b385],
2	.	.	O	.	_	0	SENT_691	[p31l1774t328r1978b385],

1	Syk	NN	MISC	syk	nn	3	SENT_692	[p31l1774t328r1978b385],
2	fusion	NN	O	fusion	nn	3	SENT_692	[p31l1989t328r2143b373],
3	gene	NN	O	gene	_	0	SENT_692	[p31l1113t414r1227b456],
4	in	IN	O	in	_	0	SENT_692	[p31l1260t400r1306b443],
5	myelodysplastic	JJ	O	myelodysplastic	amod	6	SENT_692	[p31l1340t399r1729b456],
6	syndrome	NN	O	syndrome	prep_in	3	SENT_692	[p31l1763t399r2003b456],
7	with	IN	O	with	_	0	SENT_692	[p31l2034t399r2143b444],
8	t	NN	O	t	prep_with	6	SENT_692	[p31l1113t474r1520b527],
9	(	CD	NUMBER	(	number	10	SENT_692	[p31l1113t474r1520b527],
10	9	CD	NUMBER	9	num	8	SENT_692	[p31l1113t474r1520b527],
11	;	:	O	;	_	0	SENT_692	[p31l1113t474r1520b527],
12	12	CD	NUMBER	12	number	13	SENT_692	[p31l1113t474r1520b527],
13	)	CD	NUMBER	)	dep	3	SENT_692	[p31l1113t474r1520b527],
14	(	NN	O	(	nn	15	SENT_692	[p31l1113t474r1520b527],
15	q22	NN	O	q22	dep	13	SENT_692	[p31l1113t474r1520b527],
16	;	:	O	;	_	0	SENT_692	[p31l1113t474r1520b527],
17	p12	NN	O	p12	dep	3	SENT_692	[p31l1113t474r1520b527],
18	)	NN	O	)	dep	17	SENT_692	[p31l1113t474r1520b527],
19	.	.	O	.	_	0	SENT_692	[p31l1113t474r1520b527],

1	Blood	NN	O	blood	_	0	SENT_693	[p31l1536t470r1676b515],
2	2001	CD	DATE	2001	num	1	SENT_693	[p31l1690t474r2077b524],
3	;	:	O	;	_	0	SENT_693	[p31l1690t474r2077b524],
4	97:1050	CD	NUMBER	97:1050	number	5	SENT_693	[p31l1690t474r2077b524],
5	-5	CD	NUMBER	-5	dep	1	SENT_693	[p31l1690t474r2077b524],
6	.	.	O	.	_	0	SENT_693	[p31l1690t474r2077b524],

1	41	CD	NUMBER	41	_	0	SENT_694	[p31l1112t547r1179b585],
2	.	.	O	.	_	0	SENT_694	[p31l1112t547r1179b585],

1	Van	NNP	PERSON	Van	nn	3	SENT_695	[p31l1207t545r1295b585],
2	Etten	NNP	PERSON	Etten	nn	3	SENT_695	[p31l1315t545r1440b585],
3	RA	NN	O	ra	_	0	SENT_695	[p31l1459t545r1544b595],
4	,	,	O	,	_	0	SENT_695	[p31l1459t545r1544b595],
5	Shannon	NNP	PERSON	Shannon	nn	6	SENT_695	[p31l1568t541r1782b585],
6	KM	NNP	PERSON	KM	appos	3	SENT_695	[p31l1801t545r1900b587],
7	.	.	O	.	_	0	SENT_695	[p31l1801t545r1900b587],

1	Focus	NN	O	focus	_	0	SENT_696	[p31l1922t545r2061b586],
2	on	IN	O	on	_	0	SENT_696	[p31l2083t555r2143b586],
3	myeloproliferative	JJ	O	myeloproliferative	amod	4	SENT_696	[p31l1113t612r1548b669],
4	diseases	NNS	O	disease	prep_on	1	SENT_696	[p31l1574t612r1766b657],
5	and	CC	O	and	_	0	SENT_696	[p31l1792t612r1879b657],
6	myelodysplastic	JJ	O	myelodysplastic	amod	7	SENT_696	[p31l1903t612r2142b669, p31l1112t683r1263b740],
7	syndromes	NNS	O	syndrome	prep_on	1	SENT_696	[p31l1285t683r1549b740],
8	.	.	O	.	_	0	SENT_696	[p31l1285t683r1549b740],

1	Cancer	NN	O	cancer	nn	2	SENT_697	[p31l1574t687r1736b728],
2	Cell	NN	O	cell	_	0	SENT_697	[p31l1755t683r1844b728],
3	2004	CD	DATE	2004	dep	2	SENT_697	[p31l1865t687r2143b737],
4	;	:	O	;	_	0	SENT_697	[p31l1865t687r2143b737],
5	6:547	CD	NUMBER	6:547	number	6	SENT_697	[p31l1865t687r2143b737],
6	—	CD	NUMBER	—	dep	2	SENT_697	[p31l1865t687r2143b737],
7	52	CD	NUMBER	52	dep	6	SENT_697	[p31l1114t758r1181b799],
8	.	.	O	.	_	0	SENT_697	[p31l1114t758r1181b799],

1	42	CD	NUMBER	42	_	0	SENT_698	[p31l1112t831r1179b869],
2	.	.	O	.	_	0	SENT_698	[p31l1112t831r1179b869],

1	Klion	NNP	ORGANIZATION	Klion	nn	2	SENT_699	[p31l1209t825r1338b871],
2	AD	NN	ORGANIZATION	ad	_	0	SENT_699	[p31l1350t829r1437b879],
3	,	,	O	,	_	0	SENT_699	[p31l1350t829r1437b879],
4	Noel	NNP	PERSON	Noel	nn	5	SENT_699	[p31l1454t825r1566b870],
5	P	NN	PERSON	p	appos	2	SENT_699	[p31l1580t829r1616b879],
6	,	,	O	,	_	0	SENT_699	[p31l1580t829r1616b879],
7	Akin	JJ	O	akin	amod	8	SENT_699	[p31l1631t825r1744b870],
8	C	NN	O	c	appos	2	SENT_699	[p31l1759t829r1806b879],
9	,	,	O	,	_	0	SENT_699	[p31l1759t829r1806b879],
10	et	FW	O	et	nn	11	SENT_699	[p31l1824t835r1866b869],
11	al.	FW	O	al.	appos	2	SENT_699	[p31l1878t825r1930b869],
12	.	.	O	.	_	0	SENT_699	[p31l1878t825r1930b869],

1	Elevated	JJ	O	elevated	amod	4	SENT_700	[p31l1948t825r2143b870],
2	serum	NN	O	serum	nn	4	SENT_700	[p31l1114t911r1261b941],
3	tryptase	NN	O	tryptase	nn	4	SENT_700	[p31l1275t906r1460b953],
4	levels	NNS	O	level	nsubj	5	SENT_700	[p31l1474t896r1601b941],
5	identity	NN	O	identity	_	0	SENT_700	[p31l1615t896r1795b953],
6	a	DT	O	a	det	7	SENT_700	[p31l1806t911r1831b940],
7	subset	NN	O	subset	dobj	5	SENT_700	[p31l1845t896r1998b941],
8	of	IN	O	of	_	0	SENT_700	[p31l2009t896r2066b941],
9	patients	NNS	O	patient	prep_of	7	SENT_700	[p31l2068t911r2143b953, p31l1113t968r1242b1011],
10	with	IN	O	with	_	0	SENT_700	[p31l1253t968r1359b1012],
11	a	DT	O	a	det	15	SENT_700	[p31l1371t982r1396b1011],
12	myeloproliferative	JJ	O	myeloproliferative	amod	15	SENT_700	[p31l1408t967r1837b1024],
13	variant	JJ	O	variant	amod	15	SENT_700	[p31l1847t968r2012b1012],
14	ofid	NN	O	ofid	nn	15	SENT_700	[p31l2022t967r2143b1012],
15	—	NN	O	—	prep_with	9	SENT_700	[p31l2022t967r2143b1012],
16	iopathic	JJ	O	iopathic	amod	18	SENT_700	[p31l1113t1038r1300b1095],
17	hypereosinophilic	JJ	O	hypereosinophilic	amod	18	SENT_700	[p31l1314t1038r1728b1095],
18	syndrome	NN	O	syndrome	dep	5	SENT_700	[p31l1743t1038r1971b1095],
19	associated	VBN	O	associate	partmod	18	SENT_700	[p31l1986t1039r2143b1083, p31l1113t1109r1212b1154],
20	with	IN	O	with	_	0	SENT_700	[p31l1234t1110r1341b1154],
21	tissue	NN	O	tissue	nn	22	SENT_700	[p31l1365t1110r1503b1154],
22	ﬁbrosis	NN	O	ﬁbrosis	prep_with	19	SENT_700	[p31l1527t1109r1722b1163],
23	,	,	O	,	_	0	SENT_700	[p31l1527t1109r1722b1163],
24	poor	JJ	O	poor	amod	25	SENT_700	[p31l1748t1124r1862b1166],
25	prognosis	NN	O	prognosis	conj_and	22	SENT_700	[p31l1884t1110r2140b1166],
26	,	,	O	,	_	0	SENT_700	[p31l1884t1110r2140b1166],
27	and	CC	O	and	_	0	SENT_700	[p31l1113t1180r1201b1225],
28	imatinib	NN	O	imatinib	nn	29	SENT_700	[p31l1221t1180r1424b1225],
29	responsiveness	NN	O	responsiveness	conj_and	22	SENT_700	[p31l1445t1181r1824b1237],
30	.	.	O	.	_	0	SENT_700	[p31l1445t1181r1824b1237],

1	Blood	NN	O	blood	_	0	SENT_701	[p31l1846t1180r1988b1225],
2	2003	CD	DATE	2003	num	1	SENT_701	[p31l2009t1184r2141b1234],
3	;	:	O	;	_	0	SENT_701	[p31l2009t1184r2141b1234],
4	101:4660	CD	NUMBER	101:4660	number	5	SENT_701	[p31l1115t1256r1402b1297],
5	—	CD	NUMBER	—	dep	1	SENT_701	[p31l1115t1256r1402b1297],
6	6	CD	NUMBER	6	dep	5	SENT_701	[p31l1115t1256r1402b1297],
7	.	.	O	.	_	0	SENT_701	[p31l1115t1256r1402b1297],

1	43	CD	NUMBER	43	_	0	SENT_702	[p31l1112t1328r1179b1366],
2	.	.	O	.	_	0	SENT_702	[p31l1112t1328r1179b1366],

1	Gotlib	NNP	O	Gotlib	nn	2	SENT_703	[p31l1209t1322r1355b1367],
2	J	NNP	O	J	_	0	SENT_703	[p31l1363t1326r1395b1376],
3	,	,	O	,	_	0	SENT_703	[p31l1363t1326r1395b1376],
4	Berube	NNP	PERSON	Berube	nn	5	SENT_703	[p31l1411t1322r1573b1367],
5	C	NNP	O	C	appos	2	SENT_703	[p31l1586t1326r1632b1376],
6	,	,	O	,	_	0	SENT_703	[p31l1586t1326r1632b1376],
7	Ruan	NNP	PERSON	Ruan	nn	8	SENT_703	[p31l1647t1326r1769b1369],
8	J	NNP	PERSON	J	appos	2	SENT_703	[p31l1776t1326r1809b1376],
9	,	,	O	,	_	0	SENT_703	[p31l1776t1326r1809b1376],
10	et	FW	O	et	nn	11	SENT_703	[p31l1825t1331r1867b1366],
11	al.	FW	O	al.	appos	2	SENT_703	[p31l1877t1322r1928b1366],
12	.	.	O	.	_	0	SENT_703	[p31l1877t1322r1928b1366],

1	PKC412	NN	O	pkc412	nsubj	10	SENT_704	[p31l1944t1326r2140b1376],
2	,	,	O	,	_	0	SENT_704	[p31l1944t1326r2140b1376],
3	inhibitor	NN	O	inhibitor	appos	1	SENT_704	[p31l1113t1393r1325b1438],
4	of	IN	O	of	_	0	SENT_704	[p31l1345t1393r1402b1438],
5	the	DT	O	the	det	8	SENT_704	[p31l1412t1394r1486b1438],
6	KIT	NN	O	kit	nn	8	SENT_704	[p31l1506t1397r1596b1439],
7	tyrosine	NN	O	tyrosine	nn	8	SENT_704	[p31l1615t1394r1807b1450],
8	kinase	NN	O	kinase	prep_of	3	SENT_704	[p31l1827t1393r1996b1447],
9	,	,	O	,	_	0	SENT_704	[p31l1827t1393r1996b1447],
10	demonstrates	VBZ	O	demonstrate	_	0	SENT_704	[p31l2019t1393r2142b1438, p31l1113t1474r1332b1509],
11	efficacy	NN	O	efficacy	dobj	10	SENT_704	[p31l1348t1464r1526b1521],
12	in	IN	O	in	_	0	SENT_704	[p31l1536t1465r1582b1508],
13	mast	NN	O	mast	nn	15	SENT_704	[p31l1594t1474r1711b1508],
14	cell	NN	O	cell	nn	15	SENT_704	[p31l1721t1464r1800b1509],
15	leukemia	NN	O	leukemia	prep_in	10	SENT_704	[p31l1812t1465r2028b1509],
16	with	IN	O	with	_	0	SENT_704	[p31l2038t1465r2143b1509],
17	the	DT	O	the	det	20	SENT_704	[p31l1113t1536r1185b1580],
18	D816V	NN	O	d816v	nn	20	SENT_704	[p31l1202t1539r1367b1580],
19	KIT	NN	O	kit	nn	20	SENT_704	[p31l1382t1539r1472b1581],
20	mutation	NN	O	mutation	prep_with	15	SENT_704	[p31l1487t1536r1722b1580],
21	.	.	O	.	_	0	SENT_704	[p31l1487t1536r1722b1580],

1	Blood	NN	O	blood	_	0	SENT_705	[p31l1742t1535r1884b1580],
2	2003	CD	DATE	2003	num	1	SENT_705	[p31l1901t1539r2140b1589],
3	;	:	O	;	_	0	SENT_705	[p31l1901t1539r2140b1589],
4	102	CD	NUMBER	102	dep	1	SENT_705	[p31l1901t1539r2140b1589],
5	:	:	O	:	_	0	SENT_705	[p31l1901t1539r2140b1589],
6	Suppl	NNP	O	Suppl	dep	4	SENT_705	[p31l1114t1607r1396b1663],
7	:919	CD	NUMBER	:919	num	8	SENT_705	[p31l1114t1607r1396b1663],
8	a.	NN	O	a.	npadvmod	9	SENT_705	[p31l1114t1607r1396b1663],
9	abstract	JJ	O	abstract	amod	6	SENT_705	[p31l1413t1606r1612b1651],
10	.	.	O	.	_	0	SENT_705	[p31l1413t1606r1612b1651],

1	44	CD	NUMBER	44	_	0	SENT_706	[p31l1112t1683r1179b1721],
2	.	.	O	.	_	0	SENT_706	[p31l1112t1683r1179b1721],

1	Kindler	NN	PERSON	kindler	nn	2	SENT_707	[p31l1209t1677r1386b1723],
2	T	NN	O	t	_	0	SENT_707	[p31l1401t1681r1442b1731],
3	,	,	O	,	_	0	SENT_707	[p31l1401t1681r1442b1731],
4	Breitenbuecher	NNP	PERSON	Breitenbuecher	nn	5	SENT_707	[p31l1463t1677r1825b1722],
5	F	NN	PERSON	f	appos	2	SENT_707	[p31l1841t1681r1876b1731],
6	,	,	O	,	_	0	SENT_707	[p31l1841t1681r1876b1731],
7	Marx	NNP	PERSON	Marx	nn	8	SENT_707	[p31l1896t1681r2018b1721],
8	A	NNP	O	A	appos	2	SENT_707	[p31l2033t1681r2081b1731],
9	,	,	O	,	_	0	SENT_707	[p31l2033t1681r2081b1731],
10	et	FW	O	et	nn	11	SENT_707	[p31l2103t1686r2146b1721],
11	al.	FW	O	al.	appos	2	SENT_707	[p31l1113t1748r1166b1793],
12	.	.	O	.	_	0	SENT_707	[p31l1113t1748r1166b1793],

1	Efficacy	NN	O	efficacy	_	0	SENT_708	[p31l1189t1748r1379b1805],
2	and	CC	O	and	_	0	SENT_708	[p31l1397t1748r1485b1793],
3	safety	NN	O	safety	conj_and	1	SENT_708	[p31l1507t1748r1645b1805],
4	of	IN	O	of	_	0	SENT_708	[p31l1664t1748r1721b1793],
5	imatinib	NN	O	imatinib	prep_of	1	SENT_708	[p31l1731t1748r1934b1793],
6	in	IN	O	in	_	0	SENT_708	[p31l1955t1749r2001b1792],
7	adult	JJ	O	adult	amod	8	SENT_708	[p31l2022t1748r2146b1793],
8	patients	NNS	O	patient	prep_in	5	SENT_708	[p31l1112t1820r1303b1876],
9	with	IN	O	with	_	0	SENT_708	[p31l1327t1820r1435b1864],
10	c	NN	O	c	prep_with	8	SENT_708	[p31l1461t1820r1776b1876],
11	—	CD	NUMBER	—	num	12	SENT_708	[p31l1461t1820r1776b1876],
12	kit	NN	O	kit	dep	1	SENT_708	[p31l1461t1820r1776b1876],
13	—	CD	NUMBER	—	num	17	SENT_708	[p31l1461t1820r1776b1876],
14	positive	JJ	O	positive	amod	15	SENT_708	[p31l1461t1820r1776b1876],
15	acute	JJ	O	acute	amod	17	SENT_708	[p31l1801t1829r1926b1864],
16	myeloid	JJ	O	myeloid	amod	17	SENT_708	[p31l1951t1819r2143b1876],
17	leukemia	NN	O	leukemia	dep	12	SENT_708	[p31l1112t1890r1345b1935],
18	.	.	O	.	_	0	SENT_708	[p31l1112t1890r1345b1935],

1	Blood	NN	O	blood	_	0	SENT_709	[p31l1361t1890r1501b1935],
2	2004	CD	DATE	2004	num	1	SENT_709	[p31l1515t1894r1962b1944],
3	;	:	O	;	_	0	SENT_709	[p31l1515t1894r1962b1944],
4	103:3644	CD	NUMBER	103:3644	number	5	SENT_709	[p31l1515t1894r1962b1944],
5	—	CD	NUMBER	—	dep	1	SENT_709	[p31l1515t1894r1962b1944],
6	54	CD	NUMBER	54	dep	5	SENT_709	[p31l1515t1894r1962b1944],
7	.	.	O	.	_	0	SENT_709	[p31l1515t1894r1962b1944],

1	45	CD	NUMBER	45	_	0	SENT_710	[p31l1112t1967r1179b2005],
2	.	.	O	.	_	0	SENT_710	[p31l1112t1967r1179b2005],

1	Wadleigh	NNP	PERSON	Wadleigh	nn	2	SENT_711	[p31l1207t1961r1432b2018],
2	M	NNP	O	M	_	0	SENT_711	[p31l1454t1965r1514b2015],
3	,	,	O	,	_	0	SENT_711	[p31l1454t1965r1514b2015],
4	DeAngelo	NNP	PERSON	DeAngelo	nn	5	SENT_711	[p31l1540t1961r1773b2018],
5	DJ	NNP	PERSON	DJ	appos	2	SENT_711	[p31l1796t1965r1864b2015],
6	,	,	O	,	_	0	SENT_711	[p31l1796t1965r1864b2015],
7	Griffin	NNP	PERSON	Griffin	nn	8	SENT_711	[p31l1891t1961r2051b2006],
8	JD	NNP	O	JD	appos	2	SENT_711	[p31l2069t1965r2140b2015],
9	,	,	O	,	_	0	SENT_711	[p31l2069t1965r2140b2015],
10	Stone	NNP	O	Stone	nn	11	SENT_711	[p31l1114t2036r1248b2077],
11	RM	NN	O	rm	appos	2	SENT_711	[p31l1264t2036r1361b2079],
12	.	.	O	.	_	0	SENT_711	[p31l1264t2036r1361b2079],

1	After	IN	O	after	dep	10	SENT_712	[p31l1379t2032r1501b2076],
2	chronic	JJ	O	chronic	amod	6	SENT_712	[p31l1516t2032r1699b2077],
3	myelogenous	JJ	O	myelogenous	amod	6	SENT_712	[p31l1715t2033r2035b2089],
4	leu	NN	O	leu	nn	6	SENT_712	[p31l2052t2033r2142b2077],
5	—	NN	O	—	nn	6	SENT_712	[p31l2052t2033r2142b2077],
6	kemia	NN	O	kemia	pobj	1	SENT_712	[p31l1113t2104r1272b2148],
7	:	:	O	:	_	0	SENT_712	[p31l1113t2104r1272b2148],
8	tyrosine	NN	O	tyrosine	nn	10	SENT_712	[p31l1301t2104r1488b2160],
9	kinase	NN	O	kinase	nn	10	SENT_712	[p31l1514t2103r1665b2148],
10	inhibitors	NNS	O	inhibitor	_	0	SENT_712	[p31l1690t2103r1922b2148],
11	in	IN	O	in	_	0	SENT_712	[p31l1948t2104r1994b2147],
12	other	JJ	O	other	amod	14	SENT_712	[p31l2020t2104r2145b2148],
13	hematologic	JJ	O	hematologic	amod	14	SENT_712	[p31l1113t2174r1403b2231],
14	malignancies	NNS	O	malignancy	prep_in	10	SENT_712	[p31l1418t2174r1740b2231],
15	.	.	O	.	_	0	SENT_712	[p31l1418t2174r1740b2231],

1	Blood	NN	O	blood	_	0	SENT_713	[p31l1758t2174r1896b2219],
2	2005	CD	DATE	2005	num	1	SENT_713	[p31l1911t2178r2142b2228],
3	;	:	O	;	_	0	SENT_713	[p31l1911t2178r2142b2228],
4	105	CD	NUMBER	105	num	6	SENT_713	[p31l1911t2178r2142b2228],
5	:	:	O	:	_	0	SENT_713	[p31l1911t2178r2142b2228],
6	22	CD	NUMBER	22	dep	1	SENT_713	[p31l1113t2249r1259b2290],
7	—	CD	NUMBER	—	number	8	SENT_713	[p31l1113t2249r1259b2290],
8	30	CD	NUMBER	30	dep	6	SENT_713	[p31l1113t2249r1259b2290],
9	.	.	O	.	_	0	SENT_713	[p31l1113t2249r1259b2290],

1	46	CD	NUMBER	46	_	0	SENT_714	[p31l1112t2321r1179b2360],
2	.	.	O	.	_	0	SENT_714	[p31l1112t2321r1179b2360],

1	Weisberg	NNP	ORGANIZATION	Weisberg	nn	2	SENT_715	[p31l1207t2316r1431b2373],
2	E	NNP	ORGANIZATION	E	_	0	SENT_715	[p31l1447t2320r1490b2370],
3	,	,	O	,	_	0	SENT_715	[p31l1447t2320r1490b2370],
4	Boulton	NNP	PERSON	Boulton	nn	5	SENT_715	[p31l1511t2316r1699b2361],
5	C	NNP	O	C	appos	2	SENT_715	[p31l1718t2320r1764b2370],
6	,	,	O	,	_	0	SENT_715	[p31l1718t2320r1764b2370],
7	Kelly	NNP	PERSON	Kelly	nn	8	SENT_715	[p31l1785t2316r1904b2372],
8	LM	NNP	O	LM	appos	2	SENT_715	[p31l1919t2320r2008b2370],
9	,	,	O	,	_	0	SENT_715	[p31l1919t2320r2008b2370],
10	et	FW	O	et	nn	11	SENT_715	[p31l2030t2325r2073b2360],
11	al.	FW	O	al.	appos	2	SENT_715	[p31l2088t2316r2140b2360],
12	.	.	O	.	_	0	SENT_715	[p31l2088t2316r2140b2360],

1	Inhibition	NN	O	inhibition	_	0	SENT_716	[p31l1112t2388r1351b2432],
2	of	IN	O	of	_	0	SENT_716	[p31l1369t2387r1425b2432],
3	mutant	JJ	O	mutant	amod	5	SENT_716	[p31l1433t2397r1607b2432],
4	FLT3	NN	O	flt3	nn	5	SENT_716	[p31l1621t2391r1735b2432],
5	receptors	NNS	O	receptor	prep_of	1	SENT_716	[p31l1755t2397r1973b2444],
6	in	IN	O	in	_	0	SENT_716	[p31l1991t2388r2037b2431],
7	leu	NN	O	leu	nn	10	SENT_716	[p31l2054t2388r2142b2432],
8	—	CD	NUMBER	—	num	10	SENT_716	[p31l2054t2388r2142b2432],
9	kemia	NN	O	kemia	nn	10	SENT_716	[p31l1113t2459r1260b2503],
10	cells	NNS	O	cell	prep_in	1	SENT_716	[p31l1278t2458r1382b2502],
11	by	IN	O	by	_	0	SENT_716	[p31l1402t2458r1457b2515],
12	the	DT	O	the	det	18	SENT_716	[p31l1473t2458r1546b2503],
13	small	JJ	O	small	amod	18	SENT_716	[p31l1566t2458r1695b2502],
14	molecule	NN	O	molecule	nn	18	SENT_716	[p31l1714t2458r1932b2503],
15	tyrosine	NN	O	tyrosine	nn	18	SENT_716	[p31l1951t2459r2143b2515],
16	kinase	NN	O	kinase	nn	18	SENT_716	[p31l1113t2530r1267b2574],
17	inhibitor	NN	O	inhibitor	nn	18	SENT_716	[p31l1283t2530r1494b2574],
18	PKC412	NN	O	pkc412	prep_by	1	SENT_716	[p31l1507t2533r1708b2575],
19	.	.	O	.	_	0	SENT_716	[p31l1507t2533r1708b2575],

1	Cancer	NN	O	cancer	nn	2	SENT_717	[p31l1727t2533r1892b2574],
2	Cell	NN	O	cell	_	0	SENT_717	[p31l1905t2529r1996b2574],
3	2002	CD	DATE	2002	dep	2	SENT_717	[p31l2011t2533r2141b2583],
4	;	:	O	;	_	0	SENT_717	[p31l2011t2533r2141b2583],
5	1:433	CD	NUMBER	1:433	number	6	SENT_717	[p31l1115t2604r1337b2645],
6	—	CD	NUMBER	—	dep	2	SENT_717	[p31l1115t2604r1337b2645],
7	43	CD	NUMBER	43	dep	6	SENT_717	[p31l1115t2604r1337b2645],
8	.	.	O	.	_	0	SENT_717	[p31l1115t2604r1337b2645],

1	47	CD	NUMBER	47	_	0	SENT_718	[p31l1112t2677r1179b2715],
2	.	.	O	.	_	0	SENT_718	[p31l1112t2677r1179b2715],

1	Zheng	NNP	PERSON	Zheng	nn	2	SENT_719	[p31l1208t2671r1360b2728],
2	R	NNP	PERSON	R	_	0	SENT_719	[p31l1369t2675r1417b2725],
3	,	,	O	,	_	0	SENT_719	[p31l1369t2675r1417b2725],
4	Levis	NNP	PERSON	Levis	nn	5	SENT_719	[p31l1432t2672r1547b2716],
5	M	NNP	O	M	appos	2	SENT_719	[p31l1559t2675r1620b2725],
6	,	,	O	,	_	0	SENT_719	[p31l1559t2675r1620b2725],
7	Piloto	NNP	ORGANIZATION	Piloto	nn	8	SENT_719	[p31l1634t2671r1771b2715],
8	O	NNP	ORGANIZATION	O	appos	2	SENT_719	[p31l1783t2675r1833b2725],
9	,	,	O	,	_	0	SENT_719	[p31l1783t2675r1833b2725],
10	et	FW	O	et	nn	11	SENT_719	[p31l1848t2681r1891b2715],
11	al.	FW	O	al.	appos	2	SENT_719	[p31l1900t2671r1952b2715],
12	.	.	O	.	_	0	SENT_719	[p31l1900t2671r1952b2715],

1	FLT3	NN	O	flt3	nn	2	SENT_720	[p31l1967t2675r2081b2716],
2	ligand	NN	O	ligand	nsubj	3	SENT_720	[p31l2094t2671r2142b2715, p31l1113t2742r1232b2799],
3	causes	VBZ	O	cause	_	0	SENT_720	[p31l1259t2757r1414b2787],
4	autocrine	JJ	O	autocrine	amod	5	SENT_720	[p31l1441t2743r1668b2787],
5	signaling	NN	O	signaling	dobj	3	SENT_720	[p31l1696t2742r1921b2799],
6	in	IN	O	in	_	0	SENT_720	[p31l1945t2743r1991b2786],
7	acute	JJ	O	acute	amod	8	SENT_720	[p31l2017t2752r2143b2787],
8	myeloid	JJ	O	myeloid	amod	10	SENT_720	[p31l1113t2813r1297b2870],
9	leukemia	NN	O	leukemia	nn	10	SENT_720	[p31l1308t2813r1520b2858],
10	cells	NNS	O	cell	prep_in	5	SENT_720	[p31l1532t2814r1644b2858],
11	.	.	O	.	_	0	SENT_720	[p31l1532t2814r1644b2858],

1	Blood	NN	O	blood	_	0	SENT_721	[p31l1659t2813r1796b2858],
2	2004	CD	DATE	2004	num	1	SENT_721	[p31l1807t2817r2143b2867, p31l1114t2888r1181b2929],
3	;	:	O	;	_	0	SENT_721	[p31l1807t2817r2143b2867, p31l1114t2888r1181b2929],
4	103:26774	CD	NUMBER	103:26774	dep	1	SENT_721	[p31l1807t2817r2143b2867, p31l1114t2888r1181b2929],
5	.	.	O	.	_	0	SENT_721	[p31l1807t2817r2143b2867, p31l1114t2888r1181b2929],

1	48	CD	NUMBER	48	_	0	SENT_722	[p31l1112t2960r1179b3000],
2	.	.	O	.	_	0	SENT_722	[p31l1112t2960r1179b3000],

1	Estey	NNP	ORGANIZATION	Estey	nn	2	SENT_723	[p31l1208t2959r1332b3011],
2	E	NNP	ORGANIZATION	E	_	0	SENT_723	[p31l1342t2959r1385b3009],
3	,	,	O	,	_	0	SENT_723	[p31l1342t2959r1385b3009],
4	Fisher	NNP	PERSON	Fisher	nn	5	SENT_723	[p31l1401t2955r1548b2999],
5	T	NN	O	t	appos	2	SENT_723	[p31l1558t2959r1599b3009],
6	,	,	O	,	_	0	SENT_723	[p31l1558t2959r1599b3009],
7	Giles	NNP	PERSON	Giles	nn	8	SENT_723	[p31l1615t2955r1735b3000],
8	F	NN	O	f	appos	2	SENT_723	[p31l1748t2959r1783b3009],
9	,	,	O	,	_	0	SENT_723	[p31l1748t2959r1783b3009],
10	et	FW	O	et	nn	11	SENT_723	[p31l1800t2965r1843b2999],
11	al.	FW	O	al.	appos	2	SENT_723	[p31l1852t2955r1905b2999],
12	.	.	O	.	_	0	SENT_723	[p31l1852t2955r1905b2999],

1	Randomized	VBN	O	randomize	_	0	SENT_724	[p31l1921t2955r2142b3002, p31l1113t3026r1209b3071],
2	trial	NN	O	trial	dobj	1	SENT_724	[p31l1231t3027r1324b3070],
3	of	IN	O	of	_	0	SENT_724	[p31l1345t3026r1401b3071],
4	PKC412	NN	O	pkc412	prep_of	2	SENT_724	[p31l1412t3030r1599b3072],
5	in	IN	O	in	_	0	SENT_724	[p31l1621t3027r1666b3070],
6	patients	NNS	O	patient	prep_in	1	SENT_724	[p31l1686t3027r1874b3083],
7	with	IN	O	with	_	0	SENT_724	[p31l1894t3026r1999b3071],
8	acute	JJ	O	acute	amod	13	SENT_724	[p31l2020t3036r2143b3071],
9	myeloid	JJ	O	myeloid	amod	10	SENT_724	[p31l1113t3097r1301b3154],
10	leukemia/high	JJ	O	leukemia/high	amod	13	SENT_724	[p31l1313t3097r1768b3154],
11	—	NN	O	—	nn	13	SENT_724	[p31l1313t3097r1768b3154],
12	risk	NN	O	risk	nn	13	SENT_724	[p31l1313t3097r1768b3154],
13	MDS	NN	O	md	prep_with	1	SENT_724	[p31l1777t3101r1893b3142],
14	characterized	VBN	O	characterize	partmod	13	SENT_724	[p31l1908t3098r2143b3142, p31l1113t3168r1209b3213],
15	by	IN	O	by	_	0	SENT_724	[p31l1235t3169r1289b3225],
16	wild	JJ	O	wild	amod	18	SENT_724	[p31l1309t3168r1528b3225],
17	—	NN	O	—	nn	18	SENT_724	[p31l1309t3168r1528b3225],
18	type	NN	O	type	agent	14	SENT_724	[p31l1309t3168r1528b3225],
19	or	CC	O	or	_	0	SENT_724	[p31l1554t3183r1604b3213],
20	mutated	VBN	O	mutate	conj_or	1	SENT_724	[p31l1627t3168r1822b3213],
21	FLT3	NN	O	flt3	dobj	20	SENT_724	[p31l1846t3172r1976b3213],
22	.	.	O	.	_	0	SENT_724	[p31l1846t3172r1976b3213],

1	Blood	NN	O	blood	_	0	SENT_725	[p31l2003t3168r2143b3213],
2	2003	CD	DATE	2003	num	1	SENT_725	[p31l1113t3239r1633b3296],
3	;	:	O	;	_	0	SENT_725	[p31l1113t3239r1633b3296],
4	102	CD	NUMBER	102	dep	1	SENT_725	[p31l1113t3239r1633b3296],
5	:	:	O	:	_	0	SENT_725	[p31l1113t3239r1633b3296],
6	Suppl	NNP	O	Suppl	dep	4	SENT_725	[p31l1113t3239r1633b3296],
7	:614	CD	NUMBER	:614	num	8	SENT_725	[p31l1113t3239r1633b3296],
8	a.	NN	O	a.	npadvmod	9	SENT_725	[p31l1113t3239r1633b3296],
9	abstract	JJ	O	abstract	amod	6	SENT_725	[p31l1649t3240r1848b3284],
10	.	.	O	.	_	0	SENT_725	[p31l1649t3240r1848b3284],

1	49	CD	NUMBER	49	_	0	SENT_726	[p31l1112t3315r1179b3354],
2	.	.	O	.	_	0	SENT_726	[p31l1112t3315r1179b3354],

1	Gilliland	NNP	PERSON	Gilliland	nn	2	SENT_727	[p31l1209t3310r1414b3355],
2	DG	NNS	O	dg	_	0	SENT_727	[p31l1444t3314r1538b3364],
3	,	,	O	,	_	0	SENT_727	[p31l1444t3314r1538b3364],
4	Tallman	NNP	PERSON	Tallman	nn	6	SENT_727	[p31l1571t3310r1762b3354],
5	MS.	NNP	O	MS.	nn	6	SENT_727	[p31l1792t3314r1881b3354],
6	Focus	NNP	O	Focus	appos	2	SENT_727	[p31l1915t3314r2051b3355],
7	on	IN	O	on	_	0	SENT_727	[p31l2084t3324r2144b3355],
8	acute	JJ	O	acute	amod	9	SENT_727	[p31l1113t3391r1234b3426],
9	leukemias	NNS	O	leukemia	prep_on	6	SENT_727	[p31l1246t3381r1496b3426],
10	.	.	O	.	_	0	SENT_727	[p31l1246t3381r1496b3426],

1	Cancer	NN	O	cancer	nn	2	SENT_728	[p31l1511t3385r1675b3426],
2	Cell	NN	O	cell	_	0	SENT_728	[p31l1685t3381r1775b3426],
3	2002	CD	DATE	2002	dep	2	SENT_728	[p31l1787t3385r2141b3435],
4	;	:	O	;	_	0	SENT_728	[p31l1787t3385r2141b3435],
5	1:417	CD	NUMBER	1:417	number	6	SENT_728	[p31l1787t3385r2141b3435],
6	—	CD	NUMBER	—	dep	2	SENT_728	[p31l1787t3385r2141b3435],
7	20	CD	NUMBER	20	dep	6	SENT_728	[p31l1787t3385r2141b3435],
8	.	.	O	.	_	0	SENT_728	[p31l1787t3385r2141b3435],

1	50	CD	NUMBER	50	_	0	SENT_729	[p31l1114t3457r1179b3496],
2	.	.	O	.	_	0	SENT_729	[p31l1114t3457r1179b3496],

1	Kottaridis	NNP	O	Kottaridis	nn	2	SENT_730	[p31l1209t3452r1447b3498],
2	PD	NN	O	pd	_	0	SENT_730	[p31l1469t3456r1549b3506],
3	,	,	O	,	_	0	SENT_730	[p31l1469t3456r1549b3506],
4	Gale	NNP	PERSON	Gale	nn	5	SENT_730	[p31l1574t3452r1681b3497],
5	RE	NNP	PERSON	RE	appos	2	SENT_730	[p31l1700t3456r1780b3506],
6	,	,	O	,	_	0	SENT_730	[p31l1700t3456r1780b3506],
7	Langabeer	NNP	O	Langabeer	nn	8	SENT_730	[p31l1802t3452r2050b3509],
8	SE	NN	O	se	appos	5	SENT_730	[p31l2069t3456r2140b3506],
9	,	,	O	,	_	0	SENT_730	[p31l2069t3456r2140b3506],
10	Frew	NNP	PERSON	Frew	nn	11	SENT_730	[p31l1112t3528r1229b3569],
11	ME	NNP	O	ME	appos	5	SENT_730	[p31l1245t3529r1339b3578],
12	,	,	O	,	_	0	SENT_730	[p31l1245t3529r1339b3578],
13	Bowen	NNP	PERSON	Bowen	nn	14	SENT_730	[p31l1361t3528r1522b3569],
14	DT	NNP	O	DT	appos	5	SENT_730	[p31l1541t3528r1621b3578],
15	,	,	O	,	_	0	SENT_730	[p31l1541t3528r1621b3578],
16	Linch	NNP	PERSON	Linch	nn	17	SENT_730	[p31l1644t3525r1776b3568],
17	DC	NNP	O	DC	appos	5	SENT_730	[p31l1795t3528r1883b3569],
18	.	.	O	.	_	0	SENT_730	[p31l1795t3528r1883b3569],

1	Studies	NNS	O	study	_	0	SENT_731	[p31l1907t3524r2076b3569],
2	of	IN	O	of	_	0	SENT_731	[p31l2097t3524r2153b3569],
3	FLT3	NN	O	flt3	nn	4	SENT_731	[p31l1112t3598r1227b3639],
4	mutations	NNS	O	mutation	prep_of	1	SENT_731	[p31l1248t3595r1488b3639],
5	in	IN	O	in	_	0	SENT_731	[p31l1508t3595r1554b3638],
6	paired	JJ	O	paired	amod	7	SENT_731	[p31l1572t3594r1721b3651],
7	presentation	NN	O	presentation	prep_in	4	SENT_731	[p31l1739t3595r2037b3651],
8	and	CC	O	and	_	0	SENT_731	[p31l2056t3594r2143b3639],
9	relapse	NN	O	relapse	nn	10	SENT_731	[p31l1113t3665r1280b3722],
10	samples	NNS	O	sample	prep_in	4	SENT_731	[p31l1309t3666r1500b3722],
11	from	IN	O	from	_	0	SENT_731	[p31l1530t3665r1646b3710],
12	patients	NNS	O	patient	prep_from	7	SENT_731	[p31l1673t3666r1860b3722],
13	with	IN	O	with	_	0	SENT_731	[p31l1887t3665r1993b3710],
14	acute	JJ	O	acute	amod	16	SENT_731	[p31l2020t3675r2143b3710],
15	myeloid	JJ	O	myeloid	amod	16	SENT_731	[p31l1113t3736r1301b3793],
16	leukemia	NN	O	leukemia	prep_with	12	SENT_731	[p31l1318t3736r1547b3781],
17	:	:	O	:	_	0	SENT_731	[p31l1318t3736r1547b3781],
18	implications	NNS	O	implication	dep	1	SENT_731	[p31l1567t3737r1861b3793],
19	for	IN	O	for	_	0	SENT_731	[p31l1879t3736r1948b3781],
20	the	DT	O	the	det	21	SENT_731	[p31l1964t3737r2036b3780],
21	role	NN	O	role	prep_for	18	SENT_731	[p31l2054t3737r2143b3781],

1	36	CD	NUMBER	36	_	0	SENT_732	[p32l9t20r75b59],
2	.	.	O	.	_	0	SENT_732	[p32l9t20r75b59],

1	Lacronique	NNP	MISC	Lacronique	nn	2	SENT_733	[p32l104t15r369b70],
2	V	NNP	O	V	_	0	SENT_733	[p32l380t18r420b68],
3	,	,	O	,	_	0	SENT_733	[p32l380t18r420b68],
4	Boureux	NNP	O	Boureux	nn	5	SENT_733	[p32l435t18r633b59],
5	A	NNP	O	A	appos	2	SENT_733	[p32l643t18r691b68],
6	,	,	O	,	_	0	SENT_733	[p32l643t18r691b68],
7	Valle	NNP	O	Valle	nn	8	SENT_733	[p32l705t14r818b58],
8	VD	NN	O	vd	appos	2	SENT_733	[p32l829t18r914b68],
9	,	,	O	,	_	0	SENT_733	[p32l829t18r914b68],
10	et	FW	O	et	nn	11	SENT_733	[p32l930t23r973b58],
11	al.	FW	O	al.	appos	2	SENT_733	[p32l983t14r1035b58],
12	.	.	O	.	_	0	SENT_733	[p32l983t14r1035b58],

1	A	DT	O	a	det	4	SENT_734	[p32l7t90r44b129],
2	TELJAK2	NN	O	teljak2	nn	4	SENT_734	[p32l54t89r287b136],
3	fusion	NN	O	fusion	nn	4	SENT_734	[p32l302t85r451b130],
4	protein	NN	O	protein	_	0	SENT_734	[p32l464t86r635b142],
5	with	IN	O	with	_	0	SENT_734	[p32l647t85r752b130],
6	constitutive	JJ	O	constitutive	amod	8	SENT_734	[p32l767t86r1039b130],
7	kinase	NN	O	kinase	nn	8	SENT_734	[p32l9t157r160b201],
8	activity	NN	O	activity	prep_with	4	SENT_734	[p32l179t157r344b213],
9	in	IN	O	in	_	0	SENT_734	[p32l361t157r406b200],
10	human	JJ	O	human	amod	11	SENT_734	[p32l426t157r593b201],
11	leukemia	NN	O	leukemia	prep_in	4	SENT_734	[p32l612t157r841b201],
12	.	.	O	.	_	0	SENT_734	[p32l612t157r841b201],

1	Science	NNP	O	Science	_	0	SENT_735	[p32l864t157r1039b201],
2	1997	CD	DATE	1997	num	1	SENT_735	[p32l11t232r456b282],
3	;	:	O	;	_	0	SENT_735	[p32l11t232r456b282],
4	278:1309	CD	NUMBER	278:1309	number	5	SENT_735	[p32l11t232r456b282],
5	—	CD	NUMBER	—	dep	1	SENT_735	[p32l11t232r456b282],
6	12	CD	NUMBER	12	dep	5	SENT_735	[p32l11t232r456b282],
7	.	.	O	.	_	0	SENT_735	[p32l11t232r456b282],

1	37	CD	NUMBER	37	_	0	SENT_736	[p32l9t304r75b342],
2	.	.	O	.	_	0	SENT_736	[p32l9t304r75b342],

1	Gari	NNP	PERSON	Gari	nn	2	SENT_737	[p32l105t299r206b342],
2	M	NNP	PERSON	M	_	0	SENT_737	[p32l217t302r278b352],
3	,	,	O	,	_	0	SENT_737	[p32l217t302r278b352],
4	Goodeve	NNP	O	Goodeve	nn	5	SENT_737	[p32l294t298r496b343],
5	A	NNP	O	A	appos	2	SENT_737	[p32l508t302r555b352],
6	,	,	O	,	_	0	SENT_737	[p32l508t302r555b352],
7	Wilson	NNP	PERSON	Wilson	nn	8	SENT_737	[p32l569t298r736b343],
8	G	NNP	PERSON	G	appos	2	SENT_737	[p32l749t302r801b352],
9	,	,	O	,	_	0	SENT_737	[p32l749t302r801b352],
10	et	FW	O	et	nn	12	SENT_737	[p32l818t307r861b342],
11	al.	FW	O	al.	nn	12	SENT_737	[p32l871t298r922b342],
12	c-kit	NN	O	c-kit	appos	2	SENT_737	[p32l939t298r1042b343],
13	Proto	NNP	O	Proto	nn	16	SENT_737	[p32l8t373r393b426],
14	—	NN	O	—	nn	16	SENT_737	[p32l8t373r393b426],
15	oncogene	NN	O	oncogene	nn	16	SENT_737	[p32l8t373r393b426],
16	exon	NN	O	exon	dep	12	SENT_737	[p32l419t384r532b414],
17	8	CD	NUMBER	8	dep	2	SENT_737	[p32l558t373r583b414],
18	in	IN	O	in	_	0	SENT_737	[p32l610t369r818b414],
19	—	CD	NUMBER	—	num	20	SENT_737	[p32l610t369r818b414],
20	frame	NN	O	frame	prep_in	17	SENT_737	[p32l610t369r818b414],
21	deletion	NN	O	deletion	nn	24	SENT_737	[p32l844t369r1039b414],
22	plus	CC	O	plus	_	0	SENT_737	[p32l8t441r109b497],
23	insertion	NN	O	insertion	nn	24	SENT_737	[p32l130t441r347b485],
24	mutations	NNS	O	mutation	dep	2	SENT_737	[p32l368t441r612b485],
25	in	IN	O	in	_	0	SENT_737	[p32l634t441r680b484],
26	acute	JJ	O	acute	amod	28	SENT_737	[p32l700t450r826b485],
27	myeloid	JJ	O	myeloid	amod	28	SENT_737	[p32l847t440r1038b497],
28	leukaemia	NN	O	leukaemia	prep_in	24	SENT_737	[p32l8t512r257b556],
29	.	.	O	.	_	0	SENT_737	[p32l8t512r257b556],

1	Br	NN	O	br	_	0	SENT_738	[p32l272t515r352b562],
2	]	CD	NUMBER	]	num	1	SENT_738	[p32l272t515r352b562],
3	Haematol	NN	O	haematol	dep	1	SENT_738	[p32l362t511r589b556],
4	1999	CD	DATE	1999	num	3	SENT_738	[p32l603t515r1037b565],
5	;	:	O	;	_	0	SENT_738	[p32l603t515r1037b565],
6	105:894	CD	NUMBER	105:894	num	7	SENT_738	[p32l603t515r1037b565],
7	—	NN	O	—	dep	1	SENT_738	[p32l603t515r1037b565],
8	900	CD	NUMBER	900	dep	7	SENT_738	[p32l603t515r1037b565],
9	.	.	O	.	_	0	SENT_738	[p32l603t515r1037b565],

1	38	CD	NUMBER	38	_	0	SENT_739	[p32l9t588r75b628],
2	.	.	O	.	_	0	SENT_739	[p32l9t588r75b628],

1	Furitsu	NN	ORGANIZATION	furitsu	nn	2	SENT_740	[p32l104t584r272b628],
2	T	NN	ORGANIZATION	t	_	0	SENT_740	[p32l294t587r336b637],
3	,	,	O	,	_	0	SENT_740	[p32l294t587r336b637],
4	Tsujimura	NNP	ORGANIZATION	Tsujimura	nn	5	SENT_740	[p32l362t584r609b639],
5	T	NN	ORGANIZATION	t	appos	2	SENT_740	[p32l631t587r673b637],
6	,	,	O	,	_	0	SENT_740	[p32l631t587r673b637],
7	Tono	NNP	PERSON	Tono	nn	8	SENT_740	[p32l699t587r822b627],
8	T	NN	PERSON	t	appos	2	SENT_740	[p32l845t587r888b637],
9	,	,	O	,	_	0	SENT_740	[p32l845t587r888b637],
10	et	FW	O	et	nn	11	SENT_740	[p32l916t592r959b627],
11	al.	FW	O	al.	appos	2	SENT_740	[p32l981t583r1035b627],
12	.	.	O	.	_	0	SENT_740	[p32l981t583r1035b627],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_741	[p32l8t653r335b698],
2	of	IN	O	of	_	0	SENT_741	[p32l361t653r417b698],
3	mutations	NNS	O	mutation	prep_of	1	SENT_741	[p32l432t654r677b698],
4	in	IN	O	in	_	0	SENT_741	[p32l703t654r749b697],
5	the	DT	O	the	det	7	SENT_741	[p32l775t654r848b698],
6	coding	VBG	O	code	amod	7	SENT_741	[p32l874t653r1040b710],
7	sequence	NN	O	sequence	prep_in	3	SENT_741	[p32l10t739r230b781],
8	of	IN	O	of	_	0	SENT_741	[p32l252t724r308b769],
9	the	DT	O	the	det	11	SENT_741	[p32l319t724r392b769],
10	proto-oncogene	NN	O	proto-oncogene	nn	11	SENT_741	[p32l412t734r800b781],
11	c-kit	NN	O	c-kit	prep_of	7	SENT_741	[p32l821t724r931b769],
12	in	IN	O	in	_	0	SENT_741	[p32l948t725r994b768],
13	a	DT	O	a	det	19	SENT_741	[p32l1014t739r1039b768],
14	human	JJ	O	human	amod	19	SENT_741	[p32l9t796r178b840],
15	mast	NN	O	mast	nn	19	SENT_741	[p32l196t805r313b839],
16	cell	NN	O	cell	nn	19	SENT_741	[p32l328t796r407b840],
17	leukemia	NN	O	leukemia	nn	19	SENT_741	[p32l424t795r641b840],
18	cell	NN	O	cell	nn	19	SENT_741	[p32l658t796r737b839],
19	line	NN	O	line	prep_in	11	SENT_741	[p32l753t796r840b840],
20	causing	VBG	O	cause	partmod	19	SENT_741	[p32l858t796r1041b852],
21	ligand	NN	O	ligand	nn	22	SENT_741	[p32l8t866r478b923],
22	—	NN	O	—	nn	24	SENT_741	[p32l8t866r478b923],
23	independent	JJ	O	independent	amod	24	SENT_741	[p32l8t866r478b923],
24	activation	NN	O	activation	dobj	20	SENT_741	[p32l489t867r717b911],
25	of	IN	O	of	prep	24	SENT_741	[p32l731t866r787b911],
26	c-kit	NN	O	c-kit	nn	27	SENT_741	[p32l791t867r898b911],
27	product	NN	O	product	dep	25	SENT_741	[p32l908t866r1038b923, p32l9t947r92b982],
28	.	.	O	.	_	0	SENT_741	[p32l908t866r1038b923, p32l9t947r92b982],
29	]	SYM	O	]	dep	24	SENT_741	[p32l104t942r125b988],

1	Clin	NNP	O	Clin	nn	2	SENT_742	[p32l137t938r234b982],
2	Invest	NNP	O	Invest	_	0	SENT_742	[p32l248t942r390b982],
3	1993	CD	DATE	1993	num	2	SENT_742	[p32l403t941r818b991],
4	;	:	O	;	_	0	SENT_742	[p32l403t941r818b991],
5	92:1736	CD	NUMBER	92:1736	number	6	SENT_742	[p32l403t941r818b991],
6	-44	CD	NUMBER	-44	dep	2	SENT_742	[p32l403t941r818b991],
7	.	.	O	.	_	0	SENT_742	[p32l403t941r818b991],

1	39	CD	NUMBER	39	_	0	SENT_743	[p32l9t1013r75b1052],
2	.	.	O	.	_	0	SENT_743	[p32l9t1013r75b1052],

1	Zermati	NNP	O	Zermati	nn	2	SENT_744	[p32l104t1009r289b1052],
2	Y	NN	O	y	_	0	SENT_744	[p32l300t1012r338b1062],
3	,	,	O	,	_	0	SENT_744	[p32l300t1012r338b1062],
4	De	NNP	PERSON	De	nn	6	SENT_744	[p32l354t1012r418b1052],
5	Sepulveda	NNP	PERSON	Sepulveda	nn	6	SENT_744	[p32l434t1008r670b1064],
6	P	NN	PERSON	p	appos	2	SENT_744	[p32l682t1012r718b1062],
7	,	,	O	,	_	0	SENT_744	[p32l682t1012r718b1062],
8	Feger	NN	O	feger	nn	9	SENT_744	[p32l734t1012r865b1065],
9	F	NN	O	f	appos	2	SENT_744	[p32l877t1012r912b1062],
10	,	,	O	,	_	0	SENT_744	[p32l877t1012r912b1062],
11	et	FW	O	et	nn	12	SENT_744	[p32l929t1018r972b1052],
12	al.	FW	O	al.	appos	2	SENT_744	[p32l983t1008r1035b1052],
13	.	.	O	.	_	0	SENT_744	[p32l983t1008r1035b1052],

1	Effect	NN	O	effect	nsubj	6	SENT_745	[p32l8t1079r146b1123],
2	of	IN	O	of	_	0	SENT_745	[p32l157t1079r213b1124],
3	tyrosine	NN	O	tyrosine	nn	4	SENT_745	[p32l215t1080r403b1136],
4	kinase	NN	O	kinase	prep_of	1	SENT_745	[p32l415t1080r566b1124],
5	inhibitor	NN	O	inhibitor	nn	6	SENT_745	[p32l579t1079r789b1124],
6	STI5	NN	O	sti5	_	0	SENT_745	[p32l801t1083r906b1124],
7	71	CD	NUMBER	71	dobj	6	SENT_745	[p32l911t1083r966b1124],
8	on	IN	O	on	_	0	SENT_745	[p32l980t1094r1039b1124],
9	the	DT	O	the	det	11	SENT_745	[p32l9t1151r81b1195],
10	kinase	NN	O	kinase	nn	11	SENT_745	[p32l102t1151r253b1195],
11	activity	NN	O	activity	prep_on	7	SENT_745	[p32l274t1151r439b1207],
12	of	IN	O	of	_	0	SENT_745	[p32l457t1150r514b1195],
13	wild	JJ	O	wild	amod	15	SENT_745	[p32l522t1150r742b1207],
14	—	NN	O	—	nn	15	SENT_745	[p32l522t1150r742b1207],
15	type	NN	O	type	prep_of	11	SENT_745	[p32l522t1150r742b1207],
16	and	CC	O	and	_	0	SENT_745	[p32l762t1150r849b1195],
17	various	JJ	O	various	prep_on	7	SENT_745	[p32l867t1151r1038b1195],
18	of	IN	O	of	_	0	SENT_745	[p32l1113t14r1170b59],
19	FLT3	NN	O	flt3	nn	20	SENT_745	[p32l1173t18r1287b59],
20	mutations	NNS	O	mutation	prep_of	17	SENT_745	[p32l1303t15r1544b59],
21	in	IN	O	in	_	0	SENT_745	[p32l1559t15r1604b58],
22	leukemogenesis	NN	O	leukemogenesis	prep_in	20	SENT_745	[p32l1618t14r2013b71],
23	,	,	O	,	_	0	SENT_745	[p32l1618t14r2013b71],
24	minimal	JJ	O	minimal	amod	27	SENT_745	[p32l2030t15r2143b58, p32l1113t86r1217b129],
25	residual	JJ	O	residual	amod	27	SENT_745	[p32l1238t85r1425b130],
26	disease	NN	O	disease	nn	27	SENT_745	[p32l1447t85r1616b130],
27	detection	NN	O	detection	prep_in	20	SENT_745	[p32l1638t85r1869b139],
28	,	,	O	,	_	0	SENT_745	[p32l1638t85r1869b139],
29	and	CC	O	and	_	0	SENT_745	[p32l1893t85r1980b130],
30	possible	JJ	O	possible	amod	31	SENT_745	[p32l2000t86r2143b142, p32l1113t157r1183b201],
31	therapy	NN	O	therapy	conj_and	22	SENT_745	[p32l1213t157r1397b213],
32	with	IN	O	with	_	0	SENT_745	[p32l1422t157r1531b201],
33	FLT3	NN	O	flt3	nn	34	SENT_745	[p32l1560t160r1678b201],
34	inhibitors	NNS	O	inhibitor	prep_with	6	SENT_745	[p32l1708t156r1966b201],
35	.	.	O	.	_	0	SENT_745	[p32l1708t156r1966b201],

1	Blood	NN	O	blood	_	0	SENT_746	[p32l1997t156r2142b201],
2	2002	CD	DATE	2002	num	1	SENT_746	[p32l1113t232r1534b282],
3	;	:	O	;	_	0	SENT_746	[p32l1113t232r1534b282],
4	100:2393	CD	NUMBER	100:2393	number	5	SENT_746	[p32l1113t232r1534b282],
5	—	CD	NUMBER	—	dep	1	SENT_746	[p32l1113t232r1534b282],
6	8	CD	NUMBER	8	dep	5	SENT_746	[p32l1113t232r1534b282],
7	.	.	O	.	_	0	SENT_746	[p32l1113t232r1534b282],

1	51	CD	NUMBER	51	_	0	SENT_747	[p32l1114t304r1179b342],
2	.	.	O	.	_	0	SENT_747	[p32l1114t304r1179b342],

1	Weinstein	NNP	PERSON	Weinstein	nn	2	SENT_748	[p32l1207t299r1445b342],
2	IB	NNP	O	IB	_	0	SENT_748	[p32l1469t302r1533b342],
3	.	.	O	.	_	0	SENT_748	[p32l1469t302r1533b342],

1	Addiction	NN	O	addiction	nsubj	4	SENT_749	[p32l1560t298r1793b343],
2	to	TO	O	to	_	0	SENT_749	[p32l1819t307r1863b342],
3	oncogenes	NNS	O	oncogene	prep_to	1	SENT_749	[p32l1890t312r2142b355],
4	—	VBP	O	—	_	0	SENT_749	[p32l1111t395r1171b399],
5	the	DT	O	the	det	6	SENT_749	[p32l1183t369r1255b414],
6	Achilles	NNPS	MISC	Achilles	nsubj	7	SENT_749	[p32l1267t369r1455b414],
7	heal	VBP	O	heal	ccomp	4	SENT_749	[p32l1470t369r1567b413],
8	of	IN	O	of	_	0	SENT_749	[p32l1582t369r1638b414],
9	cancer	NN	O	cancer	prep_of	7	SENT_749	[p32l1642t384r1804b414],
10	.	.	O	.	_	0	SENT_749	[p32l1642t384r1804b414],

1	Science	NNP	O	Science	_	0	SENT_750	[p32l1822t370r1997b414],
2	2002	CD	DATE	2002	num	1	SENT_750	[p32l2011t373r2141b423],
3	;	:	O	;	_	0	SENT_750	[p32l2011t373r2141b423],
4	297:63	CD	NUMBER	297:63	number	5	SENT_750	[p32l1113t444r1337b485],
5	—	CD	NUMBER	—	dep	1	SENT_750	[p32l1113t444r1337b485],
6	4	CD	NUMBER	4	dep	5	SENT_750	[p32l1113t444r1337b485],
7	.	.	O	.	_	0	SENT_750	[p32l1113t444r1337b485],

1	52	CD	NUMBER	52	_	0	SENT_751	[p32l1114t517r1179b555],
2	.	.	O	.	_	0	SENT_751	[p32l1114t517r1179b555],

1	Druker	NN	PERSON	druker	nn	3	SENT_752	[p32l1208t511r1376b556],
2	B	NN	O	b	nn	3	SENT_752	[p32l1391t515r1454b565],
3	]	NN	O	]	_	0	SENT_752	[p32l1391t515r1454b565],
4	,	,	O	,	_	0	SENT_752	[p32l1391t515r1454b565],
5	Tamura	NNP	PERSON	Tamura	nn	6	SENT_752	[p32l1472t515r1655b556],
6	S	NNP	O	S	appos	3	SENT_752	[p32l1673t515r1711b565],
7	,	,	O	,	_	0	SENT_752	[p32l1673t515r1711b565],
8	Buchdunger	NNP	O	Buchdunger	nn	9	SENT_752	[p32l1731t511r2024b568],
9	E	NNP	O	E	appos	3	SENT_752	[p32l2039t515r2082b565],
10	,	,	O	,	_	0	SENT_752	[p32l2039t515r2082b565],
11	et	FW	O	et	nn	12	SENT_752	[p32l2103t520r2146b555],
12	al.	FW	O	al.	appos	3	SENT_752	[p32l1113t584r1165b628],
13	.	.	O	.	_	0	SENT_752	[p32l1113t584r1165b628],

1	Effects	NNS	O	effect	_	0	SENT_753	[p32l1186t583r1344b627],
2	of	IN	O	of	_	0	SENT_753	[p32l1364t583r1420b628],
3	a	DT	O	a	det	5	SENT_753	[p32l1427t598r1452b627],
4	selective	JJ	O	selective	amod	5	SENT_753	[p32l1470t583r1665b628],
5	inhibitor	NN	O	inhibitor	prep_of	1	SENT_753	[p32l1683t583r1893b628],
6	of	IN	O	of	_	0	SENT_753	[p32l1910t583r1966b628],
7	the	DT	O	the	det	10	SENT_753	[p32l1974t584r2046b627],
8	Abl	NN	O	abl	nn	10	SENT_753	[p32l2062t583r2144b628],
9	tyrosine	NN	O	tyrosine	nn	10	SENT_753	[p32l1113t654r1305b710],
10	kinase	NN	O	kinase	prep_of	5	SENT_753	[p32l1329t653r1484b698],
11	on	IN	O	on	_	0	SENT_753	[p32l1509t668r1569b698],
12	the	DT	O	the	det	13	SENT_753	[p32l1594t653r1668b698],
13	growth	NN	O	growth	prep_on	1	SENT_753	[p32l1693t654r1865b710],
14	of	IN	O	of	_	0	SENT_753	[p32l1890t653r1947b698],
15	Bcr	NNP	O	Bcr	prep_of	13	SENT_753	[p32l1961t653r2143b698],
16	.	.	O	.	_	0	SENT_753	[p32l1961t653r2143b698],

1	—	NN	O	—	_	0	SENT_754	[p32l1961t653r2143b698],
2	.	.	O	.	_	0	SENT_754	[p32l1961t653r2143b698],

1	Abl	NN	O	abl	_	0	SENT_755	[p32l1961t653r2143b698],
2	positive	JJ	O	positive	amod	3	SENT_755	[p32l1112t725r1297b781],
3	cells	NNS	O	cell	dep	1	SENT_755	[p32l1311t724r1427b769],
4	.	.	O	.	_	0	SENT_755	[p32l1311t724r1427b769],

1	Nat	NNP	O	Nat	nn	2	SENT_756	[p32l1443t729r1531b769],
2	Med	NNP	O	Med	_	0	SENT_756	[p32l1540t724r1644b769],
3	1996	CD	DATE	1996	num	2	SENT_756	[p32l1660t728r1987b778],
4	;	:	O	;	_	0	SENT_756	[p32l1660t728r1987b778],
5	2:561	CD	NUMBER	2:561	number	6	SENT_756	[p32l1660t728r1987b778],
6	—	CD	NUMBER	—	dep	2	SENT_756	[p32l1660t728r1987b778],
7	6	CD	NUMBER	6	dep	6	SENT_756	[p32l1660t728r1987b778],
8	.	.	O	.	_	0	SENT_756	[p32l1660t728r1987b778],

1	53	CD	NUMBER	53	_	0	SENT_757	[p32l1114t801r1179b839],
2	.	.	O	.	_	0	SENT_757	[p32l1114t801r1179b839],

1	Wong	NNP	PERSON	Wong	nn	2	SENT_758	[p32l1207t799r1351b852],
2	S	NNP	O	S	_	0	SENT_758	[p32l1364t799r1402b849],
3	,	,	O	,	_	0	SENT_758	[p32l1364t799r1402b849],
4	McLaughlin	NNP	PERSON	McLaughlin	nn	5	SENT_758	[p32l1417t795r1703b852],
5	J	NNP	PERSON	J	appos	2	SENT_758	[p32l1710t799r1743b849],
6	,	,	O	,	_	0	SENT_758	[p32l1710t799r1743b849],
7	Cheng	NNP	PERSON	Cheng	nn	8	SENT_758	[p32l1760t795r1916b852],
8	D	NNP	PERSON	D	appos	5	SENT_758	[p32l1927t799r1976b849],
9	,	,	O	,	_	0	SENT_758	[p32l1927t799r1976b849],
10	Zhang	NNP	PERSON	Zhang	nn	11	SENT_758	[p32l1992t795r2145b852],
11	C	NNP	PERSON	C	appos	5	SENT_758	[p32l1113t870r1159b920],
12	,	,	O	,	_	0	SENT_758	[p32l1113t870r1159b920],
13	Shokat	NNP	O	Shokat	nn	14	SENT_758	[p32l1175t866r1337b911],
14	KM	NNP	O	KM	appos	5	SENT_758	[p32l1345t871r1442b920],
15	,	,	O	,	_	0	SENT_758	[p32l1345t871r1442b920],
16	Witte	NNP	PERSON	Witte	nn	17	SENT_758	[p32l1454t867r1580b911],
17	ON	NNP	O	ON	appos	5	SENT_758	[p32l1592t870r1683b911],
18	.	.	O	.	_	0	SENT_758	[p32l1592t870r1683b911],

1	Sole	NNP	O	Sole	nn	3	SENT_759	[p32l1699t866r1794b911],
2	BCR-ABL	NN	O	bcr-abl	nn	3	SENT_759	[p32l1805t870r2023b913],
3	inhibition	NN	O	inhibition	nsubj	5	SENT_759	[p32l2033t867r2143b910, p32l1113t938r1251b982],
4	is	VBZ	O	be	cop	5	SENT_759	[p32l1268t938r1304b981],
5	insufficient	JJ	O	insufficient	_	0	SENT_759	[p32l1323t937r1595b982],
6	to	TO	O	to	aux	7	SENT_759	[p32l1610t947r1654b982],
7	eliminate	VB	O	eliminate	xcomp	5	SENT_759	[p32l1673t937r1892b982],
8	all	DT	O	all	det	12	SENT_759	[p32l1910t937r1965b981],
9	myeloproliferative	JJ	O	myeloproliferative	amod	12	SENT_759	[p32l1983t938r2143b994, p32l1112t1008r1398b1065],
10	disorder	NN	O	disorder	nn	12	SENT_759	[p32l1415t1008r1613b1053],
11	cell	NN	O	cell	nn	12	SENT_759	[p32l1629t1008r1708b1052],
12	populations	NNS	O	population	dobj	7	SENT_759	[p32l1723t1009r2020b1065],
13	.	.	O	.	_	0	SENT_759	[p32l1723t1009r2020b1065],

1	Proc	NNP	O	Proc	nn	7	SENT_760	[p32l2039t1012r2144b1053],
2	Natl	NNP	O	Natl	nn	7	SENT_760	[p32l1112t1079r1212b1124],
3	Acad	NNP	O	Acad	nn	7	SENT_760	[p32l1224t1079r1342b1124],
4	Sci	NNP	O	Sci	nn	7	SENT_760	[p32l1357t1080r1423b1124],
5	U	NNP	O	U	nn	7	SENT_760	[p32l1436t1084r1475b1124],
6	S	NNP	O	S	nn	7	SENT_760	[p32l1489t1083r1513b1124],
7	A	NNP	O	A	_	0	SENT_760	[p32l1526t1084r1563b1123],
8	2004	CD	DATE	2004	num	7	SENT_760	[p32l1575t1083r2052b1133],
9	;	:	O	;	_	0	SENT_760	[p32l1575t1083r2052b1133],
10	101:17456	CD	NUMBER	101:17456	number	11	SENT_760	[p32l1575t1083r2052b1133],
11	—	CD	NUMBER	—	dep	7	SENT_760	[p32l1575t1083r2052b1133],
12	61	CD	NUMBER	61	dep	11	SENT_760	[p32l1575t1083r2052b1133],
13	.	.	O	.	_	0	SENT_760	[p32l1575t1083r2052b1133],

1	54	CD	NUMBER	54	_	0	SENT_761	[p32l1114t1156r1179b1194],
2	.	.	O	.	_	0	SENT_761	[p32l1114t1156r1179b1194],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_762	[p32l1208t1154r1316b1194],
2	JG	NNP	O	JG	_	0	SENT_762	[p32l1330t1154r1407b1204],
3	,	,	O	,	_	0	SENT_762	[p32l1330t1154r1407b1204],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_762	[p32l1424t1154r1562b1201],
5	PA	NN	PERSON	pa	appos	2	SENT_762	[p32l1581t1154r1657b1204],
6	,	,	O	,	_	0	SENT_762	[p32l1581t1154r1657b1204],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_762	[p32l1679t1154r1759b1194],
8	JC	NNP	PERSON	JC	appos	2	SENT_762	[p32l1773t1154r1843b1204],
9	,	,	O	,	_	0	SENT_762	[p32l1773t1154r1843b1204],
10	et	FW	O	et	nn	11	SENT_762	[p32l1866t1159r1910b1194],
11	al.	FW	O	al.	appos	2	SENT_762	[p32l1926t1150r1980b1194],
12	.	.	O	.	_	0	SENT_762	[p32l1926t1150r1980b1194],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_763	[p32l2002t1154r2148b1197],

1	mutations	NNS	O	mutation	_	0	SENT_764	[p32l18t1504r521b1593],
2	in	IN	O	in	_	0	SENT_764	[p32l560t1504r653b1591],
3	lung	NN	O	lung	nn	4	SENT_764	[p32l690t1502r915b1618],
4	cancer	NN	O	cancer	prep_in	1	SENT_764	[p32l948t1531r1297b1592],
5	:	:	O	:	_	0	SENT_764	[p32l948t1531r1297b1592],
6	correlation	NN	O	correlation	dep	1	SENT_764	[p32l1339t1502r1879b1593],
7	with	IN	O	with	_	0	SENT_764	[p32l1911t1502r2132b1593],
8	clinical	JJ	O	clinical	amod	9	SENT_764	[p32l18t1649r373b1740],
9	response	NN	O	response	prep_with	6	SENT_764	[p32l418t1678r862b1765],
10	to	TO	O	to	_	0	SENT_764	[p32l909t1669r1000b1740],
11	geﬁtinib	NN	O	geﬁtinib	nn	12	SENT_764	[p32l1049t1649r1465b1765],
12	therapy	NN	O	therapy	prep_to	9	SENT_764	[p32l1512t1651r1897b1765],
13	.	.	O	.	_	0	SENT_764	[p32l1512t1651r1897b1765],

1	Science	NN	O	science	_	0	SENT_765	[p32l1952t1651r2129b1740, p32l18t1828r239b1889],

1	2004	CD	DATE	2004	_	0	SENT_766	[p32l270t1806r1258b1909],
2	;	:	O	;	_	0	SENT_766	[p32l270t1806r1258b1909],
3	304:1497	CD	NUMBER	304:1497	number	4	SENT_766	[p32l270t1806r1258b1909],
4	—	CD	NUMBER	—	dep	1	SENT_766	[p32l270t1806r1258b1909],
5	500	CD	NUMBER	500	dep	4	SENT_766	[p32l270t1806r1258b1909],
6	.	.	O	.	_	0	SENT_766	[p32l270t1806r1258b1909],

1	55	CD	NUMBER	55	_	0	SENT_767	[p32l20t1958r152b2036],
2	.	.	O	.	_	0	SENT_767	[p32l20t1958r152b2036],

1	Kris	NNP	PERSON	Kris	nn	2	SENT_768	[p32l215t1948r412b2038],
2	MG	NN	PERSON	mg	_	0	SENT_768	[p32l454t1954r669b2056],
3	,	,	O	,	_	0	SENT_768	[p32l454t1954r669b2056],
4	Natale	NNP	PERSON	Natale	nn	5	SENT_768	[p32l716t1946r1037b2037],
5	RB	NN	O	rb	appos	2	SENT_768	[p32l1080t1954r1250b2056],
6	,	,	O	,	_	0	SENT_768	[p32l1080t1954r1250b2056],
7	Herbst	NNP	ORGANIZATION	Herbst	nn	8	SENT_768	[p32l1299t1946r1641b2036],
8	RS	NN	ORGANIZATION	r	appos	2	SENT_768	[p32l1676t1954r1838b2056],
9	,	,	O	,	_	0	SENT_768	[p32l1676t1954r1838b2056],
10	et	FW	O	et	nn	11	SENT_768	[p32l1889t1965r1978b2036],
11	al.	FW	O	al.	appos	2	SENT_768	[p32l2015t1946r2125b2036],
12	.	.	O	.	_	0	SENT_768	[p32l2015t1946r2125b2036],

1	Efficacy	NN	O	efficacy	_	0	SENT_769	[p32l16t2092r406b2206],
2	of	IN	O	of	_	0	SENT_769	[p32l430t2092r546b2183],
3	geﬁtinib	NN	O	geﬁtinib	prep_of	1	SENT_769	[p32l552t2092r1000b2208],
4	,	,	O	,	_	0	SENT_769	[p32l552t2092r1000b2208],
5	an	DT	O	a	det	6	SENT_769	[p32l1033t2122r1150b2183],
6	inhibitor	NN	O	inhibitor	appos	3	SENT_769	[p32l1177t2092r1617b2183],
7	of	IN	O	of	_	0	SENT_769	[p32l1642t2092r1759b2183],
8	the	DT	O	the	det	14	SENT_769	[p32l1767t2094r1917b2183],
9	epidermal	JJ	O	epidermal	amod	14	SENT_769	[p32l1946t2094r2131b2208, p32l18t2239r371b2330],
10	growth	NN	O	growth	nn	14	SENT_769	[p32l400t2241r761b2355],
11	factor	NN	O	factor	nn	14	SENT_769	[p32l793t2239r1088b2330],
12	receptor	NN	O	receptor	nn	14	SENT_769	[p32l1116t2259r1536b2355],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_769	[p32l1565t2241r1966b2353],
14	kinase	NN	O	kinase	prep_of	6	SENT_769	[p32l1999t2241r2129b2331, p32l18t2416r272b2496],
15	,	,	O	,	_	0	SENT_769	[p32l1999t2241r2129b2331, p32l18t2416r272b2496],
16	in	IN	O	in	_	0	SENT_769	[p32l333t2388r430b2475],
17	symptomatic	JJ	O	symptomatic	amod	18	SENT_769	[p32l489t2388r1132b2502],
18	patients	NNS	O	patient	prep_in	3	SENT_769	[p32l1183t2388r1575b2502],
19	with	IN	O	with	_	0	SENT_769	[p32l1626t2386r1846b2478],
20	nonsmall	JJ	O	nonsmall	amod	23	SENT_769	[p32l1899t2416r2130b2477, p32l20t2533r286b2623],
21	cell	NN	O	cell	nn	23	SENT_769	[p32l331t2533r497b2624],
22	lung	NN	O	lung	nn	23	SENT_769	[p32l540t2535r765b2649],
23	cancer	NN	O	cancer	prep_with	18	SENT_769	[p32l803t2563r1144b2624],
24	:	:	O	:	_	0	SENT_769	[p32l803t2563r1144b2624],
25	a	DT	O	a	det	27	SENT_769	[p32l1189t2564r1240b2623],
26	randomized	JJ	O	randomized	amod	27	SENT_769	[p32l1280t2533r1867b2624],
27	trial	NN	O	trial	dep	1	SENT_769	[p32l1909t2535r2126b2624],
28	.	.	O	.	_	0	SENT_769	[p32l1909t2535r2126b2624],

1	JAMA	NNP	O	JAMA	_	0	SENT_770	[p32l6t2692r298b2787],
2	2003	CD	DATE	2003	num	1	SENT_770	[p32l323t2690r1240b2793],
3	;	:	O	;	_	0	SENT_770	[p32l323t2690r1240b2793],
4	290:2149	CD	NUMBER	290:2149	number	5	SENT_770	[p32l323t2690r1240b2793],
5	—	CD	NUMBER	—	dep	1	SENT_770	[p32l323t2690r1240b2793],
6	58	CD	NUMBER	58	dep	5	SENT_770	[p32l323t2690r1240b2793],
7	.	.	O	.	_	0	SENT_770	[p32l323t2690r1240b2793],

1	56	CD	NUMBER	56	_	0	SENT_771	[p32l20t2842r152b2920],
2	.	.	O	.	_	0	SENT_771	[p32l20t2842r152b2920],

1	Shepherd	NNP	ORGANIZATION	Shepherd	nn	2	SENT_772	[p32l217t2830r678b2944],
2	FA	NNP	ORGANIZATION	FA	_	0	SENT_772	[p32l702t2838r850b2940],
3	,	,	O	,	_	0	SENT_772	[p32l702t2838r850b2940],
4	Pereira	NNP	PERSON	Pereira	nn	5	SENT_772	[p32l881t2832r1217b2920],
5	JR	NNP	O	JR	appos	2	SENT_772	[p32l1230t2838r1373b2940],
6	,	,	O	,	_	0	SENT_772	[p32l1230t2838r1373b2940],
7	Ciuleanu	NNP	ORGANIZATION	Ciuleanu	nn	8	SENT_772	[p32l1405t2830r1838b2921],
8	TE	NNP	ORGANIZATION	TE	appos	2	SENT_772	[p32l1859t2838r2017b2940],
9	,	,	O	,	_	0	SENT_772	[p32l1859t2838r2017b2940],
10	et	FW	O	et	nn	11	SENT_772	[p32l2050t2849r2139b2920],
11	al.	FW	O	al.	appos	2	SENT_772	[p32l17t2976r125b3067],
12	.	.	O	.	_	0	SENT_772	[p32l17t2976r125b3067],

1	Erlotinib	NNP	O	Erlotinib	nsubj	4	SENT_773	[p32l213t2976r639b3067],
2	in	IN	O	in	prep	1	SENT_773	[p32l722t2978r815b3065],
3	previously	RB	DATE	previously	pcomp	2	SENT_773	[p32l895t2978r1394b3092],
4	treated	VBN	O	treat	_	0	SENT_773	[p32l1471t2976r1802b3067],
5	nonsmall	JJ	O	nonsmall	amod	9	SENT_773	[p32l1885t3006r2137b3067, p32l20t3123r489b3214],
6	—	NN	O	—	nn	9	SENT_773	[p32l1885t3006r2137b3067, p32l20t3123r489b3214],
7	cell	NN	O	cell	nn	9	SENT_773	[p32l1885t3006r2137b3067, p32l20t3123r489b3214],
8	lung	NN	O	lung	nn	9	SENT_773	[p32l525t3125r748b3239],
9	cancer	NN	O	cancer	dobj	4	SENT_773	[p32l785t3153r1118b3214],
10	.	.	O	.	_	0	SENT_773	[p32l785t3153r1118b3214],

1	N	NN	O	n	nn	2	SENT_774	[p32l1161t3133r1246b3214],
2	EnglJ	NN	O	englj	nsubj	3	SENT_774	[p32l1282t3123r1576b3239],
3	Med	VBD	O	med	_	0	SENT_774	[p32l1609t3125r1822b3214],
4	2005	CD	DATE	2005	dobj	3	SENT_774	[p32l1861t3131r2128b3233],
5	;	:	O	;	_	0	SENT_774	[p32l1861t3131r2128b3233],

1	57	CD	NUMBER	57	_	0	SENT_775	[p32l20t3430r152b3508],
2	.	.	O	.	_	0	SENT_775	[p32l20t3430r152b3508],

1	Frederick	NNP	PERSON	Frederick	nn	2	SENT_776	[p32l213t3418r674b3509],
2	L	NNP	PERSON	L	_	0	SENT_776	[p32l721t3426r805b3528],
3	,	,	O	,	_	0	SENT_776	[p32l721t3426r805b3528],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_776	[p32l861t3426r1147b3534],
5	X	NNP	O	X	appos	2	SENT_776	[p32l1193t3426r1371b3528],
6	.	.	O	.	_	0	SENT_776	[p32l1193t3426r1371b3528],

1	—	NN	O	—	_	0	SENT_777	[p32l1193t3426r1371b3528],
2	.	.	O	.	_	0	SENT_777	[p32l1193t3426r1371b3528],

1	Y	NN	O	y	_	0	SENT_778	[p32l1193t3426r1371b3528],
2	,	,	O	,	_	0	SENT_778	[p32l1193t3426r1371b3528],
3	Eley	NNP	PERSON	Eley	nn	4	SENT_778	[p32l1429t3418r1630b3532],
4	G	NNP	O	G	appos	1	SENT_778	[p32l1678t3426r1787b3528],
5	,	,	O	,	_	0	SENT_778	[p32l1678t3426r1787b3528],
6	James	NNP	PERSON	James	nn	7	SENT_778	[p32l1835t3426r2130b3522],
7	CD	NNP	O	CD	appos	4	SENT_778	[p32l18t3573r194b3656],
8	.	.	O	.	_	0	SENT_778	[p32l18t3573r194b3656],

1	Diversity	NN	O	diversity	_	0	SENT_779	[p32l247t3567r684b3681],
2	and	CC	O	and	_	0	SENT_779	[p32l727t3565r909b3656],
3	frequency	NN	O	frequency	conj_and	1	SENT_779	[p32l956t3565r1445b3681],
4	of	IN	O	of	_	0	SENT_779	[p32l1490t3565r1607b3656],
5	epidermal	JJ	O	epidermal	amod	9	SENT_779	[p32l1634t3567r2133b3681],
6	growth	NN	O	growth	nn	9	SENT_779	[p33l18t22r371b138],
7	factor	NN	O	factor	nn	9	SENT_779	[p33l402t22r690b113],
8	receptor	NN	O	receptor	nn	9	SENT_779	[p33l714t42r1118b138],
9	mutations	NNS	O	mutation	prep_of	1	SENT_779	[p33l1143t24r1637b113],
10	in	IN	O	in	_	0	SENT_779	[p33l1668t24r1761b111],
11	human	JJ	O	human	amod	12	SENT_779	[p33l1788t22r2133b113],
12	glioblastomas	NNS	O	glioblastoma	prep_in	9	SENT_779	[p33l18t169r728b285],
13	.	.	O	.	_	0	SENT_779	[p33l18t169r728b285],

1	Cancer	NNP	O	Cancer	nn	2	SENT_780	[p33l763t177r1104b260],
2	Res	NNP	O	Res	_	0	SENT_780	[p33l1126t177r1298b265],
3	2000	CD	DATE	2000	num	2	SENT_780	[p33l1329t177r2125b279],
4	;	:	O	;	_	0	SENT_780	[p33l1329t177r2125b279],
5	60:1383	CD	NUMBER	60:1383	num	6	SENT_780	[p33l1329t177r2125b279],
6	—	NN	O	—	dep	2	SENT_780	[p33l1329t177r2125b279],
7	7	CD	NUMBER	7	dep	6	SENT_780	[p33l1329t177r2125b279],
8	.	.	O	.	_	0	SENT_780	[p33l1329t177r2125b279],

1	58	CD	NUMBER	58	_	0	SENT_781	[p33l20t327r152b408],
2	.	.	O	.	_	0	SENT_781	[p33l20t327r152b408],

1	Rich	NNP	O	Rich	nn	2	SENT_782	[p33l213t317r438b413],
2	JN	NN	O	jn	_	0	SENT_782	[p33l481t325r635b427],
3	,	,	O	,	_	0	SENT_782	[p33l481t325r635b427],
4	Reardon	NNP	ORGANIZATION	Reardon	nn	5	SENT_782	[p33l694t317r1120b413],
5	DA	NNP	ORGANIZATION	DA	appos	2	SENT_782	[p33l1173t325r1355b427],
6	,	,	O	,	_	0	SENT_782	[p33l1173t325r1355b427],
7	Peery	NNP	PERSON	Peery	nn	8	SENT_782	[p33l1412t325r1682b431],
8	T	NN	O	t	appos	2	SENT_782	[p33l1727t325r1814b427],
9	,	,	O	,	_	0	SENT_782	[p33l1727t325r1814b427],
10	et	FW	O	et	nn	11	SENT_782	[p33l1873t336r1964b407],
11	al.	FW	O	al.	appos	2	SENT_782	[p33l2011t317r2124b407],
12	.	.	O	.	_	0	SENT_782	[p33l2011t317r2124b407],

1	Phase	NN	O	phase	nn	3	SENT_783	[p33l16t465r302b554],
2	II	CD	NUMBER	ii	num	3	SENT_783	[p33l339t473r413b552],
3	trial	NN	O	trial	_	0	SENT_783	[p33l451t463r647b554],
4	of	IN	O	of	_	0	SENT_783	[p33l686t463r803b554],
5	geﬁtinib	NN	O	geﬁtinib	prep_of	3	SENT_783	[p33l820t463r1238b579],
6	in	IN	O	in	_	0	SENT_783	[p33l1277t465r1372b552],
7	recurrent	JJ	O	recurrent	amod	10	SENT_783	[p33l1411t483r1871b554],
8	glio	NN	O	glio	nn	10	SENT_783	[p33l1904t465r2131b579],
9	—	NN	O	—	nn	10	SENT_783	[p33l1904t465r2131b579],
10	blastoma	NN	O	blastoma	prep_in	3	SENT_783	[p33l18t611r501b702],
11	.	.	O	.	_	0	SENT_783	[p33l18t611r501b702],

1	J	NNP	O	J	nn	3	SENT_784	[p33l526t621r570b715],
2	Clin	NNP	O	Clin	nn	3	SENT_784	[p33l597t611r797b702],
3	Oncol	NNP	O	Oncol	_	0	SENT_784	[p33l824t611r1116b702],
4	2004	CD	DATE	2004	num	3	SENT_784	[p33l1144t619r1940b721],
5	;	:	O	;	_	0	SENT_784	[p33l1144t619r1940b721],
6	22:133	CD	NUMBER	22:133	number	7	SENT_784	[p33l1144t619r1940b721],
7	—	CD	NUMBER	—	dep	3	SENT_784	[p33l1144t619r1940b721],
8	42	CD	NUMBER	42	dep	7	SENT_784	[p33l1144t619r1940b721],
9	.	.	O	.	_	0	SENT_784	[p33l1144t619r1940b721],

1	59	CD	NUMBER	59	_	0	SENT_785	[p33l20t768r152b847],
2	.	.	O	.	_	0	SENT_785	[p33l20t768r152b847],

1	Mendelsohn	NNP	PERSON	Mendelsohn	nn	2	SENT_786	[p33l211t757r812b848],
2	J	NNP	PERSON	J	_	0	SENT_786	[p33l826t765r893b867],
3	,	,	O	,	_	0	SENT_786	[p33l826t765r893b867],
4	Baselga	NNP	O	Baselga	appos	2	SENT_786	[p33l923t757r1370b873],
5	]	CD	NUMBER	]	num	4	SENT_786	[p33l923t757r1370b873],
6	.	.	O	.	_	0	SENT_786	[p33l923t757r1370b873],

1	The	DT	O	the	det	4	SENT_787	[p33l1398t757r1581b847],
2	EGF	NN	ORGANIZATION	egf	nn	4	SENT_787	[p33l1607t765r1814b848],
3	receptor	NN	O	receptor	nn	4	SENT_787	[p33l1841t786r2133b871, p33l18t924r154b995],
4	family	NN	O	family	_	0	SENT_787	[p33l174t904r471b1020],
5	as	IN	O	as	_	0	SENT_787	[p33l489t935r584b995],
6	targets	NNS	O	target	prep_as	4	SENT_787	[p33l611t924r929b1020],
7	for	IN	O	for	_	0	SENT_787	[p33l956t904r1094b995],
8	cancer	NN	O	cancer	nn	9	SENT_787	[p33l1116t934r1424b995],
9	therapy	NN	O	therapy	prep_for	4	SENT_787	[p33l1445t906r1810b1020],
10	.	.	O	.	_	0	SENT_787	[p33l1445t906r1810b1020],

1	Oncogene	NN	O	oncogene	_	0	SENT_788	[p33l1841t912r2132b995, p33l18t1081r241b1167],
2	2000	CD	DATE	2000	num	1	SENT_788	[p33l268t1059r1128b1161],
3	;	:	O	;	_	0	SENT_788	[p33l268t1059r1128b1161],
4	19:6550	CD	NUMBER	19:6550	number	5	SENT_788	[p33l268t1059r1128b1161],
5	—	CD	NUMBER	—	dep	1	SENT_788	[p33l268t1059r1128b1161],
6	65	CD	NUMBER	65	dep	5	SENT_788	[p33l268t1059r1128b1161],
7	.	.	O	.	_	0	SENT_788	[p33l268t1059r1128b1161],

1	60	CD	NUMBER	60	_	0	SENT_789	[p33l18t1208r152b1289],
2	.	.	O	.	_	0	SENT_789	[p33l18t1208r152b1289],

1	Cunningham	NNP	ORGANIZATION	Cunningham	nn	2	SENT_790	[p33l215t1198r859b1314],
2	D	NNP	ORGANIZATION	D	_	0	SENT_790	[p33l895t1206r996b1308],
3	,	,	O	,	_	0	SENT_790	[p33l895t1206r996b1308],
4	Humblet	NNP	O	Humblet	nn	5	SENT_790	[p33l1041t1198r1477b1289],
5	Y	NN	O	y	appos	2	SENT_790	[p33l1504t1206r1583b1308],
6	,	,	O	,	_	0	SENT_790	[p33l1504t1206r1583b1308],
7	Siena	NNP	LOCATION	Siena	nn	8	SENT_790	[p33l1629t1200r1887b1289],
8	S	NNP	O	S	appos	2	SENT_790	[p33l1926t1206r2005b1308],
9	,	,	O	,	_	0	SENT_790	[p33l1926t1206r2005b1308],
10	et	FW	O	et	nn	11	SENT_790	[p33l2050t1217r2138b1288],
11	al.	FW	O	al.	appos	2	SENT_790	[p33l17t1347r126b1436],
12	.	.	O	.	_	0	SENT_790	[p33l17t1347r126b1436],

1	Cetuximab	JJ	O	cetuximab	amod	2	SENT_791	[p33l161t1347r692b1436],
2	monotherapy	NN	O	monotherapy	_	0	SENT_791	[p33l722t1347r1390b1461],
3	and	CC	O	and	_	0	SENT_791	[p33l1412t1345r1593b1436],
4	cetuximab	NN	O	cetuximab	conj_and	2	SENT_791	[p33l1622t1347r2131b1436],
5	plus	CC	O	plus	prep	2	SENT_791	[p33l16t1494r223b1608],
6	irinotecan	NN	O	irinotecan	dep	5	SENT_791	[p33l250t1494r745b1583],
7	in	IN	O	in	_	0	SENT_791	[p33l769t1494r862b1581],
8	irinotecan-refractory	JJ	O	irinotecan-refractory	amod	11	SENT_791	[p33l885t1492r1891b1606],
9	metastatic	JJ	O	metastatic	amod	11	SENT_791	[p33l1910t1512r2131b1583, p33l17t1641r329b1730],
10	colorectal	JJ	O	colorectal	amod	11	SENT_791	[p33l355t1639r828b1730],
11	cancer	NN	O	cancer	prep_in	2	SENT_791	[p33l854t1668r1187b1730],
12	.	.	O	.	_	0	SENT_791	[p33l854t1668r1187b1730],

1	N	NN	O	n	nn	3	SENT_792	[p33l1216t1649r1303b1730],
2	Engl	NNP	O	Engl	nn	3	SENT_792	[p33l1325t1641r1603b1755],
3	]	NNP	O	]	nsubj	4	SENT_792	[p33l1325t1641r1603b1755],
4	Med	VBD	O	med	_	0	SENT_792	[p33l1622t1641r1836b1730],
5	2004	CD	DATE	2004	dobj	4	SENT_792	[p33l1861t1647r2128b1749],
6	;	:	O	;	_	0	SENT_792	[p33l1861t1647r2128b1749],
7	351:337	CD	NUMBER	351:337	number	8	SENT_792	[p33l18t1795r598b1878],
8	—	CD	NUMBER	—	dep	5	SENT_792	[p33l18t1795r598b1878],
9	45	CD	NUMBER	45	dep	8	SENT_792	[p33l18t1795r598b1878],
10	.	.	O	.	_	0	SENT_792	[p33l18t1795r598b1878],

1	61	CD	NUMBER	61	_	0	SENT_793	[p33l18t1947r152b2025],
2	.	.	O	.	_	0	SENT_793	[p33l18t1947r152b2025],

1	Finn	NNP	O	Finn	nn	2	SENT_794	[p33l213t1937r434b2024],
2	RS	NN	O	r	_	0	SENT_794	[p33l475t1943r633b2045],
3	,	,	O	,	_	0	SENT_794	[p33l475t1943r633b2045],
4	Slamon	NNP	PERSON	Slamon	nn	5	SENT_794	[p33l686t1935r1053b2025],
5	DJ	NNP	O	DJ	appos	2	SENT_794	[p33l1094t1943r1236b2039],
6	.	.	O	.	_	0	SENT_794	[p33l1094t1943r1236b2039],

1	Monoclonal	JJ	O	monoclonal	amod	3	SENT_795	[p33l1281t1935r1869b2025],
2	antibody	NN	O	antibody	nn	3	SENT_795	[p33l1911t1937r2131b2025, p33l18t2081r258b2195],
3	therapy	NN	O	therapy	_	0	SENT_795	[p33l297t2083r668b2197],
4	for	IN	O	for	_	0	SENT_795	[p33l706t2081r850b2172],
5	breast	NN	O	breast	nn	6	SENT_795	[p33l891t2081r1195b2172],
6	cancer	NN	O	cancer	prep_for	3	SENT_795	[p33l1232t2111r1581b2172],
7	:	:	O	:	_	0	SENT_795	[p33l1232t2111r1581b2172],
8	herceptin	NN	O	herceptin	dep	3	SENT_795	[p33l1629t2081r2126b2197],
9	.	.	O	.	_	0	SENT_795	[p33l1629t2081r2126b2197],

1	Cancer	NNP	O	Cancer	nn	5	SENT_796	[p33l18t2236r363b2319],
2	Chemother	NNP	O	Chemother	nn	5	SENT_796	[p33l422t2228r982b2319],
3	Biol	NNP	O	Biol	nn	5	SENT_796	[p33l1041t2228r1237b2319],
4	Response	NNP	O	Response	nn	5	SENT_796	[p33l1297t2236r1775b2344],
5	Modif	NNP	O	Modif	_	0	SENT_796	[p33l1833t2228r2153b2319],
6	2003	CD	DATE	2003	num	5	SENT_796	[p33l18t2385r830b2488],
7	;	:	O	;	_	0	SENT_796	[p33l18t2385r830b2488],
8	21:223	CD	NUMBER	21:223	number	9	SENT_796	[p33l18t2385r830b2488],
9	-33	CD	NUMBER	-33	dep	5	SENT_796	[p33l18t2385r830b2488],
10	.	.	O	.	_	0	SENT_796	[p33l18t2385r830b2488],

1	62	CD	NUMBER	62	_	0	SENT_797	[p33l18t2536r152b2615],
2	.	.	O	.	_	0	SENT_797	[p33l18t2536r152b2615],

1	Stephens	NNP	PERSON	Stephens	nn	2	SENT_798	[p33l217t2524r661b2638],
2	P	NN	O	p	_	0	SENT_798	[p33l704t2532r777b2634],
3	,	,	O	,	_	0	SENT_798	[p33l704t2532r777b2634],
4	Hunter	NNP	PERSON	Hunter	nn	5	SENT_798	[p33l824t2532r1171b2615],
5	C	NNP	O	C	appos	2	SENT_798	[p33l1210t2532r1305b2634],
6	,	,	O	,	_	0	SENT_798	[p33l1210t2532r1305b2634],
7	Bignell	NNP	PERSON	Bignell	nn	8	SENT_798	[p33l1352t2524r1696b2640],
8	G	NNP	O	G	appos	2	SENT_798	[p33l1737t2532r1846b2634],
9	,	,	O	,	_	0	SENT_798	[p33l1737t2532r1846b2634],
10	et	FW	O	et	nn	11	SENT_798	[p33l1895t2543r1984b2614],
11	al.	FW	O	al.	appos	2	SENT_798	[p33l2019t2524r2126b2614],
12	.	.	O	.	_	0	SENT_798	[p33l2019t2524r2126b2614],

1	Lung	NN	O	lung	nn	2	SENT_799	[p33l16t2681r266b2787],
2	cancer	NN	O	cancer	_	0	SENT_799	[p33l288t2701r623b2762],
3	:	:	O	:	_	0	SENT_799	[p33l288t2701r623b2762],
4	intragenic	JJ	O	intragenic	amod	6	SENT_799	[p33l653t2673r1134b2787],
5	ERBB2	NN	O	erbb2	nn	6	SENT_799	[p33l1157t2679r1491b2767],
6	l	NN	O	l	dep	2	SENT_799	[p33l1518t2673r1822b2763],
7	<	JJR	O	<	amod	9	SENT_799	[p33l1518t2673r1822b2763],
8	inase	NN	O	inase	nn	9	SENT_799	[p33l1518t2673r1822b2763],
9	mutations	NNS	O	mutation	dep	6	SENT_799	[p33l1849t2690r2131b2762, p33l18t2821r253b2910],
10	in	IN	O	in	_	0	SENT_799	[p33l282t2821r375b2908],
11	tumours	NNS	O	tumour	prep_in	9	SENT_799	[p33l402t2839r840b2910],
12	.	.	O	.	_	0	SENT_799	[p33l402t2839r840b2910],

1	Nature	NNP	O	Nature	_	0	SENT_800	[p33l873t2829r1205b2910],
2	2004	CD	DATE	2004	num	1	SENT_800	[p33l1234t2827r2031b2929],
3	;	:	O	;	_	0	SENT_800	[p33l1234t2827r2031b2929],
4	431:525	CD	NUMBER	431:525	number	5	SENT_800	[p33l1234t2827r2031b2929],
5	—	CD	NUMBER	—	dep	1	SENT_800	[p33l1234t2827r2031b2929],
6	6	CD	NUMBER	6	dep	5	SENT_800	[p33l1234t2827r2031b2929],
7	.	.	O	.	_	0	SENT_800	[p33l1234t2827r2031b2929],

1	63	CD	NUMBER	63	_	0	SENT_801	[p33l18t2978r152b3056],
2	.	.	O	.	_	0	SENT_801	[p33l18t2978r152b3056],

1	Slamon	NNP	PERSON	Slamon	nn	2	SENT_802	[p33l217t2966r584b3057],
2	DJ	NNP	O	DJ	_	0	SENT_802	[p33l619t2974r759b3076],
3	,	,	O	,	_	0	SENT_802	[p33l619t2974r759b3076],
4	Leyland	NNP	PERSON	Leyland	appos	2	SENT_802	[p33l802t2966r1479b3080],
5	.	.	O	.	_	0	SENT_802	[p33l802t2966r1479b3080],

1	—	NN	O	—	_	0	SENT_803	[p33l802t2966r1479b3080],
2	.	.	O	.	_	0	SENT_803	[p33l802t2966r1479b3080],

1	Jones	NNP	PERSON	Jones	nn	2	SENT_804	[p33l802t2966r1479b3080],
2	B	NNP	O	B	_	0	SENT_804	[p33l1516t2974r1609b3076],
3	,	,	O	,	_	0	SENT_804	[p33l1516t2974r1609b3076],
4	Shal	NNP	PERSON	Shal	appos	2	SENT_804	[p33l1656t2966r1893b3057],
5	<	JJR	O	<	amod	6	SENT_804	[p33l1656t2966r1893b3057],
6	S	NN	O	s	dep	4	SENT_804	[p33l1928t2974r2007b3076],
7	,	,	O	,	_	0	SENT_804	[p33l1928t2974r2007b3076],
8	et	FW	O	et	nn	9	SENT_804	[p33l2051t2985r2139b3056],
9	al.	FW	O	al.	appos	2	SENT_804	[p33l17t3112r125b3203],
10	.	.	O	.	_	0	SENT_804	[p33l17t3112r125b3203],

1	Use	NN	O	use	_	0	SENT_805	[p33l164t3122r343b3203],
2	of	IN	O	of	_	0	SENT_805	[p33l378t3112r493b3203],
3	chemotherapy	NN	O	chemotherapy	prep_of	1	SENT_805	[p33l507t3112r1203b3228],
4	plus	CC	O	plus	prep	1	SENT_805	[p33l1230t3114r1432b3228],
5	a	DT	O	a	det	7	SENT_805	[p33l1467t3143r1518b3203],
6	monoclonal	JJ	O	monoclonal	amod	7	SENT_805	[p33l1550t3112r2134b3203],
7	antibody	NN	O	antibody	dep	4	SENT_805	[p33l17t3259r444b3373],
8	against	IN	O	against	_	0	SENT_805	[p33l463t3261r818b3375],
9	HER2	NN	O	her2	prep_against	1	SENT_805	[p33l838t3267r1122b3355],
10	for	IN	O	for	_	0	SENT_805	[p33l1149t3259r1290b3350],
11	metastatic	JJ	O	metastatic	amod	13	SENT_805	[p33l1313t3261r1814b3350],
12	breast	NN	O	breast	nn	13	SENT_805	[p33l1840t3261r2137b3350],
13	cancer	NN	O	cancer	prep_for	1	SENT_805	[p33l18t3436r339b3497],
14	that	WDT	O	that	nsubj	15	SENT_805	[p33l394t3406r590b3497],
15	overexpresses	VBZ	O	overexpress	rcmod	13	SENT_805	[p33l643t3436r1325b3522],
16	HER2	NN	O	her2	dobj	15	SENT_805	[p33l1386t3414r1703b3502],
17	.	.	O	.	_	0	SENT_805	[p33l1386t3414r1703b3502],

1	N	NN	O	n	nn	3	SENT_806	[p33l1765t3416r1851b3497],
2	Engl	NNP	O	Engl	nn	3	SENT_806	[p33l1906t3406r2133b3522],
3	J	NNP	O	J	nsubj	4	SENT_806	[p33l6t3564r50b3658],
4	Med	VBD	O	med	_	0	SENT_806	[p33l75t3554r292b3645],
5	2001	CD	DATE	2001	dobj	4	SENT_806	[p33l323t3562r1183b3664],
6	;	:	O	;	_	0	SENT_806	[p33l323t3562r1183b3664],
7	344:783	CD	NUMBER	344:783	number	8	SENT_806	[p33l323t3562r1183b3664],
8	—	CD	NUMBER	—	dep	5	SENT_806	[p33l323t3562r1183b3664],
9	92	CD	NUMBER	92	dep	8	SENT_806	[p33l323t3562r1183b3664],
10	.	.	O	.	_	0	SENT_806	[p33l323t3562r1183b3664],

1	64	CD	NUMBER	64	_	0	SENT_807	[p33l18t3713r152b3791],
2	.	.	O	.	_	0	SENT_807	[p33l18t3713r152b3791],

1	Schaefer	NNP	ORGANIZATION	Schaefer	nn	2	SENT_808	[p33l217t3701r637b3791],
2	KL	NNP	ORGANIZATION	KL	_	0	SENT_808	[p33l676t3709r840b3811],
3	,	,	O	,	_	0	SENT_808	[p33l676t3709r840b3811],
4	Brachwitz	NNP	PERSON	Brachwitz	nn	5	SENT_808	[p33l887t3701r1384b3792],
5	K	NNP	PERSON	K	appos	2	SENT_808	[p33l1425t3709r1526b3811],
6	,	,	O	,	_	0	SENT_808	[p33l1425t3709r1526b3811],
7	Wai	NNP	O	Wai	nn	8	SENT_808	[p33l1571t3703r1761b3791],
8	DH	NNP	O	DH	appos	2	SENT_808	[p33l1800t3709r1997b3811],
9	,	,	O	,	_	0	SENT_808	[p33l1800t3709r1997b3811],
10	et	FW	O	et	nn	11	SENT_808	[p33l2048t3720r2137b3791],
11	al.	FW	O	al.	appos	2	SENT_808	[p34l17t31r128b122],
12	.	.	O	.	_	0	SENT_808	[p34l17t31r128b122],

1	Expression	NN	O	expression	nn	2	SENT_809	[p34l169t33r716b147],
2	proﬁling	NN	O	proﬁling	nsubj	19	SENT_809	[p34l749t31r1181b147],
3	of	IN	O	of	_	0	SENT_809	[p34l1212t31r1327b122],
4	t	NN	O	t	prep_of	2	SENT_809	[p34l1341t39r1720b141],
5	(	CD	NUMBER	(	number	6	SENT_809	[p34l1341t39r1720b141],
6	12	CD	NUMBER	12	dep	4	SENT_809	[p34l1341t39r1720b141],
7	;	:	O	;	_	0	SENT_809	[p34l1341t39r1720b141],
8	22	CD	NUMBER	22	number	9	SENT_809	[p34l1341t39r1720b141],
9	)	CD	NUMBER	)	num	13	SENT_809	[p34l1341t39r1720b141],
10	positive	JJ	O	positive	amod	13	SENT_809	[p34l1759t33r2133b147],
11	clear	JJ	O	clear	amod	13	SENT_809	[p34l18t179r253b270],
12	cell	NN	O	cell	nn	13	SENT_809	[p34l278t179r444b270],
13	sarcoma	NN	O	sarcoma	dep	4	SENT_809	[p34l471t209r887b270],
14	of	IN	O	of	_	0	SENT_809	[p34l913t179r1029b270],
15	soft	JJ	O	soft	amod	18	SENT_809	[p34l1035t179r1224b270],
16	tissue	NN	O	tissue	nn	18	SENT_809	[p34l1244t181r1528b270],
17	cell	NN	O	cell	nn	18	SENT_809	[p34l1555t179r1721b270],
18	lines	NNS	O	line	prep_of	13	SENT_809	[p34l1745t179r1976b270],
19	reveals	VBZ	O	reveal	_	0	SENT_809	[p34l2005t210r2131b270, p34l12t328r243b417],
20	characteristic	JJ	O	characteristic	acomp	19	SENT_809	[p34l296t328r931b417],
21	up	IN	O	up	_	0	SENT_809	[p34l978t328r1631b442],
22	—	CD	NUMBER	—	num	23	SENT_809	[p34l978t328r1631b442],
23	regulation	NN	O	regulation	prep_up	20	SENT_809	[p34l978t328r1631b442],
24	of	IN	O	of	_	0	SENT_809	[p34l1682t326r1796b417],
25	potential	JJ	O	potential	amod	28	SENT_809	[p34l1822t346r2133b442, p34l18t473r170b563],
26	new	JJ	O	new	amod	28	SENT_809	[p34l225t502r428b564],
27	marker	NN	O	marker	nn	28	SENT_809	[p34l481t473r838b564],
28	genes	NNS	O	gene	prep_of	23	SENT_809	[p34l889t503r1170b589],
29	including	VBG	O	include	_	0	SENT_809	[p34l1228t473r1704b589],
30	ERBB3	NN	O	erbb3	prep_including	28	SENT_809	[p34l1754t481r2126b569],
31	.	.	O	.	_	0	SENT_809	[p34l1754t481r2126b569],

1	Cancer	NNP	O	Cancer	nn	2	SENT_810	[p34l18t630r363b713],
2	Res	NNP	O	Res	_	0	SENT_810	[p34l388t630r560b719],
3	2004	CD	DATE	2004	num	2	SENT_810	[p34l590t630r1508b733],
4	;	:	O	;	_	0	SENT_810	[p34l590t630r1508b733],
5	64:3395	CD	NUMBER	64:3395	num	6	SENT_810	[p34l590t630r1508b733],
6	—	NN	O	—	dep	2	SENT_810	[p34l590t630r1508b733],
7	405	CD	NUMBER	405	dep	6	SENT_810	[p34l590t630r1508b733],
8	.	.	O	.	_	0	SENT_810	[p34l590t630r1508b733],

1	65	CD	NUMBER	65	_	0	SENT_811	[p34l18t782r152b860],
2	.	.	O	.	_	0	SENT_811	[p34l18t782r152b860],

1	Hirota	NNP	ORGANIZATION	Hirota	nn	2	SENT_812	[p34l215t772r535b861],
2	S	NNP	ORGANIZATION	S	_	0	SENT_812	[p34l574t778r655b880],
3	,	,	O	,	_	0	SENT_812	[p34l574t778r655b880],
4	Isozaki	NNP	PERSON	Isozaki	nn	5	SENT_812	[p34l698t770r1053b861],
5	K	NNP	PERSON	K	appos	2	SENT_812	[p34l1090t778r1191b880],
6	,	,	O	,	_	0	SENT_812	[p34l1090t778r1191b880],
7	Moriyama	NNP	PERSON	Moriyama	nn	8	SENT_812	[p34l1234t772r1735b884],
8	Y	NN	PERSON	y	appos	2	SENT_812	[p34l1768t778r1847b880],
9	,	,	O	,	_	0	SENT_812	[p34l1768t778r1847b880],
10	et	FW	O	et	nn	11	SENT_812	[p34l1893t789r1982b860],
11	al.	FW	O	al.	appos	2	SENT_812	[p34l2013t770r2124b860],
12	.	.	O	.	_	0	SENT_812	[p34l2013t770r2124b860],

1	Gain	NN	O	gain	nn	2	SENT_813	[p34l18t917r820b1008],
2	—	NN	O	—	_	0	SENT_813	[p34l18t917r820b1008],
3	of	IN	O	of	_	0	SENT_813	[p34l18t917r820b1008],
4	—	CD	NUMBER	—	num	6	SENT_813	[p34l18t917r820b1008],
5	function	NN	O	function	nn	6	SENT_813	[p34l18t917r820b1008],
6	mutations	NNS	O	mutation	prep_of	2	SENT_813	[p34l840t919r1319b1008],
7	of	IN	O	of	_	0	SENT_813	[p34l1344t917r1457b1008],
8	c	NN	O	c	prep_of	6	SENT_813	[p34l1459t917r1670b1008],
9	—	CD	NUMBER	—	num	10	SENT_813	[p34l1459t917r1670b1008],
10	l	NN	O	l	tmod	6	SENT_813	[p34l1459t917r1670b1008],
11	<	JJR	O	<	dep	2	SENT_813	[p34l1459t917r1670b1008],
12	it	PRP	O	it	dep	11	SENT_813	[p34l1459t917r1670b1008],
13	in	IN	O	in	_	0	SENT_813	[p34l1685t919r1777b1006],
14	human	JJ	O	human	amod	17	SENT_813	[p34l1798t919r2135b1008],
15	gastrointestinal	JJ	O	gastrointestinal	amod	17	SENT_813	[p34l18t1066r791b1180],
16	stromal	JJ	O	stromal	amod	17	SENT_813	[p34l861t1066r1238b1155],
17	tumors	NNS	O	tumor	prep_in	12	SENT_813	[p34l1307t1084r1688b1155],
18	.	.	O	.	_	0	SENT_813	[p34l1307t1084r1688b1155],

1	Science	NN	O	science	_	0	SENT_814	[p34l1766t1066r2132b1155],
2	1998	CD	DATE	1998	num	1	SENT_814	[p34l22t1221r882b1324],
3	;	:	O	;	_	0	SENT_814	[p34l22t1221r882b1324],
4	279:577	CD	NUMBER	279:577	number	5	SENT_814	[p34l22t1221r882b1324],
5	—	CD	NUMBER	—	dep	1	SENT_814	[p34l22t1221r882b1324],
6	80	CD	NUMBER	80	dep	5	SENT_814	[p34l22t1221r882b1324],
7	.	.	O	.	_	0	SENT_814	[p34l22t1221r882b1324],

1	66	CD	NUMBER	66	_	0	SENT_815	[p34l18t1372r152b1451],
2	.	.	O	.	_	0	SENT_815	[p34l18t1372r152b1451],

1	Rubin	NNP	PERSON	Rubin	nn	2	SENT_816	[p34l213t1360r509b1456],
2	BP	NNP	O	BP	_	0	SENT_816	[p34l534t1368r677b1470],
3	,	,	O	,	_	0	SENT_816	[p34l534t1368r677b1470],
4	Singer	NNP	O	Singer	nn	5	SENT_816	[p34l712t1362r1023b1476],
5	S	NNP	O	S	appos	2	SENT_816	[p34l1049t1368r1128b1470],
6	,	,	O	,	_	0	SENT_816	[p34l1049t1368r1128b1470],
7	T	NN	O	t	nn	9	SENT_816	[p34l1155t1368r1226b1449],
8	sao	NN	O	sao	nn	9	SENT_816	[p34l1226t1389r1382b1451],
9	C	NN	O	c	appos	2	SENT_816	[p34l1411t1368r1507b1470],
10	,	,	O	,	_	0	SENT_816	[p34l1411t1368r1507b1470],
11	et	FW	O	et	nn	12	SENT_816	[p34l1540t1379r1629b1450],
12	al.	FW	O	al.	appos	2	SENT_816	[p34l1648t1360r1755b1451],
13	.	.	O	.	_	0	SENT_816	[p34l1648t1360r1755b1451],

1	KIT	NN	O	kit	nn	2	SENT_817	[p34l1788t1368r1970b1453],
2	activation	NN	O	activation	nsubj	6	SENT_817	[p34l1993t1390r2131b1450, p34l18t1509r379b1598],
3	is	VBZ	O	be	cop	6	SENT_817	[p34l418t1509r493b1597],
4	a	DT	O	a	det	6	SENT_817	[p34l534t1538r586b1597],
5	ubiquitous	JJ	O	ubiquitous	amod	6	SENT_817	[p34l623t1507r1144b1623],
6	feature	NN	O	feature	_	0	SENT_817	[p34l1187t1507r1519b1598],
7	of	IN	O	of	_	0	SENT_817	[p34l1561t1507r1676b1598],
8	gastrointestinal	JJ	O	gastrointestinal	amod	10	SENT_817	[p34l1694t1509r2132b1623, p34l18t1657r371b1745],
9	stromal	JJ	O	stromal	amod	10	SENT_817	[p34l418t1657r789b1746],
10	tumors	NNS	O	tumor	prep_of	6	SENT_817	[p34l834t1675r1209b1746],
11	.	.	O	.	_	0	SENT_817	[p34l834t1675r1209b1746],

1	Cancer	NNP	O	Cancer	nn	2	SENT_818	[p34l1262t1663r1601b1746],
2	Res	NNP	O	Res	_	0	SENT_818	[p34l1642t1663r1814b1751],
3	2001	CD	DATE	2001	num	2	SENT_818	[p34l1863t1663r2129b1765],
4	;	:	O	;	_	0	SENT_818	[p34l1863t1663r2129b1765],
5	61:8118	CD	NUMBER	61:8118	number	6	SENT_818	[p34l18t1810r598b1893],
6	—	CD	NUMBER	—	dep	2	SENT_818	[p34l18t1810r598b1893],
7	21	CD	NUMBER	21	dep	6	SENT_818	[p34l18t1810r598b1893],
8	.	.	O	.	_	0	SENT_818	[p34l18t1810r598b1893],

1	67	CD	NUMBER	67	_	0	SENT_819	[p34l18t1962r152b2040],
2	.	.	O	.	_	0	SENT_819	[p34l18t1962r152b2040],

1	Demetri	NNP	PERSON	Demetri	nn	2	SENT_820	[p34l213t1952r609b2040],
2	GD	NN	O	gd	_	0	SENT_820	[p34l633t1958r820b2060],
3	,	,	O	,	_	0	SENT_820	[p34l633t1958r820b2060],
4	von	NNP	PERSON	von	nn	6	SENT_820	[p34l846t1979r1022b2041],
5	Mehren	NNP	PERSON	Mehren	nn	6	SENT_820	[p34l1043t1950r1420b2040],
6	M	NN	O	m	appos	2	SENT_820	[p34l1441t1958r1566b2060],
7	,	,	O	,	_	0	SENT_820	[p34l1441t1958r1566b2060],
8	Blanke	NNP	PERSON	Blanke	nn	9	SENT_820	[p34l1595t1950r1926b2041],
9	CD	NNP	O	CD	appos	2	SENT_820	[p34l1952t1958r2125b2060],
10	,	,	O	,	_	0	SENT_820	[p34l1952t1958r2125b2060],
11	et	FW	O	et	nn	12	SENT_820	[p34l18t2116r107b2187],
12	al.	FW	O	al.	appos	2	SENT_820	[p34l124t2096r233b2187],
13	.	.	O	.	_	0	SENT_820	[p34l124t2096r233b2187],

1	Efficacy	NN	O	efficacy	_	0	SENT_821	[p34l260t2096r641b2210],
2	and	CC	O	and	_	0	SENT_821	[p34l660t2098r838b2187],
3	safety	NN	O	safety	conj_and	1	SENT_821	[p34l865t2096r1142b2212],
4	of	IN	O	of	_	0	SENT_821	[p34l1161t2096r1276b2187],
5	imatinib	NN	O	imatinib	nn	6	SENT_821	[p34l1279t2096r1688b2187],
6	mesylate	NN	O	mesylate	prep_of	1	SENT_821	[p34l1713t2098r2133b2212],
7	in	IN	O	in	_	0	SENT_821	[p34l16t2245r111b2332],
8	advanced	JJ	O	advanced	amod	11	SENT_821	[p34l134t2243r576b2334],
9	gastrointestinal	JJ	O	gastrointestinal	amod	11	SENT_821	[p34l601t2245r1345b2359],
10	stromal	JJ	O	stromal	amod	11	SENT_821	[p34l1370t2245r1735b2334],
11	tumors	NNS	O	tumor	prep_in	1	SENT_821	[p34l1759t2263r2128b2334],
12	.	.	O	.	_	0	SENT_821	[p34l1759t2263r2128b2334],

1	N	NN	O	n	nn	3	SENT_822	[p34l16t2400r101b2481],
2	Englj	NNP	O	Englj	nn	3	SENT_822	[p34l126t2392r408b2506],
3	Med	NNP	O	Med	_	0	SENT_822	[p34l432t2392r645b2481],
4	2002	CD	DATE	2002	num	3	SENT_822	[p34l674t2398r1530b2500],
5	;	:	O	;	_	0	SENT_822	[p34l674t2398r1530b2500],
6	347:472	CD	NUMBER	347:472	number	7	SENT_822	[p34l674t2398r1530b2500],
7	—	CD	NUMBER	—	dep	3	SENT_822	[p34l674t2398r1530b2500],
8	80	CD	NUMBER	80	dep	7	SENT_822	[p34l674t2398r1530b2500],
9	.	.	O	.	_	0	SENT_822	[p34l674t2398r1530b2500],

1	68	CD	NUMBER	68	_	0	SENT_823	[p34l18t2548r152b2629],
2	.	.	O	.	_	0	SENT_823	[p34l18t2548r152b2629],

1	Kemmer	NN	PERSON	kemmer	nn	2	SENT_824	[p34l215t2546r639b2630],
2	K	NN	PERSON	k	_	0	SENT_824	[p34l678t2546r777b2648],
3	,	,	O	,	_	0	SENT_824	[p34l678t2546r777b2648],
4	Corless	NNP	ORGANIZATION	Corless	nn	5	SENT_824	[p34l828t2538r1185b2628],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_824	[p34l1230t2546r1386b2648],
6	,	,	O	,	_	0	SENT_824	[p34l1230t2546r1386b2648],
7	Fletcher	NNP	PERSON	Fletcher	nn	8	SENT_824	[p34l1435t2538r1830b2628],
8	JA	NNP	O	JA	appos	2	SENT_824	[p34l1859t2546r1999b2648],
9	,	,	O	,	_	0	SENT_824	[p34l1859t2546r1999b2648],
10	et	FW	O	et	nn	11	SENT_824	[p34l2051t2557r2139b2628],
11	al.	FW	O	al.	appos	2	SENT_824	[p34l17t2687r125b2776],
12	.	.	O	.	_	0	SENT_824	[p34l17t2687r125b2776],

1	KIT	NN	O	kit	nn	2	SENT_825	[p34l166t2693r347b2778],
2	mutations	NNS	O	mutation	nsubj	4	SENT_825	[p34l379t2687r873b2776],
3	are	VBP	O	be	cop	4	SENT_825	[p34l911t2716r1055b2776],
4	common	JJ	O	common	_	0	SENT_825	[p34l1090t2715r1526b2776],
5	in	IN	O	in	_	0	SENT_825	[p34l1561t2687r1654b2774],
6	testicular	JJ	O	testicular	amod	7	SENT_825	[p34l1690t2687r2136b2776],
7	seminomas	NNS	O	seminoma	prep_in	4	SENT_825	[p34l20t2835r606b2924],
8	.	.	O	.	_	0	SENT_825	[p34l20t2835r606b2924],

1	Am	VBP	O	be	cop	3	SENT_826	[p34l637t2843r870b2937],
2	]	CD	NUMBER	]	num	3	SENT_826	[p34l637t2843r870b2937],
3	Pathol	NN	O	pathol	_	0	SENT_826	[p34l893t2833r1203b2924],
4	2004	CD	DATE	2004	dep	3	SENT_826	[p34l1230t2841r2086b2941],
5	;	:	O	;	_	0	SENT_826	[p34l1230t2841r2086b2941],
6	164:305	CD	NUMBER	164:305	number	7	SENT_826	[p34l1230t2841r2086b2941],
7	—	CD	NUMBER	—	dep	3	SENT_826	[p34l1230t2841r2086b2941],
8	13	CD	NUMBER	13	dep	7	SENT_826	[p34l1230t2841r2086b2941],
9	.	.	O	.	_	0	SENT_826	[p34l1230t2841r2086b2941],

1	69	CD	NUMBER	69	_	0	SENT_827	[p34l18t2990r152b3070],
2	.	.	O	.	_	0	SENT_827	[p34l18t2990r152b3070],

1	Boldrini	NNP	PERSON	Boldrini	nn	2	SENT_828	[p34l213t2980r602b3070],
2	L	NNP	PERSON	L	_	0	SENT_828	[p34l629t2988r710b3090],
3	,	,	O	,	_	0	SENT_828	[p34l629t2988r710b3090],
4	Ursino	NNP	PERSON	Ursino	nn	5	SENT_828	[p34l743t2982r1065b3070],
5	S	NNP	O	S	appos	2	SENT_828	[p34l1098t2988r1175b3090],
6	,	,	O	,	_	0	SENT_828	[p34l1098t2988r1175b3090],
7	Gisfredi	NNP	PERSON	Gisfredi	nn	8	SENT_828	[p34l1210t2980r1593b3070],
8	S	NNP	O	S	appos	2	SENT_828	[p34l1623t2988r1700b3090],
9	,	,	O	,	_	0	SENT_828	[p34l1623t2988r1700b3090],
10	et	FW	O	et	nn	11	SENT_828	[p34l1735t2999r1822b3070],
11	al.	FW	O	al.	appos	2	SENT_828	[p34l1844t2980r1948b3070],
12	.	.	O	.	_	0	SENT_828	[p34l1844t2980r1948b3070],

1	Expression	NN	O	expression	nn	4	SENT_829	[p34l1982t2988r2133b3069, p34l16t3128r422b3242],
2	and	CC	O	and	_	0	SENT_829	[p34l469t3126r649b3217],
3	mutational	JJ	O	mutational	conj_and	1	SENT_829	[p34l702t3128r1234b3217],
4	status	NN	O	status	dep	9	SENT_829	[p34l1288t3146r1570b3217],
5	of	IN	O	of	_	0	SENT_829	[p34l1625t3126r1741b3217],
6	c	NN	O	c	prep_of	4	SENT_829	[p34l1774t3126r1993b3217],
7	—	CD	NUMBER	—	num	8	SENT_829	[p34l1774t3126r1993b3217],
8	l	NN	O	l	dep	9	SENT_829	[p34l1774t3126r1993b3217],
9	<	JJR	O	<	dep	19	SENT_829	[p34l1774t3126r1993b3217],
10	it	PRP	O	it	dep	9	SENT_829	[p34l1774t3126r1993b3217],
11	in	IN	O	in	_	0	SENT_829	[p34l2039t3128r2133b3215],
12	small	JJ	O	small	amod	16	SENT_829	[p34l20t3273r483b3364],
13	—	JJ	O	—	amod	16	SENT_829	[p34l20t3273r483b3364],
14	cell	NN	O	cell	nn	16	SENT_829	[p34l20t3273r483b3364],
15	lung	NN	O	lung	nn	16	SENT_829	[p34l505t3275r726b3389],
16	cancer	NN	O	cancer	prep_in	10	SENT_829	[p34l749t3303r1086b3364],
17	:	:	O	:	_	0	SENT_829	[p34l749t3303r1086b3364],
18	prognostic	JJ	O	prognostic	amod	19	SENT_829	[p34l1114t3275r1635b3389],
19	relevance	NN	O	relevance	_	0	SENT_829	[p34l1658t3273r2128b3364],
20	.	.	O	.	_	0	SENT_829	[p34l1658t3273r2128b3364],

1	Clin	NNP	O	Clin	nn	3	SENT_830	[p34l18t3423r215b3512],
2	Cancer	NNP	O	Cancer	nn	3	SENT_830	[p34l244t3429r584b3512],
3	Res	NNP	O	Res	_	0	SENT_830	[p34l607t3429r779b3517],
4	2004	CD	DATE	2004	num	3	SENT_830	[p34l810t3429r1605b3529],
5	;	:	O	;	_	0	SENT_830	[p34l810t3429r1605b3529],
6	10:4101	CD	NUMBER	10:4101	number	7	SENT_830	[p34l810t3429r1605b3529],
7	—	CD	NUMBER	—	dep	3	SENT_830	[p34l810t3429r1605b3529],
8	8	CD	NUMBER	8	dep	7	SENT_830	[p34l810t3429r1605b3529],
9	.	.	O	.	_	0	SENT_830	[p34l810t3429r1605b3529],

1	70	CD	NUMBER	70	_	0	SENT_831	[p34l20t3578r152b3658],
2	.	.	O	.	_	0	SENT_831	[p34l20t3578r152b3658],

1	Johnson	NNP	PERSON	Johnson	nsubj	8	SENT_832	[p34l203t3568r617b3672],
2	BE	VB	O	be	cop	8	SENT_832	[p34l654t3576r813b3678],
3	,	,	O	,	_	0	SENT_832	[p34l654t3576r813b3678],
4	Fischer	NNP	PERSON	Fischer	nn	5	SENT_832	[p34l856t3568r1211b3658],
5	T	NN	O	t	dep	8	SENT_832	[p34l1242t3576r1327b3678],
6	,	,	O	,	_	0	SENT_832	[p34l1242t3576r1327b3678],
7	Fischer	NNP	PERSON	Fischer	nn	8	SENT_832	[p34l1370t3568r1725b3658],
8	B	NNP	O	B	_	0	SENT_832	[p34l1759t3576r1852b3678],
9	,	,	O	,	_	0	SENT_832	[p34l1759t3576r1852b3678],
10	et	FW	O	et	nn	11	SENT_832	[p34l1898t3587r1986b3658],
11	al.	FW	O	al.	appos	8	SENT_832	[p34l2019t3568r2126b3658],
12	.	.	O	.	_	0	SENT_832	[p34l2019t3568r2126b3658],

1	Phase	NN	O	phase	nn	3	SENT_833	[p35l16t27r300b116],
2	II	CD	NUMBER	ii	num	3	SENT_833	[p35l339t35r413b114],
3	study	NN	O	study	_	0	SENT_833	[p35l454t25r718b141],
4	of	IN	O	of	_	0	SENT_833	[p35l755t25r870b116],
5	imatinib	NN	O	imatinib	prep_of	3	SENT_833	[p35l889t27r1307b116],
6	in	IN	O	in	_	0	SENT_833	[p35l1347t27r1443b114],
7	patients	NNS	O	patient	prep_in	3	SENT_833	[p35l1481t27r1873b141],
8	with	IN	O	with	_	0	SENT_833	[p35l1912t27r2132b116],
9	small	JJ	O	small	amod	12	SENT_833	[p35l20t172r274b263],
10	cell	NN	O	cell	nn	12	SENT_833	[p35l303t172r462b263],
11	lung	NN	O	lung	nn	12	SENT_833	[p35l487t174r706b288],
12	cancer	NN	O	cancer	prep_with	7	SENT_833	[p35l731t202r1057b263],
13	.	.	O	.	_	0	SENT_833	[p35l731t202r1057b263],

1	Clin	NNP	O	Clin	nn	3	SENT_834	[p35l1090t172r1286b263],
2	Cancer	NNP	O	Cancer	nn	3	SENT_834	[p35l1313t180r1646b263],
3	Res	NNP	O	Res	_	0	SENT_834	[p35l1670t180r1838b268],
4	2003	CD	DATE	2003	num	3	SENT_834	[p35l1869t180r2129b282],
5	;	:	O	;	_	0	SENT_834	[p35l1869t180r2129b282],
6	9:5880	CD	NUMBER	9:5880	num	7	SENT_834	[p35l18t328r473b411],
7	—	NN	O	—	dep	3	SENT_834	[p35l18t328r473b411],
8	7	CD	NUMBER	7	dep	7	SENT_834	[p35l18t328r473b411],
9	.	.	O	.	_	0	SENT_834	[p35l18t328r473b411],

1	35	CD	NUMBER	35	_	0	SENT_835	[p35l720t487r744b509],
2	;	:	O	;	_	0	SENT_835	[p35l763t487r784b507],
3	2	CD	NUMBER	2	num	4	SENT_835	[p35l763t487r784b507],
4	WWW	NNP	O	WWW	dep	1	SENT_835	[p35l818t488r913b503],
5	.	.	O	.	_	0	SENT_835	[p35l818t488r913b503],

1	N	NN	O	n	nn	2	SENT_836	[p35l818t488r913b503],
2	EJM.ORG	NN	O	ejm.org	nsubj	14	SENT_836	[p35l921t487r1030b509],
3	JU	NNP	O	JU	nn	4	SENT_836	[p35l1063t488r1091b509],
4	LY	NNP	O	LY	dep	2	SENT_836	[p35l1099t488r1123b503],
5	14	CD	NUMBER	14	num	4	SENT_836	[p35l1136t487r1170b509],
6	,	,	O	,	_	0	SENT_836	[p35l1136t487r1170b509],
7	20	CD	NUMBER	20	num	4	SENT_836	[p35l1183t487r1215b503],
8	The	DT	O	the	det	11	SENT_836	[p35l702t520r753b544],
9	New	NNP	O	New	nn	11	SENT_836	[p35l762t521r824b544],
10	England	NNP	O	England	nn	11	SENT_836	[p35l833t520r944b551],
11	Journal	NNP	O	Journal	dep	2	SENT_836	[p35l953t520r1050b544],
12	of	IN	O	of	_	0	SENT_836	[p35l1060t520r1089b544],
13	Medicine	NNP	O	Medicine	prep_of	11	SENT_836	[p35l1095t520r1220b544],
14	ed	VBD	O	ed	_	0	SENT_836	[p35l283t561r314b584],
15	from	IN	O	from	_	0	SENT_836	[p35l323t561r387b584],
16	nejm.org	NN	O	nejm.org	prep_from	14	SENT_836	[p35l396t561r514b591],
17	at	IN	O	at	_	0	SENT_836	[p35l524t565r548b584],
18	UW-Madison	NN	O	uw-madison	prep_at	14	SENT_836	[p35l556t561r739b584],
19	on	IN	O	on	_	0	SENT_836	[p35l748t568r780b584],
20	January	NNP	DATE	January	prep_on	18	SENT_836	[p35l789t561r892b591],
21	5	CD	DATE	5	num	20	SENT_836	[p35l902t561r924b589],
22	,	,	DATE	,	_	0	SENT_836	[p35l902t561r924b589],
23	2014	CD	DATE	2014	num	20	SENT_836	[p35l935t561r1007b584],
24	.	.	O	.	_	0	SENT_836	[p35l935t561r1007b584],

1	For	IN	O	for	_	0	SENT_837	[p35l1018t561r1064b584],
2	personal	JJ	O	personal	amod	3	SENT_837	[p35l1072t561r1185b591],
3	use	NN	O	use	pobj	1	SENT_837	[p35l1194t568r1237b584],
4	only	RB	O	only	advmod	3	SENT_837	[p35l1247t561r1312b591],
5	.	.	O	.	_	0	SENT_837	[p35l1247t561r1312b591],

1	No	DT	O	no	det	3	SENT_838	[p35l1322t561r1362b584],
2	other	JJ	O	other	amod	3	SENT_838	[p35l1372t561r1440b584],
3	uses	NNS	O	use	_	0	SENT_838	[p35l1449t568r1504b584],
4	without	IN	O	without	_	0	SENT_838	[p35l1515t561r1616b584],
5	permission	NN	O	permission	prep_without	3	SENT_838	[p35l1624t561r1777b591],
6	.	.	O	.	_	0	SENT_838	[p35l1624t561r1777b591],

1	Copyright	NN	O	copyright	_	0	SENT_839	[p35l494t602r629b633],
2	©	CD	NUMBER	©	num	6	SENT_839	[p35l638t602r661b626],
3	2005	CD	DATE	2005	num	6	SENT_839	[p35l672t602r736b626],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_839	[p35l746t602r937b626],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_839	[p35l947t602r1055b626],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_839	[p35l1065t602r1170b633],
7	.	.	O	.	_	0	SENT_839	[p35l1065t602r1170b633],

1	All	DT	O	all	det	2	SENT_840	[p35l1181t602r1223b626],
2	rights	NNS	O	rights	nsubj	3	SENT_840	[p35l1232t602r1307b633],
3	reserved	VBN	O	reserve	_	0	SENT_840	[p35l1316t602r1435b626],
4	.	.	O	.	_	0	SENT_840	[p35l1316t602r1435b626],

1	NNNNNNNNNNN	NNP	O	NNNNNNNNNNN	nn	3	SENT_841	[p35l715t708r978b729],
2	ND	NNP	O	ND	nn	3	SENT_841	[p35l982t710r1034b729],
3	JOURNAL	NNP	O	JOURNAL	_	0	SENT_841	[p35l1048t710r1214b736],
4	ofMEDICINE	NN	O	ofmedicine	dep	3	SENT_841	[p35l1228t708r1444b735],

1	71	CD	NUMBER	71	_	0	SENT_842	[p35l20t1044r152b1122],
2	.	.	O	.	_	0	SENT_842	[p35l20t1044r152b1122],

1	Smithey	NNP	PERSON	Smithey	nsubj	2	SENT_843	[p35l217t1032r609b1146],
2	BE	VB	O	be	_	0	SENT_843	[p35l626t1040r786b1142],
3	,	,	O	,	_	0	SENT_843	[p35l626t1040r786b1142],
4	Pappo	NNP	O	Pappo	nn	5	SENT_843	[p35l815t1040r1115b1146],
5	AS	NNP	O	AS	dep	8	SENT_843	[p35l1138t1040r1296b1142],
6	,	,	O	,	_	0	SENT_843	[p35l1138t1040r1296b1142],
7	Hill	NNP	PERSON	Hill	nn	8	SENT_843	[p35l1327t1032r1507b1121],
8	DA	NNP	O	DA	ccomp	2	SENT_843	[p35l1530t1040r1706b1122],
9	.	.	O	.	_	0	SENT_843	[p35l1530t1040r1706b1122],

1	c	NN	O	c	nn	4	SENT_844	[p35l1737t1032r1958b1123],
2	—	CD	NUMBER	—	num	4	SENT_844	[p35l1737t1032r1958b1123],
3	kit	NN	O	kit	nn	4	SENT_844	[p35l1737t1032r1958b1123],
4	Expression	NN	O	expression	_	0	SENT_844	[p35l1974t1040r2128b1121, p35l16t1180r432b1294],
5	in	IN	O	in	_	0	SENT_844	[p35l475t1180r569b1267],
6	pediatric	JJ	O	pediatric	amod	8	SENT_844	[p35l613t1180r1038b1294],
7	solid	JJ	O	solid	amod	8	SENT_844	[p35l1085t1180r1316b1269],
8	tumors	NNS	O	tumor	prep_in	4	SENT_844	[p35l1363t1198r1739b1269],
9	:	:	O	:	_	0	SENT_844	[p35l1363t1198r1739b1269],
10	a	DT	O	a	det	13	SENT_844	[p35l1788t1209r1840b1269],
11	comparative	JJ	O	comparative	amod	13	SENT_844	[p35l1885t1208r2129b1269, p35l16t1327r406b1441],
12	immunohistochemical	JJ	O	immunohistochemical	amod	13	SENT_844	[p35l449t1325r1586b1416],
13	study	NN	O	study	dep	4	SENT_844	[p35l1629t1327r1909b1441],
14	.	.	O	.	_	0	SENT_844	[p35l1629t1327r1909b1441],

1	Am	NNP	O	Am	nn	4	SENT_845	[p35l1954t1335r2128b1414],
2	J	NNP	O	J	nn	4	SENT_845	[p35l6t1482r49b1576],
3	Surg	NNP	O	Surg	nn	4	SENT_845	[p35l81t1480r310b1588],
4	Pathol	NNP	O	Pathol	_	0	SENT_845	[p35l337t1474r652b1563],
5	2002	CD	DATE	2002	num	4	SENT_845	[p35l680t1480r1475b1582],
6	;	:	O	;	_	0	SENT_845	[p35l680t1480r1475b1582],
7	26:486	CD	NUMBER	26:486	number	8	SENT_845	[p35l680t1480r1475b1582],
8	—	CD	NUMBER	—	dep	4	SENT_845	[p35l680t1480r1475b1582],
9	92	CD	NUMBER	92	dep	8	SENT_845	[p35l680t1480r1475b1582],
10	.	.	O	.	_	0	SENT_845	[p35l680t1480r1475b1582],

1	72	CD	NUMBER	72	_	0	SENT_846	[p35l20t1632r152b1710],
2	.	.	O	.	_	0	SENT_846	[p35l20t1632r152b1710],

1	Tamborini	NNP	MISC	Tamborini	nn	2	SENT_847	[p35l211t1620r723b1710],
2	E	NNP	O	E	_	0	SENT_847	[p35l752t1628r841b1730],
3	,	,	O	,	_	0	SENT_847	[p35l752t1628r841b1730],
4	Bonadiman	NNP	PERSON	Bonadiman	nn	5	SENT_847	[p35l877t1620r1440b1710],
5	L	NNP	PERSON	L	appos	2	SENT_847	[p35l1471t1628r1554b1730],
6	,	,	O	,	_	0	SENT_847	[p35l1471t1628r1554b1730],
7	Greco	NNP	PERSON	Greco	nn	8	SENT_847	[p35l1592t1628r1881b1710],
8	A	NNP	O	A	appos	2	SENT_847	[p35l1911t1628r2009b1730],
9	,	,	O	,	_	0	SENT_847	[p35l1911t1628r2009b1730],
10	et	FW	O	et	nn	11	SENT_847	[p35l2048t1639r2137b1710],
11	al.	FW	O	al.	appos	2	SENT_847	[p35l16t1768r124b1857],
12	.	.	O	.	_	0	SENT_847	[p35l16t1768r124b1857],

1	Expression	NN	O	expression	nsubj	5	SENT_848	[p35l169t1768r717b1882],
2	of	IN	O	of	_	0	SENT_848	[p35l758t1766r875b1857],
3	ligand	NN	O	ligand	nn	4	SENT_848	[p35l894t1766r1686b1882],
4	—	NN	O	—	prep_of	1	SENT_848	[p35l894t1766r1686b1882],
5	activated	VBD	O	activate	_	0	SENT_848	[p35l894t1766r1686b1882],
6	KIT	NN	O	kit	nn	9	SENT_848	[p35l1726t1774r1911b1859],
7	and	CC	O	and	_	0	SENT_848	[p35l1948t1766r2130b1857],
8	platelet	NN	O	platelet	nn	9	SENT_848	[p35l16t1913r774b2029],
9	—	NN	O	—	dobj	5	SENT_848	[p35l16t1913r774b2029],
10	derived	VBN	O	derive	partmod	9	SENT_848	[p35l16t1913r774b2029],
11	growth	NN	O	growth	nn	17	SENT_848	[p35l806t1915r1153b2029],
12	factor	NN	O	factor	nn	17	SENT_848	[p35l1184t1913r1467b2004],
13	receptor	NN	O	receptor	nn	17	SENT_848	[p35l1495t1932r1899b2029],
14	beta	NN	O	beta	nn	17	SENT_848	[p35l1928t1913r2131b2004],
15	tyrosine	NN	O	tyrosine	nn	17	SENT_848	[p35l18t2062r402b2174],
16	kinase	NN	O	kinase	nn	17	SENT_848	[p35l441t2062r751b2152],
17	receptors	NNS	O	receptor	dobj	10	SENT_848	[p35l790t2080r1237b2176],
18	in	IN	O	in	_	0	SENT_848	[p35l1276t2062r1371b2149],
19	synovial	JJ	O	synovial	amod	20	SENT_848	[p35l1410t2062r1799b2174],
20	sarcoma	NN	O	sarcoma	prep_in	10	SENT_848	[p35l1838t2090r2129b2151, p35l18t2239r193b2299],
21	.	.	O	.	_	0	SENT_848	[p35l1838t2090r2129b2151, p35l18t2239r193b2299],

1	Clin	NNP	O	Clin	nn	3	SENT_849	[p35l227t2210r426b2299],
2	Cancer	NNP	O	Cancer	nn	3	SENT_849	[p35l455t2216r794b2299],
3	Res	NNP	O	Res	_	0	SENT_849	[p35l817t2216r989b2304],
4	2004	CD	DATE	2004	num	3	SENT_849	[p35l1020t2216r1814b2318],
5	;	:	O	;	_	0	SENT_849	[p35l1020t2216r1814b2318],
6	10:938	CD	NUMBER	10:938	number	7	SENT_849	[p35l1020t2216r1814b2318],
7	—	CD	NUMBER	—	dep	3	SENT_849	[p35l1020t2216r1814b2318],
8	43	CD	NUMBER	43	dep	7	SENT_849	[p35l1020t2216r1814b2318],
9	.	.	O	.	_	0	SENT_849	[p35l1020t2216r1814b2318],

1	73	CD	NUMBER	73	_	0	SENT_850	[p35l20t2367r152b2445],
2	.	.	O	.	_	0	SENT_850	[p35l20t2367r152b2445],

1	Wallenius	NNP	PERSON	Wallenius	nn	2	SENT_851	[p35l210t2355r689b2446],
2	V	NNP	PERSON	V	_	0	SENT_851	[p35l721t2363r802b2465],
3	,	,	O	,	_	0	SENT_851	[p35l721t2363r802b2465],
4	Hisaoka	NNP	O	Hisaoka	nn	5	SENT_851	[p35l841t2355r1241b2446],
5	M	NNP	O	M	appos	2	SENT_851	[p35l1269t2363r1393b2465],
6	,	,	O	,	_	0	SENT_851	[p35l1269t2363r1393b2465],
7	Helou	NNP	PERSON	Helou	nn	8	SENT_851	[p35l1432t2355r1728b2446],
8	K	NNP	PERSON	K	appos	2	SENT_851	[p35l1761t2363r1860b2465],
9	,	,	O	,	_	0	SENT_851	[p35l1761t2363r1860b2465],
10	et	FW	O	et	nn	11	SENT_851	[p35l1901t2374r1989b2445],
11	al.	FW	O	al.	appos	2	SENT_851	[p35l2015t2355r2124b2445],
12	.	.	O	.	_	0	SENT_851	[p35l2015t2355r2124b2445],

1	Overexpression	NN	O	overexpression	dep	10	SENT_852	[p35l18t2503r767b2617],
2	of	IN	O	of	_	0	SENT_852	[p35l831t2501r946b2592],
3	the	DT	O	the	det	5	SENT_852	[p35l989t2501r1137b2592],
4	hepatocyte	NN	O	hepatocyte	nn	5	SENT_852	[p35l1201t2503r1720b2617],
5	growth	NN	O	growth	prep_of	1	SENT_852	[p35l1783t2503r2131b2617],
6	factor	NN	O	factor	dep	10	SENT_852	[p35l18t2648r304b2739],
7	(	CD	NUMBER	(	num	6	SENT_852	[p35l351t2656r654b2752],
8	HGF	NN	O	hgf	nn	10	SENT_852	[p35l351t2656r654b2752],
9	)	NN	O	)	nn	10	SENT_852	[p35l351t2656r654b2752],
10	receptor	NN	O	receptor	dep	13	SENT_852	[p35l705t2667r1117b2764],
11	(	CD	NUMBER	(	dep	10	SENT_852	[p35l1164t2656r1418b2752],
12	Met	NNP	O	Met	nn	13	SENT_852	[p35l1164t2656r1418b2752],
13	)	NN	O	)	_	0	SENT_852	[p35l1164t2656r1418b2752],
14	and	CC	O	and	_	0	SENT_852	[p35l1469t2650r1649b2739],
15	presence	NN	O	presence	conj_and	13	SENT_852	[p35l1692t2678r2129b2764],
16	of	IN	O	of	advmod	18	SENT_852	[p35l18t2796r134b2887],
17	a	DT	O	a	dep	16	SENT_852	[p35l166t2827r217b2887],
18	truncated	VBN	O	truncate	dep	13	SENT_852	[p35l270t2796r743b2887],
19	and	CC	O	and	_	0	SENT_852	[p35l796t2796r979b2887],
20	activated	VBN	O	activate	dep	13	SENT_852	[p35l1030t2796r1470b2887],
21	intracellular	JJ	O	intracellular	acomp	20	SENT_852	[p35l1521t2796r2132b2887],

1	HGF	NN	O	hgf	nn	3	SENT_853	[p35l16t2951r252b3034],
2	receptor	NN	O	receptor	nn	3	SENT_853	[p35l294t2963r715b3059],
3	fragment	NN	O	fragment	_	0	SENT_853	[p35l752t2943r1221b3059],
4	in	IN	O	in	_	0	SENT_853	[p35l1255t2945r1352b3032],
5	locally	RB	O	locally	advmod	6	SENT_853	[p35l1391t2945r1720b3059],
6	aggressive/malignant	JJ	O	aggressive/malignant	amod	9	SENT_853	[p35l1755t2974r2127b3059, p35l19t3092r768b3206],
7	human	JJ	O	human	amod	9	SENT_853	[p35l857t3090r1210b3181],
8	musculoskeletal	JJ	O	musculoskeletal	amod	9	SENT_853	[p35l1306t3090r2128b3182],
9	tumors	NNS	O	tumor	prep_in	3	SENT_853	[p35l18t3258r400b3329],
10	.	.	O	.	_	0	SENT_853	[p35l18t3258r400b3329],

1	Am	VBP	O	be	cop	3	SENT_854	[p35l431t3248r664b3342],
2	]	CD	NUMBER	]	num	3	SENT_854	[p35l431t3248r664b3342],
3	Pathol	NN	O	pathol	_	0	SENT_854	[p35l689t3238r997b3329],
4	2000	CD	DATE	2000	dep	3	SENT_854	[p35l1024t3246r1820b3348],
5	;	:	O	;	_	0	SENT_854	[p35l1024t3246r1820b3348],
6	156:821	CD	NUMBER	156:821	number	7	SENT_854	[p35l1024t3246r1820b3348],
7	—	CD	NUMBER	—	dep	3	SENT_854	[p35l1024t3246r1820b3348],
8	9	CD	NUMBER	9	dep	7	SENT_854	[p35l1024t3246r1820b3348],
9	.	.	O	.	_	0	SENT_854	[p35l1024t3246r1820b3348],

1	74	CD	NUMBER	74	_	0	SENT_855	[p35l20t3397r152b3475],
2	.	.	O	.	_	0	SENT_855	[p35l20t3397r152b3475],

1	Ma	NNP	O	Ma	nn	2	SENT_856	[p35l211t3393r364b3475],
2	PC	NNP	O	PC	_	0	SENT_856	[p35l390t3393r548b3495],
3	,	,	O	,	_	0	SENT_856	[p35l390t3393r548b3495],
4	Kijima	NNP	PERSON	Kijima	nn	5	SENT_856	[p35l583t3387r904b3499],
5	T	NN	O	t	appos	2	SENT_856	[p35l926t3393r1011b3495],
6	,	,	O	,	_	0	SENT_856	[p35l926t3393r1011b3495],
7	Maulik	NNP	LOCATION	Maulik	nn	8	SENT_856	[p35l1044t3385r1387b3476],
8	G	NNP	LOCATION	G	appos	2	SENT_856	[p35l1412t3393r1521b3495],
9	,	,	O	,	_	0	SENT_856	[p35l1412t3393r1521b3495],
10	et	FW	O	et	nn	12	SENT_856	[p35l1556t3404r1645b3475],
11	al.	FW	O	al.	nn	12	SENT_856	[p35l1667t3385r1775b3475],
12	c	NN	O	c	appos	2	SENT_856	[p35l1812t3393r2133b3475],
13	.	.	O	.	_	0	SENT_856	[p35l1812t3393r2133b3475],

1	—	NN	O	—	_	0	SENT_857	[p35l1812t3393r2133b3475],
2	.	.	O	.	_	0	SENT_857	[p35l1812t3393r2133b3475],

1	MET	NN	O	met	nn	3	SENT_858	[p35l1812t3393r2133b3475],
2	mutational	JJ	O	mutational	amod	3	SENT_858	[p35l18t3533r550b3622],
3	analysis	NN	O	analysis	_	0	SENT_858	[p35l591t3533r971b3645],
4	in	IN	O	in	_	0	SENT_858	[p35l1016t3533r1109b3620],
5	small	JJ	O	small	amod	8	SENT_858	[p35l1154t3531r1415b3622],
6	cell	NN	O	cell	nn	8	SENT_858	[p35l1459t3531r1621b3622],
7	lung	NN	O	lung	nn	8	SENT_858	[p35l1663t3531r1885b3647],
8	cancer	NN	O	cancer	prep_in	3	SENT_858	[p35l1926t3560r2129b3622, p35l18t3709r189b3769],
9	:	:	O	:	_	0	SENT_858	[p35l1926t3560r2129b3622, p35l18t3709r189b3769],
10	novel	JJ	O	novel	amod	11	SENT_858	[p35l250t3680r512b3769],
11	juxtamembrane	NN	O	juxtamembrane	dep	3	SENT_858	[p35l551t3678r1344b3792],
12	domain	NN	O	domain	nn	13	SENT_858	[p35l1401t3678r1779b3769],
13	mutations	NNS	O	mutation	dep	11	SENT_858	[p35l1834t3698r2126b3769, p36l18t24r260b113],

1	regulating	VBG	O	regulate	_	0	SENT_859	[p36l293t24r790b138],
2	cytoskeletal	JJ	O	cytoskeletal	amod	3	SENT_859	[p36l815t22r1369b136],
3	functions	NNS	O	function	dobj	1	SENT_859	[p36l1395t22r1872b113],
4	.	.	O	.	_	0	SENT_859	[p36l1395t22r1872b113],

1	Cancer	NN	O	cancer	_	0	SENT_860	[p36l1905t30r2129b113, p36l18t201r160b260],
2	Res	NNP	O	Res	dep	1	SENT_860	[p36l181t178r351b266],
3	2003	CD	DATE	2003	num	2	SENT_860	[p36l382t178r1239b280],
4	;	:	O	;	_	0	SENT_860	[p36l382t178r1239b280],
5	63:6272	CD	NUMBER	63:6272	number	6	SENT_860	[p36l382t178r1239b280],
6	—	CD	NUMBER	—	dep	1	SENT_860	[p36l382t178r1239b280],
7	81	CD	NUMBER	81	dep	6	SENT_860	[p36l382t178r1239b280],
8	.	.	O	.	_	0	SENT_860	[p36l382t178r1239b280],

1	75	CD	NUMBER	75	_	0	SENT_861	[p36l20t328r152b406],
2	.	.	O	.	_	0	SENT_861	[p36l20t328r152b406],

1	Soman	NNP	O	Soman	nn	2	SENT_862	[p36l217t324r550b407],
2	NR	NNP	O	NR	_	0	SENT_862	[p36l575t324r761b426],
3	,	,	O	,	_	0	SENT_862	[p36l575t324r761b426],
4	Correa	NNP	PERSON	Correa	nn	5	SENT_862	[p36l794t324r1119b407],
5	PN	NNP	O	PN	appos	2	SENT_862	[p36l1144t324r1310b426],
6	,	,	O	,	_	0	SENT_862	[p36l1144t324r1310b426],
7	Ruiz	NNP	PERSON	Ruiz	nn	8	SENT_862	[p36l1343t318r1564b412],
8	BA	NN	O	ba	appos	2	SENT_862	[p36l1589t324r1755b426],
9	,	,	O	,	_	0	SENT_862	[p36l1589t324r1755b426],
10	Wogan	NNP	O	Wogan	nn	11	SENT_862	[p36l1785t324r2129b432],
11	GN	NNP	O	GN	appos	2	SENT_862	[p36l18t471r207b554],
12	.	.	O	.	_	0	SENT_862	[p36l18t471r207b554],

1	The	DT	O	the	det	2	SENT_863	[p36l234t465r420b554],
2	TPR	NN	O	tpr	_	0	SENT_863	[p36l443t471r886b555],
3	.	.	O	.	_	0	SENT_863	[p36l443t471r886b555],

1	—	NN	O	—	_	0	SENT_864	[p36l443t471r886b555],
2	.	.	O	.	_	0	SENT_864	[p36l443t471r886b555],

1	MET	NN	O	met	nn	3	SENT_865	[p36l443t471r886b555],
2	oncogenic	JJ	O	oncogenic	amod	3	SENT_865	[p36l900t465r1397b579],
3	rearrangement	NN	O	rearrangement	nsubjpass	5	SENT_865	[p36l1420t483r2136b579],
4	is	VBZ	O	be	auxpass	5	SENT_865	[p36l16t612r91b701],
5	present	JJ	DATE	present	_	0	SENT_865	[p36l130t630r503b726],
6	and	CC	O	and	_	0	SENT_865	[p36l536t610r717b701],
7	expressed	VBN	O	express	conj_and	5	SENT_865	[p36l756t610r1241b726],
8	in	IN	O	in	_	0	SENT_865	[p36l1280t612r1375b699],
9	human	JJ	O	human	amod	11	SENT_865	[p36l1412t610r1761b701],
10	gastric	JJ	O	gastric	amod	11	SENT_865	[p36l1800t612r2130b726],
11	carcinoma	NN	O	carcinoma	prep_in	7	SENT_865	[p36l18t759r536b848],
12	and	CC	O	and	_	0	SENT_865	[p36l565t757r745b848],
13	precursor	NN	O	precursor	nn	14	SENT_865	[p36l776t786r1247b873],
14	lesions	NNS	O	lesion	prep_in	7	SENT_865	[p36l1275t759r1643b848],
15	.	.	O	.	_	0	SENT_865	[p36l1275t759r1643b848],

1	Proc	NNP	O	Proc	nn	7	SENT_866	[p36l1680t765r1895b848],
2	Natl	NNP	O	Natl	nn	7	SENT_866	[p36l1924t759r2131b848],
3	Acad	NNP	O	Acad	nn	7	SENT_866	[p36l13t905r254b996],
4	Sci	NNP	O	Sci	nn	7	SENT_866	[p36l285t907r422b996],
5	U	NNP	O	U	nn	7	SENT_866	[p36l449t915r528b996],
6	S	NNP	O	S	nn	7	SENT_866	[p36l556t913r605b996],
7	A	NNP	O	A	_	0	SENT_866	[p36l632t915r709b994],
8	1991	CD	DATE	1991	num	7	SENT_866	[p36l737t913r1529b1015],
9	;	:	O	;	_	0	SENT_866	[p36l737t913r1529b1015],
10	88:4892	CD	NUMBER	88:4892	number	11	SENT_866	[p36l737t913r1529b1015],
11	—	CD	NUMBER	—	dep	7	SENT_866	[p36l737t913r1529b1015],
12	6	CD	NUMBER	6	dep	11	SENT_866	[p36l737t913r1529b1015],
13	.	.	O	.	_	0	SENT_866	[p36l737t913r1529b1015],

1	76	CD	NUMBER	76	_	0	SENT_867	[p36l20t1064r152b1142],
2	.	.	O	.	_	0	SENT_867	[p36l20t1064r152b1142],

1	Schmidt	NNP	PERSON	Schmidt	nn	2	SENT_868	[p36l217t1052r617b1142],
2	L	NNP	O	L	_	0	SENT_868	[p36l636t1060r719b1162],
3	,	,	O	,	_	0	SENT_868	[p36l636t1060r719b1162],
4	Duh	NNP	O	Duh	nn	5	SENT_868	[p36l750t1052r956b1143],
5	FM	NNP	O	FM	appos	2	SENT_868	[p36l981t1060r1162b1162],
6	,	,	O	,	_	0	SENT_868	[p36l981t1060r1162b1162],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_868	[p36l1196t1052r1444b1142],
8	P	NN	PERSON	p	appos	2	SENT_868	[p36l1470t1060r1541b1162],
9	,	,	O	,	_	0	SENT_868	[p36l1470t1060r1541b1162],
10	et	FW	O	et	nn	11	SENT_868	[p36l1574t1071r1661b1142],
11	al.	FW	O	al.	appos	2	SENT_868	[p36l1682t1052r1787b1142],
12	.	.	O	.	_	0	SENT_868	[p36l1682t1052r1787b1142],

1	Germline	NN	O	germline	nn	4	SENT_869	[p36l1820t1060r2130b1142, p36l16t1198r197b1289],
2	and	CC	O	and	_	0	SENT_869	[p36l234t1200r414b1289],
3	somatic	JJ	O	somatic	conj_and	1	SENT_869	[p36l453t1200r839b1289],
4	mutations	NNS	O	mutation	_	0	SENT_869	[p36l875t1200r1377b1289],
5	in	IN	O	in	_	0	SENT_869	[p36l1416t1200r1511b1287],
6	the	DT	O	the	det	9	SENT_869	[p36l1548t1200r1698b1289],
7	tyrosine	NN	O	tyrosine	nn	9	SENT_869	[p36l1736t1200r2128b1314],
8	kinase	NN	O	kinase	nn	9	SENT_869	[p36l16t1345r333b1437],
9	domain	NN	O	domain	prep_in	4	SENT_869	[p36l370t1345r743b1436],
10	of	IN	O	of	_	0	SENT_869	[p36l778t1345r893b1436],
11	the	DT	O	the	det	15	SENT_869	[p36l906t1345r1054b1436],
12	MET	NN	O	met	nn	15	SENT_869	[p36l1087t1353r1322b1435],
13	proto	NN	O	proto	nn	15	SENT_869	[p36l1351t1365r2130b1461],
14	—	NN	O	—	nn	15	SENT_869	[p36l1351t1365r2130b1461],
15	oncogene	NN	O	oncogene	prep_of	4	SENT_869	[p36l1351t1365r2130b1461],
16	in	IN	O	in	_	0	SENT_869	[p36l16t1494r111b1581],
17	papillary	JJ	O	papillary	amod	19	SENT_869	[p36l160t1492r601b1608],
18	renal	JJ	O	renal	amod	19	SENT_869	[p36l646t1494r896b1583],
19	carcinomas	NNS	O	carcinoma	prep_in	4	SENT_869	[p36l947t1494r1550b1583],
20	.	.	O	.	_	0	SENT_869	[p36l947t1494r1550b1583],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_870	[p36l1605t1502r1787b1583],
2	Genet	NNP	PERSON	Genet	_	0	SENT_870	[p36l1834t1500r2135b1583],
3	1997	CD	DATE	1997	num	2	SENT_870	[p36l21t1648r759b1750],
4	;	:	O	;	_	0	SENT_870	[p36l21t1648r759b1750],
5	16:68	CD	NUMBER	16:68	number	6	SENT_870	[p36l21t1648r759b1750],
6	—	CD	NUMBER	—	dep	2	SENT_870	[p36l21t1648r759b1750],
7	73	CD	NUMBER	73	dep	6	SENT_870	[p36l21t1648r759b1750],
8	.	.	O	.	_	0	SENT_870	[p36l21t1648r759b1750],

1	77	CD	NUMBER	77	_	0	SENT_871	[p36l20t1799r152b1877],
2	.	.	O	.	_	0	SENT_871	[p36l20t1799r152b1877],

1	Cruz	NNP	PERSON	Cruz	nn	2	SENT_872	[p36l215t1795r443b1878],
2	J	NNP	PERSON	J	_	0	SENT_872	[p36l469t1795r536b1897],
3	,	,	O	,	_	0	SENT_872	[p36l469t1795r536b1897],
4	Reis	NNP	PERSON	Reis	appos	2	SENT_872	[p36l579t1787r1075b1883],
5	.	.	O	.	_	0	SENT_872	[p36l579t1787r1075b1883],

1	—	NN	O	—	_	0	SENT_873	[p36l579t1787r1075b1883],
2	.	.	O	.	_	0	SENT_873	[p36l579t1787r1075b1883],

1	Filho	NNP	O	Filho	nn	2	SENT_874	[p36l579t1787r1075b1883],
2	JS	NNP	O	JS	_	0	SENT_874	[p36l1103t1795r1229b1897],
3	,	,	O	,	_	0	SENT_874	[p36l1103t1795r1229b1897],
4	Silva	NNP	PERSON	Silva	nn	5	SENT_874	[p36l1276t1787r1497b1878],
5	P	NN	PERSON	p	appos	2	SENT_874	[p36l1530t1795r1602b1897],
6	,	,	O	,	_	0	SENT_874	[p36l1530t1795r1602b1897],
7	Lopes	NNP	PERSON	Lopes	nn	8	SENT_874	[p36l1645t1795r1928b1901],
8	JM	NN	O	jm	appos	5	SENT_874	[p36l1956t1795r2124b1891],
9	.	.	O	.	_	0	SENT_874	[p36l1956t1795r2124b1891],

1	Expression	NN	O	expression	nsubj	5	SENT_875	[p36l16t1935r552b2049],
2	of	IN	O	of	_	0	SENT_875	[p36l595t1933r711b2024],
3	c	NN	O	c	prep_of	1	SENT_875	[p36l735t1953r1013b2024],
4	—	CD	NUMBER	—	num	3	SENT_875	[p36l735t1953r1013b2024],
5	met	VBD	O	meet	_	0	SENT_875	[p36l735t1953r1013b2024],
6	tyrosine	NN	O	tyrosine	nn	8	SENT_875	[p36l1052t1935r1434b2047],
7	kinase	NN	O	kinase	nn	8	SENT_875	[p36l1479t1933r1789b2025],
8	receptor	NN	O	receptor	nsubj	9	SENT_875	[p36l1832t1964r2129b2049, p36l18t2100r158b2171],
9	is	VBZ	O	be	ccomp	5	SENT_875	[p36l197t2082r272b2171],
10	biologically	RB	O	biologically	dep	9	SENT_875	[p36l321t2080r897b2196],
11	and	CC	O	and	_	0	SENT_875	[p36l936t2080r1117b2171],
12	prognostically	RB	O	prognostically	advmod	13	SENT_875	[p36l1158t2080r1872b2196],
13	relevant	JJ	O	relevant	dep	9	SENT_875	[p36l1911t2080r2128b2171, p36l12t2246r225b2318],
14	for	IN	O	for	_	0	SENT_875	[p36l250t2227r394b2318],
15	primary	JJ	O	primary	amod	18	SENT_875	[p36l418t2229r812b2343],
16	cutaneous	JJ	O	cutaneous	amod	18	SENT_875	[p36l837t2247r1338b2318],
17	malignant	JJ	O	malignant	amod	18	SENT_875	[p36l1371t2229r1883b2343],
18	melanomas	NNS	O	melanoma	prep_for	13	SENT_875	[p36l1907t2227r2127b2318, p36l16t2404r429b2465],
19	.	.	O	.	_	0	SENT_875	[p36l1907t2227r2127b2318, p36l16t2404r429b2465],

1	Oncology	NNP	O	Oncology	_	0	SENT_876	[p36l465t2376r934b2490],
2	2003	CD	DATE	2003	num	1	SENT_876	[p36l957t2382r1692b2484],
3	;	:	O	;	_	0	SENT_876	[p36l957t2382r1692b2484],
4	65:72	CD	NUMBER	65:72	number	5	SENT_876	[p36l957t2382r1692b2484],
5	—	CD	NUMBER	—	dep	1	SENT_876	[p36l957t2382r1692b2484],
6	82	CD	NUMBER	82	dep	5	SENT_876	[p36l957t2382r1692b2484],
7	.	.	O	.	_	0	SENT_876	[p36l957t2382r1692b2484],

1	78	CD	NUMBER	78	_	0	SENT_877	[p36l20t2531r152b2612],
2	.	.	O	.	_	0	SENT_877	[p36l20t2531r152b2612],

1	Greco	NNP	PERSON	Greco	nn	2	SENT_878	[p36l215t2529r506b2612],
2	A	NNP	O	A	dep	19	SENT_878	[p36l562t2529r662b2631],
3	,	,	O	,	_	0	SENT_878	[p36l562t2529r662b2631],
4	Pierotti	NNP	PERSON	Pierotti	nn	5	SENT_878	[p36l725t2523r1086b2612],
5	MA	NNP	PERSON	MA	appos	2	SENT_878	[p36l1140t2529r1340b2631],
6	,	,	O	,	_	0	SENT_878	[p36l1140t2529r1340b2631],
7	Bongarzone	NNP	O	Bongarzone	nn	11	SENT_878	[p36l1404t2529r2004b2637],
8	I	PRP	O	I	dep	11	SENT_878	[p36l2061t2529r2123b2631],
9	,	,	O	,	_	0	SENT_878	[p36l2061t2529r2123b2631],
10	Pagliardini	NNP	O	Pagliardini	dep	11	SENT_878	[p36l16t2668r536b2784],
11	S	NNP	O	S	appos	2	SENT_878	[p36l563t2676r640b2778],
12	,	,	O	,	_	0	SENT_878	[p36l563t2676r640b2778],
13	Lanzi	NNP	PERSON	Lanzi	nn	14	SENT_878	[p36l671t2670r932b2759],
14	C	NNP	O	C	appos	2	SENT_878	[p36l957t2676r1050b2778],
15	,	,	O	,	_	0	SENT_878	[p36l957t2676r1050b2778],
16	Della	NNP	PERSON	Della	nn	17	SENT_878	[p36l1081t2668r1329b2759],
17	l	NN	O	l	appos	2	SENT_878	[p36l1351t2676r1603b2759],
18	>	JJR	O	>	amod	19	SENT_878	[p36l1351t2676r1603b2759],
19	orta	NN	O	orta	_	0	SENT_878	[p36l1351t2676r1603b2759],
20	G.	NNP	O	G.	nn	21	SENT_878	[p36l1627t2676r1734b2759],
21	TRK	NNP	O	TRK	dep	19	SENT_878	[p36l1763t2676r2130b2764],
22	.	.	O	.	_	0	SENT_878	[p36l1763t2676r2130b2764],

1	—	NN	O	—	_	0	SENT_879	[p36l1763t2676r2130b2764],
2	.	.	O	.	_	0	SENT_879	[p36l1763t2676r2130b2764],

1	T1	NN	O	t1	nsubj	5	SENT_880	[p36l1763t2676r2130b2764],
2	is	VBZ	O	be	cop	5	SENT_880	[p36l16t2817r89b2906],
3	a	DT	O	a	det	5	SENT_880	[p36l118t2846r168b2906],
4	novel	JJ	O	novel	amod	5	SENT_880	[p36l195t2817r457b2906],
5	oncogene	NN	O	oncogene	_	0	SENT_880	[p36l484t2844r962b2931],
6	formed	VBN	O	form	partmod	5	SENT_880	[p36l991t2815r1351b2906],
7	by	IN	O	by	_	0	SENT_880	[p36l1379t2817r1491b2931],
8	the	DT	O	the	det	9	SENT_880	[p36l1515t2815r1665b2906],
9	fusion	NN	O	fusion	agent	6	SENT_880	[p36l1694t2815r2005b2906],
10	of	IN	O	of	_	0	SENT_880	[p36l2035t2815r2151b2906],
11	TPR	NN	ORGANIZATION	tpr	nn	14	SENT_880	[p36l14t2970r231b3058],
12	and	CC	O	and	_	0	SENT_880	[p36l252t2962r434b3053],
13	TRK	NN	O	trk	conj_and	11	SENT_880	[p36l459t2970r682b3058],
14	genes	NNS	O	gene	prep_of	9	SENT_880	[p36l707t2992r979b3078],
15	in	IN	O	in	_	0	SENT_880	[p36l1012t2964r1105b3051],
16	human	JJ	O	human	amod	19	SENT_880	[p36l1134t2964r1475b3053],
17	papillary	JJ	O	papillary	amod	19	SENT_880	[p36l1503t2962r1923b3078],
18	thyroid	NN	O	thyroid	nn	19	SENT_880	[p36l1950t2964r2130b3076, p36l18t3109r211b3200],
19	carcinomas	NNS	O	carcinoma	prep_in	6	SENT_880	[p36l238t3111r816b3200],
20	.	.	O	.	_	0	SENT_880	[p36l238t3111r816b3200],

1	Oncogene	NN	O	oncogene	_	0	SENT_881	[p36l851t3117r1338b3225],
2	1992	CD	DATE	1992	num	1	SENT_881	[p36l1369t3117r2092b3219],
3	;	:	O	;	_	0	SENT_881	[p36l1369t3117r2092b3219],
4	7:237	CD	NUMBER	7:237	number	5	SENT_881	[p36l1369t3117r2092b3219],
5	—	CD	NUMBER	—	dep	1	SENT_881	[p36l1369t3117r2092b3219],
6	42	CD	NUMBER	42	dep	5	SENT_881	[p36l1369t3117r2092b3219],
7	.	.	O	.	_	0	SENT_881	[p36l1369t3117r2092b3219],

1	79	CD	NUMBER	79	_	0	SENT_882	[p36l20t3268r152b3347],
2	.	.	O	.	_	0	SENT_882	[p36l20t3268r152b3347],

1	Knezevich	NNP	O	Knezevich	_	0	SENT_883	[p36l213t3257r719b3349],
2	SR	JJ	O	sr	dep	1	SENT_883	[p36l772t3265r928b3367],
3	,	,	O	,	_	0	SENT_883	[p36l772t3265r928b3367],
4	McFadden	NNP	PERSON	McFadden	nn	5	SENT_883	[p36l983t3257r1501b3347],
5	DE	NN	PERSON	de	appos	2	SENT_883	[p36l1550t3265r1724b3367],
6	,	,	O	,	_	0	SENT_883	[p36l1550t3265r1724b3367],
7	Tao	NNP	O	Tao	nn	8	SENT_883	[p36l1777t3265r1952b3347],
8	W	NNP	O	W	appos	2	SENT_883	[p36l2001t3265r2122b3367],
9	,	,	O	,	_	0	SENT_883	[p36l2001t3265r2122b3367],
10	Lim	NNP	LOCATION	Lim	nn	11	SENT_883	[p36l16t3406r207b3493],
11	JF	NNP	LOCATION	JF	appos	2	SENT_883	[p36l228t3414r347b3514],
12	,	,	O	,	_	0	SENT_883	[p36l228t3414r347b3514],
13	Sorensen	NNP	PERSON	Sorensen	nn	14	SENT_883	[p36l390t3412r839b3495],
14	PH.	NNP	O	PH.	appos	2	SENT_883	[p36l867t3412r1040b3495],
15	.	.	O	.	_	0	SENT_883	[p36l867t3412r1040b3495],

1	A	DT	O	a	det	3	SENT_884	[p36l1073t3414r1150b3493],
2	novel	JJ	O	novel	amod	3	SENT_884	[p36l1176t3406r1434b3495],
3	ETV6	NN	O	etv6	_	0	SENT_884	[p36l1462t3412r2126b3500],
4	.	.	O	.	_	0	SENT_884	[p36l1462t3412r2126b3500],

1	—	NN	O	—	_	0	SENT_885	[p36l1462t3412r2126b3500],
2	.	.	O	.	_	0	SENT_885	[p36l1462t3412r2126b3500],

1	NTRK3	NN	O	ntrk3	nn	3	SENT_886	[p36l1462t3412r2126b3500],
2	gene	NN	O	gene	nn	3	SENT_886	[p36l17t3580r244b3666],
3	fusion	NN	O	fusion	_	0	SENT_886	[p36l270t3550r575b3641],
4	in	IN	O	in	_	0	SENT_886	[p36l599t3552r693b3639],
5	congenital	JJ	O	congenital	amod	6	SENT_886	[p36l719t3552r1229b3666],
6	fibrosarcoma	NN	O	fibrosarcoma	prep_in	3	SENT_886	[p36l1253t3550r1927b3641],
7	.	.	O	.	_	0	SENT_886	[p36l1253t3550r1927b3641],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_887	[p36l1956t3560r2135b3641],
2	Genet	NNP	PERSON	Genet	_	0	SENT_887	[p36l18t3706r311b3789],
3	1998	CD	DATE	1998	num	2	SENT_887	[p36l339t3706r1068b3808],
4	;	:	O	;	_	0	SENT_887	[p36l339t3706r1068b3808],
5	18:184	CD	NUMBER	18:184	num	6	SENT_887	[p36l339t3706r1068b3808],
6	—	NN	O	—	dep	2	SENT_887	[p36l339t3706r1068b3808],
7	7	CD	NUMBER	7	dep	6	SENT_887	[p36l339t3706r1068b3808],
8	.	.	O	.	_	0	SENT_887	[p36l339t3706r1068b3808],

1	80	CD	NUMBER	80	_	0	SENT_888	[p37l16t40r152b121],
2	.	.	O	.	_	0	SENT_888	[p37l16t40r152b121],

1	Tognon	NN	MISC	tognon	nn	2	SENT_889	[p37l211t38r587b146],
2	C	NN	O	c	_	0	SENT_889	[p37l620t38r715b140],
3	,	,	O	,	_	0	SENT_889	[p37l620t38r715b140],
4	Knezevich	NNP	O	Knezevich	nn	5	SENT_889	[p37l752t30r1249b123],
5	SR	NN	O	sr	appos	2	SENT_889	[p37l1283t38r1436b140],
6	,	,	O	,	_	0	SENT_889	[p37l1283t38r1436b140],
7	Huntsman	NNP	PERSON	Huntsman	nn	8	SENT_889	[p37l1474t38r1992b121],
8	D	NNP	O	D	appos	2	SENT_889	[p37l2023t38r2123b140],
9	,	,	O	,	_	0	SENT_889	[p37l2023t38r2123b140],
10	et	FW	O	et	nn	11	SENT_889	[p37l18t197r106b268],
11	al.	FW	O	al.	appos	2	SENT_889	[p37l140t177r248b268],
12	.	.	O	.	_	0	SENT_889	[p37l140t177r248b268],

1	Expression	NN	O	expression	_	0	SENT_890	[p37l293t179r830b293],
2	of	IN	O	of	_	0	SENT_890	[p37l871t177r985b268],
3	the	DT	O	the	det	4	SENT_890	[p37l1006t179r1154b268],
4	ETV6	NN	O	etv6	prep_of	1	SENT_890	[p37l1194t185r1858b273],
5	.	.	O	.	_	0	SENT_890	[p37l1194t185r1858b273],

1	—	NN	O	—	_	0	SENT_891	[p37l1194t185r1858b273],
2	.	.	O	.	_	0	SENT_891	[p37l1194t185r1858b273],

1	NTRK3	NN	O	ntrk3	nn	3	SENT_892	[p37l1194t185r1858b273],
2	gene	NN	O	gene	nn	3	SENT_892	[p37l1903t207r2130b293],
3	fusion	NN	O	fusion	_	0	SENT_892	[p37l18t324r329b415],
4	as	IN	O	as	_	0	SENT_892	[p37l368t355r465b415],
5	a	DT	O	a	det	7	SENT_892	[p37l508t355r558b415],
6	primary	JJ	O	primary	amod	7	SENT_892	[p37l595t326r987b440],
7	event	NN	O	event	prep_as	3	SENT_892	[p37l1024t344r1284b415],
8	in	IN	O	in	_	0	SENT_892	[p37l1318t326r1412b413],
9	human	JJ	O	human	amod	12	SENT_892	[p37l1452t324r1800b415],
10	secretory	JJ	O	secretory	amod	12	SENT_892	[p37l1842t355r2128b415, p37l18t491r211b585],
11	breast	NN	O	breast	nn	12	SENT_892	[p37l248t473r550b562],
12	carcinoma	NN	O	carcinoma	prep_in	3	SENT_892	[p37l585t473r1119b562],
13	.	.	O	.	_	0	SENT_892	[p37l585t473r1119b562],

1	Cancer	NN	O	cancer	nn	2	SENT_893	[p37l1166t479r1503b562],
2	Cell	NN	O	cell	_	0	SENT_893	[p37l1540t471r1727b562],
3	2002	CD	DATE	2002	dep	2	SENT_893	[p37l1767t479r2126b581],
4	;	:	O	;	_	0	SENT_893	[p37l1767t479r2126b581],
5	2	CD	NUMBER	2	num	7	SENT_893	[p37l1767t479r2126b581],
6	:	:	O	:	_	0	SENT_893	[p37l1767t479r2126b581],
7	367-76	CD	NUMBER	367-76	dep	2	SENT_893	[p37l18t627r381b710],
8	.	.	O	.	_	0	SENT_893	[p37l18t627r381b710],

1	81	CD	NUMBER	81	_	0	SENT_894	[p37l16t777r152b858],
2	.	.	O	.	_	0	SENT_894	[p37l16t777r152b858],

1	I-Iermanson	NN	O	i-iermanson	nn	2	SENT_895	[p37l213t775r790b857],
2	M	NN	O	m	_	0	SENT_895	[p37l825t775r949b877],
3	,	,	O	,	_	0	SENT_895	[p37l825t775r949b877],
4	Funa	NNP	PERSON	Funa	nn	5	SENT_895	[p37l991t775r1233b858],
5	K	NNP	PERSON	K	appos	2	SENT_895	[p37l1267t777r1367b877],
6	,	,	O	,	_	0	SENT_895	[p37l1267t777r1367b877],
7	Hartman	NNP	PERSON	Hartman	nn	8	SENT_895	[p37l1410t775r1846b857],
8	M	NNP	O	M	appos	2	SENT_895	[p37l1879t777r2004b877],
9	,	,	O	,	_	0	SENT_895	[p37l1879t777r2004b877],
10	et	FW	O	et	nn	11	SENT_895	[p37l2048t787r2137b857],
11	al.	FW	O	al.	appos	2	SENT_895	[p37l16t915r126b1004],
12	.	.	O	.	_	0	SENT_895	[p37l16t915r126b1004],

1	Platelet	NN	O	platelet	nn	2	SENT_896	[p37l159t913r926b1004],
2	—	NN	O	—	nsubj	3	SENT_896	[p37l159t913r926b1004],
3	derived	VBN	O	derive	_	0	SENT_896	[p37l159t913r926b1004],
4	growth	NN	O	growth	nn	5	SENT_896	[p37l953t915r1308b1029],
5	factor	NN	O	factor	dobj	3	SENT_896	[p37l1336t913r1625b1004],
6	and	CC	O	and	_	0	SENT_896	[p37l1649t913r1830b1004],
7	its	PRP$	O	its	poss	8	SENT_896	[p37l1858t915r1970b1003],
8	receptor	NN	O	receptor	conj_and	3	SENT_896	[p37l2003t944r2129b1004, p37l18t1080r319b1176],
9	in	IN	O	in	_	0	SENT_896	[p37l339t1062r432b1149],
10	human	JJ	O	human	amod	12	SENT_896	[p37l455t1062r794b1151],
11	glioma	NN	O	glioma	nn	12	SENT_896	[p37l817t1062r1152b1176],
12	tissue	NN	O	tissue	prep_in	8	SENT_896	[p37l1174t1062r1474b1151],
13	:	:	O	:	_	0	SENT_896	[p37l1174t1062r1474b1151],
14	expression	NN	O	expression	nsubj	20	SENT_896	[p37l1503t1062r2013b1176],
15	of	IN	O	of	_	0	SENT_896	[p37l2039t1060r2153b1151],
16	messenger	NN	O	messenger	nn	17	SENT_896	[p37l18t1237r544b1323],
17	RNA	NN	O	rna	prep_of	14	SENT_896	[p37l591t1215r827b1303],
18	and	CC	O	and	_	0	SENT_896	[p37l875t1207r1054b1298],
19	protein	NN	O	protein	prep_of	14	SENT_896	[p37l1105t1209r1458b1323],
20	suggests	VBZ	O	suggest	parataxis	3	SENT_896	[p37l1511t1227r1927b1323],
21	the	DT	O	the	det	22	SENT_896	[p37l1982t1207r2130b1298],
22	presence	NN	O	presence	dobj	20	SENT_896	[p37l16t1384r443b1470],
23	of	IN	O	of	_	0	SENT_896	[p37l486t1354r601b1445],
24	autocrine	NN	O	autocrine	nn	27	SENT_896	[p37l620t1356r1076b1445],
25	and	CC	O	and	_	0	SENT_896	[p37l1117t1356r1296b1445],
26	paracrine	NN	O	paracrine	nn	27	SENT_896	[p37l1335t1356r1791b1470],
27	loops	NNS	O	loop	prep_of	22	SENT_896	[p37l1830t1356r2124b1470],
28	.	.	O	.	_	0	SENT_896	[p37l1830t1356r2124b1470],

1	Cancer	NNP	O	Cancer	nn	2	SENT_897	[p37l18t1510r357b1593],
2	Res	NNP	O	Res	_	0	SENT_897	[p37l380t1510r552b1598],
3	1992	CD	DATE	1992	num	2	SENT_897	[p37l587t1510r1377b1612],
4	;	:	O	;	_	0	SENT_897	[p37l587t1510r1377b1612],
5	52:3213	CD	NUMBER	52:3213	number	6	SENT_897	[p37l587t1510r1377b1612],
6	—	CD	NUMBER	—	dep	2	SENT_897	[p37l587t1510r1377b1612],
7	9	CD	NUMBER	9	dep	6	SENT_897	[p37l587t1510r1377b1612],
8	.	.	O	.	_	0	SENT_897	[p37l587t1510r1377b1612],

1	82	CD	NUMBER	82	_	0	SENT_898	[p37l16t1659r152b1740],
2	.	.	O	.	_	0	SENT_898	[p37l16t1659r152b1740],

1	McGary	NNP	ORGANIZATION	McGary	nn	2	SENT_899	[p37l211t1657r597b1763],
2	EC	NNP	ORGANIZATION	EC	_	0	SENT_899	[p37l615t1657r778b1759],
3	,	,	O	,	_	0	SENT_899	[p37l615t1657r778b1759],
4	Weber	NNP	PERSON	Weber	nn	5	SENT_899	[p37l806t1649r1121b1739],
5	K	NNP	PERSON	K	appos	2	SENT_899	[p37l1141t1657r1241b1759],
6	,	,	O	,	_	0	SENT_899	[p37l1141t1657r1241b1759],
7	Mills	NNP	PERSON	Mills	nn	8	SENT_899	[p37l1268t1649r1509b1739],
8	L	NNP	O	L	appos	2	SENT_899	[p37l1534t1657r1617b1759],
9	,	,	O	,	_	0	SENT_899	[p37l1534t1657r1617b1759],
10	et	FW	O	et	nn	11	SENT_899	[p37l1650t1668r1738b1739],
11	al.	FW	O	al.	appos	2	SENT_899	[p37l1755t1649r1864b1739],
12	.	.	O	.	_	0	SENT_899	[p37l1755t1649r1864b1739],

1	Inhibition	NN	O	inhibition	nsubj	11	SENT_900	[p37l1893t1649r2128b1738, p37l18t1797r296b1886],
2	of	IN	O	of	_	0	SENT_900	[p37l321t1795r434b1886],
3	platelet	NN	O	platelet	nn	4	SENT_900	[p37l435t1795r1160b1911],
4	—	NN	O	—	prep_of	1	SENT_900	[p37l435t1795r1160b1911],
5	derived	VBN	O	derive	partmod	4	SENT_900	[p37l435t1795r1160b1911],
6	growth	NN	O	growth	nn	7	SENT_900	[p37l1182t1797r1523b1911],
7	factor	NN	O	factor	dobj	5	SENT_900	[p37l1545t1795r2131b1886],
8	—	CD	NUMBER	—	num	9	SENT_900	[p37l1545t1795r2131b1886],
9	medi	NN	O	medus	tmod	5	SENT_900	[p37l1545t1795r2131b1886],
10	—	CD	NUMBER	—	dep	9	SENT_900	[p37l1545t1795r2131b1886],
11	ated	VBD	O	ate	_	0	SENT_900	[p37l16t1942r219b2033],
12	proliferation	NN	O	proliferation	dobj	11	SENT_900	[p37l252t1942r880b2058],
13	of	IN	O	of	_	0	SENT_900	[p37l916t1942r1032b2033],
14	osteosarcoma	NN	O	osteosarcoma	nn	15	SENT_900	[p37l1048t1962r1735b2033],
15	cells	NNS	O	cell	prep_of	12	SENT_900	[p37l1769t1942r1984b2033],
16	by	IN	O	by	_	0	SENT_900	[p37l2023t1944r2135b2056],
17	the	DT	O	the	det	22	SENT_900	[p37l18t2091r168b2180],
18	novel	JJ	O	novel	amod	22	SENT_900	[p37l213t2091r471b2180],
19	tyrosine	NN	O	tyrosine	nn	22	SENT_900	[p37l512t2091r896b2205],
20	kinase	NN	O	kinase	nn	22	SENT_900	[p37l936t2091r1247b2181],
21	inhibitor	NN	O	inhibitor	nn	22	SENT_900	[p37l1286t2089r1718b2180],
22	STI571	NN	O	sti571	prep_by	11	SENT_900	[p37l1757t2097r2124b2180],
23	.	.	O	.	_	0	SENT_900	[p37l1757t2097r2124b2180],

1	Clin	NNP	O	Clin	nn	3	SENT_901	[p37l18t2237r215b2328],
2	Cancer	NNP	O	Cancer	nn	3	SENT_901	[p37l244t2245r583b2328],
3	Res	NNP	O	Res	_	0	SENT_901	[p37l607t2245r778b2333],
4	2002	CD	DATE	2002	num	3	SENT_901	[p37l809t2245r1604b2345],
5	;	:	O	;	_	0	SENT_901	[p37l809t2245r1604b2345],
6	8:3584	CD	NUMBER	8:3584	number	7	SENT_901	[p37l809t2245r1604b2345],
7	—	CD	NUMBER	—	dep	3	SENT_901	[p37l809t2245r1604b2345],
8	91	CD	NUMBER	91	dep	7	SENT_901	[p37l809t2245r1604b2345],
9	.	.	O	.	_	0	SENT_901	[p37l809t2245r1604b2345],

1	83	CD	NUMBER	83	_	0	SENT_902	[p37l16t2394r152b2475],
2	.	.	O	.	_	0	SENT_902	[p37l16t2394r152b2475],

1	Kilic	JJ	ORGANIZATION	kilic	amod	2	SENT_903	[p37l213t2384r438b2476],
2	T	NN	ORGANIZATION	t	_	0	SENT_903	[p37l461t2392r548b2494],
3	,	,	O	,	_	0	SENT_903	[p37l461t2392r548b2494],
4	Alberta	NNP	ORGANIZATION	Alberta	nn	5	SENT_903	[p37l577t2384r942b2474],
5	IA	NNP	ORGANIZATION	IA	appos	2	SENT_903	[p37l957t2392r1101b2494],
6	,	,	O	,	_	0	SENT_903	[p37l957t2392r1101b2494],
7	Zdunek	NNP	ORGANIZATION	Zdunek	nn	8	SENT_903	[p37l1134t2384r1513b2475],
8	PR	NNP	O	PR	appos	2	SENT_903	[p37l1534t2392r1696b2494],
9	,	,	O	,	_	0	SENT_903	[p37l1534t2392r1696b2494],
10	et	FW	O	et	nn	11	SENT_903	[p37l1733t2403r1822b2474],
11	al.	FW	O	al.	appos	2	SENT_903	[p37l1844t2384r1954b2474],
12	.	.	O	.	_	0	SENT_903	[p37l1844t2384r1954b2474],

1	Intracranial	JJ	O	intracranial	amod	2	SENT_904	[p37l1987t2392r2127b2473, p37l18t2530r487b2621],
2	inhibition	NN	O	inhibition	nsubj	10	SENT_904	[p37l581t2530r1076b2621],
3	of	IN	O	of	_	0	SENT_904	[p37l1172t2530r1288b2621],
4	platelet	NN	O	platelet	nn	5	SENT_904	[p37l1361t2530r2130b2646],
5	—	NN	O	—	prep_of	2	SENT_904	[p37l1361t2530r2130b2646],
6	deriVed	VBN	O	derive	partmod	5	SENT_904	[p37l1361t2530r2130b2646],
7	growth	NN	O	growth	nn	9	SENT_904	[p37l17t2679r371b2793],
8	factor	NN	O	factor	nn	9	SENT_904	[p37l422t2677r1212b2768],
9	—	NN	O	—	dobj	6	SENT_904	[p37l422t2677r1212b2768],
10	mediated	VBD	O	mediate	_	0	SENT_904	[p37l422t2677r1212b2768],
11	glioblastoma	NN	O	glioblastoma	nn	13	SENT_904	[p37l1263t2677r1913b2793],
12	cell	NN	O	cell	nn	13	SENT_904	[p37l1964t2677r2130b2768],
13	growth	NN	O	growth	dobj	10	SENT_904	[p37l17t2826r370b2940],
14	by	IN	O	by	_	0	SENT_904	[p37l396t2826r509b2940],
15	an	DT	O	a	det	19	SENT_904	[p37l528t2854r645b2914],
16	orally	RB	O	orally	advmod	17	SENT_904	[p37l670t2826r940b2940],
17	active	JJ	O	active	amod	19	SENT_904	[p37l959t2826r1227b2915],
18	kinase	NN	O	kinase	nn	19	SENT_904	[p37l1251t2826r1562b2916],
19	inhibitor	NN	O	inhibitor	prep_by	10	SENT_904	[p37l1584t2824r2015b2915],
20	of	IN	O	of	_	0	SENT_904	[p37l2037t2824r2151b2915],
21	the	DT	O	the	det	25	SENT_904	[p37l18t2971r166b3062],
22	2	CD	NUMBER	2	num	25	SENT_904	[p37l197t2971r1468b3087],
23	—	NN	O	—	nn	25	SENT_904	[p37l197t2971r1468b3087],
24	phenylaminopyrimidine	NN	O	phenylaminopyrimidine	nn	25	SENT_904	[p37l197t2971r1468b3087],
25	class	NN	O	class	prep_of	19	SENT_904	[p37l1501t2971r1757b3062],
26	.	.	O	.	_	0	SENT_904	[p37l1501t2971r1757b3062],

1	Cancer	NNP	O	Cancer	nn	2	SENT_905	[p37l1795t2979r2134b3062],
2	Res	NNP	O	Res	_	0	SENT_905	[p37l16t3127r187b3215],
3	2000	CD	DATE	2000	num	2	SENT_905	[p37l217t3127r1074b3229],
4	;	:	O	;	_	0	SENT_905	[p37l217t3127r1074b3229],
5	60:5143	CD	NUMBER	60:5143	number	6	SENT_905	[p37l217t3127r1074b3229],
6	—	CD	NUMBER	—	dep	2	SENT_905	[p37l217t3127r1074b3229],
7	50	CD	NUMBER	50	dep	6	SENT_905	[p37l217t3127r1074b3229],
8	.	.	O	.	_	0	SENT_905	[p37l217t3127r1074b3229],

1	84	CD	NUMBER	84	_	0	SENT_906	[p37l16t3276r152b3357],
2	.	.	O	.	_	0	SENT_906	[p37l16t3276r152b3357],

1	Zhao	NNP	PERSON	Zhao	nn	2	SENT_907	[p37l213t3266r449b3356],
2	J	NNP	PERSON	J	_	0	SENT_907	[p37l465t3274r530b3376],
3	,	,	O	,	_	0	SENT_907	[p37l465t3274r530b3376],
4	Roth	NNP	PERSON	Roth	nn	5	SENT_907	[p37l559t3266r790b3362],
5	J	NNP	O	J	appos	2	SENT_907	[p37l803t3274r869b3376],
6	,	,	O	,	_	0	SENT_907	[p37l803t3274r869b3376],
7	Bode	NNP	O	Bode	appos	5	SENT_907	[p37l898t3266r1726b3357],
8	.	.	O	.	_	0	SENT_907	[p37l898t3266r1726b3357],

1	—	NN	O	—	_	0	SENT_908	[p37l898t3266r1726b3357],
2	.	.	O	.	_	0	SENT_908	[p37l898t3266r1726b3357],

1	LesnieWsl	NN	O	lesniewsl	_	0	SENT_909	[p37l898t3266r1726b3357],
2	<	JJR	O	<	amod	4	SENT_909	[p37l898t3266r1726b3357],
3	a	DT	O	a	det	4	SENT_909	[p37l898t3266r1726b3357],
4	B	NN	O	b	dep	1	SENT_909	[p37l1747t3274r1838b3376],
5	,	,	O	,	_	0	SENT_909	[p37l1747t3274r1838b3376],
6	]	CD	NUMBER	]	num	8	SENT_909	[p37l1867t3266r2132b3356],
7	Pfaltz	NN	O	pfaltz	nn	8	SENT_909	[p37l1867t3266r2132b3356],
8	M	NN	O	m	appos	4	SENT_909	[p37l14t3423r138b3523],
9	,	,	O	,	_	0	SENT_909	[p37l14t3423r138b3523],
10	Heitz	NNP	ORGANIZATION	Heitz	nn	11	SENT_909	[p37l169t3415r424b3503],
11	PU	NN	ORGANIZATION	pu	appos	4	SENT_909	[p37l449t3421r609b3523],
12	,	,	O	,	_	0	SENT_909	[p37l449t3421r609b3523],
13	Komminoth	NNP	O	Komminoth	nn	15	SENT_909	[p37l640t3415r1229b3506],
14	P.	NNP	O	P.	nn	15	SENT_909	[p37l1253t3421r1326b3504],
15	Combined	NNP	O	Combined	appos	4	SENT_909	[p37l1359t3413r1860b3504],
16	comparative	JJ	O	comparative	amod	15	SENT_909	[p37l1887t3442r2129b3504, p38l12t80r194b136],

1	genomic	JJ	O	genomic	amod	2	SENT_910	[p38l206t80r409b136],
2	hybridization	NN	O	hybridization	_	0	SENT_910	[p38l421t79r731b136],
3	and	CC	O	and	_	0	SENT_910	[p38l743t79r830b124],
4	genomic	JJ	O	genomic	amod	5	SENT_910	[p38l842t80r1045b136],
5	microarray	NN	O	microarray	conj_and	2	SENT_910	[p38l13t151r277b207],
6	for	IN	O	for	_	0	SENT_910	[p38l289t150r359b195],
7	detection	NN	O	detection	prep_for	2	SENT_910	[p38l372t150r595b195],
8	of	IN	O	of	_	0	SENT_910	[p38l610t150r667b195],
9	gene	NN	O	gene	nn	10	SENT_910	[p38l670t165r784b207],
10	amplifications	NNS	O	amplification	prep_of	2	SENT_910	[p38l798t150r1043b207, p38l13t222r131b266],
11	in	IN	O	in	_	0	SENT_910	[p38l149t222r196b265],
12	pulmonary	JJ	O	pulmonary	amod	15	SENT_910	[p38l212t221r473b278],
13	artery	NN	O	artery	nn	15	SENT_910	[p38l486t231r621b278],
14	intimal	JJ	O	intimal	amod	15	SENT_910	[p38l635t221r804b265],
15	sarcomas	NNS	O	sarcoma	prep_in	2	SENT_910	[p38l821t236r1043b266],
16	and	CC	O	and	_	0	SENT_910	[p38l12t293r99b338],
17	adrenocortical	JJ	O	adrenocortical	amod	18	SENT_910	[p38l113t293r453b338],
18	tumors	NNS	O	tumor	conj_and	15	SENT_910	[p38l467t303r650b338],
19	.	.	O	.	_	0	SENT_910	[p38l467t303r650b338],

1	Genes	NNS	O	gene	_	0	SENT_911	[p38l667t297r814b338],
2	Chromosomes	NNS	O	chromosome	dep	1	SENT_911	[p38l829t293r1043b338, p38l13t378r162b408],

1	Cancer	NN	O	cancer	_	0	SENT_912	[p38l177t367r343b408],
2	2002	CD	DATE	2002	num	1	SENT_912	[p38l355t367r714b417],
3	;	:	O	;	_	0	SENT_912	[p38l355t367r714b417],
4	34:48	CD	NUMBER	34:48	number	5	SENT_912	[p38l355t367r714b417],
5	—	CD	NUMBER	—	dep	1	SENT_912	[p38l355t367r714b417],
6	57	CD	NUMBER	57	dep	5	SENT_912	[p38l355t367r714b417],
7	.	.	O	.	_	0	SENT_912	[p38l355t367r714b417],

1	85	CD	NUMBER	85	_	0	SENT_913	[p38l12t439r78b479],
2	.	.	O	.	_	0	SENT_913	[p38l12t439r78b479],

1	Heinrich	NNP	PERSON	Heinrich	nn	2	SENT_914	[p38l108t434r316b478],
2	MC	NNP	PERSON	MC	_	0	SENT_914	[p38l334t438r431b488],
3	,	,	O	,	_	0	SENT_914	[p38l334t438r431b488],
4	Corless	NNP	ORGANIZATION	Corless	nn	5	SENT_914	[p38l454t434r627b479],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_914	[p38l648t438r724b488],
6	,	,	O	,	_	0	SENT_914	[p38l648t438r724b488],
7	Duensing	NNP	PERSON	Duensing	nn	8	SENT_914	[p38l746t435r977b491],
8	A	NNP	O	A	appos	2	SENT_914	[p38l993t438r1041b488],
9	,	,	O	,	_	0	SENT_914	[p38l993t438r1041b488],
10	et	FW	O	et	nn	11	SENT_914	[p38l13t515r56b549],
11	al.	FW	O	al.	appos	2	SENT_914	[p38l68t505r122b550],
12	.	.	O	.	_	0	SENT_914	[p38l68t505r122b550],

1	PDGFRA	NNP	O	PDGFRA	_	0	SENT_915	[p38l140t509r358b552],
2	activating	VBG	O	activate	partmod	1	SENT_915	[p38l372t506r607b562],
3	mutations	NNS	O	mutation	dobj	2	SENT_915	[p38l620t506r866b550],
4	in	IN	O	in	_	0	SENT_915	[p38l882t506r928b549],
5	gastrointestinal	JJ	O	gastrointestinal	amod	7	SENT_915	[p38l943t520r1042b562, p38l13t577r305b621],
6	stromal	JJ	O	stromal	amod	7	SENT_915	[p38l322t577r502b621],
7	tumors	NNS	O	tumor	prep_in	3	SENT_915	[p38l518t586r701b621],
8	.	.	O	.	_	0	SENT_915	[p38l518t586r701b621],

1	Science	NNP	O	Science	_	0	SENT_916	[p38l721t577r896b621],
2	2003	CD	DATE	2003	num	1	SENT_916	[p38l912t580r1042b630],
3	;	:	O	;	_	0	SENT_916	[p38l912t580r1042b630],
4	299:708	CD	NUMBER	299:708	number	5	SENT_916	[p38l13t651r295b692],
5	—	CD	NUMBER	—	dep	1	SENT_916	[p38l13t651r295b692],
6	10	CD	NUMBER	10	dep	5	SENT_916	[p38l13t651r295b692],
7	.	.	O	.	_	0	SENT_916	[p38l13t651r295b692],

1	86	CD	NUMBER	86	_	0	SENT_917	[p38l12t723r78b763],
2	.	.	O	.	_	0	SENT_917	[p38l12t723r78b763],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_918	[p38l110t719r262b763],
2	MP	NNP	O	MP	_	0	SENT_918	[p38l275t722r361b772],
3	,	,	O	,	_	0	SENT_918	[p38l275t722r361b772],
4	Pedeutour	NNP	O	Pedeutour	nn	5	SENT_918	[p38l378t718r621b763],
5	F	NN	O	f	appos	2	SENT_918	[p38l633t722r668b772],
6	,	,	O	,	_	0	SENT_918	[p38l633t722r668b772],
7	Sirvent	NNP	PERSON	Sirvent	nn	8	SENT_918	[p38l688t719r851b763],
8	N	NNP	O	N	appos	2	SENT_918	[p38l862t722r914b772],
9	,	,	O	,	_	0	SENT_918	[p38l862t722r914b772],
10	et	FW	O	et	nn	11	SENT_918	[p38l933t727r976b762],
11	al.	FW	O	al.	appos	2	SENT_918	[p38l988t718r1040b762],
12	.	.	O	.	_	0	SENT_918	[p38l988t718r1040b762],

1	Deregulation	NN	O	deregulation	nsubj	6	SENT_919	[p38l12t789r321b846],
2	of	IN	O	of	_	0	SENT_919	[p38l339t789r395b834],
3	the	DT	O	the	det	5	SENT_919	[p38l402t790r474b834],
4	platelet	NN	O	platelet	nn	5	SENT_919	[p38l491t789r857b846],
5	—	NN	O	—	prep_of	1	SENT_919	[p38l491t789r857b846],
6	derived	VBN	O	derive	_	0	SENT_919	[p38l491t789r857b846],
7	growth	NN	O	growth	nn	12	SENT_919	[p38l874t790r1044b846],
8	factor	NN	O	factor	nn	12	SENT_919	[p38l13t860r150b905],
9	B	NN	O	b	nn	12	SENT_919	[p38l163t861r346b904],
10	—	NN	O	—	nn	12	SENT_919	[p38l163t861r346b904],
11	chain	NN	O	chain	nn	12	SENT_919	[p38l163t861r346b904],
12	gene	NN	O	gene	dobj	6	SENT_919	[p38l360t875r471b917],
13	via	IN	O	via	_	0	SENT_919	[p38l483t861r550b905],
14	fusion	NN	O	fusion	prep_via	12	SENT_919	[p38l564t860r713b905],
15	with	IN	O	with	_	0	SENT_919	[p38l725t860r831b905],
16	collagen	NN	O	collagen	nn	18	SENT_919	[p38l846t860r1044b917],
17	gene	NN	O	gene	nn	18	SENT_919	[p38l12t946r123b988],
18	COL1A1	NN	O	col1a1	prep_with	6	SENT_919	[p38l139t935r338b976],
19	in	IN	O	in	_	0	SENT_919	[p38l353t932r399b975],
20	dermatofibrosarcoma	NN	O	dermatofibrosarcoma	nn	23	SENT_919	[p38l414t931r931b976],
21	pro	JJ	O	pro	amod	23	SENT_919	[p38l944t946r1044b988],
22	—	NN	O	—	nn	23	SENT_919	[p38l944t946r1044b988],
23	tuberans	NNS	O	tuberan	prep_in	18	SENT_919	[p38l13t1003r217b1047],
24	and	CC	O	and	_	0	SENT_919	[p38l239t1002r326b1047],
25	giant	JJ	O	giant	amod	28	SENT_919	[p38l347t1002r568b1059],
26	—	NN	O	—	nn	28	SENT_919	[p38l347t1002r568b1059],
27	cell	NN	O	cell	nn	28	SENT_919	[p38l347t1002r568b1059],
28	fibroblastoma	NN	O	fibroblastoma	conj_and	18	SENT_919	[p38l589t1002r936b1047],
29	.	.	O	.	_	0	SENT_919	[p38l589t1002r936b1047],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_920	[p38l959t1007r1047b1047],
2	Genet	NNP	PERSON	Genet	_	0	SENT_920	[p38l13t1077r156b1118],
3	1997	CD	DATE	1997	num	2	SENT_920	[p38l169t1077r496b1127],
4	;	:	O	;	_	0	SENT_920	[p38l169t1077r496b1127],
5	15:95	CD	NUMBER	15:95	number	6	SENT_920	[p38l169t1077r496b1127],
6	—	CD	NUMBER	—	dep	2	SENT_920	[p38l169t1077r496b1127],
7	8	CD	NUMBER	8	dep	6	SENT_920	[p38l169t1077r496b1127],
8	.	.	O	.	_	0	SENT_920	[p38l169t1077r496b1127],

1	87	CD	NUMBER	87	_	0	SENT_921	[p38l12t1149r78b1189],
2	.	.	O	.	_	0	SENT_921	[p38l12t1149r78b1189],

1	McArthur	NNP	PERSON	McArthur	nn	2	SENT_922	[p38l107t1144r339b1189],
2	G.	NNP	PERSON	G.	nsubj	4	SENT_922	[p38l352t1148r405b1189],
3	Molecularly	RB	PERSON	molecularly	advmod	4	SENT_922	[p38l420t1144r700b1200],
4	targeted	VBD	O	target	_	0	SENT_922	[p38l712t1144r905b1201],
5	treatment	NN	O	treatment	dobj	4	SENT_922	[p38l919t1153r1043b1188, p38l13t1225r137b1260],
6	for	IN	O	for	_	0	SENT_922	[p38l168t1215r237b1260],
7	dermatoﬁbrosarcoma	NN	O	dermatoﬁbrosarcoma	nn	8	SENT_922	[p38l269t1215r786b1260],
8	protuberans	NNS	O	protuberan	prep_for	4	SENT_922	[p38l818t1216r1044b1272, p38l12t1301r105b1331],
9	.	.	O	.	_	0	SENT_922	[p38l818t1216r1044b1272, p38l12t1301r105b1331],

1	Semin	NNP	O	Semin	nn	2	SENT_923	[p38l124t1287r272b1331],
2	Oncol	NNP	O	Oncol	_	0	SENT_923	[p38l286t1287r428b1331],
3	2004	CD	DATE	2004	num	5	SENT_923	[p38l441t1286r788b1343],
4	;	:	O	;	_	0	SENT_923	[p38l441t1286r788b1343],
5	31	CD	NUMBER	31	dep	2	SENT_923	[p38l441t1286r788b1343],
6	:	:	O	:	_	0	SENT_923	[p38l441t1286r788b1343],
7	Suppl	NNP	O	Suppl	dep	2	SENT_923	[p38l441t1286r788b1343],
8	6:30	CD	TIME	6:30	num	7	SENT_923	[p38l801t1290r966b1331],
9	—	CD	NUMBER	—	number	10	SENT_923	[p38l801t1290r966b1331],
10	6	CD	NUMBER	6	dep	7	SENT_923	[p38l801t1290r966b1331],
11	.	.	O	.	_	0	SENT_923	[p38l801t1290r966b1331],

1	88	CD	NUMBER	88	_	0	SENT_924	[p38l12t1362r78b1402],
2	.	.	O	.	_	0	SENT_924	[p38l12t1362r78b1402],

1	Santoro	NNP	PERSON	Santoro	nn	2	SENT_925	[p38l110t1361r292b1401],
2	M	NNP	O	M	_	0	SENT_925	[p38l310t1361r371b1411],
3	,	,	O	,	_	0	SENT_925	[p38l310t1361r371b1411],
4	Carlomagno	NNP	PERSON	Carlomagno	nn	5	SENT_925	[p38l392t1357r686b1414],
5	F	NN	PERSON	f	appos	2	SENT_925	[p38l705t1361r740b1411],
6	,	,	O	,	_	0	SENT_925	[p38l705t1361r740b1411],
7	Melillo	NNP	PERSON	Melillo	nn	8	SENT_925	[p38l760t1357r925b1402],
8	RM	NN	O	rm	appos	2	SENT_925	[p38l944t1361r1041b1411],
9	,	,	O	,	_	0	SENT_925	[p38l944t1361r1041b1411],
10	Fusco	NNP	PERSON	Fusco	nn	12	SENT_925	[p38l12t1433r149b1473],
11	A.	NNP	PERSON	A.	nn	12	SENT_925	[p38l162t1433r210b1473],
12	Dysfunction	NNP	PERSON	Dysfunction	appos	2	SENT_925	[p38l227t1428r516b1485],
13	of	IN	O	of	_	0	SENT_925	[p38l530t1428r586b1473],
14	the	DT	O	the	det	16	SENT_925	[p38l590t1429r663b1473],
15	RET	NN	O	ret	nn	16	SENT_925	[p38l676t1432r778b1475],
16	receptor	NN	O	receptor	prep_of	12	SENT_925	[p38l790t1438r987b1485],
17	in	IN	O	in	_	0	SENT_925	[p38l999t1429r1044b1472],
18	human	JJ	O	human	amod	19	SENT_925	[p38l13t1500r180b1544],
19	cancer	NN	O	cancer	prep_in	16	SENT_925	[p38l206t1514r369b1544],
20	.	.	O	.	_	0	SENT_925	[p38l206t1514r369b1544],

1	Cell	NN	O	cell	_	0	SENT_926	[p38l397t1499r488b1544],
2	Mol	NNP	O	Mol	nn	4	SENT_926	[p38l512t1500r606b1544],
3	Life	NNP	O	Life	nn	4	SENT_926	[p38l630t1499r718b1544],
4	Sci	NNP	O	Sci	dep	1	SENT_926	[p38l744t1500r811b1544],
5	2004	CD	DATE	2004	num	4	SENT_926	[p38l836t1503r1042b1553],
6	;	:	O	;	_	0	SENT_926	[p38l836t1503r1042b1553],
7	61	CD	NUMBER	61	num	9	SENT_926	[p38l836t1503r1042b1553],
8	:	:	O	:	_	0	SENT_926	[p38l836t1503r1042b1553],
9	2954-64	CD	NUMBER	2954-64	dep	1	SENT_926	[p38l13t1575r220b1616],
10	.	.	O	.	_	0	SENT_926	[p38l13t1575r220b1616],

1	89	CD	NUMBER	89	_	0	SENT_927	[p38l12t1647r78b1687],
2	.	.	O	.	_	0	SENT_927	[p38l12t1647r78b1687],

1	Charest	NNP	O	Charest	nn	2	SENT_928	[p38l109t1642r292b1686],
2	A	NNP	O	A	_	0	SENT_928	[p38l309t1646r357b1696],
3	,	,	O	,	_	0	SENT_928	[p38l309t1646r357b1696],
4	Lane	NNP	ORGANIZATION	Lane	nn	5	SENT_928	[p38l382t1646r494b1686],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_928	[p38l515t1646r564b1696],
6	,	,	O	,	_	0	SENT_928	[p38l515t1646r564b1696],
7	McMahon	NNP	PERSON	McMahon	nn	8	SENT_928	[p38l588t1642r831b1686],
8	K	NNP	O	K	appos	2	SENT_928	[p38l852t1646r901b1696],
9	,	,	O	,	_	0	SENT_928	[p38l852t1646r901b1696],
10	et	FW	O	et	nn	11	SENT_928	[p38l926t1652r970b1686],
11	al.	FW	O	al.	appos	2	SENT_928	[p38l988t1642r1041b1686],
12	.	.	O	.	_	0	SENT_928	[p38l988t1642r1041b1686],

1	Fusion	NN	O	fusion	_	0	SENT_929	[p38l12t1713r173b1757],
2	of	IN	O	of	_	0	SENT_929	[p38l185t1712r242b1757],
3	FIG	NNP	O	FIG	prep_of	1	SENT_929	[p38l243t1716r330b1757],
4	to	TO	O	to	_	0	SENT_929	[p38l344t1722r388b1757],
5	the	DT	O	the	det	9	SENT_929	[p38l401t1713r473b1757],
6	receptor	NN	O	receptor	nn	9	SENT_929	[p38l486t1722r682b1769],
7	tyrosine	NN	O	tyrosine	nn	9	SENT_929	[p38l693t1713r880b1769],
8	kinase	NN	O	kinase	nn	9	SENT_929	[p38l892t1712r1044b1757],
9	ROS	NN	O	ro	prep_to	1	SENT_929	[p38l12t1787r113b1830],
10	in	IN	O	in	_	0	SENT_929	[p38l139t1784r185b1827],
11	a	DT	O	a	det	12	SENT_929	[p38l210t1798r234b1827],
12	glioblastoma	NN	O	glioblastoma	prep_in	1	SENT_929	[p38l259t1783r569b1840],
13	with	IN	O	with	_	0	SENT_929	[p38l591t1783r697b1828],
14	an	DT	O	a	det	19	SENT_929	[p38l721t1798r778b1827],
15	interstitial	JJ	O	interstitial	amod	19	SENT_929	[p38l802t1784r1045b1828],
16	del	DT	O	del	det	19	SENT_929	[p38l13t1854r382b1911],
17	(	CD	NUMBER	(	number	18	SENT_929	[p38l13t1854r382b1911],
18	6	CD	NUMBER	6	num	19	SENT_929	[p38l13t1854r382b1911],
19	)	NN	O	)	prep_with	12	SENT_929	[p38l13t1854r382b1911],
20	(	CD	NUMBER	(	num	22	SENT_929	[p38l13t1854r382b1911],
21	q21q21	NN	O	q21q21	nn	22	SENT_929	[p38l13t1854r382b1911],
22	)	NN	O	)	dep	19	SENT_929	[p38l13t1854r382b1911],
23	.	.	O	.	_	0	SENT_929	[p38l13t1854r382b1911],

1	Genes	NNS	O	gene	nn	2	SENT_930	[p38l402t1858r548b1899],
2	Chromosomes	NNS	O	chromosome	_	0	SENT_930	[p38l566t1854r915b1899],
3	Cancer	NN	O	cancer	dep	2	SENT_930	[p38l933t1858r1043b1899, p38l13t1940r83b1970],
4	2003	CD	DATE	2003	num	3	SENT_930	[p38l95t1929r454b1979],
5	;	:	O	;	_	0	SENT_930	[p38l95t1929r454b1979],
6	37:58	CD	NUMBER	37:58	number	7	SENT_930	[p38l95t1929r454b1979],
7	—	CD	NUMBER	—	dep	2	SENT_930	[p38l95t1929r454b1979],
8	71	CD	NUMBER	71	dep	7	SENT_930	[p38l95t1929r454b1979],
9	.	.	O	.	_	0	SENT_930	[p38l95t1929r454b1979],

1	90	CD	NUMBER	90	_	0	SENT_931	[p38l12t2002r78b2041],
2	.	.	O	.	_	0	SENT_931	[p38l12t2002r78b2041],

1	Hurwitz	NNP	PERSON	Hurwitz	nn	2	SENT_932	[p38l108t1998r301b2042],
2	H	NNP	O	H	_	0	SENT_932	[p38l313t2001r367b2051],
3	,	,	O	,	_	0	SENT_932	[p38l313t2001r367b2051],
4	F	NN	O	f	nn	6	SENT_932	[p38l382t2001r408b2041],
5	ehrenbacher	NN	O	ehrenbacher	nn	6	SENT_932	[p38l413t1997r709b2041],
6	L	NN	O	l	appos	2	SENT_932	[p38l718t2001r759b2051],
7	,	,	O	,	_	0	SENT_932	[p38l718t2001r759b2051],
8	N	NN	O	n	nn	9	SENT_932	[p38l773t2001r815b2042],
9	ovotnyVV	NN	O	ovotnyvv	appos	2	SENT_932	[p38l817t2001r1040b2053],
10	,	,	O	,	_	0	SENT_932	[p38l817t2001r1040b2053],
11	et	FW	O	et	nn	12	SENT_932	[p38l13t2077r56b2111],
12	al.	FW	O	al.	appos	2	SENT_932	[p38l70t2067r124b2112],
13	.	.	O	.	_	0	SENT_932	[p38l70t2067r124b2112],

1	Bevacizumab	NNP	PERSON	Bevacizumab	_	0	SENT_933	[p38l144t2068r461b2112],
2	plus	CC	O	plus	_	0	SENT_933	[p38l479t2068r580b2124],
3	irinotecan	NNP	O	irinotecan	conj_plus	1	SENT_933	[p38l598t2068r856b2121],
4	,	,	O	,	_	0	SENT_933	[p38l598t2068r856b2121],
5	ﬂuorouracil	NN	O	ﬂuorouracil	conj_plus	1	SENT_933	[p38l877t2067r1043b2112, p38l13t2139r154b2192],
6	,	,	O	,	_	0	SENT_933	[p38l877t2067r1043b2112, p38l13t2139r154b2192],
7	and	CC	O	and	_	0	SENT_933	[p38l170t2138r256b2183],
8	leucovorin	NN	O	leucovorin	conj_and	1	SENT_933	[p38l268t2138r513b2183],
9	for	IN	O	for	_	0	SENT_933	[p38l525t2138r594b2183],
10	metastatic	JJ	O	metastatic	amod	11	SENT_933	[p38l605t2139r845b2183],
11	colorec	NN	O	colorec	prep_for	8	SENT_933	[p38l858t2139r1043b2183],
12	—	NN	O	—	dep	1	SENT_933	[p38l858t2139r1043b2183],
13	tal	JJ	O	tal	amod	14	SENT_933	[p38l13t2210r70b2253],
14	cancer	NN	O	cancer	dep	12	SENT_933	[p38l84t2224r247b2254],
15	.	.	O	.	_	0	SENT_933	[p38l84t2224r247b2254],

1	N	NN	O	n	nn	2	SENT_934	[p38l263t2214r304b2254],
2	EnglJ	NN	O	englj	nsubj	3	SENT_934	[p38l317t2209r454b2266],
3	Med	VBD	O	med	_	0	SENT_934	[p38l465t2209r570b2254],
4	2004	CD	DATE	2004	dobj	3	SENT_934	[p38l584t2213r1031b2263],
5	;	:	O	;	_	0	SENT_934	[p38l584t2213r1031b2263],
6	350:2335	CD	NUMBER	350:2335	number	7	SENT_934	[p38l584t2213r1031b2263],
7	—	CD	NUMBER	—	dep	4	SENT_934	[p38l584t2213r1031b2263],
8	42	CD	NUMBER	42	dep	7	SENT_934	[p38l584t2213r1031b2263],
9	.	.	O	.	_	0	SENT_934	[p38l584t2213r1031b2263],

1	91	CD	NUMBER	91	_	0	SENT_935	[p38l12t2285r78b2324],
2	.	.	O	.	_	0	SENT_935	[p38l12t2285r78b2324],

1	Nishida	NNP	PERSON	Nishida	nn	2	SENT_936	[p38l107t2280r294b2325],
2	T	NN	O	t	_	0	SENT_936	[p38l309t2284r350b2334],
3	,	,	O	,	_	0	SENT_936	[p38l309t2284r350b2334],
4	Hirota	NNP	ORGANIZATION	Hirota	nn	5	SENT_936	[p38l369t2281r523b2325],
5	S	NNP	ORGANIZATION	S	appos	2	SENT_936	[p38l541t2284r579b2334],
6	,	,	O	,	_	0	SENT_936	[p38l541t2284r579b2334],
7	Taniguchi	NNP	PERSON	Taniguchi	nn	8	SENT_936	[p38l597t2280r835b2337],
8	M	NNP	O	M	appos	2	SENT_936	[p38l850t2284r911b2334],
9	,	,	O	,	_	0	SENT_936	[p38l850t2284r911b2334],
10	et	FW	O	et	nn	11	SENT_936	[p38l931t2289r974b2324],
11	al.	FW	O	al.	appos	2	SENT_936	[p38l988t2280r1041b2324],
12	.	.	O	.	_	0	SENT_936	[p38l988t2280r1041b2324],

1	Familial	JJ	O	familial	amod	4	SENT_937	[p38l12t2351r203b2395],
2	gastrointestinal	JJ	O	gastrointestinal	amod	4	SENT_937	[p38l233t2351r603b2408],
3	stromal	JJ	O	stromal	amod	4	SENT_937	[p38l633t2351r814b2396],
4	tumours	NNS	O	tumour	_	0	SENT_937	[p38l844t2361r1043b2396],
5	with	IN	O	with	_	0	SENT_937	[p38l10t2423r116b2467],
6	germline	NN	O	germline	nn	7	SENT_937	[p38l127t2422r340b2479],
7	mutation	NN	O	mutation	prep_with	4	SENT_937	[p38l351t2423r569b2467],
8	of	IN	O	of	_	0	SENT_937	[p38l581t2422r637b2467],
9	the	DT	O	the	det	11	SENT_937	[p38l638t2423r711b2467],
10	KIT	NN	O	kit	nn	11	SENT_937	[p38l722t2426r811b2468],
11	gene	NN	O	gene	prep_of	4	SENT_937	[p38l821t2437r946b2479],
12	.	.	O	.	_	0	SENT_937	[p38l821t2437r946b2479],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_938	[p38l959t2427r1047b2467],
2	Genet	NNP	PERSON	Genet	_	0	SENT_938	[p38l13t2497r156b2538],
3	1998	CD	DATE	1998	num	2	SENT_938	[p38l169t2497r526b2547],
4	;	:	O	;	_	0	SENT_938	[p38l169t2497r526b2547],
5	19:323	CD	NUMBER	19:323	number	6	SENT_938	[p38l169t2497r526b2547],
6	—	CD	NUMBER	—	dep	2	SENT_938	[p38l169t2497r526b2547],
7	4	CD	NUMBER	4	dep	6	SENT_938	[p38l169t2497r526b2547],
8	.	.	O	.	_	0	SENT_938	[p38l169t2497r526b2547],

1	92	CD	NUMBER	92	_	0	SENT_939	[p38l12t2569r78b2608],
2	.	.	O	.	_	0	SENT_939	[p38l12t2569r78b2608],

1	Heinrich	NNP	PERSON	Heinrich	nn	2	SENT_940	[p38l108t2564r321b2608],
2	MC	NNP	PERSON	MC	_	0	SENT_940	[p38l333t2568r431b2618],
3	,	,	O	,	_	0	SENT_940	[p38l333t2568r431b2618],
4	Corless	NNP	ORGANIZATION	Corless	nn	5	SENT_940	[p38l448t2564r627b2609],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_940	[p38l641t2568r720b2618],
6	,	,	O	,	_	0	SENT_940	[p38l641t2568r720b2618],
7	Demetri	NNP	PERSON	Demetri	nn	8	SENT_940	[p38l735t2565r934b2608],
8	GD	NN	MISC	gd	appos	2	SENT_940	[p38l947t2568r1039b2618],
9	,	,	O	,	_	0	SENT_940	[p38l947t2568r1039b2618],
10	et	FW	O	et	nn	11	SENT_940	[p38l13t2645r55b2679],
11	al.	FW	O	al.	appos	2	SENT_940	[p38l63t2635r114b2680],
12	.	.	O	.	_	0	SENT_940	[p38l63t2635r114b2680],

1	Kinase	NN	O	kinase	nn	2	SENT_941	[p38l127t2636r282b2681],
2	mutations	NNS	O	mutation	_	0	SENT_941	[p38l293t2636r526b2680],
3	and	CC	O	and	_	0	SENT_941	[p38l538t2635r624b2680],
4	imatinib	NN	O	imatinib	conj_and	2	SENT_941	[p38l634t2635r827b2680],
5	response	NN	O	response	dep	2	SENT_941	[p38l839t2650r1045b2692],
6	in	IN	O	in	_	0	SENT_941	[p38l12t2707r58b2750],
7	patients	NNS	O	patient	prep_in	5	SENT_941	[p38l77t2707r265b2763],
8	with	IN	O	with	_	0	SENT_941	[p38l284t2707r390b2751],
9	metastatic	JJ	O	metastatic	amod	12	SENT_941	[p38l410t2707r654b2751],
10	gastrointestinal	JJ	O	gastrointestinal	amod	12	SENT_941	[p38l674t2707r1044b2763],
11	stromal	JJ	O	stromal	amod	12	SENT_941	[p38l13t2778r196b2822],
12	tumor	NN	O	tumor	prep_with	7	SENT_941	[p38l215t2787r372b2822],
13	.	.	O	.	_	0	SENT_941	[p38l215t2787r372b2822],

1	J	NNP	O	J	nn	3	SENT_942	[p38l387t2782r408b2828],
2	Clin	NNP	O	Clin	nn	3	SENT_942	[p38l424t2777r521b2822],
3	Oncol	NNP	O	Oncol	_	0	SENT_942	[p38l539t2777r681b2822],
4	2003	CD	DATE	2003	num	3	SENT_942	[p38l699t2781r1043b2831],
5	;	:	O	;	_	0	SENT_942	[p38l699t2781r1043b2831],
6	21:4342	CD	NUMBER	21:4342	number	7	SENT_942	[p38l699t2781r1043b2831],
7	—	CD	NUMBER	—	dep	3	SENT_942	[p38l699t2781r1043b2831],
8	9	CD	NUMBER	9	dep	7	SENT_942	[p38l13t2852r52b2893],
9	.	.	O	.	_	0	SENT_942	[p38l13t2852r52b2893],

1	93	CD	NUMBER	93	_	0	SENT_943	[p38l12t2925r78b2964],
2	.	.	O	.	_	0	SENT_943	[p38l12t2925r78b2964],

1	Holdhoff	NNP	O	Holdhoff	nn	2	SENT_944	[p38l108t2920r341b2964],
2	M	NNP	O	M	_	0	SENT_944	[p38l346t2924r408b2974],
3	,	,	O	,	_	0	SENT_944	[p38l346t2924r408b2974],
4	Kreuzer	NNP	PERSON	Kreuzer	nn	5	SENT_944	[p38l428t2924r621b2966],
5	K-A	NNP	PERSON	K-A	appos	2	SENT_944	[p38l636t2924r737b2974],
6	,	,	O	,	_	0	SENT_944	[p38l636t2924r737b2974],
7	Appelt	NNP	PERSON	Appelt	nn	8	SENT_944	[p38l755t2920r919b2976],
8	C	NNP	O	C	appos	2	SENT_944	[p38l933t2924r981b2974],
9	,	,	O	,	_	0	SENT_944	[p38l933t2924r981b2974],
10	et	FW	O	et	nn	11	SENT_944	[p38l1002t2929r1046b2964],
11	al.	FW	O	al.	appos	2	SENT_944	[p38l12t2991r65b3035],
12	.	.	O	.	_	0	SENT_944	[p38l12t2991r65b3035],

1	Imatinib	NN	O	imatinib	nn	2	SENT_945	[p38l79t2991r282b3035],
2	mesylate	NN	O	mesylate	nsubj	3	SENT_945	[p38l294t2990r499b3047],
3	radiosensitizes	VBZ	O	radiosensitize	_	0	SENT_945	[p38l511t2990r864b3035],
4	human	JJ	O	human	amod	6	SENT_945	[p38l877t2990r1044b3035],
5	glioblastoma	NN	O	glioblastoma	nn	6	SENT_945	[p38l12t3061r336b3118],
6	cells	NNS	O	cell	dobj	3	SENT_945	[p38l362t3061r469b3106],
7	through	IN	O	through	_	0	SENT_945	[p38l497t3061r696b3118],
8	inhibition	NN	O	inhibition	prep_through	3	SENT_945	[p38l722t3061r969b3106],
9	of	IN	O	of	_	0	SENT_945	[p38l996t3061r1053b3106],
10	platelet	NN	O	platelet	nn	11	SENT_945	[p38l12t3132r400b3189],
11	—	NN	O	—	prep_of	8	SENT_945	[p38l12t3132r400b3189],
12	derived	VBN	O	derive	partmod	11	SENT_945	[p38l12t3132r400b3189],
13	growth	NN	O	growth	nn	15	SENT_945	[p38l434t3133r611b3189],
14	factor	NN	O	factor	nn	15	SENT_945	[p38l644t3132r790b3177],
15	receptor	NN	O	receptor	dobj	12	SENT_945	[p38l822t3142r1039b3189],
16	.	.	O	.	_	0	SENT_945	[p38l822t3142r1039b3189],

1	Blood	NN	O	blood	nn	2	SENT_946	[p38l12t3203r157b3248],
2	Cells	NNS	O	cell	_	0	SENT_946	[p38l174t3203r294b3248],
3	Mol	NNP	O	Mol	nn	4	SENT_946	[p38l307t3204r401b3248],
4	Dis	NNP	O	Dis	dep	2	SENT_946	[p38l414t3204r491b3247],
5	2005	CD	DATE	2005	num	4	SENT_946	[p38l507t3207r865b3257],
6	;	:	O	;	_	0	SENT_946	[p38l507t3207r865b3257],
7	34:181	CD	NUMBER	34:181	num	8	SENT_946	[p38l507t3207r865b3257],
8	-5	CD	NUMBER	-5	dep	2	SENT_946	[p38l507t3207r865b3257],
9	.	.	O	.	_	0	SENT_946	[p38l507t3207r865b3257],

1	94	CD	NUMBER	94	_	0	SENT_947	[p38l12t3279r78b3318],
2	.	.	O	.	_	0	SENT_947	[p38l12t3279r78b3318],

1	Casali	NNP	PERSON	Casali	nn	2	SENT_948	[p38l109t3274r254b3319],
2	PG	NNP	O	PG	_	0	SENT_948	[p38l271t3278r356b3328],
3	,	,	O	,	_	0	SENT_948	[p38l271t3278r356b3328],
4	Messina	NNP	PERSON	Messina	nn	5	SENT_948	[p38l376t3275r578b3318],
5	A	NNP	O	A	appos	2	SENT_948	[p38l593t3278r642b3328],
6	,	,	O	,	_	0	SENT_948	[p38l593t3278r642b3328],
7	Stacchiotti	NNP	O	Stacchiotti	nn	8	SENT_948	[p38l664t3274r923b3319],
8	S	NNP	O	S	appos	2	SENT_948	[p38l941t3278r980b3328],
9	,	,	O	,	_	0	SENT_948	[p38l941t3278r980b3328],
10	et	FW	O	et	nn	11	SENT_948	[p38l1002t3283r1046b3318],
11	al.	FW	O	al.	appos	2	SENT_948	[p38l12t3345r67b3390],
12	.	.	O	.	_	0	SENT_948	[p38l12t3345r67b3390],

1	Imatinib	NN	O	imatinib	nn	2	SENT_949	[p38l90t3345r297b3390],
2	mesylate	NN	O	mesylate	_	0	SENT_949	[p38l316t3345r521b3402],
3	in	IN	O	in	_	0	SENT_949	[p38l539t3346r584b3389],
4	chordoma	NN	O	chordoma	prep_in	2	SENT_949	[p38l603t3345r858b3390],
5	.	.	O	.	_	0	SENT_949	[p38l603t3345r858b3390],

1	Cancer	NN	O	cancer	_	0	SENT_950	[p38l880t3349r1046b3390],
2	2004	CD	DATE	2004	num	1	SENT_950	[p38l13t3420r460b3470],
3	;	:	O	;	_	0	SENT_950	[p38l13t3420r460b3470],
4	101:2086	CD	NUMBER	101:2086	number	5	SENT_950	[p38l13t3420r460b3470],
5	-97	CD	NUMBER	-97	dep	1	SENT_950	[p38l13t3420r460b3470],
6	.	.	O	.	_	0	SENT_950	[p38l13t3420r460b3470],

1	95	CD	NUMBER	95	_	0	SENT_951	[p38l12t3493r78b3532],
2	.	.	O	.	_	0	SENT_951	[p38l12t3493r78b3532],

1	Herbst	NNP	ORGANIZATION	Herbst	nn	2	SENT_952	[p38l108t3488r271b3532],
2	RS	NN	ORGANIZATION	r	_	0	SENT_952	[p38l289t3492r366b3542],
3	,	,	O	,	_	0	SENT_952	[p38l289t3492r366b3542],
4	Giaccone	NNP	PERSON	Giaccone	nn	5	SENT_952	[p38l391t3489r611b3532],
5	G	NNP	PERSON	G	appos	2	SENT_952	[p38l632t3492r685b3542],
6	,	,	O	,	_	0	SENT_952	[p38l632t3492r685b3542],
7	Schiller	NNP	PERSON	Schiller	nn	8	SENT_952	[p38l711t3488r889b3532],
8	JH	NNP	O	JH	appos	2	SENT_952	[p38l903t3492r979b3542],
9	,	,	O	,	_	0	SENT_952	[p38l903t3492r979b3542],
10	et	FW	O	et	nn	11	SENT_952	[p38l1004t3497r1047b3532],
11	al.	FW	O	al.	appos	2	SENT_952	[p38l12t3559r65b3603],
12	.	.	O	.	_	0	SENT_952	[p38l12t3559r65b3603],

1	Geﬁtinib	NNP	O	Geﬁtinib	_	0	SENT_953	[p38l86t3558r297b3603],
2	in	IN	O	in	_	0	SENT_953	[p38l315t3559r360b3602],
3	combination	NN	O	combination	prep_in	1	SENT_953	[p38l379t3559r681b3603],
4	with	IN	O	with	_	0	SENT_953	[p38l696t3558r802b3603],
5	paclitaxel	NN	O	paclitaxel	prep_with	3	SENT_953	[p38l819t3558r1044b3615],
6	and	CC	O	and	_	0	SENT_953	[p38l12t3629r99b3674],
7	carboplatin	NN	O	carboplatin	conj_and	5	SENT_953	[p38l117t3630r386b3686],
8	in	IN	O	in	_	0	SENT_953	[p38l402t3630r448b3673],
9	advanced	JJ	O	advanced	amod	11	SENT_953	[p38l465t3629r684b3674],
10	non	JJ	O	non	amod	11	SENT_953	[p38l701t3629r1045b3674],
11	—	NN	O	—	prep_in	1	SENT_953	[p38l701t3629r1045b3674],
12	small	JJ	O	small	amod	16	SENT_953	[p38l701t3629r1045b3674],
13	—	NN	O	—	nn	16	SENT_953	[p38l701t3629r1045b3674],
14	cell	NN	O	cell	nn	16	SENT_953	[p38l701t3629r1045b3674],
15	lung	NN	O	lung	nn	16	SENT_953	[p38l12t3701r121b3757],
16	cancer	NN	O	cancer	dep	1	SENT_953	[p38l141t3715r307b3745],
17	:	:	O	:	_	0	SENT_953	[p38l141t3715r307b3745],
18	a	DT	O	a	det	21	SENT_953	[p38l331t3715r356b3744],
19	phase	NN	O	phase	nn	21	SENT_953	[p38l376t3701r514b3757],
20	III	CD	NUMBER	iii	num	21	SENT_953	[p38l536t3705r590b3744],
21	trial	NN	O	trial	dep	1	SENT_953	[p38l612t3700r705b3744],
22	—	CD	NUMBER	—	num	23	SENT_953	[p38l724t3726r785b3730],
23	INTACT2	NN	O	intact2	dep	21	SENT_953	[p38l804t3704r1040b3745],
24	.	.	O	.	_	0	SENT_953	[p38l804t3704r1040b3745],

1	JClin	NN	O	jclin	nn	2	SENT_954	[p38l7t3772r138b3823],
2	Oncol	NN	O	oncol	_	0	SENT_954	[p38l152t3772r294b3817],
3	2004	CD	DATE	2004	dep	2	SENT_954	[p38l308t3776r696b3826],
4	;	:	O	;	_	0	SENT_954	[p38l308t3776r696b3826],
5	22:785	CD	NUMBER	22:785	number	6	SENT_954	[p38l308t3776r696b3826],
6	—	CD	NUMBER	—	dep	2	SENT_954	[p38l308t3776r696b3826],
7	94	CD	NUMBER	94	dep	6	SENT_954	[p38l308t3776r696b3826],
8	.	.	O	.	_	0	SENT_954	[p38l308t3776r696b3826],

1	receptor	NN	O	receptor	nn	2	SENT_955	[p38l1118t89r1310b136],
2	gene	NN	O	gene	nsubj	3	SENT_955	[p38l1319t94r1428b136],
3	predict	VBP	O	predict	_	0	SENT_955	[p38l1439t79r1603b136],
4	prolonged	JJ	O	prolonged	amod	5	SENT_955	[p38l1611t79r1851b136],
5	survival	NN	O	survival	dobj	3	SENT_955	[p38l1863t79r2036b124],
6	after	IN	O	after	_	0	SENT_955	[p38l2047t79r2152b124],
7	geﬁtinib	NN	O	geﬁtinib	nn	8	SENT_955	[p38l1118t150r1320b207],
8	treatment	NN	O	treatment	prep_after	3	SENT_955	[p38l1349t159r1585b195],
9	in	IN	O	in	_	0	SENT_955	[p38l1610t151r1656b194],
10	patients	NNS	O	patient	prep_in	8	SENT_955	[p38l1683t151r1874b207],
11	with	IN	O	with	_	0	SENT_955	[p38l1901t151r2008b195],
12	nonsmall	JJ	O	nonsmall	amod	16	SENT_955	[p38l2036t165r2148b195, p38l1119t221r1352b266],
13	—	NN	O	—	nn	16	SENT_955	[p38l2036t165r2148b195, p38l1119t221r1352b266],
14	cell	NN	O	cell	nn	16	SENT_955	[p38l2036t165r2148b195, p38l1119t221r1352b266],
15	lung	NN	O	lung	nn	16	SENT_955	[p38l1381t222r1489b278],
16	cancer	NN	O	cancer	prep_with	10	SENT_955	[p38l1517t236r1671b266],
17	with	IN	O	with	_	0	SENT_955	[p38l1696t221r1802b266],
18	postoperative	JJ	O	postoperative	amod	19	SENT_955	[p38l1831t222r2149b278],
19	recurrence	NN	O	recurrence	prep_with	16	SENT_955	[p38l1118t308r1381b338],
20	.	.	O	.	_	0	SENT_955	[p38l1118t308r1381b338],

1	J	NNP	O	J	nn	3	SENT_956	[p38l1393t298r1414b344],
2	Clin	NNP	O	Clin	nn	3	SENT_956	[p38l1427t294r1524b338],
3	Oncol	NNP	O	Oncol	_	0	SENT_956	[p38l1537t293r1680b338],
4	2005	CD	DATE	2005	num	3	SENT_956	[p38l1693t297r2111b347],
5	;	:	O	;	_	0	SENT_956	[p38l1693t297r2111b347],
6	23:2513	CD	NUMBER	23:2513	number	7	SENT_956	[p38l1693t297r2111b347],
7	—	CD	NUMBER	—	dep	3	SENT_956	[p38l1693t297r2111b347],
8	20	CD	NUMBER	20	dep	7	SENT_956	[p38l1693t297r2111b347],
9	.	.	O	.	_	0	SENT_956	[p38l1693t297r2111b347],

1	100	CD	NUMBER	100	_	0	SENT_957	[p38l1120t368r1212b407],
2	.	.	O	.	_	0	SENT_957	[p38l1120t368r1212b407],

1	Baselga	NNP	PERSON	Baselga	nn	2	SENT_958	[p38l1245t363r1427b420],
2	J	NNP	PERSON	J	_	0	SENT_958	[p38l1438t367r1471b417],
3	,	,	O	,	_	0	SENT_958	[p38l1438t367r1471b417],
4	Rischin	NNP	PERSON	Rischin	nn	5	SENT_958	[p38l1491t363r1671b410],
5	D	NNP	O	D	appos	2	SENT_958	[p38l1688t367r1738b417],
6	,	,	O	,	_	0	SENT_958	[p38l1688t367r1738b417],
7	Ranson	NNP	PERSON	Ranson	nn	8	SENT_958	[p38l1758t367r1938b410],
8	M	NNP	O	M	appos	2	SENT_958	[p38l1954t367r2015b417],
9	,	,	O	,	_	0	SENT_958	[p38l1954t367r2015b417],
10	et	FW	O	et	nn	11	SENT_958	[p38l2036t373r2079b407],
11	al.	FW	O	al.	appos	2	SENT_958	[p38l2093t363r2146b407],
12	.	.	O	.	_	0	SENT_958	[p38l2093t363r2146b407],

1	Phase	NN	O	phase	nn	9	SENT_959	[p38l1117t434r1254b478],
2	1	CD	NUMBER	1	num	3	SENT_959	[p38l1274t439r1291b478],
3	safety	NN	O	safety	nn	9	SENT_959	[p38l1312t434r1453b491],
4	,	,	O	,	_	0	SENT_959	[p38l1312t434r1453b491],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_959	[p38l1477t434r1891b491],
6	,	,	O	,	_	0	SENT_959	[p38l1477t434r1891b491],
7	and	CC	O	and	_	0	SENT_959	[p38l1914t434r2001b479],
8	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	3	SENT_959	[p38l2021t435r2149b491, p38l1118t505r1455b562],
9	trial	NN	O	trial	nsubj	28	SENT_959	[p38l1479t505r1574b549],
10	of	IN	O	of	_	0	SENT_959	[p38l1598t505r1655b550],
11	ZD1839	NN	O	zd1839	prep_of	9	SENT_959	[p38l1668t509r1873b559],
12	,	,	O	,	_	0	SENT_959	[p38l1668t509r1873b559],
13	a	DT	O	a	det	22	SENT_959	[p38l1900t520r1925b549],
14	selective	JJ	O	selective	amod	22	SENT_959	[p38l1949t505r2149b550],
15	oral	JJ	O	oral	amod	22	SENT_959	[p38l1118t577r1211b621],
16	epidermal	JJ	O	epidermal	amod	22	SENT_959	[p38l1230t576r1470b633],
17	growth	NN	O	growth	nn	22	SENT_959	[p38l1487t577r1657b633],
18	factor	NN	O	factor	nn	22	SENT_959	[p38l1674t576r1812b621],
19	receptor	NN	O	receptor	nn	22	SENT_959	[p38l1828t586r2024b633],
20	tyrosine	NN	O	tyrosine	nn	22	SENT_959	[p38l2041t586r2149b633, p38l1119t648r1213b692],
21	kinase	NN	O	kinase	nn	22	SENT_959	[p38l1237t647r1389b692],
22	inhibitor	NN	O	inhibitor	appos	11	SENT_959	[p38l1413t647r1632b701],
23	,	,	O	,	_	0	SENT_959	[p38l1413t647r1632b701],
24	in	IN	O	in	_	0	SENT_959	[p38l1659t648r1704b691],
25	patients	NNS	O	patient	prep_in	9	SENT_959	[p38l1728t648r1915b704],
26	with	IN	O	with	_	0	SENT_959	[p38l1938t648r2044b692],
27	five	CD	NUMBER	five	prep_with	25	SENT_959	[p38l2068t647r2149b692],
28	selected	VBN	O	select	_	0	SENT_959	[p38l1119t718r1303b763],
29	solid	JJ	O	solid	amod	31	SENT_959	[p38l1315t718r1426b763],
30	tumor	NN	O	tumor	nn	31	SENT_959	[p38l1438t728r1583b763],
31	types	NNS	O	type	dobj	28	SENT_959	[p38l1592t728r1723b775],
32	.	.	O	.	_	0	SENT_959	[p38l1592t728r1723b775],

1	J	NNP	O	J	nn	3	SENT_960	[p38l1732t723r1753b769],
2	Clin	NNP	O	Clin	nn	3	SENT_960	[p38l1762t718r1858b763],
3	Oncol	NNP	O	Oncol	_	0	SENT_960	[p38l1869t718r2009b763],
4	2002	CD	DATE	2002	num	3	SENT_960	[p38l2020t722r2148b772],
5	;	:	O	;	_	0	SENT_960	[p38l2020t722r2148b772],
6	20:4292	CD	NUMBER	20:4292	num	7	SENT_960	[p38l1118t793r1430b834],
7	—	NN	O	—	dep	3	SENT_960	[p38l1118t793r1430b834],
8	302	CD	NUMBER	302	dep	7	SENT_960	[p38l1118t793r1430b834],
9	.	.	O	.	_	0	SENT_960	[p38l1118t793r1430b834],

1	101	CD	NUMBER	101	_	0	SENT_961	[p38l1120t865r1212b904],
2	.	.	O	.	_	0	SENT_961	[p38l1120t865r1212b904],

1	Herceptin	NNP	O	Herceptin	nsubj	5	SENT_962	[p38l1246t861r1481b916],
2	combined	VBN	O	combine	prep	1	SENT_962	[p38l1499t860r1736b904],
3	with	IN	O	with	pcomp	2	SENT_962	[p38l1751t860r1857b905],
4	chemotherapy	NN	O	chemotherapy	pobj	3	SENT_962	[p38l1875t860r2149b904, p38l1118t946r1198b988],
5	improves	VBZ	O	improve	_	0	SENT_962	[p38l1206t932r1418b988],
6	disease	NN	O	disease	npadvmod	8	SENT_962	[p38l1430t931r1700b976],
7	—	CD	NUMBER	—	num	6	SENT_962	[p38l1430t931r1700b976],
8	free	JJ	O	free	amod	9	SENT_962	[p38l1430t931r1700b976],
9	survival	NN	O	survival	dobj	5	SENT_962	[p38l1711t931r1883b976],
10	for	IN	O	for	_	0	SENT_962	[p38l1893t931r1960b976],
11	patients	NNS	O	patient	prep_for	9	SENT_962	[p38l1968t932r2149b988],
12	with	IN	O	with	_	0	SENT_962	[p38l1116t1002r1220b1047],
13	early	JJ	O	early	amod	17	SENT_962	[p38l1231t1002r1476b1059],
14	—	JJ	O	—	amod	17	SENT_962	[p38l1231t1002r1476b1059],
15	stage	NN	O	stage	nn	17	SENT_962	[p38l1231t1002r1476b1059],
16	breast	NN	O	breast	nn	17	SENT_962	[p38l1487t1003r1629b1047],
17	cancer	NN	O	cancer	prep_with	11	SENT_962	[p38l1637t1017r1795b1047],
18	.	.	O	.	_	0	SENT_962	[p38l1637t1017r1795b1047],

1	Bethesda	NNP	LOCATION	Bethesda	nn	3	SENT_963	[p38l1808t1002r2029b1056],
2	,	,	O	,	_	0	SENT_963	[p38l1808t1002r2029b1056],
3	Md.	NNP	LOCATION	Md.	_	0	SENT_963	[p38l2041t1002r2148b1047],
4	:	:	O	:	_	0	SENT_963	[p38l2041t1002r2148b1047],
5	National	NNP	ORGANIZATION	National	nn	6	SENT_963	[p38l1117t1074r1325b1118],
6	Cancer	NNP	ORGANIZATION	Cancer	dep	3	SENT_963	[p38l1347t1077r1516b1118],
7	Institute	NNP	ORGANIZATION	Institute	nn	9	SENT_963	[p38l1536t1074r1751b1127],
8	,	,	O	,	_	0	SENT_963	[p38l1536t1074r1751b1127],
9	April	NNP	DATE	April	dep	6	SENT_963	[p38l1775t1074r1896b1130],
10	25	CD	DATE	25	num	9	SENT_963	[p38l1918t1077r1989b1127],
11	,	,	DATE	,	_	0	SENT_963	[p38l1918t1077r1989b1127],
12	2005	CD	DATE	2005	num	9	SENT_963	[p38l2015t1077r2146b1118],
13	.	.	O	.	_	0	SENT_963	[p38l2015t1077r2146b1118],

1	(	NN	O	(	nsubj	2	SENT_964	[p38l1121t1144r1348b1195],
2	Accessed	VBD	O	access	_	0	SENT_964	[p38l1121t1144r1348b1195],
3	June	NNP	DATE	June	tmod	2	SENT_964	[p38l1362t1149r1468b1195],
4	17	CD	DATE	17	num	3	SENT_964	[p38l1491t1148r1557b1198],
5	,	,	DATE	,	_	0	SENT_964	[p38l1491t1148r1557b1198],
6	2005	CD	DATE	2005	num	3	SENT_964	[p38l1581t1148r1707b1198],
7	,	,	O	,	_	0	SENT_964	[p38l1581t1148r1707b1198],
8	at	IN	O	at	_	0	SENT_964	[p38l1730t1154r1773b1188],
9	http://wvvw.nci	NNS	O	http://wvvw.nci	prep_at	2	SENT_964	[p38l1791t1144r2147b1201],
10	.	.	O	.	_	0	SENT_964	[p38l1791t1144r2147b1201],

1	nih	NN	O	nih	_	0	SENT_965	[p38l1118t1215r1969b1272],
2	.	.	O	.	_	0	SENT_965	[p38l1118t1215r1969b1272],

1	gov/newscenter/pressreleasesl	NN	O	gov/newscenter/pressreleasesl	nn	2	SENT_966	[p38l1118t1215r1969b1272],
2	HerceptinCombination2005	NN	O	herceptincombination2005	_	0	SENT_966	[p38l1118t1287r1825b1343],
3	.	.	O	.	_	0	SENT_966	[p38l1118t1287r1825b1343],
4	)	SYM	O	)	dep	2	SENT_966	[p38l1118t1287r1825b1343],

1	102	CD	NUMBER	102	_	0	SENT_967	[p38l1120t1362r1212b1402],
2	.	.	O	.	_	0	SENT_967	[p38l1120t1362r1212b1402],

1	Agus	NNP	PERSON	Agus	nn	2	SENT_968	[p38l1244t1361r1364b1414],
2	DB	NNP	PERSON	DB	_	0	SENT_968	[p38l1377t1361r1463b1411],
3	,	,	O	,	_	0	SENT_968	[p38l1377t1361r1463b1411],
4	Akita	NNP	ORGANIZATION	Akita	nn	5	SENT_968	[p38l1477t1357r1603b1402],
5	RW	NNP	ORGANIZATION	RW	appos	2	SENT_968	[p38l1614t1361r1704b1411],
6	,	,	O	,	_	0	SENT_968	[p38l1614t1361r1704b1411],
7	Fox	NNP	PERSON	Fox	nn	8	SENT_968	[p38l1719t1361r1805b1401],
8	WD	NNP	O	WD	appos	2	SENT_968	[p38l1814t1361r1918b1411],
9	,	,	O	,	_	0	SENT_968	[p38l1814t1361r1918b1411],
10	et	FW	O	et	nn	11	SENT_968	[p38l1935t1367r1977b1401],
11	al.	FW	O	al.	appos	2	SENT_968	[p38l1987t1357r2040b1401],
12	.	.	O	.	_	0	SENT_968	[p38l1987t1357r2040b1401],

1	Targeting	NN	O	targeting	nn	3	SENT_969	[p38l2054t1361r2148b1401, p38l1118t1429r1274b1485],
2	ligand	NN	O	ligand	nn	3	SENT_969	[p38l1306t1428r1700b1485],
3	—	NN	O	—	nsubj	4	SENT_969	[p38l1306t1428r1700b1485],
4	activated	VBD	O	activate	_	0	SENT_969	[p38l1306t1428r1700b1485],
5	ErbB2	NN	O	erbb2	nn	6	SENT_969	[p38l1734t1429r1884b1473],
6	signaling	NN	O	signaling	nsubj	7	SENT_969	[p38l1920t1429r2150b1485],
7	inhibits	VBZ	O	inhibit	ccomp	4	SENT_969	[p38l1118t1499r1306b1544],
8	breast	NN	O	breast	nn	12	SENT_969	[p38l1323t1499r1473b1544],
9	and	CC	O	and	_	0	SENT_969	[p38l1484t1499r1572b1544],
10	prostate	NN	O	prostate	nn	12	SENT_969	[p38l1585t1509r1783b1556],
11	tumor	NN	O	tumor	nn	12	SENT_969	[p38l1797t1509r1947b1544],
12	growth	NN	O	growth	dobj	7	SENT_969	[p38l1959t1500r2146b1556],
13	.	.	O	.	_	0	SENT_969	[p38l1959t1500r2146b1556],

1	Cancer	NN	O	cancer	nn	2	SENT_970	[p38l1118t1575r1287b1616],
2	Cell	NN	O	cell	_	0	SENT_970	[p38l1300t1571r1393b1616],
3	2002	CD	DATE	2002	dep	2	SENT_970	[p38l1407t1575r1766b1625],
4	;	:	O	;	_	0	SENT_970	[p38l1407t1575r1766b1625],
5	2:127	CD	NUMBER	2:127	number	6	SENT_970	[p38l1407t1575r1766b1625],
6	—	CD	NUMBER	—	dep	2	SENT_970	[p38l1407t1575r1766b1625],
7	37	CD	NUMBER	37	dep	6	SENT_970	[p38l1407t1575r1766b1625],
8	.	.	O	.	_	0	SENT_970	[p38l1407t1575r1766b1625],

1	103	CD	NUMBER	103	_	0	SENT_971	[p38l1120t1647r1212b1686],
2	.	.	O	.	_	0	SENT_971	[p38l1120t1647r1212b1686],

1	Rowinsky	NNP	PERSON	Rowinsky	nn	2	SENT_972	[p38l1245t1642r1477b1698],
2	EK	NNP	O	EK	_	0	SENT_972	[p38l1485t1646r1565b1696],
3	,	,	O	,	_	0	SENT_972	[p38l1485t1646r1565b1696],
4	Schwartz	NNP	PERSON	Schwartz	nn	5	SENT_972	[p38l1581t1642r1792b1687],
5	GH	NN	O	gh	appos	2	SENT_972	[p38l1804t1646r1899b1696],
6	,	,	O	,	_	0	SENT_972	[p38l1804t1646r1899b1696],
7	GollobJA	NN	O	gollobja	appos	2	SENT_972	[p38l1913t1642r2147b1696],
8	,	,	O	,	_	0	SENT_972	[p38l1913t1642r2147b1696],
9	et	FW	O	et	nn	10	SENT_972	[p38l1118t1722r1161b1757],
10	al.	FW	O	al.	appos	2	SENT_972	[p38l1169t1712r1223b1757],
11	.	.	O	.	_	0	SENT_972	[p38l1169t1712r1223b1757],

1	Safety	NN	O	safety	_	0	SENT_973	[p38l1241t1712r1393b1769],
2	,	,	O	,	_	0	SENT_973	[p38l1241t1712r1393b1769],
3	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	1	SENT_973	[p38l1408t1712r1861b1769],
4	,	,	O	,	_	0	SENT_973	[p38l1408t1712r1861b1769],
5	and	CC	O	and	_	0	SENT_973	[p38l1878t1712r1966b1757],
6	activity	NN	O	activity	conj_and	1	SENT_973	[p38l1980t1713r2151b1769],
7	of	IN	O	of	_	0	SENT_973	[p38l1118t1783r1175b1828],
8	ABX-EGF	NN	O	abx-egf	prep_of	6	SENT_973	[p38l1181t1787r1418b1837],
9	,	,	O	,	_	0	SENT_973	[p38l1181t1787r1418b1837],
10	a	DT	O	a	det	14	SENT_973	[p38l1439t1798r1464b1827],
11	fully	RB	O	fully	advmod	12	SENT_973	[p38l1481t1783r1588b1840],
12	human	JJ	O	human	amod	14	SENT_973	[p38l1604t1784r1774b1828],
13	anti	JJ	O	anti	amod	14	SENT_973	[p38l1791t1783r2149b1840],
14	—	NN	O	—	conj_and	1	SENT_973	[p38l1791t1783r2149b1840],
15	epidermal	JJ	O	epidermal	amod	18	SENT_973	[p38l1791t1783r2149b1840],
16	growth	NN	O	growth	nn	18	SENT_973	[p38l1118t1854r1291b1911],
17	factor	NN	O	factor	nn	18	SENT_973	[p38l1321t1854r1461b1899],
18	receptor	NN	O	receptor	dep	14	SENT_973	[p38l1489t1863r1691b1911],
19	monoclonal	JJ	O	monoclonal	amod	20	SENT_973	[p38l1719t1854r2009b1899],
20	antibody	NN	O	antibody	dep	1	SENT_973	[p38l2038t1855r2148b1898, p38l1118t1925r1235b1982],
21	in	IN	O	in	_	0	SENT_973	[p38l1256t1926r1301b1969],
22	patients	NNS	O	patient	prep_in	20	SENT_973	[p38l1324t1926r1511b1982],
23	with	IN	O	with	_	0	SENT_973	[p38l1533t1925r1639b1970],
24	metastatic	JJ	O	metastatic	amod	27	SENT_973	[p38l1662t1926r1907b1970],
25	renal	JJ	O	renal	amod	27	SENT_973	[p38l1929t1926r2047b1969],
26	cell	NN	O	cell	nn	27	SENT_973	[p38l2070t1925r2149b1970],
27	carcinoma	NN	O	carcinoma	prep_with	22	SENT_973	[p38l1118t1998r1379b2042],
28	.	.	O	.	_	0	SENT_973	[p38l1118t1998r1379b2042],

1	J	NNP	O	J	nn	3	SENT_974	[p38l1391t2002r1412b2048],
2	Clin	NNP	O	Clin	nn	3	SENT_974	[p38l1424t1998r1522b2042],
3	Oncol	NNP	O	Oncol	_	0	SENT_974	[p38l1535t1997r1678b2042],
4	2004	CD	DATE	2004	num	3	SENT_974	[p38l1691t2001r2109b2051],
5	;	:	O	;	_	0	SENT_974	[p38l1691t2001r2109b2051],
6	22:3003	CD	NUMBER	22:3003	number	7	SENT_974	[p38l1691t2001r2109b2051],
7	—	CD	NUMBER	—	dep	3	SENT_974	[p38l1691t2001r2109b2051],
8	15	CD	NUMBER	15	dep	7	SENT_974	[p38l1691t2001r2109b2051],
9	.	.	O	.	_	0	SENT_974	[p38l1691t2001r2109b2051],

1	104	CD	NUMBER	104	_	0	SENT_975	[p38l1120t2072r1212b2111],
2	.	.	O	.	_	0	SENT_975	[p38l1120t2072r1212b2111],

1	Ferrara	NNP	PERSON	Ferrara	nn	2	SENT_976	[p38l1245t2071r1415b2111],
2	N	NNP	O	N	_	0	SENT_976	[p38l1427t2071r1479b2121],
3	,	,	O	,	_	0	SENT_976	[p38l1427t2071r1479b2121],
4	Gerber	NNP	O	Gerber	nn	5	SENT_976	[p38l1496t2067r1662b2112],
5	H	NNP	O	H	appos	2	SENT_976	[p38l1674t2071r1771b2121],
6	.	.	O	.	_	0	SENT_976	[p38l1674t2071r1771b2121],

1	—	NN	O	—	_	0	SENT_977	[p38l1674t2071r1771b2121],
2	.	.	O	.	_	0	SENT_977	[p38l1674t2071r1771b2121],

1	P	NN	O	p	_	0	SENT_978	[p38l1674t2071r1771b2121],
2	,	,	O	,	_	0	SENT_978	[p38l1674t2071r1771b2121],
3	LeCouter	NNP	O	LeCouter	nn	6	SENT_978	[p38l1788t2071r2004b2112],
4	J.	NNP	O	J.	nn	6	SENT_978	[p38l2011t2071r2044b2118],
5	The	NNP	O	The	nn	6	SENT_978	[p38l2059t2067r2149b2111],
6	biology	NN	O	biology	appos	1	SENT_978	[p38l1118t2138r1295b2195],
7	of	IN	O	of	_	0	SENT_978	[p38l1309t2138r1365b2183],
8	VEGF	NN	O	vegf	prep_of	6	SENT_978	[p38l1369t2142r1506b2183],
9	and	CC	O	and	_	0	SENT_978	[p38l1522t2138r1609b2183],
10	its	PRP$	O	its	poss	11	SENT_978	[p38l1625t2139r1679b2182],
11	receptors	NNS	O	receptor	conj_and	8	SENT_978	[p38l1696t2148r1928b2195],
12	.	.	O	.	_	0	SENT_978	[p38l1696t2148r1928b2195],

1	Nat	NNP	O	Nat	nn	2	SENT_979	[p38l1946t2143r2034b2183],
2	Med	NNP	O	Med	_	0	SENT_979	[p38l2045t2138r2150b2183],
3	2003	CD	DATE	2003	num	2	SENT_979	[p38l1118t2213r1477b2263],
4	;	:	O	;	_	0	SENT_979	[p38l1118t2213r1477b2263],
5	9:669	CD	NUMBER	9:669	number	6	SENT_979	[p38l1118t2213r1477b2263],
6	—	CD	NUMBER	—	dep	2	SENT_979	[p38l1118t2213r1477b2263],
7	76	CD	NUMBER	76	dep	6	SENT_979	[p38l1118t2213r1477b2263],
8	.	.	O	.	_	0	SENT_979	[p38l1118t2213r1477b2263],

1	105	CD	NUMBER	105	_	0	SENT_980	[p38l1120t2285r1212b2324],
2	.	.	O	.	_	0	SENT_980	[p38l1120t2285r1212b2324],

1	Liu	NNP	PERSON	Liu	nn	2	SENT_981	[p38l1245t2281r1320b2325],
2	Q	NNP	O	Q	_	0	SENT_981	[p38l1332t2284r1382b2335],
3	,	,	O	,	_	0	SENT_981	[p38l1332t2284r1382b2335],
4	Schwallerl	NNP	O	Schwallerl	nn	6	SENT_981	[p38l1399t2280r1667b2334],
5	,	,	O	,	_	0	SENT_981	[p38l1399t2280r1667b2334],
6	KutokJ	NNP	O	KutokJ	appos	2	SENT_981	[p38l1682t2280r1866b2334],
7	,	,	O	,	_	0	SENT_981	[p38l1682t2280r1866b2334],
8	et	FW	O	et	nn	9	SENT_981	[p38l1882t2289r1925b2324],
9	al.	FW	O	al.	appos	6	SENT_981	[p38l1935t2280r1987b2324],
10	.	.	O	.	_	0	SENT_981	[p38l1935t2280r1987b2324],

1	Signal	NN	O	signal	nn	2	SENT_982	[p38l2004t2280r2150b2337],
2	transduction	NN	O	transduction	_	0	SENT_982	[p38l1118t2351r1419b2396],
3	and	CC	O	and	_	0	SENT_982	[p38l1448t2351r1535b2396],
4	transforming	VBG	O	transform	amod	5	SENT_982	[p38l1565t2351r1882b2408],
5	properties	NNS	O	property	conj_and	2	SENT_982	[p38l1908t2352r2149b2408],
6	of	IN	O	of	_	0	SENT_982	[p38l1118t2422r1175b2467],
7	the	DT	O	the	det	8	SENT_982	[p38l1189t2422r1263b2467],
8	TEL	NN	O	tel	prep_of	2	SENT_982	[p38l1286t2426r1541b2469],
9	.	.	O	.	_	0	SENT_982	[p38l1286t2426r1541b2469],

1	—	NN	O	—	_	0	SENT_983	[p38l1286t2426r1541b2469],
2	.	.	O	.	_	0	SENT_983	[p38l1286t2426r1541b2469],

1	TRKC	NN	ORGANIZATION	trkc	nn	2	SENT_984	[p38l1286t2426r1541b2469],
2	fusions	NNS	O	fusion	nsubj	3	SENT_984	[p38l1567t2422r1743b2467],
3	associated	VBN	O	associate	_	0	SENT_984	[p38l1769t2422r2019b2467],
4	with	IN	O	with	_	0	SENT_984	[p38l2041t2422r2149b2467],
5	t	NN	O	t	prep_with	3	SENT_984	[p38l1118t2497r1548b2550],
6	(	CD	NUMBER	(	number	7	SENT_984	[p38l1118t2497r1548b2550],
7	12	CD	NUMBER	12	dep	5	SENT_984	[p38l1118t2497r1548b2550],
8	;	:	O	;	_	0	SENT_984	[p38l1118t2497r1548b2550],
9	15	CD	NUMBER	15	number	10	SENT_984	[p38l1118t2497r1548b2550],
10	)	CD	NUMBER	)	dep	5	SENT_984	[p38l1118t2497r1548b2550],
11	(	NN	O	(	nn	12	SENT_984	[p38l1118t2497r1548b2550],
12	p13	NN	O	p13	dep	10	SENT_984	[p38l1118t2497r1548b2550],
13	;	:	O	;	_	0	SENT_984	[p38l1118t2497r1548b2550],
14	q25	CD	NUMBER	q25	num	15	SENT_984	[p38l1118t2497r1548b2550],
15	)	NN	O	)	dep	5	SENT_984	[p38l1118t2497r1548b2550],
16	in	IN	O	in	_	0	SENT_984	[p38l1581t2494r1626b2537],
17	congenital	JJ	O	congenital	amod	20	SENT_984	[p38l1656t2493r1911b2550],
18	ﬁbrosar	JJ	O	ﬁbrosar	amod	20	SENT_984	[p38l1939t2493r2148b2538],
19	—	NN	O	—	nn	20	SENT_984	[p38l1939t2493r2148b2538],
20	coma	NN	O	coma	prep_in	15	SENT_984	[p38l1118t2579r1250b2609],
21	and	CC	O	and	_	0	SENT_984	[p38l1278t2564r1367b2609],
22	acute	JJ	O	acute	amod	23	SENT_984	[p38l1395t2574r1523b2609],
23	myelogenous	JJ	O	myelogenous	amod	24	SENT_984	[p38l1551t2565r1877b2621],
24	leukemia	NN	O	leukemia	prep_with	3	SENT_984	[p38l1907t2564r2145b2609],
25	.	.	O	.	_	0	SENT_984	[p38l1907t2564r2145b2609],

1	EMBO	NNP	O	EMBO	nn	2	SENT_985	[p38l1117t2639r1273b2680],
2	J	NNP	O	J	_	0	SENT_985	[p38l1283t2640r1304b2687],
3	2000	CD	DATE	2000	num	2	SENT_985	[p38l1316t2639r1734b2689],
4	;	:	O	;	_	0	SENT_985	[p38l1316t2639r1734b2689],
5	19:1827	CD	NUMBER	19:1827	number	6	SENT_985	[p38l1316t2639r1734b2689],
6	—	CD	NUMBER	—	dep	2	SENT_985	[p38l1316t2639r1734b2689],
7	38	CD	NUMBER	38	dep	6	SENT_985	[p38l1316t2639r1734b2689],
8	.	.	O	.	_	0	SENT_985	[p38l1316t2639r1734b2689],

1	106	CD	NUMBER	106	_	0	SENT_986	[p38l1120t2711r1212b2751],
2	.	.	O	.	_	0	SENT_986	[p38l1120t2711r1212b2751],

1	Zipfel	NNP	PERSON	Zipfel	nn	2	SENT_987	[p38l1245t2706r1382b2762],
2	PA	NN	O	pa	_	0	SENT_987	[p38l1393t2710r1468b2760],
3	,	,	O	,	_	0	SENT_987	[p38l1393t2710r1468b2760],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_987	[p38l1483t2706r1636b2763],
5	W	NNP	PERSON	W	appos	2	SENT_987	[p38l1644t2710r1702b2760],
6	,	,	O	,	_	0	SENT_987	[p38l1644t2710r1702b2760],
7	Quiroz	NNP	PERSON	Quiroz	nn	8	SENT_987	[p38l1717t2707r1880b2761],
8	M	NNP	O	M	appos	2	SENT_987	[p38l1891t2710r1952b2760],
9	,	,	O	,	_	0	SENT_987	[p38l1891t2710r1952b2760],
10	Pender	NNP	PERSON	Pender	appos	2	SENT_987	[p38l1966t2706r2149b2750],
11	—	CD	NUMBER	—	num	13	SENT_987	[p38l1966t2706r2149b2750],
12	gast	NN	O	gast	nn	13	SENT_987	[p38l1118t2786r1218b2834],
13	AM	NNP	O	AM	dep	10	SENT_987	[p38l1238t2782r1336b2822],
14	.	.	O	.	_	0	SENT_987	[p38l1238t2782r1336b2822],

1	Requirement	NN	O	requirement	_	0	SENT_988	[p38l1363t2778r1680b2834],
2	for	IN	O	for	_	0	SENT_988	[p38l1702t2777r1772b2822],
3	Abl	NN	ORGANIZATION	abl	nn	4	SENT_988	[p38l1792t2777r1875b2822],
4	kinases	NNS	O	kinase	prep_for	1	SENT_988	[p38l1900t2778r2078b2822],
5	in	IN	O	in	_	0	SENT_988	[p38l2103t2778r2149b2821],
6	T	NN	O	t	nn	9	SENT_988	[p38l1116t2852r1150b2892],
7	cell	NN	O	cell	nn	9	SENT_988	[p38l1165t2849r1246b2893],
8	receptor	NN	O	receptor	nn	9	SENT_988	[p38l1259t2858r1459b2905],
9	signaling	NN	O	signaling	prep_in	1	SENT_988	[p38l1470t2848r1702b2905],
10	.	.	O	.	_	0	SENT_988	[p38l1470t2848r1702b2905],

1	Curr	NNP	O	Curr	nn	2	SENT_989	[p38l1718t2852r1825b2893],
2	Biol	NNP	O	Biol	_	0	SENT_989	[p38l1836t2849r1930b2893],
3	2004	CD	DATE	2004	num	2	SENT_989	[p38l1942t2852r2147b2902],
4	;	:	O	;	_	0	SENT_989	[p38l1942t2852r2147b2902],
5	14	CD	NUMBER	14	num	7	SENT_989	[p38l1942t2852r2147b2902],
6	:	:	O	:	_	0	SENT_989	[p38l1942t2852r2147b2902],
7	1222-31	CD	NUMBER	1222-31	dep	2	SENT_989	[p38l1120t2924r1326b2965],
8	.	.	O	.	_	0	SENT_989	[p38l1120t2924r1326b2965],

1	107	CD	NUMBER	107	_	0	SENT_990	[p38l1120t2995r1212b3034],
2	.	.	O	.	_	0	SENT_990	[p38l1120t2995r1212b3034],

1	Gorre	NNP	ORGANIZATION	Gorre	nn	2	SENT_991	[p38l1246t2994r1384b3035],
2	ME	NNP	O	ME	_	0	SENT_991	[p38l1397t2994r1491b3044],
3	,	,	O	,	_	0	SENT_991	[p38l1397t2994r1491b3044],
4	Mohammed	NNP	PERSON	Mohammed	nn	5	SENT_991	[p38l1507t2990r1798b3035],
5	M	NNP	PERSON	M	appos	2	SENT_991	[p38l1811t2994r1872b3044],
6	,	,	O	,	_	0	SENT_991	[p38l1811t2994r1872b3044],
7	Ellwood	NNP	PERSON	Ellwood	nn	8	SENT_991	[p38l1889t2990r2084b3035],
8	K	NNP	PERSON	K	appos	2	SENT_991	[p38l2098t2994r2147b3044],
9	,	,	O	,	_	0	SENT_991	[p38l2098t2994r2147b3044],
10	et	FW	O	et	nn	11	SENT_991	[p38l1118t3071r1161b3106],
11	al.	FW	O	al.	appos	2	SENT_991	[p38l1181t3062r1233b3106],
12	.	.	O	.	_	0	SENT_991	[p38l1181t3062r1233b3106],

1	Clinical	JJ	O	clinical	amod	2	SENT_992	[p38l1259t3061r1439b3106],
2	resistance	NN	O	resistance	nsubj	9	SENT_992	[p38l1461t3062r1697b3106],
3	to	TO	O	to	_	0	SENT_992	[p38l1720t3071r1764b3106],
4	STI	NN	O	stus	nn	5	SENT_992	[p38l1789t3065r1974b3106],
5	—	NN	O	—	prep_to	2	SENT_992	[p38l1789t3065r1974b3106],
6	571	CD	NUMBER	571	num	8	SENT_992	[p38l1789t3065r1974b3106],
7	cancer	NN	O	cancer	nn	8	SENT_992	[p38l1997t3076r2151b3106],
8	therapy	NN	O	therapy	dep	5	SENT_992	[p38l1118t3132r1296b3189],
9	caused	VBN	O	cause	_	0	SENT_992	[p38l1306t3132r1466b3177],
10	by	IN	O	by	_	0	SENT_992	[p38l1478t3132r1532b3189],
11	BCR	NN	O	bcr	prep_by	9	SENT_992	[p38l1541t3136r1737b3177],
12	.	.	O	.	_	0	SENT_992	[p38l1541t3136r1737b3177],

1	—	NN	O	—	_	0	SENT_993	[p38l1541t3136r1737b3177],
2	.	.	O	.	_	0	SENT_993	[p38l1541t3136r1737b3177],

1	ABL	NN	ORGANIZATION	abl	nn	2	SENT_994	[p38l1541t3136r1737b3177],
2	gene	NN	O	gene	_	0	SENT_994	[p38l1747t3147r1859b3189],
3	mutation	NN	O	mutation	dep	2	SENT_994	[p38l1871t3133r2088b3177],
4	or	CC	O	or	_	0	SENT_994	[p38l2101t3147r2151b3177],
5	amplification	NN	O	amplification	dep	2	SENT_994	[p38l1118t3203r1447b3260],
6	.	.	O	.	_	0	SENT_994	[p38l1118t3203r1447b3260],

1	Science	NNP	O	Science	_	0	SENT_995	[p38l1465t3204r1640b3248],
2	2001	CD	DATE	2001	num	1	SENT_995	[p38l1654t3207r2072b3257],
3	;	:	O	;	_	0	SENT_995	[p38l1654t3207r2072b3257],
4	293:876	CD	NUMBER	293:876	number	5	SENT_995	[p38l1654t3207r2072b3257],
5	—	CD	NUMBER	—	dep	1	SENT_995	[p38l1654t3207r2072b3257],
6	80	CD	NUMBER	80	dep	5	SENT_995	[p38l1654t3207r2072b3257],
7	.	.	O	.	_	0	SENT_995	[p38l1654t3207r2072b3257],

1	108	CD	NUMBER	108	_	0	SENT_996	[p38l1120t3279r1212b3319],
2	.	.	O	.	_	0	SENT_996	[p38l1120t3279r1212b3319],

1	Shah	NNP	O	Shah	nn	2	SENT_997	[p38l1247t3274r1364b3319],
2	NP	NNP	O	NP	_	0	SENT_997	[p38l1389t3278r1469b3328],
3	,	,	O	,	_	0	SENT_997	[p38l1389t3278r1469b3328],
4	Nicoll	NNP	ORGANIZATION	Nicoll	nn	5	SENT_997	[p38l1497t3274r1644b3319],
5	JM	NN	ORGANIZATION	jm	appos	2	SENT_997	[p38l1665t3278r1747b3328],
6	,	,	O	,	_	0	SENT_997	[p38l1665t3278r1747b3328],
7	Nagar	NN	PERSON	nagar	nn	8	SENT_997	[p38l1776t3278r1925b3331],
8	B	NN	PERSON	b	appos	2	SENT_997	[p38l1949t3278r1995b3328],
9	,	,	O	,	_	0	SENT_997	[p38l1949t3278r1995b3328],
10	et	FW	O	et	nn	11	SENT_997	[p38l2025t3283r2069b3318],
11	al.	FW	O	al.	appos	2	SENT_997	[p38l2092t3274r2146b3318],
12	.	.	O	.	_	0	SENT_997	[p38l2092t3274r2146b3318],

1	Multiple	JJ	O	multiple	amod	2	SENT_998	[p38l1116t3345r1320b3402],
2	BCR	NN	O	bcr	_	0	SENT_998	[p38l1350t3349r1575b3392],
3	.	.	O	.	_	0	SENT_998	[p38l1350t3349r1575b3392],

1	—	NN	O	—	_	0	SENT_999	[p38l1350t3349r1575b3392],
2	.	.	O	.	_	0	SENT_999	[p38l1350t3349r1575b3392],

1	ABL	NN	ORGANIZATION	abl	nn	4	SENT_1000	[p38l1350t3349r1575b3392],
2	kinase	NN	O	kinase	nn	4	SENT_1000	[p38l1605t3346r1759b3390],
3	domain	NN	O	domain	nn	4	SENT_1000	[p38l1790t3345r1974b3390],
4	mutations	NNS	O	mutation	nsubj	5	SENT_1000	[p38l2005t3355r2148b3390, p38l1118t3417r1237b3461],
5	confer	VBP	O	confer	_	0	SENT_1000	[p38l1253t3416r1407b3461],
6	polyclonal	JJ	O	polyclonal	amod	7	SENT_1000	[p38l1419t3416r1670b3473],
7	resistance	NN	O	resistance	dobj	5	SENT_1000	[p38l1685t3417r1925b3461],
8	to	TO	O	to	_	0	SENT_1000	[p38l1941t3426r1986b3461],
9	the	DT	O	the	det	16	SENT_1000	[p38l2001t3416r2075b3461],
10	tyrosine	NN	O	tyrosine	nn	16	SENT_1000	[p38l2090t3426r2148b3473, p38l1118t3489r1268b3533],
11	kinase	NN	O	kinase	nn	16	SENT_1000	[p38l1292t3488r1447b3533],
12	inhibitor	NN	O	inhibitor	nn	16	SENT_1000	[p38l1472t3488r1687b3533],
13	imatinib	NN	O	imatinib	nn	16	SENT_1000	[p38l1710t3488r1913b3533],
14	(	CD	NUMBER	(	num	16	SENT_1000	[p38l1942t3492r2146b3539],
15	STI571	NN	O	sti571	nn	16	SENT_1000	[p38l1942t3492r2146b3539],
16	)	NN	O	)	prep_to	5	SENT_1000	[p38l1942t3492r2146b3539],
17	in	IN	O	in	_	0	SENT_1000	[p38l1118t3559r1164b3602],
18	chronic	JJ	O	chronic	amod	19	SENT_1000	[p38l1190t3558r1372b3603],
19	phase	NN	O	phase	prep_in	16	SENT_1000	[p38l1396t3558r1537b3615],
20	and	CC	O	and	_	0	SENT_1000	[p38l1562t3558r1650b3603],
21	blast	NN	O	blast	nn	22	SENT_1000	[p38l1676t3558r1793b3603],
22	crisis	NN	O	crisis	prep_to	5	SENT_1000	[p38l1815t3559r1940b3602],
23	chronic	JJ	O	chronic	amod	25	SENT_1000	[p38l1967t3558r2150b3603],
24	myeloid	JJ	O	myeloid	amod	25	SENT_1000	[p38l1118t3629r1310b3686],
25	leukemia	NN	O	leukemia	dep	22	SENT_1000	[p38l1322t3629r1556b3674],
26	.	.	O	.	_	0	SENT_1000	[p38l1322t3629r1556b3674],

1	Cancer	NN	O	cancer	nn	2	SENT_1001	[p38l1572t3633r1741b3674],
2	Cell	NN	O	cell	_	0	SENT_1001	[p38l1752t3629r1845b3674],
3	2002	CD	DATE	2002	dep	2	SENT_1001	[p38l1857t3633r2148b3683],
4	;	:	O	;	_	0	SENT_1001	[p38l1857t3633r2148b3683],
5	2:117	CD	NUMBER	2:117	number	6	SENT_1001	[p38l1857t3633r2148b3683],
6	—	CD	NUMBER	—	dep	2	SENT_1001	[p38l1857t3633r2148b3683],
7	25	CD	NUMBER	25	dep	6	SENT_1001	[p38l1118t3704r1188b3745],
8	.	.	O	.	_	0	SENT_1001	[p38l1118t3704r1188b3745],

1	109	CD	NUMBER	109	_	0	SENT_1002	[p38l1120t3777r1212b3816],
2	.	.	O	.	_	0	SENT_1002	[p38l1120t3777r1212b3816],

1	Branford	NNP	LOCATION	Branford	nn	2	SENT_1003	[p38l1245t3772r1458b3816],
2	S	NNP	LOCATION	S	_	0	SENT_1003	[p38l1481t3776r1519b3826],
3	,	,	O	,	_	0	SENT_1003	[p38l1481t3776r1519b3826],
4	Rudzki	NNP	PERSON	Rudzki	nn	5	SENT_1003	[p38l1543t3772r1713b3819],
5	Z	NNP	O	Z	appos	2	SENT_1003	[p38l1733t3776r1776b3826],
6	,	,	O	,	_	0	SENT_1003	[p38l1733t3776r1776b3826],
7	Walsh	NNP	PERSON	Walsh	nn	8	SENT_1003	[p38l1798t3772r1946b3816],
8	S	NNP	O	S	appos	2	SENT_1003	[p38l1968t3776r2007b3826],
9	,	,	O	,	_	0	SENT_1003	[p38l1968t3776r2007b3826],
10	et	FW	O	et	nn	11	SENT_1003	[p38l2032t3781r2075b3816],
11	al.	FW	O	al.	appos	2	SENT_1003	[p38l2093t3772r2146b3816],
12	.	.	O	.	_	0	SENT_1003	[p38l2093t3772r2146b3816],

1	96	CD	NUMBER	96	_	0	SENT_1004	[p39l12t24r78b63],
2	.	.	O	.	_	0	SENT_1004	[p39l12t24r78b63],

1	Giaccone	NNP	PERSON	Giaccone	nn	2	SENT_1005	[p39l109t20r334b64],
2	G	NNP	PERSON	G	_	0	SENT_1005	[p39l356t23r410b73],
3	,	,	O	,	_	0	SENT_1005	[p39l356t23r410b73],
4	Herbst	NNP	ORGANIZATION	Herbst	nn	5	SENT_1005	[p39l434t19r603b63],
5	RS	NN	ORGANIZATION	r	appos	2	SENT_1005	[p39l620t23r700b73],
6	,	,	O	,	_	0	SENT_1005	[p39l620t23r700b73],
7	Manegold	NNP	ORGANIZATION	Manegold	nn	8	SENT_1005	[p39l723t19r971b76],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_1005	[p39l992t23r1040b73],
9	,	,	O	,	_	0	SENT_1005	[p39l992t23r1040b73],
10	et	FW	O	et	nn	11	SENT_1005	[p39l13t100r57b135],
11	al.	FW	O	al.	appos	2	SENT_1005	[p39l76t91r131b135],
12	.	.	O	.	_	0	SENT_1005	[p39l76t91r131b135],

1	Geﬁtinib	NNP	O	Geﬁtinib	_	0	SENT_1006	[p39l157t90r376b135],
2	in	IN	O	in	_	0	SENT_1006	[p39l397t91r444b134],
3	combination	NN	O	combination	prep_in	1	SENT_1006	[p39l465t90r773b135],
4	with	IN	O	with	_	0	SENT_1006	[p39l791t90r899b135],
5	gemcitabine	NN	O	gemcitabine	prep_with	3	SENT_1006	[p39l920t105r1043b147, p39l13t161r208b206],
6	and	CC	O	and	_	0	SENT_1006	[p39l237t161r326b206],
7	cisplatin	NN	O	cisplatin	prep_with	3	SENT_1006	[p39l356t162r566b218],
8	in	IN	O	in	_	0	SENT_1006	[p39l595t162r642b205],
9	advanced	JJ	O	advanced	amod	12	SENT_1006	[p39l671t161r898b206],
10	nonsmall-cell	JJ	O	nonsmall-cell	amod	12	SENT_1006	[p39l928t176r1042b206, p39l13t232r247b277],
11	lung	NN	O	lung	nn	12	SENT_1006	[p39l283t233r394b289],
12	cancer	NN	O	cancer	prep_in	1	SENT_1006	[p39l429t247r596b277],
13	:	:	O	:	_	0	SENT_1006	[p39l429t247r596b277],
14	a	DT	O	a	det	15	SENT_1006	[p39l632t247r657b276],
15	phase	NN	O	phase	dep	1	SENT_1006	[p39l690t233r828b289],
16	III	CD	NUMBER	iii	num	18	SENT_1006	[p39l862t237r917b276],
17	trial	NN	O	trial	nn	18	SENT_1006	[p39l951t233r1044b276],
18	INTACT1	NN	O	intact1	dep	15	SENT_1006	[p39l12t307r249b348],
19	.	.	O	.	_	0	SENT_1006	[p39l12t307r249b348],

1	J	NNP	O	J	nn	3	SENT_1007	[p39l261t308r282b354],
2	Clin	NNP	O	Clin	nn	3	SENT_1007	[p39l294t304r391b348],
3	Oncol	NNP	O	Oncol	_	0	SENT_1007	[p39l405t304r547b348],
4	2004	CD	DATE	2004	num	3	SENT_1007	[p39l561t307r949b357],
5	;	:	O	;	_	0	SENT_1007	[p39l561t307r949b357],
6	22:777	CD	NUMBER	22:777	number	7	SENT_1007	[p39l561t307r949b357],
7	—	CD	NUMBER	—	dep	3	SENT_1007	[p39l561t307r949b357],
8	84	CD	NUMBER	84	dep	7	SENT_1007	[p39l561t307r949b357],
9	.	.	O	.	_	0	SENT_1007	[p39l561t307r949b357],

1	97	CD	NUMBER	97	_	0	SENT_1008	[p39l12t379r78b418],
2	.	.	O	.	_	0	SENT_1008	[p39l12t379r78b418],

1	Tsao	NNP	PERSON	Tsao	nn	2	SENT_1009	[p39l107t378r219b419],
2	M-S	NNP	O	M-S	_	0	SENT_1009	[p39l238t378r349b428],
3	,	,	O	,	_	0	SENT_1009	[p39l238t378r349b428],
4	Sakurada	NNP	ORGANIZATION	Sakurada	nn	5	SENT_1009	[p39l374t374r596b419],
5	A	NNP	ORGANIZATION	A	appos	2	SENT_1009	[p39l614t378r663b428],
6	,	,	O	,	_	0	SENT_1009	[p39l614t378r663b428],
7	Cutz	NNP	O	Cutz	appos	2	SENT_1009	[p39l686t378r796b419],
8	J-C	JJ	O	j-c	dep	7	SENT_1009	[p39l811t378r902b428],
9	,	,	O	,	_	0	SENT_1009	[p39l811t378r902b428],
10	et	FW	O	et	nn	11	SENT_1009	[p39l926t383r969b418],
11	al.	FW	O	al.	appos	2	SENT_1009	[p39l987t374r1040b418],
12	.	.	O	.	_	0	SENT_1009	[p39l987t374r1040b418],

1	Erlotinib	NNP	O	Erlotinib	_	0	SENT_1010	[p39l12t445r224b490],
2	in	IN	O	in	_	0	SENT_1010	[p39l245t446r292b489],
3	lung	NN	O	lung	nn	4	SENT_1010	[p39l312t445r422b502],
4	cancer	NN	O	cancer	prep_in	1	SENT_1010	[p39l441t460r598b490],
5	—	CD	NUMBER	—	number	6	SENT_1010	[p39l615t471r675b475],
6	molecular	JJ	O	molecular	dep	1	SENT_1010	[p39l693t445r937b490],
7	and	CC	O	and	_	0	SENT_1010	[p39l955t445r1044b490],
8	clinical	JJ	O	clinical	amod	9	SENT_1010	[p39l13t516r185b560],
9	predictors	NNS	O	predictor	dep	1	SENT_1010	[p39l215t516r460b573],
10	of	IN	O	of	_	0	SENT_1010	[p39l492t516r548b561],
11	outcome	NN	O	outcome	prep_of	6	SENT_1010	[p39l569t526r792b561],
12	.	.	O	.	_	0	SENT_1010	[p39l569t526r792b561],

1	N	NN	O	n	nn	3	SENT_1011	[p39l824t521r866b561],
2	Engl	NNP	O	Engl	nn	3	SENT_1011	[p39l892t517r1001b573],
3	J	NNP	O	J	nsubj	4	SENT_1011	[p39l1024t521r1045b567],
4	Med	VBD	O	med	_	0	SENT_1011	[p39l11t587r115b632],
5	2005	CD	DATE	2005	dobj	4	SENT_1011	[p39l129t591r547b641],
6	;	:	O	;	_	0	SENT_1011	[p39l129t591r547b641],
7	353:133	CD	NUMBER	353:133	num	8	SENT_1011	[p39l129t591r547b641],
8	-44	CD	NUMBER	-44	dep	5	SENT_1011	[p39l129t591r547b641],
9	.	.	O	.	_	0	SENT_1011	[p39l129t591r547b641],

1	98	CD	NUMBER	98	_	0	SENT_1012	[p39l12t663r78b703],
2	.	.	O	.	_	0	SENT_1012	[p39l12t663r78b703],

1	Han	NNP	O	Han	nn	2	SENT_1013	[p39l108t662r208b702],
2	SW	NNP	O	SW	_	0	SENT_1013	[p39l225t662r310b712],
3	,	,	O	,	_	0	SENT_1013	[p39l225t662r310b712],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_1013	[p39l329t659r428b704],
5	TY	NNP	PERSON	TY	appos	2	SENT_1013	[p39l443t662r514b712],
6	,	,	O	,	_	0	SENT_1013	[p39l443t662r514b712],
7	Hwang	NNP	PERSON	Hwang	nn	8	SENT_1013	[p39l533t662r706b715],
8	PG	NNP	O	PG	appos	2	SENT_1013	[p39l719t662r803b712],
9	,	,	O	,	_	0	SENT_1013	[p39l719t662r803b712],
10	et	FW	O	et	nn	11	SENT_1013	[p39l823t667r866b702],
11	al.	FW	O	al.	appos	2	SENT_1013	[p39l879t658r931b702],
12	.	.	O	.	_	0	SENT_1013	[p39l879t658r931b702],

1	Predictive	JJ	O	predictive	amod	4	SENT_1014	[p39l950t662r1043b702, p39l13t729r167b774],
2	and	CC	O	and	_	0	SENT_1014	[p39l181t729r270b774],
3	prognostic	JJ	O	prognostic	conj_and	1	SENT_1014	[p39l283t730r545b786],
4	impact	NN	O	impact	nsubj	16	SENT_1014	[p39l559t730r727b786],
5	of	IN	O	of	_	0	SENT_1014	[p39l739t729r796b774],
6	epidermal	JJ	O	epidermal	amod	10	SENT_1014	[p39l801t729r1044b786],
7	growth	NN	O	growth	nn	10	SENT_1014	[p39l12t801r185b857],
8	factor	NN	O	factor	nn	10	SENT_1014	[p39l213t800r354b845],
9	receptor	NN	O	receptor	nn	10	SENT_1014	[p39l380t810r580b857],
10	mutation	NN	O	mutation	prep_of	4	SENT_1014	[p39l607t801r828b845],
11	in	IN	O	in	_	0	SENT_1014	[p39l856t801r902b844],
12	nonsmall-cell	JJ	O	nonsmall-cell	amod	15	SENT_1014	[p39l930t815r1042b845, p39l13t871r247b916],
13	lung	NN	O	lung	nn	15	SENT_1014	[p39l264t872r373b928],
14	cancer	NN	O	cancer	nn	15	SENT_1014	[p39l388t886r542b916],
15	patients	NNS	O	patient	prep_in	10	SENT_1014	[p39l557t872r744b928],
16	treated	VBN	O	treat	_	0	SENT_1014	[p39l762t872r924b916],
17	with	IN	O	with	_	0	SENT_1014	[p39l938t872r1044b916],
18	geﬁtinib	NN	O	geﬁtinib	prep_with	16	SENT_1014	[p39l12t942r225b999],
19	.	.	O	.	_	0	SENT_1014	[p39l12t942r225b999],

1	J	NNP	O	J	nn	3	SENT_1015	[p39l236t947r257b993],
2	Clin	NNP	O	Clin	nn	3	SENT_1015	[p39l270t943r367b987],
3	Oncol	NNP	O	Oncol	_	0	SENT_1015	[p39l381t943r523b987],
4	2005	CD	DATE	2005	num	3	SENT_1015	[p39l537t946r984b996],
5	;	:	O	;	_	0	SENT_1015	[p39l537t946r984b996],
6	23:2493	CD	NUMBER	23:2493	number	7	SENT_1015	[p39l537t946r984b996],
7	-501	CD	NUMBER	-501	dep	3	SENT_1015	[p39l537t946r984b996],
8	.	.	O	.	_	0	SENT_1015	[p39l537t946r984b996],

1	99	CD	NUMBER	99	_	0	SENT_1016	[p39l12t1019r78b1058],
2	.	.	O	.	_	0	SENT_1016	[p39l12t1019r78b1058],

1	Mitsudomi	JJ	ORGANIZATION	mitsudomi	amod	2	SENT_1017	[p39l107t1014r369b1059],
2	T	NN	ORGANIZATION	t	_	0	SENT_1017	[p39l382t1018r423b1068],
3	,	,	O	,	_	0	SENT_1017	[p39l382t1018r423b1068],
4	Kosaka	NNP	PERSON	Kosaka	nn	5	SENT_1017	[p39l442t1014r616b1059],
5	T	NN	PERSON	t	appos	2	SENT_1017	[p39l628t1018r670b1068],
6	,	,	O	,	_	0	SENT_1017	[p39l628t1018r670b1068],
7	Endoh	NN	PERSON	endoh	nn	8	SENT_1017	[p39l688t1014r844b1058],
8	H	NN	O	h	appos	2	SENT_1017	[p39l859t1018r913b1068],
9	,	,	O	,	_	0	SENT_1017	[p39l859t1018r913b1068],
10	et	FW	O	et	nn	11	SENT_1017	[p39l932t1024r975b1058],
11	al.	FW	O	al.	appos	2	SENT_1017	[p39l988t1014r1041b1058],
12	.	.	O	.	_	0	SENT_1017	[p39l988t1014r1041b1058],

1	Mutations	NNS	O	mutation	nsubjpass	21	SENT_1018	[p39l11t1085r253b1129],
2	of	IN	O	of	_	0	SENT_1018	[p39l280t1084r337b1129],
3	the	DT	O	the	det	7	SENT_1018	[p39l352t1084r424b1128],
4	epidermal	JJ	O	epidermal	amod	7	SENT_1018	[p39l450t1084r688b1141],
5	growth	NN	O	growth	nn	7	SENT_1018	[p39l713t1084r882b1141],
6	factor	NN	O	factor	nn	7	SENT_1018	[p39l908t1084r1046b1129],
7	Detection	NN	O	detection	prep_of	1	SENT_1018	[p39l1117t20r1346b64],
8	of	IN	O	of	_	0	SENT_1018	[p39l1359t19r1415b64],
9	BCR-ABL	NN	O	bcr-abl	nn	10	SENT_1018	[p39l1417t23r1638b66],
10	mutations	NNS	O	mutation	prep_of	7	SENT_1018	[p39l1649t20r1890b64],
11	in	IN	O	in	_	0	SENT_1018	[p39l1904t20r1949b63],
12	patients	NNS	O	patient	prep_in	10	SENT_1018	[p39l1961t20r2148b76],
13	with	IN	O	with	_	0	SENT_1018	[p39l1116t90r1222b135],
14	CML	NN	ORGANIZATION	cml	prep_with	12	SENT_1018	[p39l1243t94r1356b135],
15	treated	VBN	O	treat	partmod	14	SENT_1018	[p39l1376t90r1538b135],
16	with	IN	O	with	_	0	SENT_1018	[p39l1557t91r1662b135],
17	imatinib	NN	O	imatinib	prep_with	15	SENT_1018	[p39l1683t91r1882b135],
18	is	VBZ	O	be	auxpass	21	SENT_1018	[p39l1904t91r1940b134],
19	virtually	RB	O	virtually	advmod	21	SENT_1018	[p39l1960t90r2152b147],
20	always	RB	O	always	advmod	21	SENT_1018	[p39l1118t161r1272b218],
21	accompanied	VBN	O	accompany	_	0	SENT_1018	[p39l1294t161r1610b218],
22	by	IN	O	by	_	0	SENT_1018	[p39l1633t162r1687b218],
23	clinical	JJ	O	clinical	amod	24	SENT_1018	[p39l1707t161r1875b205],
24	resistance	NN	O	resistance	agent	21	SENT_1018	[p39l1897t162r2146b215],
25	,	,	O	,	_	0	SENT_1018	[p39l1897t162r2146b215],
26	and	CC	O	and	_	0	SENT_1018	[p39l1118t232r1205b277],
27	mutations	NNS	O	mutation	tmod	39	SENT_1018	[p39l1224t233r1464b277],
28	in	IN	O	in	_	0	SENT_1018	[p39l1484t233r1530b276],
29	the	DT	O	the	det	34	SENT_1018	[p39l1549t232r1621b277],
30	ATP	NN	O	atp	nn	34	SENT_1018	[p39l1638t236r1735b276],
31	phosphate	NN	O	phosphate	nn	34	SENT_1018	[p39l1752t232r2149b289, p39l1118t304r1196b360],
32	—	NN	O	—	nn	34	SENT_1018	[p39l1752t232r2149b289, p39l1118t304r1196b360],
33	binding	NN	O	binding	nn	34	SENT_1018	[p39l1752t232r2149b289, p39l1118t304r1196b360],
34	loop	NN	O	loop	prep_in	27	SENT_1018	[p39l1208t304r1313b360],
35	(	CD	NUMBER	(	num	37	SENT_1018	[p39l1332t303r1519b360],
36	P-loop	JJ	O	p-loop	amod	37	SENT_1018	[p39l1332t303r1519b360],
37	)	NN	O	)	nsubjpass	39	SENT_1018	[p39l1332t303r1519b360],
38	are	VBP	O	be	auxpass	39	SENT_1018	[p39l1537t318r1608b348],
39	associated	VBN	O	associate	conj_and	21	SENT_1018	[p39l1622t303r1867b348],
40	with	IN	O	with	_	0	SENT_1018	[p39l1880t304r1985b348],
41	a	DT	O	a	det	43	SENT_1018	[p39l2000t318r2025b347],
42	poor	JJ	O	poor	amod	43	SENT_1018	[p39l2038t318r2152b360],
43	prognosis	NN	O	prognosis	prep_with	39	SENT_1018	[p39l1117t375r1368b431],
44	.	.	O	.	_	0	SENT_1018	[p39l1117t375r1368b431],

1	Blood	NN	O	blood	_	0	SENT_1019	[p39l1385t374r1524b419],
2	2003	CD	DATE	2003	num	1	SENT_1019	[p39l1538t378r1956b428],
3	;	:	O	;	_	0	SENT_1019	[p39l1538t378r1956b428],
4	102:276	CD	NUMBER	102:276	number	5	SENT_1019	[p39l1538t378r1956b428],
5	-83	CD	NUMBER	-83	dep	1	SENT_1019	[p39l1538t378r1956b428],
6	.	.	O	.	_	0	SENT_1019	[p39l1538t378r1956b428],

1	110	CD	NUMBER	110	_	0	SENT_1020	[p39l1120t450r1212b489],
2	.	.	O	.	_	0	SENT_1020	[p39l1120t450r1212b489],

1	Chen	NNP	O	Chen	nn	7	SENT_1021	[p39l1246t445r1370b489],
2	LL	NNP	O	LL	nn	7	SENT_1021	[p39l1384t449r1455b499],
3	,	,	O	,	_	0	SENT_1021	[p39l1384t449r1455b499],
4	TrentJC	NNP	O	TrentJC	appos	7	SENT_1021	[p39l1471t449r1676b499],
5	,	,	O	,	_	0	SENT_1021	[p39l1471t449r1676b499],
6	Wu	NNP	O	Wu	appos	7	SENT_1021	[p39l1692t449r1773b490],
7	FF	NNP	O	FF	_	0	SENT_1021	[p39l1787t449r1852b499],
8	,	,	O	,	_	0	SENT_1021	[p39l1787t449r1852b499],
9	et	FW	O	et	nn	10	SENT_1021	[p39l1870t454r1913b489],
10	al.	FW	O	al.	appos	7	SENT_1021	[p39l1925t445r1978b489],
11	.	.	O	.	_	0	SENT_1021	[p39l1925t445r1978b489],

1	A	DT	O	a	det	3	SENT_1022	[p39l1994t449r2031b489],
2	missense	NN	O	missense	nn	3	SENT_1022	[p39l2044t446r2148b489, p39l1119t531r1247b561],
3	mutation	NN	O	mutation	nsubj	9	SENT_1022	[p39l1262t517r1479b561],
4	in	IN	O	in	_	0	SENT_1022	[p39l1493t517r1539b560],
5	KIT	NN	O	kit	nn	7	SENT_1022	[p39l1553t520r1641b562],
6	kinase	NN	O	kinase	nn	7	SENT_1022	[p39l1654t517r1805b561],
7	domain	NN	O	domain	prep_in	3	SENT_1022	[p39l1820t516r2001b561],
8	1	CD	NUMBER	1	dep	7	SENT_1022	[p39l2017t520r2042b560],
9	correlates	VBZ	O	correlate	_	0	SENT_1022	[p39l2057t531r2149b561, p39l1118t588r1270b632],
10	with	IN	O	with	_	0	SENT_1022	[p39l1285t587r1391b632],
11	imatinib	NN	O	imatinib	nn	12	SENT_1022	[p39l1406t588r1606b632],
12	resistance	NN	O	resistance	prep_with	9	SENT_1022	[p39l1622t588r1858b632],
13	in	IN	O	in	_	0	SENT_1022	[p39l1874t588r1919b631],
14	gastrointestinal	JJ	O	gastrointestinal	amod	16	SENT_1022	[p39l1935t588r2148b644, p39l1118t659r1296b703],
15	stromal	JJ	O	stromal	amod	16	SENT_1022	[p39l1313t659r1499b703],
16	tumors	NNS	O	tumor	prep_in	12	SENT_1022	[p39l1516t668r1704b703],
17	.	.	O	.	_	0	SENT_1022	[p39l1516t668r1704b703],

1	Cancer	NNP	O	Cancer	nn	2	SENT_1023	[p39l1725t662r1895b703],
2	Res	NNP	O	Res	_	0	SENT_1023	[p39l1910t662r1995b705],
3	2004	CD	DATE	2004	num	2	SENT_1023	[p39l2013t662r2147b712],
4	;	:	O	;	_	0	SENT_1023	[p39l2013t662r2147b712],
5	64:5913	CD	NUMBER	64:5913	number	6	SENT_1023	[p39l1118t733r1377b774],
6	-9	CD	NUMBER	-9	dep	2	SENT_1023	[p39l1118t733r1377b774],
7	.	.	O	.	_	0	SENT_1023	[p39l1118t733r1377b774],

1	111	CD	NUMBER	111	_	0	SENT_1024	[p39l1120t806r1212b844],
2	.	.	O	.	_	0	SENT_1024	[p39l1120t806r1212b844],

1	Kobayashi	NNP	LOCATION	Kobayashi	nn	2	SENT_1025	[p39l1246t800r1492b856],
2	S	NNP	LOCATION	S	_	0	SENT_1025	[p39l1505t804r1543b854],
3	,	,	O	,	_	0	SENT_1025	[p39l1505t804r1543b854],
4	Boggon	NNP	ORGANIZATION	Boggon	nn	5	SENT_1025	[p39l1558t804r1744b857],
5	TJ	NNP	ORGANIZATION	TJ	appos	2	SENT_1025	[p39l1754t804r1817b854],
6	,	,	O	,	_	0	SENT_1025	[p39l1754t804r1817b854],
7	Dayaram	NNP	PERSON	Dayaram	nn	8	SENT_1025	[p39l1831t804r2042b856],
8	T	NN	O	t	appos	2	SENT_1025	[p39l2053t804r2093b854],
9	,	,	O	,	_	0	SENT_1025	[p39l2053t804r2093b854],
10	et	FW	O	et	nn	11	SENT_1025	[p39l2109t810r2152b844],
11	al.	FW	O	al.	appos	2	SENT_1025	[p39l1118t871r1171b916],
12	.	.	O	.	_	0	SENT_1025	[p39l1118t871r1171b916],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_1026	[p39l1194t875r1339b918],
2	mutation	NN	O	mutation	_	0	SENT_1026	[p39l1355t872r1572b916],
3	and	CC	O	and	_	0	SENT_1026	[p39l1594t871r1681b916],
4	resistance	NN	O	resistance	conj_and	2	SENT_1026	[p39l1702t872r1938b916],
5	of	IN	O	of	_	0	SENT_1026	[p39l1960t871r2017b916],
6	nonsmall-cell	JJ	O	nonsmall-cell	amod	8	SENT_1026	[p39l2028t886r2151b916, p39l1119t942r1358b987],
7	lung	NN	O	lung	nn	8	SENT_1026	[p39l1374t943r1486b999],
8	cancer	NN	O	cancer	prep_of	2	SENT_1026	[p39l1501t957r1661b987],
9	to	TO	O	to	_	0	SENT_1026	[p39l1676t952r1721b987],
10	gefitinib	NN	O	gefitinib	prep_to	2	SENT_1026	[p39l1738t942r1962b999],
11	.	.	O	.	_	0	SENT_1026	[p39l1738t942r1962b999],

1	N	NN	O	n	nn	3	SENT_1027	[p39l1980t947r2022b987],
2	Engl	NNP	O	Engl	nn	3	SENT_1027	[p39l2037t943r2149b999],
3	J	NNP	O	J	nsubj	4	SENT_1027	[p39l1112t1019r1134b1065],
4	Med	VBD	O	med	_	0	SENT_1027	[p39l1145t1014r1249b1059],
5	2005	CD	DATE	2005	dobj	4	SENT_1027	[p39l1263t1018r1681b1068],
6	;	:	O	;	_	0	SENT_1027	[p39l1263t1018r1681b1068],
7	352:786	CD	NUMBER	352:786	num	8	SENT_1027	[p39l1263t1018r1681b1068],
8	-92	CD	NUMBER	-92	dep	5	SENT_1027	[p39l1263t1018r1681b1068],
9	.	.	O	.	_	0	SENT_1027	[p39l1263t1018r1681b1068],

1	112	CD	NUMBER	112	_	0	SENT_1028	[p39l1120t1090r1212b1128],
2	.	.	O	.	_	0	SENT_1028	[p39l1120t1090r1212b1128],

1	Graham	NNP	PERSON	Graham	nn	2	SENT_1029	[p39l1246t1084r1441b1129],
2	SM	NNP	O	SM	_	0	SENT_1029	[p39l1454t1088r1541b1138],
3	,	,	O	,	_	0	SENT_1029	[p39l1454t1088r1541b1138],
4	Jorgensen	NNP	PERSON	Jorgensen	nn	5	SENT_1029	[p39l1551t1088r1793b1141],
5	HG	NNP	O	HG	appos	2	SENT_1029	[p39l1804t1088r1901b1138],
6	,	,	O	,	_	0	SENT_1029	[p39l1804t1088r1901b1138],
7	Allan	NNP	PERSON	Allan	nn	8	SENT_1029	[p39l1914t1084r2039b1128],
8	E	NNP	PERSON	E	appos	2	SENT_1029	[p39l2051t1088r2094b1138],
9	,	,	O	,	_	0	SENT_1029	[p39l2051t1088r2094b1138],
10	et	FW	O	et	appos	2	SENT_1029	[p39l2110t1093r2152b1128],

1	`	``	O	`	_	0	SENT_1030	[p39l149t1216r205b1238],
2	}	RB	O	}	advmod	3	SENT_1030	[p39l149t1216r205b1238],
3	sH	NN	O	sh	nsubj	7	SENT_1030	[p39l149t1216r205b1238],
4	+	CC	O	+	_	0	SENT_1030	[p39l149t1216r205b1238],
5	N	NN	O	n	conj_+	3	SENT_1030	[p39l918t1219r932b1234],
6	ENGLJ	NN	O	englj	dep	3	SENT_1030	[p39l947t1218r1031b1240],
7	MED	VBD	O	med	_	0	SENT_1030	[p39l1046t1219r1099b1234],
8	3532	CD	NUMBER	3532	num	10	SENT_1030	[p39l1111t1218r1175b1240],
9	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	10	SENT_1030	[p39l1210t1218r1421b1240],
10	jULY14	NN	O	july14	dobj	7	SENT_1030	[p39l1455t1218r1638b1240],
11	,2005	CD	NUMBER	,2005	tmod	7	SENT_1030	[p39l1455t1218r1638b1240],

1	The	DT	O	the	det	4	SENT_1031	[p39l935t1251r986b1275],
2	New	NNP	O	New	nn	4	SENT_1031	[p39l995t1252r1057b1275],
3	England	NNP	O	England	nn	4	SENT_1031	[p39l1066t1251r1177b1282],
4	Journal	NNP	O	Journal	_	0	SENT_1031	[p39l1186t1251r1283b1275],
5	of	IN	O	of	_	0	SENT_1031	[p39l1293t1251r1322b1275],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_1031	[p39l1329t1251r1454b1275],

1	Downloaded	VBN	O	download	_	0	SENT_1032	[p39l377t1292r547b1315],
2	from	IN	O	from	_	0	SENT_1032	[p39l556t1292r620b1315],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_1032	[p39l629t1292r747b1322],
4	at	IN	O	at	_	0	SENT_1032	[p39l758t1296r781b1315],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_1032	[p39l789t1292r972b1315],
6	on	IN	O	on	_	0	SENT_1032	[p39l981t1299r1014b1315],
7	January	NNP	DATE	January	prep_on	1	SENT_1032	[p39l1022t1292r1125b1322],
8	5	CD	DATE	5	num	7	SENT_1032	[p39l1135t1292r1158b1319],
9	,	,	DATE	,	_	0	SENT_1032	[p39l1135t1292r1158b1319],
10	2014	CD	DATE	2014	num	7	SENT_1032	[p39l1169t1292r1241b1315],
11	.	.	O	.	_	0	SENT_1032	[p39l1169t1292r1241b1315],

1	For	IN	O	for	_	0	SENT_1033	[p39l1251t1292r1298b1315],
2	personal	JJ	O	personal	amod	3	SENT_1033	[p39l1306t1292r1418b1322],
3	use	NN	O	use	pobj	1	SENT_1033	[p39l1427t1299r1471b1315],
4	only	RB	O	only	advmod	3	SENT_1033	[p39l1481t1292r1545b1322],
5	.	.	O	.	_	0	SENT_1033	[p39l1481t1292r1545b1322],

1	No	DT	O	no	det	3	SENT_1034	[p39l1556t1292r1596b1315],
2	other	JJ	O	other	amod	3	SENT_1034	[p39l1606t1292r1674b1315],
3	uses	NNS	O	use	_	0	SENT_1034	[p39l1682t1299r1738b1315],
4	without	IN	O	without	_	0	SENT_1034	[p39l1748t1292r1849b1315],
5	permission	NN	O	permission	prep_without	3	SENT_1034	[p39l1858t1292r2010b1322],
6	.	.	O	.	_	0	SENT_1034	[p39l1858t1292r2010b1322],

1	Copyright	NN	O	copyright	_	0	SENT_1035	[p39l727t1333r862b1364],
2	©	CD	NUMBER	©	num	6	SENT_1035	[p39l871t1333r895b1357],
3	2005	CD	DATE	2005	num	6	SENT_1035	[p39l905t1333r969b1357],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_1035	[p39l979t1333r1170b1357],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_1035	[p39l1180t1333r1288b1357],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_1035	[p39l1299t1333r1404b1364],
7	.	.	O	.	_	0	SENT_1035	[p39l1299t1333r1404b1364],

1	All	DT	O	all	det	2	SENT_1036	[p39l1415t1333r1456b1357],
2	rights	NNS	O	rights	nsubj	3	SENT_1036	[p39l1465t1333r1540b1364],
3	reserved	VBN	O	reserve	_	0	SENT_1036	[p39l1550t1333r1669b1357],
4	.	.	O	.	_	0	SENT_1036	[p39l1550t1333r1669b1357],

1	al.	FW	O	al.	_	0	SENT_1037	[p39l8t1688r60b1732],
2	.	.	O	.	_	0	SENT_1037	[p39l8t1688r60b1732],

1	Primitive	JJ	O	primitive	amod	9	SENT_1038	[p39l80t1689r309b1742],
2	,	,	O	,	_	0	SENT_1038	[p39l80t1689r309b1742],
3	quiescent	JJ	O	quiescent	dep	1	SENT_1038	[p39l330t1689r573b1744],
4	,	,	O	,	_	0	SENT_1038	[p39l330t1689r573b1744],
5	Philadelphia	NNP	LOCATION	Philadelphia	nn	9	SENT_1038	[p39l593t1688r1037b1744, p39l8t1759r89b1803],
6	—	CD	NUMBER	—	num	9	SENT_1038	[p39l593t1688r1037b1744, p39l8t1759r89b1803],
7	positive	JJ	O	positive	amod	9	SENT_1038	[p39l593t1688r1037b1744, p39l8t1759r89b1803],
8	stem	NN	O	stem	nn	9	SENT_1038	[p39l112t1768r227b1803],
9	cells	NNS	O	cell	nsubj	17	SENT_1038	[p39l249t1759r353b1803],
10	from	IN	O	from	_	0	SENT_1038	[p39l376t1758r494b1803],
11	patients	NNS	O	patient	prep_from	9	SENT_1038	[p39l515t1759r706b1815],
12	with	IN	O	with	_	0	SENT_1038	[p39l726t1759r834b1803],
13	chronic	JJ	O	chronic	amod	15	SENT_1038	[p39l856t1758r1038b1803],
14	myeloid	JJ	O	myeloid	amod	15	SENT_1038	[p39l8t1829r199b1886],
15	leukemia	NN	O	leukemia	prep_with	11	SENT_1038	[p39l217t1829r434b1874],
16	are	VBP	O	be	cop	17	SENT_1038	[p39l451t1844r522b1874],
17	insensitive	JJ	O	insensitive	_	0	SENT_1038	[p39l540t1830r789b1874],
18	to	TO	O	to	_	0	SENT_1038	[p39l808t1839r852b1874],
19	STI571	NN	O	sti571	prep_to	17	SENT_1038	[p39l872t1833r1038b1874],
20	in	FW	O	in	nn	21	SENT_1038	[p39l8t1901r53b1944],
21	vitro	FW	O	vitro	advmod	17	SENT_1038	[p39l64t1901r185b1945],
22	.	.	O	.	_	0	SENT_1038	[p39l64t1901r185b1945],

1	Blood	NN	O	blood	_	0	SENT_1039	[p39l202t1900r341b1945],
2	2002	CD	DATE	2002	num	1	SENT_1039	[p39l355t1904r743b1954],
3	;	:	O	;	_	0	SENT_1039	[p39l355t1904r743b1954],
4	99:319	CD	NUMBER	99:319	number	5	SENT_1039	[p39l355t1904r743b1954],
5	—	CD	NUMBER	—	dep	1	SENT_1039	[p39l355t1904r743b1954],
6	25	CD	NUMBER	25	dep	5	SENT_1039	[p39l355t1904r743b1954],
7	.	.	O	.	_	0	SENT_1039	[p39l355t1904r743b1954],

1	113	CD	NUMBER	113	_	0	SENT_1040	[p39l10t1977r102b2015],
2	.	.	O	.	_	0	SENT_1040	[p39l10t1977r102b2015],

1	Hughes	NNP	PERSON	Hughes	nn	2	SENT_1041	[p39l136t1971r318b2028],
2	TP	NNP	O	TP	_	0	SENT_1041	[p39l335t1975r405b2025],
3	,	,	O	,	_	0	SENT_1041	[p39l335t1975r405b2025],
4	Kaeda	NNP	PERSON	Kaeda	nn	5	SENT_1041	[p39l426t1971r571b2017],
5	J	NNP	PERSON	J	appos	2	SENT_1041	[p39l582t1975r615b2025],
6	,	,	O	,	_	0	SENT_1041	[p39l582t1975r615b2025],
7	Branford	NNP	LOCATION	Branford	nn	8	SENT_1041	[p39l635t1971r847b2015],
8	S	NNP	O	S	appos	2	SENT_1041	[p39l865t1975r904b2025],
9	,	,	O	,	_	0	SENT_1041	[p39l865t1975r904b2025],
10	et	FW	O	et	nn	11	SENT_1041	[p39l925t1980r968b2015],
11	al.	FW	O	al.	appos	2	SENT_1041	[p39l982t1971r1035b2015],
12	.	.	O	.	_	0	SENT_1041	[p39l982t1971r1035b2015],

1	Frequency	NN	O	frequency	_	0	SENT_1042	[p39l7t2046r252b2099],
2	of	IN	O	of	_	0	SENT_1042	[p39l268t2042r324b2087],
3	major	JJ	O	major	amod	5	SENT_1042	[p39l331t2043r470b2099],
4	molecular	JJ	O	molecular	amod	5	SENT_1042	[p39l486t2043r723b2087],
5	responses	NNS	O	response	prep_of	1	SENT_1042	[p39l739t2057r974b2099],
6	to	TO	O	to	_	0	SENT_1042	[p39l993t2052r1037b2087],
7	imatinib	NN	O	imatinib	nn	10	SENT_1042	[p39l8t2113r207b2158],
8	or	CC	O	or	_	0	SENT_1042	[p39l220t2128r270b2158],
9	interferon	NN	O	interferon	nn	10	SENT_1042	[p39l280t2113r517b2158],
10	alfa	NN	O	alfa	prep_to	1	SENT_1042	[p39l529t2113r615b2157],
11	plus	CC	O	plus	prep	1	SENT_1042	[p39l625t2114r724b2170],
12	cytarabine	NN	O	cytarabine	dep	11	SENT_1042	[p39l738t2114r980b2170],
13	in	IN	O	in	prep	1	SENT_1042	[p39l992t2114r1038b2157],
14	newly	RB	O	newly	pcomp	13	SENT_1042	[p39l8t2185r146b2241],
15	diagnosed	VBN	O	diagnose	partmod	1	SENT_1042	[p39l157t2184r400b2241],
16	chronic	JJ	O	chronic	amod	18	SENT_1042	[p39l414t2184r593b2229],
17	myeloid	JJ	O	myeloid	amod	18	SENT_1042	[p39l605t2184r793b2241],
18	leukemia	NN	O	leukemia	dobj	15	SENT_1042	[p39l806t2185r1035b2229],
19	.	.	O	.	_	0	SENT_1042	[p39l806t2185r1035b2229],

1	N	NN	O	n	nn	3	SENT_1043	[p39l7t2260r49b2300],
2	Engl	NNP	O	Engl	nn	3	SENT_1043	[p39l61t2256r198b2312],
3	]	NNP	O	]	nsubj	4	SENT_1043	[p39l61t2256r198b2312],
4	Med	VBD	O	med	_	0	SENT_1043	[p39l209t2255r314b2300],
5	2003	CD	DATE	2003	dobj	4	SENT_1043	[p39l327t2259r774b2309],
6	;	:	O	;	_	0	SENT_1043	[p39l327t2259r774b2309],
7	349:1423	CD	NUMBER	349:1423	num	8	SENT_1043	[p39l327t2259r774b2309],
8	-32	CD	NUMBER	-32	dep	5	SENT_1043	[p39l327t2259r774b2309],
9	.	.	O	.	_	0	SENT_1043	[p39l327t2259r774b2309],

1	114	CD	NUMBER	114	_	0	SENT_1044	[p39l10t2332r102b2370],
2	.	.	O	.	_	0	SENT_1044	[p39l10t2332r102b2370],

1	Nagata	NNP	O	Nagata	nn	2	SENT_1045	[p39l135t2330r305b2383],
2	Y	NN	O	y	_	0	SENT_1045	[p39l316t2330r354b2380],
3	,	,	O	,	_	0	SENT_1045	[p39l316t2330r354b2380],
4	Lan	NNP	O	Lan	nn	5	SENT_1045	[p39l371t2330r457b2370],
5	KH	NNP	O	KH	appos	2	SENT_1045	[p39l471t2330r563b2380],
6	,	,	O	,	_	0	SENT_1045	[p39l471t2330r563b2380],
7	Zhou	NNP	PERSON	Zhou	nn	8	SENT_1045	[p39l579t2326r703b2371],
8	X	NNP	PERSON	X	appos	2	SENT_1045	[p39l715t2330r761b2380],
9	,	,	O	,	_	0	SENT_1045	[p39l715t2330r761b2380],
10	et	FW	O	et	nn	11	SENT_1045	[p39l779t2336r821b2370],
11	al.	FW	O	al.	appos	2	SENT_1045	[p39l833t2326r885b2370],
12	.	.	O	.	_	0	SENT_1045	[p39l833t2326r885b2370],

1	PT	NN	O	pt	nn	3	SENT_1046	[p39l902t2330r965b2370],
2	EN	NN	O	en	nn	3	SENT_1046	[p39l965t2330r1039b2371],
3	activation	NN	O	activation	nsubj	4	SENT_1046	[p39l8t2398r241b2442],
4	contributes	VBZ	O	contribute	_	0	SENT_1046	[p39l263t2398r536b2442],
5	to	TO	O	to	_	0	SENT_1046	[p39l560t2407r604b2442],
6	tumor	NN	O	tumor	nn	7	SENT_1046	[p39l628t2407r777b2442],
7	inhibition	NN	O	inhibition	prep_to	4	SENT_1046	[p39l797t2397r1038b2442],
8	by	IN	O	by	_	0	SENT_1046	[p39l8t2468r63b2525],
9	trastuzumab	NN	O	trastuzumab	prep_by	4	SENT_1046	[p39l77t2469r394b2522],
10	,	,	O	,	_	0	SENT_1046	[p39l77t2469r394b2522],
11	and	CC	O	and	_	0	SENT_1046	[p39l413t2468r502b2513],
12	loss	NN	O	loss	nsubj	15	SENT_1046	[p39l518t2469r610b2513],
13	of	IN	O	of	_	0	SENT_1046	[p39l629t2468r685b2513],
14	PTEN	NN	ORGANIZATION	pten	prep_of	12	SENT_1046	[p39l691t2472r830b2513],
15	predicts	VBZ	O	predict	conj_and	4	SENT_1046	[p39l844t2468r1036b2525],
16	trastuzumab	NN	O	trastuzumab	nn	17	SENT_1046	[p39l8t2539r311b2584],
17	resistance	NN	O	resistance	dobj	15	SENT_1046	[p39l331t2540r567b2584],
18	in	IN	O	in	_	0	SENT_1046	[p39l586t2540r632b2583],
19	patients	NNS	O	patient	prep_in	17	SENT_1046	[p39l650t2540r852b2596],
20	.	.	O	.	_	0	SENT_1046	[p39l650t2540r852b2596],

1	Cancer	NN	O	cancer	nn	2	SENT_1047	[p39l874t2543r1039b2584],
2	Cell	NN	O	cell	_	0	SENT_1047	[p39l8t2610r98b2655],
3	2004	CD	DATE	2004	dep	2	SENT_1047	[p39l112t2614r470b2664],
4	;	:	O	;	_	0	SENT_1047	[p39l112t2614r470b2664],
5	6:117	CD	NUMBER	6:117	number	6	SENT_1047	[p39l112t2614r470b2664],
6	—	CD	NUMBER	—	dep	2	SENT_1047	[p39l112t2614r470b2664],
7	27	CD	NUMBER	27	dep	6	SENT_1047	[p39l112t2614r470b2664],
8	.	.	O	.	_	0	SENT_1047	[p39l112t2614r470b2664],

1	1	CD	NUMBER	1	num	2	SENT_1048	[p39l10t2687r30b2725],
2	15	CD	NUMBER	15	_	0	SENT_1048	[p39l38t2687r102b2725],
3	.	.	O	.	_	0	SENT_1048	[p39l38t2687r102b2725],

1	Kwak	NNP	PERSON	Kwak	nn	2	SENT_1049	[p39l136t2681r270b2727],
2	EL	NNP	O	EL	_	0	SENT_1049	[p39l281t2685r354b2735],
3	,	,	O	,	_	0	SENT_1049	[p39l281t2685r354b2735],
4	Sordella	NNP	PERSON	Sordella	nn	5	SENT_1049	[p39l373t2681r564b2726],
5	R	NNP	PERSON	R	appos	2	SENT_1049	[p39l577t2685r625b2735],
6	,	,	O	,	_	0	SENT_1049	[p39l577t2685r625b2735],
7	Bell	NNP	ORGANIZATION	Bell	nn	8	SENT_1049	[p39l641t2681r731b2725],
8	DW	NNP	ORGANIZATION	DW	appos	2	SENT_1049	[p39l744t2685r840b2735],
9	,	,	O	,	_	0	SENT_1049	[p39l744t2685r840b2735],
10	et	FW	O	et	nn	11	SENT_1049	[p39l858t2690r901b2725],
11	al.	FW	O	al.	appos	2	SENT_1049	[p39l912t2681r964b2725],
12	.	.	O	.	_	0	SENT_1049	[p39l912t2681r964b2725],

1	Irreversible	JJ	O	irreversible	amod	2	SENT_1050	[p39l981t2685r1037b2725, p39l8t2752r234b2797],
2	inhibitors	NNS	O	inhibitor	nsubj	8	SENT_1050	[p39l265t2752r497b2797],
3	of	IN	O	of	_	0	SENT_1050	[p39l529t2752r585b2797],
4	the	DT	O	the	det	6	SENT_1050	[p39l607t2752r679b2797],
5	EGF	NN	ORGANIZATION	egf	nn	6	SENT_1050	[p39l710t2756r811b2797],
6	receptor	NN	O	receptor	prep_of	2	SENT_1050	[p39l843t2762r1040b2809],
7	may	MD	O	may	aux	8	SENT_1050	[p39l8t2838r107b2880],
8	circumvent	VB	O	circumvent	_	0	SENT_1050	[p39l120t2824r385b2868],
9	acquired	VBN	O	acquire	amod	10	SENT_1050	[p39l399t2823r602b2880],
10	resistance	NN	O	resistance	dobj	8	SENT_1050	[p39l618t2824r853b2868],
11	to	TO	O	to	_	0	SENT_1050	[p39l870t2833r914b2868],
12	gefiMECHANISMS	NN	O	gefimechanism	prep_to	8	SENT_1050	[p39l931t2823r1037b2880, p39l1206t1508r1645b1544],

1	OF	IN	O	of	_	0	SENT_1051	[p39l1673t1508r1751b1544],
2	DISEASE	NN	O	disease	pobj	1	SENT_1051	[p39l1779t1508r2042b1544],

1	tinib	NN	O	tinib	_	0	SENT_1052	[p39l1112t1689r1240b1733],
2	.	.	O	.	_	0	SENT_1052	[p39l1112t1689r1240b1733],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_1053	[p39l1262t1692r1370b1733],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_1053	[p39l1388t1688r1492b1733],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_1053	[p39l1510t1688r1631b1733],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_1053	[p39l1651t1689r1720b1733],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_1053	[p39l1739t1693r1778b1733],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_1053	[p39l1797t1692r1821b1733],
7	A	NNP	O	A	_	0	SENT_1053	[p39l1840t1693r1877b1732],
8	2005	CD	DATE	2005	num	7	SENT_1053	[p39l1895t1692r2139b1742],
9	;	:	O	;	_	0	SENT_1053	[p39l1895t1692r2139b1742],
10	102	CD	NUMBER	102	num	12	SENT_1053	[p39l1895t1692r2139b1742],
11	:	:	O	:	_	0	SENT_1053	[p39l1895t1692r2139b1742],
12	7665-70	CD	NUMBER	7665-70	dep	7	SENT_1053	[p39l1113t1762r1326b1803],
13	.	.	O	.	_	0	SENT_1053	[p39l1113t1762r1326b1803],

1	116	CD	NUMBER	116	_	0	SENT_1054	[p39l1114t1834r1206b1873],
2	.	.	O	.	_	0	SENT_1054	[p39l1114t1834r1206b1873],

1	Gumireddy	JJ	O	gumireddy	amod	2	SENT_1055	[p39l1240t1829r1514b1885],
2	K	NN	O	k	_	0	SENT_1055	[p39l1531t1833r1580b1883],
3	,	,	O	,	_	0	SENT_1055	[p39l1531t1833r1580b1883],
4	Baker	NNP	PERSON	Baker	nn	5	SENT_1055	[p39l1602t1829r1741b1874],
5	SJ	NNP	O	SJ	appos	2	SENT_1055	[p39l1760t1833r1816b1883],
6	,	,	O	,	_	0	SENT_1055	[p39l1760t1833r1816b1883],
7	Cosenza	NNP	ORGANIZATION	Cosenza	nn	8	SENT_1055	[p39l1839t1833r2043b1874],
8	SC	NNP	ORGANIZATION	SC	appos	2	SENT_1055	[p39l2063t1833r2139b1883],
9	,	,	O	,	_	0	SENT_1055	[p39l2063t1833r2139b1883],
10	et	FW	O	et	nn	11	SENT_1055	[p39l1112t1910r1156b1945],
11	al.	FW	O	al.	appos	2	SENT_1055	[p39l1178t1900r1232b1945],
12	.	.	O	.	_	0	SENT_1055	[p39l1178t1900r1232b1945],

1	A	DT	O	a	det	3	SENT_1056	[p39l1258t1905r1295b1944],
2	non-ATP-competitive	JJ	O	non-atp-competitive	amod	3	SENT_1056	[p39l1318t1901r1832b1957],
3	inhibitor	NN	O	inhibitor	nsubj	6	SENT_1056	[p39l1856t1900r2071b1945],
4	of	IN	O	of	_	0	SENT_1056	[p39l2095t1900r2152b1945],
5	BCR-ABL	NN	O	bcr-abl	prep_of	3	SENT_1056	[p39l1111t1975r1336b2018],
6	overrides	VBZ	O	override	_	0	SENT_1056	[p39l1377t1971r1595b2016],
7	imatinib	JJ	O	imatinib	amod	8	SENT_1056	[p39l1638t1972r1841b2016],
8	resistance	NN	O	resistance	dobj	6	SENT_1056	[p39l1883t1972r2138b2016],
9	.	.	O	.	_	0	SENT_1056	[p39l1883t1972r2138b2016],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_1057	[p39l1111t2046r1218b2087],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_1057	[p39l1232t2042r1335b2087],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_1057	[p39l1348t2042r1468b2087],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_1057	[p39l1485t2043r1552b2087],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_1057	[p39l1567t2047r1606b2087],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_1057	[p39l1622t2046r1646b2087],
7	A	NNP	O	A	_	0	SENT_1057	[p39l1661t2047r1698b2086],
8	2005	CD	DATE	2005	num	7	SENT_1057	[p39l1713t2046r2139b2096],
9	;	:	O	;	_	0	SENT_1057	[p39l1713t2046r2139b2096],
10	102:1992	CD	NUMBER	102:1992	number	11	SENT_1057	[p39l1713t2046r2139b2096],
11	-7	CD	NUMBER	-7	dep	7	SENT_1057	[p39l1713t2046r2139b2096],
12	.	.	O	.	_	0	SENT_1057	[p39l1713t2046r2139b2096],

1	[	NN	O	[	nn	2	SENT_1058	[p39l1117t2117r1345b2167],
2	Erratum	NN	O	erratum	_	0	SENT_1058	[p39l1117t2117r1345b2167],
3	,	,	O	,	_	0	SENT_1058	[p39l1117t2117r1345b2167],
4	Proc	NNP	ORGANIZATION	Proc	nn	6	SENT_1058	[p39l1369t2117r1475b2158],
5	Natl	NNP	ORGANIZATION	Natl	nn	6	SENT_1058	[p39l1495t2113r1598b2158],
6	Acad	NNP	ORGANIZATION	Acad	appos	2	SENT_1058	[p39l1616t2113r1736b2158],
7	Sci	NNP	ORGANIZATION	Sci	nn	10	SENT_1058	[p39l1758t2114r1826b2158],
8	U	NNP	ORGANIZATION	U	nn	10	SENT_1058	[p39l1846t2118r1885b2158],
9	S	NNP	ORGANIZATION	S	nn	10	SENT_1058	[p39l1907t2117r1930b2158],
10	A	NNP	O	A	dep	2	SENT_1058	[p39l1951t2118r1988b2157],
11	2005	CD	DATE	2005	rcmod	10	SENT_1058	[p39l2008t2117r2140b2167],
12	;	:	O	;	_	0	SENT_1058	[p39l2008t2117r2140b2167],
13	102:5635	CD	NUMBER	102:5635	dep	11	SENT_1058	[p39l1114t2188r1370b2235],
14	.	.	O	.	_	0	SENT_1058	[p39l1114t2188r1370b2235],
15	]	SYM	O	]	dep	11	SENT_1058	[p39l1114t2188r1370b2235],

1	117	CD	NUMBER	117	_	0	SENT_1059	[p39l1114t2261r1206b2299],
2	.	.	O	.	_	0	SENT_1059	[p39l1114t2261r1206b2299],

1	Barber	NNP	PERSON	Barber	nn	2	SENT_1060	[p39l1239t2255r1398b2300],
2	KE	NNP	PERSON	KE	_	0	SENT_1060	[p39l1410t2259r1490b2309],
3	,	,	O	,	_	0	SENT_1060	[p39l1410t2259r1490b2309],
4	Martineau	NNP	PERSON	Martineau	nn	5	SENT_1060	[p39l1506t2256r1749b2300],
5	M	NNP	O	M	appos	2	SENT_1060	[p39l1761t2259r1822b2309],
6	,	,	O	,	_	0	SENT_1060	[p39l1761t2259r1822b2309],
7	Harewood	NNP	PERSON	Harewood	nn	8	SENT_1060	[p39l1839t2255r2085b2300],
8	L	NNP	PERSON	L	appos	2	SENT_1060	[p39l2098t2259r2139b2309],
9	,	,	O	,	_	0	SENT_1060	[p39l2098t2259r2139b2309],
10	et	FW	O	et	nn	11	SENT_1060	[p39l1112t2336r1156b2371],
11	al.	FW	O	al.	appos	2	SENT_1060	[p39l1166t2326r1220b2371],
12	.	.	O	.	_	0	SENT_1060	[p39l1166t2326r1220b2371],

1	Amplification	NN	O	amplification	_	0	SENT_1061	[p39l1234t2326r1568b2383],
2	of	IN	O	of	_	0	SENT_1061	[p39l1582t2326r1638b2371],
3	the	DT	O	the	det	5	SENT_1061	[p39l1641t2326r1714b2371],
4	ABL	NN	ORGANIZATION	abl	nn	5	SENT_1061	[p39l1724t2330r1814b2370],
5	gene	NN	O	gene	prep_of	1	SENT_1061	[p39l1825t2341r1938b2383],
6	in	IN	O	in	_	0	SENT_1061	[p39l1950t2327r1997b2370],
7	T-cell	NN	MISC	t-cell	nn	10	SENT_1061	[p39l2008t2326r2142b2371],
8	acute	JJ	O	acute	amod	10	SENT_1061	[p39l1112t2407r1239b2442],
9	lymphoblastic	JJ	O	lymphoblastic	amod	10	SENT_1061	[p39l1263t2398r1613b2454],
10	leukemia	NN	O	leukemia	prep_in	1	SENT_1061	[p39l1636t2397r1876b2442],
11	.	.	O	.	_	0	SENT_1061	[p39l1636t2397r1876b2442],

1	Leukemia	NN	O	leukemia	_	0	SENT_1062	[p39l1903t2398r2142b2442],
2	2004	CD	DATE	2004	num	1	SENT_1062	[p39l1112t2472r1510b2522],
3	;	:	O	;	_	0	SENT_1062	[p39l1112t2472r1510b2522],
4	18:1153	CD	NUMBER	18:1153	number	5	SENT_1062	[p39l1112t2472r1510b2522],
5	-6	CD	NUMBER	-6	dep	1	SENT_1062	[p39l1112t2472r1510b2522],
6	.	.	O	.	_	0	SENT_1062	[p39l1112t2472r1510b2522],

1	118	CD	NUMBER	118	_	0	SENT_1063	[p39l1114t2544r1206b2584],
2	.	.	O	.	_	0	SENT_1063	[p39l1114t2544r1206b2584],

1	Irish	JJ	O	irish	amod	2	SENT_1064	[p39l1239t2539r1349b2583],
2	JM	NN	O	jm	_	0	SENT_1064	[p39l1359t2543r1440b2593],
3	,	,	O	,	_	0	SENT_1064	[p39l1359t2543r1440b2593],
4	Hovland	NNP	PERSON	Hovland	nn	5	SENT_1064	[p39l1459t2539r1659b2584],
5	R	NNP	PERSON	R	appos	2	SENT_1064	[p39l1674t2543r1722b2593],
6	,	,	O	,	_	0	SENT_1064	[p39l1674t2543r1722b2593],
7	Krutzik	NNP	O	Krutzik	nn	8	SENT_1064	[p39l1740t2539r1919b2585],
8	PO	NNP	O	PO	appos	2	SENT_1064	[p39l1931t2543r2011b2593],
9	,	,	O	,	_	0	SENT_1064	[p39l1931t2543r2011b2593],
10	et	FW	O	et	nn	11	SENT_1064	[p39l2031t2548r2073b2583],
11	al.	FW	O	al.	appos	2	SENT_1064	[p39l2086t2539r2139b2583],
12	.	.	O	.	_	0	SENT_1064	[p39l2086t2539r2139b2583],

1	Single	JJ	O	single	amod	3	SENT_1065	[p39l1113t2611r1256b2667],
2	cell	NN	O	cell	nn	3	SENT_1065	[p39l1270t2611r1348b2655],
3	profiling	NN	O	profiling	_	0	SENT_1065	[p39l1360t2610r1568b2667],
4	of	IN	O	of	_	0	SENT_1065	[p39l1580t2610r1636b2655],
5	potentiated	JJ	O	potentiated	amod	7	SENT_1065	[p39l1638t2610r1903b2667],
6	phosphoprotein	NN	O	phosphoprotein	nn	7	SENT_1065	[p39l1916t2610r2142b2667, p39l1111t2682r1283b2738],
7	networks	NNS	O	network	prep_of	3	SENT_1065	[p39l1300t2682r1517b2726],
8	in	IN	O	in	_	0	SENT_1065	[p39l1535t2682r1580b2725],
9	cancer	NN	O	cancer	nn	10	SENT_1065	[p39l1598t2696r1751b2726],
10	cells	NNS	O	cell	prep_in	3	SENT_1065	[p39l1767t2681r1883b2726],
11	.	.	O	.	_	0	SENT_1065	[p39l1767t2681r1883b2726],

1	Cell	NN	O	cell	_	0	SENT_1066	[p39l1903t2681r1994b2726],
2	2004	CD	DATE	2004	num	1	SENT_1066	[p39l2011t2685r2140b2735],
3	;	:	O	;	_	0	SENT_1066	[p39l2011t2685r2140b2735],
4	118:217	CD	NUMBER	118:217	number	5	SENT_1066	[p39l1114t2756r1395b2797],
5	-28	CD	NUMBER	-28	dep	1	SENT_1066	[p39l1114t2756r1395b2797],
6	.	.	O	.	_	0	SENT_1066	[p39l1114t2756r1395b2797],

1	119	CD	NUMBER	119	_	0	SENT_1067	[p39l1114t2828r1206b2867],
2	.	.	O	.	_	0	SENT_1067	[p39l1114t2828r1206b2867],

1	Bardelli	NNP	PERSON	Bardelli	nn	2	SENT_1068	[p39l1239t2823r1428b2867],
2	A	NNP	O	A	_	0	SENT_1068	[p39l1448t2827r1497b2877],
3	,	,	O	,	_	0	SENT_1068	[p39l1448t2827r1497b2877],
4	Parsons	NNP	PERSON	Parsons	nn	5	SENT_1068	[p39l1521t2827r1713b2868],
5	DW	NNP	O	DW	dep	2	SENT_1068	[p39l1736t2827r1834b2877],
6	,	,	O	,	_	0	SENT_1068	[p39l1736t2827r1834b2877],
7	Silliman	NNP	PERSON	Silliman	nn	8	SENT_1068	[p39l1861t2823r2064b2867],
8	N	NNP	O	N	appos	5	SENT_1068	[p39l2084t2827r2137b2877],
9	,	,	O	,	_	0	SENT_1068	[p39l2084t2827r2137b2877],

1	et	FW	O	et	_	0	SENT_1069	[p39l12t3196r103b3267],
2	al.	FW	O	al.	dep	1	SENT_1069	[p39l148t3176r261b3267],
3	.	.	O	.	_	0	SENT_1069	[p39l148t3176r261b3267],

1	Mutational	JJ	O	mutational	amod	2	SENT_1070	[p39l314t3176r873b3267],
2	analysis	NN	O	analysis	_	0	SENT_1070	[p39l922t3176r1320b3291],
3	of	IN	O	of	_	0	SENT_1070	[p39l1373t3176r1492b3267],
4	the	DT	O	the	det	6	SENT_1070	[p39l1521t3176r1675b3267],
5	tyrosine	NN	O	tyrosine	nn	6	SENT_1070	[p39l1726t3178r2128b3291],
6	kinome	NN	O	kinome	prep_of	2	SENT_1070	[p39l12t3325r381b3418],
7	in	IN	O	in	_	0	SENT_1070	[p39l411t3327r504b3414],
8	colorectal	JJ	O	colorectal	amod	9	SENT_1070	[p39l535t3325r1010b3416],
9	cancers	NNS	O	cancer	prep_in	2	SENT_1070	[p39l1041t3355r1430b3416],
10	.	.	O	.	_	0	SENT_1070	[p39l1041t3355r1430b3416],

1	Science	NNP	O	Science	_	0	SENT_1071	[p39l1469t3327r1829b3416],
2	2003	CD	DATE	2003	num	1	SENT_1071	[p39l1859t3333r2126b3436],
3	;	:	O	;	_	0	SENT_1071	[p39l1859t3333r2126b3436],

1	120	CD	NUMBER	120	_	0	SENT_1072	[p39l16t3632r205b3713],
2	.	.	O	.	_	0	SENT_1072	[p39l16t3632r205b3713],

1	Arteaga	NNP	PERSON	Arteaga	nn	2	SENT_1073	[p39l271t3630r646b3739],
2	CL	NN	O	cl	_	0	SENT_1073	[p39l679t3630r836b3733],
3	,	,	O	,	_	0	SENT_1073	[p39l679t3630r836b3733],
4	Baselga	NNP	PERSON	Baselga	nn	5	SENT_1073	[p39l875t3622r1247b3739],
5	I.	NNP	PERSON	I.	appos	2	SENT_1073	[p39l1268t3630r1335b3727],
6	Tyrosine	NN	PERSON	tyrosine	nn	8	SENT_1073	[p39l1371t3624r1786b3737],
7	kinase	NN	O	kinase	nn	8	SENT_1073	[p39l1819t3622r2130b3713],
8	inhibitors	NNS	O	inhibitor	dep	5	SENT_1073	[p40l10t23r518b114],
9	:	:	O	:	_	0	SENT_1073	[p40l10t23r518b114],
10	Why	WRB	O	why	advmod	11	SENT_1073	[p40l555t25r759b138],
11	does	VBZ	O	do	rcmod	2	SENT_1073	[p40l794t23r1013b114],
12	the	DT	O	the	det	14	SENT_1073	[p40l1055t23r1203b114],
13	current	JJ	DATE	current	amod	14	SENT_1073	[p40l1242t43r1596b115],
14	process	NN	O	process	dobj	11	SENT_1073	[p40l1627t53r1995b140],
15	of	IN	O	of	_	0	SENT_1073	[p40l2037t23r2153b114],
16	clinical	JJ	O	clinical	amod	17	SENT_1073	[p40l12t174r350b263],
17	development	NN	O	development	prep_of	11	SENT_1073	[p40l377t172r994b289],
18	not	RB	O	not	neg	19	SENT_1073	[p40l1014t192r1176b263],
19	apply	VB	O	apply	dep	11	SENT_1073	[p40l1197t174r1454b289],
20	to	TO	O	to	_	0	SENT_1073	[p40l1476t192r1566b263],
21	them	PRP	O	they	prep_to	19	SENT_1073	[p40l1594t170r1881b263],
22	?	.	O	?	_	0	SENT_1073	[p40l1594t170r1881b263],

1	Cancer	NN	O	cancer	nn	2	SENT_1074	[p40l1908t180r2131b263, p40l12t352r154b412],
2	Cell	NN	O	cell	_	0	SENT_1074	[p40l176t321r362b412],
3	2004	CD	DATE	2004	dep	2	SENT_1074	[p40l389t329r1126b432],
4	;	:	O	;	_	0	SENT_1074	[p40l389t329r1126b432],
5	5:525	CD	NUMBER	5:525	num	6	SENT_1074	[p40l389t329r1126b432],
6	-31	CD	NUMBER	-31	dep	2	SENT_1074	[p40l389t329r1126b432],
7	.	.	O	.	_	0	SENT_1074	[p40l389t329r1126b432],

1	121	CD	NUMBER	121	_	0	SENT_1075	[p40l16t482r205b561],
2	.	.	O	.	_	0	SENT_1075	[p40l16t482r205b561],

1	Rothenberg	NNP	ORGANIZATION	Rothenberg	nn	2	SENT_1076	[p40l273t470r854b587],
2	ML	NNP	ORGANIZATION	ML	_	0	SENT_1076	[p40l877t478r1061b581],
3	,	,	O	,	_	0	SENT_1076	[p40l877t478r1061b581],
4	Carbone	NNP	PERSON	Carbone	nn	5	SENT_1076	[p40l1098t470r1507b561],
5	DP	NN	O	dp	appos	2	SENT_1076	[p40l1537t478r1691b581],
6	,	,	O	,	_	0	SENT_1076	[p40l1537t478r1691b581],
7	Johnson	NNP	PERSON	Johnson	nn	8	SENT_1076	[p40l1716t470r2130b575],
8	DH	NNP	O	DH	appos	5	SENT_1076	[p40l10t627r206b710],
9	.	.	O	.	_	0	SENT_1076	[p40l10t627r206b710],

1	Improving	NN	O	improving	_	0	SENT_1077	[p40l235t621r753b736],
2	the	DT	O	the	det	3	SENT_1077	[p40l776t621r925b710],
3	evaluation	NN	O	evaluation	dep	1	SENT_1077	[p40l952t619r1448b711],
4	of	IN	O	of	_	0	SENT_1077	[p40l1473t619r1590b710],
5	new	JJ	O	new	amod	7	SENT_1077	[p40l1594t649r1796b711],
6	cancer	NN	O	cancer	nn	7	SENT_1077	[p40l1819t649r2135b710],
7	treatments	NNS	O	treatment	prep_of	3	SENT_1077	[p40l12t788r561b859],
8	:	:	O	:	_	0	SENT_1077	[p40l12t788r561b859],
9	challenges	NNS	O	challenge	dep	1	SENT_1077	[p40l628t770r1138b885],
10	and	CC	O	and	_	0	SENT_1077	[p40l1201t768r1379b859],
11	opportunities	NNS	O	opportunity	conj_and	9	SENT_1077	[p40l1440t770r2125b885],
12	.	.	O	.	_	0	SENT_1077	[p40l1440t770r2125b885],

1	Nat	NNP	O	Nat	nn	3	SENT_1078	[p40l10t927r190b1008],
2	Rev	NN	O	rev	nn	3	SENT_1078	[p40l211t925r389b1014],
3	Cancer	NN	O	cancer	_	0	SENT_1078	[p40l413t925r753b1008],
4	2003	CD	DATE	2003	dep	3	SENT_1078	[p40l778t925r1454b1028],
5	;	:	O	;	_	0	SENT_1078	[p40l778t925r1454b1028],
6	3:303	CD	NUMBER	3:303	number	7	SENT_1078	[p40l778t925r1454b1028],
7	—	CD	NUMBER	—	dep	3	SENT_1078	[p40l778t925r1454b1028],
8	9	CD	NUMBER	9	dep	7	SENT_1078	[p40l778t925r1454b1028],
9	.	.	O	.	_	0	SENT_1078	[p40l778t925r1454b1028],

1	122	CD	NUMBER	122	_	0	SENT_1079	[p40l16t1077r205b1156],
2	.	.	O	.	_	0	SENT_1079	[p40l16t1077r205b1156],

1	FDA	NNP	ORGANIZATION	FDA	nn	2	SENT_1080	[p40l273t1073r490b1154],
2	statment	NN	O	statment	_	0	SENT_1080	[p40l549t1085r990b1156],
3	on	IN	O	on	_	0	SENT_1080	[p40l1049t1095r1173b1156],
4	Iressa	NNP	O	Iressa	prep_on	2	SENT_1080	[p40l1236t1073r1555b1156],
5	.	.	O	.	_	0	SENT_1080	[p40l1236t1073r1555b1156],

1	December	NNP	DATE	December	_	0	SENT_1081	[p40l1625t1065r2133b1156],

1	17	CD	NUMBER	17	_	0	SENT_1082	[p40l16t1222r154b1325],
2	,	,	O	,	_	0	SENT_1082	[p40l16t1222r154b1325],
3	2004	CD	DATE	2004	appos	1	SENT_1082	[p40l190t1222r455b1305],
4	.	.	O	.	_	0	SENT_1082	[p40l190t1222r455b1305],

1	(	NN	O	(	nsubj	2	SENT_1083	[p40l496t1216r970b1319],
2	Accessed	VBD	O	access	_	0	SENT_1083	[p40l496t1216r970b1319],
3	June	NNP	DATE	June	tmod	2	SENT_1083	[p40l988t1224r1211b1319],
4	17	CD	DATE	17	num	3	SENT_1083	[p40l1244t1222r1383b1325],
5	,	,	DATE	,	_	0	SENT_1083	[p40l1244t1222r1383b1325],
6	2005	CD	DATE	2005	num	3	SENT_1083	[p40l1418t1222r1683b1325],
7	,	,	O	,	_	0	SENT_1083	[p40l1418t1222r1683b1325],
8	at	IN	O	at	_	0	SENT_1083	[p40l1718t1234r1809b1305],
9	httpzl	NN	O	httpzl	prep_at	2	SENT_1083	[p40l1833t1216r2094b1331],
10	I	PRP	O	I	nsubj	11	SENT_1083	[p40l2103t1222r2129b1317],
11	WWw	VBP	O	www	rcmod	9	SENT_1083	[p40l6t1363r492b1456],
12	.	.	O	.	_	0	SENT_1083	[p40l6t1363r492b1456],

1	fda	NN	O	fda	_	0	SENT_1084	[p40l6t1363r492b1456],
2	.	.	O	.	_	0	SENT_1084	[p40l6t1363r492b1456],

1	gov	NN	O	gov	nsubj	5	SENT_1085	[p40l507t1371r717b1480],
2	]	CD	NUMBER	]	num	4	SENT_1085	[p40l507t1371r717b1480],
3	bbsl	NN	O	bbsl	nn	4	SENT_1085	[p40l731t1365r944b1466],
4	topics/news	NNS	O	topics/news	dep	1	SENT_1085	[p40l958t1365r1608b1480],
5	]	VBP	O	]	_	0	SENT_1085	[p40l958t1365r1608b1480],
6	2004	CD	DATE	2004	dobj	5	SENT_1085	[p40l1620t1371r1904b1466],
7	/	:	O	/	punct	8	SENT_1085	[p40l1620t1371r1904b1466],
8	new	JJ	O	new	dep	6	SENT_1085	[p40l1916t1393r2125b1456],
9	01145	CD	DATE	01145	dep	8	SENT_1085	[p40l12t1520r344b1603],
10	.	.	O	.	_	0	SENT_1085	[p40l12t1520r344b1603],

1	html	NN	O	html	_	0	SENT_1086	[p40l381t1514r683b1617],
2	.	.	O	.	_	0	SENT_1086	[p40l381t1514r683b1617],
3	)	SYM	O	)	dep	1	SENT_1086	[p40l381t1514r683b1617],

1	Copyright	NN	O	copyright	_	0	SENT_1087	[p40l14t1647r381b1746],
2	©	CD	NUMBER	©	num	6	SENT_1087	[p40l413t1655r496b1736],
3	2005	CD	DATE	2005	num	6	SENT_1087	[p40l531t1653r725b1722],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_1087	[p40l755t1647r1310b1722],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_1087	[p40l1341t1647r1645b1722],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_1087	[p40l1671t1651r1952b1744],
7	.	.	O	.	_	0	SENT_1087	[p40l1671t1651r1952b1744],

1	GLJ	NN	O	glj	nn	2	SENT_1088	[p40l591t1822r640b1844],
2	MED	NN	O	med	_	0	SENT_1088	[p40l655t1823r707b1838],
3	353	CD	NUMBER	353	dep	2	SENT_1088	[p40l720t1822r784b1844],
4	;	:	O	;	_	0	SENT_1088	[p40l720t1822r784b1844],
5	2	CD	NUMBER	2	dep	2	SENT_1088	[p40l720t1822r784b1844],
6	WWW	NNP	O	WWW	dep	5	SENT_1088	[p40l818t1823r973b1844],
7	.	.	O	.	_	0	SENT_1088	[p40l818t1823r973b1844],

1	NEJM	NNP	O	NEJM	_	0	SENT_1089	[p40l818t1823r973b1844],
2	.	.	O	.	_	0	SENT_1089	[p40l818t1823r973b1844],

1	R	NN	O	r	nn	2	SENT_1090	[p40l1000t1823r1011b1838],
2	JULY	NN	DATE	july	_	0	SENT_1090	[p40l1063t1823r1123b1844],
3	14	CD	DATE	14	dep	2	SENT_1090	[p40l1136t1822r1170b1844],
4	,	,	DATE	,	_	0	SENT_1090	[p40l1136t1822r1170b1844],
5	2005	CD	DATE	2005	appos	3	SENT_1090	[p40l1183t1822r1246b1844],
6	The	DT	O	the	det	9	SENT_1090	[p40l702t1855r753b1879],
7	New	NNP	O	New	nn	9	SENT_1090	[p40l762t1856r824b1879],
8	England	NNP	O	England	nn	9	SENT_1090	[p40l833t1855r944b1886],
9	Journal	NNP	O	Journal	dep	5	SENT_1090	[p40l953t1855r1050b1879],
10	of	IN	O	of	_	0	SENT_1090	[p40l1060t1855r1089b1879],
11	Medicine	NNP	O	Medicine	prep_of	9	SENT_1090	[p40l1095t1855r1220b1879],

1	Downloaded	VBN	O	download	_	0	SENT_1091	[p40l144t1896r314b1919],
2	from	IN	O	from	_	0	SENT_1091	[p40l323t1896r387b1919],
3	nejmorg	NN	O	nejmorg	prep_from	1	SENT_1091	[p40l396t1896r514b1926],
4	at	IN	O	at	_	0	SENT_1091	[p40l524t1900r548b1919],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_1091	[p40l556t1896r739b1919],
6	on	IN	O	on	_	0	SENT_1091	[p40l748t1903r780b1919],
7	J	NN	O	j	nn	8	SENT_1091	[p40l789t1896r801b1919],
8	anuar	NN	O	anuar	prep_on	1	SENT_1091	[p40l803t1903r876b1919],
9	,	,	O	,	_	0	SENT_1091	[p40l919t1915r924b1924],
10	2014	CD	DATE	2014	appos	8	SENT_1091	[p40l935t1896r1007b1919],
11	.	.	O	.	_	0	SENT_1091	[p40l935t1896r1007b1919],

1	For	IN	O	for	_	0	SENT_1092	[p40l1018t1896r1064b1919],
2	personal	JJ	O	personal	amod	3	SENT_1092	[p40l1072t1896r1185b1926],
3	use	NN	O	use	pobj	1	SENT_1092	[p40l1194t1903r1237b1919],
4	only	RB	O	only	advmod	3	SENT_1092	[p40l1247t1896r1312b1926],
5	.	.	O	.	_	0	SENT_1092	[p40l1247t1896r1312b1926],

1	No	DT	O	no	det	3	SENT_1093	[p40l1322t1896r1362b1919],
2	other	JJ	O	other	amod	3	SENT_1093	[p40l1372t1896r1440b1919],
3	uses	NNS	O	use	_	0	SENT_1093	[p40l1449t1903r1504b1919],
4	without	IN	O	without	_	0	SENT_1093	[p40l1515t1896r1616b1919],
5	permission	NN	O	permission	prep_without	3	SENT_1093	[p40l1624t1896r1777b1926],
6	.	.	O	.	_	0	SENT_1093	[p40l1624t1896r1777b1926],

1	Copyright	NN	O	copyright	nn	5	SENT_1094	[p40l494t1937r629b1968],
2	©	CD	NUMBER	©	num	5	SENT_1094	[p40l638t1937r661b1961],
3	2005	CD	DATE	2005	num	5	SENT_1094	[p40l672t1937r736b1961],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_1094	[p40l746t1938r845b1961],
5	usetts	NNP	O	usetts	_	0	SENT_1094	[p40l863t1941r937b1961],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_1094	[p40l947t1937r1055b1961],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_1094	[p40l1065t1937r1170b1968],
8	.	.	O	.	_	0	SENT_1094	[p40l1065t1937r1170b1968],

1	All	DT	O	all	det	2	SENT_1095	[p40l1181t1937r1223b1961],
2	rights	NNS	O	rights	nsubj	3	SENT_1095	[p40l1232t1937r1307b1968],
3	reserved	VBN	O	reserve	_	0	SENT_1095	[p40l1316t1937r1435b1961],
4	.	.	O	.	_	0	SENT_1095	[p40l1316t1937r1435b1961],

